<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE book PUBLIC "-//RIS Dev//DTD DocBook V4.3 -Based Variant V1.1//EN" "http://localhost/dtd/v1.1/RittDocBook.dtd" [<!ENTITY sect1.9781683674832.pt0001s0001 SYSTEM "sect1.9781683674832.pt0001s0001.xml">
<!ENTITY sect1.9781683674832.pt0002s0001 SYSTEM "sect1.9781683674832.pt0002s0001.xml">
<!ENTITY sect1.9781683674832.pt0003s0001 SYSTEM "sect1.9781683674832.pt0003s0001.xml">
<!ENTITY sect1.9781683674832.pt0004s0001 SYSTEM "sect1.9781683674832.pt0004s0001.xml">
<!ENTITY sect1.9781683674832.pt0005s0001 SYSTEM "sect1.9781683674832.pt0005s0001.xml">
<!ENTITY sect1.9781683674832.pt0006s0001 SYSTEM "sect1.9781683674832.pt0006s0001.xml">
<!ENTITY sect1.9781683674832.pt0007s0001 SYSTEM "sect1.9781683674832.pt0007s0001.xml">
<!ENTITY sect1.9781683674832.pt0008s0001 SYSTEM "sect1.9781683674832.pt0008s0001.xml">
<!ENTITY sect1.9781683674832.pt0009s0001 SYSTEM "sect1.9781683674832.pt0009s0001.xml">
<!ENTITY sect1.9781683674832.pt0010s0001 SYSTEM "sect1.9781683674832.pt0010s0001.xml">
<!ENTITY sect1.9781683674832.pt0011s0001 SYSTEM "sect1.9781683674832.pt0011s0001.xml">
<!ENTITY sect1.9781683674832.pt0012s0001 SYSTEM "sect1.9781683674832.pt0012s0001.xml">
<!ENTITY sect1.9781683674832.pt0013s0001 SYSTEM "sect1.9781683674832.pt0013s0001.xml">
<!ENTITY sect1.9781683674832.pt0014s0001 SYSTEM "sect1.9781683674832.pt0014s0001.xml">
<!ENTITY sect1.9781683674832.pt0015s0001 SYSTEM "sect1.9781683674832.pt0015s0001.xml">
<!ENTITY sect1.9781683674832.pt0016s0001 SYSTEM "sect1.9781683674832.pt0016s0001.xml">
<!ENTITY sect1.9781683674832.pt0017s0001 SYSTEM "sect1.9781683674832.pt0017s0001.xml">
<!ENTITY sect1.9781683674832.pt0018s0001 SYSTEM "sect1.9781683674832.pt0018s0001.xml"><!ENTITY sect1.9781683674832.ch0001s0001 SYSTEM "sect1.9781683674832.ch0001s0001.xml"><!ENTITY sect1.9781683674832.ch0002s0002 SYSTEM "sect1.9781683674832.ch0002s0002.xml"><!ENTITY sect1.9781683674832.ch0002s0001 SYSTEM "sect1.9781683674832.ch0002s0001.xml"><!ENTITY sect1.9781683674832.ch0003s0001 SYSTEM "sect1.9781683674832.ch0003s0001.xml"><!ENTITY sect1.9781683674832.ch0004s0001 SYSTEM "sect1.9781683674832.ch0004s0001.xml"><!ENTITY sect1.9781683674832.ch0005s0001 SYSTEM "sect1.9781683674832.ch0005s0001.xml"><!ENTITY sect1.9781683674832.ch0005s0002 SYSTEM "sect1.9781683674832.ch0005s0002.xml"><!ENTITY sect1.9781683674832.ch0005s0003 SYSTEM "sect1.9781683674832.ch0005s0003.xml"><!ENTITY sect1.9781683674832.ch0005s0004 SYSTEM "sect1.9781683674832.ch0005s0004.xml"><!ENTITY sect1.9781683674832.ch0006s0002 SYSTEM "sect1.9781683674832.ch0006s0002.xml"><!ENTITY sect1.9781683674832.ch0006s0001 SYSTEM "sect1.9781683674832.ch0006s0001.xml"><!ENTITY sect1.9781683674832.ch0007s0001 SYSTEM "sect1.9781683674832.ch0007s0001.xml"><!ENTITY sect1.9781683674832.ch0007s0002 SYSTEM "sect1.9781683674832.ch0007s0002.xml"><!ENTITY sect1.9781683674832.ch0007s0003 SYSTEM "sect1.9781683674832.ch0007s0003.xml"><!ENTITY sect1.9781683674832.ch0007s0004 SYSTEM "sect1.9781683674832.ch0007s0004.xml"><!ENTITY sect1.9781683674832.ch0007s0005 SYSTEM "sect1.9781683674832.ch0007s0005.xml"><!ENTITY sect1.9781683674832.ch0007s0007 SYSTEM "sect1.9781683674832.ch0007s0007.xml"><!ENTITY sect1.9781683674832.ch0007s0008 SYSTEM "sect1.9781683674832.ch0007s0008.xml"><!ENTITY sect1.9781683674832.ch0008s0001 SYSTEM "sect1.9781683674832.ch0008s0001.xml"><!ENTITY sect1.9781683674832.ch0008s0002 SYSTEM "sect1.9781683674832.ch0008s0002.xml"><!ENTITY sect1.9781683674832.ch0008s0003 SYSTEM "sect1.9781683674832.ch0008s0003.xml"><!ENTITY sect1.9781683674832.ch0009s0001 SYSTEM "sect1.9781683674832.ch0009s0001.xml"><!ENTITY sect1.9781683674832.ch0009s0002 SYSTEM "sect1.9781683674832.ch0009s0002.xml"><!ENTITY sect1.9781683674832.ch0009s0003 SYSTEM "sect1.9781683674832.ch0009s0003.xml"><!ENTITY sect1.9781683674832.ch0010s0001 SYSTEM "sect1.9781683674832.ch0010s0001.xml"><!ENTITY sect1.9781683674832.ch0010s0002 SYSTEM "sect1.9781683674832.ch0010s0002.xml"><!ENTITY sect1.9781683674832.ch0010s0003 SYSTEM "sect1.9781683674832.ch0010s0003.xml"><!ENTITY sect1.9781683674832.ch0011s0001 SYSTEM "sect1.9781683674832.ch0011s0001.xml"><!ENTITY sect1.9781683674832.ch0011s0002 SYSTEM "sect1.9781683674832.ch0011s0002.xml"><!ENTITY sect1.9781683674832.ch0011s0003 SYSTEM "sect1.9781683674832.ch0011s0003.xml"><!ENTITY sect1.9781683674832.ch0011s0004 SYSTEM "sect1.9781683674832.ch0011s0004.xml"><!ENTITY sect1.9781683674832.ch0011s0005 SYSTEM "sect1.9781683674832.ch0011s0005.xml"><!ENTITY sect1.9781683674832.ch0011s0006 SYSTEM "sect1.9781683674832.ch0011s0006.xml"><!ENTITY sect1.9781683674832.ch0011s0007 SYSTEM "sect1.9781683674832.ch0011s0007.xml"><!ENTITY sect1.9781683674832.ch0011s0008 SYSTEM "sect1.9781683674832.ch0011s0008.xml"><!ENTITY sect1.9781683674832.ch0011s0009 SYSTEM "sect1.9781683674832.ch0011s0009.xml"><!ENTITY sect1.9781683674832.ch0011s0010 SYSTEM "sect1.9781683674832.ch0011s0010.xml"><!ENTITY sect1.9781683674832.ch0011s0011 SYSTEM "sect1.9781683674832.ch0011s0011.xml"><!ENTITY sect1.9781683674832.ch0012s0005 SYSTEM "sect1.9781683674832.ch0012s0005.xml"><!ENTITY sect1.9781683674832.ch0012s0001 SYSTEM "sect1.9781683674832.ch0012s0001.xml"><!ENTITY sect1.9781683674832.ch0012s0002 SYSTEM "sect1.9781683674832.ch0012s0002.xml"><!ENTITY sect1.9781683674832.ch0012s0003 SYSTEM "sect1.9781683674832.ch0012s0003.xml"><!ENTITY sect1.9781683674832.ch0012s0004 SYSTEM "sect1.9781683674832.ch0012s0004.xml"><!ENTITY sect1.9781683674832.ch0013s0001 SYSTEM "sect1.9781683674832.ch0013s0001.xml"><!ENTITY sect1.9781683674832.ch0014s0001 SYSTEM "sect1.9781683674832.ch0014s0001.xml"><!ENTITY sect1.9781683674832.ch0014s0002 SYSTEM "sect1.9781683674832.ch0014s0002.xml"><!ENTITY sect1.9781683674832.ch0014s0003 SYSTEM "sect1.9781683674832.ch0014s0003.xml"><!ENTITY sect1.9781683674832.ch0014s0004 SYSTEM "sect1.9781683674832.ch0014s0004.xml"><!ENTITY sect1.9781683674832.ch0014s0005 SYSTEM "sect1.9781683674832.ch0014s0005.xml"><!ENTITY sect1.9781683674832.ch0014s0006 SYSTEM "sect1.9781683674832.ch0014s0006.xml"><!ENTITY sect1.9781683674832.ch0015s0001 SYSTEM "sect1.9781683674832.ch0015s0001.xml"><!ENTITY sect1.9781683674832.ch0015s0002 SYSTEM "sect1.9781683674832.ch0015s0002.xml"><!ENTITY sect1.9781683674832.ch0015s0003 SYSTEM "sect1.9781683674832.ch0015s0003.xml"><!ENTITY sect1.9781683674832.ch0015s0004 SYSTEM "sect1.9781683674832.ch0015s0004.xml"><!ENTITY sect1.9781683674832.ch0015s0005 SYSTEM "sect1.9781683674832.ch0015s0005.xml"><!ENTITY sect1.9781683674832.ch0015s0006 SYSTEM "sect1.9781683674832.ch0015s0006.xml"><!ENTITY sect1.9781683674832.ch0015s0007 SYSTEM "sect1.9781683674832.ch0015s0007.xml"><!ENTITY sect1.9781683674832.ch0016s0001 SYSTEM "sect1.9781683674832.ch0016s0001.xml"><!ENTITY sect1.9781683674832.ch0016s0002 SYSTEM "sect1.9781683674832.ch0016s0002.xml"><!ENTITY sect1.9781683674832.ch0016s0003 SYSTEM "sect1.9781683674832.ch0016s0003.xml"><!ENTITY sect1.9781683674832.ch0017s0001 SYSTEM "sect1.9781683674832.ch0017s0001.xml"><!ENTITY sect1.9781683674832.ch0017s0002 SYSTEM "sect1.9781683674832.ch0017s0002.xml"><!ENTITY sect1.9781683674832.ch0017s0003 SYSTEM "sect1.9781683674832.ch0017s0003.xml"><!ENTITY sect1.9781683674832.ch0017s0004 SYSTEM "sect1.9781683674832.ch0017s0004.xml"><!ENTITY sect1.9781683674832.ch0018s0001 SYSTEM "sect1.9781683674832.ch0018s0001.xml"><!ENTITY sect1.9781683674832.ch0018s0002 SYSTEM "sect1.9781683674832.ch0018s0002.xml"><!ENTITY sect1.9781683674832.ch0018s0003 SYSTEM "sect1.9781683674832.ch0018s0003.xml"><!ENTITY sect1.9781683674832.ch0019s0001 SYSTEM "sect1.9781683674832.ch0019s0001.xml"><!ENTITY sect1.9781683674832.ch0019s0002 SYSTEM "sect1.9781683674832.ch0019s0002.xml"><!ENTITY sect1.9781683674832.ch0019s0003 SYSTEM "sect1.9781683674832.ch0019s0003.xml"><!ENTITY sect1.9781683674832.ch0020s0001 SYSTEM "sect1.9781683674832.ch0020s0001.xml"><!ENTITY sect1.9781683674832.ch0020s0002 SYSTEM "sect1.9781683674832.ch0020s0002.xml"><!ENTITY sect1.9781683674832.ch0020s0003 SYSTEM "sect1.9781683674832.ch0020s0003.xml"><!ENTITY sect1.9781683674832.ch0021s0001 SYSTEM "sect1.9781683674832.ch0021s0001.xml"><!ENTITY sect1.9781683674832.ch0021s0002 SYSTEM "sect1.9781683674832.ch0021s0002.xml"><!ENTITY sect1.9781683674832.ch0021s0003 SYSTEM "sect1.9781683674832.ch0021s0003.xml"><!ENTITY sect1.9781683674832.ch0022s0001 SYSTEM "sect1.9781683674832.ch0022s0001.xml"><!ENTITY sect1.9781683674832.ch0022s0002 SYSTEM "sect1.9781683674832.ch0022s0002.xml"><!ENTITY sect1.9781683674832.ch0022s0003 SYSTEM "sect1.9781683674832.ch0022s0003.xml"><!ENTITY sect1.9781683674832.ch0023s0001 SYSTEM "sect1.9781683674832.ch0023s0001.xml"><!ENTITY sect1.9781683674832.ch0023s0002 SYSTEM "sect1.9781683674832.ch0023s0002.xml"><!ENTITY sect1.9781683674832.ch0023s0003 SYSTEM "sect1.9781683674832.ch0023s0003.xml"><!ENTITY sect1.9781683674832.ch0024s0001 SYSTEM "sect1.9781683674832.ch0024s0001.xml"><!ENTITY sect1.9781683674832.ch0024s0002 SYSTEM "sect1.9781683674832.ch0024s0002.xml"><!ENTITY sect1.9781683674832.ch0024s0003 SYSTEM "sect1.9781683674832.ch0024s0003.xml"><!ENTITY sect1.9781683674832.ch0024s0004 SYSTEM "sect1.9781683674832.ch0024s0004.xml"><!ENTITY sect1.9781683674832.ch0024s0005 SYSTEM "sect1.9781683674832.ch0024s0005.xml"><!ENTITY sect1.9781683674832.ch0024s0006 SYSTEM "sect1.9781683674832.ch0024s0006.xml"><!ENTITY sect1.9781683674832.ch0024s0007 SYSTEM "sect1.9781683674832.ch0024s0007.xml"><!ENTITY sect1.9781683674832.ch0025s0001 SYSTEM "sect1.9781683674832.ch0025s0001.xml"><!ENTITY sect1.9781683674832.ch0025s0002 SYSTEM "sect1.9781683674832.ch0025s0002.xml"><!ENTITY sect1.9781683674832.ch0025s0003 SYSTEM "sect1.9781683674832.ch0025s0003.xml"><!ENTITY sect1.9781683674832.ch0025s0004 SYSTEM "sect1.9781683674832.ch0025s0004.xml"><!ENTITY sect1.9781683674832.ch0026s0001 SYSTEM "sect1.9781683674832.ch0026s0001.xml"><!ENTITY sect1.9781683674832.ch0026s0002 SYSTEM "sect1.9781683674832.ch0026s0002.xml"><!ENTITY sect1.9781683674832.ch0026s0003 SYSTEM "sect1.9781683674832.ch0026s0003.xml"><!ENTITY sect1.9781683674832.ch0026s0004 SYSTEM "sect1.9781683674832.ch0026s0004.xml"><!ENTITY sect1.9781683674832.ch0027s0001 SYSTEM "sect1.9781683674832.ch0027s0001.xml"><!ENTITY sect1.9781683674832.ch0027s0002 SYSTEM "sect1.9781683674832.ch0027s0002.xml"><!ENTITY sect1.9781683674832.ch0027s0003 SYSTEM "sect1.9781683674832.ch0027s0003.xml"><!ENTITY sect1.9781683674832.ch0028s0001 SYSTEM "sect1.9781683674832.ch0028s0001.xml"><!ENTITY sect1.9781683674832.ch0028s0002 SYSTEM "sect1.9781683674832.ch0028s0002.xml"><!ENTITY sect1.9781683674832.ch0028s0003 SYSTEM "sect1.9781683674832.ch0028s0003.xml"><!ENTITY sect1.9781683674832.ch0029s0001 SYSTEM "sect1.9781683674832.ch0029s0001.xml"><!ENTITY sect1.9781683674832.ch0029s0002 SYSTEM "sect1.9781683674832.ch0029s0002.xml"><!ENTITY sect1.9781683674832.ch0029s0003 SYSTEM "sect1.9781683674832.ch0029s0003.xml"><!ENTITY sect1.9781683674832.ch0029s0004 SYSTEM "sect1.9781683674832.ch0029s0004.xml"><!ENTITY sect1.9781683674832.ch0029s0005 SYSTEM "sect1.9781683674832.ch0029s0005.xml"><!ENTITY sect1.9781683674832.ch0030s0001 SYSTEM "sect1.9781683674832.ch0030s0001.xml"><!ENTITY sect1.9781683674832.ch0030s0002 SYSTEM "sect1.9781683674832.ch0030s0002.xml"><!ENTITY sect1.9781683674832.ch0030s0003 SYSTEM "sect1.9781683674832.ch0030s0003.xml"><!ENTITY sect1.9781683674832.ch0031s0001 SYSTEM "sect1.9781683674832.ch0031s0001.xml"><!ENTITY sect1.9781683674832.ch0031s0002 SYSTEM "sect1.9781683674832.ch0031s0002.xml"><!ENTITY sect1.9781683674832.ch0031s0003 SYSTEM "sect1.9781683674832.ch0031s0003.xml"><!ENTITY sect1.9781683674832.ch0032s0001 SYSTEM "sect1.9781683674832.ch0032s0001.xml"><!ENTITY sect1.9781683674832.ch0032s0002 SYSTEM "sect1.9781683674832.ch0032s0002.xml"><!ENTITY sect1.9781683674832.ch0032s0003 SYSTEM "sect1.9781683674832.ch0032s0003.xml"><!ENTITY sect1.9781683674832.ch0033s0001 SYSTEM "sect1.9781683674832.ch0033s0001.xml"><!ENTITY sect1.9781683674832.ch0034s0001 SYSTEM "sect1.9781683674832.ch0034s0001.xml"><!ENTITY sect1.9781683674832.ch0034s0002 SYSTEM "sect1.9781683674832.ch0034s0002.xml"><!ENTITY sect1.9781683674832.ch0034s0003 SYSTEM "sect1.9781683674832.ch0034s0003.xml"><!ENTITY sect1.9781683674832.ch0034s0004 SYSTEM "sect1.9781683674832.ch0034s0004.xml"><!ENTITY sect1.9781683674832.ch0034s0005 SYSTEM "sect1.9781683674832.ch0034s0005.xml"><!ENTITY sect1.9781683674832.ch0034s0006 SYSTEM "sect1.9781683674832.ch0034s0006.xml"><!ENTITY sect1.9781683674832.ch0034s0007 SYSTEM "sect1.9781683674832.ch0034s0007.xml"><!ENTITY sect1.9781683674832.ch0035s0001 SYSTEM "sect1.9781683674832.ch0035s0001.xml"><!ENTITY sect1.9781683674832.ch0035s0002 SYSTEM "sect1.9781683674832.ch0035s0002.xml"><!ENTITY sect1.9781683674832.ch0035s0003 SYSTEM "sect1.9781683674832.ch0035s0003.xml"><!ENTITY sect1.9781683674832.ch0036s0001 SYSTEM "sect1.9781683674832.ch0036s0001.xml"><!ENTITY sect1.9781683674832.ch0036s0002 SYSTEM "sect1.9781683674832.ch0036s0002.xml"><!ENTITY sect1.9781683674832.ch0036s0003 SYSTEM "sect1.9781683674832.ch0036s0003.xml"><!ENTITY sect1.9781683674832.ch0036s0004 SYSTEM "sect1.9781683674832.ch0036s0004.xml"><!ENTITY sect1.9781683674832.ch0036s0005 SYSTEM "sect1.9781683674832.ch0036s0005.xml"><!ENTITY sect1.9781683674832.ch0036s0006 SYSTEM "sect1.9781683674832.ch0036s0006.xml"><!ENTITY sect1.9781683674832.ch0036s0007 SYSTEM "sect1.9781683674832.ch0036s0007.xml"><!ENTITY sect1.9781683674832.ch0037s0001 SYSTEM "sect1.9781683674832.ch0037s0001.xml"><!ENTITY sect1.9781683674832.ch0037s0002 SYSTEM "sect1.9781683674832.ch0037s0002.xml"><!ENTITY sect1.9781683674832.ch0037s0003 SYSTEM "sect1.9781683674832.ch0037s0003.xml"><!ENTITY sect1.9781683674832.ch0038s0001 SYSTEM "sect1.9781683674832.ch0038s0001.xml"><!ENTITY sect1.9781683674832.ch0038s0002 SYSTEM "sect1.9781683674832.ch0038s0002.xml"><!ENTITY sect1.9781683674832.ch0038s0003 SYSTEM "sect1.9781683674832.ch0038s0003.xml"><!ENTITY sect1.9781683674832.ch0038s0004 SYSTEM "sect1.9781683674832.ch0038s0004.xml"><!ENTITY sect1.9781683674832.ch0039s0001 SYSTEM "sect1.9781683674832.ch0039s0001.xml"><!ENTITY sect1.9781683674832.ch0039s0002 SYSTEM "sect1.9781683674832.ch0039s0002.xml"><!ENTITY sect1.9781683674832.ch0039s0003 SYSTEM "sect1.9781683674832.ch0039s0003.xml"><!ENTITY sect1.9781683674832.ch0040s0001 SYSTEM "sect1.9781683674832.ch0040s0001.xml"><!ENTITY sect1.9781683674832.ch0040s0002 SYSTEM "sect1.9781683674832.ch0040s0002.xml"><!ENTITY sect1.9781683674832.ch0040s0003 SYSTEM "sect1.9781683674832.ch0040s0003.xml"><!ENTITY sect1.9781683674832.ch0040s0004 SYSTEM "sect1.9781683674832.ch0040s0004.xml"><!ENTITY sect1.9781683674832.ch0041s0001 SYSTEM "sect1.9781683674832.ch0041s0001.xml"><!ENTITY sect1.9781683674832.ch0041s0002 SYSTEM "sect1.9781683674832.ch0041s0002.xml"><!ENTITY sect1.9781683674832.ch0041s0003 SYSTEM "sect1.9781683674832.ch0041s0003.xml"><!ENTITY sect1.9781683674832.ch0042s0001 SYSTEM "sect1.9781683674832.ch0042s0001.xml"><!ENTITY sect1.9781683674832.ch0042s0002 SYSTEM "sect1.9781683674832.ch0042s0002.xml"><!ENTITY sect1.9781683674832.ch0042s0003 SYSTEM "sect1.9781683674832.ch0042s0003.xml"><!ENTITY sect1.9781683674832.ch0042s0004 SYSTEM "sect1.9781683674832.ch0042s0004.xml"><!ENTITY sect1.9781683674832.ch0043s0001 SYSTEM "sect1.9781683674832.ch0043s0001.xml"><!ENTITY sect1.9781683674832.ch0043s0002 SYSTEM "sect1.9781683674832.ch0043s0002.xml"><!ENTITY sect1.9781683674832.ch0043s0003 SYSTEM "sect1.9781683674832.ch0043s0003.xml"><!ENTITY sect1.9781683674832.ch0044s0001 SYSTEM "sect1.9781683674832.ch0044s0001.xml"><!ENTITY sect1.9781683674832.ch0044s0002 SYSTEM "sect1.9781683674832.ch0044s0002.xml"><!ENTITY sect1.9781683674832.ch0044s0003 SYSTEM "sect1.9781683674832.ch0044s0003.xml"><!ENTITY sect1.9781683674832.ch0045s0001 SYSTEM "sect1.9781683674832.ch0045s0001.xml"><!ENTITY sect1.9781683674832.ch0045s0002 SYSTEM "sect1.9781683674832.ch0045s0002.xml"><!ENTITY sect1.9781683674832.ch0045s0003 SYSTEM "sect1.9781683674832.ch0045s0003.xml"><!ENTITY sect1.9781683674832.ch0046s0001 SYSTEM "sect1.9781683674832.ch0046s0001.xml"><!ENTITY sect1.9781683674832.ch0046s0002 SYSTEM "sect1.9781683674832.ch0046s0002.xml"><!ENTITY sect1.9781683674832.ch0046s0003 SYSTEM "sect1.9781683674832.ch0046s0003.xml"><!ENTITY sect1.9781683674832.ch0047s0001 SYSTEM "sect1.9781683674832.ch0047s0001.xml"><!ENTITY sect1.9781683674832.ch0047s0002 SYSTEM "sect1.9781683674832.ch0047s0002.xml"><!ENTITY sect1.9781683674832.ch0047s0003 SYSTEM "sect1.9781683674832.ch0047s0003.xml"><!ENTITY sect1.9781683674832.ch0047s0004 SYSTEM "sect1.9781683674832.ch0047s0004.xml"><!ENTITY sect1.9781683674832.ch0048s0001 SYSTEM "sect1.9781683674832.ch0048s0001.xml"><!ENTITY sect1.9781683674832.ch0048s0002 SYSTEM "sect1.9781683674832.ch0048s0002.xml"><!ENTITY sect1.9781683674832.ch0048s0003 SYSTEM "sect1.9781683674832.ch0048s0003.xml"><!ENTITY sect1.9781683674832.ch0049s0001 SYSTEM "sect1.9781683674832.ch0049s0001.xml"><!ENTITY sect1.9781683674832.ch0049s0002 SYSTEM "sect1.9781683674832.ch0049s0002.xml"><!ENTITY sect1.9781683674832.ch0049s0003 SYSTEM "sect1.9781683674832.ch0049s0003.xml"><!ENTITY sect1.9781683674832.ch0050s0001 SYSTEM "sect1.9781683674832.ch0050s0001.xml"><!ENTITY sect1.9781683674832.ch0050s0002 SYSTEM "sect1.9781683674832.ch0050s0002.xml"><!ENTITY sect1.9781683674832.ch0050s0003 SYSTEM "sect1.9781683674832.ch0050s0003.xml"><!ENTITY sect1.9781683674832.ch0051s0001 SYSTEM "sect1.9781683674832.ch0051s0001.xml"><!ENTITY sect1.9781683674832.ch0051s0002 SYSTEM "sect1.9781683674832.ch0051s0002.xml"><!ENTITY sect1.9781683674832.ch0051s0003 SYSTEM "sect1.9781683674832.ch0051s0003.xml"><!ENTITY sect1.9781683674832.ch0052s0003 SYSTEM "sect1.9781683674832.ch0052s0003.xml"><!ENTITY sect1.9781683674832.ch0052s0001 SYSTEM "sect1.9781683674832.ch0052s0001.xml"><!ENTITY sect1.9781683674832.ch0053s0001 SYSTEM "sect1.9781683674832.ch0053s0001.xml"><!ENTITY sect1.9781683674832.ch0054s0001 SYSTEM "sect1.9781683674832.ch0054s0001.xml"><!ENTITY sect1.9781683674832.ch0054s0002 SYSTEM "sect1.9781683674832.ch0054s0002.xml"><!ENTITY sect1.9781683674832.ch0054s0003 SYSTEM "sect1.9781683674832.ch0054s0003.xml"><!ENTITY sect1.9781683674832.ch0054s0004 SYSTEM "sect1.9781683674832.ch0054s0004.xml"><!ENTITY sect1.9781683674832.ch0054s0005 SYSTEM "sect1.9781683674832.ch0054s0005.xml"><!ENTITY sect1.9781683674832.ch0054s0006 SYSTEM "sect1.9781683674832.ch0054s0006.xml"><!ENTITY sect1.9781683674832.ch0054s0007 SYSTEM "sect1.9781683674832.ch0054s0007.xml"><!ENTITY sect1.9781683674832.ch0054s0008 SYSTEM "sect1.9781683674832.ch0054s0008.xml"><!ENTITY sect1.9781683674832.ch0055s0001 SYSTEM "sect1.9781683674832.ch0055s0001.xml"><!ENTITY sect1.9781683674832.ch0055s0002 SYSTEM "sect1.9781683674832.ch0055s0002.xml"><!ENTITY sect1.9781683674832.ch0055s0003 SYSTEM "sect1.9781683674832.ch0055s0003.xml"><!ENTITY sect1.9781683674832.ch0055s0004 SYSTEM "sect1.9781683674832.ch0055s0004.xml"><!ENTITY sect1.9781683674832.ch0055s0005 SYSTEM "sect1.9781683674832.ch0055s0005.xml"><!ENTITY sect1.9781683674832.ch0055s0006 SYSTEM "sect1.9781683674832.ch0055s0006.xml"><!ENTITY sect1.9781683674832.ch0055s0007 SYSTEM "sect1.9781683674832.ch0055s0007.xml"><!ENTITY sect1.9781683674832.ch0055s0008 SYSTEM "sect1.9781683674832.ch0055s0008.xml"><!ENTITY sect1.9781683674832.ch0056s0001 SYSTEM "sect1.9781683674832.ch0056s0001.xml"><!ENTITY sect1.9781683674832.ch0056s0002 SYSTEM "sect1.9781683674832.ch0056s0002.xml"><!ENTITY sect1.9781683674832.ch0056s0003 SYSTEM "sect1.9781683674832.ch0056s0003.xml"><!ENTITY sect1.9781683674832.ch0056s0004 SYSTEM "sect1.9781683674832.ch0056s0004.xml"><!ENTITY sect1.9781683674832.ch0056s0005 SYSTEM "sect1.9781683674832.ch0056s0005.xml"><!ENTITY sect1.9781683674832.ch0056s0006 SYSTEM "sect1.9781683674832.ch0056s0006.xml"><!ENTITY sect1.9781683674832.ch0056s0007 SYSTEM "sect1.9781683674832.ch0056s0007.xml"><!ENTITY sect1.9781683674832.ch0056s0008 SYSTEM "sect1.9781683674832.ch0056s0008.xml"><!ENTITY sect1.9781683674832.ch0057s0001 SYSTEM "sect1.9781683674832.ch0057s0001.xml"><!ENTITY sect1.9781683674832.ch0057s0002 SYSTEM "sect1.9781683674832.ch0057s0002.xml"><!ENTITY sect1.9781683674832.ch0057s0003 SYSTEM "sect1.9781683674832.ch0057s0003.xml"><!ENTITY sect1.9781683674832.ch0057s0004 SYSTEM "sect1.9781683674832.ch0057s0004.xml"><!ENTITY sect1.9781683674832.ch0057s0005 SYSTEM "sect1.9781683674832.ch0057s0005.xml"><!ENTITY sect1.9781683674832.ch0057s0006 SYSTEM "sect1.9781683674832.ch0057s0006.xml"><!ENTITY sect1.9781683674832.ch0057s0007 SYSTEM "sect1.9781683674832.ch0057s0007.xml"><!ENTITY sect1.9781683674832.ch0057s0008 SYSTEM "sect1.9781683674832.ch0057s0008.xml"><!ENTITY sect1.9781683674832.ch0058s0001 SYSTEM "sect1.9781683674832.ch0058s0001.xml"><!ENTITY sect1.9781683674832.ch0058s0002 SYSTEM "sect1.9781683674832.ch0058s0002.xml"><!ENTITY sect1.9781683674832.ch0058s0003 SYSTEM "sect1.9781683674832.ch0058s0003.xml"><!ENTITY sect1.9781683674832.ch0058s0004 SYSTEM "sect1.9781683674832.ch0058s0004.xml"><!ENTITY sect1.9781683674832.ch0058s0005 SYSTEM "sect1.9781683674832.ch0058s0005.xml"><!ENTITY sect1.9781683674832.ch0058s0006 SYSTEM "sect1.9781683674832.ch0058s0006.xml"><!ENTITY sect1.9781683674832.ch0058s0007 SYSTEM "sect1.9781683674832.ch0058s0007.xml"><!ENTITY sect1.9781683674832.ch0058s0008 SYSTEM "sect1.9781683674832.ch0058s0008.xml"><!ENTITY sect1.9781683674832.ch0059s0001 SYSTEM "sect1.9781683674832.ch0059s0001.xml"><!ENTITY sect1.9781683674832.ch0059s0002 SYSTEM "sect1.9781683674832.ch0059s0002.xml"><!ENTITY sect1.9781683674832.ch0059s0003 SYSTEM "sect1.9781683674832.ch0059s0003.xml"><!ENTITY sect1.9781683674832.ch0059s0004 SYSTEM "sect1.9781683674832.ch0059s0004.xml"><!ENTITY sect1.9781683674832.ch0059s0005 SYSTEM "sect1.9781683674832.ch0059s0005.xml"><!ENTITY sect1.9781683674832.ch0059s0006 SYSTEM "sect1.9781683674832.ch0059s0006.xml"><!ENTITY sect1.9781683674832.ch0059s0007 SYSTEM "sect1.9781683674832.ch0059s0007.xml"><!ENTITY sect1.9781683674832.ch0059s0008 SYSTEM "sect1.9781683674832.ch0059s0008.xml"><!ENTITY sect1.9781683674832.ch0060s0001 SYSTEM "sect1.9781683674832.ch0060s0001.xml"><!ENTITY sect1.9781683674832.ch0060s0002 SYSTEM "sect1.9781683674832.ch0060s0002.xml"><!ENTITY sect1.9781683674832.ch0060s0003 SYSTEM "sect1.9781683674832.ch0060s0003.xml"><!ENTITY sect1.9781683674832.ch0060s0004 SYSTEM "sect1.9781683674832.ch0060s0004.xml"><!ENTITY sect1.9781683674832.ch0060s0005 SYSTEM "sect1.9781683674832.ch0060s0005.xml"><!ENTITY sect1.9781683674832.ch0060s0006 SYSTEM "sect1.9781683674832.ch0060s0006.xml"><!ENTITY sect1.9781683674832.ch0060s0007 SYSTEM "sect1.9781683674832.ch0060s0007.xml"><!ENTITY sect1.9781683674832.ch0060s0008 SYSTEM "sect1.9781683674832.ch0060s0008.xml"><!ENTITY sect1.9781683674832.ch0061s0001 SYSTEM "sect1.9781683674832.ch0061s0001.xml"><!ENTITY sect1.9781683674832.ch0061s0002 SYSTEM "sect1.9781683674832.ch0061s0002.xml"><!ENTITY sect1.9781683674832.ch0061s0003 SYSTEM "sect1.9781683674832.ch0061s0003.xml"><!ENTITY sect1.9781683674832.ch0061s0004 SYSTEM "sect1.9781683674832.ch0061s0004.xml"><!ENTITY sect1.9781683674832.ch0061s0005 SYSTEM "sect1.9781683674832.ch0061s0005.xml"><!ENTITY sect1.9781683674832.ch0061s0006 SYSTEM "sect1.9781683674832.ch0061s0006.xml"><!ENTITY sect1.9781683674832.ch0061s0007 SYSTEM "sect1.9781683674832.ch0061s0007.xml"><!ENTITY sect1.9781683674832.ch0061s0008 SYSTEM "sect1.9781683674832.ch0061s0008.xml"><!ENTITY sect1.9781683674832.ch0062s0001 SYSTEM "sect1.9781683674832.ch0062s0001.xml"><!ENTITY sect1.9781683674832.ch0062s0002 SYSTEM "sect1.9781683674832.ch0062s0002.xml"><!ENTITY sect1.9781683674832.ch0062s0003 SYSTEM "sect1.9781683674832.ch0062s0003.xml"><!ENTITY sect1.9781683674832.ch0062s0004 SYSTEM "sect1.9781683674832.ch0062s0004.xml"><!ENTITY sect1.9781683674832.ch0062s0005 SYSTEM "sect1.9781683674832.ch0062s0005.xml"><!ENTITY sect1.9781683674832.ch0062s0006 SYSTEM "sect1.9781683674832.ch0062s0006.xml"><!ENTITY sect1.9781683674832.ch0062s0007 SYSTEM "sect1.9781683674832.ch0062s0007.xml"><!ENTITY sect1.9781683674832.ch0062s0008 SYSTEM "sect1.9781683674832.ch0062s0008.xml"><!ENTITY sect1.9781683674832.ch0063s0001 SYSTEM "sect1.9781683674832.ch0063s0001.xml"><!ENTITY sect1.9781683674832.ch0063s0002 SYSTEM "sect1.9781683674832.ch0063s0002.xml"><!ENTITY sect1.9781683674832.ch0063s0003 SYSTEM "sect1.9781683674832.ch0063s0003.xml"><!ENTITY sect1.9781683674832.ch0063s0004 SYSTEM "sect1.9781683674832.ch0063s0004.xml"><!ENTITY sect1.9781683674832.ch0063s0005 SYSTEM "sect1.9781683674832.ch0063s0005.xml"><!ENTITY sect1.9781683674832.ch0063s0006 SYSTEM "sect1.9781683674832.ch0063s0006.xml"><!ENTITY sect1.9781683674832.ch0063s0007 SYSTEM "sect1.9781683674832.ch0063s0007.xml"><!ENTITY sect1.9781683674832.ch0063s0008 SYSTEM "sect1.9781683674832.ch0063s0008.xml"><!ENTITY sect1.9781683674832.ch0064s0001 SYSTEM "sect1.9781683674832.ch0064s0001.xml"><!ENTITY sect1.9781683674832.ch0064s0002 SYSTEM "sect1.9781683674832.ch0064s0002.xml"><!ENTITY sect1.9781683674832.ch0064s0003 SYSTEM "sect1.9781683674832.ch0064s0003.xml"><!ENTITY sect1.9781683674832.ch0064s0004 SYSTEM "sect1.9781683674832.ch0064s0004.xml"><!ENTITY sect1.9781683674832.ch0064s0005 SYSTEM "sect1.9781683674832.ch0064s0005.xml"><!ENTITY sect1.9781683674832.ch0064s0006 SYSTEM "sect1.9781683674832.ch0064s0006.xml"><!ENTITY sect1.9781683674832.ch0064s0007 SYSTEM "sect1.9781683674832.ch0064s0007.xml"><!ENTITY sect1.9781683674832.ch0064s0008 SYSTEM "sect1.9781683674832.ch0064s0008.xml"><!ENTITY sect1.9781683674832.ch0065s0001 SYSTEM "sect1.9781683674832.ch0065s0001.xml"><!ENTITY sect1.9781683674832.ch0065s0002 SYSTEM "sect1.9781683674832.ch0065s0002.xml"><!ENTITY sect1.9781683674832.ch0065s0003 SYSTEM "sect1.9781683674832.ch0065s0003.xml"><!ENTITY sect1.9781683674832.ch0065s0004 SYSTEM "sect1.9781683674832.ch0065s0004.xml"><!ENTITY sect1.9781683674832.ch0065s0005 SYSTEM "sect1.9781683674832.ch0065s0005.xml"><!ENTITY sect1.9781683674832.ch0065s0006 SYSTEM "sect1.9781683674832.ch0065s0006.xml"><!ENTITY sect1.9781683674832.ch0065s0007 SYSTEM "sect1.9781683674832.ch0065s0007.xml"><!ENTITY sect1.9781683674832.ch0065s0008 SYSTEM "sect1.9781683674832.ch0065s0008.xml"><!ENTITY sect1.9781683674832.ch0066s0001 SYSTEM "sect1.9781683674832.ch0066s0001.xml"><!ENTITY sect1.9781683674832.ch0066s0002 SYSTEM "sect1.9781683674832.ch0066s0002.xml"><!ENTITY sect1.9781683674832.ch0066s0003 SYSTEM "sect1.9781683674832.ch0066s0003.xml"><!ENTITY sect1.9781683674832.ch0066s0004 SYSTEM "sect1.9781683674832.ch0066s0004.xml"><!ENTITY sect1.9781683674832.ch0066s0005 SYSTEM "sect1.9781683674832.ch0066s0005.xml"><!ENTITY sect1.9781683674832.ch0066s0006 SYSTEM "sect1.9781683674832.ch0066s0006.xml"><!ENTITY sect1.9781683674832.ch0066s0007 SYSTEM "sect1.9781683674832.ch0066s0007.xml"><!ENTITY sect1.9781683674832.ch0066s0008 SYSTEM "sect1.9781683674832.ch0066s0008.xml"><!ENTITY sect1.9781683674832.ch0067s0001 SYSTEM "sect1.9781683674832.ch0067s0001.xml"><!ENTITY sect1.9781683674832.ch0067s0002 SYSTEM "sect1.9781683674832.ch0067s0002.xml"><!ENTITY sect1.9781683674832.ch0067s0003 SYSTEM "sect1.9781683674832.ch0067s0003.xml"><!ENTITY sect1.9781683674832.ch0067s0004 SYSTEM "sect1.9781683674832.ch0067s0004.xml"><!ENTITY sect1.9781683674832.ch0067s0005 SYSTEM "sect1.9781683674832.ch0067s0005.xml"><!ENTITY sect1.9781683674832.ch0067s0006 SYSTEM "sect1.9781683674832.ch0067s0006.xml"><!ENTITY sect1.9781683674832.ch0067s0007 SYSTEM "sect1.9781683674832.ch0067s0007.xml"><!ENTITY sect1.9781683674832.ch0067s0008 SYSTEM "sect1.9781683674832.ch0067s0008.xml"><!ENTITY sect1.9781683674832.ch0068s0001 SYSTEM "sect1.9781683674832.ch0068s0001.xml"><!ENTITY sect1.9781683674832.ch0068s0002 SYSTEM "sect1.9781683674832.ch0068s0002.xml"><!ENTITY sect1.9781683674832.ch0068s0003 SYSTEM "sect1.9781683674832.ch0068s0003.xml"><!ENTITY sect1.9781683674832.ch0068s0004 SYSTEM "sect1.9781683674832.ch0068s0004.xml"><!ENTITY sect1.9781683674832.ch0068s0005 SYSTEM "sect1.9781683674832.ch0068s0005.xml"><!ENTITY sect1.9781683674832.ch0068s0006 SYSTEM "sect1.9781683674832.ch0068s0006.xml"><!ENTITY sect1.9781683674832.ch0068s0007 SYSTEM "sect1.9781683674832.ch0068s0007.xml"><!ENTITY sect1.9781683674832.ch0068s0008 SYSTEM "sect1.9781683674832.ch0068s0008.xml"><!ENTITY sect1.9781683674832.ch0069s0001 SYSTEM "sect1.9781683674832.ch0069s0001.xml"><!ENTITY sect1.9781683674832.ch0069s0002 SYSTEM "sect1.9781683674832.ch0069s0002.xml"><!ENTITY sect1.9781683674832.ch0069s0003 SYSTEM "sect1.9781683674832.ch0069s0003.xml"><!ENTITY sect1.9781683674832.ch0069s0004 SYSTEM "sect1.9781683674832.ch0069s0004.xml"><!ENTITY sect1.9781683674832.ch0069s0005 SYSTEM "sect1.9781683674832.ch0069s0005.xml"><!ENTITY sect1.9781683674832.ch0069s0006 SYSTEM "sect1.9781683674832.ch0069s0006.xml"><!ENTITY sect1.9781683674832.ch0069s0007 SYSTEM "sect1.9781683674832.ch0069s0007.xml"><!ENTITY sect1.9781683674832.ch0069s0008 SYSTEM "sect1.9781683674832.ch0069s0008.xml"><!ENTITY sect1.9781683674832.ch0070s0001 SYSTEM "sect1.9781683674832.ch0070s0001.xml"><!ENTITY sect1.9781683674832.ch0070s0002 SYSTEM "sect1.9781683674832.ch0070s0002.xml"><!ENTITY sect1.9781683674832.ch0070s0003 SYSTEM "sect1.9781683674832.ch0070s0003.xml"><!ENTITY sect1.9781683674832.ch0070s0004 SYSTEM "sect1.9781683674832.ch0070s0004.xml"><!ENTITY sect1.9781683674832.ch0070s0005 SYSTEM "sect1.9781683674832.ch0070s0005.xml"><!ENTITY sect1.9781683674832.ch0070s0006 SYSTEM "sect1.9781683674832.ch0070s0006.xml"><!ENTITY sect1.9781683674832.ch0070s0007 SYSTEM "sect1.9781683674832.ch0070s0007.xml"><!ENTITY sect1.9781683674832.ch0070s0008 SYSTEM "sect1.9781683674832.ch0070s0008.xml"><!ENTITY sect1.9781683674832.ch0071s0001 SYSTEM "sect1.9781683674832.ch0071s0001.xml"><!ENTITY sect1.9781683674832.ch0071s0002 SYSTEM "sect1.9781683674832.ch0071s0002.xml"><!ENTITY sect1.9781683674832.ch0071s0003 SYSTEM "sect1.9781683674832.ch0071s0003.xml"><!ENTITY sect1.9781683674832.ch0071s0004 SYSTEM "sect1.9781683674832.ch0071s0004.xml"><!ENTITY sect1.9781683674832.ch0071s0005 SYSTEM "sect1.9781683674832.ch0071s0005.xml"><!ENTITY sect1.9781683674832.ch0071s0006 SYSTEM "sect1.9781683674832.ch0071s0006.xml"><!ENTITY sect1.9781683674832.ch0071s0007 SYSTEM "sect1.9781683674832.ch0071s0007.xml"><!ENTITY sect1.9781683674832.ch0071s0008 SYSTEM "sect1.9781683674832.ch0071s0008.xml"><!ENTITY sect1.9781683674832.ch0072s0001 SYSTEM "sect1.9781683674832.ch0072s0001.xml"><!ENTITY sect1.9781683674832.ch0072s0002 SYSTEM "sect1.9781683674832.ch0072s0002.xml"><!ENTITY sect1.9781683674832.ch0072s0003 SYSTEM "sect1.9781683674832.ch0072s0003.xml"><!ENTITY sect1.9781683674832.ch0072s0004 SYSTEM "sect1.9781683674832.ch0072s0004.xml"><!ENTITY sect1.9781683674832.ch0072s0005 SYSTEM "sect1.9781683674832.ch0072s0005.xml"><!ENTITY sect1.9781683674832.ch0072s0006 SYSTEM "sect1.9781683674832.ch0072s0006.xml"><!ENTITY sect1.9781683674832.ch0072s0007 SYSTEM "sect1.9781683674832.ch0072s0007.xml"><!ENTITY sect1.9781683674832.ch0072s0008 SYSTEM "sect1.9781683674832.ch0072s0008.xml"><!ENTITY sect1.9781683674832.ch0073s0001 SYSTEM "sect1.9781683674832.ch0073s0001.xml"><!ENTITY sect1.9781683674832.ch0074s0001 SYSTEM "sect1.9781683674832.ch0074s0001.xml"><!ENTITY sect1.9781683674832.ch0074s0002 SYSTEM "sect1.9781683674832.ch0074s0002.xml"><!ENTITY sect1.9781683674832.ch0075s0001 SYSTEM "sect1.9781683674832.ch0075s0001.xml"><!ENTITY sect1.9781683674832.ch0076s0001 SYSTEM "sect1.9781683674832.ch0076s0001.xml"><!ENTITY sect1.9781683674832.ch0077s0001 SYSTEM "sect1.9781683674832.ch0077s0001.xml"><!ENTITY sect1.9781683674832.ch0078s0001 SYSTEM "sect1.9781683674832.ch0078s0001.xml"><!ENTITY sect1.9781683674832.ch0078s0002 SYSTEM "sect1.9781683674832.ch0078s0002.xml"><!ENTITY sect1.9781683674832.ch0079s0001 SYSTEM "sect1.9781683674832.ch0079s0001.xml"><!ENTITY sect1.9781683674832.ch0080s0001 SYSTEM "sect1.9781683674832.ch0080s0001.xml"><!ENTITY sect1.9781683674832.ch0081s0001 SYSTEM "sect1.9781683674832.ch0081s0001.xml"><!ENTITY sect1.9781683674832.ch0082s0001 SYSTEM "sect1.9781683674832.ch0082s0001.xml"><!ENTITY sect1.9781683674832.ch0083s0001 SYSTEM "sect1.9781683674832.ch0083s0001.xml"><!ENTITY sect1.9781683674832.ch0084s0001 SYSTEM "sect1.9781683674832.ch0084s0001.xml"><!ENTITY sect1.9781683674832.ch0085s0001 SYSTEM "sect1.9781683674832.ch0085s0001.xml"><!ENTITY sect1.9781683674832.ch0086s0001 SYSTEM "sect1.9781683674832.ch0086s0001.xml"><!ENTITY sect1.9781683674832.ch0087s0001 SYSTEM "sect1.9781683674832.ch0087s0001.xml"><!ENTITY sect1.9781683674832.ch0088s0001 SYSTEM "sect1.9781683674832.ch0088s0001.xml"><!ENTITY sect1.9781683674832.ch0089s0001 SYSTEM "sect1.9781683674832.ch0089s0001.xml"><!ENTITY sect1.9781683674832.ch0090s0001 SYSTEM "sect1.9781683674832.ch0090s0001.xml"><!ENTITY sect1.9781683674832.ch0091s0001 SYSTEM "sect1.9781683674832.ch0091s0001.xml"><!ENTITY sect1.9781683674832.ch0092s0001 SYSTEM "sect1.9781683674832.ch0092s0001.xml"><!ENTITY sect1.9781683674832.ch0093s0001 SYSTEM "sect1.9781683674832.ch0093s0001.xml"><!ENTITY sect1.9781683674832.ch0094s0001 SYSTEM "sect1.9781683674832.ch0094s0001.xml"><!ENTITY sect1.9781683674832.ch0095s0001 SYSTEM "sect1.9781683674832.ch0095s0001.xml"><!ENTITY sect1.9781683674832.ch0096s0001 SYSTEM "sect1.9781683674832.ch0096s0001.xml"><!ENTITY sect1.9781683674832.ch0097s0001 SYSTEM "sect1.9781683674832.ch0097s0001.xml"><!ENTITY sect1.9781683674832.ch0098s0001 SYSTEM "sect1.9781683674832.ch0098s0001.xml"><!ENTITY sect1.9781683674832.ch0099s0001 SYSTEM "sect1.9781683674832.ch0099s0001.xml"><!ENTITY sect1.9781683674832.ch0099s0002 SYSTEM "sect1.9781683674832.ch0099s0002.xml"><!ENTITY sect1.9781683674832.ch0099s0003 SYSTEM "sect1.9781683674832.ch0099s0003.xml"><!ENTITY sect1.9781683674832.ch0100s0001 SYSTEM "sect1.9781683674832.ch0100s0001.xml"><!ENTITY sect1.9781683674832.ch0100s0002 SYSTEM "sect1.9781683674832.ch0100s0002.xml"><!ENTITY sect1.9781683674832.ch0100s0003 SYSTEM "sect1.9781683674832.ch0100s0003.xml"><!ENTITY sect1.9781683674832.ch0101s0002 SYSTEM "sect1.9781683674832.ch0101s0002.xml"><!ENTITY sect1.9781683674832.ch0101s0001 SYSTEM "sect1.9781683674832.ch0101s0001.xml"><!ENTITY sect1.9781683674832.ch0102s0001 SYSTEM "sect1.9781683674832.ch0102s0001.xml"><!ENTITY sect1.9781683674832.ch0103s0001 SYSTEM "sect1.9781683674832.ch0103s0001.xml"><!ENTITY sect1.9781683674832.ch0104s0001 SYSTEM "sect1.9781683674832.ch0104s0001.xml"><!ENTITY sect1.9781683674832.ch0104s0002 SYSTEM "sect1.9781683674832.ch0104s0002.xml"><!ENTITY sect1.9781683674832.ch0104s0003 SYSTEM "sect1.9781683674832.ch0104s0003.xml"><!ENTITY sect1.9781683674832.ch0104s0004 SYSTEM "sect1.9781683674832.ch0104s0004.xml"><!ENTITY sect1.9781683674832.ch0105s0001 SYSTEM "sect1.9781683674832.ch0105s0001.xml"><!ENTITY sect1.9781683674832.ch0105s0002 SYSTEM "sect1.9781683674832.ch0105s0002.xml"><!ENTITY sect1.9781683674832.ch0105s0003 SYSTEM "sect1.9781683674832.ch0105s0003.xml"><!ENTITY sect1.9781683674832.ch0106s0001 SYSTEM "sect1.9781683674832.ch0106s0001.xml"><!ENTITY sect1.9781683674832.ch0107s0001 SYSTEM "sect1.9781683674832.ch0107s0001.xml"><!ENTITY sect1.9781683674832.ch0107s0002 SYSTEM "sect1.9781683674832.ch0107s0002.xml"><!ENTITY sect1.9781683674832.ch0107s0003 SYSTEM "sect1.9781683674832.ch0107s0003.xml"><!ENTITY sect1.9781683674832.ch0108s0001 SYSTEM "sect1.9781683674832.ch0108s0001.xml"><!ENTITY sect1.9781683674832.ch0108s0002 SYSTEM "sect1.9781683674832.ch0108s0002.xml"><!ENTITY sect1.9781683674832.ch0109s0002 SYSTEM "sect1.9781683674832.ch0109s0002.xml"><!ENTITY sect1.9781683674832.ch0109s0001 SYSTEM "sect1.9781683674832.ch0109s0001.xml"><!ENTITY sect1.9781683674832.ch0110s0001 SYSTEM "sect1.9781683674832.ch0110s0001.xml"><!ENTITY sect1.9781683674832.ch0111s0001 SYSTEM "sect1.9781683674832.ch0111s0001.xml"><!ENTITY sect1.9781683674832.ch0111s0002 SYSTEM "sect1.9781683674832.ch0111s0002.xml"><!ENTITY sect1.9781683674832.ch0111s0003 SYSTEM "sect1.9781683674832.ch0111s0003.xml"><!ENTITY sect1.9781683674832.ch0112s0001 SYSTEM "sect1.9781683674832.ch0112s0001.xml"><!ENTITY sect1.9781683674832.ch0112s0002 SYSTEM "sect1.9781683674832.ch0112s0002.xml"><!ENTITY sect1.9781683674832.ch0112s0003 SYSTEM "sect1.9781683674832.ch0112s0003.xml"><!ENTITY sect1.9781683674832.ch0113s0001 SYSTEM "sect1.9781683674832.ch0113s0001.xml"><!ENTITY sect1.9781683674832.ch0113s0002 SYSTEM "sect1.9781683674832.ch0113s0002.xml"><!ENTITY sect1.9781683674832.ch0113s0003 SYSTEM "sect1.9781683674832.ch0113s0003.xml"><!ENTITY sect1.9781683674832.ch0114s0001 SYSTEM "sect1.9781683674832.ch0114s0001.xml"><!ENTITY sect1.9781683674832.ch0114s0002 SYSTEM "sect1.9781683674832.ch0114s0002.xml"><!ENTITY sect1.9781683674832.ch0114s0003 SYSTEM "sect1.9781683674832.ch0114s0003.xml"><!ENTITY sect1.9781683674832.ch0115s0001 SYSTEM "sect1.9781683674832.ch0115s0001.xml"><!ENTITY sect1.9781683674832.ch0115s0002 SYSTEM "sect1.9781683674832.ch0115s0002.xml"><!ENTITY sect1.9781683674832.ch0115s0003 SYSTEM "sect1.9781683674832.ch0115s0003.xml"><!ENTITY sect1.9781683674832.ch0116s0001 SYSTEM "sect1.9781683674832.ch0116s0001.xml"><!ENTITY sect1.9781683674832.ch0116s0002 SYSTEM "sect1.9781683674832.ch0116s0002.xml"><!ENTITY sect1.9781683674832.ch0116s0003 SYSTEM "sect1.9781683674832.ch0116s0003.xml"><!ENTITY sect1.9781683674832.ch0117s0001 SYSTEM "sect1.9781683674832.ch0117s0001.xml"><!ENTITY sect1.9781683674832.ch0117s0002 SYSTEM "sect1.9781683674832.ch0117s0002.xml"><!ENTITY sect1.9781683674832.ch0117s0003 SYSTEM "sect1.9781683674832.ch0117s0003.xml"><!ENTITY sect1.9781683674832.ch0118s0001 SYSTEM "sect1.9781683674832.ch0118s0001.xml"><!ENTITY sect1.9781683674832.ch0118s0002 SYSTEM "sect1.9781683674832.ch0118s0002.xml"><!ENTITY sect1.9781683674832.ch0118s0003 SYSTEM "sect1.9781683674832.ch0118s0003.xml"><!ENTITY sect1.9781683674832.ch0119s0001 SYSTEM "sect1.9781683674832.ch0119s0001.xml"><!ENTITY sect1.9781683674832.ch0119s0002 SYSTEM "sect1.9781683674832.ch0119s0002.xml"><!ENTITY sect1.9781683674832.ch0119s0003 SYSTEM "sect1.9781683674832.ch0119s0003.xml"><!ENTITY sect1.9781683674832.ch0120s0001 SYSTEM "sect1.9781683674832.ch0120s0001.xml"><!ENTITY sect1.9781683674832.ch0121s0001 SYSTEM "sect1.9781683674832.ch0121s0001.xml"><!ENTITY sect1.9781683674832.ch0121s0002 SYSTEM "sect1.9781683674832.ch0121s0002.xml"><!ENTITY sect1.9781683674832.ch0121s0003 SYSTEM "sect1.9781683674832.ch0121s0003.xml"><!ENTITY sect1.9781683674832.ch0122s0001 SYSTEM "sect1.9781683674832.ch0122s0001.xml"><!ENTITY sect1.9781683674832.ch0122s0002 SYSTEM "sect1.9781683674832.ch0122s0002.xml"><!ENTITY sect1.9781683674832.ch0122s0003 SYSTEM "sect1.9781683674832.ch0122s0003.xml"><!ENTITY sect1.9781683674832.ch0123s0001 SYSTEM "sect1.9781683674832.ch0123s0001.xml"><!ENTITY sect1.9781683674832.ch0123s0002 SYSTEM "sect1.9781683674832.ch0123s0002.xml"><!ENTITY sect1.9781683674832.ch0123s0003 SYSTEM "sect1.9781683674832.ch0123s0003.xml"><!ENTITY sect1.9781683674832.ch0124s0001 SYSTEM "sect1.9781683674832.ch0124s0001.xml"><!ENTITY sect1.9781683674832.ch0124s0002 SYSTEM "sect1.9781683674832.ch0124s0002.xml"><!ENTITY sect1.9781683674832.ch0124s0003 SYSTEM "sect1.9781683674832.ch0124s0003.xml"><!ENTITY sect1.9781683674832.ch0125s0001 SYSTEM "sect1.9781683674832.ch0125s0001.xml"><!ENTITY sect1.9781683674832.ch0125s0002 SYSTEM "sect1.9781683674832.ch0125s0002.xml"><!ENTITY sect1.9781683674832.ch0125s0003 SYSTEM "sect1.9781683674832.ch0125s0003.xml"><!ENTITY sect1.9781683674832.ch0126s0001 SYSTEM "sect1.9781683674832.ch0126s0001.xml"><!ENTITY sect1.9781683674832.ch0126s0002 SYSTEM "sect1.9781683674832.ch0126s0002.xml"><!ENTITY sect1.9781683674832.ch0126s0003 SYSTEM "sect1.9781683674832.ch0126s0003.xml"><!ENTITY sect1.9781683674832.ch0127s0001 SYSTEM "sect1.9781683674832.ch0127s0001.xml"><!ENTITY sect1.9781683674832.ch0127s0002 SYSTEM "sect1.9781683674832.ch0127s0002.xml"><!ENTITY sect1.9781683674832.ch0127s0003 SYSTEM "sect1.9781683674832.ch0127s0003.xml"><!ENTITY sect1.9781683674832.ch0128s0001 SYSTEM "sect1.9781683674832.ch0128s0001.xml"><!ENTITY sect1.9781683674832.ch0128s0002 SYSTEM "sect1.9781683674832.ch0128s0002.xml"><!ENTITY sect1.9781683674832.ch0128s0003 SYSTEM "sect1.9781683674832.ch0128s0003.xml"><!ENTITY sect1.9781683674832.ch0129s0001 SYSTEM "sect1.9781683674832.ch0129s0001.xml"><!ENTITY sect1.9781683674832.ch0129s0002 SYSTEM "sect1.9781683674832.ch0129s0002.xml"><!ENTITY sect1.9781683674832.ch0129s0003 SYSTEM "sect1.9781683674832.ch0129s0003.xml"><!ENTITY sect1.9781683674832.ch0130s0001 SYSTEM "sect1.9781683674832.ch0130s0001.xml"><!ENTITY sect1.9781683674832.ch0131s0001 SYSTEM "sect1.9781683674832.ch0131s0001.xml"><!ENTITY sect1.9781683674832.ch0131s0002 SYSTEM "sect1.9781683674832.ch0131s0002.xml"><!ENTITY sect1.9781683674832.ch0131s0003 SYSTEM "sect1.9781683674832.ch0131s0003.xml"><!ENTITY sect1.9781683674832.ch0132s0001 SYSTEM "sect1.9781683674832.ch0132s0001.xml"><!ENTITY sect1.9781683674832.ch0132s0002 SYSTEM "sect1.9781683674832.ch0132s0002.xml"><!ENTITY sect1.9781683674832.ch0132s0003 SYSTEM "sect1.9781683674832.ch0132s0003.xml"><!ENTITY sect1.9781683674832.ch0133s0001 SYSTEM "sect1.9781683674832.ch0133s0001.xml"><!ENTITY sect1.9781683674832.ch0133s0002 SYSTEM "sect1.9781683674832.ch0133s0002.xml"><!ENTITY sect1.9781683674832.ch0133s0003 SYSTEM "sect1.9781683674832.ch0133s0003.xml"><!ENTITY sect1.9781683674832.ch0134s0001 SYSTEM "sect1.9781683674832.ch0134s0001.xml"><!ENTITY sect1.9781683674832.ch0134s0002 SYSTEM "sect1.9781683674832.ch0134s0002.xml"><!ENTITY sect1.9781683674832.ch0134s0003 SYSTEM "sect1.9781683674832.ch0134s0003.xml"><!ENTITY sect1.9781683674832.ch0135s0001 SYSTEM "sect1.9781683674832.ch0135s0001.xml"><!ENTITY sect1.9781683674832.ch0135s0002 SYSTEM "sect1.9781683674832.ch0135s0002.xml"><!ENTITY sect1.9781683674832.ch0135s0003 SYSTEM "sect1.9781683674832.ch0135s0003.xml"><!ENTITY sect1.9781683674832.ch0136s0001 SYSTEM "sect1.9781683674832.ch0136s0001.xml"><!ENTITY sect1.9781683674832.ch0137s0001 SYSTEM "sect1.9781683674832.ch0137s0001.xml"><!ENTITY sect1.9781683674832.ch0137s0002 SYSTEM "sect1.9781683674832.ch0137s0002.xml"><!ENTITY sect1.9781683674832.ch0137s0003 SYSTEM "sect1.9781683674832.ch0137s0003.xml"><!ENTITY sect1.9781683674832.ch0138s0001 SYSTEM "sect1.9781683674832.ch0138s0001.xml"><!ENTITY sect1.9781683674832.ch0138s0002 SYSTEM "sect1.9781683674832.ch0138s0002.xml"><!ENTITY sect1.9781683674832.ch0138s0003 SYSTEM "sect1.9781683674832.ch0138s0003.xml"><!ENTITY sect1.9781683674832.ch0139s0001 SYSTEM "sect1.9781683674832.ch0139s0001.xml"><!ENTITY sect1.9781683674832.ch0139s0002 SYSTEM "sect1.9781683674832.ch0139s0002.xml"><!ENTITY sect1.9781683674832.ch0139s0003 SYSTEM "sect1.9781683674832.ch0139s0003.xml"><!ENTITY sect1.9781683674832.ch0140s0001 SYSTEM "sect1.9781683674832.ch0140s0001.xml"><!ENTITY sect1.9781683674832.ch0140s0002 SYSTEM "sect1.9781683674832.ch0140s0002.xml"><!ENTITY sect1.9781683674832.ch0140s0003 SYSTEM "sect1.9781683674832.ch0140s0003.xml"><!ENTITY sect1.9781683674832.ch0141s0001 SYSTEM "sect1.9781683674832.ch0141s0001.xml"><!ENTITY sect1.9781683674832.ch0141s0002 SYSTEM "sect1.9781683674832.ch0141s0002.xml"><!ENTITY sect1.9781683674832.ch0142s0001 SYSTEM "sect1.9781683674832.ch0142s0001.xml"><!ENTITY sect1.9781683674832.ch0142s0002 SYSTEM "sect1.9781683674832.ch0142s0002.xml"><!ENTITY sect1.9781683674832.ch0142s0003 SYSTEM "sect1.9781683674832.ch0142s0003.xml"><!ENTITY sect1.9781683674832.ch0143s0001 SYSTEM "sect1.9781683674832.ch0143s0001.xml"><!ENTITY sect1.9781683674832.ch0143s0002 SYSTEM "sect1.9781683674832.ch0143s0002.xml"><!ENTITY sect1.9781683674832.ch0143s0003 SYSTEM "sect1.9781683674832.ch0143s0003.xml"><!ENTITY sect1.9781683674832.ch0144s0001 SYSTEM "sect1.9781683674832.ch0144s0001.xml"><!ENTITY sect1.9781683674832.ch0144s0002 SYSTEM "sect1.9781683674832.ch0144s0002.xml"><!ENTITY sect1.9781683674832.ch0145s0001 SYSTEM "sect1.9781683674832.ch0145s0001.xml"><!ENTITY sect1.9781683674832.ch0145s0002 SYSTEM "sect1.9781683674832.ch0145s0002.xml"><!ENTITY sect1.9781683674832.ch0145s0003 SYSTEM "sect1.9781683674832.ch0145s0003.xml"><!ENTITY sect1.9781683674832.ch0146s0001 SYSTEM "sect1.9781683674832.ch0146s0001.xml"><!ENTITY sect1.9781683674832.ch0146s0002 SYSTEM "sect1.9781683674832.ch0146s0002.xml"><!ENTITY sect1.9781683674832.ch0146s0003 SYSTEM "sect1.9781683674832.ch0146s0003.xml"><!ENTITY sect1.9781683674832.ch0146s0004 SYSTEM "sect1.9781683674832.ch0146s0004.xml"><!ENTITY sect1.9781683674832.ch0147s0001 SYSTEM "sect1.9781683674832.ch0147s0001.xml"><!ENTITY sect1.9781683674832.ch0148s0001 SYSTEM "sect1.9781683674832.ch0148s0001.xml"><!ENTITY sect1.9781683674832.ch0149s0001 SYSTEM "sect1.9781683674832.ch0149s0001.xml"><!ENTITY sect1.9781683674832.ch0149s0002 SYSTEM "sect1.9781683674832.ch0149s0002.xml"><!ENTITY sect1.9781683674832.ch0149s0003 SYSTEM "sect1.9781683674832.ch0149s0003.xml"><!ENTITY sect1.9781683674832.ch0150s0004 SYSTEM "sect1.9781683674832.ch0150s0004.xml"><!ENTITY sect1.9781683674832.ch0150s0001 SYSTEM "sect1.9781683674832.ch0150s0001.xml"><!ENTITY sect1.9781683674832.ch0150s0002 SYSTEM "sect1.9781683674832.ch0150s0002.xml"><!ENTITY sect1.9781683674832.ch0150s0003 SYSTEM "sect1.9781683674832.ch0150s0003.xml"><!ENTITY sect1.9781683674832.ch0151s0001 SYSTEM "sect1.9781683674832.ch0151s0001.xml"><!ENTITY sect1.9781683674832.ch0151s0002 SYSTEM "sect1.9781683674832.ch0151s0002.xml"><!ENTITY sect1.9781683674832.ch0151s0003 SYSTEM "sect1.9781683674832.ch0151s0003.xml"><!ENTITY sect1.9781683674832.ch0152s0001 SYSTEM "sect1.9781683674832.ch0152s0001.xml"><!ENTITY sect1.9781683674832.ch0153s0001 SYSTEM "sect1.9781683674832.ch0153s0001.xml"><!ENTITY sect1.9781683674832.ch0153s0002 SYSTEM "sect1.9781683674832.ch0153s0002.xml"><!ENTITY sect1.9781683674832.ch0153s0003 SYSTEM "sect1.9781683674832.ch0153s0003.xml"><!ENTITY sect1.9781683674832.ch0154s0001 SYSTEM "sect1.9781683674832.ch0154s0001.xml"><!ENTITY sect1.9781683674832.ch0154s0002 SYSTEM "sect1.9781683674832.ch0154s0002.xml"><!ENTITY sect1.9781683674832.ch0154s0003 SYSTEM "sect1.9781683674832.ch0154s0003.xml"><!ENTITY sect1.9781683674832.ch0155s0001 SYSTEM "sect1.9781683674832.ch0155s0001.xml"><!ENTITY sect1.9781683674832.ch0155s0002 SYSTEM "sect1.9781683674832.ch0155s0002.xml"><!ENTITY sect1.9781683674832.ch0155s0003 SYSTEM "sect1.9781683674832.ch0155s0003.xml"><!ENTITY sect1.9781683674832.ch0156s0001 SYSTEM "sect1.9781683674832.ch0156s0001.xml"><!ENTITY sect1.9781683674832.ch0156s0002 SYSTEM "sect1.9781683674832.ch0156s0002.xml"><!ENTITY sect1.9781683674832.ch0156s0003 SYSTEM "sect1.9781683674832.ch0156s0003.xml"><!ENTITY sect1.9781683674832.ch0157s0001 SYSTEM "sect1.9781683674832.ch0157s0001.xml"><!ENTITY sect1.9781683674832.ch0157s0002 SYSTEM "sect1.9781683674832.ch0157s0002.xml"><!ENTITY sect1.9781683674832.ch0157s0003 SYSTEM "sect1.9781683674832.ch0157s0003.xml"><!ENTITY sect1.9781683674832.ch0158s0001 SYSTEM "sect1.9781683674832.ch0158s0001.xml"><!ENTITY sect1.9781683674832.ch0159s0001 SYSTEM "sect1.9781683674832.ch0159s0001.xml"><!ENTITY sect1.9781683674832.ch0160s0001 SYSTEM "sect1.9781683674832.ch0160s0001.xml"><!ENTITY sect1.9781683674832.ch0161s0001 SYSTEM "sect1.9781683674832.ch0161s0001.xml"><!ENTITY sect1.9781683674832.ch0161s0002 SYSTEM "sect1.9781683674832.ch0161s0002.xml"><!ENTITY sect1.9781683674832.ch0161s0003 SYSTEM "sect1.9781683674832.ch0161s0003.xml"><!ENTITY sect1.9781683674832.ch0162s0001 SYSTEM "sect1.9781683674832.ch0162s0001.xml"><!ENTITY sect1.9781683674832.ch0162s0002 SYSTEM "sect1.9781683674832.ch0162s0002.xml"><!ENTITY sect1.9781683674832.ch0162s0003 SYSTEM "sect1.9781683674832.ch0162s0003.xml"><!ENTITY sect1.9781683674832.ch0163s0001 SYSTEM "sect1.9781683674832.ch0163s0001.xml"><!ENTITY sect1.9781683674832.ch0164s0001 SYSTEM "sect1.9781683674832.ch0164s0001.xml"><!ENTITY sect1.9781683674832.ch0164s0002 SYSTEM "sect1.9781683674832.ch0164s0002.xml"><!ENTITY sect1.9781683674832.ch0164s0003 SYSTEM "sect1.9781683674832.ch0164s0003.xml"><!ENTITY sect1.9781683674832.ch0165s0001 SYSTEM "sect1.9781683674832.ch0165s0001.xml"><!ENTITY sect1.9781683674832.ch0165s0002 SYSTEM "sect1.9781683674832.ch0165s0002.xml"><!ENTITY sect1.9781683674832.ch0165s0003 SYSTEM "sect1.9781683674832.ch0165s0003.xml"><!ENTITY sect1.9781683674832.ch0166s0001 SYSTEM "sect1.9781683674832.ch0166s0001.xml"><!ENTITY sect1.9781683674832.ch0167s0001 SYSTEM "sect1.9781683674832.ch0167s0001.xml"><!ENTITY sect1.9781683674832.ch0167s0002 SYSTEM "sect1.9781683674832.ch0167s0002.xml"><!ENTITY sect1.9781683674832.ch0167s0003 SYSTEM "sect1.9781683674832.ch0167s0003.xml"><!ENTITY sect1.9781683674832.ch0168s0001 SYSTEM "sect1.9781683674832.ch0168s0001.xml"><!ENTITY sect1.9781683674832.ch0168s0002 SYSTEM "sect1.9781683674832.ch0168s0002.xml"><!ENTITY sect1.9781683674832.ch0168s0003 SYSTEM "sect1.9781683674832.ch0168s0003.xml"><!ENTITY sect1.9781683674832.ch0169s0001 SYSTEM "sect1.9781683674832.ch0169s0001.xml"><!ENTITY sect1.9781683674832.ch0169s0002 SYSTEM "sect1.9781683674832.ch0169s0002.xml"><!ENTITY sect1.9781683674832.ch0169s0003 SYSTEM "sect1.9781683674832.ch0169s0003.xml"><!ENTITY sect1.9781683674832.ch0170s0004 SYSTEM "sect1.9781683674832.ch0170s0004.xml"><!ENTITY sect1.9781683674832.ch0170s0001 SYSTEM "sect1.9781683674832.ch0170s0001.xml"><!ENTITY sect1.9781683674832.ch0170s0002 SYSTEM "sect1.9781683674832.ch0170s0002.xml"><!ENTITY sect1.9781683674832.ch0170s0003 SYSTEM "sect1.9781683674832.ch0170s0003.xml"><!ENTITY sect1.9781683674832.ch0171s0001 SYSTEM "sect1.9781683674832.ch0171s0001.xml"><!ENTITY sect1.9781683674832.ch0171s0002 SYSTEM "sect1.9781683674832.ch0171s0002.xml"><!ENTITY sect1.9781683674832.ch0171s0003 SYSTEM "sect1.9781683674832.ch0171s0003.xml"><!ENTITY sect1.9781683674832.ch0172s0001 SYSTEM "sect1.9781683674832.ch0172s0001.xml"><!ENTITY sect1.9781683674832.ch0172s0002 SYSTEM "sect1.9781683674832.ch0172s0002.xml"><!ENTITY sect1.9781683674832.ch0172s0003 SYSTEM "sect1.9781683674832.ch0172s0003.xml"><!ENTITY sect1.9781683674832.ch0173s0001 SYSTEM "sect1.9781683674832.ch0173s0001.xml"><!ENTITY sect1.9781683674832.ch0173s0002 SYSTEM "sect1.9781683674832.ch0173s0002.xml"><!ENTITY sect1.9781683674832.ch0173s0003 SYSTEM "sect1.9781683674832.ch0173s0003.xml"><!ENTITY sect1.9781683674832.ch0174s0001 SYSTEM "sect1.9781683674832.ch0174s0001.xml"><!ENTITY sect1.9781683674832.ch0174s0002 SYSTEM "sect1.9781683674832.ch0174s0002.xml"><!ENTITY sect1.9781683674832.ch0174s0003 SYSTEM "sect1.9781683674832.ch0174s0003.xml"><!ENTITY sect1.9781683674832.ch0175s0001 SYSTEM "sect1.9781683674832.ch0175s0001.xml"><!ENTITY sect1.9781683674832.ch0175s0002 SYSTEM "sect1.9781683674832.ch0175s0002.xml"><!ENTITY sect1.9781683674832.ch0175s0003 SYSTEM "sect1.9781683674832.ch0175s0003.xml"><!ENTITY sect1.9781683674832.ch0176s0001 SYSTEM "sect1.9781683674832.ch0176s0001.xml"><!ENTITY sect1.9781683674832.ch0176s0002 SYSTEM "sect1.9781683674832.ch0176s0002.xml"><!ENTITY sect1.9781683674832.ch0176s0003 SYSTEM "sect1.9781683674832.ch0176s0003.xml"><!ENTITY sect1.9781683674832.ch0177s0001 SYSTEM "sect1.9781683674832.ch0177s0001.xml"><!ENTITY sect1.9781683674832.ch0178s0001 SYSTEM "sect1.9781683674832.ch0178s0001.xml"><!ENTITY sect1.9781683674832.ch0179s0001 SYSTEM "sect1.9781683674832.ch0179s0001.xml"><!ENTITY sect1.9781683674832.ch0179s0002 SYSTEM "sect1.9781683674832.ch0179s0002.xml"><!ENTITY sect1.9781683674832.ch0179s0003 SYSTEM "sect1.9781683674832.ch0179s0003.xml"><!ENTITY sect1.9781683674832.ch0180s0001 SYSTEM "sect1.9781683674832.ch0180s0001.xml"><!ENTITY sect1.9781683674832.ch0180s0002 SYSTEM "sect1.9781683674832.ch0180s0002.xml"><!ENTITY sect1.9781683674832.ch0180s0003 SYSTEM "sect1.9781683674832.ch0180s0003.xml"><!ENTITY sect1.9781683674832.ch0180s0004 SYSTEM "sect1.9781683674832.ch0180s0004.xml"><!ENTITY sect1.9781683674832.ch0181s0001 SYSTEM "sect1.9781683674832.ch0181s0001.xml"><!ENTITY sect1.9781683674832.ch0182s0001 SYSTEM "sect1.9781683674832.ch0182s0001.xml"><!ENTITY sect1.9781683674832.ch0182s0002 SYSTEM "sect1.9781683674832.ch0182s0002.xml"><!ENTITY sect1.9781683674832.ch0182s0003 SYSTEM "sect1.9781683674832.ch0182s0003.xml"><!ENTITY sect1.9781683674832.ch0183s0001 SYSTEM "sect1.9781683674832.ch0183s0001.xml"><!ENTITY sect1.9781683674832.ch0183s0002 SYSTEM "sect1.9781683674832.ch0183s0002.xml"><!ENTITY sect1.9781683674832.ch0183s0003 SYSTEM "sect1.9781683674832.ch0183s0003.xml"><!ENTITY sect1.9781683674832.ch0184s0001 SYSTEM "sect1.9781683674832.ch0184s0001.xml"><!ENTITY sect1.9781683674832.ch0184s0002 SYSTEM "sect1.9781683674832.ch0184s0002.xml"><!ENTITY sect1.9781683674832.ch0184s0003 SYSTEM "sect1.9781683674832.ch0184s0003.xml"><!ENTITY sect1.9781683674832.ch0184s0004 SYSTEM "sect1.9781683674832.ch0184s0004.xml"><!ENTITY sect1.9781683674832.ch0184s0005 SYSTEM "sect1.9781683674832.ch0184s0005.xml"><!ENTITY sect1.9781683674832.ch0185s0001 SYSTEM "sect1.9781683674832.ch0185s0001.xml"><!ENTITY sect1.9781683674832.ch0185s0002 SYSTEM "sect1.9781683674832.ch0185s0002.xml"><!ENTITY sect1.9781683674832.ch0185s0003 SYSTEM "sect1.9781683674832.ch0185s0003.xml"><!ENTITY sect1.9781683674832.ch0185s0004 SYSTEM "sect1.9781683674832.ch0185s0004.xml"><!ENTITY sect1.9781683674832.ch0185s0005 SYSTEM "sect1.9781683674832.ch0185s0005.xml"><!ENTITY sect1.9781683674832.ch0185s0006 SYSTEM "sect1.9781683674832.ch0185s0006.xml"><!ENTITY sect1.9781683674832.ch0186s0001 SYSTEM "sect1.9781683674832.ch0186s0001.xml"><!ENTITY sect1.9781683674832.ch0187s0001 SYSTEM "sect1.9781683674832.ch0187s0001.xml"><!ENTITY sect1.9781683674832.ch0187s0002 SYSTEM "sect1.9781683674832.ch0187s0002.xml"><!ENTITY sect1.9781683674832.ch0187s0003 SYSTEM "sect1.9781683674832.ch0187s0003.xml"><!ENTITY sect1.9781683674832.ch0188s0001 SYSTEM "sect1.9781683674832.ch0188s0001.xml"><!ENTITY sect1.9781683674832.ch0188s0002 SYSTEM "sect1.9781683674832.ch0188s0002.xml"><!ENTITY sect1.9781683674832.ch0188s0003 SYSTEM "sect1.9781683674832.ch0188s0003.xml"><!ENTITY sect1.9781683674832.ch0189s0001 SYSTEM "sect1.9781683674832.ch0189s0001.xml"><!ENTITY sect1.9781683674832.ch0189s0002 SYSTEM "sect1.9781683674832.ch0189s0002.xml"><!ENTITY sect1.9781683674832.ch0190s0001 SYSTEM "sect1.9781683674832.ch0190s0001.xml"><!ENTITY sect1.9781683674832.ch0191s0001 SYSTEM "sect1.9781683674832.ch0191s0001.xml"><!ENTITY sect1.9781683674832.ch0191s0002 SYSTEM "sect1.9781683674832.ch0191s0002.xml"><!ENTITY sect1.9781683674832.ch0191s0003 SYSTEM "sect1.9781683674832.ch0191s0003.xml"><!ENTITY sect1.9781683674832.ch0192s0001 SYSTEM "sect1.9781683674832.ch0192s0001.xml"><!ENTITY sect1.9781683674832.ch0192s0002 SYSTEM "sect1.9781683674832.ch0192s0002.xml"><!ENTITY sect1.9781683674832.ch0192s0003 SYSTEM "sect1.9781683674832.ch0192s0003.xml"><!ENTITY sect1.9781683674832.ch0193s0001 SYSTEM "sect1.9781683674832.ch0193s0001.xml"><!ENTITY sect1.9781683674832.ch0193s0002 SYSTEM "sect1.9781683674832.ch0193s0002.xml"><!ENTITY sect1.9781683674832.ch0193s0003 SYSTEM "sect1.9781683674832.ch0193s0003.xml"><!ENTITY sect1.9781683674832.ch0194s0001 SYSTEM "sect1.9781683674832.ch0194s0001.xml"><!ENTITY sect1.9781683674832.ch0195s0001 SYSTEM "sect1.9781683674832.ch0195s0001.xml"><!ENTITY sect1.9781683674832.ch0195s0002 SYSTEM "sect1.9781683674832.ch0195s0002.xml"><!ENTITY sect1.9781683674832.ch0195s0003 SYSTEM "sect1.9781683674832.ch0195s0003.xml"><!ENTITY sect1.9781683674832.ch0196s0001 SYSTEM "sect1.9781683674832.ch0196s0001.xml"><!ENTITY sect1.9781683674832.ch0196s0002 SYSTEM "sect1.9781683674832.ch0196s0002.xml"><!ENTITY sect1.9781683674832.ch0197s0001 SYSTEM "sect1.9781683674832.ch0197s0001.xml"><!ENTITY sect1.9781683674832.ch0197s0002 SYSTEM "sect1.9781683674832.ch0197s0002.xml"><!ENTITY sect1.9781683674832.ch0197s0003 SYSTEM "sect1.9781683674832.ch0197s0003.xml"><!ENTITY sect1.9781683674832.ch0198s0001 SYSTEM "sect1.9781683674832.ch0198s0001.xml"><!ENTITY sect1.9781683674832.ch0198s0002 SYSTEM "sect1.9781683674832.ch0198s0002.xml"><!ENTITY sect1.9781683674832.ch0198s0003 SYSTEM "sect1.9781683674832.ch0198s0003.xml"><!ENTITY sect1.9781683674832.ch0199s0001 SYSTEM "sect1.9781683674832.ch0199s0001.xml"><!ENTITY sect1.9781683674832.ch0200s0001 SYSTEM "sect1.9781683674832.ch0200s0001.xml"><!ENTITY sect1.9781683674832.ch0201s0001 SYSTEM "sect1.9781683674832.ch0201s0001.xml"><!ENTITY sect1.9781683674832.ch0202s0001 SYSTEM "sect1.9781683674832.ch0202s0001.xml"><!ENTITY sect1.9781683674832.ch0202s0002 SYSTEM "sect1.9781683674832.ch0202s0002.xml"><!ENTITY sect1.9781683674832.ch0203s0001 SYSTEM "sect1.9781683674832.ch0203s0001.xml"><!ENTITY sect1.9781683674832.ch0203s0002 SYSTEM "sect1.9781683674832.ch0203s0002.xml"><!ENTITY sect1.9781683674832.ch0203s0003 SYSTEM "sect1.9781683674832.ch0203s0003.xml"><!ENTITY sect1.9781683674832.ch0204s0001 SYSTEM "sect1.9781683674832.ch0204s0001.xml"><!ENTITY sect1.9781683674832.ch0205s0001 SYSTEM "sect1.9781683674832.ch0205s0001.xml"><!ENTITY sect1.9781683674832.ch0205s0002 SYSTEM "sect1.9781683674832.ch0205s0002.xml"><!ENTITY sect1.9781683674832.ch0205s0003 SYSTEM "sect1.9781683674832.ch0205s0003.xml"><!ENTITY sect1.9781683674832.ch0206s0001 SYSTEM "sect1.9781683674832.ch0206s0001.xml"><!ENTITY sect1.9781683674832.ch0207s0001 SYSTEM "sect1.9781683674832.ch0207s0001.xml"><!ENTITY sect1.9781683674832.ch0207s0002 SYSTEM "sect1.9781683674832.ch0207s0002.xml"><!ENTITY sect1.9781683674832.ch0207s0003 SYSTEM "sect1.9781683674832.ch0207s0003.xml"><!ENTITY sect1.9781683674832.ch0208s0001 SYSTEM "sect1.9781683674832.ch0208s0001.xml"><!ENTITY sect1.9781683674832.ch0209s0001 SYSTEM "sect1.9781683674832.ch0209s0001.xml"><!ENTITY sect1.9781683674832.ch0209s0002 SYSTEM "sect1.9781683674832.ch0209s0002.xml"><!ENTITY sect1.9781683674832.ch0209s0003 SYSTEM "sect1.9781683674832.ch0209s0003.xml"><!ENTITY sect1.9781683674832.ch0210s0001 SYSTEM "sect1.9781683674832.ch0210s0001.xml"><!ENTITY sect1.9781683674832.ch0210s0002 SYSTEM "sect1.9781683674832.ch0210s0002.xml"><!ENTITY sect1.9781683674832.ch0210s0003 SYSTEM "sect1.9781683674832.ch0210s0003.xml"><!ENTITY sect1.9781683674832.ch0211s0001 SYSTEM "sect1.9781683674832.ch0211s0001.xml"><!ENTITY sect1.9781683674832.ch0212s0001 SYSTEM "sect1.9781683674832.ch0212s0001.xml"><!ENTITY sect1.9781683674832.ch0212s0002 SYSTEM "sect1.9781683674832.ch0212s0002.xml"><!ENTITY sect1.9781683674832.ch0212s0003 SYSTEM "sect1.9781683674832.ch0212s0003.xml"><!ENTITY sect1.9781683674832.ch0213s0001 SYSTEM "sect1.9781683674832.ch0213s0001.xml"><!ENTITY sect1.9781683674832.ch0213s0002 SYSTEM "sect1.9781683674832.ch0213s0002.xml"><!ENTITY sect1.9781683674832.ch0213s0003 SYSTEM "sect1.9781683674832.ch0213s0003.xml"><!ENTITY sect1.9781683674832.ch0214s0001 SYSTEM "sect1.9781683674832.ch0214s0001.xml"><!ENTITY sect1.9781683674832.ch0215s0001 SYSTEM "sect1.9781683674832.ch0215s0001.xml"><!ENTITY sect1.9781683674832.ch0215s0002 SYSTEM "sect1.9781683674832.ch0215s0002.xml"><!ENTITY sect1.9781683674832.ch0215s0003 SYSTEM "sect1.9781683674832.ch0215s0003.xml"><!ENTITY sect1.9781683674832.ch0216s0001 SYSTEM "sect1.9781683674832.ch0216s0001.xml"><!ENTITY sect1.9781683674832.ch0216s0002 SYSTEM "sect1.9781683674832.ch0216s0002.xml"><!ENTITY sect1.9781683674832.ch0216s0003 SYSTEM "sect1.9781683674832.ch0216s0003.xml"><!ENTITY sect1.9781683674832.ch0217s0001 SYSTEM "sect1.9781683674832.ch0217s0001.xml"><!ENTITY sect1.9781683674832.ch0217s0002 SYSTEM "sect1.9781683674832.ch0217s0002.xml"><!ENTITY sect1.9781683674832.ch0217s0003 SYSTEM "sect1.9781683674832.ch0217s0003.xml"><!ENTITY sect1.9781683674832.ch0218s0001 SYSTEM "sect1.9781683674832.ch0218s0001.xml"><!ENTITY sect1.9781683674832.ch0219s0001 SYSTEM "sect1.9781683674832.ch0219s0001.xml"><!ENTITY sect1.9781683674832.ch0219s0002 SYSTEM "sect1.9781683674832.ch0219s0002.xml"><!ENTITY sect1.9781683674832.ch0219s0003 SYSTEM "sect1.9781683674832.ch0219s0003.xml"><!ENTITY sect1.9781683674832.ch0220s0001 SYSTEM "sect1.9781683674832.ch0220s0001.xml"><!ENTITY sect1.9781683674832.ch0220s0002 SYSTEM "sect1.9781683674832.ch0220s0002.xml"><!ENTITY sect1.9781683674832.ch0220s0003 SYSTEM "sect1.9781683674832.ch0220s0003.xml"><!ENTITY sect1.9781683674832.ch0221s0001 SYSTEM "sect1.9781683674832.ch0221s0001.xml"><!ENTITY sect1.9781683674832.ch0222s0002 SYSTEM "sect1.9781683674832.ch0222s0002.xml"><!ENTITY sect1.9781683674832.ch0222s0001 SYSTEM "sect1.9781683674832.ch0222s0001.xml"><!ENTITY sect1.9781683674832.ch0223s0001 SYSTEM "sect1.9781683674832.ch0223s0001.xml"><!ENTITY sect1.9781683674832.ch0224s0001 SYSTEM "sect1.9781683674832.ch0224s0001.xml"><!ENTITY sect1.9781683674832.ch0225s0001 SYSTEM "sect1.9781683674832.ch0225s0001.xml"><!ENTITY sect1.9781683674832.ch0226s0001 SYSTEM "sect1.9781683674832.ch0226s0001.xml"><!ENTITY sect1.9781683674832.ch0226s0002 SYSTEM "sect1.9781683674832.ch0226s0002.xml"><!ENTITY sect1.9781683674832.ch0226s0003 SYSTEM "sect1.9781683674832.ch0226s0003.xml"><!ENTITY sect1.9781683674832.ch0227s0001 SYSTEM "sect1.9781683674832.ch0227s0001.xml"><!ENTITY sect1.9781683674832.ch0227s0002 SYSTEM "sect1.9781683674832.ch0227s0002.xml"><!ENTITY sect1.9781683674832.ch0228s0001 SYSTEM "sect1.9781683674832.ch0228s0001.xml"><!ENTITY sect1.9781683674832.ch0228s0002 SYSTEM "sect1.9781683674832.ch0228s0002.xml"><!ENTITY sect1.9781683674832.ch0228s0003 SYSTEM "sect1.9781683674832.ch0228s0003.xml"><!ENTITY sect1.9781683674832.ch0229s0001 SYSTEM "sect1.9781683674832.ch0229s0001.xml"><!ENTITY sect1.9781683674832.ch0229s0002 SYSTEM "sect1.9781683674832.ch0229s0002.xml"><!ENTITY sect1.9781683674832.ch0229s0003 SYSTEM "sect1.9781683674832.ch0229s0003.xml"><!ENTITY sect1.9781683674832.ch0230s0001 SYSTEM "sect1.9781683674832.ch0230s0001.xml"><!ENTITY sect1.9781683674832.ch0230s0002 SYSTEM "sect1.9781683674832.ch0230s0002.xml"><!ENTITY sect1.9781683674832.ch0230s0003 SYSTEM "sect1.9781683674832.ch0230s0003.xml"><!ENTITY sect1.9781683674832.ch0231s0001 SYSTEM "sect1.9781683674832.ch0231s0001.xml"><!ENTITY sect1.9781683674832.ch0231s0002 SYSTEM "sect1.9781683674832.ch0231s0002.xml"><!ENTITY sect1.9781683674832.ch0231s0003 SYSTEM "sect1.9781683674832.ch0231s0003.xml"><!ENTITY sect1.9781683674832.ch0232s0001 SYSTEM "sect1.9781683674832.ch0232s0001.xml"><!ENTITY sect1.9781683674832.ch0232s0002 SYSTEM "sect1.9781683674832.ch0232s0002.xml"><!ENTITY sect1.9781683674832.ch0232s0003 SYSTEM "sect1.9781683674832.ch0232s0003.xml"><!ENTITY sect1.9781683674832.ch0233s0001 SYSTEM "sect1.9781683674832.ch0233s0001.xml"><!ENTITY sect1.9781683674832.ch0233s0002 SYSTEM "sect1.9781683674832.ch0233s0002.xml"><!ENTITY sect1.9781683674832.ch0233s0003 SYSTEM "sect1.9781683674832.ch0233s0003.xml"><!ENTITY sect1.9781683674832.ch0234s0001 SYSTEM "sect1.9781683674832.ch0234s0001.xml"><!ENTITY sect1.9781683674832.ch0235s0001 SYSTEM "sect1.9781683674832.ch0235s0001.xml"><!ENTITY sect1.9781683674832.ch0235s0002 SYSTEM "sect1.9781683674832.ch0235s0002.xml"><!ENTITY sect1.9781683674832.ch0235s0003 SYSTEM "sect1.9781683674832.ch0235s0003.xml"><!ENTITY sect1.9781683674832.ch0236s0002 SYSTEM "sect1.9781683674832.ch0236s0002.xml"><!ENTITY sect1.9781683674832.ch0236s0001 SYSTEM "sect1.9781683674832.ch0236s0001.xml"><!ENTITY sect1.9781683674832.ch0237s0001 SYSTEM "sect1.9781683674832.ch0237s0001.xml"><!ENTITY sect1.9781683674832.ch0237s0002 SYSTEM "sect1.9781683674832.ch0237s0002.xml"><!ENTITY sect1.9781683674832.ch0237s0003 SYSTEM "sect1.9781683674832.ch0237s0003.xml"><!ENTITY sect1.9781683674832.ch0237s0004 SYSTEM "sect1.9781683674832.ch0237s0004.xml"><!ENTITY sect1.9781683674832.ch0237s0005 SYSTEM "sect1.9781683674832.ch0237s0005.xml"><!ENTITY sect1.9781683674832.ch0237s0006 SYSTEM "sect1.9781683674832.ch0237s0006.xml"><!ENTITY sect1.9781683674832.ch0237s0007 SYSTEM "sect1.9781683674832.ch0237s0007.xml"><!ENTITY sect1.9781683674832.ch0237s0008 SYSTEM "sect1.9781683674832.ch0237s0008.xml"><!ENTITY sect1.9781683674832.ch0238s0001 SYSTEM "sect1.9781683674832.ch0238s0001.xml"><!ENTITY sect1.9781683674832.ch0239s0001 SYSTEM "sect1.9781683674832.ch0239s0001.xml"><!ENTITY sect1.9781683674832.ch0239s0002 SYSTEM "sect1.9781683674832.ch0239s0002.xml"><!ENTITY sect1.9781683674832.ch0239s0003 SYSTEM "sect1.9781683674832.ch0239s0003.xml"><!ENTITY sect1.9781683674832.ch0240s0001 SYSTEM "sect1.9781683674832.ch0240s0001.xml"><!ENTITY sect1.9781683674832.ch0240s0002 SYSTEM "sect1.9781683674832.ch0240s0002.xml"><!ENTITY sect1.9781683674832.ch0241s0001 SYSTEM "sect1.9781683674832.ch0241s0001.xml"><!ENTITY sect1.9781683674832.ch0242s0001 SYSTEM "sect1.9781683674832.ch0242s0001.xml"><!ENTITY sect1.9781683674832.ch0242s0002 SYSTEM "sect1.9781683674832.ch0242s0002.xml"><!ENTITY sect1.9781683674832.ch0242s0003 SYSTEM "sect1.9781683674832.ch0242s0003.xml"><!ENTITY sect1.9781683674832.ch0243s0001 SYSTEM "sect1.9781683674832.ch0243s0001.xml"><!ENTITY sect1.9781683674832.ch0243s0002 SYSTEM "sect1.9781683674832.ch0243s0002.xml"><!ENTITY sect1.9781683674832.ch0243s0003 SYSTEM "sect1.9781683674832.ch0243s0003.xml"><!ENTITY sect1.9781683674832.ch0244s0001 SYSTEM "sect1.9781683674832.ch0244s0001.xml"><!ENTITY sect1.9781683674832.ch0244s0002 SYSTEM "sect1.9781683674832.ch0244s0002.xml"><!ENTITY sect1.9781683674832.ch0244s0003 SYSTEM "sect1.9781683674832.ch0244s0003.xml"><!ENTITY sect1.9781683674832.ch0245s0001 SYSTEM "sect1.9781683674832.ch0245s0001.xml"><!ENTITY sect1.9781683674832.ch0245s0002 SYSTEM "sect1.9781683674832.ch0245s0002.xml"><!ENTITY sect1.9781683674832.ch0245s0003 SYSTEM "sect1.9781683674832.ch0245s0003.xml"><!ENTITY sect1.9781683674832.ch0246s0001 SYSTEM "sect1.9781683674832.ch0246s0001.xml"><!ENTITY sect1.9781683674832.ch0246s0002 SYSTEM "sect1.9781683674832.ch0246s0002.xml"><!ENTITY sect1.9781683674832.ch0246s0003 SYSTEM "sect1.9781683674832.ch0246s0003.xml"><!ENTITY sect1.9781683674832.ch0247s0001 SYSTEM "sect1.9781683674832.ch0247s0001.xml"><!ENTITY sect1.9781683674832.ch0248s0001 SYSTEM "sect1.9781683674832.ch0248s0001.xml"><!ENTITY sect1.9781683674832.ch0248s0002 SYSTEM "sect1.9781683674832.ch0248s0002.xml"><!ENTITY sect1.9781683674832.ch0248s0003 SYSTEM "sect1.9781683674832.ch0248s0003.xml"><!ENTITY sect1.9781683674832.ch0249s0001 SYSTEM "sect1.9781683674832.ch0249s0001.xml"><!ENTITY sect1.9781683674832.ch0249s0002 SYSTEM "sect1.9781683674832.ch0249s0002.xml"><!ENTITY sect1.9781683674832.ch0249s0003 SYSTEM "sect1.9781683674832.ch0249s0003.xml"><!ENTITY sect1.9781683674832.ch0250s0001 SYSTEM "sect1.9781683674832.ch0250s0001.xml"><!ENTITY sect1.9781683674832.ch0250s0002 SYSTEM "sect1.9781683674832.ch0250s0002.xml"><!ENTITY sect1.9781683674832.ch0250s0003 SYSTEM "sect1.9781683674832.ch0250s0003.xml"><!ENTITY sect1.9781683674832.ch0251s0001 SYSTEM "sect1.9781683674832.ch0251s0001.xml"><!ENTITY sect1.9781683674832.ch0251s0002 SYSTEM "sect1.9781683674832.ch0251s0002.xml"><!ENTITY sect1.9781683674832.ch0251s0003 SYSTEM "sect1.9781683674832.ch0251s0003.xml"><!ENTITY sect1.9781683674832.ch0252s0001 SYSTEM "sect1.9781683674832.ch0252s0001.xml"><!ENTITY sect1.9781683674832.ch0252s0002 SYSTEM "sect1.9781683674832.ch0252s0002.xml"><!ENTITY sect1.9781683674832.ch0252s0003 SYSTEM "sect1.9781683674832.ch0252s0003.xml"><!ENTITY sect1.9781683674832.ch0253s0001 SYSTEM "sect1.9781683674832.ch0253s0001.xml"><!ENTITY sect1.9781683674832.ch0253s0002 SYSTEM "sect1.9781683674832.ch0253s0002.xml"><!ENTITY sect1.9781683674832.ch0253s0003 SYSTEM "sect1.9781683674832.ch0253s0003.xml"><!ENTITY sect1.9781683674832.ch0254s0001 SYSTEM "sect1.9781683674832.ch0254s0001.xml"><!ENTITY sect1.9781683674832.ch0254s0002 SYSTEM "sect1.9781683674832.ch0254s0002.xml"><!ENTITY sect1.9781683674832.ch0254s0003 SYSTEM "sect1.9781683674832.ch0254s0003.xml"><!ENTITY sect1.9781683674832.ch0255s0001 SYSTEM "sect1.9781683674832.ch0255s0001.xml"><!ENTITY sect1.9781683674832.ch0256s0001 SYSTEM "sect1.9781683674832.ch0256s0001.xml"><!ENTITY sect1.9781683674832.ch0256s0002 SYSTEM "sect1.9781683674832.ch0256s0002.xml"><!ENTITY sect1.9781683674832.ch0256s0003 SYSTEM "sect1.9781683674832.ch0256s0003.xml"><!ENTITY sect1.9781683674832.ch0257s0001 SYSTEM "sect1.9781683674832.ch0257s0001.xml"><!ENTITY sect1.9781683674832.ch0257s0002 SYSTEM "sect1.9781683674832.ch0257s0002.xml"><!ENTITY sect1.9781683674832.ch0257s0003 SYSTEM "sect1.9781683674832.ch0257s0003.xml"><!ENTITY sect1.9781683674832.ch0258s0001 SYSTEM "sect1.9781683674832.ch0258s0001.xml"><!ENTITY sect1.9781683674832.ch0258s0002 SYSTEM "sect1.9781683674832.ch0258s0002.xml"><!ENTITY sect1.9781683674832.ch0258s0003 SYSTEM "sect1.9781683674832.ch0258s0003.xml"><!ENTITY sect1.9781683674832.ch0259s0001 SYSTEM "sect1.9781683674832.ch0259s0001.xml"><!ENTITY sect1.9781683674832.ch0259s0002 SYSTEM "sect1.9781683674832.ch0259s0002.xml"><!ENTITY sect1.9781683674832.ch0259s0003 SYSTEM "sect1.9781683674832.ch0259s0003.xml"><!ENTITY sect1.9781683674832.ch0260s0001 SYSTEM "sect1.9781683674832.ch0260s0001.xml"><!ENTITY sect1.9781683674832.ch0260s0002 SYSTEM "sect1.9781683674832.ch0260s0002.xml"><!ENTITY sect1.9781683674832.ch0260s0003 SYSTEM "sect1.9781683674832.ch0260s0003.xml"><!ENTITY sect1.9781683674832.ch0261s0001 SYSTEM "sect1.9781683674832.ch0261s0001.xml"><!ENTITY sect1.9781683674832.ch0261s0002 SYSTEM "sect1.9781683674832.ch0261s0002.xml"><!ENTITY sect1.9781683674832.ch0261s0003 SYSTEM "sect1.9781683674832.ch0261s0003.xml"><!ENTITY sect1.9781683674832.ch0262s0001 SYSTEM "sect1.9781683674832.ch0262s0001.xml"><!ENTITY sect1.9781683674832.ch0262s0002 SYSTEM "sect1.9781683674832.ch0262s0002.xml"><!ENTITY sect1.9781683674832.ch0262s0003 SYSTEM "sect1.9781683674832.ch0262s0003.xml"><!ENTITY sect1.9781683674832.ch0263s0001 SYSTEM "sect1.9781683674832.ch0263s0001.xml"><!ENTITY sect1.9781683674832.ch0264s0001 SYSTEM "sect1.9781683674832.ch0264s0001.xml"><!ENTITY sect1.9781683674832.ch0264s0002 SYSTEM "sect1.9781683674832.ch0264s0002.xml"><!ENTITY sect1.9781683674832.ch0264s0003 SYSTEM "sect1.9781683674832.ch0264s0003.xml"><!ENTITY sect1.9781683674832.ch0265s0001 SYSTEM "sect1.9781683674832.ch0265s0001.xml"><!ENTITY sect1.9781683674832.ch0265s0002 SYSTEM "sect1.9781683674832.ch0265s0002.xml"><!ENTITY sect1.9781683674832.ch0265s0003 SYSTEM "sect1.9781683674832.ch0265s0003.xml"><!ENTITY sect1.9781683674832.ch0266s0001 SYSTEM "sect1.9781683674832.ch0266s0001.xml"><!ENTITY sect1.9781683674832.ch0266s0002 SYSTEM "sect1.9781683674832.ch0266s0002.xml"><!ENTITY sect1.9781683674832.ch0266s0003 SYSTEM "sect1.9781683674832.ch0266s0003.xml"><!ENTITY sect1.9781683674832.ch0267s0001 SYSTEM "sect1.9781683674832.ch0267s0001.xml"><!ENTITY sect1.9781683674832.ch0267s0002 SYSTEM "sect1.9781683674832.ch0267s0002.xml"><!ENTITY sect1.9781683674832.ch0267s0003 SYSTEM "sect1.9781683674832.ch0267s0003.xml"><!ENTITY sect1.9781683674832.ch0268s0001 SYSTEM "sect1.9781683674832.ch0268s0001.xml"><!ENTITY sect1.9781683674832.ch0268s0002 SYSTEM "sect1.9781683674832.ch0268s0002.xml"><!ENTITY sect1.9781683674832.ch0268s0003 SYSTEM "sect1.9781683674832.ch0268s0003.xml"><!ENTITY sect1.9781683674832.ch0269s0001 SYSTEM "sect1.9781683674832.ch0269s0001.xml"><!ENTITY sect1.9781683674832.ch0269s0002 SYSTEM "sect1.9781683674832.ch0269s0002.xml"><!ENTITY sect1.9781683674832.ch0269s0003 SYSTEM "sect1.9781683674832.ch0269s0003.xml"><!ENTITY sect1.9781683674832.ch0270s0001 SYSTEM "sect1.9781683674832.ch0270s0001.xml"><!ENTITY sect1.9781683674832.ch0270s0002 SYSTEM "sect1.9781683674832.ch0270s0002.xml"><!ENTITY sect1.9781683674832.ch0270s0003 SYSTEM "sect1.9781683674832.ch0270s0003.xml"><!ENTITY sect1.9781683674832.ch0271s0001 SYSTEM "sect1.9781683674832.ch0271s0001.xml"><!ENTITY sect1.9781683674832.ch0272s0001 SYSTEM "sect1.9781683674832.ch0272s0001.xml"><!ENTITY sect1.9781683674832.ch0272s0002 SYSTEM "sect1.9781683674832.ch0272s0002.xml"><!ENTITY sect1.9781683674832.ch0272s0003 SYSTEM "sect1.9781683674832.ch0272s0003.xml"><!ENTITY sect1.9781683674832.ch0273s0001 SYSTEM "sect1.9781683674832.ch0273s0001.xml"><!ENTITY sect1.9781683674832.ch0273s0002 SYSTEM "sect1.9781683674832.ch0273s0002.xml"><!ENTITY sect1.9781683674832.ch0273s0003 SYSTEM "sect1.9781683674832.ch0273s0003.xml"><!ENTITY sect1.9781683674832.ch0274s0001 SYSTEM "sect1.9781683674832.ch0274s0001.xml"><!ENTITY sect1.9781683674832.ch0275s0001 SYSTEM "sect1.9781683674832.ch0275s0001.xml"><!ENTITY sect1.9781683674832.ch0275s0002 SYSTEM "sect1.9781683674832.ch0275s0002.xml"><!ENTITY sect1.9781683674832.ch0275s0003 SYSTEM "sect1.9781683674832.ch0275s0003.xml"><!ENTITY sect1.9781683674832.ch0276s0001 SYSTEM "sect1.9781683674832.ch0276s0001.xml"><!ENTITY sect1.9781683674832.ch0276s0002 SYSTEM "sect1.9781683674832.ch0276s0002.xml"><!ENTITY sect1.9781683674832.ch0276s0003 SYSTEM "sect1.9781683674832.ch0276s0003.xml"><!ENTITY sect1.9781683674832.ch0277s0001 SYSTEM "sect1.9781683674832.ch0277s0001.xml"><!ENTITY sect1.9781683674832.ch0277s0002 SYSTEM "sect1.9781683674832.ch0277s0002.xml"><!ENTITY sect1.9781683674832.ch0277s0003 SYSTEM "sect1.9781683674832.ch0277s0003.xml"><!ENTITY sect1.9781683674832.ch0278s0001 SYSTEM "sect1.9781683674832.ch0278s0001.xml"><!ENTITY sect1.9781683674832.ch0278s0002 SYSTEM "sect1.9781683674832.ch0278s0002.xml"><!ENTITY sect1.9781683674832.ch0278s0003 SYSTEM "sect1.9781683674832.ch0278s0003.xml"><!ENTITY sect1.9781683674832.ch0279s0001 SYSTEM "sect1.9781683674832.ch0279s0001.xml"><!ENTITY sect1.9781683674832.ch0279s0002 SYSTEM "sect1.9781683674832.ch0279s0002.xml"><!ENTITY sect1.9781683674832.ch0279s0003 SYSTEM "sect1.9781683674832.ch0279s0003.xml"><!ENTITY sect1.9781683674832.ch0280s0001 SYSTEM "sect1.9781683674832.ch0280s0001.xml"><!ENTITY sect1.9781683674832.ch0280s0002 SYSTEM "sect1.9781683674832.ch0280s0002.xml"><!ENTITY sect1.9781683674832.ch0280s0003 SYSTEM "sect1.9781683674832.ch0280s0003.xml"><!ENTITY sect1.9781683674832.ch0281s0001 SYSTEM "sect1.9781683674832.ch0281s0001.xml"><!ENTITY sect1.9781683674832.ch0281s0002 SYSTEM "sect1.9781683674832.ch0281s0002.xml"><!ENTITY sect1.9781683674832.ch0281s0003 SYSTEM "sect1.9781683674832.ch0281s0003.xml"><!ENTITY sect1.9781683674832.ch0282s0004 SYSTEM "sect1.9781683674832.ch0282s0004.xml"><!ENTITY sect1.9781683674832.ch0282s0001 SYSTEM "sect1.9781683674832.ch0282s0001.xml"><!ENTITY sect1.9781683674832.ch0282s0002 SYSTEM "sect1.9781683674832.ch0282s0002.xml"><!ENTITY sect1.9781683674832.ch0282s0003 SYSTEM "sect1.9781683674832.ch0282s0003.xml"><!ENTITY sect1.9781683674832.ch0283s0001 SYSTEM "sect1.9781683674832.ch0283s0001.xml"><!ENTITY sect1.9781683674832.ch0283s0002 SYSTEM "sect1.9781683674832.ch0283s0002.xml"><!ENTITY sect1.9781683674832.ch0284s0001 SYSTEM "sect1.9781683674832.ch0284s0001.xml"><!ENTITY sect1.9781683674832.ch0284s0002 SYSTEM "sect1.9781683674832.ch0284s0002.xml"><!ENTITY sect1.9781683674832.ch0284s0003 SYSTEM "sect1.9781683674832.ch0284s0003.xml"><!ENTITY sect1.9781683674832.ch0285s0002 SYSTEM "sect1.9781683674832.ch0285s0002.xml"><!ENTITY sect1.9781683674832.ch0285s0001 SYSTEM "sect1.9781683674832.ch0285s0001.xml"><!ENTITY sect1.9781683674832.ch0286s0001 SYSTEM "sect1.9781683674832.ch0286s0001.xml"><!ENTITY sect1.9781683674832.ch0287s0001 SYSTEM "sect1.9781683674832.ch0287s0001.xml"><!ENTITY sect1.9781683674832.ch0287s0002 SYSTEM "sect1.9781683674832.ch0287s0002.xml"><!ENTITY sect1.9781683674832.ch0287s0003 SYSTEM "sect1.9781683674832.ch0287s0003.xml"><!ENTITY sect1.9781683674832.ch0288s0001 SYSTEM "sect1.9781683674832.ch0288s0001.xml"><!ENTITY sect1.9781683674832.ch0288s0002 SYSTEM "sect1.9781683674832.ch0288s0002.xml"><!ENTITY sect1.9781683674832.ch0288s0003 SYSTEM "sect1.9781683674832.ch0288s0003.xml"><!ENTITY sect1.9781683674832.ch0289s0001 SYSTEM "sect1.9781683674832.ch0289s0001.xml"><!ENTITY sect1.9781683674832.ch0289s0002 SYSTEM "sect1.9781683674832.ch0289s0002.xml"><!ENTITY sect1.9781683674832.ch0289s0003 SYSTEM "sect1.9781683674832.ch0289s0003.xml"><!ENTITY sect1.9781683674832.ch0290s0001 SYSTEM "sect1.9781683674832.ch0290s0001.xml"><!ENTITY sect1.9781683674832.ch0291s0002 SYSTEM "sect1.9781683674832.ch0291s0002.xml"><!ENTITY sect1.9781683674832.ch0291s0001 SYSTEM "sect1.9781683674832.ch0291s0001.xml"><!ENTITY sect1.9781683674832.ch0292s0002 SYSTEM "sect1.9781683674832.ch0292s0002.xml"><!ENTITY sect1.9781683674832.ch0292s0001 SYSTEM "sect1.9781683674832.ch0292s0001.xml"><!ENTITY sect1.9781683674832.ch0293s0002 SYSTEM "sect1.9781683674832.ch0293s0002.xml"><!ENTITY sect1.9781683674832.ch0293s0001 SYSTEM "sect1.9781683674832.ch0293s0001.xml"><!ENTITY sect1.9781683674832.ch0294s0001 SYSTEM "sect1.9781683674832.ch0294s0001.xml"><!ENTITY sect1.9781683674832.ch0295s0003 SYSTEM "sect1.9781683674832.ch0295s0003.xml"><!ENTITY sect1.9781683674832.ch0295s0001 SYSTEM "sect1.9781683674832.ch0295s0001.xml"><!ENTITY sect1.9781683674832.ch0295s0002 SYSTEM "sect1.9781683674832.ch0295s0002.xml"><!ENTITY sect1.9781683674832.ch0296s0001 SYSTEM "sect1.9781683674832.ch0296s0001.xml"><!ENTITY sect1.9781683674832.ch0297s0002 SYSTEM "sect1.9781683674832.ch0297s0002.xml"><!ENTITY sect1.9781683674832.ch0297s0001 SYSTEM "sect1.9781683674832.ch0297s0001.xml"><!ENTITY sect1.9781683674832.ch0298s0001 SYSTEM "sect1.9781683674832.ch0298s0001.xml"><!ENTITY sect1.9781683674832.ch0298s0002 SYSTEM "sect1.9781683674832.ch0298s0002.xml"><!ENTITY sect1.9781683674832.ch0298s0003 SYSTEM "sect1.9781683674832.ch0298s0003.xml"><!ENTITY sect1.9781683674832.ch0299s0002 SYSTEM "sect1.9781683674832.ch0299s0002.xml"><!ENTITY sect1.9781683674832.ch0299s0001 SYSTEM "sect1.9781683674832.ch0299s0001.xml"><!ENTITY sect1.9781683674832.ch0300s0002 SYSTEM "sect1.9781683674832.ch0300s0002.xml"><!ENTITY sect1.9781683674832.ch0300s0001 SYSTEM "sect1.9781683674832.ch0300s0001.xml"><!ENTITY sect1.9781683674832.ch0301s0004 SYSTEM "sect1.9781683674832.ch0301s0004.xml"><!ENTITY sect1.9781683674832.ch0301s0001 SYSTEM "sect1.9781683674832.ch0301s0001.xml"><!ENTITY sect1.9781683674832.ch0301s0002 SYSTEM "sect1.9781683674832.ch0301s0002.xml"><!ENTITY sect1.9781683674832.ch0301s0003 SYSTEM "sect1.9781683674832.ch0301s0003.xml"><!ENTITY sect1.9781683674832.ch0302s0004 SYSTEM "sect1.9781683674832.ch0302s0004.xml"><!ENTITY sect1.9781683674832.ch0302s0001 SYSTEM "sect1.9781683674832.ch0302s0001.xml"><!ENTITY sect1.9781683674832.ch0302s0002 SYSTEM "sect1.9781683674832.ch0302s0002.xml"><!ENTITY sect1.9781683674832.ch0302s0003 SYSTEM "sect1.9781683674832.ch0302s0003.xml"><!ENTITY sect1.9781683674832.ch0303s0004 SYSTEM "sect1.9781683674832.ch0303s0004.xml"><!ENTITY sect1.9781683674832.ch0303s0001 SYSTEM "sect1.9781683674832.ch0303s0001.xml"><!ENTITY sect1.9781683674832.ch0303s0002 SYSTEM "sect1.9781683674832.ch0303s0002.xml"><!ENTITY sect1.9781683674832.ch0303s0003 SYSTEM "sect1.9781683674832.ch0303s0003.xml"><!ENTITY sect1.9781683674832.ch0304s0004 SYSTEM "sect1.9781683674832.ch0304s0004.xml"><!ENTITY sect1.9781683674832.ch0304s0001 SYSTEM "sect1.9781683674832.ch0304s0001.xml"><!ENTITY sect1.9781683674832.ch0304s0002 SYSTEM "sect1.9781683674832.ch0304s0002.xml"><!ENTITY sect1.9781683674832.ch0304s0003 SYSTEM "sect1.9781683674832.ch0304s0003.xml"><!ENTITY sect1.9781683674832.ch0305s0001 SYSTEM "sect1.9781683674832.ch0305s0001.xml"><!ENTITY sect1.9781683674832.ch0306s0004 SYSTEM "sect1.9781683674832.ch0306s0004.xml"><!ENTITY sect1.9781683674832.ch0306s0001 SYSTEM "sect1.9781683674832.ch0306s0001.xml"><!ENTITY sect1.9781683674832.ch0306s0002 SYSTEM "sect1.9781683674832.ch0306s0002.xml"><!ENTITY sect1.9781683674832.ch0306s0003 SYSTEM "sect1.9781683674832.ch0306s0003.xml"><!ENTITY sect1.9781683674832.ch0307s0004 SYSTEM "sect1.9781683674832.ch0307s0004.xml"><!ENTITY sect1.9781683674832.ch0307s0001 SYSTEM "sect1.9781683674832.ch0307s0001.xml"><!ENTITY sect1.9781683674832.ch0307s0002 SYSTEM "sect1.9781683674832.ch0307s0002.xml"><!ENTITY sect1.9781683674832.ch0307s0003 SYSTEM "sect1.9781683674832.ch0307s0003.xml"><!ENTITY sect1.9781683674832.ch0308s0004 SYSTEM "sect1.9781683674832.ch0308s0004.xml"><!ENTITY sect1.9781683674832.ch0308s0001 SYSTEM "sect1.9781683674832.ch0308s0001.xml"><!ENTITY sect1.9781683674832.ch0308s0002 SYSTEM "sect1.9781683674832.ch0308s0002.xml"><!ENTITY sect1.9781683674832.ch0308s0003 SYSTEM "sect1.9781683674832.ch0308s0003.xml"><!ENTITY sect1.9781683674832.ch0309s0004 SYSTEM "sect1.9781683674832.ch0309s0004.xml"><!ENTITY sect1.9781683674832.ch0309s0001 SYSTEM "sect1.9781683674832.ch0309s0001.xml"><!ENTITY sect1.9781683674832.ch0309s0002 SYSTEM "sect1.9781683674832.ch0309s0002.xml"><!ENTITY sect1.9781683674832.ch0309s0003 SYSTEM "sect1.9781683674832.ch0309s0003.xml"><!ENTITY sect1.9781683674832.ch0310s0001 SYSTEM "sect1.9781683674832.ch0310s0001.xml"><!ENTITY sect1.9781683674832.ch0311s0001 SYSTEM "sect1.9781683674832.ch0311s0001.xml"><!ENTITY sect1.9781683674832.ch0312s0001 SYSTEM "sect1.9781683674832.ch0312s0001.xml"><!ENTITY sect1.9781683674832.ch0313s0001 SYSTEM "sect1.9781683674832.ch0313s0001.xml"><!ENTITY sect1.9781683674832.ch0313s0002 SYSTEM "sect1.9781683674832.ch0313s0002.xml"><!ENTITY sect1.9781683674832.ch0314s0001 SYSTEM "sect1.9781683674832.ch0314s0001.xml"><!ENTITY sect1.9781683674832.ch0315s0001 SYSTEM "sect1.9781683674832.ch0315s0001.xml"><!ENTITY sect1.9781683674832.ch0315s0002 SYSTEM "sect1.9781683674832.ch0315s0002.xml"><!ENTITY sect1.9781683674832.ch0315s0003 SYSTEM "sect1.9781683674832.ch0315s0003.xml"><!ENTITY sect1.9781683674832.ch0316s0001 SYSTEM "sect1.9781683674832.ch0316s0001.xml"><!ENTITY sect1.9781683674832.ch0316s0002 SYSTEM "sect1.9781683674832.ch0316s0002.xml"><!ENTITY sect1.9781683674832.ch0316s0003 SYSTEM "sect1.9781683674832.ch0316s0003.xml"><!ENTITY sect1.9781683674832.ch0317s0001 SYSTEM "sect1.9781683674832.ch0317s0001.xml"><!ENTITY sect1.9781683674832.ch0318s0001 SYSTEM "sect1.9781683674832.ch0318s0001.xml"><!ENTITY sect1.9781683674832.ch0318s0002 SYSTEM "sect1.9781683674832.ch0318s0002.xml"><!ENTITY sect1.9781683674832.ch0318s0003 SYSTEM "sect1.9781683674832.ch0318s0003.xml"><!ENTITY sect1.9781683674832.ch0319s0001 SYSTEM "sect1.9781683674832.ch0319s0001.xml"><!ENTITY sect1.9781683674832.ch0319s0002 SYSTEM "sect1.9781683674832.ch0319s0002.xml"><!ENTITY sect1.9781683674832.ch0319s0003 SYSTEM "sect1.9781683674832.ch0319s0003.xml"><!ENTITY sect1.9781683674832.ch0320s0001 SYSTEM "sect1.9781683674832.ch0320s0001.xml"><!ENTITY sect1.9781683674832.ch0321s0001 SYSTEM "sect1.9781683674832.ch0321s0001.xml"><!ENTITY sect1.9781683674832.ch0321s0002 SYSTEM "sect1.9781683674832.ch0321s0002.xml"><!ENTITY sect1.9781683674832.ch0321s0003 SYSTEM "sect1.9781683674832.ch0321s0003.xml"><!ENTITY sect1.9781683674832.ch0322s0001 SYSTEM "sect1.9781683674832.ch0322s0001.xml"><!ENTITY sect1.9781683674832.ch0322s0002 SYSTEM "sect1.9781683674832.ch0322s0002.xml"><!ENTITY sect1.9781683674832.ch0322s0003 SYSTEM "sect1.9781683674832.ch0322s0003.xml"><!ENTITY sect1.9781683674832.ch0323s0001 SYSTEM "sect1.9781683674832.ch0323s0001.xml"><!ENTITY sect1.9781683674832.ch0323s0002 SYSTEM "sect1.9781683674832.ch0323s0002.xml"><!ENTITY sect1.9781683674832.ch0323s0003 SYSTEM "sect1.9781683674832.ch0323s0003.xml"><!ENTITY sect1.9781683674832.ch0324s0001 SYSTEM "sect1.9781683674832.ch0324s0001.xml"><!ENTITY sect1.9781683674832.ch0324s0002 SYSTEM "sect1.9781683674832.ch0324s0002.xml"><!ENTITY sect1.9781683674832.ch0324s0003 SYSTEM "sect1.9781683674832.ch0324s0003.xml"><!ENTITY sect1.9781683674832.ch0325s0001 SYSTEM "sect1.9781683674832.ch0325s0001.xml"><!ENTITY sect1.9781683674832.ch0325s0002 SYSTEM "sect1.9781683674832.ch0325s0002.xml"><!ENTITY sect1.9781683674832.ch0325s0003 SYSTEM "sect1.9781683674832.ch0325s0003.xml"><!ENTITY sect1.9781683674832.ch0326s0001 SYSTEM "sect1.9781683674832.ch0326s0001.xml"><!ENTITY sect1.9781683674832.ch0326s0002 SYSTEM "sect1.9781683674832.ch0326s0002.xml"><!ENTITY sect1.9781683674832.ch0326s0003 SYSTEM "sect1.9781683674832.ch0326s0003.xml"><!ENTITY sect1.9781683674832.ch0327s0001 SYSTEM "sect1.9781683674832.ch0327s0001.xml"><!ENTITY sect1.9781683674832.ch0327s0002 SYSTEM "sect1.9781683674832.ch0327s0002.xml"><!ENTITY sect1.9781683674832.ch0327s0003 SYSTEM "sect1.9781683674832.ch0327s0003.xml"><!ENTITY sect1.9781683674832.ch0328s0001 SYSTEM "sect1.9781683674832.ch0328s0001.xml"><!ENTITY sect1.9781683674832.ch0328s0002 SYSTEM "sect1.9781683674832.ch0328s0002.xml"><!ENTITY sect1.9781683674832.ch0328s0003 SYSTEM "sect1.9781683674832.ch0328s0003.xml"><!ENTITY sect1.9781683674832.ch0328s0004 SYSTEM "sect1.9781683674832.ch0328s0004.xml"><!ENTITY sect1.9781683674832.ch0329s0001 SYSTEM "sect1.9781683674832.ch0329s0001.xml"><!ENTITY sect1.9781683674832.ch0329s0002 SYSTEM "sect1.9781683674832.ch0329s0002.xml"><!ENTITY sect1.9781683674832.ch0329s0003 SYSTEM "sect1.9781683674832.ch0329s0003.xml"><!ENTITY sect1.9781683674832.ch0330s0001 SYSTEM "sect1.9781683674832.ch0330s0001.xml"><!ENTITY sect1.9781683674832.ch0331s0001 SYSTEM "sect1.9781683674832.ch0331s0001.xml"><!ENTITY sect1.9781683674832.ch0331s0002 SYSTEM "sect1.9781683674832.ch0331s0002.xml"><!ENTITY sect1.9781683674832.ch0331s0003 SYSTEM "sect1.9781683674832.ch0331s0003.xml"><!ENTITY sect1.9781683674832.ch0332s0001 SYSTEM "sect1.9781683674832.ch0332s0001.xml"><!ENTITY sect1.9781683674832.ch0332s0002 SYSTEM "sect1.9781683674832.ch0332s0002.xml"><!ENTITY sect1.9781683674832.ch0332s0003 SYSTEM "sect1.9781683674832.ch0332s0003.xml"><!ENTITY sect1.9781683674832.ch0333s0001 SYSTEM "sect1.9781683674832.ch0333s0001.xml"><!ENTITY sect1.9781683674832.ch0334s0001 SYSTEM "sect1.9781683674832.ch0334s0001.xml"><!ENTITY sect1.9781683674832.ch0334s0002 SYSTEM "sect1.9781683674832.ch0334s0002.xml"><!ENTITY sect1.9781683674832.ch0334s0003 SYSTEM "sect1.9781683674832.ch0334s0003.xml"><!ENTITY sect1.9781683674832.ch0335s0004 SYSTEM "sect1.9781683674832.ch0335s0004.xml"><!ENTITY sect1.9781683674832.ch0335s0001 SYSTEM "sect1.9781683674832.ch0335s0001.xml"><!ENTITY sect1.9781683674832.ch0335s0002 SYSTEM "sect1.9781683674832.ch0335s0002.xml"><!ENTITY sect1.9781683674832.ch0335s0003 SYSTEM "sect1.9781683674832.ch0335s0003.xml"><!ENTITY sect1.9781683674832.ch0336s0001 SYSTEM "sect1.9781683674832.ch0336s0001.xml"><!ENTITY sect1.9781683674832.ch0337s0001 SYSTEM "sect1.9781683674832.ch0337s0001.xml"><!ENTITY sect1.9781683674832.ch0337s0002 SYSTEM "sect1.9781683674832.ch0337s0002.xml"><!ENTITY sect1.9781683674832.ch0337s0003 SYSTEM "sect1.9781683674832.ch0337s0003.xml"><!ENTITY sect1.9781683674832.ch0338s0001 SYSTEM "sect1.9781683674832.ch0338s0001.xml"><!ENTITY sect1.9781683674832.ch0338s0002 SYSTEM "sect1.9781683674832.ch0338s0002.xml"><!ENTITY sect1.9781683674832.ch0338s0003 SYSTEM "sect1.9781683674832.ch0338s0003.xml"><!ENTITY sect1.9781683674832.ch0339s0001 SYSTEM "sect1.9781683674832.ch0339s0001.xml"><!ENTITY sect1.9781683674832.ch0339s0002 SYSTEM "sect1.9781683674832.ch0339s0002.xml"><!ENTITY sect1.9781683674832.ch0339s0003 SYSTEM "sect1.9781683674832.ch0339s0003.xml"><!ENTITY sect1.9781683674832.ch0339s0004 SYSTEM "sect1.9781683674832.ch0339s0004.xml"><!ENTITY sect1.9781683674832.ch0340s0001 SYSTEM "sect1.9781683674832.ch0340s0001.xml"><!ENTITY sect1.9781683674832.ch0340s0002 SYSTEM "sect1.9781683674832.ch0340s0002.xml"><!ENTITY sect1.9781683674832.ch0340s0003 SYSTEM "sect1.9781683674832.ch0340s0003.xml"><!ENTITY sect1.9781683674832.ch0340s0004 SYSTEM "sect1.9781683674832.ch0340s0004.xml"><!ENTITY sect1.9781683674832.ch0341s0001 SYSTEM "sect1.9781683674832.ch0341s0001.xml"><!ENTITY sect1.9781683674832.ch0341s0002 SYSTEM "sect1.9781683674832.ch0341s0002.xml"><!ENTITY sect1.9781683674832.ch0341s0003 SYSTEM "sect1.9781683674832.ch0341s0003.xml"><!ENTITY sect1.9781683674832.ch0341s0004 SYSTEM "sect1.9781683674832.ch0341s0004.xml"><!ENTITY sect1.9781683674832.ch0342s0001 SYSTEM "sect1.9781683674832.ch0342s0001.xml"><!ENTITY sect1.9781683674832.ch0342s0002 SYSTEM "sect1.9781683674832.ch0342s0002.xml"><!ENTITY sect1.9781683674832.ch0342s0003 SYSTEM "sect1.9781683674832.ch0342s0003.xml"><!ENTITY sect1.9781683674832.ch0343s0001 SYSTEM "sect1.9781683674832.ch0343s0001.xml"><!ENTITY sect1.9781683674832.ch0344s0001 SYSTEM "sect1.9781683674832.ch0344s0001.xml"><!ENTITY sect1.9781683674832.ch0344s0002 SYSTEM "sect1.9781683674832.ch0344s0002.xml"><!ENTITY sect1.9781683674832.ch0344s0003 SYSTEM "sect1.9781683674832.ch0344s0003.xml"><!ENTITY sect1.9781683674832.ch0345s0001 SYSTEM "sect1.9781683674832.ch0345s0001.xml"><!ENTITY sect1.9781683674832.ch0345s0002 SYSTEM "sect1.9781683674832.ch0345s0002.xml"><!ENTITY sect1.9781683674832.ch0345s0003 SYSTEM "sect1.9781683674832.ch0345s0003.xml"><!ENTITY sect1.9781683674832.ch0346s0001 SYSTEM "sect1.9781683674832.ch0346s0001.xml"><!ENTITY sect1.9781683674832.ch0347s0001 SYSTEM "sect1.9781683674832.ch0347s0001.xml"><!ENTITY sect1.9781683674832.ch0347s0002 SYSTEM "sect1.9781683674832.ch0347s0002.xml"><!ENTITY sect1.9781683674832.ch0347s0003 SYSTEM "sect1.9781683674832.ch0347s0003.xml"><!ENTITY sect1.9781683674832.ch0348s0001 SYSTEM "sect1.9781683674832.ch0348s0001.xml"><!ENTITY sect1.9781683674832.ch0348s0002 SYSTEM "sect1.9781683674832.ch0348s0002.xml"><!ENTITY sect1.9781683674832.ch0348s0003 SYSTEM "sect1.9781683674832.ch0348s0003.xml"><!ENTITY sect1.9781683674832.ch0349s0001 SYSTEM "sect1.9781683674832.ch0349s0001.xml"><!ENTITY sect1.9781683674832.ch0349s0002 SYSTEM "sect1.9781683674832.ch0349s0002.xml"><!ENTITY sect1.9781683674832.ch0349s0003 SYSTEM "sect1.9781683674832.ch0349s0003.xml"><!ENTITY sect1.9781683674832.ch0350s0001 SYSTEM "sect1.9781683674832.ch0350s0001.xml"><!ENTITY sect1.9781683674832.ch0350s0002 SYSTEM "sect1.9781683674832.ch0350s0002.xml"><!ENTITY sect1.9781683674832.ch0350s0003 SYSTEM "sect1.9781683674832.ch0350s0003.xml"><!ENTITY sect1.9781683674832.ch0351s0001 SYSTEM "sect1.9781683674832.ch0351s0001.xml"><!ENTITY sect1.9781683674832.ch0351s0002 SYSTEM "sect1.9781683674832.ch0351s0002.xml"><!ENTITY sect1.9781683674832.ch0351s0003 SYSTEM "sect1.9781683674832.ch0351s0003.xml"><!ENTITY sect1.9781683674832.ch0352s0001 SYSTEM "sect1.9781683674832.ch0352s0001.xml"><!ENTITY sect1.9781683674832.ch0352s0002 SYSTEM "sect1.9781683674832.ch0352s0002.xml"><!ENTITY sect1.9781683674832.ch0352s0003 SYSTEM "sect1.9781683674832.ch0352s0003.xml"><!ENTITY sect1.9781683674832.ch0352s0004 SYSTEM "sect1.9781683674832.ch0352s0004.xml"><!ENTITY sect1.9781683674832.ch0352s0005 SYSTEM "sect1.9781683674832.ch0352s0005.xml"><!ENTITY sect1.9781683674832.ch0352s0006 SYSTEM "sect1.9781683674832.ch0352s0006.xml"><!ENTITY sect1.9781683674832.ch0352s0007 SYSTEM "sect1.9781683674832.ch0352s0007.xml"><!ENTITY sect1.9781683674832.ch0353s0001 SYSTEM "sect1.9781683674832.ch0353s0001.xml"><!ENTITY sect1.9781683674832.ch0353s0002 SYSTEM "sect1.9781683674832.ch0353s0002.xml"><!ENTITY sect1.9781683674832.ch0353s0003 SYSTEM "sect1.9781683674832.ch0353s0003.xml"><!ENTITY sect1.9781683674832.ch0354s0001 SYSTEM "sect1.9781683674832.ch0354s0001.xml"><!ENTITY sect1.9781683674832.ch0354s0002 SYSTEM "sect1.9781683674832.ch0354s0002.xml"><!ENTITY sect1.9781683674832.ch0354s0003 SYSTEM "sect1.9781683674832.ch0354s0003.xml"><!ENTITY sect1.9781683674832.ch0355s0001 SYSTEM "sect1.9781683674832.ch0355s0001.xml"><!ENTITY sect1.9781683674832.ch0355s0002 SYSTEM "sect1.9781683674832.ch0355s0002.xml"><!ENTITY sect1.9781683674832.ch0355s0003 SYSTEM "sect1.9781683674832.ch0355s0003.xml"><!ENTITY sect1.9781683674832.ch0356s0001 SYSTEM "sect1.9781683674832.ch0356s0001.xml"><!ENTITY sect1.9781683674832.ch0356s0002 SYSTEM "sect1.9781683674832.ch0356s0002.xml"><!ENTITY sect1.9781683674832.ch0356s0003 SYSTEM "sect1.9781683674832.ch0356s0003.xml"><!ENTITY sect1.9781683674832.ch0357s0001 SYSTEM "sect1.9781683674832.ch0357s0001.xml"><!ENTITY sect1.9781683674832.ch0357s0002 SYSTEM "sect1.9781683674832.ch0357s0002.xml"><!ENTITY sect1.9781683674832.ch0357s0003 SYSTEM "sect1.9781683674832.ch0357s0003.xml"><!ENTITY sect1.9781683674832.ch0358s0001 SYSTEM "sect1.9781683674832.ch0358s0001.xml"><!ENTITY sect1.9781683674832.ch0358s0002 SYSTEM "sect1.9781683674832.ch0358s0002.xml"><!ENTITY sect1.9781683674832.ch0358s0003 SYSTEM "sect1.9781683674832.ch0358s0003.xml"><!ENTITY sect1.9781683674832.ch0359s0001 SYSTEM "sect1.9781683674832.ch0359s0001.xml"><!ENTITY sect1.9781683674832.ch0359s0002 SYSTEM "sect1.9781683674832.ch0359s0002.xml"><!ENTITY sect1.9781683674832.ch0359s0003 SYSTEM "sect1.9781683674832.ch0359s0003.xml"><!ENTITY sect1.9781683674832.ch0360s0001 SYSTEM "sect1.9781683674832.ch0360s0001.xml"><!ENTITY sect1.9781683674832.ch0361s0001 SYSTEM "sect1.9781683674832.ch0361s0001.xml"><!ENTITY sect1.9781683674832.ch0362s0002 SYSTEM "sect1.9781683674832.ch0362s0002.xml"><!ENTITY sect1.9781683674832.ch0362s0001 SYSTEM "sect1.9781683674832.ch0362s0001.xml"><!ENTITY sect1.9781683674832.ch0363s0001 SYSTEM "sect1.9781683674832.ch0363s0001.xml"><!ENTITY sect1.9781683674832.ch0363s0002 SYSTEM "sect1.9781683674832.ch0363s0002.xml"><!ENTITY sect1.9781683674832.ch0363s0003 SYSTEM "sect1.9781683674832.ch0363s0003.xml"><!ENTITY sect1.9781683674832.ch0364s0001 SYSTEM "sect1.9781683674832.ch0364s0001.xml"><!ENTITY sect1.9781683674832.ch0365s0001 SYSTEM "sect1.9781683674832.ch0365s0001.xml"><!ENTITY sect1.9781683674832.ch0366s0001 SYSTEM "sect1.9781683674832.ch0366s0001.xml"><!ENTITY sect1.9781683674832.ch0367s0001 SYSTEM "sect1.9781683674832.ch0367s0001.xml"><!ENTITY sect1.9781683674832.ch0367s0002 SYSTEM "sect1.9781683674832.ch0367s0002.xml"><!ENTITY sect1.9781683674832.ch0367s0003 SYSTEM "sect1.9781683674832.ch0367s0003.xml"><!ENTITY sect1.9781683674832.ch0367s0004 SYSTEM "sect1.9781683674832.ch0367s0004.xml"><!ENTITY sect1.9781683674832.ch0368s0001 SYSTEM "sect1.9781683674832.ch0368s0001.xml"><!ENTITY sect1.9781683674832.ch0368s0002 SYSTEM "sect1.9781683674832.ch0368s0002.xml"><!ENTITY sect1.9781683674832.ch0368s0003 SYSTEM "sect1.9781683674832.ch0368s0003.xml"><!ENTITY sect1.9781683674832.ch0368s0004 SYSTEM "sect1.9781683674832.ch0368s0004.xml"><!ENTITY sect1.9781683674832.ch0368s0005 SYSTEM "sect1.9781683674832.ch0368s0005.xml"><!ENTITY sect1.9781683674832.ch0368s0006 SYSTEM "sect1.9781683674832.ch0368s0006.xml"><!ENTITY sect1.9781683674832.ch0369s0001 SYSTEM "sect1.9781683674832.ch0369s0001.xml"><!ENTITY sect1.9781683674832.ch0369s0002 SYSTEM "sect1.9781683674832.ch0369s0002.xml"><!ENTITY sect1.9781683674832.ch0369s0003 SYSTEM "sect1.9781683674832.ch0369s0003.xml"><!ENTITY sect1.9781683674832.ch0370s0001 SYSTEM "sect1.9781683674832.ch0370s0001.xml"><!ENTITY sect1.9781683674832.ch0370s0002 SYSTEM "sect1.9781683674832.ch0370s0002.xml"><!ENTITY sect1.9781683674832.ch0370s0003 SYSTEM "sect1.9781683674832.ch0370s0003.xml"><!ENTITY sect1.9781683674832.ch0371s0001 SYSTEM "sect1.9781683674832.ch0371s0001.xml"><!ENTITY sect1.9781683674832.ch0371s0002 SYSTEM "sect1.9781683674832.ch0371s0002.xml"><!ENTITY sect1.9781683674832.ch0371s0003 SYSTEM "sect1.9781683674832.ch0371s0003.xml"><!ENTITY sect1.9781683674832.ch0372s0001 SYSTEM "sect1.9781683674832.ch0372s0001.xml"><!ENTITY sect1.9781683674832.ch0372s0002 SYSTEM "sect1.9781683674832.ch0372s0002.xml"><!ENTITY sect1.9781683674832.ch0372s0003 SYSTEM "sect1.9781683674832.ch0372s0003.xml"><!ENTITY sect1.9781683674832.ch0373s0001 SYSTEM "sect1.9781683674832.ch0373s0001.xml"><!ENTITY sect1.9781683674832.ch0373s0002 SYSTEM "sect1.9781683674832.ch0373s0002.xml"><!ENTITY sect1.9781683674832.ch0373s0003 SYSTEM "sect1.9781683674832.ch0373s0003.xml"><!ENTITY sect1.9781683674832.ch0374s0001 SYSTEM "sect1.9781683674832.ch0374s0001.xml"><!ENTITY sect1.9781683674832.ch0374s0002 SYSTEM "sect1.9781683674832.ch0374s0002.xml"><!ENTITY sect1.9781683674832.ch0374s0003 SYSTEM "sect1.9781683674832.ch0374s0003.xml"><!ENTITY sect1.9781683674832.ch0375s0001 SYSTEM "sect1.9781683674832.ch0375s0001.xml"><!ENTITY sect1.9781683674832.ch0375s0002 SYSTEM "sect1.9781683674832.ch0375s0002.xml"><!ENTITY sect1.9781683674832.ch0375s0003 SYSTEM "sect1.9781683674832.ch0375s0003.xml"><!ENTITY sect1.9781683674832.ch0376s0001 SYSTEM "sect1.9781683674832.ch0376s0001.xml"><!ENTITY sect1.9781683674832.ch0377s0004 SYSTEM "sect1.9781683674832.ch0377s0004.xml"><!ENTITY sect1.9781683674832.ch0377s0001 SYSTEM "sect1.9781683674832.ch0377s0001.xml"><!ENTITY sect1.9781683674832.ch0377s0002 SYSTEM "sect1.9781683674832.ch0377s0002.xml"><!ENTITY sect1.9781683674832.ch0377s0003 SYSTEM "sect1.9781683674832.ch0377s0003.xml"><!ENTITY sect1.9781683674832.ch0378s0001 SYSTEM "sect1.9781683674832.ch0378s0001.xml"><!ENTITY sect1.9781683674832.ch0378s0002 SYSTEM "sect1.9781683674832.ch0378s0002.xml"><!ENTITY sect1.9781683674832.ch0378s0003 SYSTEM "sect1.9781683674832.ch0378s0003.xml"><!ENTITY sect1.9781683674832.ch0378s0004 SYSTEM "sect1.9781683674832.ch0378s0004.xml"><!ENTITY sect1.9781683674832.ch0378s0005 SYSTEM "sect1.9781683674832.ch0378s0005.xml"><!ENTITY sect1.9781683674832.ch0379s0001 SYSTEM "sect1.9781683674832.ch0379s0001.xml"><!ENTITY sect1.9781683674832.ch0380s0004 SYSTEM "sect1.9781683674832.ch0380s0004.xml"><!ENTITY sect1.9781683674832.ch0380s0001 SYSTEM "sect1.9781683674832.ch0380s0001.xml"><!ENTITY sect1.9781683674832.ch0380s0002 SYSTEM "sect1.9781683674832.ch0380s0002.xml"><!ENTITY sect1.9781683674832.ch0380s0003 SYSTEM "sect1.9781683674832.ch0380s0003.xml"><!ENTITY sect1.9781683674832.ch0381s0001 SYSTEM "sect1.9781683674832.ch0381s0001.xml"><!ENTITY sect1.9781683674832.ch0381s0002 SYSTEM "sect1.9781683674832.ch0381s0002.xml"><!ENTITY sect1.9781683674832.ch0381s0003 SYSTEM "sect1.9781683674832.ch0381s0003.xml"><!ENTITY sect1.9781683674832.ch0381s0004 SYSTEM "sect1.9781683674832.ch0381s0004.xml"><!ENTITY sect1.9781683674832.ch0382s0001 SYSTEM "sect1.9781683674832.ch0382s0001.xml"><!ENTITY sect1.9781683674832.ch0382s0002 SYSTEM "sect1.9781683674832.ch0382s0002.xml"><!ENTITY sect1.9781683674832.ch0382s0003 SYSTEM "sect1.9781683674832.ch0382s0003.xml"><!ENTITY sect1.9781683674832.ch0382s0004 SYSTEM "sect1.9781683674832.ch0382s0004.xml"><!ENTITY sect1.9781683674832.ch0382s0005 SYSTEM "sect1.9781683674832.ch0382s0005.xml"><!ENTITY sect1.9781683674832.ch0382s0006 SYSTEM "sect1.9781683674832.ch0382s0006.xml"><!ENTITY sect1.9781683674832.ch0382s0007 SYSTEM "sect1.9781683674832.ch0382s0007.xml"><!ENTITY sect1.9781683674832.ch0383s0001 SYSTEM "sect1.9781683674832.ch0383s0001.xml"><!ENTITY sect1.9781683674832.ch0384s0002 SYSTEM "sect1.9781683674832.ch0384s0002.xml"><!ENTITY sect1.9781683674832.ch0384s0001 SYSTEM "sect1.9781683674832.ch0384s0001.xml"><!ENTITY sect1.9781683674832.ch0385s0001 SYSTEM "sect1.9781683674832.ch0385s0001.xml"><!ENTITY sect1.9781683674832.ch0386s0001 SYSTEM "sect1.9781683674832.ch0386s0001.xml"><!ENTITY sect1.9781683674832.ch0386s0002 SYSTEM "sect1.9781683674832.ch0386s0002.xml"><!ENTITY sect1.9781683674832.ch0386s0003 SYSTEM "sect1.9781683674832.ch0386s0003.xml"><!ENTITY sect1.9781683674832.ch0387s0001 SYSTEM "sect1.9781683674832.ch0387s0001.xml"><!ENTITY sect1.9781683674832.ch0387s0002 SYSTEM "sect1.9781683674832.ch0387s0002.xml"><!ENTITY sect1.9781683674832.ch0387s0003 SYSTEM "sect1.9781683674832.ch0387s0003.xml"><!ENTITY sect1.9781683674832.ch0388s0001 SYSTEM "sect1.9781683674832.ch0388s0001.xml"><!ENTITY sect1.9781683674832.ch0388s0002 SYSTEM "sect1.9781683674832.ch0388s0002.xml"><!ENTITY sect1.9781683674832.ch0388s0003 SYSTEM "sect1.9781683674832.ch0388s0003.xml"><!ENTITY sect1.9781683674832.ch0389s0001 SYSTEM "sect1.9781683674832.ch0389s0001.xml"><!ENTITY sect1.9781683674832.ch0389s0002 SYSTEM "sect1.9781683674832.ch0389s0002.xml"><!ENTITY sect1.9781683674832.ch0389s0003 SYSTEM "sect1.9781683674832.ch0389s0003.xml"><!ENTITY sect1.9781683674832.ch0390s0001 SYSTEM "sect1.9781683674832.ch0390s0001.xml"><!ENTITY sect1.9781683674832.ch0390s0002 SYSTEM "sect1.9781683674832.ch0390s0002.xml"><!ENTITY sect1.9781683674832.ch0390s0003 SYSTEM "sect1.9781683674832.ch0390s0003.xml"><!ENTITY sect1.9781683674832.ch0391s0001 SYSTEM "sect1.9781683674832.ch0391s0001.xml"><!ENTITY sect1.9781683674832.ch0391s0002 SYSTEM "sect1.9781683674832.ch0391s0002.xml"><!ENTITY sect1.9781683674832.ch0391s0003 SYSTEM "sect1.9781683674832.ch0391s0003.xml"><!ENTITY sect1.9781683674832.ch0392s0001 SYSTEM "sect1.9781683674832.ch0392s0001.xml"><!ENTITY sect1.9781683674832.ch0393s0001 SYSTEM "sect1.9781683674832.ch0393s0001.xml"><!ENTITY sect1.9781683674832.ch0393s0002 SYSTEM "sect1.9781683674832.ch0393s0002.xml"><!ENTITY sect1.9781683674832.ch0393s0003 SYSTEM "sect1.9781683674832.ch0393s0003.xml"><!ENTITY sect1.9781683674832.ch0393s0004 SYSTEM "sect1.9781683674832.ch0393s0004.xml"><!ENTITY sect1.9781683674832.ch0394s0001 SYSTEM "sect1.9781683674832.ch0394s0001.xml"><!ENTITY sect1.9781683674832.ch0394s0002 SYSTEM "sect1.9781683674832.ch0394s0002.xml"><!ENTITY sect1.9781683674832.ch0394s0003 SYSTEM "sect1.9781683674832.ch0394s0003.xml"><!ENTITY sect1.9781683674832.ch0395s0001 SYSTEM "sect1.9781683674832.ch0395s0001.xml"><!ENTITY sect1.9781683674832.ch0395s0002 SYSTEM "sect1.9781683674832.ch0395s0002.xml"><!ENTITY sect1.9781683674832.ch0395s0003 SYSTEM "sect1.9781683674832.ch0395s0003.xml"><!ENTITY sect1.9781683674832.ch0395s0004 SYSTEM "sect1.9781683674832.ch0395s0004.xml"><!ENTITY sect1.9781683674832.ch0396s0001 SYSTEM "sect1.9781683674832.ch0396s0001.xml"><!ENTITY sect1.9781683674832.ch0396s0002 SYSTEM "sect1.9781683674832.ch0396s0002.xml"><!ENTITY sect1.9781683674832.ch0396s0003 SYSTEM "sect1.9781683674832.ch0396s0003.xml"><!ENTITY sect1.9781683674832.ch0397s0001 SYSTEM "sect1.9781683674832.ch0397s0001.xml"><!ENTITY sect1.9781683674832.ch0397s0002 SYSTEM "sect1.9781683674832.ch0397s0002.xml"><!ENTITY sect1.9781683674832.ch0397s0003 SYSTEM "sect1.9781683674832.ch0397s0003.xml"><!ENTITY sect1.9781683674832.ch0398s0001 SYSTEM "sect1.9781683674832.ch0398s0001.xml"><!ENTITY sect1.9781683674832.ch0398s0002 SYSTEM "sect1.9781683674832.ch0398s0002.xml"><!ENTITY sect1.9781683674832.ch0398s0003 SYSTEM "sect1.9781683674832.ch0398s0003.xml"><!ENTITY sect1.9781683674832.ch0399s0001 SYSTEM "sect1.9781683674832.ch0399s0001.xml"><!ENTITY sect1.9781683674832.ch0400s0001 SYSTEM "sect1.9781683674832.ch0400s0001.xml"><!ENTITY sect1.9781683674832.ch0400s0002 SYSTEM "sect1.9781683674832.ch0400s0002.xml"><!ENTITY sect1.9781683674832.ch0401s0002 SYSTEM "sect1.9781683674832.ch0401s0002.xml"><!ENTITY sect1.9781683674832.ch0401s0001 SYSTEM "sect1.9781683674832.ch0401s0001.xml"><!ENTITY sect1.9781683674832.ch0402s0001 SYSTEM "sect1.9781683674832.ch0402s0001.xml"><!ENTITY sect1.9781683674832.ch0403s0001 SYSTEM "sect1.9781683674832.ch0403s0001.xml"><!ENTITY sect1.9781683674832.ch0404s0001 SYSTEM "sect1.9781683674832.ch0404s0001.xml"><!ENTITY sect1.9781683674832.ch0404s0002 SYSTEM "sect1.9781683674832.ch0404s0002.xml"><!ENTITY sect1.9781683674832.ch0404s0003 SYSTEM "sect1.9781683674832.ch0404s0003.xml"><!ENTITY sect1.9781683674832.ch0405s0001 SYSTEM "sect1.9781683674832.ch0405s0001.xml"><!ENTITY sect1.9781683674832.ch0405s0002 SYSTEM "sect1.9781683674832.ch0405s0002.xml"><!ENTITY sect1.9781683674832.ch0405s0003 SYSTEM "sect1.9781683674832.ch0405s0003.xml"><!ENTITY sect1.9781683674832.ch0406s0001 SYSTEM "sect1.9781683674832.ch0406s0001.xml"><!ENTITY sect1.9781683674832.ch0406s0002 SYSTEM "sect1.9781683674832.ch0406s0002.xml"><!ENTITY sect1.9781683674832.ch0406s0003 SYSTEM "sect1.9781683674832.ch0406s0003.xml"><!ENTITY sect1.9781683674832.ch0407s0001 SYSTEM "sect1.9781683674832.ch0407s0001.xml"><!ENTITY sect1.9781683674832.ch0407s0002 SYSTEM "sect1.9781683674832.ch0407s0002.xml"><!ENTITY sect1.9781683674832.ch0407s0003 SYSTEM "sect1.9781683674832.ch0407s0003.xml"><!ENTITY sect1.9781683674832.ch0408s0001 SYSTEM "sect1.9781683674832.ch0408s0001.xml"><!ENTITY sect1.9781683674832.ch0408s0002 SYSTEM "sect1.9781683674832.ch0408s0002.xml"><!ENTITY sect1.9781683674832.ch0408s0003 SYSTEM "sect1.9781683674832.ch0408s0003.xml"><!ENTITY sect1.9781683674832.ch0409s0001 SYSTEM "sect1.9781683674832.ch0409s0001.xml"><!ENTITY sect1.9781683674832.ch0410s0001 SYSTEM "sect1.9781683674832.ch0410s0001.xml"><!ENTITY sect1.9781683674832.ch0410s0002 SYSTEM "sect1.9781683674832.ch0410s0002.xml"><!ENTITY sect1.9781683674832.ch0410s0003 SYSTEM "sect1.9781683674832.ch0410s0003.xml"><!ENTITY sect1.9781683674832.ch0411s0001 SYSTEM "sect1.9781683674832.ch0411s0001.xml"><!ENTITY sect1.9781683674832.ch0411s0002 SYSTEM "sect1.9781683674832.ch0411s0002.xml"><!ENTITY sect1.9781683674832.ch0411s0003 SYSTEM "sect1.9781683674832.ch0411s0003.xml"><!ENTITY sect1.9781683674832.ch0412s0001 SYSTEM "sect1.9781683674832.ch0412s0001.xml"><!ENTITY sect1.9781683674832.ch0412s0002 SYSTEM "sect1.9781683674832.ch0412s0002.xml"><!ENTITY sect1.9781683674832.ch0412s0003 SYSTEM "sect1.9781683674832.ch0412s0003.xml"><!ENTITY sect1.9781683674832.ch0412s0004 SYSTEM "sect1.9781683674832.ch0412s0004.xml"><!ENTITY sect1.9781683674832.ch0413s0001 SYSTEM "sect1.9781683674832.ch0413s0001.xml"><!ENTITY sect1.9781683674832.ch0413s0002 SYSTEM "sect1.9781683674832.ch0413s0002.xml"><!ENTITY sect1.9781683674832.ch0413s0003 SYSTEM "sect1.9781683674832.ch0413s0003.xml"><!ENTITY sect1.9781683674832.ch0414s0001 SYSTEM "sect1.9781683674832.ch0414s0001.xml"><!ENTITY sect1.9781683674832.ch0414s0002 SYSTEM "sect1.9781683674832.ch0414s0002.xml"><!ENTITY sect1.9781683674832.ch0414s0003 SYSTEM "sect1.9781683674832.ch0414s0003.xml"><!ENTITY sect1.9781683674832.ch0415s0001 SYSTEM "sect1.9781683674832.ch0415s0001.xml"><!ENTITY sect1.9781683674832.ch0416s0001 SYSTEM "sect1.9781683674832.ch0416s0001.xml"><!ENTITY sect1.9781683674832.ch0417s0002 SYSTEM "sect1.9781683674832.ch0417s0002.xml"><!ENTITY sect1.9781683674832.ch0417s0001 SYSTEM "sect1.9781683674832.ch0417s0001.xml"><!ENTITY sect1.9781683674832.ch0418s0001 SYSTEM "sect1.9781683674832.ch0418s0001.xml"><!ENTITY sect1.9781683674832.ch0419s0001 SYSTEM "sect1.9781683674832.ch0419s0001.xml"><!ENTITY sect1.9781683674832.ch0420s0001 SYSTEM "sect1.9781683674832.ch0420s0001.xml"><!ENTITY sect1.9781683674832.ch0421s0001 SYSTEM "sect1.9781683674832.ch0421s0001.xml"><!ENTITY sect1.9781683674832.ch0422s0001 SYSTEM "sect1.9781683674832.ch0422s0001.xml"><!ENTITY sect1.9781683674832.ch0422s0002 SYSTEM "sect1.9781683674832.ch0422s0002.xml"><!ENTITY sect1.9781683674832.ch0422s0003 SYSTEM "sect1.9781683674832.ch0422s0003.xml"><!ENTITY sect1.9781683674832.ch0423s0001 SYSTEM "sect1.9781683674832.ch0423s0001.xml"><!ENTITY sect1.9781683674832.ch0424s0001 SYSTEM "sect1.9781683674832.ch0424s0001.xml"><!ENTITY sect1.9781683674832.ch0425s0001 SYSTEM "sect1.9781683674832.ch0425s0001.xml"><!ENTITY sect1.9781683674832.ch0426s0001 SYSTEM "sect1.9781683674832.ch0426s0001.xml"><!ENTITY sect1.9781683674832.ch0427s0001 SYSTEM "sect1.9781683674832.ch0427s0001.xml"><!ENTITY sect1.9781683674832.ch0428s0001 SYSTEM "sect1.9781683674832.ch0428s0001.xml"><!ENTITY sect1.9781683674832.ch0428s0002 SYSTEM "sect1.9781683674832.ch0428s0002.xml"><!ENTITY sect1.9781683674832.ch0429s0001 SYSTEM "sect1.9781683674832.ch0429s0001.xml"><!ENTITY sect1.9781683674832.ch0429s0002 SYSTEM "sect1.9781683674832.ch0429s0002.xml"><!ENTITY sect1.9781683674832.ch0430s0001 SYSTEM "sect1.9781683674832.ch0430s0001.xml"><!ENTITY sect1.9781683674832.ch0431s0001 SYSTEM "sect1.9781683674832.ch0431s0001.xml"><!ENTITY sect1.9781683674832.ch0432s0001 SYSTEM "sect1.9781683674832.ch0432s0001.xml"><!ENTITY sect1.9781683674832.ch0433s0002 SYSTEM "sect1.9781683674832.ch0433s0002.xml"><!ENTITY sect1.9781683674832.ch0433s0001 SYSTEM "sect1.9781683674832.ch0433s0001.xml"><!ENTITY sect1.9781683674832.ch0434s0004 SYSTEM "sect1.9781683674832.ch0434s0004.xml"><!ENTITY sect1.9781683674832.ch0434s0001 SYSTEM "sect1.9781683674832.ch0434s0001.xml"><!ENTITY sect1.9781683674832.ch0434s0002 SYSTEM "sect1.9781683674832.ch0434s0002.xml"><!ENTITY sect1.9781683674832.ch0434s0003 SYSTEM "sect1.9781683674832.ch0434s0003.xml"><!ENTITY sect1.9781683674832.ch0435s0004 SYSTEM "sect1.9781683674832.ch0435s0004.xml"><!ENTITY sect1.9781683674832.ch0435s0001 SYSTEM "sect1.9781683674832.ch0435s0001.xml"><!ENTITY sect1.9781683674832.ch0435s0002 SYSTEM "sect1.9781683674832.ch0435s0002.xml"><!ENTITY sect1.9781683674832.ch0435s0003 SYSTEM "sect1.9781683674832.ch0435s0003.xml"><!ENTITY sect1.9781683674832.ch0436s0001 SYSTEM "sect1.9781683674832.ch0436s0001.xml"><!ENTITY sect1.9781683674832.ch0437s0001 SYSTEM "sect1.9781683674832.ch0437s0001.xml"><!ENTITY sect1.9781683674832.ch0438s0002 SYSTEM "sect1.9781683674832.ch0438s0002.xml"><!ENTITY sect1.9781683674832.ch0438s0001 SYSTEM "sect1.9781683674832.ch0438s0001.xml"><!ENTITY sect1.9781683674832.ch0439s0002 SYSTEM "sect1.9781683674832.ch0439s0002.xml"><!ENTITY sect1.9781683674832.ch0439s0001 SYSTEM "sect1.9781683674832.ch0439s0001.xml"><!ENTITY sect1.9781683674832.ch0440s0001 SYSTEM "sect1.9781683674832.ch0440s0001.xml"><!ENTITY sect1.9781683674832.ch0441s0001 SYSTEM "sect1.9781683674832.ch0441s0001.xml"><!ENTITY sect1.9781683674832.ch0442s0004 SYSTEM "sect1.9781683674832.ch0442s0004.xml"><!ENTITY sect1.9781683674832.ch0442s0001 SYSTEM "sect1.9781683674832.ch0442s0001.xml"><!ENTITY sect1.9781683674832.ch0442s0002 SYSTEM "sect1.9781683674832.ch0442s0002.xml"><!ENTITY sect1.9781683674832.ch0442s0003 SYSTEM "sect1.9781683674832.ch0442s0003.xml"><!ENTITY sect1.9781683674832.ch0443s0004 SYSTEM "sect1.9781683674832.ch0443s0004.xml"><!ENTITY sect1.9781683674832.ch0443s0001 SYSTEM "sect1.9781683674832.ch0443s0001.xml"><!ENTITY sect1.9781683674832.ch0443s0002 SYSTEM "sect1.9781683674832.ch0443s0002.xml"><!ENTITY sect1.9781683674832.ch0443s0003 SYSTEM "sect1.9781683674832.ch0443s0003.xml"><!ENTITY sect1.9781683674832.ch0444s0002 SYSTEM "sect1.9781683674832.ch0444s0002.xml"><!ENTITY sect1.9781683674832.ch0444s0001 SYSTEM "sect1.9781683674832.ch0444s0001.xml"><!ENTITY sect1.9781683674832.ch0445s0004 SYSTEM "sect1.9781683674832.ch0445s0004.xml"><!ENTITY sect1.9781683674832.ch0445s0001 SYSTEM "sect1.9781683674832.ch0445s0001.xml"><!ENTITY sect1.9781683674832.ch0445s0002 SYSTEM "sect1.9781683674832.ch0445s0002.xml"><!ENTITY sect1.9781683674832.ch0445s0003 SYSTEM "sect1.9781683674832.ch0445s0003.xml"><!ENTITY sect1.9781683674832.ch0446s0002 SYSTEM "sect1.9781683674832.ch0446s0002.xml"><!ENTITY sect1.9781683674832.ch0446s0001 SYSTEM "sect1.9781683674832.ch0446s0001.xml"><!ENTITY sect1.9781683674832.ch0447s0001 SYSTEM "sect1.9781683674832.ch0447s0001.xml"><!ENTITY sect1.9781683674832.ch0448s0001 SYSTEM "sect1.9781683674832.ch0448s0001.xml"><!ENTITY sect1.9781683674832.ch0449s0001 SYSTEM "sect1.9781683674832.ch0449s0001.xml"><!ENTITY sect1.9781683674832.ch0450s0001 SYSTEM "sect1.9781683674832.ch0450s0001.xml"><!ENTITY sect1.9781683674832.ch0451s0001 SYSTEM "sect1.9781683674832.ch0451s0001.xml"><!ENTITY sect1.9781683674832.ch0452s0001 SYSTEM "sect1.9781683674832.ch0452s0001.xml"><!ENTITY sect1.9781683674832.ch0453s0001 SYSTEM "sect1.9781683674832.ch0453s0001.xml"><!ENTITY sect1.9781683674832.ch0454s0002 SYSTEM "sect1.9781683674832.ch0454s0002.xml"><!ENTITY sect1.9781683674832.ch0454s0001 SYSTEM "sect1.9781683674832.ch0454s0001.xml"><!ENTITY sect1.9781683674832.ch0455s0002 SYSTEM "sect1.9781683674832.ch0455s0002.xml"><!ENTITY sect1.9781683674832.ch0455s0001 SYSTEM "sect1.9781683674832.ch0455s0001.xml"><!ENTITY sect1.9781683674832.ch0456s0001 SYSTEM "sect1.9781683674832.ch0456s0001.xml"><!ENTITY sect1.9781683674832.ch0457s0002 SYSTEM "sect1.9781683674832.ch0457s0002.xml"><!ENTITY sect1.9781683674832.ch0457s0001 SYSTEM "sect1.9781683674832.ch0457s0001.xml"><!ENTITY sect1.9781683674832.ch0458s0001 SYSTEM "sect1.9781683674832.ch0458s0001.xml"><!ENTITY sect1.9781683674832.ch0459s0001 SYSTEM "sect1.9781683674832.ch0459s0001.xml"><!ENTITY sect1.9781683674832.ch0460s0001 SYSTEM "sect1.9781683674832.ch0460s0001.xml"><!ENTITY sect1.9781683674832.ch0460s0002 SYSTEM "sect1.9781683674832.ch0460s0002.xml"><!ENTITY sect1.9781683674832.ch0460s0003 SYSTEM "sect1.9781683674832.ch0460s0003.xml"><!ENTITY sect1.9781683674832.ch0461s0001 SYSTEM "sect1.9781683674832.ch0461s0001.xml"><!ENTITY sect1.9781683674832.ch0461s0002 SYSTEM "sect1.9781683674832.ch0461s0002.xml"><!ENTITY sect1.9781683674832.ch0461s0003 SYSTEM "sect1.9781683674832.ch0461s0003.xml"><!ENTITY sect1.9781683674832.ch0462s0001 SYSTEM "sect1.9781683674832.ch0462s0001.xml"><!ENTITY sect1.9781683674832.ch0462s0002 SYSTEM "sect1.9781683674832.ch0462s0002.xml"><!ENTITY sect1.9781683674832.ch0462s0003 SYSTEM "sect1.9781683674832.ch0462s0003.xml"><!ENTITY sect1.9781683674832.ch0463s0001 SYSTEM "sect1.9781683674832.ch0463s0001.xml"><!ENTITY sect1.9781683674832.ch0463s0002 SYSTEM "sect1.9781683674832.ch0463s0002.xml"><!ENTITY sect1.9781683674832.ch0463s0003 SYSTEM "sect1.9781683674832.ch0463s0003.xml"><!ENTITY sect1.9781683674832.ch0464s0001 SYSTEM "sect1.9781683674832.ch0464s0001.xml"><!ENTITY sect1.9781683674832.ch0464s0002 SYSTEM "sect1.9781683674832.ch0464s0002.xml"><!ENTITY sect1.9781683674832.ch0464s0003 SYSTEM "sect1.9781683674832.ch0464s0003.xml"><!ENTITY sect1.9781683674832.ch0465s0001 SYSTEM "sect1.9781683674832.ch0465s0001.xml"><!ENTITY sect1.9781683674832.ch0465s0002 SYSTEM "sect1.9781683674832.ch0465s0002.xml"><!ENTITY sect1.9781683674832.ch0465s0003 SYSTEM "sect1.9781683674832.ch0465s0003.xml"><!ENTITY sect1.9781683674832.ch0466s0001 SYSTEM "sect1.9781683674832.ch0466s0001.xml"><!ENTITY sect1.9781683674832.ch0466s0002 SYSTEM "sect1.9781683674832.ch0466s0002.xml"><!ENTITY sect1.9781683674832.ch0466s0003 SYSTEM "sect1.9781683674832.ch0466s0003.xml"><!ENTITY sect1.9781683674832.ch0467s0001 SYSTEM "sect1.9781683674832.ch0467s0001.xml"><!ENTITY sect1.9781683674832.ch0467s0002 SYSTEM "sect1.9781683674832.ch0467s0002.xml"><!ENTITY sect1.9781683674832.ch0467s0003 SYSTEM "sect1.9781683674832.ch0467s0003.xml"><!ENTITY sect1.9781683674832.ch0468s0001 SYSTEM "sect1.9781683674832.ch0468s0001.xml"><!ENTITY sect1.9781683674832.ch0468s0002 SYSTEM "sect1.9781683674832.ch0468s0002.xml"><!ENTITY sect1.9781683674832.ch0468s0003 SYSTEM "sect1.9781683674832.ch0468s0003.xml"><!ENTITY sect1.9781683674832.ch0469s0001 SYSTEM "sect1.9781683674832.ch0469s0001.xml"><!ENTITY sect1.9781683674832.ch0469s0002 SYSTEM "sect1.9781683674832.ch0469s0002.xml"><!ENTITY sect1.9781683674832.ch0470s0001 SYSTEM "sect1.9781683674832.ch0470s0001.xml"><!ENTITY sect1.9781683674832.ch0470s0002 SYSTEM "sect1.9781683674832.ch0470s0002.xml"><!ENTITY sect1.9781683674832.ch0471s0001 SYSTEM "sect1.9781683674832.ch0471s0001.xml"><!ENTITY sect1.9781683674832.ch0472s0001 SYSTEM "sect1.9781683674832.ch0472s0001.xml"><!ENTITY sect1.9781683674832.ch0473s0001 SYSTEM "sect1.9781683674832.ch0473s0001.xml"><!ENTITY sect1.9781683674832.ch0473s0002 SYSTEM "sect1.9781683674832.ch0473s0002.xml"><!ENTITY sect1.9781683674832.ch0473s0003 SYSTEM "sect1.9781683674832.ch0473s0003.xml"><!ENTITY sect1.9781683674832.ch0474s0001 SYSTEM "sect1.9781683674832.ch0474s0001.xml"><!ENTITY sect1.9781683674832.ch0474s0002 SYSTEM "sect1.9781683674832.ch0474s0002.xml"><!ENTITY sect1.9781683674832.ch0474s0003 SYSTEM "sect1.9781683674832.ch0474s0003.xml"><!ENTITY sect1.9781683674832.ch0475s0001 SYSTEM "sect1.9781683674832.ch0475s0001.xml"><!ENTITY sect1.9781683674832.ch0475s0002 SYSTEM "sect1.9781683674832.ch0475s0002.xml"><!ENTITY sect1.9781683674832.ch0475s0003 SYSTEM "sect1.9781683674832.ch0475s0003.xml"><!ENTITY sect1.9781683674832.ch0476s0001 SYSTEM "sect1.9781683674832.ch0476s0001.xml"><!ENTITY sect1.9781683674832.ch0476s0002 SYSTEM "sect1.9781683674832.ch0476s0002.xml"><!ENTITY sect1.9781683674832.ch0476s0003 SYSTEM "sect1.9781683674832.ch0476s0003.xml"><!ENTITY sect1.9781683674832.ch0477s0001 SYSTEM "sect1.9781683674832.ch0477s0001.xml"><!ENTITY sect1.9781683674832.ch0477s0002 SYSTEM "sect1.9781683674832.ch0477s0002.xml"><!ENTITY sect1.9781683674832.ch0477s0003 SYSTEM "sect1.9781683674832.ch0477s0003.xml"><!ENTITY sect1.9781683674832.ch0478s0001 SYSTEM "sect1.9781683674832.ch0478s0001.xml"><!ENTITY sect1.9781683674832.ch0478s0002 SYSTEM "sect1.9781683674832.ch0478s0002.xml"><!ENTITY sect1.9781683674832.ch0478s0003 SYSTEM "sect1.9781683674832.ch0478s0003.xml"><!ENTITY sect1.9781683674832.ch0479s0001 SYSTEM "sect1.9781683674832.ch0479s0001.xml"><!ENTITY sect1.9781683674832.ch0479s0002 SYSTEM "sect1.9781683674832.ch0479s0002.xml"><!ENTITY sect1.9781683674832.ch0479s0003 SYSTEM "sect1.9781683674832.ch0479s0003.xml"><!ENTITY sect1.9781683674832.ch0480s0001 SYSTEM "sect1.9781683674832.ch0480s0001.xml"><!ENTITY preface.9781683674832.pr0001 SYSTEM "preface.9781683674832.pr0001.xml"><!ENTITY preface.9781683674832.pr0002 SYSTEM "preface.9781683674832.pr0002.xml"><!ENTITY preface.9781683674832.pr0003 SYSTEM "preface.9781683674832.pr0003.xml"><!ENTITY preface.9781683674832.pr0004 SYSTEM "preface.9781683674832.pr0004.xml"><!ENTITY dedication.9781683674832.dd0001 SYSTEM "dedication.9781683674832.dd0001.xml"><!ENTITY preface.9781683674832.pr0005 SYSTEM "preface.9781683674832.pr0005.xml"><!ENTITY sect1.9781683674832.ch0007s0006 SYSTEM "sect1.9781683674832.ch0007s0006.xml"><!ENTITY sect1.9781683674832.ch0052s0002 SYSTEM "sect1.9781683674832.ch0052s0002.xml"><!ENTITY sect1.9781683674832.ch0054s0009 SYSTEM "sect1.9781683674832.ch0054s0009.xml"><!ENTITY sect1.9781683674832.ch0055s0009 SYSTEM "sect1.9781683674832.ch0055s0009.xml"><!ENTITY sect1.9781683674832.ch0056s0009 SYSTEM "sect1.9781683674832.ch0056s0009.xml"><!ENTITY sect1.9781683674832.ch0057s0009 SYSTEM "sect1.9781683674832.ch0057s0009.xml"><!ENTITY sect1.9781683674832.ch0058s0009 SYSTEM "sect1.9781683674832.ch0058s0009.xml"><!ENTITY sect1.9781683674832.ch0059s0009 SYSTEM "sect1.9781683674832.ch0059s0009.xml"><!ENTITY sect1.9781683674832.ch0060s0009 SYSTEM "sect1.9781683674832.ch0060s0009.xml"><!ENTITY sect1.9781683674832.ch0061s0009 SYSTEM "sect1.9781683674832.ch0061s0009.xml"><!ENTITY sect1.9781683674832.ch0062s0009 SYSTEM "sect1.9781683674832.ch0062s0009.xml"><!ENTITY sect1.9781683674832.ch0063s0009 SYSTEM "sect1.9781683674832.ch0063s0009.xml"><!ENTITY sect1.9781683674832.ch0064s0009 SYSTEM "sect1.9781683674832.ch0064s0009.xml"><!ENTITY sect1.9781683674832.ch0065s0009 SYSTEM "sect1.9781683674832.ch0065s0009.xml"><!ENTITY sect1.9781683674832.ch0066s0009 SYSTEM "sect1.9781683674832.ch0066s0009.xml"><!ENTITY sect1.9781683674832.ch0067s0009 SYSTEM "sect1.9781683674832.ch0067s0009.xml"><!ENTITY sect1.9781683674832.ch0068s0009 SYSTEM "sect1.9781683674832.ch0068s0009.xml"><!ENTITY sect1.9781683674832.ch0069s0009 SYSTEM "sect1.9781683674832.ch0069s0009.xml"><!ENTITY sect1.9781683674832.ch0070s0009 SYSTEM "sect1.9781683674832.ch0070s0009.xml"><!ENTITY sect1.9781683674832.ch0071s0009 SYSTEM "sect1.9781683674832.ch0071s0009.xml"><!ENTITY sect1.9781683674832.ch0072s0009 SYSTEM "sect1.9781683674832.ch0072s0009.xml">]><?aptxml version="1.0" encoding="utf-8"?>
<book id="b001">
   <bookinfo>
      <isbn>9781683674832</isbn>
      <title>Clinical Microbiology Procedures Handbook</title>
      <primaryauthor>
         <personname>
            <firstname>Amy L.</firstname>
            <surname>Leber</surname>
         </personname>
      </primaryauthor>
      <authorgroup>
         <author>
            <personname>
               <firstname>Amy L.</firstname>
               <surname>Leber</surname>
            </personname>
         </author>
         <author>
            <personname>
               <firstname>Carey-Ann D.</firstname>
               <surname>Burnham</surname>
            </personname>
         </author>
      </authorgroup>
      <publisher>
         <publishername>John Wiley &amp; Sons</publishername>
      </publisher>
      <pubdate>2023</pubdate>
      <edition>1st Edition</edition>
      <copyright>
         <year>2024</year>
         <holder>Copyright Holder</holder>
      </copyright>
   </bookinfo> &preface.9781683674832.pr0001;
     &preface.9781683674832.pr0002;
     &preface.9781683674832.pr0003;
     &preface.9781683674832.pr0004;
     &dedication.9781683674832.dd0001;
    <chapter id="ch0001" label="1" role="frontmatter">
      <title>
         <emphasis role="strong">Editorial Board</emphasis>
      </title> &sect1.9781683674832.ch0001s0001;
    </chapter>
   <chapter id="ch0002" label="2" role="contributors">
      <title>
         <emphasis role="strong">Contributors</emphasis>
      </title> &sect1.9781683674832.ch0002s0002;
     &sect1.9781683674832.ch0002s0001;
    </chapter>
   <chapter id="ch0003" label="3" role="frontmatter">
      <title>Author and Editor Conflicts of Interest</title> &sect1.9781683674832.ch0003s0001;
    </chapter> &preface.9781683674832.pr0005;
    <chapter id="ch0004" label="Acknowledgments" role="acknowledgments">
      <title>Acknowledgments</title> &sect1.9781683674832.ch0004s0001;
    </chapter>
   <chapter id="ch0005" label="5" role="frontmatter">
      <title>How To Use This Handbook</title> &sect1.9781683674832.ch0005s0001;
     &sect1.9781683674832.ch0005s0002;
     &sect1.9781683674832.ch0005s0003;
     &sect1.9781683674832.ch0005s0004;
    </chapter>
   <chapter id="ch0006" label="6" role="frontmatter">
      <title>Abbreviations</title> &sect1.9781683674832.ch0006s0002;
     &sect1.9781683674832.ch0006s0001;
    </chapter>
   <part id="pt0001">
      <title>
         <emphasis role="partNumber">SECTION 1</emphasis><?lb?>
         <emphasis role="partTitle">Procedure Coding, Reimbursement, and Billing Compliance</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">Vickie S. Baselski and Alice S. Weissfeld</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0001s0001;
<chapter id="ch0007" label="7">
         <title>
            <emphasis role="chapterNumber">1.1</emphasis>
            <emphasis role="chapterTitle">Introduction</emphasis>
         </title> &sect1.9781683674832.ch0007s0001;
     &sect1.9781683674832.ch0007s0002;
     &sect1.9781683674832.ch0007s0003;
     &sect1.9781683674832.ch0007s0004;
     &sect1.9781683674832.ch0007s0005;
     &sect1.9781683674832.ch0007s0007;
     &sect1.9781683674832.ch0007s0008;
     &sect1.9781683674832.ch0007s0006;
    </chapter>
      <chapter id="ch0008" label="8">
         <title>
            <emphasis role="chapterNumber">1.2</emphasis>
            <emphasis role="chapterTitle">P <emphasis role="small">ROCEDURE</emphasis> C <emphasis role="small">ODING</emphasis>, R <emphasis role="small">EIMBURSEMENT</emphasis>, <emphasis role="small">AND</emphasis> B <emphasis role="small">ILLING</emphasis> C <emphasis role="small">OMPLIANCE</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0008s0001;
     &sect1.9781683674832.ch0008s0002;
     &sect1.9781683674832.ch0008s0003;
    </chapter>
      <chapter id="ch0009" label="9">
         <title>
            <emphasis role="chapterNumber">1.2.2</emphasis>
            <emphasis role="chapterTitle">Procedure Billing</emphasis>
         </title> &sect1.9781683674832.ch0009s0001;
     &sect1.9781683674832.ch0009s0002;
     &sect1.9781683674832.ch0009s0003;
    </chapter>
      <chapter id="ch0010" label="10">
         <title>
            <emphasis role="chapterNumber">1.2.3</emphasis>
            <emphasis role="chapterTitle">Coverage of Laboratory Services</emphasis>
         </title> &sect1.9781683674832.ch0010s0001;
     &sect1.9781683674832.ch0010s0002;
     &sect1.9781683674832.ch0010s0003;
    </chapter>
      <chapter id="ch0011" label="11">
         <title>
            <emphasis role="chapterNumber">1.2.4</emphasis>
            <emphasis role="chapterTitle">Billing Compliance Programs</emphasis>
         </title> &sect1.9781683674832.ch0011s0001;
     &sect1.9781683674832.ch0011s0002;
     &sect1.9781683674832.ch0011s0003;
     &sect1.9781683674832.ch0011s0004;
     &sect1.9781683674832.ch0011s0005;
     &sect1.9781683674832.ch0011s0006;
     &sect1.9781683674832.ch0011s0007;
     &sect1.9781683674832.ch0011s0008;
     &sect1.9781683674832.ch0011s0009;
     &sect1.9781683674832.ch0011s0010;
     &sect1.9781683674832.ch0011s0011;
    </chapter>
   </part>
   <part id="pt0002">
      <title>
         <emphasis role="partNumber">SECTION 2</emphasis><?lb?>
         <emphasis role="partTitle">Specimen Collection, Transport, and Acceptability</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">Andrea J. Linscott and Huanyu Wang</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0002s0001;
<chapter id="ch0012" label="12">
         <title>
            <emphasis role="chapterNumber">2.1</emphasis>
            <emphasis role="chapterTitle">Collection, Transport, and Manipulation of Clinical Specimens and Other Preanalytical Concerns</emphasis>
         </title> &sect1.9781683674832.ch0012s0005;
     &sect1.9781683674832.ch0012s0001;
     &sect1.9781683674832.ch0012s0002;
     &sect1.9781683674832.ch0012s0003;
     &sect1.9781683674832.ch0012s0004;
    </chapter>
   </part>
   <part id="pt0003">
      <title>
         <emphasis role="partNumber">SECTION 3</emphasis><?lb?>
         <emphasis role="partTitle">Aerobic Bacteriology</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">Amanda T. Harrington and Melanie L. Yarbrough</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0003s0001;
<chapter id="ch0013" label="13">
         <title>
            <emphasis role="chapterNumber">3.1</emphasis>
            <emphasis role="chapterTitle">Introduction</emphasis>
         </title> &sect1.9781683674832.ch0013s0001;
    </chapter>
      <chapter id="ch0014" label="14">
         <title>
            <emphasis role="chapterNumber">3.2</emphasis>
            <emphasis role="chapterTitle">Staining Procedures</emphasis>
         </title> &sect1.9781683674832.ch0014s0001;
     &sect1.9781683674832.ch0014s0002;
     &sect1.9781683674832.ch0014s0003;
     &sect1.9781683674832.ch0014s0004;
     &sect1.9781683674832.ch0014s0005;
     &sect1.9781683674832.ch0014s0006;
    </chapter>
      <chapter id="ch0015" label="15">
         <title>
            <emphasis role="chapterNumber">3.2.2</emphasis>
            <emphasis role="chapterTitle">Acridine Orange Stain</emphasis>
         </title> &sect1.9781683674832.ch0015s0001;
     &sect1.9781683674832.ch0015s0002;
     &sect1.9781683674832.ch0015s0003;
     &sect1.9781683674832.ch0015s0004;
     &sect1.9781683674832.ch0015s0005;
     &sect1.9781683674832.ch0015s0006;
     &sect1.9781683674832.ch0015s0007;
    </chapter>
      <chapter id="ch0016" label="16">
         <title>
            <emphasis role="chapterNumber">3.2.3</emphasis>
            <emphasis role="chapterTitle">Vaginal Wet Mount</emphasis>
         </title> &sect1.9781683674832.ch0016s0001;
     &sect1.9781683674832.ch0016s0002;
     &sect1.9781683674832.ch0016s0003;
    </chapter>
      <chapter id="ch0017" label="17">
         <title>
            <emphasis role="chapterNumber">3.2.4</emphasis>
            <emphasis role="chapterTitle">Methylene Blue Stain for Fecal Leukocytes</emphasis>
         </title> &sect1.9781683674832.ch0017s0001;
     &sect1.9781683674832.ch0017s0002;
     &sect1.9781683674832.ch0017s0003;
     &sect1.9781683674832.ch0017s0004;
    </chapter>
      <chapter id="ch0018" label="18">
         <title>
            <emphasis role="chapterNumber">3.2.5</emphasis>
            <emphasis role="chapterTitle">Dark-Field Microscopy for <emphasis>Treponema pallidum</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0018s0001;
     &sect1.9781683674832.ch0018s0002;
     &sect1.9781683674832.ch0018s0003;
    </chapter>
      <chapter id="ch0019" label="19">
         <title>
            <emphasis role="chapterNumber">3.3</emphasis>
            <emphasis role="chapterTitle">Processing, Isolation, Detection, and Interpretation of Aerobic Bacteriology Cultures</emphasis>
         </title> &sect1.9781683674832.ch0019s0001;
     &sect1.9781683674832.ch0019s0002;
     &sect1.9781683674832.ch0019s0003;
    </chapter>
      <chapter id="ch0020" label="20">
         <title>
            <emphasis role="chapterNumber">3.3.2</emphasis>
            <emphasis role="chapterTitle">Interpretation and Rapid Identification of Bacterial Growth on Primary Culture Media</emphasis>
         </title> &sect1.9781683674832.ch0020s0001;
     &sect1.9781683674832.ch0020s0002;
     &sect1.9781683674832.ch0020s0003;
    </chapter>
      <chapter id="ch0021" label="21">
         <title>
            <emphasis role="chapterNumber">3.4.</emphasis>
            <emphasis role="chapterTitle">Body Fluid Cultures (Excluding Blood, Cerebrospinal Fluid, and Urine)</emphasis>
         </title> &sect1.9781683674832.ch0021s0001;
     &sect1.9781683674832.ch0021s0002;
     &sect1.9781683674832.ch0021s0003;
    </chapter>
      <chapter id="ch0022" label="22">
         <title>
            <emphasis role="chapterNumber">3.5.</emphasis>
            <emphasis role="chapterTitle">Cerebrospinal Fluid Cultures</emphasis>
         </title> &sect1.9781683674832.ch0022s0001;
     &sect1.9781683674832.ch0022s0002;
     &sect1.9781683674832.ch0022s0003;
    </chapter>
      <chapter id="ch0023" label="23">
         <title>
            <emphasis role="chapterNumber">3.6.</emphasis>
            <emphasis role="chapterTitle">Medical Devices: Pre- and Postimplant Testing</emphasis>
         </title> &sect1.9781683674832.ch0023s0001;
     &sect1.9781683674832.ch0023s0002;
     &sect1.9781683674832.ch0023s0003;
    </chapter>
      <chapter id="ch0024" label="24">
         <title>
            <emphasis role="chapterNumber">3.7.</emphasis>
            <emphasis role="chapterTitle">Fecal and Other Gastrointestinal Cultures</emphasis>
         </title> &sect1.9781683674832.ch0024s0001;
     &sect1.9781683674832.ch0024s0002;
     &sect1.9781683674832.ch0024s0003;
     &sect1.9781683674832.ch0024s0004;
     &sect1.9781683674832.ch0024s0005;
     &sect1.9781683674832.ch0024s0006;
     &sect1.9781683674832.ch0024s0007;
    </chapter>
      <chapter id="ch0025" label="25">
         <title>
            <emphasis role="chapterNumber">3.7.2.</emphasis>
            <emphasis role="chapterTitle">Culture for <emphasis role="strong">
                  <emphasis>Campylobacter</emphasis>
               </emphasis> and Related Organisms</emphasis>
         </title> &sect1.9781683674832.ch0025s0001;
     &sect1.9781683674832.ch0025s0002;
     &sect1.9781683674832.ch0025s0003;
     &sect1.9781683674832.ch0025s0004;
    </chapter>
      <chapter id="ch0026" label="26">
         <title>
            <emphasis role="chapterNumber">3.7.3.</emphasis>
            <emphasis role="chapterTitle">
               <emphasis role="strong">
                  <emphasis>Helicobacter pylori</emphasis>
               </emphasis> Cultures</emphasis>
         </title> &sect1.9781683674832.ch0026s0001;
     &sect1.9781683674832.ch0026s0002;
     &sect1.9781683674832.ch0026s0003;
     &sect1.9781683674832.ch0026s0004;
    </chapter>
      <chapter id="ch0027" label="27">
         <title>
            <emphasis role="chapterNumber">3.7.4.</emphasis>
            <emphasis role="chapterTitle">Quantitative Culture of Small-Bowel Contents</emphasis>
         </title> &sect1.9781683674832.ch0027s0001;
     &sect1.9781683674832.ch0027s0002;
     &sect1.9781683674832.ch0027s0003;
    </chapter>
      <chapter id="ch0028" label="28">
         <title>
            <emphasis role="chapterNumber">3.8.</emphasis>
            <emphasis role="chapterTitle">Genital Cultures</emphasis>
         </title> &sect1.9781683674832.ch0028s0001;
     &sect1.9781683674832.ch0028s0002;
     &sect1.9781683674832.ch0028s0003;
    </chapter>
      <chapter id="ch0029" label="29">
         <title>
            <emphasis role="chapterNumber">3.8.2</emphasis>
            <emphasis role="chapterTitle">Group B <emphasis role="strong">
                  <emphasis>Streptococcus</emphasis>
               </emphasis> Cultures</emphasis>
         </title> &sect1.9781683674832.ch0029s0001;
     &sect1.9781683674832.ch0029s0002;
     &sect1.9781683674832.ch0029s0003;
     &sect1.9781683674832.ch0029s0004;
     &sect1.9781683674832.ch0029s0005;
    </chapter>
      <chapter id="ch0030" label="30">
         <title>
            <emphasis role="chapterNumber">3.8.3</emphasis>
            <emphasis role="chapterTitle">
               <emphasis role="strong">
                  <emphasis>Neisseria gonorrhoeae</emphasis>
               </emphasis> Cultures</emphasis>
         </title> &sect1.9781683674832.ch0030s0001;
     &sect1.9781683674832.ch0030s0002;
     &sect1.9781683674832.ch0030s0003;
    </chapter>
      <chapter id="ch0031" label="31">
         <title>
            <emphasis role="chapterNumber">3.8.4</emphasis>
            <emphasis role="chapterTitle">
               <emphasis>Haemophilus ducreyi</emphasis> Cultures</emphasis>
         </title> &sect1.9781683674832.ch0031s0001;
     &sect1.9781683674832.ch0031s0002;
     &sect1.9781683674832.ch0031s0003;
    </chapter>
      <chapter id="ch0032" label="32">
         <title>
            <emphasis role="chapterNumber">3.9</emphasis>
            <emphasis role="chapterTitle">Ocular Cultures</emphasis>
         </title> &sect1.9781683674832.ch0032s0001;
     &sect1.9781683674832.ch0032s0002;
     &sect1.9781683674832.ch0032s0003;
    </chapter>
      <chapter id="ch0033" label="33">
         <title>
            <emphasis role="chapterNumber">3.10</emphasis>
            <emphasis role="chapterTitle">Respiratory Tract Cultures</emphasis>
         </title> &sect1.9781683674832.ch0033s0001;
    </chapter>
      <chapter id="ch0034" label="34">
         <title>
            <emphasis role="chapterNumber">3.10.2</emphasis>
            <emphasis role="chapterTitle">Lower Respiratory Tract Cultures</emphasis>
         </title> &sect1.9781683674832.ch0034s0001;
     &sect1.9781683674832.ch0034s0002;
     &sect1.9781683674832.ch0034s0003;
     &sect1.9781683674832.ch0034s0004;
     &sect1.9781683674832.ch0034s0005;
     &sect1.9781683674832.ch0034s0006;
     &sect1.9781683674832.ch0034s0007;
    </chapter>
      <chapter id="ch0035" label="35">
         <title>
            <emphasis role="chapterNumber">3.10.3</emphasis>
            <emphasis role="chapterTitle">Respiratory Cultures from Cystic Fibrosis Patients</emphasis>
         </title> &sect1.9781683674832.ch0035s0001;
     &sect1.9781683674832.ch0035s0002;
     &sect1.9781683674832.ch0035s0003;
    </chapter>
      <chapter id="ch0036" label="36">
         <title>
            <emphasis role="chapterNumber">3.10.4</emphasis>
            <emphasis role="chapterTitle">
               <emphasis>Legionella</emphasis> Cultures and Urinary Antigen Testing</emphasis>
         </title> &sect1.9781683674832.ch0036s0001;
     &sect1.9781683674832.ch0036s0002;
     &sect1.9781683674832.ch0036s0003;
     &sect1.9781683674832.ch0036s0004;
     &sect1.9781683674832.ch0036s0005;
     &sect1.9781683674832.ch0036s0006;
     &sect1.9781683674832.ch0036s0007;
    </chapter>
      <chapter id="ch0037" label="37">
         <title>
            <emphasis role="chapterNumber">3.10.5</emphasis>
            <emphasis role="chapterTitle">Ear Cultures</emphasis>
         </title> &sect1.9781683674832.ch0037s0001;
     &sect1.9781683674832.ch0037s0002;
     &sect1.9781683674832.ch0037s0003;
    </chapter>
      <chapter id="ch0038" label="38">
         <title>
            <emphasis role="chapterNumber">3.10.6</emphasis>
            <emphasis role="chapterTitle">
               <emphasis>Bordetella</emphasis> Cultures</emphasis>
         </title> &sect1.9781683674832.ch0038s0001;
     &sect1.9781683674832.ch0038s0002;
     &sect1.9781683674832.ch0038s0003;
     &sect1.9781683674832.ch0038s0004;
    </chapter>
      <chapter id="ch0039" label="39">
         <title>
            <emphasis role="chapterNumber">3.10.7</emphasis>
            <emphasis role="chapterTitle">Culture of <emphasis>Corynebacterium diphtheriae</emphasis> and Other Diphtheria Toxin-Producing Bacterial Species</emphasis>
         </title> &sect1.9781683674832.ch0039s0001;
     &sect1.9781683674832.ch0039s0002;
     &sect1.9781683674832.ch0039s0003;
    </chapter>
      <chapter id="ch0040" label="40">
         <title>
            <emphasis role="chapterNumber">3.10.8</emphasis>
            <emphasis role="chapterTitle">Throat Culture and Nonculture Tests for Pharyngitis</emphasis>
         </title> &sect1.9781683674832.ch0040s0001;
     &sect1.9781683674832.ch0040s0002;
     &sect1.9781683674832.ch0040s0003;
     &sect1.9781683674832.ch0040s0004;
    </chapter>
      <chapter id="ch0041" label="41">
         <title>
            <emphasis role="chapterNumber">3.10.9</emphasis>
            <emphasis role="chapterTitle">Nasal Sinus Cultures</emphasis>
         </title> &sect1.9781683674832.ch0041s0001;
     &sect1.9781683674832.ch0041s0002;
     &sect1.9781683674832.ch0041s0003;
    </chapter>
      <chapter id="ch0042" label="42">
         <title>
            <emphasis role="chapterNumber">3.11</emphasis>
            <emphasis role="chapterTitle">Urine Cultures</emphasis>
         </title> &sect1.9781683674832.ch0042s0001;
     &sect1.9781683674832.ch0042s0002;
     &sect1.9781683674832.ch0042s0003;
     &sect1.9781683674832.ch0042s0004;
    </chapter>
      <chapter id="ch0043" label="43">
         <title>
            <emphasis role="chapterNumber">3.11.2</emphasis>
            <emphasis role="chapterTitle">Stone Cultures</emphasis>
         </title> &sect1.9781683674832.ch0043s0001;
     &sect1.9781683674832.ch0043s0002;
     &sect1.9781683674832.ch0043s0003;
    </chapter>
      <chapter id="ch0044" label="44">
         <title>
            <emphasis role="chapterNumber">3.12</emphasis>
            <emphasis role="chapterTitle">Wound Cultures</emphasis>
         </title> &sect1.9781683674832.ch0044s0001;
     &sect1.9781683674832.ch0044s0002;
     &sect1.9781683674832.ch0044s0003;
    </chapter>
      <chapter id="ch0045" label="45">
         <title>
            <emphasis role="chapterNumber">3.12.2</emphasis>
            <emphasis role="chapterTitle">Quantitative Cultures of Wound Tissues</emphasis>
         </title> &sect1.9781683674832.ch0045s0001;
     &sect1.9781683674832.ch0045s0002;
     &sect1.9781683674832.ch0045s0003;
    </chapter>
      <chapter id="ch0046" label="46">
         <title>
            <emphasis role="chapterNumber">3.13</emphasis>
            <emphasis role="chapterTitle">
               <emphasis>Leptospira</emphasis> Culture</emphasis>
         </title> &sect1.9781683674832.ch0046s0001;
     &sect1.9781683674832.ch0046s0002;
     &sect1.9781683674832.ch0046s0003;
    </chapter>
      <chapter id="ch0047" label="47">
         <title>
            <emphasis role="chapterNumber">3.14</emphasis>
            <emphasis role="chapterTitle">Detection of Human Mycoplasmas and Ureaplasmas from Clinical Specimens by Culture and PCR</emphasis>
         </title> &sect1.9781683674832.ch0047s0001;
     &sect1.9781683674832.ch0047s0002;
     &sect1.9781683674832.ch0047s0003;
     &sect1.9781683674832.ch0047s0004;
    </chapter>
      <chapter id="ch0048" label="48">
         <title>
            <emphasis role="chapterNumber">3.14.2</emphasis>
            <emphasis role="chapterTitle">Antimicrobial Susceptibility Testing of Mycoplasmas and Ureaplasmas</emphasis>
         </title> &sect1.9781683674832.ch0048s0001;
     &sect1.9781683674832.ch0048s0002;
     &sect1.9781683674832.ch0048s0003;
    </chapter>
      <chapter id="ch0049" label="49">
         <title>
            <emphasis role="chapterNumber">3.14.3</emphasis>
            <emphasis role="chapterTitle">Detection of <emphasis>Mycoplasma pneumoniae</emphasis> by Nucleic Acid Amplification Tests</emphasis>
         </title> &sect1.9781683674832.ch0049s0001;
     &sect1.9781683674832.ch0049s0002;
     &sect1.9781683674832.ch0049s0003;
    </chapter>
      <chapter id="ch0050" label="50">
         <title>
            <emphasis role="chapterNumber">3.14.4</emphasis>
            <emphasis role="chapterTitle">Detection of <emphasis>Mycoplasma genitalium</emphasis>, <emphasis>Mycoplasma hominis</emphasis>, and <emphasis>Ureaplasma</emphasis> Species by Nucleic Acid Amplification Tests</emphasis>
         </title> &sect1.9781683674832.ch0050s0001;
     &sect1.9781683674832.ch0050s0002;
     &sect1.9781683674832.ch0050s0003;
    </chapter>
      <chapter id="ch0051" label="51">
         <title>
            <emphasis role="chapterNumber">3.15</emphasis>
            <emphasis role="chapterTitle">
               <emphasis>Bartonella</emphasis> Culture</emphasis>
         </title> &sect1.9781683674832.ch0051s0001;
     &sect1.9781683674832.ch0051s0002;
     &sect1.9781683674832.ch0051s0003;
    </chapter>
      <chapter id="ch0052" label="52">
         <title>
            <emphasis role="chapterNumber">3.16</emphasis>
            <emphasis role="chapterTitle">Guidelines for Biochemical Identification of Aerobic Bacteria</emphasis>
         </title> &sect1.9781683674832.ch0052s0003;
     &sect1.9781683674832.ch0052s0001;
     &sect1.9781683674832.ch0052s0002;
    </chapter>
      <chapter id="ch0053" label="53">
         <title>
            <emphasis role="chapterNumber">3.17</emphasis>
            <emphasis role="chapterTitle">Biochemical Tests for the Identification of Aerobic Bacteria</emphasis>
         </title> &sect1.9781683674832.ch0053s0001;
    </chapter>
      <chapter id="ch0054" label="54">
         <title>
            <emphasis role="chapterNumber">3.17.2</emphasis>
            <emphasis role="chapterTitle">Acetate Utilization Test (Acetate Differential Agar)</emphasis>
         </title> &sect1.9781683674832.ch0054s0001;
     &sect1.9781683674832.ch0054s0002;
     &sect1.9781683674832.ch0054s0003;
     &sect1.9781683674832.ch0054s0004;
     &sect1.9781683674832.ch0054s0005;
     &sect1.9781683674832.ch0054s0006;
     &sect1.9781683674832.ch0054s0007;
     &sect1.9781683674832.ch0054s0008;
     &sect1.9781683674832.ch0054s0009;
    </chapter>
      <chapter id="ch0055" label="55">
         <title>
            <emphasis role="chapterNumber">3.17.3</emphasis>
            <emphasis role="chapterTitle">ALA (<emphasis role="strong"></emphasis>-Aminolevulinic Acid) Test for Porphyrin SynthesisTube or Disk Test</emphasis>
         </title> &sect1.9781683674832.ch0055s0001;
     &sect1.9781683674832.ch0055s0002;
     &sect1.9781683674832.ch0055s0003;
     &sect1.9781683674832.ch0055s0004;
     &sect1.9781683674832.ch0055s0005;
     &sect1.9781683674832.ch0055s0006;
     &sect1.9781683674832.ch0055s0007;
     &sect1.9781683674832.ch0055s0008;
     &sect1.9781683674832.ch0055s0009;
    </chapter>
      <chapter id="ch0056" label="56">
         <title>
            <emphasis role="chapterNumber">3.17.4</emphasis>
            <emphasis role="chapterTitle">Antimicrobial Disk Tests for Identification</emphasis>
         </title> &sect1.9781683674832.ch0056s0001;
     &sect1.9781683674832.ch0056s0002;
     &sect1.9781683674832.ch0056s0003;
     &sect1.9781683674832.ch0056s0004;
     &sect1.9781683674832.ch0056s0005;
     &sect1.9781683674832.ch0056s0006;
     &sect1.9781683674832.ch0056s0007;
     &sect1.9781683674832.ch0056s0008;
     &sect1.9781683674832.ch0056s0009;
    </chapter>
      <chapter id="ch0057" label="57">
         <title>
            <emphasis role="chapterNumber">3.17.5</emphasis>
            <emphasis role="chapterTitle">Bile-Esculin and Esculin Tests</emphasis>
         </title> &sect1.9781683674832.ch0057s0001;
     &sect1.9781683674832.ch0057s0002;
     &sect1.9781683674832.ch0057s0003;
     &sect1.9781683674832.ch0057s0004;
     &sect1.9781683674832.ch0057s0005;
     &sect1.9781683674832.ch0057s0006;
     &sect1.9781683674832.ch0057s0007;
     &sect1.9781683674832.ch0057s0008;
     &sect1.9781683674832.ch0057s0009;
    </chapter>
      <chapter id="ch0058" label="58">
         <title>
            <emphasis role="chapterNumber">3.17.6</emphasis>
            <emphasis role="chapterTitle">Bile Solubility Test</emphasis>
         </title> &sect1.9781683674832.ch0058s0001;
     &sect1.9781683674832.ch0058s0002;
     &sect1.9781683674832.ch0058s0003;
     &sect1.9781683674832.ch0058s0004;
     &sect1.9781683674832.ch0058s0005;
     &sect1.9781683674832.ch0058s0006;
     &sect1.9781683674832.ch0058s0007;
     &sect1.9781683674832.ch0058s0008;
     &sect1.9781683674832.ch0058s0009;
    </chapter>
      <chapter id="ch0059" label="59">
         <title>
            <emphasis role="chapterNumber">3.17.7</emphasis>
            <emphasis role="chapterTitle">Butyrate Esterase Test</emphasis>
         </title> &sect1.9781683674832.ch0059s0001;
     &sect1.9781683674832.ch0059s0002;
     &sect1.9781683674832.ch0059s0003;
     &sect1.9781683674832.ch0059s0004;
     &sect1.9781683674832.ch0059s0005;
     &sect1.9781683674832.ch0059s0006;
     &sect1.9781683674832.ch0059s0007;
     &sect1.9781683674832.ch0059s0008;
     &sect1.9781683674832.ch0059s0009;
    </chapter>
      <chapter id="ch0060" label="60">
         <title>
            <emphasis role="chapterNumber">3.17.8</emphasis>
            <emphasis role="chapterTitle">CAMP Factor Tests (Standard/Rapid, Reverse, and Inhibition)</emphasis>
         </title> &sect1.9781683674832.ch0060s0001;
     &sect1.9781683674832.ch0060s0002;
     &sect1.9781683674832.ch0060s0003;
     &sect1.9781683674832.ch0060s0004;
     &sect1.9781683674832.ch0060s0005;
     &sect1.9781683674832.ch0060s0006;
     &sect1.9781683674832.ch0060s0007;
     &sect1.9781683674832.ch0060s0008;
     &sect1.9781683674832.ch0060s0009;
    </chapter>
      <chapter id="ch0061" label="61">
         <title>
            <emphasis role="chapterNumber">3.17.9</emphasis>
            <emphasis role="chapterTitle">Carbohydrate Utilization Tests</emphasis>
         </title> &sect1.9781683674832.ch0061s0001;
     &sect1.9781683674832.ch0061s0002;
     &sect1.9781683674832.ch0061s0003;
     &sect1.9781683674832.ch0061s0004;
     &sect1.9781683674832.ch0061s0005;
     &sect1.9781683674832.ch0061s0006;
     &sect1.9781683674832.ch0061s0007;
     &sect1.9781683674832.ch0061s0008;
     &sect1.9781683674832.ch0061s0009;
    </chapter>
      <chapter id="ch0062" label="62">
         <title>
            <emphasis role="chapterNumber">3.17.10</emphasis>
            <emphasis role="chapterTitle">Catalase Test</emphasis>
         </title> &sect1.9781683674832.ch0062s0001;
     &sect1.9781683674832.ch0062s0002;
     &sect1.9781683674832.ch0062s0003;
     &sect1.9781683674832.ch0062s0004;
     &sect1.9781683674832.ch0062s0005;
     &sect1.9781683674832.ch0062s0006;
     &sect1.9781683674832.ch0062s0007;
     &sect1.9781683674832.ch0062s0008;
     &sect1.9781683674832.ch0062s0009;
    </chapter>
      <chapter id="ch0063" label="63">
         <title>
            <emphasis role="chapterNumber">3.17.11</emphasis>
            <emphasis role="chapterTitle">Cetrimide Test</emphasis>
         </title> &sect1.9781683674832.ch0063s0001;
     &sect1.9781683674832.ch0063s0002;
     &sect1.9781683674832.ch0063s0003;
     &sect1.9781683674832.ch0063s0004;
     &sect1.9781683674832.ch0063s0005;
     &sect1.9781683674832.ch0063s0006;
     &sect1.9781683674832.ch0063s0007;
     &sect1.9781683674832.ch0063s0008;
     &sect1.9781683674832.ch0063s0009;
    </chapter>
      <chapter id="ch0064" label="64">
         <title>
            <emphasis role="chapterNumber">3.17.12</emphasis>
            <emphasis role="chapterTitle">Citrate Utilization Test (Simmons)</emphasis>
         </title> &sect1.9781683674832.ch0064s0001;
     &sect1.9781683674832.ch0064s0002;
     &sect1.9781683674832.ch0064s0003;
     &sect1.9781683674832.ch0064s0004;
     &sect1.9781683674832.ch0064s0005;
     &sect1.9781683674832.ch0064s0006;
     &sect1.9781683674832.ch0064s0007;
     &sect1.9781683674832.ch0064s0008;
     &sect1.9781683674832.ch0064s0009;
    </chapter>
      <chapter id="ch0065" label="65">
         <title>
            <emphasis role="chapterNumber">3.17.13</emphasis>
            <emphasis role="chapterTitle">Coagulase TestProtein A/Clumping Factor Agglutination Method</emphasis>
         </title> &sect1.9781683674832.ch0065s0001;
     &sect1.9781683674832.ch0065s0002;
     &sect1.9781683674832.ch0065s0003;
     &sect1.9781683674832.ch0065s0004;
     &sect1.9781683674832.ch0065s0005;
     &sect1.9781683674832.ch0065s0006;
     &sect1.9781683674832.ch0065s0007;
     &sect1.9781683674832.ch0065s0008;
     &sect1.9781683674832.ch0065s0009;
    </chapter>
      <chapter id="ch0066" label="66">
         <title>
            <emphasis role="chapterNumber">3.17.14</emphasis>
            <emphasis role="chapterTitle">Coagulase TestRabbit Plasma Method</emphasis>
         </title> &sect1.9781683674832.ch0066s0001;
     &sect1.9781683674832.ch0066s0002;
     &sect1.9781683674832.ch0066s0003;
     &sect1.9781683674832.ch0066s0004;
     &sect1.9781683674832.ch0066s0005;
     &sect1.9781683674832.ch0066s0006;
     &sect1.9781683674832.ch0066s0007;
     &sect1.9781683674832.ch0066s0008;
     &sect1.9781683674832.ch0066s0009;
    </chapter>
      <chapter id="ch0067" label="67">
         <title>
            <emphasis role="chapterNumber">3.17.15</emphasis>
            <emphasis role="chapterTitle">Decarboxylase-Dihydrolase Tests</emphasis>
         </title> &sect1.9781683674832.ch0067s0001;
     &sect1.9781683674832.ch0067s0002;
     &sect1.9781683674832.ch0067s0003;
     &sect1.9781683674832.ch0067s0004;
     &sect1.9781683674832.ch0067s0005;
     &sect1.9781683674832.ch0067s0006;
     &sect1.9781683674832.ch0067s0007;
     &sect1.9781683674832.ch0067s0008;
     &sect1.9781683674832.ch0067s0009;
    </chapter>
      <chapter id="ch0068" label="68">
         <title>
            <emphasis role="chapterNumber">3.17.16</emphasis>
            <emphasis role="chapterTitle">DNase TestRapid Thermonuclease Test</emphasis>
         </title> &sect1.9781683674832.ch0068s0001;
     &sect1.9781683674832.ch0068s0002;
     &sect1.9781683674832.ch0068s0003;
     &sect1.9781683674832.ch0068s0004;
     &sect1.9781683674832.ch0068s0005;
     &sect1.9781683674832.ch0068s0006;
     &sect1.9781683674832.ch0068s0007;
     &sect1.9781683674832.ch0068s0008;
     &sect1.9781683674832.ch0068s0009;
    </chapter>
      <chapter id="ch0069" label="69">
         <title>
            <emphasis role="chapterNumber">3.17.17</emphasis>
            <emphasis role="chapterTitle">Fluorescent-Pigment Agars for <emphasis>Pseudomonas</emphasis> Identification</emphasis>
         </title> &sect1.9781683674832.ch0069s0001;
     &sect1.9781683674832.ch0069s0002;
     &sect1.9781683674832.ch0069s0003;
     &sect1.9781683674832.ch0069s0004;
     &sect1.9781683674832.ch0069s0005;
     &sect1.9781683674832.ch0069s0006;
     &sect1.9781683674832.ch0069s0007;
     &sect1.9781683674832.ch0069s0008;
     &sect1.9781683674832.ch0069s0009;
    </chapter>
      <chapter id="ch0070" label="70">
         <title>
            <emphasis role="chapterNumber">3.17.18</emphasis>
            <emphasis role="chapterTitle">Gelatin Liquefaction</emphasis>
         </title> &sect1.9781683674832.ch0070s0001;
     &sect1.9781683674832.ch0070s0002;
     &sect1.9781683674832.ch0070s0003;
     &sect1.9781683674832.ch0070s0004;
     &sect1.9781683674832.ch0070s0005;
     &sect1.9781683674832.ch0070s0006;
     &sect1.9781683674832.ch0070s0007;
     &sect1.9781683674832.ch0070s0008;
     &sect1.9781683674832.ch0070s0009;
    </chapter>
      <chapter id="ch0071" label="71">
         <title>
            <emphasis role="chapterNumber">3.17.19</emphasis>
            <emphasis role="chapterTitle">Gram Reaction Enzymatic Test</emphasis>
         </title> &sect1.9781683674832.ch0071s0001;
     &sect1.9781683674832.ch0071s0002;
     &sect1.9781683674832.ch0071s0003;
     &sect1.9781683674832.ch0071s0004;
     &sect1.9781683674832.ch0071s0005;
     &sect1.9781683674832.ch0071s0006;
     &sect1.9781683674832.ch0071s0007;
     &sect1.9781683674832.ch0071s0008;
     &sect1.9781683674832.ch0071s0009;
    </chapter>
      <chapter id="ch0072" label="72">
         <title>
            <emphasis role="chapterNumber">3.17.20</emphasis>
            <emphasis role="chapterTitle">Hippurate Hydrolysis Rapid Test</emphasis>
         </title> &sect1.9781683674832.ch0072s0001;
     &sect1.9781683674832.ch0072s0002;
     &sect1.9781683674832.ch0072s0003;
     &sect1.9781683674832.ch0072s0004;
     &sect1.9781683674832.ch0072s0005;
     &sect1.9781683674832.ch0072s0006;
     &sect1.9781683674832.ch0072s0007;
     &sect1.9781683674832.ch0072s0008;
     &sect1.9781683674832.ch0072s0009;
    </chapter>
      <chapter id="ch0073" label="73">
         <title>
            <emphasis role="chapterNumber">3.17.21</emphasis>
            <emphasis role="chapterTitle">Hydrogen Sulfide Production</emphasis>
         </title> &sect1.9781683674832.ch0073s0001;
    </chapter>
      <chapter id="ch0074" label="74">
         <title>
            <emphasis role="chapterNumber">3.17.22</emphasis>
            <emphasis role="chapterTitle">Indole Test</emphasis>
         </title> &sect1.9781683674832.ch0074s0001;
     &sect1.9781683674832.ch0074s0002;
    </chapter>
      <chapter id="ch0075" label="75">
         <title>
            <emphasis role="chapterNumber">3.17.23</emphasis>
            <emphasis role="chapterTitle">Indoxyl Acetate Disk Test</emphasis>
         </title> &sect1.9781683674832.ch0075s0001;
    </chapter>
      <chapter id="ch0076" label="76">
         <title>
            <emphasis role="chapterNumber">3.17.24</emphasis>
            <emphasis role="chapterTitle">Kliglers Iron Agar Test and Triple Sugar Iron Agar Test</emphasis>
         </title> &sect1.9781683674832.ch0076s0001;
    </chapter>
      <chapter id="ch0077" label="77">
         <title>
            <emphasis role="chapterNumber">3.17.25</emphasis>
            <emphasis role="chapterTitle">Leucine Aminopeptidase Test</emphasis>
         </title> &sect1.9781683674832.ch0077s0001;
    </chapter>
      <chapter id="ch0078" label="78">
         <title>
            <emphasis role="chapterNumber">3.17.26</emphasis>
            <emphasis role="chapterTitle">Lecithinase and Lipase Detection</emphasis>
         </title> &sect1.9781683674832.ch0078s0001;
     &sect1.9781683674832.ch0078s0002;
    </chapter>
      <chapter id="ch0079" label="79">
         <title>
            <emphasis role="chapterNumber">3.17.27</emphasis>
            <emphasis role="chapterTitle">Lipophilism Test for <emphasis>Corynebacterium</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0079s0001;
    </chapter>
      <chapter id="ch0080" label="80">
         <title>
            <emphasis role="chapterNumber">3.17.28</emphasis>
            <emphasis role="chapterTitle">Malonate Test</emphasis>
         </title> &sect1.9781683674832.ch0080s0001;
    </chapter>
      <chapter id="ch0081" label="81">
         <title>
            <emphasis role="chapterNumber">3.17.29</emphasis>
            <emphasis role="chapterTitle">Methyl Glucopyranoside (MGP) Test</emphasis>
         </title> &sect1.9781683674832.ch0081s0001;
    </chapter>
      <chapter id="ch0082" label="82">
         <title>
            <emphasis role="chapterNumber">3.17.30</emphasis>
            <emphasis role="chapterTitle">Motility Tests</emphasis>
         </title> &sect1.9781683674832.ch0082s0001;
    </chapter>
      <chapter id="ch0083" label="83">
         <title>
            <emphasis role="chapterNumber">3.17.31</emphasis>
            <emphasis role="chapterTitle">MRS Broth</emphasis>
         </title> &sect1.9781683674832.ch0083s0001;
    </chapter>
      <chapter id="ch0084" label="84">
         <title>
            <emphasis role="chapterNumber">3.17.32</emphasis>
            <emphasis role="chapterTitle">Methyl RedVoges-Proskauer (MR-VP) Tests</emphasis>
         </title> &sect1.9781683674832.ch0084s0001;
    </chapter>
      <chapter id="ch0085" label="85">
         <title>
            <emphasis role="chapterNumber">3.17.33</emphasis>
            <emphasis role="chapterTitle">MUG (4-Methylumbelliferyl--<emphasis role="small">D</emphasis>-Glucuronide) Test</emphasis>
         </title> &sect1.9781683674832.ch0085s0001;
    </chapter>
      <chapter id="ch0086" label="86">
         <title>
            <emphasis role="chapterNumber">3.17.34</emphasis>
            <emphasis role="chapterTitle">Nitrate/Nitrite Reduction Test</emphasis>
         </title> &sect1.9781683674832.ch0086s0001;
    </chapter>
      <chapter id="ch0087" label="87">
         <title>
            <emphasis role="chapterNumber">3.17.35</emphasis>
            <emphasis role="chapterTitle">O/129 Disk Susceptibility Testing for <emphasis>Vibrio</emphasis> and <emphasis>Aeromonas</emphasis> spp.</emphasis>
         </title> &sect1.9781683674832.ch0087s0001;
    </chapter>
      <chapter id="ch0088" label="88">
         <title>
            <emphasis role="chapterNumber">3.17.36</emphasis>
            <emphasis role="chapterTitle">ONPG (<emphasis>o</emphasis>-Nitrophenyl--<emphasis role="small">D</emphasis>-Galactopyranoside) Test</emphasis>
         </title> &sect1.9781683674832.ch0088s0001;
    </chapter>
      <chapter id="ch0089" label="89">
         <title>
            <emphasis role="chapterNumber">3.17.37</emphasis>
            <emphasis role="chapterTitle">Optochin Susceptibility Test</emphasis>
         </title> &sect1.9781683674832.ch0089s0001;
    </chapter>
      <chapter id="ch0090" label="90">
         <title>
            <emphasis role="chapterNumber">3.17.38</emphasis>
            <emphasis role="chapterTitle">Oxidase Test</emphasis>
         </title> &sect1.9781683674832.ch0090s0001;
    </chapter>
      <chapter id="ch0091" label="91">
         <title>
            <emphasis role="chapterNumber">3.17.39</emphasis>
            <emphasis role="chapterTitle">Phenylalanine Deaminase Test</emphasis>
         </title> &sect1.9781683674832.ch0091s0001;
    </chapter>
      <chapter id="ch0092" label="92">
         <title>
            <emphasis role="chapterNumber">3.17.40</emphasis>
            <emphasis role="chapterTitle">PYR (<emphasis role="small">L</emphasis>-Pyrrolidonyl--Naphthylamide) Test</emphasis>
         </title> &sect1.9781683674832.ch0092s0001;
    </chapter>
      <chapter id="ch0093" label="93">
         <title>
            <emphasis role="chapterNumber">3.17.41</emphasis>
            <emphasis role="chapterTitle">Quellung Reaction for <emphasis>Streptococcus pneumoniae</emphasis> (Neufeld Test)</emphasis>
         </title> &sect1.9781683674832.ch0093s0001;
    </chapter>
      <chapter id="ch0094" label="94">
         <title>
            <emphasis role="chapterNumber">3.17.42</emphasis>
            <emphasis role="chapterTitle">6.5% Salt and Temperature Tolerance Test</emphasis>
         </title> &sect1.9781683674832.ch0094s0001;
    </chapter>
      <chapter id="ch0095" label="95">
         <title>
            <emphasis role="chapterNumber">3.17.43</emphasis>
            <emphasis role="chapterTitle">Satellite Test</emphasis>
         </title> &sect1.9781683674832.ch0095s0001;
    </chapter>
      <chapter id="ch0096" label="96">
         <title>
            <emphasis role="chapterNumber">3.17.44</emphasis>
            <emphasis role="chapterTitle">SPS (Sodium Polyanethol Sulfonate) Disk Test</emphasis>
         </title> &sect1.9781683674832.ch0096s0001;
    </chapter>
      <chapter id="ch0097" label="97">
         <title>
            <emphasis role="chapterNumber">3.17.45</emphasis>
            <emphasis role="chapterTitle">Starch Hydrolysis Test</emphasis>
         </title> &sect1.9781683674832.ch0097s0001;
    </chapter>
      <chapter id="ch0098" label="98">
         <title>
            <emphasis role="chapterNumber">3.17.46</emphasis>
            <emphasis role="chapterTitle">Urease Test</emphasis>
         </title> &sect1.9781683674832.ch0098s0001;
    </chapter>
      <chapter id="ch0099" label="99">
         <title>
            <emphasis role="chapterNumber">3.18</emphasis>
            <emphasis role="chapterTitle">Identification of Gram-Positive Bacteria</emphasis>
         </title> &sect1.9781683674832.ch0099s0001;
     &sect1.9781683674832.ch0099s0002;
     &sect1.9781683674832.ch0099s0003;
    </chapter>
      <chapter id="ch0100" label="100">
         <title>
            <emphasis role="chapterNumber">3.19</emphasis>
            <emphasis role="chapterTitle">Identification of Gram-Negative Bacteria</emphasis>
         </title> &sect1.9781683674832.ch0100s0001;
     &sect1.9781683674832.ch0100s0002;
     &sect1.9781683674832.ch0100s0003;
    </chapter>
   </part>
   <part id="pt0004">
      <title>
         <emphasis role="partNumber">SECTION 4</emphasis><?lb?>
         <emphasis role="partTitle">Anaerobic Bacteriology</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITOR</emphasis>: <emphasis>
               <emphasis role="strong">Audrey N. Schuetz</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0004s0001;
<chapter id="ch0101" label="101">
         <title>
            <emphasis role="chapterNumber">4.1</emphasis>
            <emphasis role="chapterTitle">Introduction</emphasis>
         </title> &sect1.9781683674832.ch0101s0002;
     &sect1.9781683674832.ch0101s0001;
    </chapter>
      <chapter id="ch0102" label="102" role="bibliography">
         <title>
            <emphasis role="chapterNumber">4.2</emphasis>
            <emphasis role="chapterTitle">Taxonomy Updates for Anaerobes</emphasis>
         </title> &sect1.9781683674832.ch0102s0001;
    </chapter>
      <chapter id="ch0103" label="103">
         <title>
            <emphasis role="chapterNumber">4.3</emphasis>
            <emphasis role="chapterTitle">Specimen Selection, Collection, and Transport for Anaerobic Culture</emphasis>
         </title> &sect1.9781683674832.ch0103s0001;
    </chapter>
      <chapter id="ch0104" label="104">
         <title>
            <emphasis role="chapterNumber">4.4</emphasis>
            <emphasis role="chapterTitle">Culture Media for Anaerobes</emphasis>
         </title> &sect1.9781683674832.ch0104s0001;
     &sect1.9781683674832.ch0104s0002;
     &sect1.9781683674832.ch0104s0003;
     &sect1.9781683674832.ch0104s0004;
    </chapter>
      <chapter id="ch0105" label="105">
         <title>
            <emphasis role="chapterNumber">4.4.2</emphasis>
            <emphasis role="chapterTitle">Secondary Culture Media for Anaerobes</emphasis>
         </title> &sect1.9781683674832.ch0105s0001;
     &sect1.9781683674832.ch0105s0002;
     &sect1.9781683674832.ch0105s0003;
    </chapter>
      <chapter id="ch0106" label="106">
         <title>
            <emphasis role="chapterNumber">4.5</emphasis>
            <emphasis role="chapterTitle">Processing Specimens for Anaerobic Culture</emphasis>
         </title> &sect1.9781683674832.ch0106s0001;
    </chapter>
      <chapter id="ch0107" label="107">
         <title>
            <emphasis role="chapterNumber">4.6</emphasis>
            <emphasis role="chapterTitle">Incubation Techniques for Anaerobic Bacteriology Specimens</emphasis>
         </title> &sect1.9781683674832.ch0107s0001;
     &sect1.9781683674832.ch0107s0002;
     &sect1.9781683674832.ch0107s0003;
    </chapter>
      <chapter id="ch0108" label="108">
         <title>
            <emphasis role="chapterNumber">4.7</emphasis>
            <emphasis role="chapterTitle">Examination of Primary Culture Plates for Anaerobic Bacteria</emphasis>
         </title> &sect1.9781683674832.ch0108s0001;
     &sect1.9781683674832.ch0108s0002;
    </chapter>
      <chapter id="ch0109" label="109">
         <title>
            <emphasis role="chapterNumber">4.8</emphasis>
            <emphasis role="chapterTitle">A Practical Guide to the Workup of Anaerobic Cultures</emphasis>
         </title> &sect1.9781683674832.ch0109s0002;
     &sect1.9781683674832.ch0109s0001;
    </chapter>
      <chapter id="ch0110" label="110">
         <title>
            <emphasis role="chapterNumber">4.9</emphasis>
            <emphasis role="chapterTitle">Rapid Disk, Spot Tests, and Other Rapid or Primary Methods for the Identification of Anaerobes</emphasis>
         </title> &sect1.9781683674832.ch0110s0001;
    </chapter>
      <chapter id="ch0111" label="111">
         <title>
            <emphasis role="chapterNumber">4.9.2</emphasis>
            <emphasis role="chapterTitle">Indole Test</emphasis>
         </title> &sect1.9781683674832.ch0111s0001;
     &sect1.9781683674832.ch0111s0002;
     &sect1.9781683674832.ch0111s0003;
    </chapter>
      <chapter id="ch0112" label="112">
         <title>
            <emphasis role="chapterNumber">4.9.3</emphasis>
            <emphasis role="chapterTitle">Nitrate Disk Reduction Test</emphasis>
         </title> &sect1.9781683674832.ch0112s0001;
     &sect1.9781683674832.ch0112s0002;
     &sect1.9781683674832.ch0112s0003;
    </chapter>
      <chapter id="ch0113" label="113">
         <title>
            <emphasis role="chapterNumber">4.9.4</emphasis>
            <emphasis role="chapterTitle">Catalase Test</emphasis>
         </title> &sect1.9781683674832.ch0113s0001;
     &sect1.9781683674832.ch0113s0002;
     &sect1.9781683674832.ch0113s0003;
    </chapter>
      <chapter id="ch0114" label="114">
         <title>
            <emphasis role="chapterNumber">4.9.5</emphasis>
            <emphasis role="chapterTitle">Identification by Using Special-Potency Disks</emphasis>
         </title> &sect1.9781683674832.ch0114s0001;
     &sect1.9781683674832.ch0114s0002;
     &sect1.9781683674832.ch0114s0003;
    </chapter>
      <chapter id="ch0115" label="115">
         <title>
            <emphasis role="chapterNumber">4.9.6</emphasis>
            <emphasis role="chapterTitle">Sodium Polyanethol Sulfonate (SPS) Disk for Differentiation of Gram-Positive Anaerobic Cocci</emphasis>
         </title> &sect1.9781683674832.ch0115s0001;
     &sect1.9781683674832.ch0115s0002;
     &sect1.9781683674832.ch0115s0003;
    </chapter>
      <chapter id="ch0116" label="116">
         <title>
            <emphasis role="chapterNumber">4.9.7</emphasis>
            <emphasis role="chapterTitle">Bile Disk Test/Bile Broth Test/<emphasis>Bacteroides</emphasis> Bile Esculin Agar for Differentiation of Anaerobic Gram-Negative Rods</emphasis>
         </title> &sect1.9781683674832.ch0116s0001;
     &sect1.9781683674832.ch0116s0002;
     &sect1.9781683674832.ch0116s0003;
    </chapter>
      <chapter id="ch0117" label="117">
         <title>
            <emphasis role="chapterNumber">4.9.8</emphasis>
            <emphasis role="chapterTitle">Fluorescence</emphasis>
         </title> &sect1.9781683674832.ch0117s0001;
     &sect1.9781683674832.ch0117s0002;
     &sect1.9781683674832.ch0117s0003;
    </chapter>
      <chapter id="ch0118" label="118">
         <title>
            <emphasis role="chapterNumber">4.9.9</emphasis>
            <emphasis role="chapterTitle">Lipase Test</emphasis>
         </title> &sect1.9781683674832.ch0118s0001;
     &sect1.9781683674832.ch0118s0002;
     &sect1.9781683674832.ch0118s0003;
    </chapter>
      <chapter id="ch0119" label="119">
         <title>
            <emphasis role="chapterNumber">4.9.10</emphasis>
            <emphasis role="chapterTitle">Lecithinase Test</emphasis>
         </title> &sect1.9781683674832.ch0119s0001;
     &sect1.9781683674832.ch0119s0002;
     &sect1.9781683674832.ch0119s0003;
    </chapter>
      <chapter id="ch0120" label="120">
         <title>
            <emphasis role="chapterNumber">4.9.11</emphasis>
            <emphasis role="chapterTitle">Pigment Production</emphasis>
         </title> &sect1.9781683674832.ch0120s0001;
    </chapter>
      <chapter id="ch0121" label="121">
         <title>
            <emphasis role="chapterNumber">4.9.12</emphasis>
            <emphasis role="chapterTitle">Urease Test</emphasis>
         </title> &sect1.9781683674832.ch0121s0001;
     &sect1.9781683674832.ch0121s0002;
     &sect1.9781683674832.ch0121s0003;
    </chapter>
      <chapter id="ch0122" label="122">
         <title>
            <emphasis role="chapterNumber">4.9.13</emphasis>
            <emphasis role="chapterTitle">Gelatinase Production</emphasis>
         </title> &sect1.9781683674832.ch0122s0001;
     &sect1.9781683674832.ch0122s0002;
     &sect1.9781683674832.ch0122s0003;
    </chapter>
      <chapter id="ch0123" label="123">
         <title>
            <emphasis role="chapterNumber">4.9.14</emphasis>
            <emphasis role="chapterTitle">Alkaline Phosphatase</emphasis>
         </title> &sect1.9781683674832.ch0123s0001;
     &sect1.9781683674832.ch0123s0002;
     &sect1.9781683674832.ch0123s0003;
    </chapter>
      <chapter id="ch0124" label="124">
         <title>
            <emphasis role="chapterNumber">4.9.15</emphasis>
            <emphasis role="chapterTitle">Glutamic Acid Decarboxylase</emphasis>
         </title> &sect1.9781683674832.ch0124s0001;
     &sect1.9781683674832.ch0124s0002;
     &sect1.9781683674832.ch0124s0003;
    </chapter>
      <chapter id="ch0125" label="125">
         <title>
            <emphasis role="chapterNumber">4.9.16</emphasis>
            <emphasis role="chapterTitle">
               <emphasis role="small">L</emphasis>-Alanyl-Alanylaminopeptidase</emphasis>
         </title> &sect1.9781683674832.ch0125s0001;
     &sect1.9781683674832.ch0125s0002;
     &sect1.9781683674832.ch0125s0003;
    </chapter>
      <chapter id="ch0126" label="126">
         <title>
            <emphasis role="chapterNumber">4.9.17</emphasis>
            <emphasis role="chapterTitle">
               <emphasis role="small">L</emphasis>-Proline Aminopeptidase</emphasis>
         </title> &sect1.9781683674832.ch0126s0001;
     &sect1.9781683674832.ch0126s0002;
     &sect1.9781683674832.ch0126s0003;
    </chapter>
      <chapter id="ch0127" label="127">
         <title>
            <emphasis role="chapterNumber">4.9.18</emphasis>
            <emphasis role="chapterTitle">4-Methylumbelliferone Derivative Substrates</emphasis>
         </title> &sect1.9781683674832.ch0127s0001;
     &sect1.9781683674832.ch0127s0002;
     &sect1.9781683674832.ch0127s0003;
    </chapter>
      <chapter id="ch0128" label="128">
         <title>
            <emphasis role="chapterNumber">4.9.19</emphasis>
            <emphasis role="chapterTitle">Combination Enzymatic Tablets for Nitrophenol, Aminopeptidase, and Glycosidases</emphasis>
         </title> &sect1.9781683674832.ch0128s0001;
     &sect1.9781683674832.ch0128s0002;
     &sect1.9781683674832.ch0128s0003;
    </chapter>
      <chapter id="ch0129" label="129">
         <title>
            <emphasis role="chapterNumber">4.10</emphasis>
            <emphasis role="chapterTitle">Commercial Kit and Rapid Enzymatic Systems for the Identification of Anaerobes</emphasis>
         </title> &sect1.9781683674832.ch0129s0001;
     &sect1.9781683674832.ch0129s0002;
     &sect1.9781683674832.ch0129s0003;
    </chapter>
      <chapter id="ch0130" label="130">
         <title>
            <emphasis role="chapterNumber">4.11</emphasis>
            <emphasis role="chapterTitle">Storage and Stocking of Anaerobes</emphasis>
         </title> &sect1.9781683674832.ch0130s0001;
    </chapter>
      <chapter id="ch0131" label="131">
         <title>
            <emphasis role="chapterNumber">4.12</emphasis>
            <emphasis role="chapterTitle">Use of Matrix-Assisted Laser Desorption IonizationTime of Flight Mass Spectrometry for the Identification of Anaerobic Bacteria</emphasis>
         </title> &sect1.9781683674832.ch0131s0001;
     &sect1.9781683674832.ch0131s0002;
     &sect1.9781683674832.ch0131s0003;
    </chapter>
      <chapter id="ch0132" label="132">
         <title>
            <emphasis role="chapterNumber">4.13</emphasis>
            <emphasis role="chapterTitle">Anaerobic Gram-Negative Bacilli</emphasis>
         </title> &sect1.9781683674832.ch0132s0001;
     &sect1.9781683674832.ch0132s0002;
     &sect1.9781683674832.ch0132s0003;
    </chapter>
      <chapter id="ch0133" label="133">
         <title>
            <emphasis role="chapterNumber">4.14</emphasis>
            <emphasis role="chapterTitle">Anaerobic Gram-Positive Bacilli</emphasis>
         </title> &sect1.9781683674832.ch0133s0001;
     &sect1.9781683674832.ch0133s0002;
     &sect1.9781683674832.ch0133s0003;
    </chapter>
      <chapter id="ch0134" label="134">
         <title>
            <emphasis role="chapterNumber">4.15</emphasis>
            <emphasis role="chapterTitle">Anaerobic Cocci</emphasis>
         </title> &sect1.9781683674832.ch0134s0001;
     &sect1.9781683674832.ch0134s0002;
     &sect1.9781683674832.ch0134s0003;
    </chapter>
      <chapter id="ch0135" label="135">
         <title>
            <emphasis role="chapterNumber">4.16</emphasis>
            <emphasis role="chapterTitle">
               <emphasis>Clostridioides</emphasis> (<emphasis>Clostridium</emphasis>) <emphasis>difficile</emphasis> as a Pathogen Involved in Antimicrobial Agent-Associated Diarrhea, Colitis, and Pseudomembranous Colitis</emphasis>
         </title> &sect1.9781683674832.ch0135s0001;
     &sect1.9781683674832.ch0135s0002;
     &sect1.9781683674832.ch0135s0003;
    </chapter>
   </part>
   <part id="pt0005">
      <title>
         <emphasis role="partNumber">SECTION 5</emphasis><?lb?>
         <emphasis role="partTitle">Blood Culture</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">Amanda T. Harrington and Erin McElvania</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0005s0001;
<chapter id="ch0136" label="136">
         <title>
            <emphasis role="chapterNumber">5.1</emphasis>
            <emphasis role="chapterTitle">Introduction</emphasis>
         </title> &sect1.9781683674832.ch0136s0001;
    </chapter>
      <chapter id="ch0137" label="137">
         <title>
            <emphasis role="chapterNumber">5.2</emphasis>
            <emphasis role="chapterTitle">Preanalytical Considerations and Laboratory Processing of Samples for Blood Culture</emphasis>
         </title> &sect1.9781683674832.ch0137s0001;
     &sect1.9781683674832.ch0137s0002;
     &sect1.9781683674832.ch0137s0003;
    </chapter>
      <chapter id="ch0138" label="138">
         <title>
            <emphasis role="chapterNumber">5.3</emphasis>
            <emphasis role="chapterTitle">Continuous-Monitoring Blood Culture Systems for Detection of Aerobic and Anaerobic Bacteria</emphasis>
         </title> &sect1.9781683674832.ch0138s0001;
     &sect1.9781683674832.ch0138s0002;
     &sect1.9781683674832.ch0138s0003;
    </chapter>
      <chapter id="ch0139" label="139">
         <title>
            <emphasis role="chapterNumber">5.4</emphasis>
            <emphasis role="chapterTitle">Lysis Centrifugation</emphasis>
         </title> &sect1.9781683674832.ch0139s0001;
     &sect1.9781683674832.ch0139s0002;
     &sect1.9781683674832.ch0139s0003;
    </chapter>
      <chapter id="ch0140" label="140">
         <title>
            <emphasis role="chapterNumber">5.5</emphasis>
            <emphasis role="chapterTitle">Continuous Monitoring Blood Culture Systems for Detection of Acid-Fast Bacilli and Fungi</emphasis>
         </title> &sect1.9781683674832.ch0140s0001;
     &sect1.9781683674832.ch0140s0002;
     &sect1.9781683674832.ch0140s0003;
    </chapter>
      <chapter id="ch0141" label="141">
         <title>
            <emphasis role="chapterNumber">5.6</emphasis>
            <emphasis role="chapterTitle">Quality Control and Quality Assurance for Blood Cultures</emphasis>
         </title> &sect1.9781683674832.ch0141s0001;
     &sect1.9781683674832.ch0141s0002;
    </chapter>
      <chapter id="ch0142" label="142">
         <title>
            <emphasis role="chapterNumber">5.7</emphasis>
            <emphasis role="chapterTitle">Staining, Culture, and Identification Methods for Aerobic and Anaerobic Bacteria Recovered from Positive Blood Cultures</emphasis>
         </title> &sect1.9781683674832.ch0142s0001;
     &sect1.9781683674832.ch0142s0002;
     &sect1.9781683674832.ch0142s0003;
    </chapter>
      <chapter id="ch0143" label="143">
         <title>
            <emphasis role="chapterNumber">5.8</emphasis>
            <emphasis role="chapterTitle">Staining, Culture, and Identification Methods for Acid-Fast Bacilli and Fungi Recovered from Positive Blood Cultures</emphasis>
         </title> &sect1.9781683674832.ch0143s0001;
     &sect1.9781683674832.ch0143s0002;
     &sect1.9781683674832.ch0143s0003;
    </chapter>
      <chapter id="ch0144" label="144">
         <title>
            <emphasis role="chapterNumber">5.9</emphasis>
            <emphasis role="chapterTitle">Blood Cultures: Postanalytical Considerations</emphasis>
         </title> &sect1.9781683674832.ch0144s0001;
     &sect1.9781683674832.ch0144s0002;
    </chapter>
      <chapter id="ch0145" label="145">
         <title>
            <emphasis role="chapterNumber">5.10</emphasis>
            <emphasis role="chapterTitle">Supplementing Blood Cultures with Chromogenic Media to Expedite Microorganism Identification and/or Antimicrobial Resistance Detection</emphasis>
         </title> &sect1.9781683674832.ch0145s0001;
     &sect1.9781683674832.ch0145s0002;
     &sect1.9781683674832.ch0145s0003;
    </chapter>
      <chapter id="ch0146" label="146">
         <title>
            <emphasis role="chapterNumber">5.11</emphasis>
            <emphasis role="chapterTitle">Specialized Processing of Blood</emphasis>
         </title> &sect1.9781683674832.ch0146s0001;
     &sect1.9781683674832.ch0146s0002;
     &sect1.9781683674832.ch0146s0003;
     &sect1.9781683674832.ch0146s0004;
    </chapter>
      <chapter id="ch0147" label="147">
         <title>
            <emphasis role="chapterNumber">5.11.2</emphasis>
            <emphasis role="chapterTitle">Autopsy Blood Cultures</emphasis>
         </title> &sect1.9781683674832.ch0147s0001;
    </chapter>
      <chapter id="ch0148" label="148">
         <title>
            <emphasis role="chapterNumber">5.11.3</emphasis>
            <emphasis role="chapterTitle">Special Media or Stains for Fastidious and Infrequently Encountered Organisms</emphasis>
         </title> &sect1.9781683674832.ch0148s0001;
    </chapter>
      <chapter id="ch0149" label="149">
         <title>
            <emphasis role="chapterNumber">5.12</emphasis>
            <emphasis role="chapterTitle">Diagnosis of Catheter-Related Bloodstream Infection: Differential-Time-to-Positivity Cultures and Catheter Tip Cultures</emphasis>
         </title> &sect1.9781683674832.ch0149s0001;
     &sect1.9781683674832.ch0149s0002;
     &sect1.9781683674832.ch0149s0003;
    </chapter>
      <chapter id="ch0150" label="150">
         <title>
            <emphasis role="chapterNumber">5.13</emphasis>
            <emphasis role="chapterTitle">Multiplex Molecular Panels for Positive Blood Cultures</emphasis>
         </title> &sect1.9781683674832.ch0150s0004;
     &sect1.9781683674832.ch0150s0001;
     &sect1.9781683674832.ch0150s0002;
     &sect1.9781683674832.ch0150s0003;
    </chapter>
      <chapter id="ch0151" label="151">
         <title>
            <emphasis role="chapterNumber">5.14</emphasis>
            <emphasis role="chapterTitle">Broad-Range PCR and Emerging Technologies for the Direct Detection of Microorganisms from Blood Specimens</emphasis>
         </title> &sect1.9781683674832.ch0151s0001;
     &sect1.9781683674832.ch0151s0002;
     &sect1.9781683674832.ch0151s0003;
    </chapter>
   </part>
   <part id="pt0006">
      <title>
         <emphasis role="partNumber">SECTION 6</emphasis><?lb?>
         <emphasis role="partTitle">MALDI-TOF MS</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITOR</emphasis>: <emphasis>
               <emphasis role="strong">Erin McElvania</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0006s0001;
<chapter id="ch0152" label="152">
         <title>
            <emphasis role="chapterNumber">6.1</emphasis>
            <emphasis role="chapterTitle">Introduction</emphasis>
         </title> &sect1.9781683674832.ch0152s0001;
    </chapter>
      <chapter id="ch0153" label="153">
         <title>
            <emphasis role="chapterNumber">6.2</emphasis>
            <emphasis role="chapterTitle">MALDI-TOF MS for Bacterial and Yeast Identification</emphasis>
         </title> &sect1.9781683674832.ch0153s0001;
     &sect1.9781683674832.ch0153s0002;
     &sect1.9781683674832.ch0153s0003;
    </chapter>
      <chapter id="ch0154" label="154">
         <title>
            <emphasis role="chapterNumber">6.3</emphasis>
            <emphasis role="chapterTitle">Identification of Highly Pathogenic Bacteria by MALDI-TOF MS</emphasis>
         </title> &sect1.9781683674832.ch0154s0001;
     &sect1.9781683674832.ch0154s0002;
     &sect1.9781683674832.ch0154s0003;
    </chapter>
      <chapter id="ch0155" label="155">
         <title>
            <emphasis role="chapterNumber">6.4</emphasis>
            <emphasis role="chapterTitle">MALDI-TOF MS for Identification of Acid-Fast Bacilli and Aerobic Actinomycetes</emphasis>
         </title> &sect1.9781683674832.ch0155s0001;
     &sect1.9781683674832.ch0155s0002;
     &sect1.9781683674832.ch0155s0003;
    </chapter>
      <chapter id="ch0156" label="156">
         <title>
            <emphasis role="chapterNumber">6.5</emphasis>
            <emphasis role="chapterTitle">MALDI-TOF MS for Filamentous Fungi Identification</emphasis>
         </title> &sect1.9781683674832.ch0156s0001;
     &sect1.9781683674832.ch0156s0002;
     &sect1.9781683674832.ch0156s0003;
    </chapter>
      <chapter id="ch0157" label="157">
         <title>
            <emphasis role="chapterNumber">6.6</emphasis>
            <emphasis role="chapterTitle">MALDI-TOF MS for Identification of Bacteria and Yeast from Positive Blood Culture Broth</emphasis>
         </title> &sect1.9781683674832.ch0157s0001;
     &sect1.9781683674832.ch0157s0002;
     &sect1.9781683674832.ch0157s0003;
    </chapter>
   </part>
   <part id="pt0007">
      <title>
         <emphasis role="partNumber">SECTION 7</emphasis><?lb?>
         <emphasis role="partTitle">Antimicrobial Susceptibility Testing</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">Romney M. Humphries and Patricia J. Simner</emphasis>
            </emphasis>
         </para>
         <para>
            <emphasis role="strong">ROUTINE TESTS PERFORMED FOR AST</emphasis>
         </para>
         <para>
            <emphasis role="strong">PHENOTYPIC DETECTION OF RESISTANCE MECHANISMSGENERAL</emphasis>
         </para>
         <para>
            <emphasis role="strong">PHENOTYPIC DETECTION OF RESISTANCE MECHANISMSGRAM POSITIVE BACTERIA</emphasis>
         </para>
         <para>
            <emphasis role="strong">PHENOTYPIC DETECTION OF RESISTANCE MECHANISMSENTEROBACTERIACEAE</emphasis>
         </para>
         <para>
            <emphasis role="strong">SPECIALIZED SUSCEPTIBILITY TESTS</emphasis>
         </para>
         <para>
            <emphasis role="strong">MISCELLANEOUS</emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0007s0001;
<chapter id="ch0158" label="158">
         <title>
            <emphasis role="chapterNumber">7.1</emphasis>
            <emphasis role="chapterTitle">Introduction to Antimicrobial Susceptibility Testing Methods</emphasis>
         </title> &sect1.9781683674832.ch0158s0001;
    </chapter>
      <chapter id="ch0159" label="159">
         <title>
            <emphasis role="chapterNumber">7.1.1</emphasis>
            <emphasis role="chapterTitle">Types of Antimicrobial Susceptibility Tests</emphasis>
         </title> &sect1.9781683674832.ch0159s0001;
    </chapter>
      <chapter id="ch0160" label="160">
         <title>
            <emphasis role="chapterNumber">7.1.2</emphasis>
            <emphasis role="chapterTitle">Selecting and Applying Clinical Breakpoints</emphasis>
         </title> &sect1.9781683674832.ch0160s0001;
    </chapter>
      <chapter id="ch0161" label="161">
         <title>
            <emphasis role="chapterNumber">7.2</emphasis>
            <emphasis role="chapterTitle">
               <emphasis role="strong">Disk Diffusion Testing</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0161s0001;
     &sect1.9781683674832.ch0161s0002;
     &sect1.9781683674832.ch0161s0003;
    </chapter>
      <chapter id="ch0162" label="162">
         <title>
            <emphasis role="chapterNumber">7.3</emphasis>
            <emphasis role="chapterTitle">Disk Diffusion from Positive Blood Culture</emphasis>
         </title> &sect1.9781683674832.ch0162s0001;
     &sect1.9781683674832.ch0162s0002;
     &sect1.9781683674832.ch0162s0003;
    </chapter>
      <chapter id="ch0163" label="163">
         <title>
            <emphasis role="chapterNumber">7.4</emphasis>
            <emphasis role="chapterTitle">Broth Microdilution Test</emphasis>
         </title> &sect1.9781683674832.ch0163s0001;
    </chapter>
      <chapter id="ch0164" label="164">
         <title>
            <emphasis role="chapterNumber">7.4.2</emphasis>
            <emphasis role="chapterTitle">Broth Microdilution MIC Test for Anaerobic Bacteria</emphasis>
         </title> &sect1.9781683674832.ch0164s0001;
     &sect1.9781683674832.ch0164s0002;
     &sect1.9781683674832.ch0164s0003;
    </chapter>
      <chapter id="ch0165" label="165">
         <title>
            <emphasis role="chapterNumber">7.5</emphasis>
            <emphasis role="chapterTitle">Gradient Diffusion Tests</emphasis>
         </title> &sect1.9781683674832.ch0165s0001;
     &sect1.9781683674832.ch0165s0002;
     &sect1.9781683674832.ch0165s0003;
    </chapter>
      <chapter id="ch0166" label="166">
         <title>
            <emphasis role="chapterNumber">7.6</emphasis>
            <emphasis role="chapterTitle">Agar Dilution MIC Test</emphasis>
         </title> &sect1.9781683674832.ch0166s0001;
    </chapter>
      <chapter id="ch0167" label="167">
         <title>
            <emphasis role="chapterNumber">7.6.2</emphasis>
            <emphasis role="chapterTitle">Agar Dilution MIC Test for Anaerobic Bacteria</emphasis>
         </title> &sect1.9781683674832.ch0167s0001;
     &sect1.9781683674832.ch0167s0002;
     &sect1.9781683674832.ch0167s0003;
    </chapter>
      <chapter id="ch0168" label="168">
         <title>
            <emphasis role="chapterNumber">7.7</emphasis>
            <emphasis role="chapterTitle">Beta-Lactamase Tests</emphasis>
         </title> &sect1.9781683674832.ch0168s0001;
     &sect1.9781683674832.ch0168s0002;
     &sect1.9781683674832.ch0168s0003;
    </chapter>
      <chapter id="ch0169" label="169">
         <title>
            <emphasis role="chapterNumber">7.8</emphasis>
            <emphasis role="chapterTitle">Oxacillin Salt Agar Test To Detect Methicillin (Oxacillin)-Resistant <emphasis role="strong">
                  <emphasis>Staphylococcus aureus</emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0169s0001;
     &sect1.9781683674832.ch0169s0002;
     &sect1.9781683674832.ch0169s0003;
    </chapter>
      <chapter id="ch0170" label="170">
         <title>
            <emphasis role="chapterNumber">7.9</emphasis>
            <emphasis role="chapterTitle">Detection of VRSA, VISA, and Vancomycin-Heteroresistant <emphasis role="strong">
                  <emphasis>Staphylococcus</emphasis>
               </emphasis>
               <emphasis>
                  <emphasis role="strong">aureus</emphasis>
               </emphasis> (hVISA)</emphasis>
         </title> &sect1.9781683674832.ch0170s0004;
     &sect1.9781683674832.ch0170s0001;
     &sect1.9781683674832.ch0170s0002;
     &sect1.9781683674832.ch0170s0003;
    </chapter>
      <chapter id="ch0171" label="171">
         <title>
            <emphasis role="chapterNumber">7.10</emphasis>
            <emphasis role="chapterTitle">Screening Tests for Detection of High-Level Mupirocin Resistance in <emphasis>
                  <emphasis role="strong">Staphylococcus aureus</emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0171s0001;
     &sect1.9781683674832.ch0171s0002;
     &sect1.9781683674832.ch0171s0003;
    </chapter>
      <chapter id="ch0172" label="172">
         <title>
            <emphasis role="chapterNumber">7.11</emphasis>
            <emphasis role="chapterTitle">Detection of Inducible Clindamycin Resistance in <emphasis role="strong">
                  <emphasis>Staphylococcus</emphasis>
               </emphasis> spp., <emphasis role="strong">
                  <emphasis>Streptococcus pneumoniae</emphasis>
               </emphasis>, and <emphasis role="strong">
                  <emphasis>Streptococcus</emphasis>
               </emphasis> spp. Beta-Hemolytic Group</emphasis>
         </title> &sect1.9781683674832.ch0172s0001;
     &sect1.9781683674832.ch0172s0002;
     &sect1.9781683674832.ch0172s0003;
    </chapter>
      <chapter id="ch0173" label="173">
         <title>
            <emphasis role="chapterNumber">7.12</emphasis>
            <emphasis role="chapterTitle">Screen Tests to Detect High-Level Aminoglycoside Resistance in <emphasis role="strong">
                  <emphasis>Enterococcus</emphasis>
               </emphasis> spp.</emphasis>
         </title> &sect1.9781683674832.ch0173s0001;
     &sect1.9781683674832.ch0173s0002;
     &sect1.9781683674832.ch0173s0003;
    </chapter>
      <chapter id="ch0174" label="174">
         <title>
            <emphasis role="chapterNumber">7.13</emphasis>
            <emphasis role="chapterTitle">Agar Screen Test To Detect Vancomycin Resistance in <emphasis role="strong">
                  <emphasis>Enterococcus</emphasis>
               </emphasis> spp.</emphasis>
         </title> &sect1.9781683674832.ch0174s0001;
     &sect1.9781683674832.ch0174s0002;
     &sect1.9781683674832.ch0174s0003;
    </chapter>
      <chapter id="ch0175" label="175">
         <title>
            <emphasis role="chapterNumber">7.14</emphasis>
            <emphasis role="chapterTitle">
               <emphasis role="strong">Extended-Spectrum Beta-Lactamase Testing for</emphasis>
               <emphasis>
                  <emphasis role="strong">
                     <emphasis>Enterobacterales</emphasis>
                  </emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0175s0001;
     &sect1.9781683674832.ch0175s0002;
     &sect1.9781683674832.ch0175s0003;
    </chapter>
      <chapter id="ch0176" label="176">
         <title>
            <emphasis role="chapterNumber">7.15</emphasis>
            <emphasis role="chapterTitle">AmpC Beta-Lactamase Testing</emphasis>
         </title> &sect1.9781683674832.ch0176s0001;
     &sect1.9781683674832.ch0176s0002;
     &sect1.9781683674832.ch0176s0003;
    </chapter>
      <chapter id="ch0177" label="177">
         <title>
            <emphasis role="chapterNumber">7.16</emphasis>
            <emphasis role="chapterTitle">Phenotypic Carbapenemase Detection Methods</emphasis>
         </title> &sect1.9781683674832.ch0177s0001;
    </chapter>
      <chapter id="ch0178" label="178">
         <title>
            <emphasis role="chapterNumber">7.16.2</emphasis>
            <emphasis role="chapterTitle">Modified Hodge Test and Modified Carbapenem Inactivation Method for Phenotypic Detection of Carbapenemases</emphasis>
         </title> &sect1.9781683674832.ch0178s0001;
    </chapter>
      <chapter id="ch0179" label="179">
         <title>
            <emphasis role="chapterNumber">7.16.3</emphasis>
            <emphasis role="chapterTitle">Carbapenemase Nordmann-Poirel (Carba NP) Test for the Phenotypic Detection of Carbapenemases</emphasis>
         </title> &sect1.9781683674832.ch0179s0001;
     &sect1.9781683674832.ch0179s0002;
     &sect1.9781683674832.ch0179s0003;
    </chapter>
      <chapter id="ch0180" label="180">
         <title>
            <emphasis role="chapterNumber">7.16.4</emphasis>
            <emphasis role="chapterTitle">Phenotypic Tests for the Detection of Metallo--Lactamases</emphasis>
         </title> &sect1.9781683674832.ch0180s0001;
     &sect1.9781683674832.ch0180s0002;
     &sect1.9781683674832.ch0180s0003;
     &sect1.9781683674832.ch0180s0004;
    </chapter>
      <chapter id="ch0181" label="181">
         <title>
            <emphasis role="chapterNumber">7.17</emphasis>
            <emphasis role="chapterTitle">Tests to Assess Bactericidal Activity</emphasis>
         </title> &sect1.9781683674832.ch0181s0001;
    </chapter>
      <chapter id="ch0182" label="182">
         <title>
            <emphasis role="chapterNumber">7.17.2</emphasis>
            <emphasis role="chapterTitle">Time-Kill Assay</emphasis>
         </title> &sect1.9781683674832.ch0182s0001;
     &sect1.9781683674832.ch0182s0002;
     &sect1.9781683674832.ch0182s0003;
    </chapter>
      <chapter id="ch0183" label="183">
         <title>
            <emphasis role="chapterNumber">7.17.3</emphasis>
            <emphasis role="chapterTitle">Time-Kill Assay for Determining Synergy</emphasis>
         </title> &sect1.9781683674832.ch0183s0001;
     &sect1.9781683674832.ch0183s0002;
     &sect1.9781683674832.ch0183s0003;
    </chapter>
      <chapter id="ch0184" label="184">
         <title>
            <emphasis role="chapterNumber">7.18</emphasis>
            <emphasis role="chapterTitle">Serum Inhibitory and Bactericidal Titers</emphasis>
         </title> &sect1.9781683674832.ch0184s0001;
     &sect1.9781683674832.ch0184s0002;
     &sect1.9781683674832.ch0184s0003;
     &sect1.9781683674832.ch0184s0004;
     &sect1.9781683674832.ch0184s0005;
    </chapter>
      <chapter id="ch0185" label="185">
         <title>
            <emphasis role="chapterNumber">7.19</emphasis>
            <emphasis role="chapterTitle">Synergy Testing: Broth Microdilution and Broth Macrodilution Checkerboard Methods</emphasis>
         </title> &sect1.9781683674832.ch0185s0001;
     &sect1.9781683674832.ch0185s0002;
     &sect1.9781683674832.ch0185s0003;
     &sect1.9781683674832.ch0185s0004;
     &sect1.9781683674832.ch0185s0005;
     &sect1.9781683674832.ch0185s0006;
    </chapter>
      <chapter id="ch0186" label="186">
         <title>
            <emphasis role="chapterNumber">7.20</emphasis>
            <emphasis role="chapterTitle">Quality Assurance Measures for Antimicrobial Susceptibility Testing</emphasis>
         </title> &sect1.9781683674832.ch0186s0001;
    </chapter>
      <chapter id="ch0187" label="187">
         <title>
            <emphasis role="chapterNumber">7.21</emphasis>
            <emphasis role="chapterTitle">Creation of an Antibiogram and Verification of Data</emphasis>
         </title> &sect1.9781683674832.ch0187s0001;
     &sect1.9781683674832.ch0187s0002;
     &sect1.9781683674832.ch0187s0003;
    </chapter>
      <chapter id="ch0188" label="188">
         <title>
            <emphasis role="chapterNumber">7.22</emphasis>
            <emphasis role="chapterTitle">Evaluation and Verification of Antimicrobial Susceptibility Test Systems</emphasis>
         </title> &sect1.9781683674832.ch0188s0001;
     &sect1.9781683674832.ch0188s0002;
     &sect1.9781683674832.ch0188s0003;
    </chapter>
      <chapter id="ch0189" label="189">
         <title>
            <emphasis role="chapterNumber">7.23</emphasis>
            <emphasis role="chapterTitle">Selecting Antimicrobial Agents for Testing and Reporting</emphasis>
         </title> &sect1.9781683674832.ch0189s0001;
     &sect1.9781683674832.ch0189s0002;
    </chapter>
      <chapter id="ch0190" label="190">
         <title>
            <emphasis role="chapterNumber">7.24</emphasis>
            <emphasis role="chapterTitle">Preparation of Routine Media and Reagents Used in Antimicrobial Susceptibility Testing</emphasis>
         </title> &sect1.9781683674832.ch0190s0001;
    </chapter>
      <chapter id="ch0191" label="191">
         <title>
            <emphasis role="chapterNumber">7.24.2</emphasis>
            <emphasis role="chapterTitle">Antimicrobial Stock Solutions</emphasis>
         </title> &sect1.9781683674832.ch0191s0001;
     &sect1.9781683674832.ch0191s0002;
     &sect1.9781683674832.ch0191s0003;
    </chapter>
      <chapter id="ch0192" label="192">
         <title>
            <emphasis role="chapterNumber">7.24.3</emphasis>
            <emphasis role="chapterTitle">Preparation of Agar and Broth Media Used in Routine Antimicrobial Susceptibility Tests</emphasis>
         </title> &sect1.9781683674832.ch0192s0001;
     &sect1.9781683674832.ch0192s0002;
     &sect1.9781683674832.ch0192s0003;
    </chapter>
      <chapter id="ch0193" label="193">
         <title>
            <emphasis role="chapterNumber">7.25</emphasis>
            <emphasis role="chapterTitle">Preparation of Broth Microdilution MIC Trays</emphasis>
         </title> &sect1.9781683674832.ch0193s0001;
     &sect1.9781683674832.ch0193s0002;
     &sect1.9781683674832.ch0193s0003;
    </chapter>
   </part>
   <part id="pt0008">
      <title>
         <emphasis role="partNumber">SECTION 8</emphasis><?lb?>
         <emphasis role="partTitle">Aerobic Actinomycetes</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">Michael A. Saubolle and A. Brian Mochon</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0008s0001;
<chapter id="ch0194" label="194">
         <title>
            <emphasis role="chapterNumber">8.1</emphasis>
            <emphasis role="chapterTitle">Introduction</emphasis>
         </title> &sect1.9781683674832.ch0194s0001;
    </chapter>
      <chapter id="ch0195" label="195">
         <title>
            <emphasis role="chapterNumber">8.2</emphasis>
            <emphasis role="chapterTitle">Specimen Examination and Primary Isolation</emphasis>
         </title> &sect1.9781683674832.ch0195s0001;
     &sect1.9781683674832.ch0195s0002;
     &sect1.9781683674832.ch0195s0003;
    </chapter>
      <chapter id="ch0196" label="196">
         <title>
            <emphasis role="chapterNumber">8.3</emphasis>
            <emphasis role="chapterTitle">Media and Methods Used for Phenotypic Characterization of Aerobic Actinomycetes</emphasis>
         </title> &sect1.9781683674832.ch0196s0001;
     &sect1.9781683674832.ch0196s0002;
    </chapter>
      <chapter id="ch0197" label="197">
         <title>
            <emphasis role="chapterNumber">8.4</emphasis>
            <emphasis role="chapterTitle">Definitive Identification of Aerobic Actinomycetes</emphasis>
         </title> &sect1.9781683674832.ch0197s0001;
     &sect1.9781683674832.ch0197s0002;
     &sect1.9781683674832.ch0197s0003;
    </chapter>
      <chapter id="ch0198" label="198">
         <title>
            <emphasis role="chapterNumber">8.5</emphasis>
            <emphasis role="chapterTitle">Susceptibility Testing</emphasis>
         </title> &sect1.9781683674832.ch0198s0001;
     &sect1.9781683674832.ch0198s0002;
     &sect1.9781683674832.ch0198s0003;
    </chapter>
      <chapter id="ch0199" label="199">
         <title>
            <emphasis role="chapterNumber">8.6</emphasis>
            <emphasis role="chapterTitle">Appendixes</emphasis>
         </title> &sect1.9781683674832.ch0199s0001;
    </chapter>
   </part>
   <part id="pt0009">
      <title>
         <emphasis role="partNumber">SECTION 9</emphasis><?lb?>
         <emphasis role="partTitle">Mycobacteriology and Antimycobacterial Susceptibility Testing</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITOR</emphasis>: <emphasis>
               <emphasis role="strong">Nancy L. Wengenack</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0009s0001;
<chapter id="ch0200" label="200">
         <title>
            <emphasis role="chapterNumber">9.1</emphasis>
            <emphasis role="chapterTitle">Introduction</emphasis>
         </title> &sect1.9781683674832.ch0200s0001;
    </chapter>
      <chapter id="ch0201" label="201">
         <title>
            <emphasis role="chapterNumber">9.1</emphasis>
            <emphasis role="chapterTitle">G <emphasis role="small">ENERAL</emphasis> M <emphasis role="small">YCOBACTERIAL</emphasis> P <emphasis role="small">ROCEDURES</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0201s0001;
    </chapter>
      <chapter id="ch0202" label="202">
         <title>
            <emphasis role="chapterNumber">9.2.2</emphasis>
            <emphasis role="chapterTitle">Digestion and Decontamination</emphasis>
         </title> &sect1.9781683674832.ch0202s0001;
     &sect1.9781683674832.ch0202s0002;
    </chapter>
      <chapter id="ch0203" label="203">
         <title>
            <emphasis role="chapterNumber">9.2.3</emphasis>
            <emphasis role="chapterTitle">Acid-Fast Stains</emphasis>
         </title> &sect1.9781683674832.ch0203s0001;
     &sect1.9781683674832.ch0203s0002;
     &sect1.9781683674832.ch0203s0003;
    </chapter>
      <chapter id="ch0204" label="204">
         <title>
            <emphasis role="chapterNumber">9.2.4</emphasis>
            <emphasis role="chapterTitle">Reporting</emphasis>
         </title> &sect1.9781683674832.ch0204s0001;
    </chapter>
      <chapter id="ch0205" label="205">
         <title>
            <emphasis role="chapterNumber">9.3</emphasis>
            <emphasis role="chapterTitle">Solid Media Used for Isolation</emphasis>
         </title> &sect1.9781683674832.ch0205s0001;
     &sect1.9781683674832.ch0205s0002;
     &sect1.9781683674832.ch0205s0003;
    </chapter>
      <chapter id="ch0206" label="206">
         <title>
            <emphasis role="chapterNumber">9.4</emphasis>
            <emphasis role="chapterTitle">Liquid Media Used for Isolation</emphasis>
         </title> &sect1.9781683674832.ch0206s0001;
    </chapter>
      <chapter id="ch0207" label="207">
         <title>
            <emphasis role="chapterNumber">9.4.2</emphasis>
            <emphasis role="chapterTitle">VersaTREK Myco Culture System</emphasis>
         </title> &sect1.9781683674832.ch0207s0001;
     &sect1.9781683674832.ch0207s0002;
     &sect1.9781683674832.ch0207s0003;
    </chapter>
      <chapter id="ch0208" label="208">
         <title>
            <emphasis role="chapterNumber">9.5</emphasis>
            <emphasis role="chapterTitle">Identification of Mycobacteria</emphasis>
         </title> &sect1.9781683674832.ch0208s0001;
    </chapter>
      <chapter id="ch0209" label="209">
         <title>
            <emphasis role="chapterNumber">9.5.2</emphasis>
            <emphasis role="chapterTitle">Accu Probe Mycobacterial Culture Identification Tests</emphasis>
         </title> &sect1.9781683674832.ch0209s0001;
     &sect1.9781683674832.ch0209s0002;
     &sect1.9781683674832.ch0209s0003;
    </chapter>
      <chapter id="ch0210" label="210">
         <title>
            <emphasis role="chapterNumber">9.5.3</emphasis>
            <emphasis role="chapterTitle">INNO-LiPA MYCOBACTERIA v 2 Line Probe Assay</emphasis>
         </title> &sect1.9781683674832.ch0210s0001;
     &sect1.9781683674832.ch0210s0002;
     &sect1.9781683674832.ch0210s0003;
    </chapter>
      <chapter id="ch0211" label="211">
         <title>
            <emphasis role="chapterNumber">9.6</emphasis>
            <emphasis role="chapterTitle">Nucleic Acid Amplification Procedures for Identification from Specimens</emphasis>
         </title> &sect1.9781683674832.ch0211s0001;
    </chapter>
      <chapter id="ch0212" label="212">
         <title>
            <emphasis role="chapterNumber">9.6.2</emphasis>
            <emphasis role="chapterTitle">Cepheid Xpert MTB/RIF Tests: Xpert MTB/RIF Ultra</emphasis>
         </title> &sect1.9781683674832.ch0212s0001;
     &sect1.9781683674832.ch0212s0002;
     &sect1.9781683674832.ch0212s0003;
    </chapter>
      <chapter id="ch0213" label="213">
         <title>
            <emphasis role="chapterNumber">9.6.3</emphasis>
            <emphasis role="chapterTitle">Cepheid Xpert MTB/XDR Test</emphasis>
         </title> &sect1.9781683674832.ch0213s0001;
     &sect1.9781683674832.ch0213s0002;
     &sect1.9781683674832.ch0213s0003;
    </chapter>
      <chapter id="ch0214" label="214">
         <title>
            <emphasis role="chapterNumber">9.7</emphasis>
            <emphasis role="chapterTitle">Susceptibility Testing by Liquid Media Methods</emphasis>
         </title> &sect1.9781683674832.ch0214s0001;
    </chapter>
      <chapter id="ch0215" label="215">
         <title>
            <emphasis role="chapterNumber">9.7.2</emphasis>
            <emphasis role="chapterTitle">BACTEC MGIT Pyrazinamide (PZA)Nonradiometric Susceptibility Testing for <emphasis role="strong">
                  <emphasis>Mycobacterium tuberculosis</emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0215s0001;
     &sect1.9781683674832.ch0215s0002;
     &sect1.9781683674832.ch0215s0003;
    </chapter>
      <chapter id="ch0216" label="216">
         <title>
            <emphasis role="chapterNumber">9.7.3</emphasis>
            <emphasis role="chapterTitle">VersaTREKIndirect Susceptibility Testing for <emphasis role="strong">
                  <emphasis>Mycobacterium tuberculosis</emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0216s0001;
     &sect1.9781683674832.ch0216s0002;
     &sect1.9781683674832.ch0216s0003;
    </chapter>
      <chapter id="ch0217" label="217">
         <title>
            <emphasis role="chapterNumber">9.8</emphasis>
            <emphasis role="chapterTitle">
               <emphasis role="strong">Susceptibility Testing by the Agar Proportion Method for <emphasis>Mycobacterium tuberculosis</emphasis> Complex</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0217s0001;
     &sect1.9781683674832.ch0217s0002;
     &sect1.9781683674832.ch0217s0003;
    </chapter>
      <chapter id="ch0218" label="218">
         <title>
            <emphasis role="chapterNumber">9.9</emphasis>
            <emphasis role="chapterTitle">S <emphasis role="small">USCEPTIBILITY</emphasis> T <emphasis role="small">ESTING</emphasis>
               <emphasis role="small">BY</emphasis> TREK S <emphasis role="small">ENSITITRE</emphasis> M <emphasis role="small">ICRODILUTION</emphasis> P <emphasis role="small">LATES</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0218s0001;
    </chapter>
      <chapter id="ch0219" label="219">
         <title>
            <emphasis role="chapterNumber">9.9.2</emphasis>
            <emphasis role="chapterTitle">Antimicrobial Susceptibility Testing for Slowly Growing Nontuberculous Mycobacteria</emphasis>
         </title> &sect1.9781683674832.ch0219s0001;
     &sect1.9781683674832.ch0219s0002;
     &sect1.9781683674832.ch0219s0003;
    </chapter>
      <chapter id="ch0220" label="220">
         <title>
            <emphasis role="chapterNumber">9.9.3</emphasis>
            <emphasis role="chapterTitle">Antimicrobial Susceptibility Testing for the <emphasis>
                  <emphasis role="strong">Mycobacterium tuberculosis</emphasis>
               </emphasis> Complex Using Broth Microdilution</emphasis>
         </title> &sect1.9781683674832.ch0220s0001;
     &sect1.9781683674832.ch0220s0002;
     &sect1.9781683674832.ch0220s0003;
    </chapter>
      <chapter id="ch0221" label="221">
         <title>
            <emphasis role="chapterNumber">9.10</emphasis>
            <emphasis role="chapterTitle">M <emphasis role="small">OLECULAR</emphasis> S <emphasis role="small">USCEPTIBILITY</emphasis> T <emphasis role="small">ESTING FOR</emphasis>
               <emphasis>M <emphasis role="small">YCOBACTERIUM TUBERCULOSIS</emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0221s0001;
    </chapter>
   </part>
   <part id="pt0010">
      <title>
         <emphasis role="partNumber">SECTION 10</emphasis><?lb?>
         <emphasis role="partTitle">Mycology and Antifungal Susceptibility Testing</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">Shawn R. Lockhart and Nathan P. Wiederhold</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0010s0001;
<chapter id="ch0222" label="222">
         <title>
            <emphasis role="chapterNumber">10.1</emphasis>
            <emphasis role="chapterTitle">Introduction and General Considerations</emphasis>
         </title> &sect1.9781683674832.ch0222s0002;
     &sect1.9781683674832.ch0222s0001;
    </chapter>
      <chapter id="ch0223" label="223">
         <title>
            <emphasis role="chapterNumber">10.2</emphasis>
            <emphasis role="chapterTitle">Fungal Taxonomy and Nomenclature</emphasis>
         </title> &sect1.9781683674832.ch0223s0001;
    </chapter>
      <chapter id="ch0224" label="224">
         <title>
            <emphasis role="chapterNumber">10.3</emphasis>
            <emphasis role="chapterTitle">Specimen Selection, Collection, and Transport</emphasis>
         </title> &sect1.9781683674832.ch0224s0001;
    </chapter>
      <chapter id="ch0225" label="225">
         <title>
            <emphasis role="chapterNumber">10.4</emphasis>
            <emphasis role="chapterTitle">S <emphasis role="small">PECIMEN</emphasis> E <emphasis role="small">XAMINATION</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0225s0001;
    </chapter>
      <chapter id="ch0226" label="226">
         <title>
            <emphasis role="chapterNumber">10.4.2</emphasis>
            <emphasis role="chapterTitle">Staining Procedure for Direct Microscopic Detection of <emphasis role="strong">
                  <emphasis>Pneumocystis jirovecii</emphasis>
               </emphasis> in Respiratory Samples</emphasis>
         </title> &sect1.9781683674832.ch0226s0001;
     &sect1.9781683674832.ch0226s0002;
     &sect1.9781683674832.ch0226s0003;
    </chapter>
      <chapter id="ch0227" label="227">
         <title>
            <emphasis role="chapterNumber">10.5</emphasis>
            <emphasis role="chapterTitle">Processing Specimens for Fungal Culture</emphasis>
         </title> &sect1.9781683674832.ch0227s0001;
     &sect1.9781683674832.ch0227s0002;
    </chapter>
      <chapter id="ch0228" label="228">
         <title>
            <emphasis role="chapterNumber">10.6</emphasis>
            <emphasis role="chapterTitle">Examination and Evaluation of Primary Cultures</emphasis>
         </title> &sect1.9781683674832.ch0228s0001;
     &sect1.9781683674832.ch0228s0002;
     &sect1.9781683674832.ch0228s0003;
    </chapter>
      <chapter id="ch0229" label="229">
         <title>
            <emphasis role="chapterNumber">10.7</emphasis>
            <emphasis role="chapterTitle">Presumptive Identification Tests for Yeasts Isolated on Primary Culture</emphasis>
         </title> &sect1.9781683674832.ch0229s0001;
     &sect1.9781683674832.ch0229s0002;
     &sect1.9781683674832.ch0229s0003;
    </chapter>
      <chapter id="ch0230" label="230">
         <title>
            <emphasis role="chapterNumber">10.8</emphasis>
            <emphasis role="chapterTitle">Identification of Molds on Primary Culture</emphasis>
         </title> &sect1.9781683674832.ch0230s0001;
     &sect1.9781683674832.ch0230s0002;
     &sect1.9781683674832.ch0230s0003;
    </chapter>
      <chapter id="ch0231" label="231">
         <title>
            <emphasis role="chapterNumber">10.9</emphasis>
            <emphasis role="chapterTitle">Full Identification of Yeasts</emphasis>
         </title> &sect1.9781683674832.ch0231s0001;
     &sect1.9781683674832.ch0231s0002;
     &sect1.9781683674832.ch0231s0003;
    </chapter>
      <chapter id="ch0232" label="232">
         <title>
            <emphasis role="chapterNumber">10.10</emphasis>
            <emphasis role="chapterTitle">Phenotypic Identification of Molds</emphasis>
         </title> &sect1.9781683674832.ch0232s0001;
     &sect1.9781683674832.ch0232s0002;
     &sect1.9781683674832.ch0232s0003;
    </chapter>
      <chapter id="ch0233" label="233">
         <title>
            <emphasis role="chapterNumber">10.11</emphasis>
            <emphasis role="chapterTitle">Molecular Identification of Yeasts and Molds</emphasis>
         </title> &sect1.9781683674832.ch0233s0001;
     &sect1.9781683674832.ch0233s0002;
     &sect1.9781683674832.ch0233s0003;
    </chapter>
      <chapter id="ch0234" label="234">
         <title>
            <emphasis role="chapterNumber">10.12</emphasis>
            <emphasis role="chapterTitle">A <emphasis role="small">NTIFUNGAL</emphasis> S <emphasis role="small">USCEPTIBILITY</emphasis> T <emphasis role="small">ESTING</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0234s0001;
    </chapter>
      <chapter id="ch0235" label="235">
         <title>
            <emphasis role="chapterNumber">10.12.2</emphasis>
            <emphasis role="chapterTitle">Disk Diffusion and Gradient Diffusion Antifungal Susceptibility Testing</emphasis>
         </title> &sect1.9781683674832.ch0235s0001;
     &sect1.9781683674832.ch0235s0002;
     &sect1.9781683674832.ch0235s0003;
    </chapter>
      <chapter id="ch0236" label="236">
         <title>
            <emphasis role="chapterNumber">10.13</emphasis>
            <emphasis role="chapterTitle">Clinical Breakpoints and Epidemiological Cutoff Values</emphasis>
         </title> &sect1.9781683674832.ch0236s0002;
     &sect1.9781683674832.ch0236s0001;
    </chapter>
   </part>
   <part id="pt0011">
      <title>
         <emphasis role="partNumber">SECTION 11</emphasis><?lb?>
         <emphasis role="partTitle">Parasitology</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">Bobbi S. Pritt and Marc R. Couturier</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0011s0001;
<chapter id="ch0237" label="237">
         <title>
            <emphasis role="chapterNumber">11.1</emphasis>
            <emphasis role="chapterTitle">Introduction</emphasis>
         </title> &sect1.9781683674832.ch0237s0001;
     &sect1.9781683674832.ch0237s0002;
     &sect1.9781683674832.ch0237s0003;
     &sect1.9781683674832.ch0237s0004;
     &sect1.9781683674832.ch0237s0005;
     &sect1.9781683674832.ch0237s0006;
     &sect1.9781683674832.ch0237s0007;
     &sect1.9781683674832.ch0237s0008;
    </chapter>
      <chapter id="ch0238" label="238">
         <title>
            <emphasis role="chapterNumber">11.2</emphasis>
            <emphasis role="chapterTitle">C <emphasis role="small">OLLECTION</emphasis>
               <emphasis role="small">AND</emphasis> P <emphasis role="small">RESERVATION</emphasis>
               <emphasis role="small">OF</emphasis> F <emphasis role="small">ECAL</emphasis> S <emphasis role="small">PECIMENS</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0238s0001;
    </chapter>
      <chapter id="ch0239" label="239">
         <title>
            <emphasis role="chapterNumber">11.2.2</emphasis>
            <emphasis role="chapterTitle">Fixation and Preservation of Specimens</emphasis>
         </title> &sect1.9781683674832.ch0239s0001;
     &sect1.9781683674832.ch0239s0002;
     &sect1.9781683674832.ch0239s0003;
    </chapter>
      <chapter id="ch0240" label="240">
         <title>
            <emphasis role="chapterNumber">11.2.3</emphasis>
            <emphasis role="chapterTitle">Shipment of Specimens</emphasis>
         </title> &sect1.9781683674832.ch0240s0001;
     &sect1.9781683674832.ch0240s0002;
    </chapter>
      <chapter id="ch0241" label="241">
         <title>
            <emphasis role="chapterNumber">11.3</emphasis>
            <emphasis role="chapterTitle">M <emphasis role="small">ACROSCOPIC</emphasis>
               <emphasis role="small">AND</emphasis> M <emphasis role="small">ICROSCOPIC</emphasis> E <emphasis role="small">XAMINATION</emphasis>
               <emphasis role="small">OF</emphasis> F <emphasis role="small">ECAL</emphasis> S <emphasis role="small">PECIMENS</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0241s0001;
    </chapter>
      <chapter id="ch0242" label="242">
         <title>
            <emphasis role="chapterNumber">11.3.2</emphasis>
            <emphasis role="chapterTitle">Microscopic Examination of Fecal Specimens: Direct Smears</emphasis>
         </title> &sect1.9781683674832.ch0242s0001;
     &sect1.9781683674832.ch0242s0002;
     &sect1.9781683674832.ch0242s0003;
    </chapter>
      <chapter id="ch0243" label="243">
         <title>
            <emphasis role="chapterNumber">11.3.3</emphasis>
            <emphasis role="chapterTitle">Microscopic Examination of Fecal Specimens: Concentration by Formalin-Ethyl Acetate Sedimentation</emphasis>
         </title> &sect1.9781683674832.ch0243s0001;
     &sect1.9781683674832.ch0243s0002;
     &sect1.9781683674832.ch0243s0003;
    </chapter>
      <chapter id="ch0244" label="244">
         <title>
            <emphasis role="chapterNumber">11.3.4</emphasis>
            <emphasis role="chapterTitle">Microscopic Examination of Fecal Specimens: Concentration by Zinc Sulfate Flotation</emphasis>
         </title> &sect1.9781683674832.ch0244s0001;
     &sect1.9781683674832.ch0244s0002;
     &sect1.9781683674832.ch0244s0003;
    </chapter>
      <chapter id="ch0245" label="245">
         <title>
            <emphasis role="chapterNumber">11.3.5</emphasis>
            <emphasis role="chapterTitle">Microscopic Examination of Fecal Specimens: Permanent Stained Smear (Trichrome)</emphasis>
         </title> &sect1.9781683674832.ch0245s0001;
     &sect1.9781683674832.ch0245s0002;
     &sect1.9781683674832.ch0245s0003;
    </chapter>
      <chapter id="ch0246" label="246">
         <title>
            <emphasis role="chapterNumber">11.3.6</emphasis>
            <emphasis role="chapterTitle">Microscopic Examination of Fecal Specimens: Iron Hematoxylin Stain (Modified Spencer-Monroe Method)</emphasis>
         </title> &sect1.9781683674832.ch0246s0001;
     &sect1.9781683674832.ch0246s0002;
     &sect1.9781683674832.ch0246s0003;
    </chapter>
      <chapter id="ch0247" label="247">
         <title>
            <emphasis role="chapterNumber">11.4</emphasis>
            <emphasis role="chapterTitle">Special Stains for Coccidia and Microsporidia</emphasis>
         </title> &sect1.9781683674832.ch0247s0001;
    </chapter>
      <chapter id="ch0248" label="248">
         <title>
            <emphasis role="chapterNumber">11.4.2</emphasis>
            <emphasis role="chapterTitle">Special Stains for <emphasis role="strong">
                  <emphasis>Cryptosporidium</emphasis>
               </emphasis> and the Coccidia: Modified Ziehl-Neelsen Acid-Fast Stain (Hot)</emphasis>
         </title> &sect1.9781683674832.ch0248s0001;
     &sect1.9781683674832.ch0248s0002;
     &sect1.9781683674832.ch0248s0003;
    </chapter>
      <chapter id="ch0249" label="249">
         <title>
            <emphasis role="chapterNumber">11.4.3</emphasis>
            <emphasis role="chapterTitle">Special Stains for Microsporidia: Modified Trichrome-Weber Green</emphasis>
         </title> &sect1.9781683674832.ch0249s0001;
     &sect1.9781683674832.ch0249s0002;
     &sect1.9781683674832.ch0249s0003;
    </chapter>
      <chapter id="ch0250" label="250">
         <title>
            <emphasis role="chapterNumber">11.4.4</emphasis>
            <emphasis role="chapterTitle">Special Stains for Microsporidia: Modified Trichrome-Ryan Blue</emphasis>
         </title> &sect1.9781683674832.ch0250s0001;
     &sect1.9781683674832.ch0250s0002;
     &sect1.9781683674832.ch0250s0003;
    </chapter>
      <chapter id="ch0251" label="251">
         <title>
            <emphasis role="chapterNumber">11.4.5</emphasis>
            <emphasis role="chapterTitle">Special Stains for Microsporidia: Combination Acid-Fast Modified Trichrome Stain for the Apicomplexa and the Microsporidia</emphasis>
         </title> &sect1.9781683674832.ch0251s0001;
     &sect1.9781683674832.ch0251s0002;
     &sect1.9781683674832.ch0251s0003;
    </chapter>
      <chapter id="ch0252" label="252">
         <title>
            <emphasis role="chapterNumber">11.4.6</emphasis>
            <emphasis role="chapterTitle">Special Stain for <emphasis role="strong">
                  <emphasis>Cryptosporidium</emphasis>
               </emphasis> and the Coccidia: Modified Safranin Technique with Microwave Heating</emphasis>
         </title> &sect1.9781683674832.ch0252s0001;
     &sect1.9781683674832.ch0252s0002;
     &sect1.9781683674832.ch0252s0003;
    </chapter>
      <chapter id="ch0253" label="253">
         <title>
            <emphasis role="chapterNumber">11.4.7</emphasis>
            <emphasis role="chapterTitle">Autofluorescence for <emphasis role="strong">
                  <emphasis>Cyclospora</emphasis>, <emphasis>Cystoisospora</emphasis>
               </emphasis>, and <emphasis role="strong">
                  <emphasis>Sarcocystis</emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0253s0001;
     &sect1.9781683674832.ch0253s0002;
     &sect1.9781683674832.ch0253s0003;
    </chapter>
      <chapter id="ch0254" label="254">
         <title>
            <emphasis role="chapterNumber">11.4.8</emphasis>
            <emphasis role="chapterTitle">Calcofluor White for Detection of Microsporidial Spores, <emphasis>Acanthamoeba</emphasis>, and <emphasis>Balamuthia mandrillaris</emphasis> Cysts</emphasis>
         </title> &sect1.9781683674832.ch0254s0001;
     &sect1.9781683674832.ch0254s0002;
     &sect1.9781683674832.ch0254s0003;
    </chapter>
      <chapter id="ch0255" label="255">
         <title>
            <emphasis role="chapterNumber">11.5</emphasis>
            <emphasis role="chapterTitle">A <emphasis role="small">DDITIONAL</emphasis> T <emphasis role="small">ECHNIQUES</emphasis>
               <emphasis role="small">FOR</emphasis> S <emphasis role="small">TOOL</emphasis> E <emphasis role="small">XAMINATION</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0255s0001;
    </chapter>
      <chapter id="ch0256" label="256">
         <title>
            <emphasis role="chapterNumber">11.5.2</emphasis>
            <emphasis role="chapterTitle">Culture of Larval-Stage Nematodes: Harada-Mori Technique</emphasis>
         </title> &sect1.9781683674832.ch0256s0001;
     &sect1.9781683674832.ch0256s0002;
     &sect1.9781683674832.ch0256s0003;
    </chapter>
      <chapter id="ch0257" label="257">
         <title>
            <emphasis role="chapterNumber">11.5.3</emphasis>
            <emphasis role="chapterTitle">Culture of Larval-Stage Nematodes: Petri Dish-Filter Paper Slant</emphasis>
         </title> &sect1.9781683674832.ch0257s0001;
     &sect1.9781683674832.ch0257s0002;
     &sect1.9781683674832.ch0257s0003;
    </chapter>
      <chapter id="ch0258" label="258">
         <title>
            <emphasis role="chapterNumber">11.5.4</emphasis>
            <emphasis role="chapterTitle">Culture of Larval-Stage Nematodes: Agar Plate Culture for <emphasis>Strongyloides stercoralis</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0258s0001;
     &sect1.9781683674832.ch0258s0002;
     &sect1.9781683674832.ch0258s0003;
    </chapter>
      <chapter id="ch0259" label="259">
         <title>
            <emphasis role="chapterNumber">11.5.5</emphasis>
            <emphasis role="chapterTitle">Determination of Egg Viability: Schistosomal Egg Hatching</emphasis>
         </title> &sect1.9781683674832.ch0259s0001;
     &sect1.9781683674832.ch0259s0002;
     &sect1.9781683674832.ch0259s0003;
    </chapter>
      <chapter id="ch0260" label="260">
         <title>
            <emphasis role="chapterNumber">11.5.6</emphasis>
            <emphasis role="chapterTitle">Recovery of Scolices and Proglottids of Cestodes</emphasis>
         </title> &sect1.9781683674832.ch0260s0001;
     &sect1.9781683674832.ch0260s0002;
     &sect1.9781683674832.ch0260s0003;
    </chapter>
      <chapter id="ch0261" label="261">
         <title>
            <emphasis role="chapterNumber">11.5.7</emphasis>
            <emphasis role="chapterTitle">Qualitative Fecal Fat</emphasis>
         </title> &sect1.9781683674832.ch0261s0001;
     &sect1.9781683674832.ch0261s0002;
     &sect1.9781683674832.ch0261s0003;
    </chapter>
      <chapter id="ch0262" label="262">
         <title>
            <emphasis role="chapterNumber">11.5.8</emphasis>
            <emphasis role="chapterTitle">Reducing Substances (AimTab)</emphasis>
         </title> &sect1.9781683674832.ch0262s0001;
     &sect1.9781683674832.ch0262s0002;
     &sect1.9781683674832.ch0262s0003;
    </chapter>
      <chapter id="ch0263" label="263">
         <title>
            <emphasis role="chapterNumber">11.6</emphasis>
            <emphasis role="chapterTitle">Other Specimens from the Intestinal Tract and the Urogenital System</emphasis>
         </title> &sect1.9781683674832.ch0263s0001;
    </chapter>
      <chapter id="ch0264" label="264">
         <title>
            <emphasis role="chapterNumber">11.6.2</emphasis>
            <emphasis role="chapterTitle">Sigmoidoscopy Specimen: Direct Wet Mount</emphasis>
         </title> &sect1.9781683674832.ch0264s0001;
     &sect1.9781683674832.ch0264s0002;
     &sect1.9781683674832.ch0264s0003;
    </chapter>
      <chapter id="ch0265" label="265">
         <title>
            <emphasis role="chapterNumber">11.6.3</emphasis>
            <emphasis role="chapterTitle">Sigmoidoscopy Specimen: Permanent Stained Smear</emphasis>
         </title> &sect1.9781683674832.ch0265s0001;
     &sect1.9781683674832.ch0265s0002;
     &sect1.9781683674832.ch0265s0003;
    </chapter>
      <chapter id="ch0266" label="266">
         <title>
            <emphasis role="chapterNumber">11.6.4</emphasis>
            <emphasis role="chapterTitle">Duodenal Contents: Duodenal Aspirate</emphasis>
         </title> &sect1.9781683674832.ch0266s0001;
     &sect1.9781683674832.ch0266s0002;
     &sect1.9781683674832.ch0266s0003;
    </chapter>
      <chapter id="ch0267" label="267">
         <title>
            <emphasis role="chapterNumber">11.6.5</emphasis>
            <emphasis role="chapterTitle">Urogenital Specimens: Direct Saline Mount</emphasis>
         </title> &sect1.9781683674832.ch0267s0001;
     &sect1.9781683674832.ch0267s0002;
     &sect1.9781683674832.ch0267s0003;
    </chapter>
      <chapter id="ch0268" label="268">
         <title>
            <emphasis role="chapterNumber">11.6.6</emphasis>
            <emphasis role="chapterTitle">Urogenital Specimens: Permanent Stained Smear (Giemsa)</emphasis>
         </title> &sect1.9781683674832.ch0268s0001;
     &sect1.9781683674832.ch0268s0002;
     &sect1.9781683674832.ch0268s0003;
    </chapter>
      <chapter id="ch0269" label="269">
         <title>
            <emphasis role="chapterNumber">11.6.7</emphasis>
            <emphasis role="chapterTitle">Urine Concentration: Centrifugation</emphasis>
         </title> &sect1.9781683674832.ch0269s0001;
     &sect1.9781683674832.ch0269s0002;
     &sect1.9781683674832.ch0269s0003;
    </chapter>
      <chapter id="ch0270" label="270">
         <title>
            <emphasis role="chapterNumber">11.6.8</emphasis>
            <emphasis role="chapterTitle">Urine Concentration: Membrane Filter (Nuclepore)</emphasis>
         </title> &sect1.9781683674832.ch0270s0001;
     &sect1.9781683674832.ch0270s0002;
     &sect1.9781683674832.ch0270s0003;
    </chapter>
      <chapter id="ch0271" label="271">
         <title>
            <emphasis role="chapterNumber">11.7</emphasis>
            <emphasis role="chapterTitle">Sputum, Aspirates, and Biopsy Material</emphasis>
         </title> &sect1.9781683674832.ch0271s0001;
    </chapter>
      <chapter id="ch0272" label="272">
         <title>
            <emphasis role="chapterNumber">11.7.2</emphasis>
            <emphasis role="chapterTitle">Aspirates and Bronchoscopy Specimens</emphasis>
         </title> &sect1.9781683674832.ch0272s0001;
     &sect1.9781683674832.ch0272s0002;
     &sect1.9781683674832.ch0272s0003;
    </chapter>
      <chapter id="ch0273" label="273">
         <title>
            <emphasis role="chapterNumber">11.7.3</emphasis>
            <emphasis role="chapterTitle">Biopsy Specimens</emphasis>
         </title> &sect1.9781683674832.ch0273s0001;
     &sect1.9781683674832.ch0273s0002;
     &sect1.9781683674832.ch0273s0003;
    </chapter>
      <chapter id="ch0274" label="274">
         <title>
            <emphasis role="chapterNumber">11.8</emphasis>
            <emphasis role="chapterTitle">D <emphasis role="small">ETECTION</emphasis>
               <emphasis role="small">OF</emphasis> B <emphasis role="small">LOOD</emphasis> P <emphasis role="small">ARASITES</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0274s0001;
    </chapter>
      <chapter id="ch0275" label="275">
         <title>
            <emphasis role="chapterNumber">11.8.2</emphasis>
            <emphasis role="chapterTitle">Preparation of Thin Blood Films</emphasis>
         </title> &sect1.9781683674832.ch0275s0001;
     &sect1.9781683674832.ch0275s0002;
     &sect1.9781683674832.ch0275s0003;
    </chapter>
      <chapter id="ch0276" label="276">
         <title>
            <emphasis role="chapterNumber">11.8.3</emphasis>
            <emphasis role="chapterTitle">Preparation of Thick Blood Films</emphasis>
         </title> &sect1.9781683674832.ch0276s0001;
     &sect1.9781683674832.ch0276s0002;
     &sect1.9781683674832.ch0276s0003;
    </chapter>
      <chapter id="ch0277" label="277">
         <title>
            <emphasis role="chapterNumber">11.8.4</emphasis>
            <emphasis role="chapterTitle">Combination Thick and Thin Blood Films</emphasis>
         </title> &sect1.9781683674832.ch0277s0001;
     &sect1.9781683674832.ch0277s0002;
     &sect1.9781683674832.ch0277s0003;
    </chapter>
      <chapter id="ch0278" label="278">
         <title>
            <emphasis role="chapterNumber">11.8.5</emphasis>
            <emphasis role="chapterTitle">Giemsa Stain</emphasis>
         </title> &sect1.9781683674832.ch0278s0001;
     &sect1.9781683674832.ch0278s0002;
     &sect1.9781683674832.ch0278s0003;
    </chapter>
      <chapter id="ch0279" label="279">
         <title>
            <emphasis role="chapterNumber">11.8.6</emphasis>
            <emphasis role="chapterTitle">Wrights Stain</emphasis>
         </title> &sect1.9781683674832.ch0279s0001;
     &sect1.9781683674832.ch0279s0002;
     &sect1.9781683674832.ch0279s0003;
    </chapter>
      <chapter id="ch0280" label="280">
         <title>
            <emphasis role="chapterNumber">11.8.7</emphasis>
            <emphasis role="chapterTitle">Determination of Parasitemia: Parasite Quantification</emphasis>
         </title> &sect1.9781683674832.ch0280s0001;
     &sect1.9781683674832.ch0280s0002;
     &sect1.9781683674832.ch0280s0003;
    </chapter>
      <chapter id="ch0281" label="281">
         <title>
            <emphasis role="chapterNumber">11.8.8</emphasis>
            <emphasis role="chapterTitle">Delafields Hematoxylin Stain</emphasis>
         </title> &sect1.9781683674832.ch0281s0001;
     &sect1.9781683674832.ch0281s0002;
     &sect1.9781683674832.ch0281s0003;
    </chapter>
      <chapter id="ch0282" label="282">
         <title>
            <emphasis role="chapterNumber">11.8.9</emphasis>
            <emphasis role="chapterTitle">Concentration Procedures: Buffy Coat Concentration</emphasis>
         </title> &sect1.9781683674832.ch0282s0004;
     &sect1.9781683674832.ch0282s0001;
     &sect1.9781683674832.ch0282s0002;
     &sect1.9781683674832.ch0282s0003;
    </chapter>
      <chapter id="ch0283" label="283">
         <title>
            <emphasis role="chapterNumber">11.8.10</emphasis>
            <emphasis role="chapterTitle">Concentration Procedures: Membrane Filtration Concentration</emphasis>
         </title> &sect1.9781683674832.ch0283s0001;
     &sect1.9781683674832.ch0283s0002;
    </chapter>
      <chapter id="ch0284" label="284">
         <title>
            <emphasis role="chapterNumber">11.8.11</emphasis>
            <emphasis role="chapterTitle">Concentration Procedures: Knott Concentration</emphasis>
         </title> &sect1.9781683674832.ch0284s0001;
     &sect1.9781683674832.ch0284s0002;
     &sect1.9781683674832.ch0284s0003;
    </chapter>
      <chapter id="ch0285" label="285">
         <title>
            <emphasis role="chapterNumber">11.8.12</emphasis>
            <emphasis role="chapterTitle">Testing Modalities and Algorithms for Malaria Diagnosis</emphasis>
         </title> &sect1.9781683674832.ch0285s0002;
     &sect1.9781683674832.ch0285s0001;
    </chapter>
      <chapter id="ch0286" label="286">
         <title>
            <emphasis role="chapterNumber">11.9</emphasis>
            <emphasis role="chapterTitle">C <emphasis role="small">ULTURE</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0286s0001;
    </chapter>
      <chapter id="ch0287" label="287">
         <title>
            <emphasis role="chapterNumber">11.9.2</emphasis>
            <emphasis role="chapterTitle">Parasite Culture: <emphasis role="strong">
                  <emphasis>Trichomonas vaginalis</emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0287s0001;
     &sect1.9781683674832.ch0287s0002;
     &sect1.9781683674832.ch0287s0003;
    </chapter>
      <chapter id="ch0288" label="288">
         <title>
            <emphasis role="chapterNumber">11.9.3</emphasis>
            <emphasis role="chapterTitle">Parasite Culture: <emphasis>Leishmania</emphasis> spp. and <emphasis>Trypanosoma cruzi</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0288s0001;
     &sect1.9781683674832.ch0288s0002;
     &sect1.9781683674832.ch0288s0003;
    </chapter>
      <chapter id="ch0289" label="289">
         <title>
            <emphasis role="chapterNumber">11.10</emphasis>
            <emphasis role="chapterTitle">Gross Examination of Helminths and Arthropods</emphasis>
         </title> &sect1.9781683674832.ch0289s0001;
     &sect1.9781683674832.ch0289s0002;
     &sect1.9781683674832.ch0289s0003;
    </chapter>
      <chapter id="ch0290" label="290">
         <title>
            <emphasis role="chapterNumber">11.11.1</emphasis>
            <emphasis role="chapterTitle">APPENDIX 11.11.11Identification Aids: Artifacts</emphasis>
         </title> &sect1.9781683674832.ch0290s0001;
    </chapter>
      <chapter id="ch0291" label="291">
         <title>
            <emphasis role="chapterNumber">11.11.2</emphasis>
            <emphasis role="chapterTitle">APPENDIX 11.11.21Information Tables</emphasis>
         </title> &sect1.9781683674832.ch0291s0002;
     &sect1.9781683674832.ch0291s0001;
    </chapter>
      <chapter id="ch0292" label="292">
         <title>
            <emphasis role="chapterNumber">11.11.3</emphasis>
            <emphasis role="chapterTitle">APPENDIX 11.11.31Common Problems in Organism Identification</emphasis>
         </title> &sect1.9781683674832.ch0292s0002;
     &sect1.9781683674832.ch0292s0001;
    </chapter>
      <chapter id="ch0293" label="293">
         <title>
            <emphasis role="chapterNumber">11.11.4</emphasis>
            <emphasis role="chapterTitle">APPENDIX 11.11.41Quality Control Recording Sheets</emphasis>
         </title> &sect1.9781683674832.ch0293s0002;
     &sect1.9781683674832.ch0293s0001;
    </chapter>
      <chapter id="ch0294" label="294">
         <title>
            <emphasis role="chapterNumber">11.11.5</emphasis>
            <emphasis role="chapterTitle">APPENDIX 11.11.51Flowcharts for Processing Stool Specimens</emphasis>
         </title> &sect1.9781683674832.ch0294s0001;
    </chapter>
      <chapter id="ch0295" label="295">
         <title>
            <emphasis role="chapterNumber">11.11.6</emphasis>
            <emphasis role="chapterTitle">APPENDIX 11.11.61 Current OSHA Regulations on the Use of Formaldehyde</emphasis>
         </title> &sect1.9781683674832.ch0295s0003;
     &sect1.9781683674832.ch0295s0001;
     &sect1.9781683674832.ch0295s0002;
    </chapter>
      <chapter id="ch0296" label="296">
         <title>
            <emphasis role="chapterNumber">11.11.7</emphasis>
            <emphasis role="chapterTitle">APPENDIX 11.11.71</emphasis>
         </title> &sect1.9781683674832.ch0296s0001;
    </chapter>
   </part>
   <part id="pt0012">
      <title>
         <emphasis role="partNumber">SECTION 12</emphasis><?lb?>
         <emphasis role="partTitle">Viruses and Chlamydiae</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">Richard L. Hodinka</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0012s0001;
<chapter id="ch0297" label="297">
         <title>
            <emphasis role="chapterNumber">12.1</emphasis>
            <emphasis role="chapterTitle">Introduction: Traditional Methods for Laboratory Diagnosis of Viral and Chlamydial Infections</emphasis>
         </title> &sect1.9781683674832.ch0297s0002;
     &sect1.9781683674832.ch0297s0001;
    </chapter>
      <chapter id="ch0298" label="298">
         <title>
            <emphasis role="chapterNumber">12.2</emphasis>
            <emphasis role="chapterTitle">Selection, Collection, Transport, and Processing of Specimens for Viral Diagnosis</emphasis>
         </title> &sect1.9781683674832.ch0298s0001;
     &sect1.9781683674832.ch0298s0002;
     &sect1.9781683674832.ch0298s0003;
    </chapter>
      <chapter id="ch0299" label="299">
         <title>
            <emphasis role="chapterNumber">12.3</emphasis>
            <emphasis role="chapterTitle">Quality Control and Quality Assurance in Clinical Virology</emphasis>
         </title> &sect1.9781683674832.ch0299s0002;
     &sect1.9781683674832.ch0299s0001;
    </chapter>
      <chapter id="ch0300" label="300">
         <title>
            <emphasis role="chapterNumber">12.4</emphasis>
            <emphasis role="chapterTitle">Biosafety in the Clinical Virology Laboratory</emphasis>
         </title> &sect1.9781683674832.ch0300s0002;
     &sect1.9781683674832.ch0300s0001;
    </chapter>
      <chapter id="ch0301" label="301">
         <title>
            <emphasis role="chapterNumber">12.5</emphasis>
            <emphasis role="chapterTitle">Conventional Tube Cell Culture for Primary Virus Isolation</emphasis>
         </title> &sect1.9781683674832.ch0301s0004;
     &sect1.9781683674832.ch0301s0001;
     &sect1.9781683674832.ch0301s0002;
     &sect1.9781683674832.ch0301s0003;
    </chapter>
      <chapter id="ch0302" label="302">
         <title>
            <emphasis role="chapterNumber">12.6</emphasis>
            <emphasis role="chapterTitle">Shell Vial/Multiwell Plate Culture for Rapid Virus Isolation</emphasis>
         </title> &sect1.9781683674832.ch0302s0004;
     &sect1.9781683674832.ch0302s0001;
     &sect1.9781683674832.ch0302s0002;
     &sect1.9781683674832.ch0302s0003;
    </chapter>
      <chapter id="ch0303" label="303">
         <title>
            <emphasis role="chapterNumber">12.7</emphasis>
            <emphasis role="chapterTitle">Selection, Maintenance, and Serial Propagation of Uninoculated Monolayer Cell Cultures</emphasis>
         </title> &sect1.9781683674832.ch0303s0004;
     &sect1.9781683674832.ch0303s0001;
     &sect1.9781683674832.ch0303s0002;
     &sect1.9781683674832.ch0303s0003;
    </chapter>
      <chapter id="ch0304" label="304">
         <title>
            <emphasis role="chapterNumber">12.8</emphasis>
            <emphasis role="chapterTitle">Preparation of Cell Culture Media and Supplemental Components</emphasis>
         </title> &sect1.9781683674832.ch0304s0004;
     &sect1.9781683674832.ch0304s0001;
     &sect1.9781683674832.ch0304s0002;
     &sect1.9781683674832.ch0304s0003;
    </chapter>
      <chapter id="ch0305" label="305">
         <title>
            <emphasis role="chapterNumber">12.9</emphasis>
            <emphasis role="chapterTitle">T <emphasis role="small">ESTS</emphasis>
               <emphasis role="small">FOR</emphasis> D <emphasis role="small">IRECT</emphasis> D <emphasis role="small">ETECTION</emphasis>
               <emphasis role="small">OF</emphasis> V <emphasis role="small">IRUSES</emphasis>
               <emphasis role="small">IN</emphasis> C <emphasis role="small">LINICAL</emphasis> S <emphasis role="small">PECIMENS</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0305s0001;
    </chapter>
      <chapter id="ch0306" label="306">
         <title>
            <emphasis role="chapterNumber">12.9.2</emphasis>
            <emphasis role="chapterTitle">Rapid Solid-Phase Immunoassays for Direct Detection of Viruses in Clinical Specimens: Influenza Virus, Respiratory Syncytial Virus, and SARS-CoV-2</emphasis>
         </title> &sect1.9781683674832.ch0306s0004;
     &sect1.9781683674832.ch0306s0001;
     &sect1.9781683674832.ch0306s0002;
     &sect1.9781683674832.ch0306s0003;
    </chapter>
      <chapter id="ch0307" label="307">
         <title>
            <emphasis role="chapterNumber">12.9.3</emphasis>
            <emphasis role="chapterTitle">Histologic and Cytologic Procedures for Detection of Viruses in Exfoliated Cells and Tissues</emphasis>
         </title> &sect1.9781683674832.ch0307s0004;
     &sect1.9781683674832.ch0307s0001;
     &sect1.9781683674832.ch0307s0002;
     &sect1.9781683674832.ch0307s0003;
    </chapter>
      <chapter id="ch0308" label="308">
         <title>
            <emphasis role="chapterNumber">12.10</emphasis>
            <emphasis role="chapterTitle">Isolation of <emphasis>
                  <emphasis role="strong">Chlamydia</emphasis>
               </emphasis> spp. in Cell Culture</emphasis>
         </title> &sect1.9781683674832.ch0308s0004;
     &sect1.9781683674832.ch0308s0001;
     &sect1.9781683674832.ch0308s0002;
     &sect1.9781683674832.ch0308s0003;
    </chapter>
      <chapter id="ch0309" label="309">
         <title>
            <emphasis role="chapterNumber">12.11</emphasis>
            <emphasis role="chapterTitle">Hemagglutination Inhibition Assay for Quantitative Measurement of Antibody Responses to Influenza Virus</emphasis>
         </title> &sect1.9781683674832.ch0309s0004;
     &sect1.9781683674832.ch0309s0001;
     &sect1.9781683674832.ch0309s0002;
     &sect1.9781683674832.ch0309s0003;
    </chapter>
   </part>
   <part id="pt0013">
      <title>
         <emphasis role="partNumber">SECTION 13</emphasis><?lb?>
         <emphasis role="partTitle">Serology</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">Elitza S. Theel</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0013s0001;
<chapter id="ch0310" label="310">
         <title>
            <emphasis role="chapterNumber">13.1</emphasis>
            <emphasis role="chapterTitle">I <emphasis role="small">MMUNOASSAYS FOR</emphasis> D <emphasis role="small">ETECTION OF</emphasis> I <emphasis role="small">NFECTIOUS</emphasis> D <emphasis role="small">ISEASES</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0310s0001;
    </chapter>
      <chapter id="ch0311" label="311">
         <title>
            <emphasis role="chapterNumber">13.1.2</emphasis>
            <emphasis role="chapterTitle">Common Immunologic Assays Used for Detection of Antibodies to and Antigens from Infectious Pathogens</emphasis>
         </title> &sect1.9781683674832.ch0311s0001;
    </chapter>
      <chapter id="ch0312" label="312">
         <title>
            <emphasis role="chapterNumber">13.2</emphasis>
            <emphasis role="chapterTitle">S <emphasis role="small">EROLOGIC</emphasis> D <emphasis role="small">IAGNOSIS OF</emphasis> G <emphasis role="small">ROUP</emphasis> A S <emphasis role="small">TREPTOCOCCAL</emphasis> I <emphasis role="small">NFECTIONS</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0312s0001;
    </chapter>
      <chapter id="ch0313" label="313">
         <title>
            <emphasis role="chapterNumber">13.2.2</emphasis>
            <emphasis role="chapterTitle">Anti-Streptolysin O and Anti-DNase B Tests</emphasis>
         </title> &sect1.9781683674832.ch0313s0001;
     &sect1.9781683674832.ch0313s0002;
    </chapter>
      <chapter id="ch0314" label="314">
         <title>
            <emphasis role="chapterNumber">13.3</emphasis>
            <emphasis role="chapterTitle">D <emphasis role="small">ETECTION OF</emphasis>
               <emphasis role="strong">
                  <emphasis>B <emphasis role="small">RUCELLA</emphasis>
                  </emphasis>
               </emphasis>
               <emphasis role="small">SPP</emphasis>. A <emphasis role="small">NTIBODIES</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0314s0001;
    </chapter>
      <chapter id="ch0315" label="315">
         <title>
            <emphasis role="chapterNumber">13.3.2</emphasis>
            <emphasis role="chapterTitle">Detection of <emphasis>
                  <emphasis role="strong">Brucella</emphasis>
               </emphasis> spp. by Microagglutination Test</emphasis>
         </title> &sect1.9781683674832.ch0315s0001;
     &sect1.9781683674832.ch0315s0002;
     &sect1.9781683674832.ch0315s0003;
    </chapter>
      <chapter id="ch0316" label="316">
         <title>
            <emphasis role="chapterNumber">13.3.3</emphasis>
            <emphasis role="chapterTitle">Detection of <emphasis>Brucella</emphasis> spp. Antibodies by Tube Agglutination Test</emphasis>
         </title> &sect1.9781683674832.ch0316s0001;
     &sect1.9781683674832.ch0316s0002;
     &sect1.9781683674832.ch0316s0003;
    </chapter>
      <chapter id="ch0317" label="317">
         <title>
            <emphasis role="chapterNumber">13.4</emphasis>
            <emphasis role="chapterTitle">D <emphasis role="small">ETECTION OF</emphasis>
               <emphasis>F <emphasis role="small">RANCISELLA</emphasis>
               </emphasis>
               <emphasis role="small">TULARENSIS</emphasis> A <emphasis role="small">NTIBODIES</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0317s0001;
    </chapter>
      <chapter id="ch0318" label="318">
         <title>
            <emphasis role="chapterNumber">13.4.2</emphasis>
            <emphasis role="chapterTitle">Detection of <emphasis>
                  <emphasis role="strong">Francisella tularensis</emphasis>
               </emphasis> Antibodies by Agglutination</emphasis>
         </title> &sect1.9781683674832.ch0318s0001;
     &sect1.9781683674832.ch0318s0002;
     &sect1.9781683674832.ch0318s0003;
    </chapter>
      <chapter id="ch0319" label="319">
         <title>
            <emphasis role="chapterNumber">13.4.3</emphasis>
            <emphasis role="chapterTitle">Detection of <emphasis>
                  <emphasis role="strong">Francisella tularensis</emphasis>
               </emphasis> Antibodies by ELISA</emphasis>
         </title> &sect1.9781683674832.ch0319s0001;
     &sect1.9781683674832.ch0319s0002;
     &sect1.9781683674832.ch0319s0003;
    </chapter>
      <chapter id="ch0320" label="320">
         <title>
            <emphasis role="chapterNumber">13.5</emphasis>
            <emphasis role="chapterTitle">L <emphasis role="small">ABORATORY</emphasis> D <emphasis role="small">IAGNOSIS OF</emphasis> S <emphasis role="small">YPHILIS</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0320s0001;
    </chapter>
      <chapter id="ch0321" label="321">
         <title>
            <emphasis role="chapterNumber">13.5.2</emphasis>
            <emphasis role="chapterTitle">Venereal Disease Research Laboratory (VDRL) Tests</emphasis>
         </title> &sect1.9781683674832.ch0321s0001;
     &sect1.9781683674832.ch0321s0002;
     &sect1.9781683674832.ch0321s0003;
    </chapter>
      <chapter id="ch0322" label="322">
         <title>
            <emphasis role="chapterNumber">13.5.3</emphasis>
            <emphasis role="chapterTitle">Rapid Plasma Reagin (RPR) Test</emphasis>
         </title> &sect1.9781683674832.ch0322s0001;
     &sect1.9781683674832.ch0322s0002;
     &sect1.9781683674832.ch0322s0003;
    </chapter>
      <chapter id="ch0323" label="323">
         <title>
            <emphasis role="chapterNumber">13.5.4</emphasis>
            <emphasis role="chapterTitle">Automated Nontreponemal Rapid Plasma Reagin (RPR) Tests</emphasis>
         </title> &sect1.9781683674832.ch0323s0001;
     &sect1.9781683674832.ch0323s0002;
     &sect1.9781683674832.ch0323s0003;
    </chapter>
      <chapter id="ch0324" label="324">
         <title>
            <emphasis role="chapterNumber">13.5.5</emphasis>
            <emphasis role="chapterTitle">
               <emphasis role="strong">
                  <emphasis>Treponema pallidum</emphasis>
               </emphasis> Particle Agglutination (TP-PA) Test</emphasis>
         </title> &sect1.9781683674832.ch0324s0001;
     &sect1.9781683674832.ch0324s0002;
     &sect1.9781683674832.ch0324s0003;
    </chapter>
      <chapter id="ch0325" label="325">
         <title>
            <emphasis role="chapterNumber">13.5.6</emphasis>
            <emphasis role="chapterTitle">Trep-Sure Enzyme Immunoassay</emphasis>
         </title> &sect1.9781683674832.ch0325s0001;
     &sect1.9781683674832.ch0325s0002;
     &sect1.9781683674832.ch0325s0003;
    </chapter>
      <chapter id="ch0326" label="326">
         <title>
            <emphasis role="chapterNumber">13.5.7</emphasis>
            <emphasis role="chapterTitle">Automated Treponemal Tests</emphasis>
         </title> &sect1.9781683674832.ch0326s0001;
     &sect1.9781683674832.ch0326s0002;
     &sect1.9781683674832.ch0326s0003;
    </chapter>
      <chapter id="ch0327" label="327">
         <title>
            <emphasis role="chapterNumber">13.5.8</emphasis>
            <emphasis role="chapterTitle">INNO-LIA Syphilis Score</emphasis>
         </title> &sect1.9781683674832.ch0327s0001;
     &sect1.9781683674832.ch0327s0002;
     &sect1.9781683674832.ch0327s0003;
    </chapter>
      <chapter id="ch0328" label="328">
         <title>
            <emphasis role="chapterNumber">13.6</emphasis>
            <emphasis role="chapterTitle">Detection of <emphasis>
                  <emphasis role="strong">Borrelia burgdorferi</emphasis>
               </emphasis> Antibodies</emphasis>
         </title> &sect1.9781683674832.ch0328s0001;
     &sect1.9781683674832.ch0328s0002;
     &sect1.9781683674832.ch0328s0003;
     &sect1.9781683674832.ch0328s0004;
    </chapter>
      <chapter id="ch0329" label="329">
         <title>
            <emphasis role="chapterNumber">13.7</emphasis>
            <emphasis role="chapterTitle">SARS-CoV-2 Serologic Testing</emphasis>
         </title> &sect1.9781683674832.ch0329s0001;
     &sect1.9781683674832.ch0329s0002;
     &sect1.9781683674832.ch0329s0003;
    </chapter>
      <chapter id="ch0330" label="330">
         <title>
            <emphasis role="chapterNumber">13.8</emphasis>
            <emphasis role="chapterTitle">Epstein-Barr Virus Serology</emphasis>
         </title> &sect1.9781683674832.ch0330s0001;
    </chapter>
      <chapter id="ch0331" label="331">
         <title>
            <emphasis role="chapterNumber">13.8.2</emphasis>
            <emphasis role="chapterTitle">Detection of Heterophile Antibodies</emphasis>
         </title> &sect1.9781683674832.ch0331s0001;
     &sect1.9781683674832.ch0331s0002;
     &sect1.9781683674832.ch0331s0003;
    </chapter>
      <chapter id="ch0332" label="332">
         <title>
            <emphasis role="chapterNumber">13.8.3</emphasis>
            <emphasis role="chapterTitle">Detection of Epstein-Barr Virus-Specific Antibodies</emphasis>
         </title> &sect1.9781683674832.ch0332s0001;
     &sect1.9781683674832.ch0332s0002;
     &sect1.9781683674832.ch0332s0003;
    </chapter>
      <chapter id="ch0333" label="333">
         <title>
            <emphasis role="chapterNumber">13.9</emphasis>
            <emphasis role="chapterTitle">Cytomegalovirus Serology</emphasis>
         </title> &sect1.9781683674832.ch0333s0001;
    </chapter>
      <chapter id="ch0334" label="334">
         <title>
            <emphasis role="chapterNumber">13.9.2</emphasis>
            <emphasis role="chapterTitle">Detection of Antibodies Against Cytomegalovirus by Enzyme-Linked Immunosorbent Assays and Chemiluminescence Immunoassays</emphasis>
         </title> &sect1.9781683674832.ch0334s0001;
     &sect1.9781683674832.ch0334s0002;
     &sect1.9781683674832.ch0334s0003;
    </chapter>
      <chapter id="ch0335" label="335">
         <title>
            <emphasis role="chapterNumber">13.9.3</emphasis>
            <emphasis role="chapterTitle">Cytomegalovirus IgG Avidity Testing</emphasis>
         </title> &sect1.9781683674832.ch0335s0004;
     &sect1.9781683674832.ch0335s0001;
     &sect1.9781683674832.ch0335s0002;
     &sect1.9781683674832.ch0335s0003;
    </chapter>
      <chapter id="ch0336" label="336">
         <title>
            <emphasis role="chapterNumber">13.10</emphasis>
            <emphasis role="chapterTitle">H <emphasis role="small">UMAN</emphasis> I <emphasis role="small">MMUNODEFICIENCY</emphasis> V <emphasis role="small">IRUS</emphasis> S <emphasis role="small">EROLOGY</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0336s0001;
    </chapter>
      <chapter id="ch0337" label="337">
         <title>
            <emphasis role="chapterNumber">13.10.2</emphasis>
            <emphasis role="chapterTitle">HIV Screening Immunoassays</emphasis>
         </title> &sect1.9781683674832.ch0337s0001;
     &sect1.9781683674832.ch0337s0002;
     &sect1.9781683674832.ch0337s0003;
    </chapter>
      <chapter id="ch0338" label="338">
         <title>
            <emphasis role="chapterNumber">13.10.3</emphasis>
            <emphasis role="chapterTitle">HIV-1/2 Supplemental Immunoassays</emphasis>
         </title> &sect1.9781683674832.ch0338s0001;
     &sect1.9781683674832.ch0338s0002;
     &sect1.9781683674832.ch0338s0003;
    </chapter>
      <chapter id="ch0339" label="339">
         <title>
            <emphasis role="chapterNumber">13.11</emphasis>
            <emphasis role="chapterTitle">S <emphasis role="small">EROLOGIC</emphasis> T <emphasis role="small">ESTING FOR</emphasis> H <emphasis role="small">EPATITIS</emphasis> V <emphasis role="small">IRUSES</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0339s0001;
     &sect1.9781683674832.ch0339s0002;
     &sect1.9781683674832.ch0339s0003;
     &sect1.9781683674832.ch0339s0004;
    </chapter>
      <chapter id="ch0340" label="340">
         <title>
            <emphasis role="chapterNumber">13.11.2</emphasis>
            <emphasis role="chapterTitle">Hepatitis B Virus Serology</emphasis>
         </title> &sect1.9781683674832.ch0340s0001;
     &sect1.9781683674832.ch0340s0002;
     &sect1.9781683674832.ch0340s0003;
     &sect1.9781683674832.ch0340s0004;
    </chapter>
      <chapter id="ch0341" label="341">
         <title>
            <emphasis role="chapterNumber">13.11.3</emphasis>
            <emphasis role="chapterTitle">Hepatitis C Virus Serology</emphasis>
         </title> &sect1.9781683674832.ch0341s0001;
     &sect1.9781683674832.ch0341s0002;
     &sect1.9781683674832.ch0341s0003;
     &sect1.9781683674832.ch0341s0004;
    </chapter>
      <chapter id="ch0342" label="342">
         <title>
            <emphasis role="chapterNumber">13.12</emphasis>
            <emphasis role="chapterTitle">Serologic Diagnosis of Arbovirus Infections</emphasis>
         </title> &sect1.9781683674832.ch0342s0001;
     &sect1.9781683674832.ch0342s0002;
     &sect1.9781683674832.ch0342s0003;
    </chapter>
      <chapter id="ch0343" label="343">
         <title>
            <emphasis role="chapterNumber">13.13</emphasis>
            <emphasis role="chapterTitle">Serologic Tests for Diagnosis of <emphasis role="strong">
                  <emphasis>Histoplasma capsulatum</emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0343s0001;
    </chapter>
      <chapter id="ch0344" label="344">
         <title>
            <emphasis role="chapterNumber">13.13.2</emphasis>
            <emphasis role="chapterTitle">
               <emphasis>Histoplasma capsulatum</emphasis> Antibody Detection by Complement Fixation</emphasis>
         </title> &sect1.9781683674832.ch0344s0001;
     &sect1.9781683674832.ch0344s0002;
     &sect1.9781683674832.ch0344s0003;
    </chapter>
      <chapter id="ch0345" label="345">
         <title>
            <emphasis role="chapterNumber">13.13.3</emphasis>
            <emphasis role="chapterTitle">
               <emphasis>Histoplasma capsulatum</emphasis> Antibody Detection by Immunodiffusion (ID)</emphasis>
         </title> &sect1.9781683674832.ch0345s0001;
     &sect1.9781683674832.ch0345s0002;
     &sect1.9781683674832.ch0345s0003;
    </chapter>
      <chapter id="ch0346" label="346">
         <title>
            <emphasis role="chapterNumber">13.14</emphasis>
            <emphasis role="chapterTitle">S <emphasis role="small">EROLOGIC</emphasis> M <emphasis role="small">ETHODS FOR</emphasis> D <emphasis role="small">IAGNOSIS OF</emphasis>
               <emphasis role="strong">
                  <emphasis>C <emphasis role="small">OCCIDIOIDES</emphasis>
                  </emphasis>
               </emphasis> I <emphasis role="small">NFECTIONS</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0346s0001;
    </chapter>
      <chapter id="ch0347" label="347">
         <title>
            <emphasis role="chapterNumber">13.14.2</emphasis>
            <emphasis role="chapterTitle">Detection of Antibodies to <emphasis role="strong">
                  <emphasis>Coccidioides</emphasis>
               </emphasis> spp. by Immunodiffusion</emphasis>
         </title> &sect1.9781683674832.ch0347s0001;
     &sect1.9781683674832.ch0347s0002;
     &sect1.9781683674832.ch0347s0003;
    </chapter>
      <chapter id="ch0348" label="348">
         <title>
            <emphasis role="chapterNumber">13.14.3</emphasis>
            <emphasis role="chapterTitle">Detection of Antibodies to <emphasis role="strong">
                  <emphasis>Coccidioides</emphasis>
               </emphasis> spp. by Complement Fixation</emphasis>
         </title> &sect1.9781683674832.ch0348s0001;
     &sect1.9781683674832.ch0348s0002;
     &sect1.9781683674832.ch0348s0003;
    </chapter>
      <chapter id="ch0349" label="349">
         <title>
            <emphasis role="chapterNumber">13.14.4</emphasis>
            <emphasis role="chapterTitle">Detection of Antibodies to <emphasis role="strong">
                  <emphasis>Coccidioides</emphasis>
               </emphasis> spp. by EIA</emphasis>
         </title> &sect1.9781683674832.ch0349s0001;
     &sect1.9781683674832.ch0349s0002;
     &sect1.9781683674832.ch0349s0003;
    </chapter>
      <chapter id="ch0350" label="350">
         <title>
            <emphasis role="chapterNumber">13.14.5</emphasis>
            <emphasis role="chapterTitle">Detection of Antibodies to <emphasis role="strong">
                  <emphasis>Coccidioides</emphasis>
               </emphasis> spp. by Lateral Flow Assay (LFA)</emphasis>
         </title> &sect1.9781683674832.ch0350s0001;
     &sect1.9781683674832.ch0350s0002;
     &sect1.9781683674832.ch0350s0003;
    </chapter>
      <chapter id="ch0351" label="351">
         <title>
            <emphasis role="chapterNumber">13.15</emphasis>
            <emphasis role="chapterTitle">Serologic Diagnosis of Chagas Disease</emphasis>
         </title> &sect1.9781683674832.ch0351s0001;
     &sect1.9781683674832.ch0351s0002;
     &sect1.9781683674832.ch0351s0003;
    </chapter>
      <chapter id="ch0352" label="352">
         <title>
            <emphasis role="chapterNumber">13.16</emphasis>
            <emphasis role="chapterTitle">Serologic Testing for Toxoplasmosis</emphasis>
         </title> &sect1.9781683674832.ch0352s0001;
     &sect1.9781683674832.ch0352s0002;
     &sect1.9781683674832.ch0352s0003;
     &sect1.9781683674832.ch0352s0004;
     &sect1.9781683674832.ch0352s0005;
     &sect1.9781683674832.ch0352s0006;
     &sect1.9781683674832.ch0352s0007;
    </chapter>
      <chapter id="ch0353" label="353">
         <title>
            <emphasis role="chapterNumber">13.16.2</emphasis>
            <emphasis role="chapterTitle">Detection of <emphasis role="strong">
                  <emphasis>Toxoplasma</emphasis>
               </emphasis> IgM Antibodies by ELISA (Remington Method)</emphasis>
         </title> &sect1.9781683674832.ch0353s0001;
     &sect1.9781683674832.ch0353s0002;
     &sect1.9781683674832.ch0353s0003;
    </chapter>
      <chapter id="ch0354" label="354">
         <title>
            <emphasis role="chapterNumber">13.16.3</emphasis>
            <emphasis role="chapterTitle">Detection of <emphasis role="strong">
                  <emphasis>Toxoplasma</emphasis>
               </emphasis> IgM Antibodies by the Immunoglobulin M Immunosorbent Agglutination Assay</emphasis>
         </title> &sect1.9781683674832.ch0354s0001;
     &sect1.9781683674832.ch0354s0002;
     &sect1.9781683674832.ch0354s0003;
    </chapter>
      <chapter id="ch0355" label="355">
         <title>
            <emphasis role="chapterNumber">13.16.4</emphasis>
            <emphasis role="chapterTitle">Detection of <emphasis>
                  <emphasis role="strong">Toxoplasma</emphasis>
               </emphasis> IgA Antibodies by ELISA (Remington Method)</emphasis>
         </title> &sect1.9781683674832.ch0355s0001;
     &sect1.9781683674832.ch0355s0002;
     &sect1.9781683674832.ch0355s0003;
    </chapter>
      <chapter id="ch0356" label="356">
         <title>
            <emphasis role="chapterNumber">13.16.5</emphasis>
            <emphasis role="chapterTitle">Detection of <emphasis role="strong">
                  <emphasis>Toxoplasma</emphasis>
               </emphasis> IgE Antibodies by ELISA (Remington Method)</emphasis>
         </title> &sect1.9781683674832.ch0356s0001;
     &sect1.9781683674832.ch0356s0002;
     &sect1.9781683674832.ch0356s0003;
    </chapter>
      <chapter id="ch0357" label="357">
         <title>
            <emphasis role="chapterNumber">13.16.6</emphasis>
            <emphasis role="chapterTitle">Vidas Toxo IgG Avidity Assay</emphasis>
         </title> &sect1.9781683674832.ch0357s0001;
     &sect1.9781683674832.ch0357s0002;
     &sect1.9781683674832.ch0357s0003;
    </chapter>
      <chapter id="ch0358" label="358">
         <title>
            <emphasis role="chapterNumber">13.16.7</emphasis>
            <emphasis role="chapterTitle">AC/HS (Differential Agglutination)</emphasis>
         </title> &sect1.9781683674832.ch0358s0001;
     &sect1.9781683674832.ch0358s0002;
     &sect1.9781683674832.ch0358s0003;
    </chapter>
      <chapter id="ch0359" label="359">
         <title>
            <emphasis role="chapterNumber">13.17</emphasis>
            <emphasis role="chapterTitle">Interferon Gamma Release Assays for Latent Tuberculosis Infection</emphasis>
         </title> &sect1.9781683674832.ch0359s0001;
     &sect1.9781683674832.ch0359s0002;
     &sect1.9781683674832.ch0359s0003;
    </chapter>
   </part>
   <part id="pt0014">
      <title>
         <emphasis role="partNumber">SECTION 14</emphasis><?lb?>
         <emphasis role="partTitle">Molecular Techniques</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">Samia N. Naccache and Alexander L. Greninger</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0014s0001;
<chapter id="ch0360" label="360">
         <title>
            <emphasis role="chapterNumber">14.1</emphasis>
            <emphasis role="chapterTitle">Introduction</emphasis>
         </title> &sect1.9781683674832.ch0360s0001;
    </chapter>
      <chapter id="ch0361" label="361">
         <title>
            <emphasis role="chapterNumber">14.2</emphasis>
            <emphasis role="chapterTitle">G <emphasis role="small">ENERAL</emphasis> A <emphasis role="small">SPECTS OF</emphasis> M <emphasis role="small">OLECULAR</emphasis> D <emphasis role="small">IAGNOSTICS</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0361s0001;
    </chapter>
      <chapter id="ch0362" label="362">
         <title>
            <emphasis role="chapterNumber">14.2.2</emphasis>
            <emphasis role="chapterTitle">Molecular Workflow and Contamination Control in a Clinical Microbiology Laboratory</emphasis>
         </title> &sect1.9781683674832.ch0362s0002;
     &sect1.9781683674832.ch0362s0001;
    </chapter>
      <chapter id="ch0363" label="363">
         <title>
            <emphasis role="chapterNumber">14.2.3</emphasis>
            <emphasis role="chapterTitle">Biosafety in the Molecular Microbiology Laboratory</emphasis>
         </title> &sect1.9781683674832.ch0363s0001;
     &sect1.9781683674832.ch0363s0002;
     &sect1.9781683674832.ch0363s0003;
    </chapter>
      <chapter id="ch0364" label="364">
         <title>
            <emphasis role="chapterNumber">14.2.4</emphasis>
            <emphasis role="chapterTitle">Verification and Validation of Molecular Tests</emphasis>
         </title> &sect1.9781683674832.ch0364s0001;
    </chapter>
      <chapter id="ch0365" label="365">
         <title>
            <emphasis role="chapterNumber">14.2.5</emphasis>
            <emphasis role="chapterTitle">Use of Controls and Calibrators</emphasis>
         </title> &sect1.9781683674832.ch0365s0001;
    </chapter>
      <chapter id="ch0366" label="366">
         <title>
            <emphasis role="chapterNumber">14.2.6</emphasis>
            <emphasis role="chapterTitle">Postanalytical Considerations for Molecular Testing</emphasis>
         </title> &sect1.9781683674832.ch0366s0001;
    </chapter>
      <chapter id="ch0367" label="367">
         <title>
            <emphasis role="chapterNumber">14.3</emphasis>
            <emphasis role="chapterTitle">Molecular Methods for Identification of Microorganisms</emphasis>
         </title> &sect1.9781683674832.ch0367s0001;
     &sect1.9781683674832.ch0367s0002;
     &sect1.9781683674832.ch0367s0003;
     &sect1.9781683674832.ch0367s0004;
    </chapter>
      <chapter id="ch0368" label="368">
         <title>
            <emphasis role="chapterNumber">14.3.2</emphasis>
            <emphasis role="chapterTitle">HIV Genotypic Resistance Testing</emphasis>
         </title> &sect1.9781683674832.ch0368s0001;
     &sect1.9781683674832.ch0368s0002;
     &sect1.9781683674832.ch0368s0003;
     &sect1.9781683674832.ch0368s0004;
     &sect1.9781683674832.ch0368s0005;
     &sect1.9781683674832.ch0368s0006;
    </chapter>
      <chapter id="ch0369" label="369">
         <title>
            <emphasis role="chapterNumber">14.3.3</emphasis>
            <emphasis role="chapterTitle">Molecular Methods for Identification of High-Risk Human Papillomaviruses</emphasis>
         </title> &sect1.9781683674832.ch0369s0001;
     &sect1.9781683674832.ch0369s0002;
     &sect1.9781683674832.ch0369s0003;
    </chapter>
      <chapter id="ch0370" label="370">
         <title>
            <emphasis role="chapterNumber">14.3.4</emphasis>
            <emphasis role="chapterTitle">Molecular Detection of Herpes Simplex Viruses 1 and 2 and Varicella-Zoster Virus</emphasis>
         </title> &sect1.9781683674832.ch0370s0001;
     &sect1.9781683674832.ch0370s0002;
     &sect1.9781683674832.ch0370s0003;
    </chapter>
      <chapter id="ch0371" label="371">
         <title>
            <emphasis role="chapterNumber">14.3.5</emphasis>
            <emphasis role="chapterTitle">Quantitative Detection of Human Cytomegalovirus DNA by Real-Time PCR</emphasis>
         </title> &sect1.9781683674832.ch0371s0001;
     &sect1.9781683674832.ch0371s0002;
     &sect1.9781683674832.ch0371s0003;
    </chapter>
      <chapter id="ch0372" label="372">
         <title>
            <emphasis role="chapterNumber">14.3.6</emphasis>
            <emphasis role="chapterTitle">Human Cytomegalovirus Drug Resistance Testing</emphasis>
         </title> &sect1.9781683674832.ch0372s0001;
     &sect1.9781683674832.ch0372s0002;
     &sect1.9781683674832.ch0372s0003;
    </chapter>
      <chapter id="ch0373" label="373">
         <title>
            <emphasis role="chapterNumber">14.3.7</emphasis>
            <emphasis role="chapterTitle">Molecular Diagnostics of Epstein-Barr Virus Infections</emphasis>
         </title> &sect1.9781683674832.ch0373s0001;
     &sect1.9781683674832.ch0373s0002;
     &sect1.9781683674832.ch0373s0003;
    </chapter>
      <chapter id="ch0374" label="374">
         <title>
            <emphasis role="chapterNumber">14.3.8</emphasis>
            <emphasis role="chapterTitle">Molecular Diagnostics of BK Virus Infections</emphasis>
         </title> &sect1.9781683674832.ch0374s0001;
     &sect1.9781683674832.ch0374s0002;
     &sect1.9781683674832.ch0374s0003;
    </chapter>
      <chapter id="ch0375" label="375">
         <title>
            <emphasis role="chapterNumber">14.3.9</emphasis>
            <emphasis role="chapterTitle">
               <emphasis role="strong">
                  <emphasis>Chlamydia trachomatis</emphasis>
               </emphasis> and <emphasis role="strong">
                  <emphasis>Neisseria gonorrhoeae</emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0375s0001;
     &sect1.9781683674832.ch0375s0002;
     &sect1.9781683674832.ch0375s0003;
    </chapter>
      <chapter id="ch0376" label="376">
         <title>
            <emphasis role="chapterNumber">14.4</emphasis>
            <emphasis role="chapterTitle">S <emphasis role="small">YNDROMIC</emphasis> P <emphasis role="small">ANELS</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0376s0001;
    </chapter>
      <chapter id="ch0377" label="377">
         <title>
            <emphasis role="chapterNumber">14.4.2</emphasis>
            <emphasis role="chapterTitle">Syndromic Panels: Respiratory Panels</emphasis>
         </title> &sect1.9781683674832.ch0377s0004;
     &sect1.9781683674832.ch0377s0001;
     &sect1.9781683674832.ch0377s0002;
     &sect1.9781683674832.ch0377s0003;
    </chapter>
      <chapter id="ch0378" label="378">
         <title>
            <emphasis role="chapterNumber">14.4.3</emphasis>
            <emphasis role="chapterTitle">Meningitis/Encephalitis Molecular Panels</emphasis>
         </title> &sect1.9781683674832.ch0378s0001;
     &sect1.9781683674832.ch0378s0002;
     &sect1.9781683674832.ch0378s0003;
     &sect1.9781683674832.ch0378s0004;
     &sect1.9781683674832.ch0378s0005;
    </chapter>
      <chapter id="ch0379" label="379">
         <title>
            <emphasis role="chapterNumber">14.5</emphasis>
            <emphasis role="chapterTitle">Sequence-Based Identification and Typing</emphasis>
         </title> &sect1.9781683674832.ch0379s0001;
    </chapter>
      <chapter id="ch0380" label="380">
         <title>
            <emphasis role="chapterNumber">14.5.2</emphasis>
            <emphasis role="chapterTitle">Deep Amplicon Sequencing for Direct Microbial Detection and Identification</emphasis>
         </title> &sect1.9781683674832.ch0380s0004;
     &sect1.9781683674832.ch0380s0001;
     &sect1.9781683674832.ch0380s0002;
     &sect1.9781683674832.ch0380s0003;
    </chapter>
      <chapter id="ch0381" label="381">
         <title>
            <emphasis role="chapterNumber">14.5.3</emphasis>
            <emphasis role="chapterTitle">Whole-Genome Sequencing</emphasis>
         </title> &sect1.9781683674832.ch0381s0001;
     &sect1.9781683674832.ch0381s0002;
     &sect1.9781683674832.ch0381s0003;
     &sect1.9781683674832.ch0381s0004;
    </chapter>
      <chapter id="ch0382" label="382">
         <title>
            <emphasis role="chapterNumber">14.5.4</emphasis>
            <emphasis role="chapterTitle">Shotgun Metagenomic Next-Generation Sequencing (mNGS) for Direct Microbial Detection and Identification</emphasis>
         </title> &sect1.9781683674832.ch0382s0001;
     &sect1.9781683674832.ch0382s0002;
     &sect1.9781683674832.ch0382s0003;
     &sect1.9781683674832.ch0382s0004;
     &sect1.9781683674832.ch0382s0005;
     &sect1.9781683674832.ch0382s0006;
     &sect1.9781683674832.ch0382s0007;
    </chapter>
   </part>
   <part id="pt0015">
      <title>
         <emphasis role="partNumber">SECTION 15</emphasis><?lb?>
         <emphasis role="partTitle">Epidemiologic and Infection Control Microbiology</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">J. Kristie Johnson</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0015s0001;
<chapter id="ch0383" label="383">
         <title>
            <emphasis role="chapterNumber">15.1</emphasis>
            <emphasis role="chapterTitle">Introduction</emphasis>
         </title> &sect1.9781683674832.ch0383s0001;
    </chapter>
      <chapter id="ch0384" label="384">
         <title>
            <emphasis role="chapterNumber">15.2</emphasis>
            <emphasis role="chapterTitle">Laboratory Support for Infection Prevention: Collaboration with Benefits for All</emphasis>
         </title> &sect1.9781683674832.ch0384s0002;
     &sect1.9781683674832.ch0384s0001;
    </chapter>
      <chapter id="ch0385" label="385">
         <title>
            <emphasis role="chapterNumber">15.3</emphasis>
            <emphasis role="chapterTitle">Microbiological Sampling for Pharmacies that Compound Sterile Preparations</emphasis>
         </title> &sect1.9781683674832.ch0385s0001;
    </chapter>
      <chapter id="ch0386" label="386">
         <title>
            <emphasis role="chapterNumber">15.3.1</emphasis>
            <emphasis role="chapterTitle">Environmental Monitoring by Viable Air Sampling</emphasis>
         </title> &sect1.9781683674832.ch0386s0001;
     &sect1.9781683674832.ch0386s0002;
     &sect1.9781683674832.ch0386s0003;
    </chapter>
      <chapter id="ch0387" label="387">
         <title>
            <emphasis role="chapterNumber">15.3.2</emphasis>
            <emphasis role="chapterTitle">Surface Sampling</emphasis>
         </title> &sect1.9781683674832.ch0387s0001;
     &sect1.9781683674832.ch0387s0002;
     &sect1.9781683674832.ch0387s0003;
    </chapter>
      <chapter id="ch0388" label="388">
         <title>
            <emphasis role="chapterNumber">15.3.3</emphasis>
            <emphasis role="chapterTitle">Gloved Fingertip Testing</emphasis>
         </title> &sect1.9781683674832.ch0388s0001;
     &sect1.9781683674832.ch0388s0002;
     &sect1.9781683674832.ch0388s0003;
    </chapter>
      <chapter id="ch0389" label="389">
         <title>
            <emphasis role="chapterNumber">15.3.4</emphasis>
            <emphasis role="chapterTitle">Media Fill Test Procedure</emphasis>
         </title> &sect1.9781683674832.ch0389s0001;
     &sect1.9781683674832.ch0389s0002;
     &sect1.9781683674832.ch0389s0003;
    </chapter>
      <chapter id="ch0390" label="390">
         <title>
            <emphasis role="chapterNumber">15.3.5</emphasis>
            <emphasis role="chapterTitle">USP &lt;71&gt; Sterility Testing</emphasis>
         </title> &sect1.9781683674832.ch0390s0001;
     &sect1.9781683674832.ch0390s0002;
     &sect1.9781683674832.ch0390s0003;
    </chapter>
      <chapter id="ch0391" label="391">
         <title>
            <emphasis role="chapterNumber">15.3.6</emphasis>
            <emphasis role="chapterTitle">Endotoxin Testing</emphasis>
         </title> &sect1.9781683674832.ch0391s0001;
     &sect1.9781683674832.ch0391s0002;
     &sect1.9781683674832.ch0391s0003;
    </chapter>
      <chapter id="ch0392" label="392">
         <title>
            <emphasis role="chapterNumber">15.4</emphasis>
            <emphasis role="chapterTitle">Culture of Hospital Water for Legionellaceae</emphasis>
         </title> &sect1.9781683674832.ch0392s0001;
    </chapter>
      <chapter id="ch0393" label="393">
         <title>
            <emphasis role="chapterNumber">15.4.2</emphasis>
            <emphasis role="chapterTitle">Heterotrophic Plate Count and Endotoxin Assay of Hemodialysis Fluids</emphasis>
         </title> &sect1.9781683674832.ch0393s0001;
     &sect1.9781683674832.ch0393s0002;
     &sect1.9781683674832.ch0393s0003;
     &sect1.9781683674832.ch0393s0004;
    </chapter>
      <chapter id="ch0394" label="394">
         <title>
            <emphasis role="chapterNumber">15.4.3</emphasis>
            <emphasis role="chapterTitle">Air Cultures for Fungi</emphasis>
         </title> &sect1.9781683674832.ch0394s0001;
     &sect1.9781683674832.ch0394s0002;
     &sect1.9781683674832.ch0394s0003;
    </chapter>
      <chapter id="ch0395" label="395">
         <title>
            <emphasis role="chapterNumber">15.4.4</emphasis>
            <emphasis role="chapterTitle">Environmental Surface Testing</emphasis>
         </title> &sect1.9781683674832.ch0395s0001;
     &sect1.9781683674832.ch0395s0002;
     &sect1.9781683674832.ch0395s0003;
     &sect1.9781683674832.ch0395s0004;
    </chapter>
      <chapter id="ch0396" label="396">
         <title>
            <emphasis role="chapterNumber">15.4.5</emphasis>
            <emphasis role="chapterTitle">Culture of Blood and Cellular Therapy Products in Blood Banking</emphasis>
         </title> &sect1.9781683674832.ch0396s0001;
     &sect1.9781683674832.ch0396s0002;
     &sect1.9781683674832.ch0396s0003;
    </chapter>
      <chapter id="ch0397" label="397">
         <title>
            <emphasis role="chapterNumber">15.4.6</emphasis>
            <emphasis role="chapterTitle">Culture of Human Cadaveric Tissues for Transplantation</emphasis>
         </title> &sect1.9781683674832.ch0397s0001;
     &sect1.9781683674832.ch0397s0002;
     &sect1.9781683674832.ch0397s0003;
    </chapter>
      <chapter id="ch0398" label="398">
         <title>
            <emphasis role="chapterNumber">15.4.7</emphasis>
            <emphasis role="chapterTitle">Duodenoscope Surveillance</emphasis>
         </title> &sect1.9781683674832.ch0398s0001;
     &sect1.9781683674832.ch0398s0002;
     &sect1.9781683674832.ch0398s0003;
    </chapter>
      <chapter id="ch0399" label="399">
         <title>
            <emphasis role="chapterNumber">15.5</emphasis>
            <emphasis role="chapterTitle">O <emphasis role="small">UTBREAK</emphasis> I <emphasis role="small">NVESTIGATIONS</emphasis>: L <emphasis role="small">ABORATORY AND</emphasis> E <emphasis role="small">PIDEMIOLOGIC</emphasis> C <emphasis role="small">ONCEPTS</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0399s0001;
    </chapter>
      <chapter id="ch0400" label="400">
         <title>
            <emphasis role="chapterNumber">15.5.2</emphasis>
            <emphasis role="chapterTitle">Collection and Storage of Outbreak Isolates</emphasis>
         </title> &sect1.9781683674832.ch0400s0001;
     &sect1.9781683674832.ch0400s0002;
    </chapter>
      <chapter id="ch0401" label="401">
         <title>
            <emphasis role="chapterNumber">15.5.3</emphasis>
            <emphasis role="chapterTitle">Systematic Analysis of Nosocomial Outbreaks</emphasis>
         </title> &sect1.9781683674832.ch0401s0002;
     &sect1.9781683674832.ch0401s0001;
    </chapter>
      <chapter id="ch0402" label="402">
         <title>
            <emphasis role="chapterNumber">15.5.4</emphasis>
            <emphasis role="chapterTitle">Public Health Reporting of Infectious Diseases: A Collaborative Approach by the Microbiology Laboratory and Clinicians</emphasis>
         </title> &sect1.9781683674832.ch0402s0001;
    </chapter>
      <chapter id="ch0403" label="403">
         <title>
            <emphasis role="chapterNumber">15.6</emphasis>
            <emphasis role="chapterTitle">M <emphasis role="small">OLECULAR</emphasis> M <emphasis role="small">ETHODS FOR</emphasis> E <emphasis role="small">PIDEMIOLOGICAL</emphasis> T <emphasis role="small">YPING OF</emphasis> M <emphasis role="small">ICROORGANISMS</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0403s0001;
    </chapter>
      <chapter id="ch0404" label="404">
         <title>
            <emphasis role="chapterNumber">15.6.2</emphasis>
            <emphasis role="chapterTitle">PCR Ribotyping</emphasis>
         </title> &sect1.9781683674832.ch0404s0001;
     &sect1.9781683674832.ch0404s0002;
     &sect1.9781683674832.ch0404s0003;
    </chapter>
      <chapter id="ch0405" label="405">
         <title>
            <emphasis role="chapterNumber">15.6.3</emphasis>
            <emphasis role="chapterTitle">Molecular Strain Typing Using Pulsed-Field Gel Electrophoresis</emphasis>
         </title> &sect1.9781683674832.ch0405s0001;
     &sect1.9781683674832.ch0405s0002;
     &sect1.9781683674832.ch0405s0003;
    </chapter>
      <chapter id="ch0406" label="406">
         <title>
            <emphasis role="chapterNumber">15.6.4</emphasis>
            <emphasis role="chapterTitle">Strain Typing Analysis of <emphasis role="strong">
                  <emphasis>Staphylococcus aureus</emphasis>
               </emphasis> Isolates Using Staphylococcal Protein A (<emphasis role="strong">
                  <emphasis>spa</emphasis>
               </emphasis>) Typing</emphasis>
         </title> &sect1.9781683674832.ch0406s0001;
     &sect1.9781683674832.ch0406s0002;
     &sect1.9781683674832.ch0406s0003;
    </chapter>
      <chapter id="ch0407" label="407">
         <title>
            <emphasis role="chapterNumber">15.6.5</emphasis>
            <emphasis role="chapterTitle">Multilocus Sequence Typing</emphasis>
         </title> &sect1.9781683674832.ch0407s0001;
     &sect1.9781683674832.ch0407s0002;
     &sect1.9781683674832.ch0407s0003;
    </chapter>
      <chapter id="ch0408" label="408">
         <title>
            <emphasis role="chapterNumber">15.6.6</emphasis>
            <emphasis role="chapterTitle">Strain Typing Using Next-Generation Sequencing</emphasis>
         </title> &sect1.9781683674832.ch0408s0001;
     &sect1.9781683674832.ch0408s0002;
     &sect1.9781683674832.ch0408s0003;
    </chapter>
      <chapter id="ch0409" label="409">
         <title>
            <emphasis role="chapterNumber">15.7</emphasis>
            <emphasis role="chapterTitle">S <emphasis role="small">URVEILLANCE</emphasis> C <emphasis role="small">ULTURES FOR</emphasis> H <emphasis role="small">OSPITAL</emphasis>-A <emphasis role="small">SSOCIATED</emphasis> I <emphasis role="small">NFECTIONS</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0409s0001;
    </chapter>
      <chapter id="ch0410" label="410">
         <title>
            <emphasis role="chapterNumber">15.7.2</emphasis>
            <emphasis role="chapterTitle">Screening for Methicillin-Resistant <emphasis>Staphylococcus aureus</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0410s0001;
     &sect1.9781683674832.ch0410s0002;
     &sect1.9781683674832.ch0410s0003;
    </chapter>
      <chapter id="ch0411" label="411">
         <title>
            <emphasis role="chapterNumber">15.7.3</emphasis>
            <emphasis role="chapterTitle">Screening for Vancomycin-Resistant Enterococci</emphasis>
         </title> &sect1.9781683674832.ch0411s0001;
     &sect1.9781683674832.ch0411s0002;
     &sect1.9781683674832.ch0411s0003;
    </chapter>
      <chapter id="ch0412" label="412">
         <title>
            <emphasis role="chapterNumber">15.7.4</emphasis>
            <emphasis role="chapterTitle">Surveillance Cultures of Multidrug-Resistant <emphasis>
                  <emphasis role="strong">Enterobacterales</emphasis>
               </emphasis>, <emphasis>
                  <emphasis role="strong">Pseudomonas aeruginosa</emphasis>
               </emphasis>, and <emphasis>
                  <emphasis role="strong">Acinetobacter baumannii</emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0412s0001;
     &sect1.9781683674832.ch0412s0002;
     &sect1.9781683674832.ch0412s0003;
     &sect1.9781683674832.ch0412s0004;
    </chapter>
      <chapter id="ch0413" label="413">
         <title>
            <emphasis role="chapterNumber">15.7.5</emphasis>
            <emphasis role="chapterTitle">Surveillance Cultures for <emphasis role="strong">
                  <emphasis>Candida auris</emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0413s0001;
     &sect1.9781683674832.ch0413s0002;
     &sect1.9781683674832.ch0413s0003;
    </chapter>
      <chapter id="ch0414" label="414">
         <title>
            <emphasis role="chapterNumber">15.7.6</emphasis>
            <emphasis role="chapterTitle">Surveillance Cultures from Immunocompromised Hosts</emphasis>
         </title> &sect1.9781683674832.ch0414s0001;
     &sect1.9781683674832.ch0414s0002;
     &sect1.9781683674832.ch0414s0003;
    </chapter>
      <chapter id="ch0415" label="415">
         <title>
            <emphasis role="chapterNumber">15.7.7</emphasis>
            <emphasis role="chapterTitle">Infection Surveillance Prior to Transplantation</emphasis>
         </title> &sect1.9781683674832.ch0415s0001;
    </chapter>
      <chapter id="ch0416" label="416">
         <title>
            <emphasis role="chapterNumber">15.8</emphasis>
            <emphasis role="chapterTitle">Infection Control in the Laboratory</emphasis>
         </title> &sect1.9781683674832.ch0416s0001;
    </chapter>
      <chapter id="ch0417" label="417">
         <title>
            <emphasis role="chapterNumber">15.8.2</emphasis>
            <emphasis role="chapterTitle">Laboratory Support of Blood-Borne Pathogen Exposures</emphasis>
         </title> &sect1.9781683674832.ch0417s0002;
     &sect1.9781683674832.ch0417s0001;
    </chapter>
      <chapter id="ch0418" label="418">
         <title>
            <emphasis role="chapterNumber">15.8.3</emphasis>
            <emphasis role="chapterTitle">Investigation of Laboratory Exposures</emphasis>
         </title> &sect1.9781683674832.ch0418s0001;
    </chapter>
      <chapter id="ch0419" label="419">
         <title>
            <emphasis role="chapterNumber">15.8.4</emphasis>
            <emphasis role="chapterTitle">Laboratory Isolation Codes and Notification Fan-Out for Suspected Biosafety Risk Group 3 and 4 Microorganisms</emphasis>
         </title> &sect1.9781683674832.ch0419s0001;
    </chapter>
   </part>
   <part id="pt0016">
      <title>
         <emphasis role="partNumber">SECTION 16</emphasis><?lb?>
         <emphasis role="partTitle">Quality Assurance, Quality Control, Laboratory Records, and Water Quality</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">Linoj Samuel</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0016s0001;
<chapter id="ch0420" label="420">
         <title>
            <emphasis role="chapterNumber">16.1</emphasis>
            <emphasis role="chapterTitle">Quality Assessment and Improvement (Quality Assurance)</emphasis>
         </title> &sect1.9781683674832.ch0420s0001;
    </chapter>
      <chapter id="ch0421" label="421">
         <title>
            <emphasis role="chapterNumber">16.1.1</emphasis>
            <emphasis role="chapterTitle">Process Improvement</emphasis>
         </title> &sect1.9781683674832.ch0421s0001;
    </chapter>
      <chapter id="ch0422" label="422">
         <title>
            <emphasis role="chapterNumber">16.1.2</emphasis>
            <emphasis role="chapterTitle">Quality Control and Assurance for Microbiology Full Laboratory Automation</emphasis>
         </title> &sect1.9781683674832.ch0422s0001;
     &sect1.9781683674832.ch0422s0002;
     &sect1.9781683674832.ch0422s0003;
    </chapter>
      <chapter id="ch0423" label="423">
         <title>
            <emphasis role="chapterNumber">16.2</emphasis>
            <emphasis role="chapterTitle">Quality Control</emphasis>
         </title> &sect1.9781683674832.ch0423s0001;
    </chapter>
      <chapter id="ch0424" label="424">
         <title>
            <emphasis role="chapterNumber">16.3</emphasis>
            <emphasis role="chapterTitle">Verification and Validation of Test System Performance Specifications</emphasis>
         </title> &sect1.9781683674832.ch0424s0001;
    </chapter>
      <chapter id="ch0425" label="425">
         <title>
            <emphasis role="chapterNumber">16.4</emphasis>
            <emphasis role="chapterTitle">CLIA Certification and Accreditation, ISO 15189 Accreditation, and Proficiency Testing</emphasis>
         </title> &sect1.9781683674832.ch0425s0001;
    </chapter>
      <chapter id="ch0426" label="426">
         <title>
            <emphasis role="chapterNumber">16.5</emphasis>
            <emphasis role="chapterTitle">Individualized Quality Control Plan</emphasis>
         </title> &sect1.9781683674832.ch0426s0001;
    </chapter>
      <chapter id="ch0427" label="427">
         <title>
            <emphasis role="chapterNumber">16.6</emphasis>
            <emphasis role="chapterTitle">Laboratory Records</emphasis>
         </title> &sect1.9781683674832.ch0427s0001;
    </chapter>
      <chapter id="ch0428" label="428">
         <title>
            <emphasis role="chapterNumber">16.7</emphasis>
            <emphasis role="chapterTitle">Preparation and Quality Control of Laboratory Water</emphasis>
         </title> &sect1.9781683674832.ch0428s0001;
     &sect1.9781683674832.ch0428s0002;
    </chapter>
      <chapter id="ch0429" label="429">
         <title>
            <emphasis role="chapterNumber">16.8</emphasis>
            <emphasis role="chapterTitle">P<emphasis role="small">ipette and</emphasis> L<emphasis role="small">oop</emphasis> C<emphasis role="small">alibration</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0429s0001;
     &sect1.9781683674832.ch0429s0002;
    </chapter>
      <chapter id="ch0430" label="430">
         <title>
            <emphasis role="chapterNumber">16.8.2</emphasis>
            <emphasis role="chapterTitle">Use and Performance Verification of Pipettors</emphasis>
         </title> &sect1.9781683674832.ch0430s0001;
    </chapter>
   </part>
   <part id="pt0017">
      <title>
         <emphasis role="partNumber">SECTION 17</emphasis><?lb?>
         <emphasis role="partTitle">Biohazards and Safety</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">Ryan F. Relich</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0017s0001;
<chapter id="ch0431" label="431">
         <title>
            <emphasis role="chapterNumber">17.1</emphasis>
            <emphasis role="chapterTitle">Introduction</emphasis>
         </title> &sect1.9781683674832.ch0431s0001;
    </chapter>
      <chapter id="ch0432" label="432">
         <title>
            <emphasis role="chapterNumber">17.2</emphasis>
            <emphasis role="chapterTitle">Biological Safety and Biohazard Prevention</emphasis>
         </title> &sect1.9781683674832.ch0432s0001;
    </chapter>
      <chapter id="ch0433" label="433">
         <title>
            <emphasis role="chapterNumber">17.2.2</emphasis>
            <emphasis role="chapterTitle">Safe Work Practices</emphasis>
         </title> &sect1.9781683674832.ch0433s0002;
     &sect1.9781683674832.ch0433s0001;
    </chapter>
      <chapter id="ch0434" label="434">
         <title>
            <emphasis role="chapterNumber">17.2.3</emphasis>
            <emphasis role="chapterTitle">Decontamination</emphasis>
         </title> &sect1.9781683674832.ch0434s0004;
     &sect1.9781683674832.ch0434s0001;
     &sect1.9781683674832.ch0434s0002;
     &sect1.9781683674832.ch0434s0003;
    </chapter>
      <chapter id="ch0435" label="435">
         <title>
            <emphasis role="chapterNumber">17.2.4</emphasis>
            <emphasis role="chapterTitle">Biohazardous Spills</emphasis>
         </title> &sect1.9781683674832.ch0435s0004;
     &sect1.9781683674832.ch0435s0001;
     &sect1.9781683674832.ch0435s0002;
     &sect1.9781683674832.ch0435s0003;
    </chapter>
      <chapter id="ch0436" label="436">
         <title>
            <emphasis role="chapterNumber">17.2.5</emphasis>
            <emphasis role="chapterTitle">Hand Hygiene for Laboratory Personnel</emphasis>
         </title> &sect1.9781683674832.ch0436s0001;
    </chapter>
      <chapter id="ch0437" label="437">
         <title>
            <emphasis role="chapterNumber">17.3</emphasis>
            <emphasis role="chapterTitle">B<emphasis role="small">iohazard</emphasis> C<emphasis role="small">ontainment</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0437s0001;
    </chapter>
      <chapter id="ch0438" label="438">
         <title>
            <emphasis role="chapterNumber">17.3.2</emphasis>
            <emphasis role="chapterTitle">Biosafety Levels</emphasis>
         </title> &sect1.9781683674832.ch0438s0002;
     &sect1.9781683674832.ch0438s0001;
    </chapter>
      <chapter id="ch0439" label="439">
         <title>
            <emphasis role="chapterNumber">17.3.3</emphasis>
            <emphasis role="chapterTitle">Biological Safety Cabinet</emphasis>
         </title> &sect1.9781683674832.ch0439s0002;
     &sect1.9781683674832.ch0439s0001;
    </chapter>
      <chapter id="ch0440" label="440">
         <title>
            <emphasis role="chapterNumber">17.3.4</emphasis>
            <emphasis role="chapterTitle">PPE and Engineering Controls</emphasis>
         </title> &sect1.9781683674832.ch0440s0001;
    </chapter>
      <chapter id="ch0441" label="441">
         <title>
            <emphasis role="chapterNumber">17.4</emphasis>
            <emphasis role="chapterTitle">L<emphasis role="small">aboratory</emphasis> I<emphasis role="small">nstrumentation and</emphasis> E<emphasis role="small">quipment</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0441s0001;
    </chapter>
      <chapter id="ch0442" label="442">
         <title>
            <emphasis role="chapterNumber">17.4.2</emphasis>
            <emphasis role="chapterTitle">Autoclave</emphasis>
         </title> &sect1.9781683674832.ch0442s0004;
     &sect1.9781683674832.ch0442s0001;
     &sect1.9781683674832.ch0442s0002;
     &sect1.9781683674832.ch0442s0003;
    </chapter>
      <chapter id="ch0443" label="443">
         <title>
            <emphasis role="chapterNumber">17.4.3</emphasis>
            <emphasis role="chapterTitle">Centrifuge</emphasis>
         </title> &sect1.9781683674832.ch0443s0004;
     &sect1.9781683674832.ch0443s0001;
     &sect1.9781683674832.ch0443s0002;
     &sect1.9781683674832.ch0443s0003;
    </chapter>
      <chapter id="ch0444" label="444">
         <title>
            <emphasis role="chapterNumber">17.4.4</emphasis>
            <emphasis role="chapterTitle">Compressed Gas Cylinders</emphasis>
         </title> &sect1.9781683674832.ch0444s0002;
     &sect1.9781683674832.ch0444s0001;
    </chapter>
      <chapter id="ch0445" label="445">
         <title>
            <emphasis role="chapterNumber">17.4.5</emphasis>
            <emphasis role="chapterTitle">Pneumatic Tube System</emphasis>
         </title> &sect1.9781683674832.ch0445s0004;
     &sect1.9781683674832.ch0445s0001;
     &sect1.9781683674832.ch0445s0002;
     &sect1.9781683674832.ch0445s0003;
    </chapter>
      <chapter id="ch0446" label="446">
         <title>
            <emphasis role="chapterNumber">17.4.6</emphasis>
            <emphasis role="chapterTitle">Specimen/Microorganism Storage and Retention</emphasis>
         </title> &sect1.9781683674832.ch0446s0002;
     &sect1.9781683674832.ch0446s0001;
    </chapter>
      <chapter id="ch0447" label="447">
         <title>
            <emphasis role="chapterNumber">17.4.7</emphasis>
            <emphasis role="chapterTitle">Other Equipment and Devices</emphasis>
         </title> &sect1.9781683674832.ch0447s0001;
    </chapter>
      <chapter id="ch0448" label="448">
         <title>
            <emphasis role="chapterNumber">17.5</emphasis>
            <emphasis role="chapterTitle">Special Pathogens and Employee Safety</emphasis>
         </title> &sect1.9781683674832.ch0448s0001;
    </chapter>
      <chapter id="ch0449" label="449">
         <title>
            <emphasis role="chapterNumber">17.5.2</emphasis>
            <emphasis role="chapterTitle">Early (Bench-Level) Recognition of Biothreat Agents and Laboratory-Acquired Infections</emphasis>
         </title> &sect1.9781683674832.ch0449s0001;
    </chapter>
      <chapter id="ch0450" label="450">
         <title>
            <emphasis role="chapterNumber">17.5.3</emphasis>
            <emphasis role="chapterTitle">Select Agents</emphasis>
         </title> &sect1.9781683674832.ch0450s0001;
    </chapter>
      <chapter id="ch0451" label="451">
         <title>
            <emphasis role="chapterNumber">17.5.4</emphasis>
            <emphasis role="chapterTitle">Environmental, Non-Human, and Suspicious Specimens and Substances</emphasis>
         </title> &sect1.9781683674832.ch0451s0001;
    </chapter>
      <chapter id="ch0452" label="452">
         <title>
            <emphasis role="chapterNumber">17.5.5</emphasis>
            <emphasis role="chapterTitle">Prions, Prion Diseases (Including Creutzfeldt-Jakob Disease), and Safety Issues Specific to Specimens Suspected of Containing Prions</emphasis>
         </title> &sect1.9781683674832.ch0452s0001;
    </chapter>
      <chapter id="ch0453" label="453">
         <title>
            <emphasis role="chapterNumber">17.5.6</emphasis>
            <emphasis role="chapterTitle">Resources for Information on Specific Pathogens</emphasis>
         </title> &sect1.9781683674832.ch0453s0001;
    </chapter>
      <chapter id="ch0454" label="454">
         <title>
            <emphasis role="chapterNumber">17.6</emphasis>
            <emphasis role="chapterTitle">Packing and Shipping Infectious Substances*</emphasis>
         </title> &sect1.9781683674832.ch0454s0002;
     &sect1.9781683674832.ch0454s0001;
    </chapter>
      <chapter id="ch0455" label="455">
         <title>
            <emphasis role="chapterNumber">17.7</emphasis>
            <emphasis role="chapterTitle">Management of Laboratory Accidents</emphasis>
         </title> &sect1.9781683674832.ch0455s0002;
     &sect1.9781683674832.ch0455s0001;
    </chapter>
      <chapter id="ch0456" label="456">
         <title>
            <emphasis role="chapterNumber">17.8</emphasis>
            <emphasis role="chapterTitle">Management of Infectious Waste</emphasis>
         </title> &sect1.9781683674832.ch0456s0001;
    </chapter>
      <chapter id="ch0457" label="457">
         <title>
            <emphasis role="chapterNumber">17.9</emphasis>
            <emphasis role="chapterTitle">Risk Assessment</emphasis>
         </title> &sect1.9781683674832.ch0457s0002;
     &sect1.9781683674832.ch0457s0001;
    </chapter>
   </part>
   <part id="pt0018">
      <title>
         <emphasis role="partNumber">SECTION 18</emphasis><?lb?>
         <emphasis role="partTitle">Bioterrorism</emphasis>
      </title>
      <partintro>
         <para role="chapterAuthor">
            <emphasis role="small">SECTION EDITORS</emphasis>: <emphasis>
               <emphasis role="strong">Marie-Claire Rowlinson</emphasis>
            </emphasis>
         </para>
      </partintro>
      &sect1.9781683674832.pt0018s0001;
<chapter id="ch0458" label="458">
         <title>
            <emphasis role="chapterNumber">18.1</emphasis>
            <emphasis role="chapterTitle">General Introduction to Bioterrorism and Emerging Infectious Diseases</emphasis>
         </title> &sect1.9781683674832.ch0458s0001;
    </chapter>
      <chapter id="ch0459" label="459">
         <title>
            <emphasis role="chapterNumber">18.2</emphasis>
            <emphasis role="chapterTitle">Levels of Laboratory Biosafety</emphasis>
         </title> &sect1.9781683674832.ch0459s0001;
    </chapter>
      <chapter id="ch0460" label="460">
         <title>
            <emphasis role="chapterNumber">18.3</emphasis>
            <emphasis role="chapterTitle">
               <emphasis>
                  <emphasis role="strong">Bacillus anthracis</emphasis>
               </emphasis> and <emphasis>
                  <emphasis role="strong">Bacillus cereus</emphasis>
               </emphasis> biovar anthracisAnthrax</emphasis>
         </title> &sect1.9781683674832.ch0460s0001;
     &sect1.9781683674832.ch0460s0002;
     &sect1.9781683674832.ch0460s0003;
    </chapter>
      <chapter id="ch0461" label="461">
         <title>
            <emphasis role="chapterNumber">18.4</emphasis>
            <emphasis role="chapterTitle">
               <emphasis role="strong">
                  <emphasis>Brucella</emphasis>
               </emphasis> spp.Brucellosis</emphasis>
         </title> &sect1.9781683674832.ch0461s0001;
     &sect1.9781683674832.ch0461s0002;
     &sect1.9781683674832.ch0461s0003;
    </chapter>
      <chapter id="ch0462" label="462">
         <title>
            <emphasis role="chapterNumber">18.5</emphasis>
            <emphasis role="chapterTitle">
               <emphasis>
                  <emphasis role="strong">Yersinia pestis</emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0462s0001;
     &sect1.9781683674832.ch0462s0002;
     &sect1.9781683674832.ch0462s0003;
    </chapter>
      <chapter id="ch0463" label="463">
         <title>
            <emphasis role="chapterNumber">18.6</emphasis>
            <emphasis role="chapterTitle">Tularemia<emphasis role="strong">
                  <emphasis>Francisella tularensis</emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0463s0001;
     &sect1.9781683674832.ch0463s0002;
     &sect1.9781683674832.ch0463s0003;
    </chapter>
      <chapter id="ch0464" label="464">
         <title>
            <emphasis role="chapterNumber">18.7</emphasis>
            <emphasis role="chapterTitle">Melioidosis (<emphasis role="strong">
                  <emphasis>Burkholderia pseudomallei</emphasis>)</emphasis> and Glanders (<emphasis role="strong">
                  <emphasis>Burkholderia mallei</emphasis>
               </emphasis>)</emphasis>
         </title> &sect1.9781683674832.ch0464s0001;
     &sect1.9781683674832.ch0464s0002;
     &sect1.9781683674832.ch0464s0003;
    </chapter>
      <chapter id="ch0465" label="465">
         <title>
            <emphasis role="chapterNumber">18.8</emphasis>
            <emphasis role="chapterTitle">Smallpox and Other Poxviruses</emphasis>
         </title> &sect1.9781683674832.ch0465s0001;
     &sect1.9781683674832.ch0465s0002;
     &sect1.9781683674832.ch0465s0003;
    </chapter>
      <chapter id="ch0466" label="466">
         <title>
            <emphasis role="chapterNumber">18.9</emphasis>
            <emphasis role="chapterTitle">Novel Influenza Viruses and Highly Pathogenic Coronaviruses</emphasis>
         </title> &sect1.9781683674832.ch0466s0001;
     &sect1.9781683674832.ch0466s0002;
     &sect1.9781683674832.ch0466s0003;
    </chapter>
      <chapter id="ch0467" label="467">
         <title>
            <emphasis role="chapterNumber">18.10</emphasis>
            <emphasis role="chapterTitle">Q Fever<emphasis role="strong">
                  <emphasis>Coxiella burnetii</emphasis>
               </emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0467s0001;
     &sect1.9781683674832.ch0467s0002;
     &sect1.9781683674832.ch0467s0003;
    </chapter>
      <chapter id="ch0468" label="468">
         <title>
            <emphasis role="chapterNumber">18.11</emphasis>
            <emphasis role="chapterTitle">Toxins: Botulinum Toxin (<emphasis role="strong">
                  <emphasis>Clostridium botulinum</emphasis>
               </emphasis>) and Staphylococcal Enterotoxin B (<emphasis role="strong">
                  <emphasis>Staphylococcus aureus</emphasis>
               </emphasis>)</emphasis>
         </title> &sect1.9781683674832.ch0468s0001;
     &sect1.9781683674832.ch0468s0002;
     &sect1.9781683674832.ch0468s0003;
    </chapter>
      <chapter id="ch0469" label="469">
         <title>
            <emphasis role="chapterNumber">18.12</emphasis>
            <emphasis role="chapterTitle">High-Consequence Viral Pathogens</emphasis>
         </title> &sect1.9781683674832.ch0469s0001;
     &sect1.9781683674832.ch0469s0002;
    </chapter>
      <chapter id="ch0470" label="470">
         <title>
            <emphasis role="chapterNumber">18.13</emphasis>
            <emphasis role="chapterTitle">Eastern Equine Encephalitis Virus</emphasis>
         </title> &sect1.9781683674832.ch0470s0001;
     &sect1.9781683674832.ch0470s0002;
    </chapter>
      <chapter id="ch0471" label="471">
         <title>
            <emphasis role="chapterNumber">18.14</emphasis>
            <emphasis role="chapterTitle">Clinical Laboratory Bioterrorism Readiness Plan</emphasis>
         </title> &sect1.9781683674832.ch0471s0001;
    </chapter>
      <chapter id="ch0472" label="472">
         <title>
            <emphasis role="chapterNumber">18.15</emphasis>
            <emphasis role="chapterTitle">P<emphasis role="small">henotypic</emphasis> T<emphasis role="small">ests and</emphasis> B<emphasis role="small">iochemical</emphasis> P<emphasis role="small">rocedures</emphasis>
            </emphasis>
         </title> &sect1.9781683674832.ch0472s0001;
    </chapter>
      <chapter id="ch0473" label="473">
         <title>
            <emphasis role="chapterNumber">18.15.2</emphasis>
            <emphasis role="chapterTitle">Catalase Test</emphasis>
         </title> &sect1.9781683674832.ch0473s0001;
     &sect1.9781683674832.ch0473s0002;
     &sect1.9781683674832.ch0473s0003;
    </chapter>
      <chapter id="ch0474" label="474">
         <title>
            <emphasis role="chapterNumber">18.15.3</emphasis>
            <emphasis role="chapterTitle">Spot Indole Test</emphasis>
         </title> &sect1.9781683674832.ch0474s0001;
     &sect1.9781683674832.ch0474s0002;
     &sect1.9781683674832.ch0474s0003;
    </chapter>
      <chapter id="ch0475" label="475">
         <title>
            <emphasis role="chapterNumber">18.15.4</emphasis>
            <emphasis role="chapterTitle">Beta-Lactamase Test</emphasis>
         </title> &sect1.9781683674832.ch0475s0001;
     &sect1.9781683674832.ch0475s0002;
     &sect1.9781683674832.ch0475s0003;
    </chapter>
      <chapter id="ch0476" label="476">
         <title>
            <emphasis role="chapterNumber">18.15.5</emphasis>
            <emphasis role="chapterTitle">Motility Tests</emphasis>
         </title> &sect1.9781683674832.ch0476s0001;
     &sect1.9781683674832.ch0476s0002;
     &sect1.9781683674832.ch0476s0003;
    </chapter>
      <chapter id="ch0477" label="477">
         <title>
            <emphasis role="chapterNumber">18.15.6</emphasis>
            <emphasis role="chapterTitle">Urease Test</emphasis>
         </title> &sect1.9781683674832.ch0477s0001;
     &sect1.9781683674832.ch0477s0002;
     &sect1.9781683674832.ch0477s0003;
    </chapter>
      <chapter id="ch0478" label="478">
         <title>
            <emphasis role="chapterNumber">18.15.7</emphasis>
            <emphasis role="chapterTitle">Antimicrobial Disk Tests for Identification</emphasis>
         </title> &sect1.9781683674832.ch0478s0001;
     &sect1.9781683674832.ch0478s0002;
     &sect1.9781683674832.ch0478s0003;
    </chapter>
      <chapter id="ch0479" label="479">
         <title>
            <emphasis role="chapterNumber">18.15.8</emphasis>
            <emphasis role="chapterTitle">Satellite Test</emphasis>
         </title> &sect1.9781683674832.ch0479s0001;
     &sect1.9781683674832.ch0479s0002;
     &sect1.9781683674832.ch0479s0003;
    </chapter>
      <index id="in0001">
         <title>Index</title>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>A</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Abbott Architect Syphilis TP assay, 13.5.1.3, 13.5.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Abbott m 2000, C. trachomatis and N. gonorrhoeae, 14.3.9.3, 14.3.9.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Abbott Molecular, Des Plaines, IL, 14.3.1.2, 14.3.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ABCs (Active Bacterial Core surveillance), 15.5.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Abdomen, anaerobic specimen selection, 4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Abiotrophia, 3.17.43.1, 3.17.43.3, 3.18.9, 7.17.1.14, 7.17.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Abiotrophia defectiva, 3.17.43.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ABN (advanced beneficiary notice), 1.2.4.31.2.4.5, 1.2.4.111.2.4.13, 1.2.4.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Abortion, septic, 3.8.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Abrasions, 3.12.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Abscess(es)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aerobic cultures, 3.12.1.13.12.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture workup, 3.12.1.143.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>deep, 3.12.1.1, 3.12.1.2, 3.12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.12.1.13, 3.12.1.14, 3.12.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation conditions, 3.12.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>initial evaluation, 3.12.1.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation, 3.12.1.133.12.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 3.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.12.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.12.1.113.12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.12.1.13.12.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.12.1.133.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.12.1.103.12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.12.1.163.12.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety, 3.12.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.12.1.93.12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>superficial, 3.12.1.1, 3.12.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic specimen collection, 4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aspirates, 11.7.2.1, 11.7.2.311.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>brain, 2.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cranial epidural, 2.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cutaneous, 2.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dental, 2.1.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>epidural, 2.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal, 10.3.3, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital, 3.8.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>liver, 2.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>male genital tract, 2.1.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.7.2.111.7.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>peritonsilar, 2.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>prostatic, 3.8.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>renal, 2.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>root, 2.1.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>splenic, 2.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess and soft tissue cultures, 3.12.1.13.12.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Absidia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.1110.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Abuse, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acanthamoeba</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.211.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calcofluor white for detection of cysts, 11.4.8.111.4.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture, 11.7.3.211.7.3.4, 11.9.1.111.9.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 11.9.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 11.9.1.2, 11.9.1.611.9.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 11.9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 11.9.1.311.9.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 11.9.1.511.9.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 11.9.1.211.9.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 11.9.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results, 11.9.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 11.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enflagellation experiment, 11.9.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>eye infection, 2.1.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>granulomatous amebic encephalitis, 11.9.1.1, 11.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>keratitis, 3.9.4, 11.9.1.1, 11.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>NAAT, 3.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PYG medium for, 11.9.1.711.9.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.511.11.2.6, 11.11.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>STAT testing, 11.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acanthamoeba and Naegleria culture, 11.9.1.111.9.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acanthamoeba castellanii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calcofluor white stain, 11.4.8.211.4.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture, 11.9.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acanthocephalans, gross examination, 11.10.2, 11.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Accession list, 16.6.2, 16.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Accidental fires, 17.7.217.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Accreditation Organizations under the Clinical Laboratory Improvement Amendments (CLIA), 16.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Accreditation, quality assurance, 16.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Accu Probe, 9.1.1, 9.5.2.19.5.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Accuracy, 16.2.26</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular tests, 14.2.4.114.2.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acetamide agar, 16.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acetamide utilization test, 3.17.1.13.17.1.2, 8.3.18.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acetate agar, 16.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acetate utilization test, 3.17.2.13.17.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acetobacter, calcofluor white stain, 11.4.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acetoin (acetylmethylcarbinol), 3.17.32.13.17.32.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acetyl coenzyme A acetyltransferase, 15.6.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acetylmethylcarbinol (acetoin), 3.17.32.13.17.32.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Achromobacter, 3.10.3.1, 3.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, cystic fibrosis, 3.10.3.1, 3.10.3.33.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Achromobacter piechaudii, identification, 3.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Achromobacter xylosoxidans, 3.17.1.2, 3.17.11.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.7, 7.2.9, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.9, 3.19.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AC/HS (differential agglutination), 13.16.7.113.16.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.16.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.16.7.413.16.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.7.113.16.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.16.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.16.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagent preparation, 13.16.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.16.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acidaminococcus, 4.15.3, 4.15.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acid-fast bacilli (AFB), 5.8.15.8.7, 6.4.16.4.15. See also Continuous monitoring blood culture systems</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT automated mycobacterial culture system, 9.4.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bactec Myco/F Lytic, 5.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calibration and quality control, 6.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/RIF test, 9.6.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>digestion and decontamination, 9.2.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.8.55.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 5.8.7, 6.4.96.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>liquid media for isolation</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT automated system, 9.4.1.3, 9.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK Myco Culture system, 9.4.2.19.4.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI Biotyper, 6.4.26.4.5, 6.4.76.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MALDI-TOF MS, 5.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 5.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>meningitis, 3.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>order of inoculation media, 2.1.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>positive blood cultures, 5.8.35.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 5.8.1, 6.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.8.25.8.5, 6.4.56.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pyrosequencing (PSQ), 9.10.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 5.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents and equipment, 6.4.16.4.3, 6.4.126.4.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting, 5.8.65.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 6.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 6.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sequencing-based identification, 14.5.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>solid media used for isolation, 9.3.19.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 6.4.46.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, 5.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 2.1.26</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK Myco, 5.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VITEK MS, 6.4.16.4.2, 6.4.46.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acid-fast modified trichrome stain, 11.4.5.111.4.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acid-fast stains, 9.2.3.19.2.3.5, 16.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyouns acid-fast stain (cold), 11.4.1.111.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.28.2.4, 8.2.78.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified trichrome stain, 11.4.5.111.4.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Ziehl-Neelsen acid-fast stain (hot), 11.4.2.111.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acidimetric method, 7.7.37.7.5, 7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acidominococcus, 4.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acidovorax, identification, 3.19.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acinetobacillus, urease test, 3.17.46.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acinetobacter</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood products, 15.4.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.6, 7.4.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>butyrate esterase test, 3.17.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbapenemase, 7.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.7, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of antimicrobial susceptibility test systems, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.4, 3.19.6, 3.19.8, 3.19.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>motility tests, 3.17.30.4, 18.15.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multidrug-resistant, 15.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.1, 3.10.2.6, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vs. Yersinia pestis, 18.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acinetobacter baumannii, 7.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar media, 15.7.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>multidrug-resistant, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate/nitrite reduction test, 3.17.34.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acinetobacter baumannii-Acinetobacter calcoaceticus complex</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acquired AmpC beta lactamases, 7.15.17.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acquired immunodeficiency syndrome (AIDS). See Human immunodeficiency virus (HIV)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acremonium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification on primary media, 10.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.12, 10.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acridine orange (AO) stain, 3.2.2.13.2.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acronyms, 1.1.71.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinobacillus, 3.17.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinobaculum, 4.14.4, 4.14.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy update, 4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Actinomadura, 8.1.1, 8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 8.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation of growth, 8.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1, 8.2.4, 8.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Actinomadura madurae, 8.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomadura pelletieri, 8.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomyces, 4.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth culture, 4.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.24.14.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.2.14.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dacryocystitis/dacryoadenitis canaliculitis, 3.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital infections, 3.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain and colonial morphology of, 4.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.1, 3.18.10, 3.18.12, 4.14.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation of growth, 8.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>intrauterine devive (IUD), 2.1.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.1, 4.12.2, 4.12.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>practical guide to workup, 4.8.44.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid enzymatic systems, 4.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Actinomyces dentalis, 4.14.2, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomyces georgiae, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomyces gerencseriae, 4.14.2, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomyces graevenitzii, 4.14.8, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Actinomyces israelii, 4.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Actinomyces johnsonii, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomyces massiliensis, 4.14.2, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomyces naeslundii, 4.14.8, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Actinomyces neuii, 3.17.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CAMP factor tests and reverse CAMP test, 3.17.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Actinomyces odontolyticus, 4.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomyces oricola, 4.14.3, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomyces oris, 4.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Actinomyces pyogenes, 3.8.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomyces radicidentis, 4.14.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomyces selective agar (FAA/BRU + MTZ/NAL), 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomyces timonensis, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomyces urogenitalis, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomyces viscosus, 4.14.8, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Actinomycetales, 8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinomycetes</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media and methods for phenotypic characterization, 8.3.18.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.28.2.4, 8.2.78.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, cystic fibrosis, 3.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sequencing-based identification, 14.5.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.18.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 8.5.18.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Actinomycosis, 2.1.18, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actinotignum, 4.14.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Actinotignum sanguinis, 4.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Actinotignum schaalii, 4.2.2, 4.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Actinotignum urinale, 4.14.8, 4.14.13, 4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Active Bacterial Core surveillance (ABCs), 15.5.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Actonomyces viscosus, catalase test, 3.17.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acute bacterial rhinosinusitis (ABRS), 3.10.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acute pelvic inflammatory disease, 2.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acute rhinosinusitis (ARS), 3.10.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acute urethral syndrome, 3.11.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ADB (anti-DNase B) antibodies, 13.2.1.113.2.1.3, 13.2.2.113.2.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>Additive effect, 7.19.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Add-on, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Adenocephalus, gross examination, 11.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Adenovirus(es), 12.9.1.1, 12.9.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5, 14.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Adlercreutzia, 4.14.5, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Administrative controls, 17.9.417.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Adonitol, 16.2.6, 16.2.10, 16.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AdV (Adenoviruses), 12.9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Advance Beneficiary Notice of Noncoverage (ABN), 1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Advanced beneficiary notice (ABN), 1.2.4.31.2.4.5, 1.2.4.111.2.4.13, 1.2.4.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Advanced Diagnostic Laboratory Tests (ADLTs), 1.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Advancement of Blood &amp; Biotherapies (AABB), 5.11.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Adventitious septa, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ADVIA Centaur Anti-HBe 2 Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ADVIA Centaur Anti-HBs 2 Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ADVIA Centaur HAV Total Assay, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ADVIA Centaur HBc IgM Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ADVIA Centaur HBc Total Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ADVIA Centaur HBeAg Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ADVIA Centaur HBsAg II Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ADVIA Centaur HCV, 13.11.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ADVIA Centaur HIV Ag/Ab Combo (CHIV), 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ADVIA Centaur HIV 1/O/2 enhanced (EHIV), 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ADVIA Centaur IgM Total Assay, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ADVIA Centaur Syphilis, 13.5.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ADVIA Centaur Syphilis assay, 13.5.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aerial arthroconidia, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aerobe(s)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 7.1.1.37.1.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical tests (see Biochemical tests, aerobes)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body fluid cultures, 3.4.13.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>commercial biochemical identification systems, 3.16.13.16.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.13.7.1.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital cultures (See Genital cultures)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-negative bacilli (See Gram-negative bacilli, aerobic)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-positive, 3.2.1.1, 3.18.13.18.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-positive bacilli (See Gram-positive bacilli, aerobic)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-positive cocci (See Gram-positive cocci, aerobic)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation and rapid identification on primary culture media, 3.3.2.13.3.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate/nitrite reduction test, 3.17.34.13.17.34.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>organization of procedures, 3.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing specimens for bacteriology, 3.3.1.13.3.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture media selection, 3.3.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluids, 3.3.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram staining, 3.3.1.6, 3.3.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation, 3.3.1.83.3.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation technique, 3.3.1.83.3.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.3.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>manual incubation, 3.3.1.83.3.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 3.3.1.23.3.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>media commonly used, 3.3.1.23.3.1.3, 3.3.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedure, 3.3.1.43.3.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.3.1.33.3.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting specimen information, 3.3.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>saving specimens, 3.3.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.3.1.13.3.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>swabs, 3.3.1.53.3.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>timing, 3.3.1.43.3.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bordetella, 3.10.6.13.10.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>C. diphtheriae, 3.10.7.13.10.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Legionella, 3.10.4.13.10.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>staining procedures, wet mount, 3.2.3.13.2.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing considerations for biochemical identification, 3.16.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine cultures, 3.11.1.13.11.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aerobic actinomycetes, 6.4.16.4.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calibration and quality control, 6.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>definitive identification of, 8.4.18.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>flowchart for isolation, 8.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations of, 6.4.96.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI Biotyper, 6.4.26.4.5, 6.4.76.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.28.2.4, 8.2.78.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characterization, 8.3.18.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 6.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 6.4.56.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents and equipment, 6.4.16.4.3, 6.4.126.4.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 6.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 6.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 6.4.46.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.18.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 8.5.18.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VITEK MS, 6.4.16.4.2, 6.4.46.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aerobic bacteria, 5.3.15.3.7, 5.7.15.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar dilution susceptibility testing, timetable for, 7.6.1.137.6.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>automated blood culture systems, 5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BacT/ALE, 5.3.2, 5.3.4, 5.3.5, 5.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BACTEC, 5.3.4, 5.3.5, 5.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.3.65.3.7, 5.7.65.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 5.3.7, 5.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 5.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 5.3.3, 5.7.15.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.3.1, 5.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.3.45.3.6, 5.7.25.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 5.3.35.3.4, 5.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 5.3.7, 5.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 5.3.25.3.3, 5.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 5.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK bottles, 5.3.4, 5.3.6, 5.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aerobic bacteriology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>order of inoculation media, 2.1.38</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection of specimens, 2.1.26</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aerobic (vented) bottle, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aerococcus, 3.17.25.13.17.25.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.1, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aerococcus sanguinicola, disk diffusion testing, 7.2.2, 7.2.7, 7.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aerococcus urinae, 3.11.1.3, 3.11.1.10, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.7, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aerococcus viridans, 3.17.25.1, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aeromonas</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile-esculin and esculin tests, 3.17.5.1, 3.17.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter fecal culture, 3.7.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.23.17.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.7, 7.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.1, 3.17.16.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.1, 3.7.1.7, 3.7.1.8, 3.7.1.123.7.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.2, 14.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.3, 3.19.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 3.17.22.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.2, 3.17.32.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>O129 disk susceptibility testing, 3.17.35.13.17.35.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oxidase test, 3.17.38.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.1, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>spot indole test, 18.15.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aeromonas hydrophila, 3.7.1.8, 3.17.35.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aeromonas spp., MALDI-TOF, 6.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aeromonas veronii, 3.17.35.2, 3.17.35.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aerosols, 17.1.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aerotolerance testing, 4.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AFB. See Acid-fast bacilli</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AFB-rapid growers</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>keratitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Affordable Care Act (ACA), 1.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aflatoxins, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AFST. See Antifungal susceptibility testing (AFST)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Agar dilution MIC test</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aerobic bacteria, 7.6.1.17.6.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic bacteria, 7.6.2.17.6.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vancomycin resistance in Staphylococcus aureus, 7.9.17.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>worksheet, 7.6.1.16, 7.6.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Agar media preparation, for antimicrobial susceptibility testing (AST), 7.24.3.17.24.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>additives and supplements, 7.24.3.97.24.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.24.3.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.24.3.17.24.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.24.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.24.3.37.24.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.24.3.27.24.3.3, 7.24.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Agar plate culture for Strongyloides stercoralis larvae, 11.5.4.111.5.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 11.5.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 11.5.4.111.5.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 11.5.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 11.5.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 11.5.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 11.5.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 11.5.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results, 11.5.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 11.5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Agar plates, culture for Strongyloides stercoralis, 11.5.4.111.5.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Agar proportion method, 9.8.19.8.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Agar screen test, 7.13.17.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aggregatibacter</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aggregatibacter actinomycetemcomitans, 3.19.6, 3.19.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aggregatibacter aphrophilus, 3.19.10, 3.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Agrobacterium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calcofluor white stain, 11.4.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Agrobacterium radiobacter, 3.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AIDS. See Human immunodeficiency virus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AimTab, 11.5.8.111.5.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Airborne microorganisms, 15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Air cultures, fungi, 15.4.3.115.4.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>air sampling device, 15.4.3.215.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 15.4.3.515.4.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 15.4.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonviable sampling, 15.4.3.715.4.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 15.4.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 15.4.3.415.4.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 15.4.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 15.4.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sample site selection, 15.4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sample volume, 15.4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 15.4.3.215.4.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surface sampling methods, 15.4.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Air sampling</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>environmental monitoring, 15.3.1.115.3.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>frequency and process, 15.3.1.215.3.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>A. israelii, MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Akhmeta virus, 18.8.1, 18.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ALA (aminolevulinic acid), 16.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-Alanyl-alanylaminopeptidase, 4.9.16.14.9.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>L-Alanyl-alanylaminopeptidase test, anaerobes, 4.9.16.14.9.16.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>ALA (-aminolevulinic acid) test, 3.17.3.13.17.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alcaligenes faecalis, 3.17.1.2, 3.17.11.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.9, 3.19.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Alcaligenes odorans, 3.17.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alcaligenes xylosoxidans, 3.17.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AlcorFix, 11.2.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alere Determine HIV-1/2 Ag/Ab Combo rapid test, 13.10.1.213.10.1.3, 13.10.1.4, 13.10.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alert request, 2.1.4, 2.1.40</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aleurioconidia, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alistipes, 4.9.7.1, 4.13.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile test, 4.13.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special-potency antimicrobial agent disks, 4.13.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Alistipes putredinis, 4.13.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alkaline peptone water (APW), 3.7.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alkaline phosphatase (ALP), 4.9.14.14.9.14.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alkhurma hemorrhagic fever virus (AHFV), 18.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alloiococcus otitidis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>otitis media, 3.10.5.13.10.5.2, 3.10.5.43.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Alloiococcus, 6.5% salt and temperature tolerance test, 3.17.42.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alloprevotella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 4.13.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescence, 4.13.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pigmentation, 4.13.10, 4.13.11, 4.13.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Alloprevotella rava, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alloprevotella tannerae, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alloscardovia omnicolens, 4.14.4, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ALP (alkaline phosphatase), 4.9.14.14.9.14.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>-glucosidase, 4.9.18.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Alpha-hemolysis, 3.3.2.2, 3.3.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alpha-hemolytic Streptococcus, 3.17.6.1, 15.4.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alphaviruses, 13.12.1, 13.12.2, 18.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Alternaria</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>by broth dilution, 10.12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.43</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Alternaria alternata</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.38</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Alternate arthroconidia, 10.10.4, 10.10.46</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Alternia, phenotypic identification, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ambulatory payment classifications (APC), 1.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amebae. See also specific organisms</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.1, 11.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.1111.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Amebiasis, 11.11.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amebic keratitis, 11.11.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amebic meningoencephalitis, 11.9.1.1, 11.9.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amedibacillus dolichus, 4.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amedibacterium, 4.14.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amedibacterium intestinale, 4.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>American Association of Tissue Banks, 15.7.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>American Medical Association (AMA) CPT system, 13.6.113.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>American trypanosomiasis, 11.11.2.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ameroconidia, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amies charcoal transport medium, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amies transport medium, ocular cultures, 3.9.2, 3.9.4, 3.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amikacin (Amikin), 9.9.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar proportion method, 9.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-level aminoglycoside resistance (HLAR) in Enterococcus, 7.12.17.12.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>high-level resistance in Enterococcus, 7.12.17.12.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria, 9.9.1.2, 9.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slowly growing nontuberculous mycobacteria, 9.9.2.1, 9.9.2.3, 9.9.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.2, 7.19.3, 7.19.5, 7.19.6, 7.19.7, 7.19.8, 7.19.10, 7.19.12, 7.19.15, 7.19.16, 7.19.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Amikacin (AMK) resistance, Cepheid Xpert MTB/XDR test, 9.6.3.59.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aminoglycodides resistance, high-level aminoglycoside resistance (HLAR) in Enterococcus, 7.12.17.12.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aminoglycoside(s)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, selection of agents for testing and reporting, 7.23.4, 7.23.9, 7.23.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.9, 7.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxacillin salt-agar test, 7.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.3, 7.20.12, 7.20.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>second-line injectable drugs (SLID) resistance, Cepheid Xpert MTB/XDR test, 9.6.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>time-kill assay, 7.17.2.1, 7.17.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aminoglycoside resistance, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>in Enterococcus spp., 7.12.17.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aminolevulinic acid (ALA), 16.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>-Aminolevulinic acid (ALA) test, 3.17.3.13.17.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aminopenicillin, 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aminopeptidase test, combination enzymatic tablets for nitrophenol, aminopeptidase, and glucosidases, 4.9.19.14.9.19.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>p-Aminosalicylic acid, 9.9.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>p-Aminosalicylic acid, agar proportion method, 9.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Amisakis, gross examination, 11.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ammonium chloride lysis method, 12.2.912.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ammonium oxalate solution, 3.2.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amniotic fluid infections, 2.1.12, 3.4.2, 3.8.1.5, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amoebae, 17.1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amoxicillin</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Amoxicillin-clavulanic acid (Augmentin), 18.15.7.1, 18.15.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.20.3, 7.20.9, 7.23.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.15.57.15.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.15.17.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.15.37.15.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 7.15.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Amphotericin B</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.8, 10.13.9, 10.13.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.2, 10.12.1.4, 10.12.1.7, 10.12.1.910.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.3, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Ampicillin</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antagonism, 7.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.6, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.4, 7.23.5, 7.23.6, 7.23.9, 7.23.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.16, 7.4.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Ampicillin-sulbactam (Unasyn)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.3, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Amplicon detection, 14.3.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amplification-based assays, 14.2.2.5, 14.2.5.3. See also Polymerase chain reaction (PCR)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amplivue HSV 1+2 assay, 14.3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Amycolata, 8.1.1, 8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Amycolatopsis, 8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AnaBAP (anaerobic blood agar plate), 4.7.1, 4.7.24.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anadulafungin, antifungal susceptibility testing, broth dilution, 10.12.1.2, 10.12.1.4, 10.12.1610.12.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerobe(s)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase testing, 7.4.2.7, 7.7.67.7.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biochemical tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alkaline phosphatase, 4.9.14.14.9.14.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>combination enzymatic tablets for nitrophenol, aminopeptidase, and glucosidases, 4.9.19.14.9.19.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>glutamic acid decarboxylase (GDC), 4.9.15.14.9.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-proline aminopeptidase, 4.9.17.14.9.17.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>4</title>
            <indexentry>
               <primaryie>4-methylumbelliferone derivative substrates, 4.9.18.14.9.18.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood cultures, 4.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body fluid cultures, 3.4.4, 4.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridium difficile, 4.16.14.16.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cocci, 4.15.14.15.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alkaline phosphatase test, 4.9.14.14.9.14.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.15.54.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>GPAC classification, 4.15.14.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 4.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 4.15.14.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 4.15.34.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid enzymatic biochemical identification, 4.15.124.15.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rapid nitrate and urease test, 4.15.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 4.15.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sodium polyanethol sulfonate disk, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special-potency antibiotic disks, 4.15.114.15.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen, 4.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole, 4.15.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SPS (sodium polyanethol sulfonate) disk for Gram-positive, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SPS disk testing, 4.15.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>commercial kit and rapid enzymatic systems for identification, 4.10.14.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CSF cultures, 3.5.1, 4.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.14.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enriched, nonselective, all-purpose agar media, 4.4.1.54.4.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formulas, 4.4.1.54.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital tract, 3.8.1.1, 3.8.1.3, 3.8.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations of procedure, 4.4.1.2, 4.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>liquid media, 4.4.1.5, 4.4.1.94.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 4.4.1.14.4.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonselective liquid broth media, 4.4.1.94.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>prereduced, anaerobically sterilized (PRAS) media, 4.4.1.14.4.1.2, 4.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>primary, 4.4.1.14.4.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 4.4.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 4.4.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>secondary, 4.4.2.14.4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>selective and/or differential agar media, 4.4.1.74.4.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>solid media, 4.4.1.34.4.1.4, 4.4.1.54.4.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen, 4.4.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>uses for primary media, 4.4.1.34.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, specimen processing for, 4.5.14.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dacryocystitis/dacryoadenitis canaliculitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk tests, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination of primary culture, 4.7.14.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescence, 4.9.8.14.9.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital tract, 3.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-negative bacilli (See Gram-negative bacilli, anaerobic)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-positive bacilli (See Gram-positive bacilli, anaerobic)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-positive cocci (See Gram-positive cocci, anaerobic)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification by using special-potency disks, 4.9.5.14.9.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation systems, 4.6.24.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic bag or pouch, 4.6.24.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic chamber/workstation, 4.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic jars, 4.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>J</title>
            <indexentry>
               <primaryie>jar gassing systems, 4.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation techniques, 4.6.14.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation systems, 4.6.24.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 4.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 4.6.34.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimens, 4.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 4.9.2.14.9.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-alanyl-alanylaminopeptidase test, 4.9.16.14.9.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lecithinase test, 4.9.10.14.9.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lipase test, 4.9.9.14.9.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>matrix-assisted laser desorption ionizationtime of flight mass spectrometry, 4.12.14.12.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical specimens, 4.12.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>database and differentiation, 4.12.24.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>failure factors, 4.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory culture, 4.12.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 4.12.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 4.12.14.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sequencing, 4.12.34.12.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, 4.12.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>typing and subtyping, 4.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MIC test</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution, 7.6.1.17.6.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution, 7.4.1.17.4.1.13, 7.4.2.17.4.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.1, 3.10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nitrate disk reduction test, 4.9.3.14.9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>orbital cellulitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>order of inoculation media, 2.1.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>overview, 4.1.14.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>performance standards for reagents, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pigment production, 4.9.11.14.9.11.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>practical guide to workup, 4.8.14.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid biochemical tests, L-Alanyl-alanylaminopeptidase, 4.9.16.14.9.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rapid disk, spot tests, and other rapid or primary methods for identification, 4.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile disk test/bile broth test/Bacteroides bile esculin agar for Gram-negative rods, 4.9.7.14.9.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 4.9.4.14.9.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gelatinase production, 4.9.13.14.9.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sodium polyanethol sulfonate (SPS) disk for Gram-positive anaerobic cocci, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 4.9.12.14.9.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection of specimens, 2.1.252.1.26</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.23.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sequencing-based identification, 14.5.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.2, 2.1.4, 2.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen selection, collection, and transport for, 4.3.14.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>abdomen, 4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>abscess, 4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bone and joint, 4.3.2, 4.3.34.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>central nervous system, 4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>collection methods, 4.3.34.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decubiti and other surface ulcers, 4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>female genital tract, 4.3.2, 4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>head and neck, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lung, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 4.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pulmonary specimens, 4.3.2, 4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sinus tracts and deep-wound drainages, 4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>soft tissue, 4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen selection, 4.3.14.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 4.3.44.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>swabs, 4.3.1, 4.3.2, 4.3.3, 4.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urinary tract, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen transport, 2.1.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>storage and stocking of, 4.11.14.11.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 4.11.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 4.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 4.11.14.11.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 4.11.24.11.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 4.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 4.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy updates for anaerobes, 4.2.14.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 4.9.12.14.9.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urine cultures, 3.11.1.3, 3.11.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.13.12.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Anaerobic agar with neomycin and 5% sheep blood (NEO), 4.4.1.2, 4.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerobic bacteria, 5.3.15.3.7, 5.7.15.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>automated blood culture systems, 5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BacT/ALE, 5.3.2, 5.3.4, 5.3.5, 5.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BACTEC, 5.3.4, 5.3.5, 5.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.3.65.3.7, 5.7.65.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 5.3.7, 5.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 5.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 5.3.3, 5.7.15.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.3.1, 5.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.3.45.3.6, 5.7.25.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 5.3.35.3.4, 5.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 5.3.7, 5.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 5.3.25.3.3, 5.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 5.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK bottles, 5.3.4, 5.3.6, 5.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Anaerobic bag or pouch, 4.6.24.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerobic blood agar plate (anaBAP), 4.7.1, 4.7.24.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerobic (unvented) bottle, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerobic chamber/workstation, 4.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerobic jars, 4.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerobic postanginal septicemia, 4.13.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerobiospirillum, 4.13.8, 4.13.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Anaerococcus, 4.15.2, 4.15.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid nitrate and urease tests, 4.15.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Anaerococcus hydrogenalis, 4.2.3, 4.15.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>alkaline phosphatase (ALP), 4.9.14.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>spot indole, 4.15.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Anaerococcus lactolyticus, 4.2.3, 4.15.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerococcus murdochii, 4.15.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerococcus octavius, 4.2.3, 4.15.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerococcus prevotii, 4.2.3, 4.15.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Anaerococcus tetradius, 4.2.3, 4.15.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerococcus vaginalis, 4.2.3, 4.15.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerocolumna jejuensis, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerocolumna xylanovorans, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerofustis, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerofustis stercorihominis, 4.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaeroglobus, 4.15.2, 4.15.3, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Anaerosphaera, 4.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerospirillum, 4.13.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerostipes, 4.14.5, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerotignum lactatifermentans, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerotignum propionicum, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaerotruncus colihominis, 4.14.5, 4.14.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Analyte-specific reagents (ASRs), 1.1.2, 1.2.4.13, 14.2.4.7, 14.3.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Analytical measurement range (AMR), 14.2.6.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Analytical sensitivity, molecular tests, 14.2.4.1, 14.2.4.3, 14.2.4.514.2.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anamorph, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature of, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Anamorph-teleomorph binomials, 10.9.1, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anaplasma</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious, 5.11.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 11.8.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Anaplasma phagocytophilum, blood films, 11.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ancyclostoma, body sites, 11.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ancyclostoma braziliensis, key characteristics, 11.11.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ancyclostoma duodenale, key characteristics, 11.11.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ancylostoma duodenale</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Andrades fermentation control, 16.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Andrades indicator, 3.17.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anginosus group streptococci, 3.18.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Angiomatosis, bacillary, 3.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Angiostrongylus cantonensis, body sites, 11.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anidulafungin, antifungal susceptibility testing, 10.13.2, 10.13.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Animal bites, 3.12.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Animal specimens, shipping, 17.6.4, 17.6.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anisakid nematodes, gross examination, 11.10.1, 11.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anisakis, 11.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anncalia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Annellide, 10.10.5, 10.10.47</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Annual notices of coding and billing practices, 1.2.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ansamycin, 7.23.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anspor (cephradine), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Antagonism</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>synergism testing, 7.19.12, 7.19.16, 7.19.17, 7.19.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>time-kill assay, 7.17.3.1, 7.17.3.2, 7.17.3.3, 7.17.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Anthrax, 18.3.118.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility, 18.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.1.2, 18.3.118.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biovar, case history, 18.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 18.3.7, 18.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CDC case definition, 18.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cerebrospinal fluid, 18.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical summary, 18.14.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture identification, 18.3.718.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cutaneous, 18.3.218.3.3, 18.3.6, 18.3.7, 18.14.1518.14.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>destruction, 18.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>diseases and clinical presentation, 18.3.218.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of cultures, 18.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastrointestinal, 18.3.3, 18.3.6, 18.14.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>geographic distribution, 18.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inhalational, 18.3.318.3.4, 18.3.6, 18.3.7, 18.14.16, 18.14.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.3.518.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>meningitis, 18.14.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 17.6.1, 17.6.4, 18.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>postmortem tissue, 18.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.3.118.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection of specimens, 18.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting, notification, and transfer, 18.3.818.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance, 18.3.1118.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sentinel Level Clinical Microbiology Laboratory Guidelines, 18.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.3.1018.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.3.518.3.6, 18.14.1518.14.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>syndromic surveillance, 15.5.4.615.5.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vaccine for laboratory personnel, 15.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Antibiogram, 7.20.97.20.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>constructing tables, 7.21.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>data verification, 7.21.47.21.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disseminating data, 7.21.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>generating reports, 7.21.37.21.4, 7.21.77.21.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>planning, 7.21.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 7.21.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.21.37.21.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recommendations, 7.21.17.21.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reports, information to include in, 7.21.17.21.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>statistical applications, 7.21.57.21.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>uses of, 7.21.67.21.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Antibiotic Resistance Laboratory Network (AR Lab Network), 15.7.1.115.7.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Antibiotic stewardship program (ASP), 7.1.2.57.1.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Antibody detection, Borrelia burgdorferi, 13.6.113.6.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anticoagulants, 11.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anti-DNase B (ADB) antibodies, 13.2.1.113.2.1.3, 13.2.2.113.2.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Antifungal susceptibility testing (AFST)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aerobic actinomycetes, 8.3.128.3.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.110.12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>filamentous fungi, 10.12.1.710.12.1.8, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation and endpoint reading, 10.12.1.910.12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation of macrodilution plates, 10.12.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation of microdilution plates, 10.12.1.810.12.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculum preparation, 10.12.1.610.12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 10.12.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>molds, 10.12.1.1, 10.12.1.5, 10.12.1.710.12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical considerations, 10.12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>preparation of stock solutions, 10.12.1.210.12.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 10.12.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.12.1.510.12.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimens, 10.12.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeasts, 10.12.1.1, 10.12.1.610.12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.110.12.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>epidemiologic cutoff values (ECV/ECOFF), 10.12.1.11, 10.13.110.13.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.110.12.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.12.2.210.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Antimicrobial agent carryover, 7.17.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Antimicrobial dilutions, preparation of, 7.6.1.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Antimicrobial disk tests, 3.17.4.13.17.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Antimicrobial powders, 7.24.2.1, 7.24.2.37.24.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Antimicrobial resistance (AMR), 7.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Antimicrobial resistance detection, 5.10.15.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 5.10.45.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 5.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 5.10.15.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.10.25.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 5.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 5.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, 5.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Antimicrobial resistance surveillance, public health reporting, 15.5.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Antimicrobial stewardship program (ASP), 15.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Antimicrobial stock solutions, 7.24.2.17.24.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formulas for preparation, 7.24.2.77.24.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.24.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.24.2.17.24.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation of dilutions from, 7.6.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 7.24.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedural notes, 7.24.2.37.24.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.24.2.27.24.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.24.2.2, 7.24.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>solvents and diluents, preparation of, 7.24.2.57.24.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Antimicrobial susceptibility testing (AST)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar dilution MIC test, anaerobic bacteria, 7.6.2.17.6.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.17.15.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antibiogram, 7.21.17.21.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bactericidal activity</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>minimum bactericidal concentration testing, 7.17.1.17.17.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>time-kill assay, 7.17.2.17.17.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>time-kill assay for synergy, 7.17.3.17.17.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase tests, 7.7.17.7.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>breakpoints</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>data considerations, 7.1.2.17.1.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>documentation, 7.1.2.57.1.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretive categories, 7.1.2.27.1.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>introduction, 7.1.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>organizations involved, 7.1.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>resources on, 7.1.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting and applying clinical, 7.1.2.17.1.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>steps for selecting, 7.1.2.67.1.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution test, aerobic bacteria, 7.4.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>C. diphtheriae cultures, 3.10.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 7.3.17.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.17.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterococcus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar screen test for vancomycin resistance, 7.13.17.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-level aminoglycoside resistance, 7.12.17.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.17.22.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>analysis of results, 7.22.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>breakpoint (qualitative) comparison, 7.22.5, 7.22.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>challenge strains, 7.22.4, 7.22.117.22.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>choice of system, 7.22.27.22.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>comparing test with reference result, 7.22.57.22.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>correlation of data, 7.22.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>determining precision (reproducibility), 7.22.67.22.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>essential vs. category agreement, 7.22.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation of correlations, 7.22.77.22.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.22.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.22.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MIC (quantitative) comparison, 7.22.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.22.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.22.27.22.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.22.97.22.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recording results, 7.22.6, 7.22.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>resolution of discrepancies, 7.22.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>strategy, 7.22.47.22.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>extended-spectrum beta-lactamase testing for Enterobacterales, 7.14.17.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>group B streptococci, 3.8.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inducible clindamycin resistance in Staphylococcus, Streptococcus pneumoniae, and Streptococcus beta-hemolytic group, 7.11.17.11.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>introduction to methods, 7.1.17.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Legionella, 3.10.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mc Farland standards, 7.24.1.17.24.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium tuberculosis complex, 9.9.3.19.9.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycoplasma and Ureaplasma, 3.14.2.13.14.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>N. gonorrhoeae, 3.8.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular cultures, 3.9.83.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pharmacodynamic (PD) and pharmacokinetic (PK) properties of the antimicrobial under investigation, 7.1.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypes, Candida auris, 15.7.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>preparation of routine media and reagents</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar and broth media, 7.24.3.17.24.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial stock solutions, 7.24.2.17.24.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mc Farland standards, 7.24.1.17.24.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality assurance, 7.20.17.20.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antibiograms, 7.20.107.20.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>competency assessment, 7.20.10, 7.20.157.20.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>confirmation of results, 7.20.97.20.10, 7.20.157.20.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>controlling and limitations of strains, 7.20.8, 7.20.147.20.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cumulative data reports, 16.1.116.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>individualized quality control plan, 16.5.116.5.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>maintenance of strains, 7.20.57.20.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials and resources, 16.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.20.1, 16.1.7, 16.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>requirements of accrediting agencies, 7.20.17.20.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>review, 16.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sources of strains, 7.20.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>strains with on-scale endpoints, 7.20.4, 7.20.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>suggested microorganisms, 7.20.37.20.5, 7.20.127.20.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance report, 16.1.4, 16.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.17.23.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>basic steps in development, 7.23.27.23.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>commonly used agents, 7.23.1, 7.23.57.23.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.23.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selective drug reporting (cascade) reporting option, 7.23.37.23.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serum inhibitory and bactericidal titers, 7.18.17.18.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>summary for testing and reporting considerations for major pathogen groups, 7.1.27.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution checkerboard and broth macrodilution methods, 7.19.17.19.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>time-kill assay, 7.17.3.17.17.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>types of tests, 7.1.1.17.1.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>ancillary, 7.1.1.1, 7.1.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>definitions, 7.1.1.17.1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 7.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>routine, 7.1.1.1, 7.1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>screening, 7.1.1.1, 7.1.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>supplemental, 7.1.1.1, 7.1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surrogate/equivalent agent tests for aerobes, 7.1.1.1, 7.1.1.37.1.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VRSA, VISA, and vancomycin-heteroresistant Staphylococcus aureus (hVISA), 7.9.17.9.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Antimycobacterial susceptibility testing</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar proportion method, 9.8.19.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT PZA kit, 9.7.2.19.7.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BACTEC MGIT SIRE kit, 9.7.1.19.7.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pyrosequencing prediction of drug resistance in Mycobacterium tuberculosis complex, 9.10.1.19.10.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sensititre SLOWMYCO2 broth microdilution plate, 9.9.2.19.9.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>slowly growing nontuberculous mycobacteria (NTM), 9.9.2.19.9.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>TREK sensitivity microdilution plates, rapidly growing nontuberculous mycobacteria, 9.9.1.19.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Antipseudomonal beta-lactam, 7.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Antiretroviral therapy (ART), HIV genotypic resistance testing, 14.3.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Antisera, 16.2.2, 16.2.2016.2.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Anti-streptolysin O (ASO) antibodies, 13.2.1.113.2.1.3, 13.2.2.113.2.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AO (acridine orange) stain, 3.2.2.13.2.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aphanoascus fulvescens, toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>APHL (Association of Public Health Laboratories), 10.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>API 20A system, 4.10.14.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics of, 4.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 4.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedure for, 4.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>API 20 C AUX, 10.9.210.9.3, 10.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Apicomplexa</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acid-fast modified trichrome stain, 11.4.5.111.4.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>API CORYNE, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>API 20E, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>API LISTERIA, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>API 20 NE, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>API NH, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>API RAPID 20E, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>API STAPH, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>API STREP, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Apophysis, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Apophysomyces</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification on primary media, 10.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold identification on primary culture, 10.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Apophysomyces elegans, phenotypic identification, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Appendicitis, 2.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Applied Bio Code, syndromic panels, 14.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Appropriate use criteria, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Apsergillus, antifungal susceptibility testing (AFST), 10.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aptima HIV-1 RNA Qualitative Assay, 14.3.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aptima HPV assay, 14.3.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>APW (alkaline peptone water), 3.7.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arabinose, 16.2.6, 16.2.10, 16.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arabitol, 16.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aracanobacterium haemolyticum, wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arachnia propionica, 4.2.3, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arboviruses</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Arbovirus infections, serologic diagnosis, 13.12.113.12.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnostic approaches, 13.12.113.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.12.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.12.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.12.213.12.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.12.513.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recommended, 13.12.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection considerations, 13.12.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>types of assays, 13.12.313.12.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Arcanobacterium, gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arcanobacterium haemolyticum, 3.18.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CAMP factor tests and reverse CAMP test, 3.17.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital culture, 3.8.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hippurate hydrolysis rapid test, 3.17.20.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.1, 3.17.26.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pharyngitis, 3.10.8.1, 3.10.8.43.10.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Architect Anti-HCV, 13.11.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Architect AUSAB Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Architect CORE Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Architect CORE-M Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Architect HAVAB-G test, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Architect HAVAB-M test, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Architect HBsAg Qualitative and Qualitative Conformatory Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Architect HIV Ag/Ab Combo Assay, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Architect Syphilis TP assay, 13.5.1.3, 13.5.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Archobacter cryaerophilus, indoxyl acetate disk test, 3.17.23.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Archobacter, indoxyl acetate disk test, 3.17.23.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arcobacter, 3.7.2.1, 3.7.2.6, 3.7.2.8, 3.7.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arcobacter butzleri, 3.7.2.2, 3.7.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arcobacter cryaerophilus, 3.7.2.2, 3.7.2.4, 3.7.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Area under the curve (AUC)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>example calculations for AUC, 7.9.87.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>population analysis profile area under the curve (PAP-AUC) ratio, 7.9.17.9.4, 7.9.6, 7.9.87.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Arenaviruses, 18.12.618.12.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.33</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Arginine, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Armored DNA (aDNA), 14.2.5.114.2.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Armored RNA (aRNA), 14.2.5.114.2.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ARS-CoV-2, 14.2.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arterial lines, 2.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arthritis, septic, 2.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arthroconidia, 10.10.4, 10.10.6, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>alternate, 10.10.4, 10.10.46</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>simple, 10.10.4, 10.10.46</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Arthroderma ciferrii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cornmeal glucose agar, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 10.10.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Arthroderma cuniculi</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potato flake agar, 10.10.49</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Arthroderma persicolor, phenotypic identification characteristics, 10.10.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arthroderma, phenotypic identification, 10.10.5, 10.10.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arthroderma terrestre</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cornmeal glucose agar, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.32, 10.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>potato flake agar, 10.10.49</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Arthroderma tuberculatum, phenotypic identification, 10.10.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arthroderma uncinatum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BCP milk glucose test, 10.10.29</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Arthroderma vanbreuseghemii, micromorphological characteristics, 10.10.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arthrographis, microscopic examination, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arthropod-borne infections, donor screening, 15.7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arthropods, 11.1.2111.1.26</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.111.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Artifacts, parasite, 11.11.1.111.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>in blood, 11.11.1.211.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>in body fluids, 11.11.1.211.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>corrective action, 11.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>in stool, 11.11.1.111.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Artus HSV-1/2 QS-RGQ MDx assay, 14.3.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arylsulfatase agar, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Arylsulfatase test</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aerobic actinomycetes, 8.3.28.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria, 9.5.1.19.5.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Asaccharospora irregularis, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ascaris</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zinc sulfate flotation, 11.3.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Ascaris lumbricoides, 11.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct smears, 11.3.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>eggs, 11.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>expectorated sputum, 11.7.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gross examination, 11.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>macroscopic examination, 11.3.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sputum expectorated, 11.7.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Ascaris suum, gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ascomata, 10.10.2, 10.10.5, 10.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ascomo, 10.10.47</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ascomycota, 10.10.110.10.2, 10.10.410.10.5, 10.10.8, 10.10.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, 10.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Ascospore agar, 10.9.3, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ascospore production test, 10.9.7, 10.9.8, 10.9.1110.9.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aseptate filaments, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aseptic technique, 15.3.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aseptic technique and related practices, of compounding personnel, 15.3.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aseptic work practice assessment and evaluation, 15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ASI Evolution, 13.5.4.113.5.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ASO (anti-streptolysin O) antibodies, 13.2.1.113.2.1.3, 13.2.2.113.2.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ASP (antimicrobial stewardship program), 15.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aspergillosis, 2.1.35, 15.5.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aspergillus, 10.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>amphotericin B susceptibility, 10.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.2.310.12.2.4, 10.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.710.12.1.8, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>asexual reproduction, 10.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cycloheximide susceptibility, 10.5.3, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>filamentous fungi, 6.5.3, 6.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 10.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation temperature, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory safety, 18.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.1110.4.1.13, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>orbital cellulitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>otitis externa, 3.10.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.910.5.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.13.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.1.2, 3.10.3.1, 3.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>structures, 10.10.47</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.210.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aspergillus brasiliensis, filamentous fungi, 6.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aspergillus candidus, toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aspergillus conicus, nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aspergillus flavus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>air cultures for fungi, 15.4.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ear canals, 10.10.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.38</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aspergillus fumigatus, 10.2.2, 10.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>air cultures for fungi, 15.4.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.13.1, 10.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ear canals, 10.10.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation temperature, 10.8.2, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.38</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.5, 10.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aspergillus fumigatus species complex, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aspergillus glaucus, nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aspergillus lentulus, taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aspergillus nidulans, 10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ear canals, 10.10.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.38, 10.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aspergillus niger</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BHI medium, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Czapek-Dox agar, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dermatophyte test, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ear canals, 10.10.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungus selection agar, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inhibitory mold agar, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sabouraud medium, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aspergillus penicillioides, nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aspergillus restrictus, nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aspergillus section Nidulantes, phenotypic identification, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aspergillus sydowii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aspergillus terreus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>air cultures for fungi, 15.4.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>amphotericin B susceptibility, 10.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ear canals, 10.10.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 10.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.38</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aspergillus ustus, filamentous fungi, 6.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aspergillus versicolor</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>filamentous fungi, 6.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aspirates</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inoculation, 3.12.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.7.2.111.7.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitology, 11.7.2.111.7.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Aspiration pneumonia, 2.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.72.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>ASRs (analyte-specific reagents), 1.2.4.13, 14.2.4.7, 14.3.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Assay calibrators, 14.2.5.114.2.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Assay controls, 14.2.5.114.2.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Assay harmonization, 14.2.5.414.2.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Association of Public Health Laboratories (APHL), 10.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida auris, 15.7.1.315.7.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AST. See Antimicrobial susceptibility testing</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Astroviruses</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5, 14.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Atopobium, 4.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy update, 4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Atopobium parvulum, 4.15.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Atopobium vaginae, 3.8.1.3, 4.14.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Auditing compliance, 1.2.4.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Audits, 1.2.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Auger suction specimens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.10.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing and culture examination, 3.10.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Augmentin. See Amoxicillin-clavulanic acid</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aureobasidium, 10.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aureobasidium pullulans, examination and evaluation of primary cultures, 10.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Autoclave, 17.4.2.117.4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Autofluorescence, for Cyclospora, Cystoisospora, and Sarcocystis, 11.4.7.111.4.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Automated inoculation methods, 3.11.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Automated nontreponemal rapid plasma reagin (RPR) tests, 13.5.4.113.5.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Automation considerations, 14.2.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Autopsy blood cultures, 5.11.2.15.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Autopsy material, 2.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Avelox (moxifloxacin), 7.23.11, 9.9.1.2, 9.9.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Avian influenza, clinical manifestations, 12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Avian influenza virus, 18.9.1, 18.9.2, 18.9.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Avibacterium gallinarum, 3.19.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Avioq HIV-1 Microelisa system, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Avycaz (ceftazidime-avibactam), 7.23.3, 7.23.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Azactam. See Aztreonam</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Azithromycin (Zithromax), 7.23.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Azole-resistant Aspergillus fumigatus, 15.7.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Azoles, antifungal susceptibility testing, 10.12.1.110.12.1.4, 10.12.1.610.12.1.7, 10.12.1.910.12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Aztreonam (Azactam)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, selecting agents for testing and reporting, 7.23.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.1, 7.14.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>B</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BA (bacillary angiomatosis), 3.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Babesia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood films, 11.8.1.1, 11.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitemia, 11.8.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitemia, determination of, 11.8.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>ring forms, 11.11.3.1511.11.3.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>STAT testing, 11.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.311.8.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Babesia microti, donor screening, 15.7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Babesiosis, donor screening, 15.7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Baby botulism immune globulin (BabyBIG), 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacillary angiomatosis (BA), 3.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacillary peliosis (BP), 3.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacillus, 4.14.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>beta-lactamase test, 18.15.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, laboratory process, 5.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vs. B. pseudomallei and B. mallei, 18.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 3.17.10.2, 18.15.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. diphtheriae cultures, 3.10.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.7, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hematopoietic stem cell products, 15.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.10, 3.19.3, 4.14.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>keratitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.1, 3.17.26.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>motility tests, 3.17.30.13.17.30.4, 18.15.5.1, 18.15.5.2, 18.15.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular cultures, 3.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>spore stain, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surface testing, 15.4.4.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacillus anthracis, 3.3.2.9, 18.3.118.3.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility, 18.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.1.2, 18.3.118.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biovar, case history, 18.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 18.3.7, 18.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body fluids, 3.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CDC case definition, 18.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cerebrospinal fluid, 18.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>characteristics, 18.14.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture identification, 18.3.718.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cutaneous, 18.3.218.3.3, 18.3.6, 18.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>destruction, 18.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>diseases and clinical presentation, 18.3.218.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.217.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination of cultures, 18.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.13, 3.7.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastrointestinal, 18.3.3, 18.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>geographic distribution, 18.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>highly pathogenic bacteria, 6.3.5, 6.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>immunization of laboratory personnel, 15.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation period, 18.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inhalational, 17.1.1.1, 18.3.318.3.4, 18.3.6, 18.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.1, 15.8.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory safety, 18.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.13.17.26.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.3.518.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 17.6.10, 17.6.35, 18.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>postmortem tissue, 18.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.3.118.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>readiness checklist, 18.14.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>recommended BSL, 18.14.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rejection of specimens, 18.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting, notification, and transfer, 18.3.818.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.6, 3.10.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent, 17.5.3.1, 17.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting and compliance, 18.3.1118.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special considerations, 18.3.1018.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.3.518.3.6, 18.14.1518.14.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacillus cereus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood products, 15.4.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.217.5.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.3, 3.7.1.13, 3.7.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hematopoietic stem cell products, 15.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.5, 3.18.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.13.17.26.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacillus cereus biovar anthracis (Bcbva), 18.3.118.3.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility, 18.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.3.118.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biovar, case history, 18.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 18.3.7, 18.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CDC case definition, 18.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cerebrospinal fluid, 18.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture identification, 18.3.718.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cutaneous, 18.3.218.3.3, 18.3.6, 18.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>destruction, 18.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>diseases and clinical presentation, 18.3.218.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of cultures, 18.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastrointestinal, 18.3.3, 18.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>geographic distribution, 18.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation period, 18.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inhalational, 18.3.318.3.4, 18.3.6, 18.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.3.518.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 18.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>postmortem tissue, 18.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.3.118.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection of specimens, 18.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting, notification, and transfer, 18.3.818.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent, reporting and compliance, 18.3.1118.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.3.1018.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.3.518.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacillus cereus biovar anthracis (anthrax), laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacillus fragilis, 7.20.13, 7.23.7, 7.23.9, 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacillus megaterium, 3.18.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacillus mycoides, 3.18.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacillus stearothermophilus, 17.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacillus subtilis, 7.18.12, 17.3.2.1, 18.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacillus thuringiensis, 3.18.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacillus weihenstephanensis, 3.18.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacitracin, 3.17.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacitracin disk, 3.17.4.1, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BacT/Alert system, 15.4.5.2, 15.4.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BacT/ALE system, continuous-monitoring blood culture systems, 5.3.2, 5.3.4, 5.3.5, 5.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BACTEC, continuous-monitoring blood culture systems, 5.3.4, 5.3.5, 5.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BACTEC MGIT automated mycobacterial culture system, 9.4.1.19.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BACTEC MGIT automated system, 9.4.1.19.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BACTEC MGIT PZA kit, 9.7.2.19.7.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BACTEC MGIT SIRE kit, 9.7.1.19.7.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BACTEC Myco, 5.5.15.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bactec Myco/F Lytic, acid-fast bacilli, 5.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteremia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacterial amplification, deep amplicon sequencing, 14.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacterial contamination, viral monolayer cell cultures, 12.7.6, 12.7.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacterial endophthalmitis, 3.9.2, 3.9.4, 3.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacterial endotoxin (pyrogen) testing, 15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacterial infections</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor-derived, 15.7.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor screening, 15.7.7.615.7.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.1415.7.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacterial keratitis, 3.9.2, 3.9.4, 3.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacterial meningitis, cerebrospinal fluid (CSF) cultures, 3.5.13.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacterial pharyngitis, respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacterial vaginosis (BV), 3.8.1.13.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteria, MALDI-TOF MS, 6.6.16.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calibration, 6.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 6.6.66.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI Biotyper CA system, 6.6.26.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic correlation, 6.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 6.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 6.6.46.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 6.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents and equipment, 6.6.16.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 6.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sensitivity, 6.6.66.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specificity, 6.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 6.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VITEK MS, 6.6.26.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bactericidal activity. See Minimum&amp; bactericidal concentration (MBC) testing; Time-kill assay</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bactericidal titers, 7.18.17.18.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteriological media, quality control, 16.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteriology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cultures, maintenance of stock, 16.2.2416.2.25</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reflex and composite testing scenarios, 1.2.4.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.3, 2.1.182.1.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tests, 16.1.1116.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacteriostatic vs. bactericidal agents, photographic reading guide for, 7.5.117.5.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteriuria, 3.11.1.1, 3.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteroides, 4.13.9, 4.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-Alanyl-alanylaminopeptidase test, 4.9.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile test, 4.13.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution (MIC) test, 7.4.2.1, 7.4.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 4.9.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical considerations, 4.13.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology, 4.13.84.13.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain morphology, 4.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-alanyl-alanylaminopeptidase test, 4.9.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.1, 4.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>4</title>
            <indexentry>
               <primaryie>4-methylumbelliferone derivative substrates test, 4.9.18.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>QC strains for API 20A system, 4.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.5, 7.23.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special-potency antimicrobial agent disks, 4.13.144.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole, 4.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole test, 4.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, 4.13.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>taxonomy update, 4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacteroides bile esculin agar (BBE), 4.4.1.1, 4.4.1.3, 4.4.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for differentiation of anaerobic Gram-negative rods, 4.9.7.14.9.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gram-negative rods, 4.13.84.13.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>performance standards, 16.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacteroides caccae, 4.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteroides dorei, 4.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteroides eggerthii, 4.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteroides faecis, MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteroides finegoldii, 4.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteroides fragilis, 4.13.9, 4.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.2.2, 7.6.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-Alanyl-alanylaminopeptidase test, 4.9.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.11.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic bacteria, 5.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile disk test/bile broth test/Bacteroides bile esculin agar, 4.9.7.14.9.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bile test/Bacteroides bill esculin agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 5.6.7, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution (MIC) test, 7.4.2.17.4.2.2, 7.4.2.57.4.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella agar, 16.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 4.9.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridium difficile agar, 16.2.7, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology, 4.13.8, 4.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cooked meat medium, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.34.4.1.5, 4.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescence, 4.9.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>glutamic acid decarboxylase (GDC), 4.9.15.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 3.17.22.2, 4.9.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laked blood agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>L-alanyl-alanylaminopeptidase test, 4.9.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lecithinase test, 4.9.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lipase test, 4.9.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenylethyl alcohol medium, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pigment production, 4.9.11.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.2216.2.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.7, 7.23.9, 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special-potency disks, 4.9.5.14.9.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, 4.13.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>tryptic soy blood agar, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 4.9.12.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wilkins-Chalgren anaerobic agar and broth, 16.2.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacteroides fragilis group</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.2.1, 7.6.2.67.6.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase producers, 7.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture media, 4.4.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacteroides gracilis, 3.7.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteroides koreensis, MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteroides kribbi, MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteroides massiliensis, 4.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteroides ovatus, 4.13.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture media, 4.4.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacteroides stercoris, 4.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteroides thetaiotaomicron, 4.13.9, 7.20.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution (MIC) test, 7.4.2.2, 7.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 4.9.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacteroides uniformis, 4.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bacteroides ureolyticus, 4.13.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate/nitrite reduction test, 3.17.34.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, known sources, and disease associations, 3.7.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacteroides vulgatus, 4.13.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.13.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>glutamic acid decarboxylase (GDC), 4.9.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>thioglycolate broth, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacteroides xylanisolvens, MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bactrim. See Trimethoprim-sulfamethoxazole</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BacTx system, 15.4.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BAL (bronchoalveolar lavage), 3.2.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Balamuthia, 11.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 11.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>STAT testing, 11.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Balamuthia mandrillaris, 11.9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calcofluor white for detection of cysts, 11.4.8.111.4.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture, 11.9.1.1, 11.9.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.711.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Balanoposthitis, 3.8.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Balantidium coli, sputum expectorated, 11.7.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Balantiodes (formerly Balantidium) coli, artifacts mimicking, 11.11.1.2, 11.11.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Balantiodes coli, gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Balantioides coli</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.2, 11.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Balloon forms, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Balneatrix alpica, identification, 3.19.11, 3.19.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bangs disease, 18.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>B. anthracis, anaerobic bacteria, 5.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BAP. See Blood agar plate</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bartholin cyst, 3.8.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bartholin glands, 2.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bartholinitis, 3.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bartonella</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 3.15.13.15.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broad-range PCR, 5.14.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious, 5.11.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lysis centrifugation, 5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bartonella alsatica, 3.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bartonella bacilliformis, 3.15.1, 3.15.2, 3.15.3, 3.15.4, 3.15.5, 3.15.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bartonella henselae, 3.15.1, 3.15.2, 3.15.3, 3.15.4, 3.15.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bartonella quintana, 3.15.1, 3.15.2, 3.15.4, 3.15.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bartonella schoenbuchensis, 3.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bartonellosis, 3.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Based upon related sequence types (BURST), 15.6.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Basic fuchsin, 3.2.1.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Basic Local Alignment Search Tool (BLAST) algorithm, 14.5.1.414.5.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Basidiobolomyceta, 10.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Basidiobolomycota, 10.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Basidiobolus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Basidiome, 10.10.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Basidiomycota, 10.10.1, 10.10.510.10.6, 10.10.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Basidiospores, 10.10.48</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Basidium, 10.10.48</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Basisiomycete yeasts, presumptive identification, 10.7.2, 10.7.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BAT-AB (botulinum antitoxin AB), 18.11.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BAT-E (botulinum antitoxin E), 18.11.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Baylisascaris procyonis, body sites, 11.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bB, 2.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BBE. See Bacteroides bile esculin agar</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BBL Crystal E/NF, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BBL Crystal GP, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BBL Crystal N/H, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BBL Crystal Rapid GP, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BBL Enterotube II, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>B-cell lymphoma, diffuse large, 14.3.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>B. cepacia, respiratory tract cultures, cystic fibrosis, 3.10.3.1, 3.10.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BCP milk glucose test, 10.10.11, 10.10.2210.10.29, 10.10.3210.10.34, 10.10.53</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BD BACTEC Myco/F lytic, 10.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>B. dolosa, respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BD Phoenix yeast ID panel, 10.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BD ProbeTec HSV Q X Amplified DNA Assays, 14.3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BD Viper (LT vs XTR), 14.3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Beauveria bassiana</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.38</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bedaquiline, agar proportion method, 9.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bed bugs, gross examination, 11.10.1, 11.10.4, 11.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Beef tapeworm, 11.11.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bejel, 3.2.5.1, 3.2.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bench level recognition, 17.5.2.117.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Benchmarking, 16.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Benedicts copper sulfate reduction reaction, 11.5.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Benomyl, 10.10.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bent glass rod hockey sticks, 7.17.1.147.17.1.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bergeyella zoohelcum, 3.19.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>-fucosidase, 4.9.18.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>-galactosidase, 3.17.36.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>-glucosidase, 4.9.18.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>-lactamases</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>classification, 7.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>metallo--lactamases (MBLs), 7.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic carbapenemase detection methods, 7.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>-Lactam combination agents, 7.23.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>-xylosidase, 4.9.18.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Beta-hemolysis, 3.3.2.2, 3.3.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Beta-hemolytic streptococci</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.167.4.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.8, 7.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of antimicrobial susceptibility test systems, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inducible clindamycin resistance, 7.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>latex agglutination method, 3.10.8.93.10.8.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular cultures, 3.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>penicillin-nonsusceptible, 7.20.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>throat culture and nonculture tests for pharyngitis, 3.10.8.13.10.8.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess and soft tissue cultures, 3.12.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Beta-lactam(s)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antagonism, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Beta-lactamase disks, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Beta-lactamase tests, 7.7.17.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acidimetric method, 7.7.37.7.5, 7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic bacteria, 7.4.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.15.4.118.15.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>chromogenic cephalosporin (nitrocefin) method, 7.7.2, 7.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>extended-spectrum beta-lactamase testing for Enterobacterales, 7.14.17.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>iodometric method, 7.7.5, 7.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>penicillin disk diffusion zone edge method for S. aureus method, 7.7.27.7.3, 7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 7.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.7.67.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.7.17.7.2, 7.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>results, 7.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>summary, 7.7.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Beta-lactam combination agents, 7.20.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BFPs (biologic false-positives), nontreponemal tests, 13.5.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>B. fragilis, MALDI-TOF MS, 4.12.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BHI blood agar, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BHI broth, 4.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biaxin. See Clarithromycin</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bifidobacterium, 4.14.4, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biochemical/rapid enzymatic systems, 4.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture media, 4.4.2.14.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.10, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bifidobacterium longum, culture media, 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bifidobacterium selective agar (BIFIDO), 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bile broth test, for differentiation of anaerobic Gram-negative rods, 4.9.7.14.9.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bile disk test, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for differentiation of anaerobic Gram-negative rods, 4.9.7.14.9.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bile disk test/bile broth test/Bacteroides bile esculin agar for anaerobic Gram-negative rods, 4.9.7.14.9.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bile duct infection, 2.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bile esculin agar, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bile esculin azide agar, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bile esculin test, 3.17.5.13.17.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bile solubility test, 3.17.6.13.17.6.3, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bile, specimen collection, 2.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bile test, anaerobic gram-negative rods, 4.13.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biliary tube, 3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Billing</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for calculations, 1.2.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>compliance programs, 1.2.4.91.2.4.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>coverage of laboratory services, 1.2.3.71.2.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>issues, 1.2.4.51.2.4.6, 1.2.4.131.2.4.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>practices, annual notices of, 1.2.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure billing, 1.2.2.51.2.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bilophila, 4.13.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special-potency antimicrobial agent disks, 4.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bilophila wadsworthia, 4.13.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bile disk test/bile broth test/Bacteroides bile esculin agar, 4.9.7.14.9.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth culture, 4.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 4.9.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, 4.13.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bioaerosol sampling cassettes, 15.4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biochemical tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 3.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acetamide utilization, 3.17.1.13.17.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acetate utilization, 3.17.2.13.17.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ALA (-aminolevulinic acid) test, 3.17.3.13.17.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial disk (esp. staphylococci), 3.17.4.13.17.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile-esculin and esculin, 3.17.5.13.17.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bile solubility, 3.17.6.13.17.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>butyrate esterase test, 3.17.7.13.17.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CAMP factor (standard and rapid) and reverse CAMP, 3.17.8.13.17.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>carbohydrate utilization, 3.17.9.13.17.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catalase, 3.17.10.13.17.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cetrimide, 3.17.11.13.17.11.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>citrate utilization (Simmons), 3.17.12.13.17.12.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>coagulase (protein A/clumping factor agglutination method), 3.17.13.13.17.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>coagulase (rabbit plasma method), 3.17.14.13.17.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.13.17.15.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.13.17.16.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescent-pigment agars (Pseudomonas), 3.17.17.13.17.17.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gelatin liquefaction, 3.17.18.13.17.18.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.13.17.19.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>guidelines for biochemical identification, 3.16.13.16.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hippurate hydrolysis rapid test, 3.17.20.13.17.20.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hydrogen sulfide production, 3.17.21.13.17.21.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 3.17.22.13.17.22.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>indoxyl acetate disk test, 3.17.23.13.17.23.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.13.17.24.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>LAP (leucine aminopeptidase), 3.17.25.13.17.25.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.13.17.26.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lipophilism (Corynebacterium), 3.17.27.13.17.27.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>malonate, 3.17.28.13.17.28.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.13.17.32.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MGP (methyl glucopyranoside), 3.17.29.13.17.29.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.13.17.30.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MRS broth, 3.17.31.13.17.31.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MUG (4-methylumbelliferyl--D-glucuronide) test, 3.17.33.13.17.33.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate/nitrite reduction test, 3.17.34.13.17.34.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>O/129 disk susceptibility (Vibrio and Aeromonas), 3.17.35.13.17.35.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ONPG (o-nitrophenyl--D-galactopyranoside) test, 3.17.36.13.17.36.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>optochin susceptibility, 3.17.37.13.17.37.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oxidase, 3.17.38.13.17.38.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oxidase test, 3.17.38.13.17.38.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenylalanine deaminase (PDA) test, 3.17.39.13.17.39.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.13.17.40.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>Quellung reaction (pneumococci), 3.17.41.13.17.41.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.13.17.42.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>satellite, 3.17.43.13.17.43.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SPS (sodium polyethanol sulfonate) disk, 3.17.44.13.17.44.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>starch hydrolysis, 3.17.45.13.17.45.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.13.17.24.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.13.17.46.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-alanyl-alanylaminopeptidase, 4.9.16.14.9.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>L-alanyl-alanylaminopeptidase test, 4.9.16.14.9.16.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 4.9.2.14.9.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lipase test, 4.9.9.14.9.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate disk reduction test, 4.9.3.14.9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>beta-lactamase tests, 18.15.4.118.15.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 18.15.2.118.15.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>motility tests, 18.15.5.118.15.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxidase test, 18.15.1.118.15.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic tests, 18.15.7.118.15.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>satellite test, 18.15.8.118.15.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole test, 18.15.3.118.15.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 18.15.6.118.15.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lecithinase test, 4.9.10.14.9.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria, 9.5.1.19.5.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing considerations for biochemical identification, 3.16.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bio Code Diagnostics, syndromic panels, 14.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biocrime, 18.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bio Fire Diagnostics, syndromic panels, 14.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biohazard(s)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>containment, 17.3.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biological safety cabinet, 17.3.3.117.3.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biosafety levels, 17.3.2.117.3.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PPE and engineering controls, 17.3.4.117.3.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory instrumentation and equipment, 17.4.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autoclave, 17.4.2.117.4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>centrifuge, 17.4.3.117.4.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>compressed gas cylinders, 17.4.4.117.4.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>other equipment and devices, 17.4.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pneumatic tube system, 17.4.5.117.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen/microorganism storage and retention, 17.4.6.117.4.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>management, infectious waste, 17.8.117.8.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>management, laboratory accidents, 17.7.117.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 17.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 17.6.117.6.36</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>prevention</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decontamination, 17.1.3.117.1.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>routes of infection and laboratory activities, 17.1.1.117.1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safe work practices, 17.1.2.117.1.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spills, 17.1.4.117.1.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>risk assessment, 17.9.117.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special pathogens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.117.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>environmental, nonanimal, and suspicious specimens and substances, 17.5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>prions, 17.5.5.117.5.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>resources for information, 17.5.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>select agents, 17.5.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Biohazard pail, decontamination, 17.1.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bioinformatics</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida auris, 15.7.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>platforms, 15.6.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Biological agents</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>response to potential exposures, 15.8.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>shipping, 17.6.1, 17.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Biological hazards, 17.7.317.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biological safety cabinet (BSC), 17.3.3.117.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitology, 11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Biological safety cabinets (BSCs), 15.3.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biological safety levels (BSLs), 18.2.118.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biologic false-positives (BFPs), nontreponemal tests, 13.5.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bio Numerics, 15.6.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bioplex 2200 HIV Ag-Ab assay, 13.10.1.2, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bio Plex 2200 Syphilis Total &amp; RPR, 13.5.4.113.5.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biopsy, skin, 2.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biopsy specimens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.83.2.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.7.3.111.7.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitology, 11.7.3.111.7.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bio-Rad Bioplex 2200 HIV Ag-Ab assay, 13.10.1.2, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bio-Rad Geenius assay, 13.10.1.3, 13.10.3.113.10.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BioRad Geenius supplemental assay, 13.10.3.113.10.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biosafety</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biohazard signs and warning labels, 12.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>chemical safety, 12.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>in clinical microbiology laboratory, 17.5.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>electrical safety, 12.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>environmental safety, 12.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fire safety, 12.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory-acquired infections, 18.2.118.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory equipment, 12.4.412.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular virology work areas, 12.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>personal protective equipment, 12.4.312.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pest management, 12.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rules, 12.4.112.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen transportation, receipt, and storage, 12.4.212.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>virus antigen detection assay, 12.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>virus cell cultures, 12.4.612.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>work area safety, 12.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Biosafety cabinet (BSC), 14.2.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biosafety level 3 (BSL3) agents, laboratory isolation codes and notification fan-out for suspected, 15.8.4.115.8.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biosafety level 4 (BSL4) agents, laboratory isolation codes and notification fan-out for suspected, 15.8.4.115.8.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biosafety levels (BSLs), 17.3.2.117.3.2.2, 18.14.1318.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biosafety, molecular microbiology laboratory</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>employee health and/or emergency medical services, 14.2.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>extraction protocols, 14.2.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>handling of specimens following biohazardous agent identification, 14.2.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>high-risk organisms within the laboratory, 14.2.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 14.2.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>molecular methods, 14.2.3.614.2.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid sequencing, 14.2.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nucleic acid target amplification, 14.2.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pathogen heat inactivation, 14.2.3.514.2.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 14.2.3.114.2.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.2.3.214.2.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bioterrorism (BT)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anthrax, 18.3.118.3.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 18.15.4.118.15.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biochemical procedures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 18.15.2.118.15.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>motility tests, 18.15.5.118.15.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxidase test, 18.15.1.118.15.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic tests, 18.15.7.118.15.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>satellite test, 18.15.8.118.15.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 18.15.6.118.15.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>botulinum toxin, 18.11.118.11.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>brucellosis, 18.4.118.4.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical laboratory readiness plan, 18.14.118.14.33</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agent characteristics, 18.14.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agent clinical summary, 18.14.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>alternative names for agents, 18.14.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BSL designations, 18.14.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>contact information, 18.14.118.14.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fever watch and postexposure measures, 18.14.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>information checklist, 18.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Laboratory Response Network, 18.14.218.14.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory training documentation, 18.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>policy review documentation, 18.14.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>purpose, 18.14.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>readiness checklist, 18.14.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>recommended BSLs, 18.14.1318.14.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sentinel clinical laboratory, 18.14.418.14.5, 18.14.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>shipping and handling, 18.14.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection and handling, 18.14.8, 18.14.1518.14.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>treatment or prophylaxis, 18.14.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>when to implement, 18.14.118.14.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>defined, 18.14.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.117.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>eastern equine encephalitis virus, 18.13.118.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>epidemiological clues, 18.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>federal level laboratories, 18.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-consequence viral pathogens, 18.12.118.12.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Laboratory Response Network (LRN), 18.1.1, 18.1.318.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>levels of laboratory biosafety, 18.2.118.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>melioidosis and glanders, 18.7.118.7.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overt vs. covert event, 18.1.2, 18.14.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>overview, 18.1.118.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>plague, 18.5.118.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.1.118.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>Q fever, 18.10.118.10.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reference level laboratories, 18.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sentinel level clinical laboratory</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>defined, 18.1.4, 18.14.318.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>guidelines, 18.14.518.14.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recommendations, 18.1.618.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>responsibilities, 18.1.6, 18.14.418.14.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>spot indole test, 18.15.3.118.15.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Tier I agents, 18.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>treatment or prophylaxis, 18.14.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>tularemia, 18.6.118.6.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>websites, 18.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bioterrorism agents, 18.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Biothreat, 18.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biothreat agents, 18.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.117.5.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Biotyper 2.0 Microflex LT spectrometer, 10.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biphasic bottle, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bipolaris, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing by broth dilution, 10.12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bipolaris australiensis, taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bipolaris/Curvularia, antifungal susceptibility testing (AFST), 10.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bipolaris hawaiiensis, taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bipolaris spicifera, taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Birdseed agar, 10.7.210.7.3, 10.7.810.7.10, 10.7.13, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Biseriate, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bismuth sulfite, 3.7.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bite infections, potential etiological agents, 2.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bites, 3.12.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BKV. see BK virus (BKV)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BK virus (BKV), 12.9.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>epidemiology, 14.3.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular diagnostics, 14.3.8.114.3.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quantification of, 14.2.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Black piedra, 2.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blastic, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BLAST (Basic Local Alignment Search Tool), identification of molds and yeasts, 10.11.1010.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blastoconidia, 10.10.4, 10.10.46</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blastocystis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.111.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays, 11.11.2.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.414.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>iron hematoxylin stain (modified Spencer-Monroe method), 11.3.6.311.3.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained smear (trichrome), 11.3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stool artifacts, 11.11.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Blastocystis hominis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zinc sulfate flotation, 11.3.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Blasto D medium, 10.10.5010.10.51</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blastomyces, 10.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>exoantigen testing, 10.10.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>filamentous fungi, 6.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inhalation, 17.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.13, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.9, 10.5.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slide cultures, 10.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Blastomyces dermatitidis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial resistance, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conversion, 10.10.10, 10.10.12, 10.10.1410.10.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory safety, 18.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media, 10.10.51</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mold phase characteristics, 10.10.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.6, 10.10.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Blastomyces dermatitidis (blastomycosis), laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blastomyces gilchristii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conversion, 10.10.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold phase characteristics, 10.10.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Blastomycetes, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blastomycosis, specimen collection and culture medium, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blastoschizomyces, 10.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blastoschizomyces capitatus, 10.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate fermentation test, 10.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Blautia, 4.15.2, 4.15.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Blautia coccoides, 4.15.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blautia producta, 4.2.3, 4.15.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blautia productus, Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blautia wexlerae, 4.15.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid nitrate and urease tests, 4.15.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Blepharitis, 3.9.23.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blepharoconjunctivitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blood</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts, parasite, 11.11.1.211.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics of parasites found in, 11.11.2.1911.11.2.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal specimens, 10.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.1911.11.2.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>helminths, 11.11.2.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts, 11.11.1.2, 11.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>buffy coat concentration, 11.8.9.111.8.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>capillary blood tube centrifugation for parasite detection, 11.8.9.311.8.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>combination thick and thin films, 11.8.4.111.8.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Delafields hematoxylin stain, 11.8.8.111.8.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>determination of parasitemia, 11.8.7.111.8.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Knott concentration, 11.8.11.111.8.11.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>membrane filtration concentration, 11.8.10.111.8.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>shipment of smears, 11.2.3.111.2.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.111.8.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 10.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, parasites, 11.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Blood agar base, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blood agar plate (BAP), 3.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic culture, 3.3.1.2, 3.3.1.63.3.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aerobic pathogens of gastroenteritis, 3.7.1.6, 3.7.1.8, 3.7.1.123.7.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic, 4.7.1, 4.7.24.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brucella, 18.4.6, 18.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tryptic soy sheep, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Blood banking, culture of blood and cellular therapy products, blood products, 15.4.5.115.4.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blood-borne exposures, 17.7.4, 17.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>investigation, 15.8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory support, 15.8.2.415.8.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Blood culture broth, 6.6.16.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calibration, 6.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 6.6.66.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI Biotyper CA system, 6.6.26.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic correlation, 6.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 6.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 6.6.46.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 6.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents and equipment, 6.6.16.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 6.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sensitivity, 6.6.66.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specificity, 6.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 6.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VITEK MS, 6.6.26.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Blood cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.15.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aerobes, Bartonella, 3.15.13.15.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aerobic and anaerobic bacteria, 5.7.15.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic bacteria, 4.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>automated blood culture systems, 5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood banking, 15.4.5.115.4.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bottle manual mark line, 5.6.2, 5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Broad-range PCR, 5.14.15.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catheter-related bloodstream infection, 5.12.15.12.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>chromogenic media, 5.10.15.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>continuous monitoring, 5.5.15.5.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>continuous-monitoring blood culture systems, 5.3.15.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>defined, 5.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lysis centrifugation, 5.4.15.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>multiplex molecular panels, 5.13.15.13.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>performance standards, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>positive blood culture broth, 5.13.35.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>postanalytical considerations, 5.9.15.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>preanalysis, laboratory processing, 5.2.15.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 5.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 5.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>negative bottles, 5.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>positive bottles, 5.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 5.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.2.75.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 5.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 5.2.95.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 5.2.25.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport and handling, 5.2.65.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control and quality assurance, 5.6.15.5.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quality indicators, 16.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specialized process</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autopsy blood cultures, 5.11.2.15.11.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious and infrequently encountered organisms, 5.11.3.15.11.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>transfusion reactions, 5.11.1.15.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection and transport, 2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>staining, culture, identification methods, 5.7.15.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>viral, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>worksheet, 16.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Blood films, parasites, 11.8.1.111.8.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blood flukes, 11.11.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blood-glucose cysteine agar, 10.10.51</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Blood parasites</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood films, 11.8.1.111.8.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 11.8.5.111.8.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitemia, 11.8.7.111.8.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Blood specimens, 5.14.15.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autopsy material, 2.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cell-free metagenomic sequencing, 5.14.15.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal, 10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 5.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>magnetic resonance, 5.14.15.14.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 5.14.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.14.15.14.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.14.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control and quality assurance, 5.14.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 5.14.35.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for bacteriological analysis, 2.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>fungal, 10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 2.1.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection of samples, 2.1.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>transport, 5.14.25.14.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>test report comments, parasites, 11.11.7.411.11.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bloodstream infections</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catheter-related (See Catheter-related bloodstream infection)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>central lineassociated, 15.5.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BMAT (Brucella microagglutination test), 18.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BMD. See Broth microdilution</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BMT (bone marrow transplant) patients, BK virus, 14.3.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bocavirus, clinical manifestations, 12.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Body fluid(s)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts in, 11.11.1.211.11.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>artifacts resembling parasites, 11.11.1.2, 11.11.1.311.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>exposure, 15.8.3.315.8.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.18, 2.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Body fluid cultures, 3.4.13.4.9, 4.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic, 3.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>drainage tubes, 3.4.23.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.4.83.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.4.13.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.4.63.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.4.43.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.4.23.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>types, 3.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Boils, 3.12.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bone, fungal specimens, 10.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bone infections</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic specimen selection, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bone marrow</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal specimens, 10.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 10.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for bacteriological analysis, 2.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>fungal, 10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 2.1.36, 11.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bone marrow aspirates</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.7.2.111.7.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for parasites, 11.7.2.1, 11.7.2.311.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bone marrow culture, viral, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bone marrow transplant (BMT) patients, BK virus, 14.3.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bordetella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.6.13.10.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.10.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.10.6.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lower, 3.10.2.6, 3.10.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.10.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.10.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.10.6.63.10.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.10.6.53.10.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.10.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.10.6.83.10.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.10.6.23.10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bordetella avium, 3.10.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bordetella avium/hinzii, 3.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bordetella bronchiseptica</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bordet-Gengou agar, 16.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vs. Brucella, 18.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.9, 3.19.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxidase test, 3.17.38.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.6.1, 3.10.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.6, 3.10.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bordetella hinzii, 3.10.6.1, 3.10.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bordetella holmesii, 3.10.6.1, 3.10.6.6, 3.10.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bordetella parapertussis, 3.10.6.1, 3.10.6.53.10.6.6, 3.10.6.8, 3.19.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.6, 3.19.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bordetella pertussis, 3.14.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bordet-Gengou agar, 16.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media for, 3.3.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxidase test, 3.17.38.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Regan-Lowe pertussis agar, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.13.10.1.2, 3.10.6.13.10.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.10.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.10.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.10.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.10.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.10.6.63.10.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.10.6.53.10.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.10.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.10.6.83.10.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.10.6.23.10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bordetella trematum, 3.10.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.8, 3.19.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bordet-Gengou agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Borrelia</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood films, 11.8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious, 5.11.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 11.8.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Borrelia afzelli, 13.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Borrelia burgdorferi</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antibody detection, 13.6.113.6.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>algorithms used for serology, 13.6.513.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>commercially available assays, 13.6.213.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>first-tier tests, 13.6.5, 13.6.7, 13.6.913.6.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunoblot, 13.6.2, 13.6.413.6.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>indications for antibody testing, 13.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 13.6.913.6.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified two-tiered testing (MTTT), 13.6.613.6.7, 13.6.1013.6.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.6.113.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical recommendations, 13.6.1013.6.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 13.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.6.813.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sample collection, 13.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>standard two-tiered testing (STTT), 13.6.513.6.7, 13.6.1013.6.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Babesia infection and, 11.11.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious, 5.11.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Borrelia garinii, 13.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Borrelia lusitaniae, 13.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Borrelia mayonii, 13.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Borrelia spielmanii, 13.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Borrelia valaisiana, 13.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Borrelia vincentii, respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Borreliosis, Lyme. See Lyme disease</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Both media preparation, for antimicrobial susceptibility testing (AST), materials, 7.24.3.17.24.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Botryomycosis, 8.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Botulinum antitoxin AB (BAT-AB), 18.11.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Botulinum antitoxin E (BAT-E), 18.11.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Botulinum toxin, 18.11.118.11.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>case definition, 18.11.418.11.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clusters, 18.11.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>destruction, 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.11.318.11.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>geographic distribution, 18.11.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.11.918.11.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation and examination of cultures, 18.11.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.11.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packaging and shipping, 17.6.7, 18.11.6, 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive diagnosis, 18.11.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 18.11.618.11.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting and notification, 18.11.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.11.518.11.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance, 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sentinel Level Clinical Microbiology Laboratory Guidelines, 18.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.11.1018.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.11.618.11.8, 18.14.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.11.818.11.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>therapeutic, 18.11.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>treatment, 18.11.4, 18.11.1018.11.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Botulism</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>adult intestinal toxemia, 18.11.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>case definition, 18.11.418.11.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical summary, 18.14.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.11.318.11.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>etiology, 18.11.118.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>foodborne, 18.11.318.11.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>iatrogenic, 18.11.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>infant, 18.11.3, 18.11.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inhalational, 18.11.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection/handling, 18.11.618.11.8, 18.14.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>treatment, 18.11.4, 18.11.1018.11.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, 18.11.3, 18.11.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Botulism selective agar (BSM), 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bovine papular stomatitis virus (BPSV), 18.8.1, 18.8.4, 18.8.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bowdeniella, 4.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bowdeniella nasicola, 4.2.2, 4.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BP (bacillary peliosis), 3.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brachiola</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brachyspira pilosicoli, 4.13.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brain abscess, 2.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brain biopsy</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brain, fungal specimens, 10.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brain heart infusion (BHI)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic culture, 3.3.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood agar, 4.4.1.1, 4.4.1.3, 4.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brain heart infusion broth (BHIB), 15.3.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Breakpoint comparison, 7.22.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Breakpoint MIC panels, 7.4.1.197.4.1.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Breast milk, specimen collection, 2.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brevibacterium, 3.18.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brevundimonas diminuta, 3.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brevundimonas vesicularis, 3.19.8, 3.19.12, 3.19.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brilliant green agar, 3.7.1.6, 3.7.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Broad fish tapeworm, 11.11.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Broad-range PCR, 5.14.15.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cell-free metagenomic sequencing, 5.14.15.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 5.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>magnetic resonance, 5.14.15.14.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 5.14.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.14.15.14.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.14.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control and quality assurance, 5.14.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 5.14.35.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, 5.14.25.14.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bromcresol green agar, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bromocresol purple, 3.17.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bronchial brush specimens, 3.10.2.23.10.2.5, 3.10.2.83.10.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bronchial washings (BWs)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal specimens, 10.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.7.2.111.7.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitology, 11.7.2.1, 11.7.2.311.7.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing and culture examination, 3.10.2.83.10.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.10.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.10.2.33.10.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 3.10.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bronchiolitis, respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bronchitis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bronchoalveolar lavage/bronchial wash culture, viral, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bronchoalveolar lavage (BAL) fluid, parasites, 11.7.2.111.7.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bronchoalveolar lavage (BAL), parasitology, 11.7.2.1, 11.7.2.311.7.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bronchoalveolar lavage (BAL) specimens, 3.10.2.23.10.2.5, 3.10.2.83.10.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing and culture examination, 3.10.2.83.10.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quantitative culture, 3.10.2.133.10.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.10.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.10.2.33.10.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 3.10.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bronchoscopy, specimen collection, 2.1.23, 3.10.2.33.10.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bronchoscopy specimens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.7.2.111.7.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitology, 11.7.2.111.7.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Broth(s), anaerobes, 4.7.44.7.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Broth cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>handling for aerobic bacteriology, 3.3.2.103.3.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Broth dilution antifungal susceptibility testing (AFST), 10.12.1.110.12.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Broth enrichment methods, C. difficile, 4.16.74.16.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Broth macrodilution method, 7.19.17.19.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inoculation and incubation, 7.19.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.19.107.19.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.19.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparing broth macrodilution limited checkerboard, 7.19.67.19.7, 7.19.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>preparing inoculum, 7.19.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 7.19.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.19.67.19.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.19.97.19.10, 7.19.207.19.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.19.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reading MICs, 7.19.8, 7.19.18, 7.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 7.19.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.19.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Broth media preparation, for antimicrobial susceptibility testing (AST), 7.24.3.17.24.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>additives and supplements, 7.24.3.97.24.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.24.3.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.24.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.24.3.47.24.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.24.3.27.24.3.3, 7.24.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Broth microdilution (BMD) checkerboard method, 7.19.17.19.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calculations, 7.19.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examples of reported combination interactions, 7.19.1, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inoculation and incubation, 7.19.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.19.107.19.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.19.17.19.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparing checkerboard microdilution panels, 7.19.27.19.3, 7.19.13, 7.19.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>preparing inoculum, 7.19.37.19.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 7.19.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.19.27.19.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.19.97.19.10, 7.19.20, 7.19.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.19.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reading MICs, 7.19.4, 7.19.8, 7.19.15, 7.19.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 7.19.57.19.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.19.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Broth microdilution (BMD) MIC test, 7.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic bacteria, 7.4.1.17.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>breakpoint MIC panels, 7.4.1.197.4.1.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>H. influenzae and H. parainfluenzae, 7.4.1.157.4.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.4.1.127.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.4.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>N. meningitidis, 7.4.1.187.4.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.4.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.4.1.47.4.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.4.1.97.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.4.1.27.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 7.4.1.87.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.4.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>S. pneumoniae and Streptococcus sp. (beta-hemolytic and viridans group), 7.4.1.167.4.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic bacteria, 7.4.2.17.4.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.4.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.4.2.17.4.2.2, 7.4.2.87.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.4.2.47.4.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.4.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.4.2.27.4.2.4, 7.4.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 7.4.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.4.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.67.14.7, 7.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-level mupirocin resistance in S. aureus, 7.10.17.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vancomycin resistance in Staphylococcus aureus, 7.9.17.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bruce, David, 18.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella, 18.4.118.4.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.11.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antibody detection, 13.3.113.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnostic assays, 13.3.113.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enzyme-linked immunosorbent assay (ELISA), 13.3.213.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microagglutination test (MAT), 13.3.413.3.7, 13.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serologic test interpretation considerations, 13.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serum agglutination test (SAT), 13.3.213.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>slide agglutination test (Rose Bengal test), 13.3.213.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tube agglutination test (TAT), 13.3.813.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility, 18.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.1.2, 18.4.118.4.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 18.4.518.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, laboratory process, 5.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body fluids, 3.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bordetella cultures, 3.10.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CDC case definition, 18.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>characteristics, 18.14.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture identification, 18.4.618.4.9, 18.4.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>destruction, 18.4.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.4.218.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.217.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination of cultures, 18.4.518.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious, 5.11.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>geographic distribution, 18.4.118.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.1, 18.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>highly pathogenic bacteria, 6.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.3, 3.19.6, 3.19.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation period, 18.4.3, 18.4.518.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inhalation, 17.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory-acquired, 18.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory safety, 17.3.2.1, 18.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 18.4.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.4.318.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microagglutination test (MAT), 13.3.413.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpreting results, 13.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.3.413.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.3.513.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 13.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>multiplex molecular panels, 5.13.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification test (NAAT), 13.3.1, 13.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overlap select agent, 18.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oxidase test, 18.15.1.1, 18.15.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 18.4.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenylalanine deaminase (PDA) test, 3.17.39.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive diagnosis, 18.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.4.118.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>readiness checklist, 18.14.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>recommended BSL, 18.14.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rejection of specimens, 18.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting, notification, and transfer, 18.4.918.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Legionella, 3.10.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>satellite test, 3.17.43.3, 18.15.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance, 18.4.1118.4.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sentinel level clinical laboratory, 18.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sentinel Level Clinical Microbiology Laboratory Guidelines, 18.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serology, 13.3.113.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.4.1118.4.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.4.418.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tube agglutination test (TAT), 13.3.813.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpreting results, 13.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.3.913.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 13.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1, 3.17.46.33.17.46.4, 18.15.6.118.15.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.15, 3.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brucella abortus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antibody detection, 13.3.213.3.4, 13.3.713.3.8, 13.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>brucellosis, 13.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.4.218.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.115.8.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 18.4.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>patient population, 18.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>select agent, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>shipping, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.14.25</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brucella agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella anthropi, 3.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella blood agar, 4.4.1.1, 4.4.1.3, 4.4.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplemented, 7.6.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brucella broth preparation, 7.4.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella canis, 13.3.1, 13.3.3, 13.3.10, 18.4.2, 18.4.12, 18.14.25, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucellacapt, 13.3.213.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella ceti, 18.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella inopinata, 18.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella (brucellosis), laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella laked blood agar with kanamycin and vancomycin (KVLB or LKV), 4.4.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella melitensis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antibody detection, 13.3.2, 13.3.4, 13.3.7, 13.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>brucellosis, 13.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.4.218.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 18.4.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>patient population, 18.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>select agent, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>shipping, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.14.25</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brucella microagglutination test (BMAT), 18.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella pinnipedialis, 18.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella suis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antibody detection, 13.3.4, 13.3.7, 13.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>brucellosis, 13.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.4.218.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 18.4.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>patient population, 18.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>select agent, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>shipping, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.14.25</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brucellosis, 18.4.118.4.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antibody response in untreated, 13.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility, 18.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.1.2, 18.4.118.4.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bone marrow, 2.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella antibody detection, 13.3.113.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CDC case definition, 18.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical summary, 18.14.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture identification, 18.4.618.4.9, 18.4.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>destruction, 18.4.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.4.218.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>etiology and pathogenesis, 13.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination of cultures, 18.4.518.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>geographic distribution, 18.4.118.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation period, 18.4.3, 18.4.518.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory-acquired, 18.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 18.4.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.4.318.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 18.4.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive diagnosis, 18.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.4.118.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection of specimens, 18.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting, notification, and transfer, 18.4.918.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance, 18.4.1118.4.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.4.1118.4.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.4.418.4.5, 18.14.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tests for laboratory diagnosis, 13.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brugia malayi, 11.6.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine concentration: membrane filter (Nuclepore), 11.6.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bruker Biotyper, highly pathogenic bacteria, 6.3.36.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BSC. See Biological safety cabinet</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BSLs (Biological safety levels), 17.3.2.1, 18.2.118.2.8, 18.14.1318.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>B19, specimen collection, 2.1.34</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BT. See Bioterrorism</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BT readiness plan, Sentinel Level Clinical Microbiology Laboratory Guidelines, 18.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bubonic plague, 18.5.1, 18.14.1818.14.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Buccal swab culture, viral, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Buchananella hordeovulneris, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bulleidia extructa, 4.14.5, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bundling, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bunyavirus, 13.12.1, 13.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Burkholderia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic tests, 18.15.7.118.15.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.6, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sentinel level clinical laboratory, 18.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sentinel Level Clinical Microbiology Laboratory Guidelines, 18.14.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Burkholderia cenocepacia, 3.10.3.1, 3.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, cystic fibrosis, 3.10.3.1, 3.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Burkholderia cepacia, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vs. B. pseudomallei and B. mallei, 18.7.9, 18.7.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.6, 7.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.23.17.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.15, 3.19.18, 3.19.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF, 6.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxidative-fermentative medium, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic tests, 18.15.7.118.15.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, cystic fibrosis, 3.10.1.2, 3.10.3.13.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.2, 7.23.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Burkholderia cepacia agar, 16.2.13, 18.7.5, 18.7.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Burkholderia cepacia complex</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AST, testing and reporting considerations, 7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.7, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, cystic fibrosis, 3.10.3.13.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Burkholderia dolosa, respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Burkholderia gladioli</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.15, 3.19.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Burkholderia gladioli/Pandoraea, 3.19.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Burkholderia mallei, 18.7.118.7.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility, 18.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical tests, 18.7.718.7.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bioterrorism, 18.1.2, 18.7.118.7.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 18.14.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony and Gram stain morphology, 18.7.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture identification, 18.7.618.7.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>destruction, 18.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.7.218.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.217.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination of cultures, 18.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>geographic distribution, 18.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.6, 3.19.8, 3.19.9, 3.19.13, 3.19.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation period, 18.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 18.7.1618.7.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxidase test, 18.15.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 17.6.10, 17.6.35, 18.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypic tests, 18.15.7.1, 18.15.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>readiness checklist, 18.14.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>recommended BSL, 18.14.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>referral to LRN reference laboratory, 18.7.1518.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting, notification, and transfer, 18.7.1318.7.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.7.318.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance, 18.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.7.1518.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.7.5, 18.14.2318.14.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.7.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 18.7.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole test, 18.15.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>therapy, 18.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Burkholderia mallei (glanders), laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Burkholderia multivorans</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Burkholderia multivorans, respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Burkholderia oklahomensis, 18.7.3, 18.7.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Burkholderia pseudomallei, 16.2.12, 16.2.13, 18.7.118.7.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility, 18.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical tests, 18.7.718.7.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bioterrorism, 18.1.2, 18.7.118.7.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 18.14.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony and Gram stain morphology, 18.7.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture identification, 18.7.618.7.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>destruction, 18.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.7.218.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.7, 7.2.9, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.217.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination of cultures, 18.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>geographic distribution, 18.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.9, 3.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation period, 18.7.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inhalation, 17.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 18.7.1618.7.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxidase test, 18.15.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 17.6.10, 18.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypic tests, 18.15.7.118.15.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>readiness checklist, 18.14.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>recommended BSL, 18.14.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>referral to LRN reference laboratory, 18.7.1518.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting, notification, and transfer, 18.7.1318.7.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.7.318.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance, 18.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.7.1518.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.7.5, 18.14.2318.14.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.7.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 18.7.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole test, 18.15.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>therapy, 18.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Burkholderia stabilis, identification, 3.19.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Burkholderia thailandensis, 18.7.218.7.3, 18.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Burkholderia vietnamiensis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Burkitts lymphoma, 13.8.1.2, 13.8.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Burn infections, potential etiological agents, 2.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Burns, specimen collection, 2.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Burn wounds, 3.12.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BURST (Based Upon Related Sequence Types), 15.6.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Butyrate esterase test, 3.17.7.13.17.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Butyricimonas, special-potency antimicrobial agent disks, 4.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Butyricimonas virosa, 4.13.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BV. See Bacterial vaginosis</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BV (B virus), 18.12.518.12.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>B. vietnamiensis, respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>B virus (BV), 18.12.518.12.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>B19 virus, clinical manifestations, 12.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>B. wadsworthia</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bile test, 4.13.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate and urease tests, 4.13.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BWs. See Bronchial washings</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>C</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. acnes</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical correlations, 4.14.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cadaveric tissue culture, 15.4.6.115.4.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture of human cadaveric tissues for transplantation, 15.4.6.115.4.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Caffeic acid disk for C. neoformans screen, 10.7.110.7.3, 10.7.810.7.11, 10.7.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. albicans enzyme screen, 10.7.210.7.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Calcofluor White for Detection of Microsporidial Spores, Acanthamoeba, and Balamuthia, mandrillaris Cysts, 11.4.8.111.4.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Calcofluor white (CFW) stain, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Calculations, billing for, 1.2.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Calibrated loop method, 3.11.1.83.11.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Calibration curves, 14.2.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Calibrators, 14.2.5.114.2.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Caliciviruses, clinical manifestations, 12.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Camelpox virus (CMLV), 18.8.1, 18.8.318.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CAMHB (cation-adjusted Mueller-Hinton broth), 7.24.3.47.24.3.5, 7.24.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CAMP factor tests, 3.17.8.13.17.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter, 4.13.3, 4.13.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>collection and storage of outbreak isolates, 15.5.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology, 4.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture, 14.4.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disease associations, 3.7.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.2.13.7.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 3.7.2.53.7.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct antigen detection, 3.7.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.7.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.7.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.7.2.33.7.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microscopic and gross observations, 3.7.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microscopic observations, 3.7.2.43.7.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.7.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.7.2.43.7.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 3.7.1.15, 3.7.2.93.7.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.7.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5, 14.4.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain morphology, 4.13.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hydrogen sulfide production, 3.17.21.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indoxyl acetate disk test, 3.17.23.13.17.23.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>known sources, 3.7.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF, 6.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.1, 3.17.30.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate/nitrite reduction test, 3.17.34.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxidase test, 3.17.38.3, 3.17.38.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.7.2.13.7.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special-potency antimicrobial agent disks, 4.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.7.2.23.7.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance, 15.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.13.17.24.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wet mount, 3.2.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter agars, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter butzleri, 3.7.2.1, 3.7.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter cinaedi, 3.7.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter coli</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.7, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.2.3, 3.7.2.5, 3.7.2.6, 3.7.2.7, 3.7.2.93.7.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.314.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indoxyl acetate disk test, 3.17.23.13.17.23.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, known sources, and disease associations, 3.7.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter concisus, 3.7.2.2, 3.7.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter cryaerophilus, 3.7.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter curvus, 3.7.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter fennelliae, 3.7.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter fetus, 3.7.2.2, 3.7.2.4, 3.7.2.8, 3.7.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indoxyl acetate disk test, 3.17.23.13.17.23.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter gracilis, 3.7.2.2, 4.13.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology, 4.13.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.13.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate and urease tests, 4.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter hyointestinalis, 3.7.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indoxyl acetate disk test, 3.17.23.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.23.17.24.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.23.17.24.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter jejuni</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter agars, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.4, 7.2.7, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical tests, 3.7.2.8, 3.7.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk susceptibility tests, 3.7.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.7.2.63.7.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification methods, 3.7.2.63.7.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation, 3.7.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 3.7.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.7.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.7.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.7.2.5, 3.7.2.6, 3.7.2.7, 3.7.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.7.1.9, 3.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid assays, 3.7.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.7.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wet mount examination, 3.7.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.314.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hippurate hydrolysis rapid test, 3.17.20.1, 3.17.20.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, rapid, 3.3.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>indoxyl acetate disk test, 3.17.23.13.17.23.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ingestion, 17.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen transport, 3.7.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, known sources, and disease associations, 3.7.2.1, 3.7.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>transport media, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter lari, 3.7.2.2, 3.7.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indoxyl acetate disk test, 3.17.23.13.17.23.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter mucosalis, 3.7.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter pylori, 3.7.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter rectus, 3.7.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter sputorum, 3.7.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter upsaliensis,, 3.7.2.3, 3.17.23.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.2.2, 3.7.2.3, 3.7.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>other tests, 3.7.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, rapid, 3.3.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>indoxyl acetate disk test, 3.17.23.13.17.23.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, known sources, and disease associations, 3.7.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter ureolyticus, 3.7.2.2, 4.2.3, 4.13.1, 4.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology, 4.13.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gelatin hydrolysis test, 4.9.13.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain morphology, 4.13.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification by special-potency antimicrobial agent disks, 4.9.5.14.9.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 4.9.12.14.9.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campy-Pak envelope, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Canaliculitis, 3.9.23.9.3, 3.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida, 7.21.3, 10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic bacteria, 5.7.1, 5.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.13.1, 10.13.2, 10.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.1, 10.12.1.6, 10.12.1.910.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.210.12.2.3, 10.12.2.510.12.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood cultures, laboratory process, 5.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body fluids, 3.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broad-range PCR, 5.14.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catheter-related bloodstream infection, 5.12.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>chromogenic media, 5.10.1, 5.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>continuous-monitoring blood culture systems, 5.3.1, 5.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cycloheximide susceptibility, 10.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dacryocystitis/dacryoadenitis canaliculitis, 3.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital infections, 3.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunocompromised hosts, 15.7.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF, 10.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.12, 10.4.1.13, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>N. gonorrhoeae cultures, 3.8.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular cultures, 3.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identification, 10.7.110.7.4, 10.7.6, 10.7.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.410.5.5, 10.5.7, 10.5.9, 10.5.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.2.6, 3.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, 10.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.110.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>transfusion reactions, 5.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wet mount, 3.2.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeast-inhibiting blood agar, 10.10.55</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida acnes, catheter-related bloodstream infection, 5.12.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida albicans</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>ascospore agar, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BHI medium, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 5.6.7, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broad-range PCR, 5.14.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bromcresol green agar, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calcofluor white stain, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter agars, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>carbohydrate fermentation test, 10.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CHOC medium, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cornmeal agar, 10.9.6, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture examination, 3.8.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dermatophyte test, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.2, 10.6.3, 10.6.4, 10.6.5, 10.6.6, 10.6.7, 10.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungus selection agar, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>germ tube test, 10.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hematopoietic stem cell products, 15.4.5.3, 15.4.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunocompromised hosts, 15.7.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inhibitory mold agar, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular methods for identification, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>New York City agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nickerson-bismuth sulfite-glucose-glycineyeast agar, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nitrate assimilation test, 10.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>otitis externa, 3.10.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>peritoneal fluid, 3.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>potato dextrose agar, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive identification, 10.7.110.7.7, 10.7.910.7.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rice extract agar, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sabouraud medium, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vaginitis, 3.8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeast carbohydrate assimilation, 16.2.1816.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>yeast carbohydrate fermentation broth, 16.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>yeast-inhibiting blood agar, 10.10.55</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida albicans enzyme screen, 10.7.210.7.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida albidus, presumptive identfication, 10.7.210.7.3, 10.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida auris</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.7, 10.7.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.410.5.5, 10.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>skin colonization, 15.7.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance cultures, 15.7.5.115.7.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>transmission-based precautions, 15.7.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida bracarensis, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida catenulata, culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida ciferrii, anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida dubliniensis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.7, 10.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>germ tube, 10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular methods for identification, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identification, 10.7.110.7.2, 10.7.410.7.6, 10.7.9, 10.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida famata</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida glabrata, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 5.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broad-range PCR, 5.14.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate fermentation test, 10.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>commercial yeast identification systems, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.3, 10.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital culture, 3.8.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunocompromised hosts, 15.7.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.210.7.4, 10.7.710.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida glabrata species complex, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida guilliermondii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>commercial yeast identification systems, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida haemulonii, presumptive identfication, 10.7.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida inconspicua, culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida kefyr</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate fermentation test, 10.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>commercial yeast identification systems, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cornmeal agar, 10.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeast carbohydrate fermentation broth, 16.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida krusei, 10.10.55</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.2, 10.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broad-range PCR, 5.14.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bromcresol green agar, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cornmeal agar, 10.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.2, 10.6.3, 10.6.5, 10.6.6, 10.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunocompromised hosts, 15.7.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nickerson-bismuth sulfite-glucose-glycineyeast agar, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.210.7.4, 10.7.7, 10.7.910.7.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rice extract agar, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeast carbohydrate assimilation, 16.2.1816.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>yeast carbohydrate fermentation broth, 16.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida lambica</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida laurentii, 16.2.17, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida lipolytica</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida lusitaniae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate fermentation test, 10.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeast carbohydrate fermentation broth, 16.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida macdoniensis, anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida metapsilosis, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.1, 10.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida neoformans</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.7, 10.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida nivariensis, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida norvegensis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ascospore production, 10.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida orthopsilosis, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.1, 10.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida parapsilosis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.1, 10.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.1, 10.12.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broad-range PCR, 5.14.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunocompromised hosts, 15.7.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.210.7.3, 10.7.7, 10.7.1010.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.110.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida parapsilosis species complex, 10.2.110.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.110.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida pelliculosa, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida pintolopesii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida pseudotropicalis, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida pulcherrima, anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida rugosa</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida sojae, presumptive identfication, 10.7.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida stellatoidea, molecular methods for identification, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida tropicalis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broad-range PCR, 5.14.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.3, 10.6.4, 10.6.5, 10.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunocompromised hosts, 15.7.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.210.7.4, 10.7.610.7.7, 10.7.910.7.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pseudohyphae, 10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeast carbohydrate fermentation broth, 16.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candidatus, 3.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida utilis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida viswanathii, culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candida zeylanoides, culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Candidiasis, 2.1.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>surveillance, 15.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Canine hepatitis virus, 18.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CAP/CTM CMV Test. See COBAS Ampli Prep/COBAS TaqMan CMV Test</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Capillaria hepatica</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Capillary blood tube centrifugation for parasite detection, 11.8.9.311.8.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Capillary gel electrophoresis, 15.6.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Capitated, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Capnocytophaga, 4.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology, 4.13.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital infections, 3.8.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain morphology, 4.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>H. ducreyi culture, 3.8.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sodium polyethanol sulfonate (SPS) disk test, 3.17.44.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole, 4.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole test, 4.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Capnocytophaga canimorsus/cynodegmi, identification, 3.19.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Capnocytophaga ochracea, identification, 3.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Capreomycin, agar proportion method, 9.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Capreomycin (CAP) resistance, Cepheid Xpert MTB/XDR test, 9.6.3.59.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CAP (College of American Pathologists) requirements for quality control of antimicrobial susceptibility tests, 7.20.17.20.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Capsularis zoogleoformans, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carbamate kinase, 15.6.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carbapenem(s), antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.3, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Carbapenem-resistant Acinetobacter baumannii (CRAB), 15.7.1.6, 15.7.4.115.7.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carbapenem-resistant Enterobacteriaceae (CRE), 15.5.2.1, 15.5.4.5, 15.7.4.1, 15.7.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>chromogenic media, 5.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carbapenems, broth microdilution MIC test, 7.4.1.9, 7.4.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carbenicillin, 7.20.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carbohydrate basal medium, 8.3.38.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carbohydrate fermentation test for yeast identification, 10.9.6, 10.9.710.9.8, 10.9.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carbohydrate utilization tests, 3.17.9.13.17.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carbol fuchsin. See specific stains</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carbon adsorption, laboratory water, 16.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carbon assimilation test for yeast identification, 10.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carboxypenicillin, 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carbuncles, 2.1.12, 3.12.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cardiac device infections, 3.6.13.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cardiobacterium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cardiobacterium hominis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.11, 3.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>indole test, 3.17.22.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>spot indole test, 18.15.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cardiobacterium valvarum, identification, 3.19.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cardiovascular infections, potential etiological agents, 2.1.82.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cardiovascular tissues, culture of human cadaveric tissues for transplantation, 15.4.6.515.4.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cargo only shipping, 17.6.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carriers, 1.1.2, 1.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>shipping, 17.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Carrions disease, 3.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carryover studies, 14.2.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Carve-out, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cary-Blair transport medium, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cascade reporting, 7.23.37.23.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Case definition, 15.5.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Casein agar, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Caspofungin</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.2, 10.13.3, 10.13.8, 10.13.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.2, 10.12.1.4, 10.12.1.6, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.2, 10.12.2.3, 10.12.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cassette filter samplers, 15.4.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Catalase test(s)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 3.17.10.13.17.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobes, 4.9.4.14.9.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.15.2.118.15.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>B. pseudomallei and B. mallei, 18.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria, 9.5.1.1, 9.5.1.2, 9.5.1.4, 9.5.1.69.5.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>performance standards, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Category agreement, evaluation and verification of antimicrobial susceptibility test systems, 7.22.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Category A substance, 17.6.4, 17.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Category B substance, 17.6.10, 17.6.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Catenibacterium mitsuokai, 4.14.5, 4.14.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Catheter-associated urinary tract infections (CAUTIs), 15.5.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Catheter exit site, 10.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Catheter-related bloodstream infection, 5.12.15.12.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catheter tip cultures, 5.12.35.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>differential-time-to-positivity cultures, 5.12.15.12.3, 5.12.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 5.12.65.12.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 5.12.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.12.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.12.45.12.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 5.12.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 5.12.55.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, 5.12.15.12.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vascular and hemodialysis access catheters, 5.12.1, 5.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Catheter-related bloodstream infection (CRBSI), postanalytical blood cultures, 5.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Catheter tip cultures, 2.1.192.1.20, 5.12.35.12.6, 10.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Catheter urine collection, 3.11.1.2, 3.11.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cation-adjusted Mueller-Hinton broth (CAMHB), 7.4.1.1, 7.11.4, 7.24.3.47.24.3.5, 7.24.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cat scratch fever, 2.1.28</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cause-and-effect diagrams, 16.1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CAUTIs (catheter-associated urinary tract infections), 15.5.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. baratii, 4.14.9, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. botulinum, 4.14.9, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CBPs (Clinical breakpoints), 10.13.110.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. butyricum, 4.14.9, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. cadaveris, 4.14.9, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. carnis, 4.14.9, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CCHF (Congo-Crimean hemorrhagic fever virus), 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CCHFV (Crimean-Congo hemorrhagic fever virus), 18.12.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CCNA (cell culture neutralization assay), 4.16.24.16.3, 4.16.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CCO (Chief Compliance Officer), 1.2.4.91.2.4.10, 1.2.4.151.2.4.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CCO (chief compliance officer), 1.2.4.1, 1.2.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CDC. See Centers for Disease Control and Prevention</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CDC anaerobe agar, 4.4.1.1, 4.4.1.3, 4.4.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. difficile, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical correlations, 4.14.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cedax (ceftibuten), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefaclor (Ceclor), 7.23.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cefadroxil (Duricef, Ultracef), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefamandole (Mandol), 7.19.12, 7.23.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cefazolin, antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cefdinir (Omnicef), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefditoren (Spectracef), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefepime (Maxipime), antimicrobial susceptibility tests, selecting agents for testing and reporting, 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefetamet, broth microdilution MIC test, 7.4.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefiderocol, 7.24.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cefixime (Suprax), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefonicid, broth microdilution MIC test, 7.4.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefotan (cefotetan), 7.23.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefotaxime (Claforan), 7.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.17.14.7, 7.14.97.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.3, 7.23.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cefotaxime (Claforan)-resistant H. influenzae, 7.20.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefotetan (Cefotan), 7.23.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefoxitin (Mefoxin, Zefazone), 7.15.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.6, 7.6.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antagonism, 7.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.77.22.8, 7.22.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.9, 7.20.12, 7.20.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>M. peregrinum, 9.9.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxacillin salt-agar test, 7.8.37.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapidly growing mycobacteria, 9.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cefpodoxime (Vantin), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefpodoxime, ESBL testing, 7.14.1, 7.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefprozil (Cefzil), 7.23.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cefsulodin-Irgasan-novobiocin agar (CIN), 3.7.1.6, 3.7.1.9, 3.7.1.14, 16.2.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ceftaroline (Teflaro), 7.23.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Staphylococcus aureus, 7.1.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Ceftazidime, 7.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.17.14.7, 7.14.97.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Ceftazidime-avibactam (Avycaz), 7.23.3, 7.23.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ceftazidime (Fortaz, Tazicef, Tazidime), selecting agents for testing and reporting, 7.23.3, 7.23.7, 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ceftibuten (Cedax), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ceftin (cefuroxime-axetil), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ceftolozane-tazobactam (Zerbaxa), 7.23.3, 7.23.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ceftriaxone (Rocephin)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.3, 7.23.7, 7.23.8, 7.23.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.1, 7.14.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Ceftriaxone-resistant S. pneumoniae, 7.20.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefuroxime (Zinacef, Kefurox, Monocid), antimicrobial susceptibility tests, selection of agents for testing and reporting, 7.23.7, 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefuroxime-axetil (Ceftin), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefuroxime, broth microdilution MIC test, 7.4.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cefzil (cefprozil), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cell count, viral monolayer cell cultures, 12.7.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cell culture media</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>amino acids, 12.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antibacterial-antimycotic mixtures, 12.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>basal, 12.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>basic and trace elements, 12.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>buffering systems, 12.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrates, 12.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>complex, 12.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fetal bovine serum, 12.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inorganic salts, 12.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 12.8.412.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenol red, 12.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>preparation, 12.8.712.8.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 12.8.112.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 12.8.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 12.8.512.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sources, 12.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vitamins, 12.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cell culture neutralization assay (CCNA), 4.16.24.16.3, 4.16.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cell culture, virus identification, 12.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cell-free metagenomic sequencing, 5.14.15.14.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cell lysis, 15.6.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cellobiose, 16.2.18, 16.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cellobiose fermentation, by yeast, 10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cellophane tape mount, 10.8.310.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cellular cross-contamination, viral monolayer cell cultures, 12.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cellular therapy product culture, 15.4.5.115.4.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cellulitis, 3.12.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>orbital, 3.9.2, 3.9.4, 3.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>preseptal (periorbital), 3.9.23.9.3, 3.9.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cellulomonas, 3.18.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cellulose tape preparation, 11.6.1.111.6.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cellulosilyticum lentocellum, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cellulosimicrobium, identification, 3.18.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Centaur HIV Ag/Ab Combo (CHIV), 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Centaur HIV 1/O/2 enhanced (EHIV), 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Center for Drug Evaluation and Research (CDER), 7.1.2.2, 7.1.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Centers for Disease Control and Prevention (CDC)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antibiotic resistance coordination, 15.7.1.115.7.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>National Healthcare Safety Network (NHSN), 15.5.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>National Notifiable Diseases Surveillance System (NNDSS), 15.5.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Centers for Medicare and Medicaid Services (CMS), 1.1.21.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>documents, 1.1.81.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 16.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.20.27.20.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Central line-associated bloodstream infections (CLABSIs), 5.6.3, 15.5.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Central nervous system (CNS)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>devices, 3.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, parasites, 2.1.36, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen selection, anaerobic, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Central venous access catheter (CVC), 5.12.25.12.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Centrifugal impactor, 15.4.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Centrifuge(s), 17.4.3.117.4.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitology, 11.1.3, 11.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cephalexin (Kefzol, Zolicef-Keflex, Keflex), 7.23.6, 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cephalosporin(s)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.4, 7.23.6, 7.23.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.9, 7.4.1.13, 7.4.1.16, 7.4.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cephamycins, 7.23.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Gene Xpert, 14.3.9.3, 14.3.9.8, 14.3.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cepheid Gene Xpert MTB/RIF assays, 9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cepheid Xpert GBS assay, 3.8.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/RIF test, 9.6.1.19.6.1.5, 9.6.2.19.6.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 9.6.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 9.6.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 9.6.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 9.6.1.29.6.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 9.6.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 9.6.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results and interpretation, 9.6.1.39.6.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimens, 9.6.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/XDR test, 9.6.3.19.6.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 9.6.3.59.6.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 9.6.3.19.6.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 9.6.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 9.6.3.29.6.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 9.6.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 9.6.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results and interpretation, 9.6.3.39.6.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimens, 9.6.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cephems, 7.23.6, 7.23.8, 7.23.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cephradine (Anspor, Velosef), 7.23.6, 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cereal agar, 10.10.7, 10.10.50</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cerebrospinal fluid (CSF)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen handling, 13.5.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VDRL-CSF test, 13.5.2.413.5.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cerebrospinal fluid (CSF) cultures, 3.5.13.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture examination, 3.5.53.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.5.1, 3.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.5.63.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.5.43.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.5.13.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal, 10.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen processing, 3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>viral, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cerebrospinal fluid (CSF) specimen</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal specimens, 10.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.7, 16.1.3, 16.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality indicators, 16.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cerebrospinal fluidVenereal Disease Research Laboratory (CSF-VDRL) test</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indications, 13.5.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specificity and sensitivity, 13.5.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Certificate of accreditation, 16.4.616.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Certificate of compliance, 16.4.416.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cervical cytology samples, 14.3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cervical swab culture, viral, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cervical swab, NAAT testing, 14.3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cervicitis, 2.1.11, 3.8.1.2, 3.8.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cervista HPV HR assay, 14.3.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cervix, 2.1.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.8.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cestodes</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.2, 11.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recovery of scolices and proglottids, 11.5.6.111.5.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cetrimide agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cetrimide test, 3.17.11.13.17.11.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CF. See Cystic fibrosis</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CFR (Code of Federal Regulation), 17.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. freundii, AmpC beta-lactamase testing, 7.15.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CFUs (colony-forming units), 7.17.2.1, 7.17.2.4, 7.17.2.57.17.2.6, 7.17.2.97.17.2.10, 7.17.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CFW (calcofluor white) stain, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CGB agar, 10.7.210.7.3, 10.7.8, 10.7.10, 10.9.6, 10.9.8, 10.9.1210.9.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chaetomium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.43</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chaetomium globosum, toenails and fingernails, 10.10.40, 10.10.43</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chagas disease, 11.9.3.1, 11.9.3.611.9.3.8, 11.11.2.20. See Trypanosoma cruzi</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>epidemiological and clinical indications for testing, 13.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>schema for testing in United States, 13.15.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serologic diagnosis, 13.15.113.15.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ELISA, 13.15.213.15.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>epidemiological and clinical indications for testing, 13.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>FDA-cleared assays for anti-T. cruzi antibody detection, 13.15.213.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunoblot, 13.15.313.15.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>indirect immunofluorescence assays (IFA), 13.15.313.15.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lateral flow assay (LFA), 13.15.213.15.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and reagents, 13.15.413.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.15.113.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.15.413.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recommended testing by phase and context, 13.15.213.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results reporting and interpretation, 13.15.513.15.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.15.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>types of assays, 13.15.313.15.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>transmission, 13.15.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Challenge strains, 7.22.4, 7.22.117.22.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chancroid, 3.8.1.2, 3.8.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chapare virus, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Check sheet, 16.1.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chembio DPP HIV-1/2, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chembio Sure Check HIV 1/2 assay, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chemical hazards, 17.9.117.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chemical hygiene plan (CHP), 11.11.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chemical(s), safety, 17.1.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chemiluminescence assay (CIA), SARS-CoV-2, 13.7.113.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chemiluminescence-based signal amplification, high-risk human papillomaviruses, 14.3.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chemiluminescence immunoassays (CLIAs)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>competitive, 13.1.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cytomegalovirus (CMV), 13.9.1.1, 13.9.2.113.9.2.4, 13.9.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epstein-Barr virus (EBV), 13.8.3.113.8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>FDA-approved assays for hepatitis A virus (HAV) serology, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>FDA-approved assays for hepatitis B virus (HBV) serology, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>FDA-approved assays for hepatitis C virus (HCV) serology, 13.11.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>noncompetitive, 13.1.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>syphilis, 13.5.7.113.5.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trypanosoma cruzi, 13.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chemiluminescent microparticle assays (CMIA)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epstein-Barr virus (EBV), 13.8.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>FDA-approved assays for hepatitis C virus (HCV) serology, 13.11.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hepatitis A virus (HAV), 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hepatitis B virus (HBV), 13.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chest tube, 3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chief Compliance Officer (CCO), 1.2.4.1, 1.2.4.8, 1.2.4.91.2.4.10, 1.2.4.151.2.4.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chikungunya virus, specimen collection, 2.1.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Child abuse, 14.3.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chilomastix mesnili</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chinese liver fluke, 11.11.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chiron RIBA HCV, 13.11.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chlamydia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>associated infections, 12.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>developmental cycle, 12.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>elementary body, 12.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>isolation in cell culture, 12.10.112.10.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blind subpassage, 12.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cell lines, 12.10.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>control stock, 12.10.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>detection of inclusions, 12.10.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fixation of monolayers, 12.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunostaining of monolayers, 12.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation and incubation of cell cultures, 12.10.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 12.10.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 12.10.912.10.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 12.10.312.10.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 12.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 12.10.712.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 12.10.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 12.10.312.10.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 12.10.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 12.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen preparation, 12.10.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>swabs, 12.10.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory diagnosis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 12.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>traditional methods, 12.1.112.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>NAAT, 3.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>public health reporting, 15.5.4.3, 15.5.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection and transport, 2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 2.1.26</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chlamydia pneumoniae, 3.14.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cell lines, 12.10.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>control stock, 12.10.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>detection of inclusions, 12.10.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.11, 7.23.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chlamydia psittaci</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>shipping, 17.6.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chlamydia trachomatis</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.1, 14.3.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical syndromes, 3.8.1.2, 3.8.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>conjunctivitis, 3.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>epidemiology, 14.3.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital cultures, 3.8.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification tests, 3.8.3.1, 14.3.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rectum, 3.8.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>screening, 14.3.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 3.8.1.4, 3.8.1.5, 3.8.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection and transport, 2.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test utilization monitoring, 1.2.4.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chlamydospores, 10.10.2, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>terminal, 10.10.21, 10.10.48</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chloramphenicol (Chloromycetin)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antagonism, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.8, 7.4.1.11, 7.4.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxacillin salt-agar test, 7.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chlorine, neutralizers of, 15.4.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chocolate agar (CHOC), 3.3.2.4, 4.7.34.7.4, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic culture, 3.3.1.2, 3.3.1.63.3.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cholangiocarcinoma, 13.11.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chopped meat broth with formate and fumarate or vitamin K1, 4.4.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chopped meat-carbohydrate broth, 4.4.1.2, 4.4.1.5, 4.4.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chopped meat-glucose broth, 4.4.1.2, 4.4.1.5, 4.4.1.94.4.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Choroid infections, 2.1.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CHP (chemical hygiene plan), 11.11.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Christensenella hongkongensis, 4.14.4, 4.14.13, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Christensens urea agar, 10.10.11, 10.10.53</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CHROMagar</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic pathogens of gastroenteritis, 3.7.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Salmonella, 3.7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeast identification from primary cultures, 10.6.3, 10.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CHROMagar Candida, 10.7.210.7.6, 10.7.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chromobacterium violaceum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vs. B. pseudomallei and B. mallei, 18.7.9, 18.7.11, 18.7.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.8, 3.19.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chromoblastomycoses, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chromogenic agar, for C. difficile recovery, 4.16.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chromogenic cephalosporin (nitrocefin) method, 7.7.2, 7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chromogenic media, 3.11.1.7, 5.10.15.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 5.10.45.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 5.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 5.10.15.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.10.25.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 5.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 5.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, 5.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chromomycosis, 2.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chromosomally encoded inducible resistance, AmpC beta-lactamases, 7.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chronic bronchitis, respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chronic inflammatory response syndrome, 15.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chronic rhinosinusitis (CRS), 3.10.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chryseobacterium gleum, 3.17.45.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.11, 3.19.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chryseobacterium indologenes, 3.17.45.1, 3.17.45.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.11, 3.19.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chryseobacterium, respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chrysosporium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>potato flake agar, 10.10.49</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 10.10.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chrysosporium georgiae</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cornmeal glucose agar, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 10.10.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Ciliates</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Ciliocytophthoria, 11.7.1.3, 11.11.1.311.11.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cimex, gross examination, 11.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CIN (cefsulodin-Irgasan-novobiocin agar), 3.7.1.9, 3.7.1.14, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>[</title>
            <indexentry>
               <primaryie>[C.] innocuum, 4.14.9, 4.14.10, 4.14.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Ciprofloxacin (Cipro)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, evaluation and verification of systems, 7.22.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>M. peregrinum, 9.9.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapidly growing, 9.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>slowly growing nontuberculous mycobacteria, 9.9.2.1, 9.9.2.3, 9.9.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Ciprofloxacin-resistant E. coli, surveillance cultures, 15.7.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Citrate utilization test (Simmons), 3.17.12.13.17.12.3, 8.3.48.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Citrobacter</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), testing and reporting considerations, 7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.1, 7.14.5, 7.14.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>evaluation and verification of antimicrobial susceptibility test systems, 7.22.3, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.2, 3.7.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>malonate test, 3.17.28.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>positive blood culture broth, 5.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1, 18.15.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Citrobacter amalonaticus, malonate test, 3.17.28.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Citrobacter freundii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Andrades fermentation medium, 16.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF, 6.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>malonate test, 3.17.28.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenol red medium, 16.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control of antimicrobial susceptibility tests, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Citrobacter koseri</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>malonate test, 3.17.28.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>4</title>
            <indexentry>
               <primaryie>4-methylumbelliferone derivative substrates test, 4.9.18.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CJD (Creutzfeldt-Jakob disease), 17.5.5.117.5.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CLABSIs (central lineassociated bloodstream infections), 15.5.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cladophialophora</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation temperature, 10.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.13, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cladophialophora arxii, temperature tests, 10.10.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cladophialophora bantiana, 10.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing by broth dilution, 10.12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cladophialophora boppii, temperature tests, 10.10.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cladophialophora carrionii, temperature tests, 10.10.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cladophialophora devriesii, temperature tests, 10.10.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cladophialophora emmonsii, temperature tests, 10.10.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cladosporiaceae, temperature tests, 10.10.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cladosporium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blastoconidia, 10.10.46</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.38</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cladosporium cladosporioides, temperature tests, 10.10.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cladosporium herbarum, temperature tests, 10.10.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Claforan. See Cefotaxime</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clamydospores</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>asymmetrical, 10.10.48</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>symmetrical, 10.10.48</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clarithromycin (Biaxin)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>M. peregrinum, 9.9.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapidly growing, 9.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>slowly growing nontuberculous mycobacteria, 9.9.2.1, 9.9.2.3, 9.9.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Classification</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal, 10.2.110.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>human immunodeficiency virus (HIV), 13.10.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycology, 10.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>poxviruses, 18.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clavispora lusitaniae, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clean-voided midstream urine collection, 3.11.1.23.11.1.3, 3.11.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clearview HIV-1/2 Stat-Pak, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cleistothecium, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clerical errors, 2.1.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CLIA. See Clinical Laboratory Improvement Amendment</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CLIA environment, 14.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clindamycin (Cleocin)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.6, 7.6.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.4, 7.20.9, 7.20.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.3, 7.23.4, 7.23.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.8, 7.4.1.9, 7.4.1.10, 7.4.1.11, 7.4.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inducible clindamycin resistance in Staphylococcus, Streptococcus pneumoniae, and Streptococcus beta-hemolytic group, 7.11.17.11.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxacillin salt-agar test, 7.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clinical and Laboratory Standards Institute (CLSI), 10.3.10, 10.13.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.17.2.13, 7.2.157.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clinical breakpoints (CBPs), 10.13.110.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clinical diagnostic laboratory services (CDLT), 1.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clinical Laboratory Fee Schedule (CLFS), 1.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clinical Laboratory Improvement Advisory Committee (CLIAC), 1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clinical Laboratory Improvement Amendment (CLIA), 1.1.11.1.2, 1.1.4, 14.2.6.1, 14.5.3.3, 16.1.6, 18.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>certification and accreditation, 16.4.116.4.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distribution of, 16.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>documents for laboratory inspections, 16.4.1416.4.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor testing certification, 15.7.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratories, individualized quality control plan, 16.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>proficiency testing (PT) programs for 2021, 16.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>requirements for quality control of antimicrobial susceptibility tests, 7.20.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>waived NAATs for near-patient testing, 14.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cloacibacillus, 4.13.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clonorchis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clonorchis sinensis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>duodenal aspirate, 11.6.4.111.6.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridiodes difficile agar, 4.4.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridioides</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical characteristics of, 4.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gram stain and colonial morphology of, 4.14.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridioides difficile, 4.14.9, 4.2.2, 4.5.2, 15.6.2.1, 15.6.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution (MIC) test, 7.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture media, 4.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cycloserine-cefoxitin fructose agar (CCFA), 4.4.1.1, 4.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescence, 4.9.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5, 14.4.1.9, 14.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-proline aminopeptidase, 4.9.17.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF, 6.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.6, 15.5.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, 4.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridioides (formerly Clostridum) difficile, agar dilution MIC test, 7.6.2.27.6.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridioides mangenotii, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridium, 4.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerotolerance, 4.14.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>API 20A systems, 4.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical characteristics of, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biochemical/rapid enzymatic systems, 4.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 3.17.10.2, 18.15.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.34.4.1.4, 4.4.2.14.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture of human cadaveric tissues for transplantation, 15.4.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.3, 4.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gram stain and colonial morphology of, 4.14.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.10, 4.14.114.14.13, 4.14.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lecithinase test, 4.9.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lipase test, 4.9.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.1, 4.12.2, 4.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid enzymatic systems, 4.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>surface testing, 15.4.4.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, 4.14.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>taxonomy update, 4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridium argentinense, 18.11.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridium baratii, 18.11.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>glutamic acid decarboxylase (GDC), 4.9.15.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridium botulinum, 4.5.2, 18.11.118.11.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.11.118.11.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>case definition, 18.11.418.11.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clusters, 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>destruction, 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.11.318.11.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>geographic distribution, 18.11.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.11.918.11.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation and examination of cultures, 18.11.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.1, 15.8.3.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.11.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>neurotoxin-producing, 17.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packaging and shipping, 17.6.7, 17.6.10, 18.11.6, 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive diagnosis, 18.11.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recommended BSL, 18.14.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rejection criteria, 18.11.618.11.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting and notification, 18.11.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.11.518.11.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent, 17.5.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance, 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.11.1018.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.11.618.11.8, 18.14.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.11.818.11.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>therapeutic, 18.11.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>treatment, 18.11.4, 18.11.1018.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>types, 18.11.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridium budayi, 4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridium butyricum, 18.11.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution (MIC) test, 7.4.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridium carnis, 4.14.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridium chauvoei, MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridium combesii, 4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridium difficile, 4.16.14.16.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical identification of, 4.16.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth enrichment methods, 4.16.74.16.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carriage rates, 4.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CHROMagar for isolation, 4.16.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>community-associated, 4.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.16.24.16.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnosis, 4.16.14.16.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enzyme immunoassays, 4.16.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>glutamate dehydrogenase, 4.16.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.12, 4.16.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>infections caused by, 4.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 4.16.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 4.16.94.16.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.16.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nucleic acid amplification tests, 4.16.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pathophysiology of, 4.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 4.16.14.16.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control of antimicrobial susceptibility tests, 7.20.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting, 15.5.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 4.16.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 4.16.34.16.4, 4.16.64.16.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 2.1.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 4.16.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surface testing, 15.4.4.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance, 15.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>toxigenic culture, 4.16.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>toxin, 4.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridium difficile agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridium haemolyticum, identification, 4.14.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridium innocuum, 4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-proline aminopeptidase, 4.9.17.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridium novyi, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic incubation system monitoring, 4.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridium novyi A, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridium perfringens, 4.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bacteroides bile esculin agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 5.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella agar, 16.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CAMP factor tests and reverse CAMP test, 3.17.8.1, 3.17.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridium difficile agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cooked meat medium, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.34.4.1.5, 4.4.2.14.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>egg yolk agar, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gelatin hydrolysis test, 4.9.13.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>genital infections, 3.8.1.4, 3.8.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>glutamic acid decarboxylase (GDC), 4.9.15.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laked blood agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lecithinase test, 4.9.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>L-proline aminopeptidase, 4.9.17.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenylethyl alcohol medium, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>practical guide to workup, 4.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special-potency disks, 4.9.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>thioglycolate broth, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>tryptic soy blood agar, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wilkins-Chalgren anaerobic agar and broth, 16.2.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridium ramosum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution (MIC) test, 7.4.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridium sensu stricto, 4.14.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridium septicum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridium sordellii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>glutamic acid decarboxylase (GDC), 4.9.15.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 3.17.22.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridium sporogenes, 15.3.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>egg yolk agar, 16.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lipase test, 4.9.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>L-proline aminopeptidase, 4.9.17.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clostridium tetani</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Clothing, protective, 17.3.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cloxacillin, 7.15.2, 7.15.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CLSI (Clinical and Laboratory Standards Institute), 10.3.10, 10.13.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AST breakpoints, 7.1.2.17.1.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.1, 7.14.47.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inducible clindamycin resistance, 7.11.17.11.2, 7.11.47.11.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CLSI antifungal susceptibility testing microdilution method, 10.12.1.110.12.1.3, 10.12.1.510.12.1.7, 10.12.1.9, 10.12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CLSI direct disk diffusion method, 7.3.17.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clumping factor agglutination method, 3.17.13.13.17.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CMBCS. See Continuous-monitoring blood culture systems (CMBCS)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CMPH, 14.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CMS. See Centers for Medicare &amp; Medicaid Services</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CMS-approved accreditation organizations, 16.4.716.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CMV (Cytomegalovirus), 12.9.1.1, 12.9.3.2. See also Cytomegalovirus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CMV DNA Accu Span Linearity Panel, 14.3.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CNA, 3.3.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CNA (colistin) agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Columbia, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. novyi, 4.14.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. novyi A, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CNS. See Central nervous system</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Co Actin (mecillinam), 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coagulase, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coagulase-negative staphylococci (CoNS), 3.11.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blepharitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood products, 15.4.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>evaluation and verification of antimicrobial susceptibility test systems, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital tract, 3.8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hematopoietic stem cell products, 15.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.2, 3.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.13.17.40.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.4, 3.12.1.6, 3.12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Coagulase test</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>protein A/clumping factor agglutination method, 3.17.13.13.17.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rabbit plasma method, 3.17.14.13.17.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cobas Amplicor HIV-1 Monitor version 1.5 test, 14.3.1.2, 14.3.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cobas Ampli Prep/Cobas Amplicor HIV-1 Monitor version 1.5 test, 14.3.1.2, 14.3.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>COBAS Ampli Prep/COBAS TaqMan (CAP/ CTM) CMV Test, 14.3.5.114.3.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cleanup, 14.3.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>data analysis, 14.3.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 14.3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.3.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>load samples, 14.3.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and required equipment, 14.3.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.3.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.3.5.214.3.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.3.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagent and consumable loading, 14.3.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 14.3.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>run size and workflow, 14.3.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sample preparation, 14.3.5.214.3.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.3.5.114.3.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cobas Ampli Prep/Cobas TaqMan HIV-1 Qualitative v 2.0 test, 14.3.1.2, 14.3.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cobas Ampli Prep/Cobas TaqMan HIV-1 v 2.0 test, 14.3.1.2, 14.3.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cobas BKV test, 14.3.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cobas HPV test, 14.3.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cobas HSV 1&amp;2 assay, 14.3.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coccidia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast modified trichrome stain, 11.4.5.111.4.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autofluorescence for Cyclospora, Cystoisospora, and Sarcocystis, 11.4.7.111.4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyouns acid-fast stain (cold), 11.4.1.111.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified safranin technique with microwave heating, 11.4.6.111.4.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Ziehl-Neelsen acid-fast stain (hot), 11.4.2.111.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Coccidioides</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternate arthroconidia, 10.10.46</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conversion, 10.10.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnosis, 13.14.1.113.14.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>exoantigen testing, 10.10.1710.10.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inhalation, 17.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.13, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.14.1.113.14.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>particulate phase, 10.10.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.4, 10.10.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>region of endemicity, 13.14.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slide cultures, 10.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.110.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Coccidioides immitis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial resistance, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endemicity, 13.14.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory safety, 18.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold phase characteristics, 10.10.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>shipping, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.110.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Coccidioides immitis (coccidioidomycosis), laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coccidioides posadasii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endemicity, 13.14.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold phase characteristics, 10.10.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Coccidioides serology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>available assays, 13.14.1.113.14.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>complement fixation (CF), 13.14.3.113.14.3.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>EIA, 13.14.1.1, 13.14.4.113.14.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunodiffusion, 13.14.2.113.14.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>introduction, 13.14.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lateral flow assay (LFA), 13.14.1.113.14.1.2, 13.14.5.113.14.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 13.14.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Coccidioidomycosis, 2.1.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnosis, 13.14.1.113.14.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor screening, 15.7.7.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>etiology and pathogenesis, 13.14.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Coccidiomycosis, autopsy material, 2.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coccobacillus, identification, 3.19.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Code jamming, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Code of Federal Regulation (CFR), 17.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Code stacking, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Code steering, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coding, 1.2.1.11.2.1.3. See also Procedure coding</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>annual notices of practices, 1.2.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>code selection for documentation and billing, 1.2.1.21.2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>code types, 1.2.1.11.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CPT (Current Procedural Terminology) codes, 1.1.3, 1.2.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Current Procedural Terminology (CPT), 1.2.3.51.2.3.6, 1.2.3.7, 1.2.4.101.2.4.14, 1.2.4.17, 1.2.4.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>HCPCS (Healthcare Common Procedure Coding System) codes, 1.1.3, 1.2.1.11.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Healthcare Common Procedure Coding System (HCPCS), 1.2.3.51.2.3.6, 1.2.3.7, 1.2.4.13, 1.2.4.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>International Classification of Diseases, Clinical Modification (ICD-CM), 1.2.4.101.2.4.14, 1.2.4.171.2.4.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>issues, 1.2.4.51.2.4.6, 1.2.4.131.2.4.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MAAA (multianalyte assays with algorithmic analyses), 1.1.3, 1.2.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MUEs (medically unlikely edits), 1.1.4, 1.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>National Correct Coding Initiative (NCCI) edits, 1.1.4, 1.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PLA (proprietary laboratory analysis) codes, 1.1.3, 1.2.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure types, 1.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>purpose, 1.2.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>resources, 1.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Coelomycetes, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Colistin, 7.20.9, 18.15.7.1, 18.15.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special-potency disks, 4.9.5.14.9.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Colistin disks, 3.17.4.1, 3.17.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Colistin-nalidixic acid (CNA)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic culture, 3.3.1.3, 3.3.1.63.3.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Columbia, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Colistin special-potency disks, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Colitis, hemorrhagic, 3.7.1.1, 3.7.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Collarette, 10.10.3, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>College of American Pathologists (CAP) require ments for quality control of antimicrobial susceptibility tests, 7.20.17.20.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Collinsella aerofaciens, 4.2.3, 4.14.5, 4.14.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Colon biopsy, parasites, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Colonial morphology, mycobacteria, 9.5.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Colonies from solid media, 3.2.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Colony counts, 3.11.1.1, 3.11.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bent glass rod hockey sticks, 7.17.1.147.17.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>time-kill assay, 7.17.2.87.17.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Colony-forming units (CFUs), 7.17.2.1, 7.17.2.4, 7.17.2.57.17.2.6, 7.17.2.97.17.2.10, 7.17.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Colony morphology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 3.3.2.2, 3.3.2.3, 3.3.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic cocci, 4.15.54.15.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic Gram-negative bacilli, 4.13.84.13.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molds on primary culture, 10.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Colorado teck fever, donor screening, 15.7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Columbia blood agar, 4.4.1.1, 4.4.1.3, 4.4.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>performance standards, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Columbia colistinnalidixic acid (CNA) agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Columella, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Comamonas, identification, 3.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Combination enzymatic tablets for nitrophenol, aminopeptidase, and glucosidases, 4.9.19.14.9.19.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Commercial kits</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 16.2.1, 16.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>and rapid enzymatic systems for anaerobe identification, 4.10.14.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Commercially prepared media</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>exempt from quality control, 16.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>requiring quality control testing, 16.2.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Common-cause variation, 16.1.1.2, 16.1.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Common cold, potential etiological agents, 2.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Communication, effective lines of, 1.2.4.8, 1.2.4.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Community-acquired pneumonia (CAP), 2.1.7, 3.10.1.23.10.1.3, 3.10.2.1, 3.10.2.7, 3.10.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Comparative effectiveness, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Competency assessment, 7.20.10, 7.20.157.20.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Competency Assessment Program, 16.1.816.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Complement, 13.14.3.613.14.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Complement fixation (CF)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coccidioides, 13.14.3.113.14.3.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>buffers, 13.14.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>equipment and materials, 13.14.3.113.14.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.14.3.1313.14.3.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.14.3.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.14.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.14.3.1013.14.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.14.3.913.14.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 13.14.3.313.14.3.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety, 13.14.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen, 13.14.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Histoplasma capsulatum, 13.13.1.1, 13.13.2.113.13.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.13.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.13.2.913.13.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.13.2.113.13.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.13.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.13.2.213.13.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.13.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.13.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Complement fixation test, 13.1.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Compliance</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>areas requiring policy, 1.2.4.91.2.4.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>with fraud alerts, 1.2.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>glossary of terminology and acronyms, 1.1.51.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>regulations, 1.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Compliance Committee, 1.2.4.1, 1.2.4.8, 1.2.4.91.2.4.10, 1.2.4.131.2.4.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Compliance program, 1.2.4.11.2.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>billing, 1.2.4.91.2.4.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>areas requiring policy development, 1.2.4.171.2.4.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>auditing and monitoring, 1.2.4.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CCO and Compliance Committee in, 1.2.4.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>coding and billing issues, 1.2.4.131.2.4.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>communication, effective lines of, 1.2.4.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>education and training, 1.2.4.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>elements of comprehensive, 1.2.4.91.2.4.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>enforcing standards through disciplinary guidelines, 1.2.4.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fraud alerts, 1.2.4.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>marketing, 1.2.4.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>medical-necessity items, 1.2.4.101.2.4.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>prices charged to physicians and other providers, 1.2.4.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>purpose, 1.2.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reflex and composite scenarios, 1.2.4.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>responding to issues, 1.2.4.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>retention of records, 1.2.4.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>standards of conduct, 1.2.4.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>standing orders, 1.2.4.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>written procedures and policies applicable to microbiology, 1.2.4.101.2.4.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CCO and Compliance Committee in, 1.2.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>coding and billing issues in, 1.2.4.51.2.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>education and training in, 1.2.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>effective lines of communication in, 1.2.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>elements of comprehensive, 1.2.4.11.2.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>enforcing standards through disciplinary guidelines, 1.2.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fraud alerts in, 1.2.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>marketing in, 1.2.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>medical-necessity issues in, 1.2.4.21.2.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>prices charges to physicians and other providers in, 1.2.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reflex and composite scenarios in, 1.2.4.101.2.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>responding to issues in, 1.2.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>retention of records in, 1.2.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>standard orders in, 1.2.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>standards of conduct in, 1.2.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>written procedures and policies in, 1.2.4.21.2.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Composite, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Composite testing, 1.2.4.6, 1.2.4.101.2.4.11, 1.2.4.14, 1.2.4.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Compounded sterile preparations (CSPs), 15.3.1, 15.3.5.115.3.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Compounding aseptic containment isolators (CACIs), 15.3.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Compounding aseptic isolators (CAIs), 15.3.1.1, 15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Compressed gas(es), 17.1.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Compressed gas cylinders, 17.4.4.117.4.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Computerized analysis, 15.6.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Computer keyboards, decontamination, 17.1.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Conception products, specimen collection, 2.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Concerned with sterile preparations (CSPs), 15.3.1, 15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Confidence interval, 95%, 14.2.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Congenital syphilis, 13.5.1.1, 13.5.1.713.5.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Congo-Crimean hemorrhagic fever virus (CCHF), 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Conidia, 10.10.110.10.2, 10.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>definition, 10.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Conidiobolus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.12, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Conidiophore, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Conjunctiva biopsy, parasites, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Conjunctiva(e), fungal specimen collection, 10.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Conjunctival culture, 3.8.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Conjunctival swab culture, viral, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Conjunctivitis (pink eye), 3.9.23.9.5, 3.9.93.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CoNS. See Coagulase-negative staphylococci; Coagulase-negative staphylococci (CoNS)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Consignee, 17.6.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Contact lens, 10.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Contact lens associated keratitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Contact lens solution, Acanthamoeba or Naegleria culture, 11.9.1.411.9.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Contamination</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular diagnostics, 14.2.2.114.2.2.3, 14.2.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Continuous-monitoring blood culture systems (CMBCS), 5.3.15.3.7, 5.5.15.5.8, 5.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>automated blood culture systems, 5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BacT/ALE, 5.3.2, 5.3.4, 5.3.5, 5.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BACTEC, 5.3.4, 5.3.5, 5.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BACTEC Myco, 5.5.15.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.3.65.3.7, 5.5.65.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 5.3.7, 5.5.75.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 5.5.4, 5.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.5.1, 5.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.3.45.3.6, 5.5.55.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 5.3.35.3.4, 5.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 5.3.7, 5.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 5.3.25.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, 5.5.15.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 5.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK bottles, 5.3.4, 5.3.6, 5.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VersaTREK Myco, 5.5.15.5.6, 5.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Continuous monolayer cell cultures, 12.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Contractor, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Control charts, 16.1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Controlled Environment Testing Association (CETA), 15.3.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Controls, molecular diagnostics and, 14.2.5.114.2.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Control standard endotoxin (CSE), 15.3.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cooked meet medium, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coombs test, indirect, Brucella, 13.3.213.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Copper sulfate reduction reaction, 11.5.8.111.5.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coprococcus, 4.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology, 4.15.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cornea biopsy, parasites, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cornea, culture of human cadaveric tissues for transplantation, 15.4.6.3, 15.4.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corneal/conjunctival scraping culture, viral, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corneal keratitis, 2.1.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corneal scrapings, 3.9.2, 3.9.6, 10.3.4, 10.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold identification, 10.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corneal ulcer, 3.9.33.9.4, 3.9.6, 3.9.93.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cornmeal agar, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>common yeast morphology on, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>with polysorbate 80, 10.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipe, 10.9.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeast identification, 10.9.6, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cornmeal glucose agar, 10.10.11, 10.10.2910.10.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coronavirus (COVID-19), 17.5.3.2. See also Highly pathogenic coronaviruses</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.3, 12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MERS-CoV, 18.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pandemic, 14.1.1, 14.1.2, 14.2.1.1, 14.2.1.3, 14.2.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>SARS-CoV, 18.9.318.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SARS-CoV-2, 18.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>transmission electron micrograph, 18.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zoonotic, 12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corrected report, 16.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corynebacterineae, 8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corynebacterium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autopsy blood cultures, 5.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CAMP factor tests and reverse CAMP test, 3.17.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catheter-related bloodstream infection, 5.12.1, 5.12.5, 5.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital tract, 3.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hematopoietic stem cell products, 15.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.1, 3.18.2, 3.18.5, 3.18.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lipophilism test, 3.17.27.13.17.27.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>meningitis, 3.5.2, 3.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>O129 disk susceptibility testing, 3.17.35.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures lower, 3.10.2.6, 3.10.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stone cultures, 3.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease-negative, 3.18.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urease-positive, 3.18.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urease test, 3.17.46.1, 18.15.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urine culture, 3.11.1.3, 3.11.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.6, 3.12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium accolens, 3.17.27.2, 15.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium afermentans, 3.17.8.4, 3.17.27.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium amycolatum, 3.17.35.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.12, 3.18.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium aurimucosum, identification, 3.18.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corynebacterium auris, otitis media, 3.10.5.13.10.5.2, 3.10.5.43.10.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corynebacterium coyleae, 3.17.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corynebacterium diphtheriae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.5, 3.18.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Loeffler medium, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pharyngitis, 3.10.8.13.10.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>potassium tellurite cystine agar, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.13.10.1.2, 3.10.7.13.10.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 3.10.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.10.7.63.10.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.10.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.10.7.23.10.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.10.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.10.7.33.10.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.10.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 3.10.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.10.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium falsenii, identification, 3.18.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corynebacterium glucuronolyticum, 3.17.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium imitans, 3.17.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corynebacterium jeikeium, 3.17.27.1, 3.17.27.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium kroppenstedtii, wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corynebacterium lipophiloflavum, 3.17.27.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium macginleyi, 3.17.27.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>conjunctivitis, 3.9.3, 3.9.93.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium minutissimum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium mucifaciens, identification, 3.18.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corynebacterium otitidis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>otitis media, 3.10.5.13.10.5.2, 3.10.5.43.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium propinquum, identification, 3.18.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corynebacterium pseudodiphtheriticum, 3.10.7.6, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium pseudotuberculosis, 3.17.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium regelii, urease test, 3.17.46.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corynebacterium resistens, identification, 3.18.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corynebacterium riegelii, identification, 3.18.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corynebacterium spp.</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.7, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium striatum, 3.17.8.4, 3.17.35.2, 3.17.35.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium tuberculostearicum, 3.17.27.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium ulcerans, 3.17.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CAMP factor tests and reverse CAMP test, 3.17.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium urealyticum, 3.17.27.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stone cultures, 3.11.2.1, 3.11.2.3, 3.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Corynebacterium ureicelerivorans, identification, 3.18.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Corynebacterium xerosis, 3.17.35.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Coryneform bacilli, identification, rapid, 3.3.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Council of State and Territorial Epidemiologists (CSTE), 15.5.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Counterstain, 3.2.1.1, 3.2.1.173.2.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coverage of laboratory services, 1.2.3.71.2.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Covered lives, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>COVID-19, 14.4.2.1, 15.5.4.1, 17.5.3.2, 18.9.2. See also Coronavirus (COVID-19); Highly pathogenic coronaviruses</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.3, 12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>highly sensitive SARS-CoV-2 assay, 14.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MERS-CoV, 18.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multiple FDA-authorized molecular assays, 14.1.114.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pandemic, 14.1.1, 14.1.2, 14.2.1.1, 14.2.1.3, 14.2.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pneumonitis, 10.4.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>problem-solving PDCA-A3 form, 16.1.1.716.1.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>public health emergency, 14.2.1.1014.2.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality indicator report, 16.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapidly expanding/diversifying testing capacity, 14.2.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rapid solid-phase immunoassays, 12.9.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>real-time monitoring of test data, 12.9.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>SARS-CoV, 18.9.318.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SARS-CoV-2, 12.2.4, 12.9.2.1, 12.9.2.412.9.2.5, 15.7.7.13, 18.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>transmission electron micrograph, 18.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>and urgency</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>global surveillance, 15.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>national level, 15.5.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>public health reporting, 15.5.4.815.5.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>state level, 15.5.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zoonotic, 12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cowpox virus (CPXV), 18.8.1, 18.8.4, 18.8.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coxiella burnetii, 18.10.118.10.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial therapy, 18.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.1.2, 18.10.118.10.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broad-range PCR, 5.14.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical presentation, 18.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of cultures, 18.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>geographic distribution, 18.10.1, 18.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.10.418.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inhalation, 17.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.1, 15.8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 18.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>notifications, 18.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.10.118.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recommended BSL, 18.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.2.5, 18.10.218.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sentinel Level Clinical Microbiology Laboratory Guidelines, 18.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serologic results, 18.10.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.10.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.10.318.10.4, 18.14.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 18.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 17.6.10, 17.6.35, 18.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Coxiella, specimen collection, 2.1.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coxsackievirus group A, clinical manifestations, 12.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coxsackievirus group B, clinical manifestations, 12.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. paraputrificum, 4.14.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CPE. See Cytopathic effect</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. perfringens, 4.14.9, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CPT (Current Procedural Terminology), 1.2.3.51.2.3.6, 1.2.3.7, 1.2.4.21.2.4.6, 1.2.4.101.2.4.14, 1.2.4.17, 1.2.4.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>codes, 1.1.3, 1.2.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. putrificum, 4.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>[</title>
            <indexentry>
               <primaryie>[C.] ramosum, 4.14.9, 4.14.10, 4.14.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cranial epidural abscess, 2.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CRE. See Carbapenem-resistant Enterobacteriaceae</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Creutzfeldt-Jakob disease (CJD), 17.5.5.117.5.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.315.8.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Criibacterium bergeronii, 4.14.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical correlations, 4.14.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Crimean-Congo hemorrhagic fever (CCHF), 18.12.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Crimean-Congo hemorrhagic fever virus (CCHFV), 18.12.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Crimean-Congo virus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory safety, 18.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>select agent, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>shipping, 17.6.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.14.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Critical values in microbiology, 2.1.4, 2.1.40</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cronobacter, citrate utilization test (Simmons), 3.17.12.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Crosswalked, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CRPA antimicrobial susceptibility testing (AST) phenotypes, Candida auris, 15.7.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cryopreservation, anaerobe storage, 4.11.1, 4.11.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cryopreservation method, viral monolayer cell cultures, 12.7.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cryopreservation procedure, 11.9.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cryptic species, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature of fungal, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cryptobacterium, 4.14.5, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cryptococcosis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection and culture medium, 2.1.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cryptococcus, 10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic bacteria, 5.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.2.3, 10.13.4, 10.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.2, 10.12.1.6, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood cultures, laboratory process, 5.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.1, 10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.13, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identification, 10.7.2, 10.7.610.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 18.15.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cryptococcus albidus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate assimilation test, 10.9.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cryptococcus dubliniensis, examination and evaluation of primary cultures, 10.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cryptococcus gatti</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CGB agar, 10.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nomenclature, 10.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identification, 10.7.110.7.2, 10.7.810.7.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cryptococcus glabrata, phenotypic identification, 10.10.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cryptococcus laurentii, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CGB agar, 10.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>commercial yeast identification systems, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cryptococcus luteolus, culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cryptococcus neoformans, 10.4.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.2.3, 10.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>birdseed (niger) agar, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>caffeic acid disk for, 10.7.110.7.3, 10.7.810.7.11, 10.7.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CGB agar, 10.9.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inoculation, 17.1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>micromorphology, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive identification, 10.7.110.7.3, 10.7.710.7.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cryptococcus neoformans/C. gattii complex</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cycloheximide susceptibility, 10.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.7, 10.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slide cultures, 10.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cryptococcus neoformans species complex</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CGB agar, 10.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cryptococcus terreus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identification, 10.7.2, 10.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cryptococcus uniguttulatus, culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cryptosporidiosis, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pulmonary, 11.7.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cryptosporidium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast modified trichrome stain, 11.4.5.111.4.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.111.7.2.2, 11.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.211.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>duodenal aspirate, 11.6.4.111.6.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>expectorated sputum, 11.7.1.1, 11.7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays for intestinal protozoa, 11.11.2.2311.11.2.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>formalin-ethyl acetate sedimentation, 11.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5, 14.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>ingestion, 17.1.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>iron hematoxylin stain (modified Spencer-Monroe method), 11.3.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyouns acid-fast stain (cold), 11.4.1.111.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified safranin technique with microwave heating, 11.4.6.111.4.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Ziehl-Neelsen acid-fast stain (hot), 11.4.2.111.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained smear (trichrome), 11.3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy specimen permanent stained smear, 11.6.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen handling, 11.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 2.1.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sputum expectorated, 11.7.1.1, 11.7.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.611.11.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance, 15.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zinc sulfate flotation, 11.3.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cryptosporidium hominis, gastroenteritis panels, 14.4.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cryptosporidium parvum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cryptosporium, aspirates and bronchoscopy specimens, 11.7.2.111.7.2.2, 11.7.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Crystal violet, 3.2.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Crystal violet erythromycin agar (CVE), 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. septicum, 4.14.9, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CSF. See also Cerebrospinal fluid (CSF)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acanthamoeba or Naegleria culture, 11.9.1.3, 11.9.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CSF cultures, anaerobic bacteria in, 4.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. sporogenes, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CSTE (Council of State and Territorial Epidemiologists), 15.5.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. subterminale, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. symbiosum, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CTA (cystine trypticase agar), 3.17.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. tertium, 4.14.10, 4.14.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. tetani, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CT-SMAC (Mac Conkey agar-sorbitol with cefixime and tellurite), 3.7.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cubicin (daptomycin), 7.22.11, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cul-de-sac, 2.1.21, 3.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Culdocentesis, 2.1.21, 3.8.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Culiseta melanura, eastern equine encephalitis virus, 18.13.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Culture and Antimicrobial Susceptibility/Therapy Review, 16.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Culture, defined, 17.6.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Culture media</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.4.1.14.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enriched, nonselective, all-purpose agar media, 4.4.1.54.4.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formulas, 4.4.1.54.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations of procedure, 4.4.1.2, 4.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>liquid media, 4.4.1.2, 4.4.1.5, 4.4.1.94.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 4.4.1.14.4.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonselective liquid broth media, 4.4.1.94.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>prereduced, anaerobically sterilized (PRAS) media, 4.4.1.14.4.1.2, 4.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>primary, 4.4.1.14.4.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 4.4.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 4.4.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>secondary, 4.4.2.14.4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>selective and/or differential agar media, 4.4.1.74.4.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>solid media, 4.4.1.34.4.1.4, 4.4.1.54.4.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen, 4.4.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>uses for primary media, 4.4.1.34.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, C. difficile, 4.16.24.16.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>commercially prepared CLSI-exempt,, 16.5.11, 16.5.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>environmental surface testing, 15.4.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>expiration date, 16.2.5, 16.2.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing specimens for fungal culture, 10.5.110.5.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 16.2.116.2.29, 16.6.5, 16.6.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Culture methods, environmental surface testing, 15.4.4.5, 15.4.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Culture, quality control sheet for parasitology, 11.11.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Culture worksheet, 16.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cumulative antimicrobial susceptibility test data reports, 16.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cunninghamella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing by broth dilution, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cunninghamella bertholletiae, temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cunninghamella elegans, temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cupriavidus pauculus, identification, 3.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. ureolyticus, nitrate and urease tests, 4.13.15, 4.13.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Curetis, syndromic panels, 14.4.2.2, 14.4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Current Procedural Terminology (CPT), 1.2.3.51.2.3.6, 1.2.3.7, 1.2.4.21.2.4.6, 1.2.4.101.2.4.14, 1.2.4.17, 1.2.4.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Curvularia, 10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing by broth dilution, 10.12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.210.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Customer Feedback Survey, 16.1.716.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Custom panel, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cut(s), 3.12.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cutaneous abscess, 2.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cutaneous leishmaniasis, 11.11.2.9, 11.11.2.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cutaneous mycoses, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cutaneous ulcers, 2.1.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, parasites, 11.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cutibacterium, 4.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autopsy blood cultures, 5.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 3.17.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cutibacterium acne, 4.2.3, 4.11.2, 4.14.1, 4.14.8, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blepharitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood products, 15.4.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 4.9.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catheter-related bloodstream infection, 5.12.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hematopoietic stem cell products, 15.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 3.17.22.3, 4.9.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.13.5.2, 3.5.43.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular cultures, 3.9.8, 3.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cutibacterium avidum, 4.2.3, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cutibacterium avidum/granulosum, identification, 3.18.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cutibacterium granulosum, 4.2.3, 4.14.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cutibacterium modestum, 4.14.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cutibacterium namnetense, 4.2.3, 4.14.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cutting-edge technology, Candida auris, 15.7.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cyberlindnera jadinii, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cycle sequencing, 15.6.4.315.6.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cycloheximide responses, mold identification, 10.10.10, 10.10.12, 10.10.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cycloheximide susceptibility, 10.5.3, 10.8.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cycloserine-cefoxitin fructose agar (CCFA), 4.4.1.1, 4.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cyclospora</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast modified trichrome stain, 11.4.5.2, 11.4.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.1, 11.7.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autofluorescence, 11.4.7.111.4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy specimen permanent stained smear, 11.6.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance, 15.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zinc sulfate flotation, 11.3.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cyclospora cayetanensis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast modified trichrome stain, 11.4.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autofluorescence, 11.4.7.111.4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays, 11.11.2.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5, 14.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>iron hematoxylin stain (modified Spencer-Monroe method), 11.3.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyouns acid-fast stain (cold), 11.4.1.111.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified safranin technique with microwave heating, 11.4.6.111.4.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Ziehl-Neelsen acid-fast stain (hot), 11.4.2.111.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained smear (trichrome), 11.3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.611.11.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cyclospora, Cystoisospora, and Sarcocystis, autofluorescence, 11.4.7.111.4.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cyctic fibrosis, 2.1.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cylindrocarpon, normally sterile sites, 10.10.36</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cyst(s), 3.12.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cysteine proteose peptone agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cysticercosis, 11.5.6.311.5.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cystic fibrosis (CF), respiratory tract cultures, 3.10.1.2, 3.10.3.13.10.3.4, 3.10.3.13.10.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>criteria for workup of organisms, 3.10.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture methods, 3.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.10.3.23.10.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microscopic examination, 3.10.3.33.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>organisms workup criteria, 3.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.10.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.10.3.33.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.10.3.13.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cystine lactose electrolyte-deficient agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cystine tryptic agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cystitis, 3.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cystoisospora</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast modified trichrome stain, 11.4.5.211.4.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autofluorescence, 11.4.7.111.4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>duodenal aspirate, 11.6.4.111.6.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zinc sulfate flotation, 11.3.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cystoisospora belli</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast modified trichrome stain, 11.4.5.311.4.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autofluorescence, 11.4.7.111.4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formalin-ethyl acetate sedimentation, 11.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>iron hematoxylin stain (modified Spencer-Monroe method), 11.3.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyouns acid-fast stain (cold), 11.4.1.111.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified safranin technique with microwave heating, 11.4.6.111.4.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Ziehl-Neelsen acid-fast stain (hot), 11.4.2.111.4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained smear (trichrome), 11.3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.611.11.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cystoscopy, 3.11.1.4, 3.11.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cystostomy, 3.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cysts, 11.11.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspirates of, 11.7.2.1, 11.7.2.311.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.7.2.111.7.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>in sigmoidoscopy specimen (permanent stained smear), 11.6.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>protozoal</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.111.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calcofluor white for detection of, 11.4.8.111.4.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct smears, 11.3.2.111.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>expectorated sputum, 11.7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formalin-ethyl acetate sedimentation, 11.3.3.311.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>iron hematoxylin stain (modified Spencer-Monroe method), 11.3.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained smear (trichrome), 11.3.5.111.3.5.2, 11.3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy specimen permanent stained smear, 11.6.3.111.6.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zinc sulfate flotation, 11.3.4.311.3.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cytology, virus identification, 12.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cytomegalovirus (CMV), 12.9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>calibrator for quantitative CMV testing, 14.2.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.6, 13.9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>congenital, 13.9.1.113.9.1.2, 13.9.2.4, 13.9.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.315.7.7.4, 15.7.7.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>drug resistance testing, 14.3.6.114.3.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>versus Epstein-Barr virus (EBV), 13.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>etiology and pathogenesis, 13.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fragmented DNA, 14.2.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory diagnosis, 13.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.9.1.113.9.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quantitative detection of DNA by real-time PCR, 14.3.5.114.3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cleanup, 14.3.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>data analysis, 14.3.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 14.3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.3.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>load samples, 14.3.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and required equipment, 14.3.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.3.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.3.5.214.3.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.3.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagent and consumable loading, 14.3.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 14.3.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>run size and workflow, 14.3.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sample preparation, 14.3.5.214.3.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.3.5.114.3.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>screening during pregnancy, 13.9.1.113.9.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>chemiluminescence assay (CIA), 13.9.2.113.9.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enzyme-linked immunosorbent assay and chemiluminescense assay, 13.9.2.113.9.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>enzyme-linked immunosorbent assays (ELISAs), 13.9.2.113.9.2.4, 13.9.3.113.9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>IgG avidity testing, 13.9.1.113.9.1.2, 13.9.3.113.9.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.9.1.113.9.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cytopathic effect (CPE), 18.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. difficile, 4.16.2, 4.16.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>highly pathogenic coronaviruses, 18.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cytotoxin B tissue culture, 4.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Czapek-Dox agar, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>D</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dacryocystitis, 3.9.23.9.3, 3.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dacryodenitis, 3.9.23.9.3, 3.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dactylaria, normally sterile sites, 10.10.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dactylitis, 2.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dalbavancin (Dalvance), 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dangerous goods, 17.6.32, 17.6.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dangerous Goods Regulations, 17.6.1, 17.6.9, 17.6.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dangerous goods, shipping. See Shipping of infectious substances</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DAntonis iodine, 11.3.2.311.3.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Daptomycin (Cubicin), 7.22.11, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dark-field (DF) microscopy, 2.1.22, 3.8.1.6, 13.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for Treponema pallidum, 3.2.5.13.2.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Data analysis, 15.6.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular diagnostics, 14.2.4.614.2.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality assurance, 16.1.116.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Debaryomyces hansenii, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Decarboxylase (Moeller) broth, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Decarboxylase-dihydrolase tests, 3.17.15.13.17.15.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Decolorizers, 3.2.1.1, 3.2.1.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Decomposition of substrates, 8.3.58.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Decontamination, 17.1.3.117.1.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>of cultures contaminated with antimicrobial agentpolyresistant bacteria, 10.10.1910.10.20, 10.10.31, 10.10.54</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteriology, 9.2.2.19.2.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Decubitus ulcer, 3.12.1.1, 4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Deep amplicon sequencing, direct microbial detection and identification, 14.5.2.114.5.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioinformatics, 14.5.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 14.5.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.5.2.714.5.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and equipment, 14.5.2.314.5.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mNGS, 14.5.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>NGS technologies, 14.5.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>open-source software, 14.5.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.5.2.214.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.5.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.5.2.414.5.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 14.5.2.514.5.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.5.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Deep supporative lesion, 2.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Deep-wound drainage, 4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Deionization, laboratory water, 16.3.1, 16.3.316.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Delafields hematoxylin stain, 11.8.8.111.8.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Delamanid, agar proportion method, 9.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Delftia acidovorans, 3.17.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>indole test, 3.17.22.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Delftia, identification, 3.19.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dematiaceae, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dengue virus (DENV), shipping, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dental abscess, 2.1.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Deoxycholate, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Deoxycholate agar, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Deoxyuridine triphosphate (dUTP), 14.2.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Department of Transportation (DOT), 17.6.2, 17.6.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dermabacter hominis, identification, 3.18.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dermatitis verrucosa, 2.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dermatophilus, 8.1.1, 8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation of growth, 8.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1, 8.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Dermatophilus congolensis, 8.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dermatophyte(s)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial resistance, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 10.10.1910.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BCP milk glucose test, 10.10.11, 10.10.2210.10.29, 10.10.3210.10.34, 10.10.53</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Christensens urea agar, 10.10.11, 10.10.53</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cornmeal glucose agar, 10.10.11, 10.10.2910.10.30, 10.10.54</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cyclohexide responses, 10.10.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decontamination of cultures contaminated with antimicrobial agentpolyresistant bacteria, 10.10.1910.10.20, 10.10.31, 10.10.54</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>growth factor tests, 10.10.2010.10.28, 10.10.5210.10.54</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair perforation test, 10.10.11, 10.10.2310.10.28, 10.10.3010.10.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media, 10.10.7, 10.10.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>micromorphology, 10.10.20, 10.10.21, 10.10.2310.10.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>physiological and other special medium tests, 10.10.2010.10.31</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>polished-rice test for Microsporum, 10.10.11, 10.10.30, 10.10.54</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>practical scheme, 10.10.3110.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>on primary media, 10.8.2, 10.8.510.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.10.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sabouraud dermatophyte decontamination broth, 10.10.7, 10.10.54</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton agars, 10.10.7, 10.10.20, 10.10.2210.10.23, 10.10.25, 10.10.2710.10.28, 10.10.32, 10.10.5210.10.53</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 10.10.2210.10.28, 10.10.3310.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>performance standards, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test medium, 10.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Dermatophytic onychomycosis, 2.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dermatophytosis, 2.1.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>Destructive testing of human cadaveric tissues for transplantation, 15.4.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Desulfomicrobium, 4.13.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Desulfovibrio, 4.13.2, 4.13.8, 4.13.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Determine HIV-1/2 Ag/Ab Combo test, 13.10.1.4, 13.10.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Deuteromycota, 10.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DFA test. See Direct immunofluorescence antibody test</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DF (dark-field) microscopy, 3.8.1.6, 13.5.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Diabetic foot ulcer, 3.12.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Diagnosis related groups (DRG), 1.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dialister, 4.13.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Diarrhea, potential etiological agents, 2.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Diaslide system, 3.11.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dia Sorin LIASON Treponema Screen, 13.5.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dibothriocephalus, 11.1.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.1, 11.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Dibothriocephalus latus, gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dibothriocephalus nihonkaiensis, gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dicloxacillin (Dynapen, Pathocil), 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dicrocoelium dendriticum, artifacts mimicking, 11.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dictyoconidia, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Didymoconidia, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dientamoeba fragilis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays, 11.11.2.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification versus Endolimax nana trophozoites, 11.11.3.911.11.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>trophozoites, 11.11.3.9, 11.11.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Dietzia, 8.1.1, 8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Differential media, anaerobes, 4.4.1.74.4.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Differential-time-to-positivity (DTP) cultures, 5.12.15.12.3, 5.12.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Diffuse large B-cell lymphoma, 14.3.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Digene HC2 HPV DNA test, 14.3.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Digestion and decontamination, 9.2.2.19.2.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dihydrolase tests, 3.17.15.13.17.15.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dikaryotic basidiomycetous hypha, cell division in, 10.10.48</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>5</title>
            <indexentry>
               <primaryie>5% p-Dimethylaminobenzaldehyde, 3.17.22.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>1</title>
            <indexentry>
               <primaryie>1% p-Dimethylaminocinnamaldehyde, 3.17.22.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Dimethylaminocinnamaldehyde (DMACA) solution, 4.9.2.14.9.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dimethyl sulfoxide (DMSO), 12.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.11.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Dimorphic fungi</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification of molds, 10.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conversion to particulate phases, 10.10.12, 10.10.1510.10.17, 10.10.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media, 10.10.5010.10.51</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.10.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting and interpretation, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>species conformation, 10.10.1210.10.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection and culture medium, 2.1.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Dingers ring, 3.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Diphtheria, 3.10.7.13.10.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Diphtheroids, selecting agents for testing and reporting, 7.23.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Diphyllobothrium, 11.1.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.1, 11.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Diphyllobothrium latum, key characteristics, 11.11.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Diplococci, identification, 3.19.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Diploid monolayer cell cultures, 12.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dip N Count system, 3.11.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dipslides, for environmental surface testing, 15.4.4.3, 15.4.4.6, 15.4.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dipylidium caninum, 11.1.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.111.10.2, 11.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Direct immunofluorescence antibody (DFA) test, syphilis, 13.5.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Direct microbial detection and identification</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>deep amplicon sequencing, 14.5.2.114.5.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioinformatics, 14.5.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 14.5.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.5.2.714.5.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and equipment, 14.5.2.314.5.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mNGS, 14.5.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>NGS technologies, 14.5.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>open-source software, 14.5.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.5.2.214.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.5.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.5.2.414.5.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 14.5.2.514.5.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>shotgun metagenomic next generation sequencing (mNGS), 14.5.4.114.5.4.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DNA, 14.5.4.114.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>RNA, 14.5.4.814.5.4.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Direct mount, expectorated sputum specimen, 11.7.1.111.7.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Direct saline mount, urogenital parasites, 11.6.5.111.6.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Direct smears</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 3.2.1.103.2.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slide preparation, 3.2.1.103.2.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, sigmoidoscopy specimen, 11.6.2.111.6.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitology fecal specimens, 11.3.2.111.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Direct spotting method, 4.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dirofilaria, 11.1.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Dirofilaria immitis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Delafields hematoxylin stain, 11.8.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Disciplinary guidelines, 1.2.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enforcing standards through, 1.2.4.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Discomycetes, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Discordant/discrepant analysis, 14.2.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Disinfectants, neutralizers of, 15.4.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Disinfectant soap dispenser, 15.5.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Disinfection</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biohazardous spills, 17.1.4.117.1.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>work areas, 17.1.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Disk diffusion</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>from positive blood culture</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>future, 7.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpreting and reporting results, 7.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.3.47.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.3.67.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.3.27.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methods, 7.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Disk diffusion test, 7.2.17.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility, 10.12.2.110.12.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>B. pseudomallei and B. mallei, 18.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.47.14.6, 7.14.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-level mupirocin resistance in S. aureus, 7.10.17.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inducible clindamycin resistance in Staphylococcus, Streptococcus pneumoniae, and Streptococcus beta-hemolytic group, 7.11.17.11.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.2.27.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.2.17.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.2.57.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>application of disks, 7.2.67.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation, 7.2.77.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation of plates, 7.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculum preparation methods, 7.2.57.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation of disks and media, 7.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reading plates, 7.2.87.2.10, 7.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.2.37.2.4, 7.2.57.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 7.2.107.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>synergism, 7.19.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>troubleshooting, 7.2.137.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vancomycin resistance in Staphylococcus aureus, 7.9.17.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Distillation, laboratory water, 16.3.116.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Distoseptate, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Diverticula, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Diverticulitis, 2.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DMEM (Dulbeccos modified Eagles medium), 12.8.2, 12.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DMSO (dimethyl sulfoxide), 12.7.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNA, armored DNA (aDNA), 14.2.5.114.2.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNA extraction, 15.6.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for molecular identification of yeasts and molds, 10.11.210.11.3, 10.11.510.11.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedures, 15.6.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DNAGear, 15.6.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNase B, 13.2.1.113.2.1.3, 13.2.2.113.2.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNA sequencing, 15.6.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification of molds and yeasts, 10.11.910.11.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.13.17.16.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dobrava virus, 18.12.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Documentation</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality assurance, 16.1.4, 16.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>shipping, 17.6.3, 17.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Dog-cat ascarid, 11.11.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dog-cat hookworm, 11.11.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dolosicoccus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Dolosigranulum, identification, 3.18.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Domestic Mail Manual, 17.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Donor screening, 15.7.7.315.7.7.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacterial infections, 15.7.7.615.7.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal infections, 15.7.7.815.7.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>general approach, 15.7.7.115.7.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation of serologic tests, 15.7.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>minimal screening tests required, 15.7.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mycobacterial infections, 15.7.7.715.7.7.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>NAAT, 15.7.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 15.7.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitic infections, 15.7.7.915.7.7.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>product sterility, 15.7.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>regulatory requirements, 15.7.7.215.7.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>timing, 15.7.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>viral infections, 15.7.7.1015.7.7.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Donovanosis, 3.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dorea, 4.14.5, 4.14.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Doripenem (Doribax), 7.23.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Doripenem, broth microdilution MIC test, 7.4.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dornatoblastomycosis, 2.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DOT (Department of Transportation), 17.6.2, 17.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Downcoding, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Doxycycline (Vibramycin), 7.23.13, 9.9.1.2, 9.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slowly growing nontuberculous mycobacteria, 9.9.2.1, 9.9.2.3, 9.9.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DPP HIV-1/2, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Drainage(s)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal specimens, 10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Drainage tubes, body fluid cultures, 3.4.23.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Drift, 14.2.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Drug resistance-associated mutations (DRMs), HIV, 14.3.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Drug resistance, pyrosequencing prediction of drug resistance in Mycobacterium tuberculosis complex, 9.10.1.19.10.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dry ice, 17.6.7, 17.6.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DTP (differential-time-to-positivity) cultures, 5.12.15.12.3, 5.12.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dubos broth, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dulbeccos modified Eagles medium (DMEM), 12.8.2, 12.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dulcitol, 16.2.6, 16.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Duodenal aspirates</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.6.4.111.6.4.5, 11.7.2.111.7.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for parasites, 11.7.2.1, 11.7.2.311.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Duodenal contents, 2.1.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, duodenal aspirate, 11.6.4.111.6.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Duodenoscope surveillance</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 15.4.7.1015.4.7.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 15.4.7.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 15.4.7.715.4.7.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 15.4.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 15.4.7.815.4.7.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 15.4.7.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 15.4.7.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 15.4.7.115.4.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Duodenum biopsy, parasites, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Duricef (cefadroxil), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>dUTP (deoxyuridine triphosphate), 14.2.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Duval catheter tip, 3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dwarf tapeworm, 11.11.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dynabac. See Erythromycin</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dynapen (dicloxacillin), 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dysgonomonas capnocytophagoides, identification, 3.19.6, 3.19.11, 3.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dysuria, 3.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>D-zone test, 7.11.17.11.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>E</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eagle effect, 7.17.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eagles Minimum Essential Medium (EMEM), 12.7.3, 12.8.2, 12.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ear canals, mold identification, 10.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ear culture, 3.10.5.13.10.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacterial organisms associated with infections, 3.10.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture examination, 3.10.5.33.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>otitis externa, 3.10.5.33.10.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>otitis media, 3.10.5.43.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations of, 3.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.10.5.23.10.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.10.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.10.5.33.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.10.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 3.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.10.5.13.10.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>expernal ear, 3.10.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tympanocentesis fluid, 3.10.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen transport, 3.10.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Ear infections, potential etiological agents, 2.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Earles balanced salt solution (EBSS), 12.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Early recognition, bioterrorism agents and laboratory-acquired infections, 17.5.2.117.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ear swab, 10.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eastern equine encephalitis (EEE) disease, 18.13.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eastern equine encephalitis virus (EEEV), 18.13.118.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.13.218.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.1, 15.8.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.13.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification testing, 18.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>plaque reduction neutralization assay, 18.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.13.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting, notification, and transfer, 18.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.13.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serology, 18.13.218.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>shipping, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.13.318.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection and transport, 18.13.118.13.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.14.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Ebola virus disease (EVD)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biosafety levels, 17.3.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-consequence viral pathogens, 18.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory safety, 18.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>select agent, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>shipping, 17.6.28</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.14.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>EBSS (Earles balanced salt solution), 12.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>e-BURST analyses, 15.6.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>EBV, 12.9.3.2. See also Epstein-Barr virus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>EBV ELITe MGB Kit, 14.3.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>EBV-encoded RNA transcripts (EBERs), 13.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>EBV nuclear antigens (EBNAs), 13.8.1.2, 13.8.3.1, 13.8.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>EBV PCR Kit, 14.3.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Echinocandins</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, broth dilution, 10.12.1.1, 10.12.1.4, 10.12.1.910.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Echinococcus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.1, 11.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>expectorated sputum, 11.7.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sputum expectorated, 11.7.1.1, 11.7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Echinococcus granulosus, key characteristics, 11.11.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Echinococcus multilocularis, key characteristics, 11.11.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Echoviruses, clinical manifestations, 12.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Echthyma, 2.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>E. clostridioformis, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>E codes, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ECOFF (epidemiologic cutoff values), antifungal susceptibility testing, 10.13.110.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>E. coli</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>filamentous fungi, 6.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>positive blood culture broth, 5.13.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ECVs (Epidemiological cutoff values), 10.13.110.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>EDTA, 11.8.1.3, 11.8.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Education</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>compliance, 1.2.4.8, 1.2.4.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>infection control, 15.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Outbreak Database, 15.5.3.515.5.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Edwardsiella, 3.7.1.2, 3.7.1.9, 3.7.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Edwardsiella tarda, 3.7.1.16, 16.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>EEEV. See Eastern equine encephalitis virus (EEEV)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eequipment maintenance, quality control recording sheet, 11.11.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>E. faecalis, gradient diffusion tests, 7.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>E. faecium, 7.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Efficiency, 16.2.28</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eggerthella, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical correlations, 4.14.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Eggerthella lenta, 4.2.3, 4.14.4, 4.14.14,</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.2.2, 7.6.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution (MIC) test, 7.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 3.17.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescence, 4.9.8.14.9.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Eggerthella lenta, catalase test, 4.9.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eggerthella sinensis, identification, 4.14.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Egg yolk agar (EYA), 4.4.1.2, 4.4.1.4, 4.4.1.8, 4.9.9.14.9.9.2, 4.9.10.14.9.10.2, 16.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>medium, 3.17.26.13.17.26.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>EHEC (enterohemorrhagic E. coli), 3.7.1.1, 3.7.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>E. histolytica/E. dispar group, artifacts mimicking, 11.11.1.1, 11.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ehrlichia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious, 5.11.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 11.8.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Ehrlichia chaffeensis, blood films, 11.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ehrlich indole reagent, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ehrlichs reagent, 3.17.22.13.17.22.4, 4.9.2.14.9.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>EIA (Enzyme immunoassay), 10.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays for intestinal protozoa, 11.11.2.2311.11.2.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>EIEC (enteroinvasive E. coli), 3.7.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eikenella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>butyrate esterase test, 3.17.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.6, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Eikenella corrodens, 4.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.6, 3.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>odor, 3.3.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>EIN (Emerging Infections Network), 15.5.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>EIP (Emerging Infections Program), 15.5.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Elecsys Anti-HAV IgM, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Elecsys Anti-HAV II, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Elecsys Anti-HBc IgM Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Elecsys Anti-HBc Immunoassay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Elecsys Anti-HBs II, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Elecsys Anti-HCV, 13.11.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Elecsys Anti-HCV II, 13.11.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Elecsys HBeAg Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Elecsys HBsAg II and HBsAg Confirmatory Test, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Elecsys HIV combi PT, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Elecsys Syphilis system, 13.5.7.1, 13.5.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Electrochemiluminescence immunoassay (ECLIA)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>FDA-approved assays for hepatitis A virus (HAV) serology, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>FDA-approved assays for hepatitis B virus (HBV) serology, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>FDA-approved assays for hepatitis C virus (HCV) serology, 13.11.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Electronic Clinical Laboratory Reporting System (ECLRS), 15.5.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Electronic laboratory reporting (ELR), 15.5.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Electronic medical record (EMR), 7.1.2.57.1.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Electronic specimen worksheet, 16.6.1, 16.6.2, 16.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Electronic Support for Public Health (ESP), 15.5.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Electron microscopy</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>poxviruses, 18.8.1218.8.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>virus identification, 12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Electrophoresis, 15.6.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Electrophoretic banding patterns, 15.6.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eliminating Kickbacks in Recovery Act (EKRA), 1.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ELISA (enzyme-linked immunosorbent assay). See Enzyme-linked immunosorbent assay</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>detection of Borrelia burgdorferi antibodies, 13.6.213.6.4, 13.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays for intestinal protozoa, 11.11.2.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Francisella tularensis, 13.4.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>for Leptospira, 3.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Toxoplasma IgA antibodies</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.16.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.4.113.16.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.16.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.16.4.313.16.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.4.213.16.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 13.16.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.16.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Toxoplasma IgE antibodies (Remington method)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.16.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.16.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.16.5.213.16.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 13.16.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.16.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Toxoplasma IgM antibodies detection, 13.16.2.113.16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high background, 13.16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.16.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.16.2.213.16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection considerations, 13.16.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trypanosoma cruzi, 13.15.213.15.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trypanosoma cruzi, serologic diagnosis, 13.15.513.15.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Elizabethkingia, 3.19.6, 3.19.8, 3.19.11, 3.19.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Elizabethkingia meningoseptica, 3.17.45.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ellinghausen-Mc Cullough-Johnson-Harris (EMJH) medium, 3.13.13.13.2, 3.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ELR (electronic laboratory reporting), 15.5.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>EMB (eosin methylene blue), 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>EMEM (Eagles Minimum Essential Medium), 12.7.3, 12.8.2, 12.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Emergency Use Authorization (EUA), 1.2.4.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Emerging Infections Network (EIN), 15.5.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Emerging Infections Program (EIP), 15.5.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Emerging infectious diseases, 18.1.118.1.2, 18.9.118.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Emericella nidulans, phenotypic identification, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Emericella, taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Emmonsia, phenotypic identification, 10.10.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Emmons modification of Sabouraud medium, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>emm typing, 13.2.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>emm typing of group A streptococci, 13.2.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Empedobacter brevis, identification, 3.19.11, 3.19.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Empyema, respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Encephalitis molecular panels, meningitis, 14.4.3.114.4.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>additional reporting comments, 14.4.3.614.4.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory result interpretation and reporting, 14.4.3.514.4.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 14.4.3.714.4.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.4.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.4.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>proficiency testing, 14.4.3.314.4.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>provider result interpretation, 14.4.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>resolution of discrepant results, 14.4.3.414.4.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 14.4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection and handling, 14.4.3.114.4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen storage, 14.4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>verification panels, 14.4.3.214.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Encephalitis, potential etiological agents, 2.1.152.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Encephalitozoon</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast modified trichrome stain, 11.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified trichrome-Ryan blue stain, 11.4.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified trichrome-Weber green, 11.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Encephalitozoon intestinalis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast modified trichrome stain, 11.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnosis, 11.4.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.414.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified trichrome-Ryan blue stain, 11.4.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified trichrome-Weber green, 11.4.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Encephalopathy, transmissible spongiform, 17.5.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Endocarditis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intravenous, 2.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>native valve, 2.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.82.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>prosthetic valve, 2.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vascular graft infection, 2.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Endocervical swabs, NAAT testing, 14.3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Endocervix, 2.1.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>N. gonorrhoeae cultures, 3.8.3.1, 3.8.3.2, 3.8.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Endogenous viruses contamination, viral monolayer cell cultures, 12.7.612.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Endolimax nana</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification versus Dientamoeba fragilis trophozoites, 11.11.3.911.11.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>identification versus Iodamoeba betschlii trophozoites, 11.11.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nuclear variants, 11.11.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>trophozoites, 11.11.3.911.11.3.10, 11.11.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Endometritis, 2.1.12, 3.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Endometrium, 2.1.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.8.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Endomyometritis, postpartum, 3.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Endoparametritis, postpartum, 3.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Endophthalmitis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacterial, 3.9.2, 3.9.4, 3.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Endoscopic retrograde cholangiopancreatography (ERCP), 15.4.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Endotoxin(s), 15.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Endotoxin-mediated pyrogenic reactions, 15.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Endotoxin testing, 15.3.6.115.3.6.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Endotracheal (ET) aspirates specimens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.10.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing and culture examination, 3.10.2.7, 3.10.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quantitative culture, 3.10.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.10.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enflagellation experiment, 11.9.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Engineering and design controls to minimize contamination, 14.2.2.114.2.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Engineering controls, 17.3.4.117.3.4.2, 17.9.317.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Engyodontium album, nonsterile respiratory sites, 10.10.38</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enriched media, anaerobes, 4.4.1.1, 4.4.1.54.4.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entamoeba</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autofluorescence, 11.4.7.2, 11.4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cyst morphology, 11.11.3.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct smears, 11.3.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formalin-ethyl acetate sedimentation, 11.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>organism identification</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Entamoeba coli versus Entamoeba histolytica/E. dispar precysts and cysts, 11.11.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entamoeba cyst morphology, 11.11.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entamoeba histolytica/E. dispar cyst versus PMN, 11.11.3.611.11.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entamoeba histolytica/E. dispar precyst versus PMN, 11.11.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entamoeba histolytica/E. dispar versus Entamoeba coli trophozoites, 11.11.3.111.11.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entamoeba histolytica trophozoite versus human macrophage, 11.11.3.411.11.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zinc sulfate flotation, 11.3.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Entamoeba bangladeshi, 11.11.2.11, 11.11.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Entamoeba coli</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cysts, 11.11.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct smears, 11.3.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification versus Entamoeba histolytica/E. dispar precysts and cysts, 11.11.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>identification versus Entamoeba histolytica/E. dispar trophozoites, 11.11.3.111.11.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy specimen, permanent stained smear, 11.6.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>trophozoites, 11.11.3.111.11.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Entamoeba dispar</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays, 11.11.2.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.211.11.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy specimen, direct wet smear, 11.6.2.111.6.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 11.2.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Entamoeba gingivalis</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>expectorated sputum, 11.7.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sputum expectorated, 11.7.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Entamoeba hartmanni</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Entamoeba histolytica</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.211.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture, 11.7.3.211.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>expectorated sputum, 11.7.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays, 11.11.2.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5, 14.4.1.914.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, trophozoite versus human macrophage, 11.11.3.411.11.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.211.11.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy specimen</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct wet smear, 11.6.2.111.6.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained smear, 11.6.3.111.6.3.4, 11.6.3.311.6.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sputum expectorated, 11.7.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.511.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Entamoeba histolytica/dispar group, artifacts mimicking, 11.11.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entamoeba histolytica/E. dispar</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cysts, 11.11.3.611.11.3.7, 11.11.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays, 11.11.2.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>of cyst versus PMN, 11.11.3.611.11.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>versus Entamoeba coli precysts and cysts, 11.11.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>versus Entamoeba coli trophozoites, 11.11.3.111.11.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>of precyst versus PMN, 11.11.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>iron hematoxylin stain (modified Spencer-Monroe method), 11.3.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained smear (trichrome), 11.3.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>precysts, 11.11.3.6, 11.11.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy specimen, permanent stained smear, 11.6.3.111.6.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 2.1.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>trophozoites, 11.11.3.111.11.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Entamoeba moshkovskii, 11.11.2.11, 11.11.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enteric bacteria, genital infections, 3.8.1.2, 3.8.1.3, 3.8.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enteric Gram-negative rods, 3.12.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterobacter</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1, 7.15.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), testing and reporting considerations, 7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood products, 15.4.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>malonate test, 3.17.28.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterobacter aerogenes</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acanthamoeba and Naegleria culture, 11.9.1.211.9.1.3, 11.9.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Andrades fermentation medium, 16.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>heart infusion fermentation base, 16.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenol red agar, 16.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>purple broth, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterobacterales, 7.3.1, 7.21.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar media, 15.7.4.215.7.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1, 7.15.2, 7.15.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.37.1.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>breakpoints, 7.1.2.67.1.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.9, 7.23.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.2, 7.23.5, 7.23.6, 7.23.7, 7.23.8, 7.23.9, 7.23.10, 7.23.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autopsy blood cultures, 5.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth media, 15.7.4.315.7.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.5, 7.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbapenemase, 7.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>carbapenem-resistant, 7.20.9, 15.7.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catheter-related bloodstream infection, 5.12.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.13.17.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>conjunctivitis, 3.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.23.17.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.7, 7.2.9, 7.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.1, 3.17.16.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>extended-spectrum beta-lactamase testing for Enterobacterales, 7.14.17.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gelatin liquefaction, 3.17.18.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 3.17.22.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory transport and storage, 15.7.4.515.7.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>malonate test, 3.17.28.13.17.28.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.1, 3.17.32.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>minimum bactericidal concentration testing, 7.17.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.1, 3.17.30.33.17.30.4, 18.15.5.1, 18.15.5.2, 18.15.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MUG (4-methylumbelliferyl--D-glucuronide) test, 3.17.33.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multidrug-resistant, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.1, 3.10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nitrate/nitrite reduction test, 3.17.34.1, 3.17.34.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nucleic acid-based assays, 15.7.4.415.7.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ONPG (o-nitrophenyl--D-galactopyranoside) test, 3.17.36.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oxidase test, 3.17.38.23.17.38.3, 18.15.1.2, 18.15.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenylalanine deaminase (PDA) test, 3.17.39.1, 3.17.39.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid non-nucleic acid-based tests, 15.7.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.3.13.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>screening method selection, 15.7.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>selection of culture sites, 15.7.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serum inhibitory and bactericidal titers, 7.18.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 15.7.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 15.7.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole test, 18.15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>time-kill assay, 7.17.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.1, 3.17.24.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1, 3.17.46.3, 18.15.6.1, 18.15.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterobacterales coli, MALDI-TOF, 6.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterobacterales Shigella, MALDI-TOF, 6.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterobacter cloacae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.23.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbapenemase, 7.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase (Moeller) broth, 16.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of antimicrobial susceptibility test systems, 7.22.8, 7.22.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hydrogen sulfide production, 3.17.21.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF, 6.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterobacteriaceae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acetate utilization test, 3.17.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbapenem-resistant, 15.5.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>evaluation and verification of antimicrobial susceptibility test systems, 7.22.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.9, 3.7.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital tract, 3.8.1.1, 3.8.1.4, 3.8.1.9, 3.8.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.3, 3.19.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>multidrug-resistant, 15.7.6.1, 15.7.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxidase test, 3.17.38.2, 3.17.38.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>peritoneal fluid, 3.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sequencing-based identification, 14.5.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>small bowel, 3.7.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess and soft tissue cultures, 3.12.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterobius vermicularis, 11.1.21, 11.3.1.1, 11.3.1.2, 11.6.1.111.6.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autofluorescence, 11.4.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autofluorescence of eggs, 11.4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gross examination, 11.10.1, 11.10.3, 11.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen handling, 11.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enteroblastic, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterocloster</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical characteristics of, 4.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gram stain and colonial morphology of, 4.14.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterocloster aldenensis, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterocloster bolteae, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterocloster citroniae, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterocloster clostridioformis, 4.2.2, 4.14.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution (MIC) test, 7.4.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterocloster lavalensis, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterococci, 3.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.63.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.13.17.30.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.1, 3.17.42.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterococcus, 7.21.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial disk tests, 3.17.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.4, 7.20.6, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.2, 7.23.3, 7.23.9, 7.23.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autopsy blood cultures, 5.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile-esculin and esculin tests, 3.17.5.13.17.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.6, 7.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.1, 3.17.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catheter-related bloodstream infection, 5.12.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.7, 7.2.9, 7.2.12, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of antimicrobial susceptibility test systems, 7.22.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital tract, 3.8.1.1, 3.8.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-level aminoglycoside resistance (HLAR) in, 7.12.17.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.3, 3.18.8, 3.18.9, 3.18.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>leucine aminopeptidase test, 3.17.25.1, 3.17.25.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methyl glucopyranoside test, 3.17.29.13.17.29.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>minimum bactericidal concentration testing, 7.17.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.33.17.30.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>practical guide to workup, 4.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.13.17.40.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.1, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serum inhibitory and bactericidal titers, 7.18.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>time-kill assay, 7.17.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.1, 3.11.1.3, 3.11.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.5, 3.12.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterococcus asini, 3.18.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterococcus avium, 3.18.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterococcus casseliflavus, 3.17.29.1, 3.17.29.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>chromogenic media, 5.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>motility tests, 3.17.30.33.17.30.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vancomycin-resistant agar screen test, 7.13.17.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterococcus dispar, 3.18.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterococcus durans, 3.18.8, 7.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterococcus faecalis, 3.18.8, 7.21.3, 7.3.1, 7.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation of agar and broth media, 7.24.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.4, 7.20.6, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile-esculin and esculin tests, 3.17.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bile solubility test, 3.17.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 5.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood products, 15.4.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.2, 7.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>chromogenic media, 5.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cysteine proteose peptone agar, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>deoxycholate agar, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.4, 7.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>eosin methylene blue, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>esculin hydrolysis medium, 16.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>group B streptococcus cultures, 3.8.2.6, 3.8.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hematopoietic stem cell products, 15.4.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>high-level aminoglycoside resistance (HLAR), 7.12.2, 7.12.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>high-level mupirocin resistance, 7.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>leucine aminopeptidase test, 3.17.25.1, 3.17.25.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mac Conkey-sorbitol agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MAC medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methyl glucopyranoside test, 3.17.29.13.17.29.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MRS broth, 3.17.31.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>optochin susceptibility test, 3.17.37.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>positive blood culture broth, 5.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pyruvate broth, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Salmonella-Shigella agar (SS) test, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>screening, 15.7.3.1, 15.7.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>starch hydrolysis test, 3.17.45.2, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Todd-Hewitt broth, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vancomycin resistance, 7.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>vancomycin-resistant, 7.13.27.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>X</title>
            <indexentry>
               <primaryie>xylose lysine deoxycholate agar, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>Yersinia selective agar, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterococcus faecium, 7.21.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial stewardship program, 15.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>chromogenic media, 5.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of antimicrobial susceptibility test systems, 7.22.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-level aminoglycoside resistance, 7.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.3, 3.18.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methyl glucopyranoside test, 3.17.29.13.17.29.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>positive blood culture broth, 5.13.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>screening, 15.7.3.1, 15.7.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vancomycin-resistant, 3.17.29.13.17.29.3, 7.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterococcus gallinarum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>chromogenic media, 5.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methyl glucopyranoside test, 3.17.29.1, 3.17.29.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.23.17.30.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vancomycin-resistant, agar screen test, 7.13.17.13.4, 7.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterococcus gilvus, 3.18.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterococcus hirae, 3.18.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterococcus malodoratus, 3.18.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterococcus mundtii, 3.18.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterococcus pallens, 3.18.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterococcus pseudoavium, 3.18.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterococcus raffinosus, 3.18.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterococcus spp., beta-lactamase test, 7.7.67.7.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterococcus sulfureus, 3.18.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterococcus(i), vancomycin-resistant. See Vancomycin-resistant enterococci (VRE)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterocytozoon</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterocytozoon bieneusi, 11.4.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast modified trichrome stain, 11.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnosis, 11.4.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.414.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified trichrome-Ryan blue stain, 11.4.4.1, 11.4.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterohemorrhagic E. coli (EHEC), 3.7.1.1, 3.7.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enteroinvasive E. coli (EIEC), 3.7.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enteromonas hominis, report comments, 11.11.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enteropathogenic E. coli (EPEC), 3.7.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterotoxigenic E. coli (ETEC), 3.7.1.3, 3.7.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterovirus D68, specimen collection, 2.1.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enteroviruses</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enterovirus type 68, clinical manifestations, 12.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterovirus type 70, clinical manifestations, 12.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enterovirus type 71, clinical manifestations, 12.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>En thyrse, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entomophthoromycota, 10.10.1, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entral nervous system, specimen collection, for bacteriology, 2.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Enumeration for aerobic cultures, 3.3.2.2, 3.3.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Environmental monitoring (EM), 15.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>air sampling, 15.3.1.115.3.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Environmental sampling and cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>air cultures for fungi, 15.4.3.115.4.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture of blood and cellular therapy products in blood banking, 15.4.5.115.4.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture of hospital water for Legionellaceae, 15.4.1.115.4.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedure, 15.4.1.815.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pre-and postimplant testing of medical devices, 3.6.13.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Environmental specimens and substances, 17.5.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Environmental surface testing, 15.4.4.115.4.4.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>collection and assay of specimens, 15.4.4.515.4.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>collection devices, 15.4.4.215.4.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>considerations before undertaking, 15.4.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture workup, 15.4.4.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 15.4.4.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media, 15.4.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>monitoring plan, 15.4.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 15.4.4.115.4.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 15.4.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rinse fluid, 15.4.4.5, 15.4.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>choice of fluid, 15.4.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture methods for, 15.4.4.5, 15.4.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sampling methods, 15.4.4.6, 15.4.4.815.4.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>comparison of, 15.4.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dipslides, 15.4.4.3, 15.4.4.6, 15.4.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>direct sampling methods, 15.4.4.3, 15.4.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Petrifilm, 15.4.4.3, 15.4.4.6, 15.4.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rinse sampling method (containment), 15.4.4.6, 15.4.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rinse sampling method (direct immersion), 15.4.4.6, 15.4.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RODAC, 15.4.4.3, 15.4.4.6, 15.4.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sponge-rinse method, 15.4.4.6, 15.4.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>swab-rinse method, 15.4.4.6, 15.4.4.815.4.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wipe-rinse method, 15.4.4.6, 15.4.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enzyme-linked immunoassays (EIAs), 10.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>C. difficile, 4.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coccidioides, 13.14.1.1, 13.14.4.113.14.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>competitive, 13.1.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>detection of Borrelia burgdorferi antibodies, 13.6.513.6.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hepatitis A virus (HAV), 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hepatitis B virus (HBV), 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hepatitis C virus (HCV), 13.11.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Histoplasma capsulatum, 13.13.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for HIV, 13.10.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>human immunodeficiency virus (HIV), 13.10.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>noncompetitive, 13.1.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>SARS-CoV-2, 13.7.313.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>syphilis, 13.5.1.3, 13.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trep-Sure enzyme immunoassay, 13.5.6.113.5.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Enzyme-linked immunosorbent assay (ELISA)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brucella, 13.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cytomegalovirus (CMV), 13.9.1.1, 13.9.2.113.9.2.4, 13.9.3.113.9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epstein-Barr virus (EBV), 13.8.3.113.8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Francisella tularensis antibodies detection, 13.4.3.113.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.4.3.213.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.4.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.4.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.4.3.113.4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 13.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.4.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SARS-CoV-2, 13.7.113.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Eosin methylene blue (EMB), 3.3.2.2, 3.3.2.4, 16.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic culture, 3.3.1.3, 3.3.1.6, 3.3.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>EPEC (enteropathogenic E. coli), 3.7.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Epicoccum nigrum, toenails and fingernails, 10.10.43</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Epidemic nosocomial infections, 15.5.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Epidemiological cutoff value (ECV), 7.1.2.17.1.2.2, 10.13.110.13.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.1.11, 10.13.110.13.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epidemiology</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>environmental sampling and cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>air cultures for fungi, 15.4.3.115.4.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture of blood and cellular therapy products in blood banking, 15.4.5.115.4.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture of hospital water for Legionellaceae, 15.4.1.115.4.1.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture of human cadaveric tissues for transplantation, 15.4.6.115.4.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hematopoietic stem cell products, 15.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pre-and postimplant testing of medical devices, 3.6.13.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>infection control in laboratory</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hand hygiene, 17.2.5.117.2.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunization, 15.8.1.115.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>investigation of laboratory exposures, 15.8.3.115.8.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory support of blood-borne pathogen exposures, 15.8.2.115.8.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory isolation codes and notification fan-out for suspected biosafety risk Group 3 and 4 microorganisms, 15.8.4.115.8.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory support for infection prevention, 15.2.115.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>outbreak investigations</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>collection and storage of isolates, 15.5.2.115.5.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>collection and tracking of surveillance and clinical specimens, 15.5.1.115.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>public health reporting, 15.5.4.115.5.4.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>systematic analysis of nosocomial outbreaks, 15.5.3.115.5.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunocompromised hosts, 15.7.6.115.7.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methicillin-resistant S. aureus, 15.7.2.115.7.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multidrug-resistant Acinetobacter baumannii, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multidrug-resistant Enterobacterales, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multidrug-resistant Pseudomonas aeruginosa, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vancomycin-resistant enterococci, 15.7.3.115.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>surveillance, infection surveillance prior to transplantation, 15.7.7.115.7.7.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epidermophyton, 10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, broth dilution, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.12, 10.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epidermophyton floccosum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BCP milk glucose test, 10.10.2210.10.23, 10.10.29</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.32, 10.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epididymis, Neisseria gonorrhoeae, 3.8.3.23.8.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Epididymitis, 3.8.1.4, 3.8.1.63.8.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Epidural abscess, 2.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Epiglottitis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epstein-Barr virus (EBV)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.6, 13.8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>versus cytomegalovirus (CMV), 13.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnosis, 13.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor screening, 15.7.7.315.7.7.4, 15.7.7.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>encephalitis, 14.3.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>etiology and pathogenesis, 13.8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>infections, overview, 14.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular diagnostics, 14.3.7.114.3.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>EBV-specific antibodies, 13.8.1.113.8.1.2, 13.8.3.113.8.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>heterophile antibodies, 13.8.1.113.8.1.2, 13.8.2.113.8.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.8.1.113.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>virus-specific antibodies, 13.8.1.2, 13.8.3.113.8.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.33</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>viral load testing, 14.2.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epstein-Barr virus-specific antibodies, 13.8.1.113.8.1.2, 13.8.3.113.8.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Equipment</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decontamination, 17.1.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>to minimize contamination in molecular diagnostics, 14.2.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitology, 11.1.111.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>personal protective, 17.3.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>prions, 17.5.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 16.2.25, 16.2.26</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sterilization, 17.1.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Error(s)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>classification, 16.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>defined, 16.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>detection, 16.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>random review, 16.1.2, 16.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reported error description log, 16.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reported error summary, 16.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>threshold, 16.1.4, 16.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>tracking for quality assurance, 16.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Ertapenem (Invanz)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Erysipelas, 2.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Erysipelothrix, 3.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gelatin liquefaction, 3.17.18.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hydrogen sulfide production, 3.17.21.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Erysipelothrix rhusiopathiae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar screen test for vancomycin-resistant enterococci, 7.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gelatin liquefaction, 3.17.18.13.17.18.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hydrogen sulfide production, 3.17.21.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.5, 3.18.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Erythema migrans, 2.1.12, 13.6.113.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Erythromycin (Dynabac)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.8, 7.4.1.10, 7.4.1.11, 7.4.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxacillin salt-agar test, 7.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL(s). See Extended-spectrum beta-lactamase(s)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Escherichia coli, 7.3.1, 7.3.3, 7.3.5, 7.3.6, 7.21.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acanthamoeba and Naegleria culture, 11.9.1.211.9.1.3, 11.9.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acanthamoeba or Naegleria culture, 11.9.1.211.9.1.3, 11.9.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acetamide utilization test, 3.17.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acetate agar, 16.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acetate utilization test, 3.17.2.13.17.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acid-fast stain, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acridine orange stain, 3.2.2.2, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.2, 7.6.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1, 7.15.2, 7.15.3, 7.15.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Andrades fermentation medium, 16.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial disk test, 3.17.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.6, 7.22.8, 7.22.12, 7.22.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation of agar and broth media, 7.24.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.3, 7.20.6, 7.20.8, 7.20.12, 7.20.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.3, 7.23.5, 7.23.6, 7.23.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>B. cepacia agar, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>beta-hemolytic Streptococcus agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BHI medium, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bile-esculin and esculin tests, 3.17.5.2, 3.17.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood agar base, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 5.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood products, 15.4.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bordetella cultures, 3.10.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bromcresol green agar, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.2, 7.4.1.9, 7.4.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calcofluor white stain, 11.4.8.211.4.8.3, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Campylobacter agars, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. difficile agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cetrimide agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cetrimide test, 3.17.11.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CHOC media, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.1, 3.17.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.34.4.1.5, 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cystine lactose electrolyte-deficient agar, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>deoxycholate agar, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>dermatophyte test, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.47.2.5, 7.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>eosin methylene blue, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ESBL testing, 7.14.17.14.5, 7.14.77.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>esculin agars, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.1, 3.7.1.8, 3.7.1.15, 3.7.1.17, 3.7.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>filamentous fungi, 6.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>fluorescent-pigment agars, 3.17.17.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>fungus selection agar, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5, 14.4.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gelatin, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gelatin liquefaction, 3.17.18.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>genital tract, 3.8.1.1, 3.8.1.2, 3.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-negative broth, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.6, 16.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>heart infusion fermentation base, 16.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hektoen enteric agar, 16.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hospital water, 15.4.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 3.17.22.23.17.22.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ingestion, 17.1.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inhibitory mold agar, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laked blood agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Legionella agars, 16.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lowenstein-Jensen medium, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mac Conkey-sorbitol agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MAC medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>malonate broth, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>malonate test, 3.17.28.13.17.28.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mc Farland standards, 7.24.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>meningitis, 3.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methyl redVoges-Proskauer (MR-VP) medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.33.17.32.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Middlebrook medium, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility-indole-lysine medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility-indole-ornithine medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility test, 3.17.30.2, 16.2.11, 18.15.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MUG (4-methylumbelliferyl--D-glucuronide) test, 3.17.33.13.17.33.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>New York City agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nickerson-bismuth sulfite-glucose-glycineyeast agar, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nitrate/nitrite reduction test, 3.17.34.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nutrient base, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ONPG (o-nitrophenyl--D-galactopyranoside) test, 3.17.36.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oxidase test, 3.17.38.2, 18.15.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenol red agar, 16.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenylalanine agar, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenylalanine deaminase (PDA) test, 3.17.39.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>positive blood culture broth, 5.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>purple broth, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.13.17.40.3, 3.17.40.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Regan-Lowe pertussis transport medium, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sabouraud medium, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Salmonella-Shigella (SS) agar, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>shipping of verotoxigenic, 17.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Simmons citrate agar, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>solid media used for isolation of mycobacteria, 9.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole test, 18.15.3.118.15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus group B selective broth, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance cultures, 15.7.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>TCBS medium, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>transfusion reactions, 5.11.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>triple-sugar iron agar (TSI), 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>tryptic soy agar or broth, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>tryptone medium, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urea broth or agar, 16.2.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urease test, 3.17.46.3, 18.15.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urine culture, 3.11.1.1, 3.11.1.10, 3.11.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.6, 3.12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>X</title>
            <indexentry>
               <primaryie>xylose lysine deoxycholate agar, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>Yersinia selective agar, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Escherichia coli O157</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>collection and storage of outbreak isolates, 15.5.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AST, 3.7.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>and Campylobacter, 3.7.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CT-SMAC or CHROMagar, 3.7.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inoculation of media, 3.7.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>latex agglutination, 3.7.1.203.7.1.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.7.1.63.7.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.7.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.7.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 3.7.1.15, 3.7.1.17, 3.7.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mac Conkey-sorbitol agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MUG (4-methylumbelliferyl--D-glucuronide) test, 3.17.33.1, 3.17.33.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Escherichia coli O157: H7, surveillance, 15.5.4.7, 15.5.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Escherichia hermannii, 3.7.1.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Esculin agar, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Esculin hydrolysis medium, 8.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Esculin test, 3.17.5.13.17.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Esophagitis, respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ESP (Electronic Support for Public Health), 15.5.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Espundia, 11.9.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Essential agreement, 7.22.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ET. See Endotracheal</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ETEC (enterotoxigenic E. coli), 3.7.1.1, 3.7.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Etest</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ESBL testing, 7.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vancomycin resistance in Staphylococcus aureus, 7.9.17.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Ethambutol (EMB), 9.9.3.2, 9.9.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar proportion method, 9.8.19.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK automated microbial detection system, 9.7.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Ethanol, as perservative, 11.2.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ethionamide, 9.9.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar proportion method, 9.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Ethionamide (ETH) resistance, Cepheid Xpert MTB/XDR test, 9.6.3.1, 9.6.3.59.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ethylacetate, 11.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>EUA (Emergency Use Authorization), 1.2.4.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eubacterium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical correlations, 4.14.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy update, 4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Eubacterium callanderi, 4.14.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eubacterium lentum, 7.20.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eubacterium limosum, 4.14.4, 4.14.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>glutamic acid decarboxylase (GDC), 4.9.15.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Eubacterium nodatum, 4.14.4, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>EUCAST</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing microdilution method, 10.12.1.110.12.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.1, 7.14.47.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inducible clindamycin resistance, 7.11.1, 7.11.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>EUCAST rapid antimicrobial susceptibility test (RAST) method, 7.3.17.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>European Committee on Antimicrobial Susceptibility Testing (EUCAST)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AST breakpoints, 7.1.2.17.1.2.4, 7.1.2.67.1.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.17.2.13, 7.2.177.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MIC interpretation, 7.4.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Eurotiales, temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eurotium, ascomo, 10.10.47</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Euruncles, 2.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Evaluation, tests and use of test results, 16.1.2, 16.1.3, 16.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Evanescent, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Evans, Alice, 18.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Evans modified Tobies medium, 11.9.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Exact Diagnostics (Bio-Rad), syndromic panels, 14.4.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Exempt human or animal specimens, 17.6.11, 17.6.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Exempt substances, shipping, 17.6.7, 17.6.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Exiguobacterium acetylicum, identification, 3.18.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Exoantigen testimmunodiffusion agar, 10.10.5110.10.52</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Exoantigen testing, 10.10.7, 10.10.1510.10.18, 10.10.37</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Exogenous viruses contamination, viral monolayer cell cultures, 12.7.612.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Exophiala, 10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>annellide, 10.10.47</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing by broth dilution, 10.12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation temperature, 10.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.13, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.4, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.4, 10.5.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Exophiala dermatitidis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation temperature, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.43</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Exophiala infection, 15.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>from contaminated injectable steroids, 15.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Exophiala jeanselmei</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Exophiala mesophila, temperature tests, 10.10.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Exophiala moniliae, temperature tests, 10.10.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Exophiala spinifera, temperature tests, 10.10.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Expanded antimicrobial susceptibility testing (ExAST), 15.7.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Expectorated sputum specimen for direct-mount and stained preparations, 11.7.1.111.7.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Expiration date, 16.2.20, 16.2.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Exserohilum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Extended-spectrum beta-lactamase(s) (ESBLs)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.14.17.14.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.14.47.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC method, 7.14.67.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion method, 7.14.47.14.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedure notes, 7.14.77.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.14.4, 7.14.97.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 7.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.14.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance cultures, 15.7.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing for Enterobacterales, 7.14.17.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Extensively drug-resistant (XDR), Cepheid Xpert MTB/XDR test, 9.6.3.19.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>External assessments, quality assurance, 16.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>External auditory canal, fungal specimens, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>External quality assessment (EQA), quality assurance, 16.1.116.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Extracted water control, 14.2.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Extranodal NK/T-cell lymphoma, nasal type, 14.3.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>EYA (egg yolk agar), 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eye infections, potential etiological agents, 2.1.142.1.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eyelid infections, 2.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eye protection, 17.3.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Eyes</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common infections, 3.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular cultures, 3.9.13.9.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection for bacteriology, 2.1.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, parasites, 2.1.36, 11.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Ezakiella coagulans, 4.2.3, 4.13.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>F</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Face protection, 17.3.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Facklamia, identification, 3.18.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Faecalibacterium prausnitzii, 4.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Faecalicatena contorta, 4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Faecalicatena fissicatena, 4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Faecalimonas, 4.14.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Faecalimonas umbilicata, 4.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fair market value, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fallopian tube(s), specimen collection, 3.8.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>False Claim Act, 1.1.4, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Falseniella, identification, 3.18.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fannyhessea vaginae, 4.2.2, 4.14.4, 4.14.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical correlations, 4.14.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Far Eastern subtype, laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fasciitis, necrotizing, 2.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fasciola, gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fasciola hepatica</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fasciolopsis buski</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fastidious anaerobe agar (FAA), 4.4.1.1, 4.4.1.3, 4.4.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fastidious anaerobe broth, 4.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fastidious bacillus, identification, 3.19.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fastidious organisms, 5.11.3.15.11.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fat, qualitative fecal, 11.5.7.111.5.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Favic chandeliers, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>FBI (Federal Bureau of Investigation), 18.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>FBS (fetal bovine serum), 12.7.3, 12.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>FDA, approved assays</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hepatitis A virus (HAV) serology, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hepatitis B virus (HBV) serology, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hepatitis C virus (HCV) serology, 13.11.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>FDA-cleared or approved syndromic panels, 14.4.2.114.4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fecal culture</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 3.7.1.13.7.1.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter and related organisms, 3.7.2.13.7.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture methods, 3.7.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of culture media, 3.7.1.93.7.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>H. pylori, 3.7.3.13.7.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.7.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.7.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.7.1.53.7.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>plating media for Salmonella and Shigella, 3.7.1.1, 3.7.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 3.7.1.13.7.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.7.1.93.7.1.15, 3.7.1.203.7.1.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.7.1.73.7.1.9, 3.7.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quantitative small-bowel contents, 3.7.4.13.7.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.7.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.7.1.153.7.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.7.1.43.7.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>order of inoculation media, 2.1.38</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.7.1.43.7.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fecal fat, qualitative, 11.5.7.111.5.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fecal immunoassays</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>flowchart, 11.11.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>for intestinal protozoa, 11.11.2.2311.11.2.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fecal leukocytes, 3.2.4.13.2.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fecal specimens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts, parasite, 11.11.1.111.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.114.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites (See Parasite(s), fecal specimens; Parasitology, fecal specimens)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>qualitative fecal fat, 11.5.7.111.5.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quality indicators, 16.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 2.1.262.1.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wet mount, bacteria, 3.2.4.13.2.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Federal Bureau of Investigation (FBI), 18.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Federal level laboratories, 18.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fee-for-service, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Female genital tract</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic specimen collection, 4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic specimen selection, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cultures (See Genital cultures)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>infections, 3.8.1.1, 3.8.1.23.8.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.8.1.53.8.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fermenters, 3.17.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ferric ammonium citrate reagent, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ferric chloride, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fetal bovine serum (FBS), 12.7.3, 12.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fetal tissue, 2.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fevers, potential etiological agents, 2.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fever watch, bioterrorism agents, 18.14.31</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Filamentous fungi, 6.5.16.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.2.310.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>by broth dilution, 10.12.1.710.12.1.8, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.410.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calibration and quality control, 6.5.46.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 6.5.96.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI Biotyper (MBT) CA system, 6.5.26.5.5, 6.5.76.5.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MALDI-TOF, 6.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 6.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 6.5.56.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents and equipment, 6.5.16.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 6.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sequencing-based identification, 14.5.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 6.5.36.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VITEK MS, 6.5.2, 6.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Filariae, blood films, 11.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Filariasis, 11.6.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine concentration, 11.6.7.111.6.7.4, 11.6.8.111.6.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Filifactor, 4.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Filifactor alocis, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Filiform, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Film Array meningitis/encephalitis molecular panels, 14.4.3.1, 14.4.3.4, 14.4.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Filoviridae, high-consequence viral pathogens, 18.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Filoviruses, 18.12.218.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.33</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Filters (cassette), 15.4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Filtration, laboratory water, 16.3.1, 16.3.316.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Final report, 16.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Finegoldia, 4.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Finegoldia magna, 4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Finegoldia magna, 4.15.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fine-needle aspirates (FNA), 3.12.1.10, 3.12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.7.2.111.7.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitology, 11.7.2.311.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fishbone diagrams, 16.1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fish tapeworms, gross examination, 11.10.1, 11.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fistula, 2.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>FITC (Fluorescein isothiocyanate), 12.9.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>FITC (fluorescein isothiocyanate)labeled monoclonal antibody, 13.5.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>5</title>
            <indexentry>
               <primaryie>5-Flucytosine (5-FC), antifungal susceptibility testing</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.210.12.1.4, 10.12.1.6, 10.12.1.910.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fixation and preservation of parasitology specimens, quality control, 11.2.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fixatives, parasitology, 11.2.2.111.2.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>formalin (5 or 10%), 11.2.2.611.2.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>merthiolate (thimerosal)-iodine-formalin (MIF), 11.2.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>polyvinyl alcohol (PVA), 11.2.2.2, 11.2.2.311.2.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Schaudinns fixative, 11.2.2.2, 11.2.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>single-vial alcohol-based fixatives, 11.2.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sodium acetate-acetic acid-formalin (SAF), 11.2.2.2, 11.2.2.511.2.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Flagellates</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.1, 11.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Flagellum stain, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Flagyl (metronidazole), 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Flaviviruses, 13.12.1, 13.12.2, 18.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Flavobacterium, 3.10.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Flavonifractor plautii, 4.2.3, 4.14.1, 4.14.4, 4.14.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fleas, gross examination, 11.10.1, 11.10.4, 11.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fletchers Leptospira medium, 3.13.13.13.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Flowcharts, 3.1.2, 16.1.1.4, 16.1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Floxin (ofloxacin), 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fluconazole, antifungal susceptibility testing, 10.13.2, 10.13.3, 10.13.8, 10.13.9, 10.13.10, 10.13.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.210.12.1.4, 10.12.1.6, 10.12.1.910.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fluconazole, disk diffusion, 10.12.2.2, 10.12.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Flucytosine, antifungal susceptibility testing, 10.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fluids, specimen processing, 3.3.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Flukes, key characteristics, 11.11.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fluorescein, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fluorescein isothiocyanate (FITC), 12.9.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fluorescein isothiocyanate (FITC)labeled monoclonal antibody, 13.5.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fluorescence</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.9.8.14.9.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram-negative bacilli, 4.13.124.13.13, 4.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>IFA (immunofluorescence assay), 13.1.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fluorescence assays, fecal immunoassays for intestinal protozoa, 11.11.2.2311.11.2.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fluorescent antibody staining of antigens, influenza, 18.9.718.9.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fluorescent-pigment agars, Pseudomonas, 3.17.17.13.17.17.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fluorescent treponemal antibody absorption (FTA-ABS) test, 13.5.1.3, 13.5.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fluorochrome stain, 9.2.3.29.2.3.4, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fluoroquinolone (FLQ) resistance, Cepheid Xpert MTB/XDR test, 9.6.3.1, 9.6.3.49.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fluoroquinolones</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.9, 7.4.1.16, 7.4.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.3, 7.23.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fly larvae, gross examination, 11.10.1, 11.10.411.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>F. magna, 4.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.15.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>FNA (fine-needle aspiration), 3.12.1.10, 3.12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>F. necrophorum, spot indole, 4.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>F. nucleatum, spot indole, 4.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Focus Diagnostics VZV ASR, 14.3.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>FOCUS summary, 16.1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Folate pathway inhibitors, 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Foley catheter, 2.1.19, 2.1.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Folliculitis, 2.1.12, 3.12.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fonsecaea, microscopic examination, 10.4.1.13, 10.4.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fonsecaea pedrosoi, phenotypic identification, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Food and Drug Administration (FDA), 1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AST breakpoints, 7.1.2.17.1.2.3, 7.1.2.5, 7.1.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>documents, 1.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>FDA-cleared assays for anti-T. cruzi antibody detection, 13.15.213.15.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Foodborne illness, surveillance, 15.5.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>FoodNet, 15.5.4.715.5.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Food poisoning, potential etiological agents, 2.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Foot-and-mouth disease virus, 17.6.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Forget-Fredette agar, 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Formaldehyde, neutralizers of, 15.4.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Formaldehyde use (OSHA regulations), 11.11.6.111.11.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Formalin</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>current use in clinical laboratory, 11.11.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>harmful effects, 11.11.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Formalin-ethyl acetate sedimentation, 11.3.3.111.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 11.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 11.3.3.111.3.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 11.3.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 11.3.3.211.3.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 11.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 11.3.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 11.3.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results, 11.3.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 11.3.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Formalin-fixed, paraffin-embedded (FFPE), 18.12.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Formalin-fixed paraffin-embedded (FFPE) tissue, 14.2.3.1, 14.2.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Formalin (5 or 10%) for parasitology, 11.2.2.611.2.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fortaz. See Ceftazidime</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fosfomycin (Monurol), 7.23.3, 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Francisella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biosafety levels, 17.3.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.29</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.15, 3.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Francisella tularensis, 3.3.2.8, 18.6.118.6.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>-aminolevulinic acid (ALA) test, 3.17.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility, 18.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical tests, 18.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bioterrorism, 18.1.2, 18.6.118.6.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>case definition, 18.6.218.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vs. C. burnetii, 18.10.1, 18.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 18.14.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cultures, 18.6.618.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>destruction, 18.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.217.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination of cultures, 18.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>geographic distribution, 18.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>glandular, 18.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 18.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>highly pathogenic bacteria, 6.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.5, 18.6.618.6.7, 18.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation period, 18.6.2, 18.6.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inhalation, 17.1.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>intestinal, 18.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.1, 15.8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 18.6.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.6.318.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oculoglandular, 18.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oropharyngeal, 18.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oxidase test, 18.15.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 17.6.10, 17.6.35, 18.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>peritoneal fluid, 3.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypic tests, 18.15.7.1, 18.15.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pneumonic, 18.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive diagnosis, 18.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.6.118.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>readiness checklist, 18.14.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>recommended BSL, 18.14.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting, notification, and transfer, 18.6.718.6.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.3, 3.10.4.63.10.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.6, 3.10.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.2.5, 18.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>satellite test, 3.17.43.3, 18.15.8.1, 18.15.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent, 17.5.3.1, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance, 18.6.918.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sentinel level clinical laboratory, 18.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sentinel Level Clinical Microbiology Laboratory Guidelines, 18.14.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.6.918.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.6.418.6.5, 18.14.2018.14.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.6.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 18.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>typhoidal, 18.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>ulceroglandular, 18.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Francisella tularensis antibodies detection, 13.4.1.113.4.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agglutination</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>general notes and considerations, 13.4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.4.2.313.4.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.4.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.4.2.213.4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.4.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agglutination test, 13.4.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ELISA, 13.4.1.1, 13.4.3.113.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.4.3.213.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.4.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.4.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.4.3.113.4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 13.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.4.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serology, 13.4.1.113.4.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Francisella tularensis (tularemia), laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fraud, 1.1.5, 1.2.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fraud alerts, 1.2.4.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Freezer storage, 11.1.5, 17.4.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Frequency limits, 1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Frozen culture stock</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteriology, 16.2.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mycology, 16.2.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fructose, 16.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>FTA-ABS (fluorescent treponemal antibody absorption) test, 13.5.1.3, 13.5.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fume hood, 11.1.4, 11.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fungal amplification, deep amplicon sequencing, 14.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fungal contamination, viral monolayer cell cultures, 12.7.6, 12.7.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fungal culture</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>air, 15.4.3.115.4.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>air sampling device, 15.4.3.215.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 15.4.3.515.4.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 15.4.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonviable sampling, 15.4.3.715.4.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 15.4.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 15.4.3.415.4.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 15.4.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 15.4.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sample site selection, 15.4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sample volume, 15.4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 15.4.3.215.4.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surface sampling methods, 15.4.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary, 10.6.110.6.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 10.6.410.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 10.6.610.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 10.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microscopic examination, 10.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation of culture materials, 10.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 10.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting, 10.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>subsequent testing, 10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>useful tests, 10.6.310.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification on primary culture, 10.8.110.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>order of inoculation media, 2.1.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identification tests for yeast, 10.7.110.7.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens, 10.5.110.5.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation and examination of cultures, 10.5.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation of culture media, 10.5.610.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 10.5.210.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pretreatment, 10.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 10.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 10.5.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens, 10.5.110.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.110.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fungal infections</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor-derived, 15.7.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor screening, 15.7.7.815.7.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.1515.7.7.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fungal specimens, microscopic examination, 10.4.1.110.4.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood, 10.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bone and bone marrow, 10.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>brain, 10.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bronchial lavage, wash, 10.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>corneal scrapings, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CSF, 10.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>external auditory canal, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 10.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>India ink method, 10.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>KOH and KOH-DMSO mount, 10.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>KOH-calcofluor mount, 10.4.1.310.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 10.4.1.110.4.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>morphologies seen, 10.4.1.510.4.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mucocutaneous tissue, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nail, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nasal tissue, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>paranasal sinus, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>peritoneal fluid, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 10.4.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedures, 10.4.1.310.4.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>prostatic fluid/tissue, 10.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.4.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 10.4.1.1410.4.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>skin, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 10.4.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sputum, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stratum corneum, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>subcutaneous granules, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>subcutaneous tissue, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synovial fluid, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vaginal specimens, 10.4.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>vitreous, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fungal taxonomy and nomenclature, 10.2.110.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph versus teleomorph, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>classification, 10.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cryptic species, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incorporation of changes, 10.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reasons for name changes, 10.2.110.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>significance of species identification, 10.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>species complxes, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fungemia, 5.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fungi</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), broth dilution, 10.12.1.110.12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>classification, 10.1.1, 10.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 2.1.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>learning more, 10.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lysis of fungal cells, 10.11.3, 10.11.510.11.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mold identification on primary culture, 10.8.110.8.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>molecular identification of yeasts and molds, 10.11.110.11.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.1, 3.10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 10.1.110.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identification tests for yeast, 10.7.110.7.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.3.13.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety, 10.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.3, 2.1.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.110.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph versus teleomorph, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>classification, 10.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cryptic species and species complexes, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incorporation of taxonomic changes, 10.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>name changes, 10.2.110.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>significance of species identification, 10.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fungus(i)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dimorphic, 17.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>systemic, 17.3.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fungus selection agar, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Furadantin (nitrofurantoin), 7.20.9, 7.23.3, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fusarium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>air cultures for fungi, 15.4.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.2.310.12.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>by broth dilution, 10.12.1.8, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>continuous monitoring blood culture systems, 5.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>filamentous fungi, 6.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification on primary media, 10.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.1110.4.1.12, 10.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.3510.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sequencing-based identification, 14.5.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wounds, ulcers, and pus, 10.10.43</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fusarium oxysporum species complex, toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fusarium solani, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fusarium solani species complex, toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fusarium spp., 10.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fusarium verticillioides, AFST, broth dilution, 10.12.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fusarium verticilloides, AFST, disk diffusion, 10.12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fusobacteria</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lecithinase test, 4.9.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lipase test, 4.9.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fusobacterium, 4.13.1, 4.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-Alanyl-alanylaminopeptidase test, 4.9.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>API 20A systems, 4.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile test, 4.13.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical considerations, 4.13.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology, 4.13.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.34.4.1.4, 4.4.2.14.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.1, 4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescence, 4.13.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram-negative bacilli, 4.13.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain morphology, 4.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-alanyl-alanylaminopeptidase test, 4.9.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate and urease tests, 4.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special-potency antimicrobial agent disks, 4.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole test, 4.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fusobacterium mortiferum, 4.9.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-Alanyl-alanylaminopeptidase test, 4.9.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile test, 4.13.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.13.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.13.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-alanyl-alanylaminopeptidase test, 4.9.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>practical guide to workup, 4.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fusobacterium naviforme, MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fusobacterium necrophorum, 4.13.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile test, 4.13.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.13.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.34.4.1.4, 4.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.13.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lemierres syndrome, 4.13.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lipase test, 4.9.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special-potency disks, 4.9.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole test, 4.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fusobacterium nucleatum, 4.11.2, 4.13.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.11.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic incubation system monitoring, 4.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brucella agar, 16.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.13.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.34.4.1.4, 4.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>glutamic acid decarboxylase (GDC), 4.9.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain morphology, 4.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 4.9.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lemierres syndrome, 4.13.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate disk reduction test, 4.9.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tryptic soy blood agar, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wilkins-Chalgren anaerobic medium, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fusobacterium selective agar, 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Fusobacterium spp.</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>fluorescence, 4.9.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification by special-potency antimicrobial agent disks, 4.9.5.14.9.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>Fusobacterium varium, 4.9.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile test, 4.13.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.13.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>G</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Galactitol, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Galactose, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gallicola, 4.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gallicola barnesae, 4.15.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gamma-hemolysis, 3.3.2.2, 3.3.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gammaproteobacteria, 18.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gapfill, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Garamycin. See Gentamicin</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gardnerella, 3.18.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vagina, 2.1.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gardnerella agar, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gardnerella vaginalis, 3.8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical syndromes, 3.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>continuous-monitoring blood culture systems, 5.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture examination, 3.8.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gardnerella agar, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hippurate hydrolysis rapid test, 3.17.20.1, 3.17.20.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.5, 3.18.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.1, 3.17.26.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sodium polyethanol sulfonate (SPS) disk test, 3.17.44.13.17.44.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>starch hydrolysis test, 3.17.45.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.3, 3.11.1.10, 3.11.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vaginalis agar, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Garenoxacin, 7.23.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>GAS. See Group A streptococci</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>GasPak envelope, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gastric aspirate, neonate, 2.1.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gastric/duodenal ulcers, potential etiological agents, 2.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gastroenteritis, fecal culture of aerobes, 3.7.1.13.7.1.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter and related organisms, 3.7.2.13.7.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture methods, 3.7.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of culture media, 3.7.1.93.7.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>H. pylori, 3.7.3.13.7.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.7.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.7.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.7.1.53.7.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>plating media for Salmonella and Shigella, 3.7.1.1, 3.7.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.7.1.93.7.1.15, 3.7.1.203.7.1.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.7.1.73.7.1.9, 3.7.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quantitative small-bowel contents, 3.7.4.13.7.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.7.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.7.1.153.7.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.7.1.43.7.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gastroenteritis panels, 14.4.1.114.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical testing, 14.4.1.1014.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>commercially available, 14.4.1.214.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>discrepant results, 14.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations of testing, 14.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid extraction, 14.4.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.4.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.4.1.914.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.4.1.814.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rare analytes and spiking, 14.4.1.714.4.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results and interpretation, 14.4.1.1014.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection and storage for validation, 14.4.1.1, 14.4.1.614.4.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>submission conditions, 14.4.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>validation data, 14.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gastrointestinal pathogen panel (GPP). See Gastroenteritis panels</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>GBS. See Group B streptococci</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>GC (gonococcus). See Neisseria gonorrhoeae</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>GC agar base with 1% defined supplement, 7.24.3.4, 7.24.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>GDC (glutamic acid decarboxylase), 4.9.15.14.9.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>GDH (glutamate dehydrogenase), C. difficile, 4.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Geenius assay, 13.10.1.3, 13.10.3.113.10.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gel and sample quality, 15.6.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gelatin, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gelatinase production</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 3.17.18.13.17.18.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobes, 4.9.13.14.9.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gelatin liquefaction, 3.17.18.13.17.18.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gel casting, 15.6.3.315.6.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gel clot method, 15.3.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>control standard endotoxin, 15.3.6.215.3.6.5, 15.3.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gemella</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Genetically modified organisms (GMOs), 17.6.12, 17.6.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>GEN III Micro Plate, 3.16.2, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Genital cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>female, 3.8.1.1, 3.8.1.23.8.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>group B streptococcus, 3.8.2.13.8.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>guidelines, 3.8.1.13.8.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>H. ducreyi, 3.8.4.13.8.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intrapartum, postpartum, and postabortal, 3.8.1.33.8.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>male, 3.8.1.1, 3.8.1.43.8.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>N. gonorrhoeae, 3.8.3.13.8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>order of inoculation media, 2.1.38</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postmenopausal, 3.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>prepubescent females, 3.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 3.8.1.13.8.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sexually transmitted diseases, 3.8.1.23.8.1.4, 3.8.1.6, 3.8.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 3.8.1.103.8.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>toxic shock syndrome, 3.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vaginitis and vaginosis, 3.8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Genital tract, 10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>female</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic specimen collection, 4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic specimen selection, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>infections, 3.8.1.1, 3.8.1.23.8.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>male infections, 3.8.1.1, 3.8.1.43.8.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>female, 2.1.202.1.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>male, 2.1.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Genital ulcers, 3.8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>with lymphadenopathy, 2.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Genitourinary tract infections, potential etiological agents, 2.1.112.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gen Mark Diagnostics, syndromic panels, 14.4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Genotypic assay, human immunodeficiency virus (HIV), 14.3.2.114.3.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Genotypic resistance testing, human immunodeficiency virus (HIV), 14.3.2.114.3.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gentamicin (Garamycin, Gentocin)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.7, 7.22.12, 7.22.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-level aminoglycoside resistance (HLAR) in Enterococcus, 7.12.17.12.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>high-level resistance in Enterococcus, 7.12.17.12.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Geotrichosis, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Geotrichum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>simple arthroconidia, 10.10.46</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Geotrichum candidum, culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Germicides, liquid, 17.1.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Germ tube test, 10.7.110.7.2, 10.7.410.7.6, 10.7.8, 10.7.11, 10.9.110.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>G. europaea, clinical significance and biochemical characteristics of, 4.14.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Giant intestinal fluke, 11.11.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Giardia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays for intestinal protozoa, 11.11.2.2311.11.2.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>formalin-ethyl acetate sedimentation, 11.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5, 14.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sputum expectorated, 11.7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giardia duodenalis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct smears, 11.3.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>duodenal aspirate, 11.6.4.111.6.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays, 11.11.2.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>formalin-ethyl acetate sedimentation, 11.3.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>macroscopic examination, 11.3.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.611.11.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zinc sulfate flotation, 11.3.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giardia intestinalis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>duodenal aspirate, 11.6.4.111.6.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays, 11.11.2.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.611.11.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giardia lamblia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>duodenal aspirate, 11.6.4.111.6.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays, 11.11.2.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.611.11.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giardiasis, 11.11.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gibraltar fever, 18.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Giemsa-like stains, Pneumocystis jirovecii, 10.4.2.310.4.2.4, 10.4.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Giemsa stain</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens for parasites, 11.7.2.111.7.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens for parasitology, 11.7.3.111.7.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood parasites, 11.8.5.111.8.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>H. capsulatum, 10.4.1.410.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular specimens, 3.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pneumocystis jirovecii, 10.4.2.310.4.2.4, 10.4.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 16.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urogenital parasite, 11.6.6.111.6.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gingivitis, potential etiological agents, 2.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Glanders, 18.7.118.7.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility, 18.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.1.2, 18.7.118.7.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical summary, 18.14.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture identification, 18.7.618.7.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>destruction, 18.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.7.218.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of cultures, 18.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>geographic distribution, 18.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation period, 18.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 18.7.1618.7.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 17.6.1, 17.6.4, 18.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>referral to LRN reference laboratory, 18.7.1518.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting, notification, and transfer, 18.7.1318.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.7.318.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance, 18.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.7.1518.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.7.5, 18.14.2318.14.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.7.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 18.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>therapy, 18.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Glandular tularemia, 18.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Glass beads pulverization, 10.11.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gleimia, 4.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gleimia coleocanis, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gleimia europaea, 4.2.2, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gleimia hominis, 4.2.2, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Globicatella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Glomerulonephritis, poststreptococcal, 13.2.1.113.2.1.3, 13.2.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Glossary of reimbursement and compliance terminology and acronyms, 1.1.51.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gloved fingertip testing, 15.3.3.115.3.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gloves, 17.1.2.1, 17.2.5.2, 17.3.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Glucose</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Andrades fermentation control, 16.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cysteine proteose peptone agar, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>heart infusion fermentation base, 16.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>King medium, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenol red agar, 16.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>purple broth, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeast carbohydrate assimilation medium, 16.2.1816.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>yeast carbohydrate fermentation broth, 16.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Glucose fermentation, yeast, 10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Glucose-nonfermenting Gram-negative bacilli, wound, abscess, and soft tissue cultures, 3.12.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Glucosidase test, combination enzymatic tablets for nitrophenol, aminopeptidase, and glucosidases, 4.9.19.14.9.19.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Glutamate dehydrogenase (GDH), C. difficile, 4.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Glutamic acid decarboxylase (GDC), 4.9.15.14.9.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Glutaraldehyde, neutralizers of, 15.4.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Glycerin jelly mounting procedure for nematodes, 11.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Glycerol kinase, 15.6.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Glycine assimilation/canavanine resistance, by yeast, 10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Glycopeptide(s), 7.17.2.6, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Glycopeptide-resistant enterococci. See Vancomycin-resistant enterococci</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>GMOs (genetically modified organisms), 17.6.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gnathostoma, body sites, 11.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Goatpox virus, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gomori methenamine-silver (GMS) stain, aerobic actinomycetes, 8.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gonococcus (GC). See Neisseria gonorrhoeae</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gonorrhea. See Neisseria gonorrhoeae</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gordonia, 8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation of growth, 8.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.3, 8.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2, 8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1, 8.2.68.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 8.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gordonia aichiensis, 8.3.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gordonia araii, 8.3.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gordonia bronchialis, 8.3.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 8.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gordonia effusa, 8.3.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gordonia otitidis, 8.3.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gordonia polyisoprenivorans, 8.3.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gordonia rubripertincta, 8.3.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gordonia sputi, 8.3.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gordonia terrae, 8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gordonibacter, 4.14.5, 4.14.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gordons oxidative agar slants, 8.3.38.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gowns, 17.1.2.1, 17.3.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>GPP (gastrointestinal pathogen panel). See Gastroenteritis panels</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gradient diffusion tests, 7.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility, 10.12.2.110.12.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.5.17.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.5.47.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.5.27.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 7.5.67.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gradient test QC table, 7.5.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram, Christian, 3.2.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-negative bacilli</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial disk tests, 3.17.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct smears, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.13.19.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>algorithm, 3.19.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 3.19.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.19.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microorganisms, 3.19.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonmotile, yellow, nonfermenting, catalase positive rods, 3.19.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>non-yellow-pigmented, oxidase-positive that grow well on MAC, 3.19.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>observe plate for 48 hours for new colony formation, 3.19.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oxidase-positive, glucose-fermenting, non-yellow-pigmented that grow on MAC, 3.19.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.19.13.19.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.19.23.19.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents and supplies, 3.19.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting and interpretation of results, 3.19.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>that do not grow on BAP, 3.19.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>that grow on BAP and MAC, 3.19.7, 3.19.8, 3.19.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>that grow on BAP but not (or poorly) on MAC, 3.19.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.2, 3.5.4, 3.5.63.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.3, 3.11.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, fluorescence, 4.9.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic, 4.13.14.13.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile disk test/bile broth test/Bacteroides bile esculin agar, 4.9.7.14.9.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bile tests, 4.13.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical considerations, 4.13.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CLSI antimicrobial susceptibility testing guidelines, 4.13.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology, 4.13.84.13.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>definitive identification, 4.13.174.13.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescence, 4.13.124.13.13, 4.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital culture, 3.8.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain morphology, 4.13.64.13.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lemierres syndrome, 4.13.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lipase, 4.13.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>minimum bactericidal concentration testing, 7.17.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility, 4.13.134.13.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate, 4.13.154.13.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nitrate and urease tests, 4.13.154.13.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pigmentation, 4.13.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 4.13.14.13.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 4.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control of antimicrobial susceptibility tests, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid presumptive identification tests, 4.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special-potency antimicrobial agent disks, 4.13.144.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens, 4.13.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole, 4.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease, 4.13.154.13.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.23.17.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, rapid, 3.3.2.73.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media for, 3.3.1.23.3.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.1, 3.17.30.33.17.30.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate/nitrite reduction test, 3.17.34.13.17.34.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>orbital cellulitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>otitis externa, 3.10.5.23.10.5.3, 3.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.13.17.40.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.23.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.1, 3.10.2.6, 3.10.2.8, 3.10.2.103.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sequencing-based identification, 14.5.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serum inhibitory and bactericidal titers, 7.18.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy update, 4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram-negative bacteremia with sepsis, principle</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-negative bacteria, 3.2.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>commercial manual and automated bacterial identification systems, 3.16.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.13.19.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>algorithm, 3.19.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diplococci, 3.19.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>guidelines, 3.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 3.19.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.19.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microorganisms, 3.19.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonmotile, yellow, nonfermenting, catalase positive rods, 3.19.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>non-yellow-pigmented, oxidase-positive that grow well on MAC, 3.19.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>observe plate for 48 hours for new colony formation, 3.19.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oxidase-positive, glucose-fermenting, nonyellow-pigmented that grow on MAC, 3.19.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.19.13.19.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.19.83.19.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents and supplies, 3.19.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting and interpretation of results, 3.19.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rods that do not grow on BAP, 3.19.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rods that grow on BAP and MAC, 3.19.7, 3.19.8, 3.19.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rods that grow on BAP but not (or poorly) n MAC, 3.19.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>keratitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram-negative broth, 3.7.1.3, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-negative cocci</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 4.15.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.15.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate/nitrite reduction test, 3.17.34.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram-negative coccobacilli, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, rapid, 3.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram-negative diplococci, 3.19.3, 3.19.4, 3.19.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.53.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram-negative enteric bacilli, primary plating media, 3.3.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-negative organisms, primary plating media, 3.3.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-negative rod(s). See Gram-negative bacilli</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-negative rod, nasal sinus cultures, 3.10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-positive anaerobic cocci, SPS (sodium polyanethol sulfonate) disk for, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-positive bacilli</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase-negative, 3.18.3, 3.18.9, 3.18.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catalase-positive, 3.18.3, 3.18.9, 3.18.11, 3.18.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.5, 3.18.10, 3.18.11, 3.18.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic, 4.14.14.14.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical correlations, 4.14.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.114.14.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 4.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>non-spore-forming, 4.14.1, 4.14.4, 4.14.144.14.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principles, 4.14.14.14.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 4.14.74.14.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 4.14.154.14.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 4.14.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 4.14.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spore forming, 4.14.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, 4.14.1, 4.14.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct smears, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification by special-potency antimicrobial agent disks, 4.9.5.14.9.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>identification, rapid, 3.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy update, 4.2.24.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram-positive bacteria, 3.2.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>commercial manual and automated bacterial identification systems, 3.16.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.13.18.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-hemolytic, catalase-negative, Grampositive coccus, 3.18.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase-negative, Gram-positive rods, 3.18.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catalase-positive, Gram-positive coccus, 3.18.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catalase-positive, Gram-positive rods, 3.18.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>guidelines, 3.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.18.43.18.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media, reagents, and supplies, 3.18.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microorganisms tested, 3.18.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>not beta-hemolytic, catalase-negative, Gram-positive coccus, 3.18.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.18.13.18.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.18.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PYR-negative, LAP-positive, 6.5% Na Clnegative cocci in chains, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PYR-positive, catalase-negative, Gram-positive coccus, 3.18.8, 3.18.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PYR-positive cocci in chains, 3.18.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting and interpretation of results, 3.18.33.18.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media for, 3.3.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram-positive cocci</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase-negative, beta-hemolytic, 3.18.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catalase-positive, 3.18.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct smears, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>not beta-hemolytic, 3.18.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PYR-positive, 3.18.8, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, alkaline phosphatase test, 4.9.14.14.9.14.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic, 4.15.1, 4.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 4.15.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology, 4.15.54.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>GPAC classification, 4.15.14.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.15.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 4.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 4.15.14.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 4.15.34.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid enzymatic biochemical identification, 4.15.124.15.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rapid nitrate and urease test, 4.15.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 4.15.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sodium polyanethol sulfonate disk, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special-potency antibiotic disks, 4.15.114.15.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen, 4.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole, 4.15.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SPS (sodium polyanethol sulfonate) disk, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SPS disk testing, 4.15.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>in ear cultures, 3.10.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>identification</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.83.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>by special-potency antimicrobial agent disks, 4.9.5.14.9.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.13.17.40.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.13.17.42.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy update, 4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram-positive organisms, primary plating media, 3.3.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.13.17.19.2, 3.18.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram reaction, oil immersion observations, 3.2.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.13.2.1.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic actinomycetes, 8.2.18.2.3, 8.2.68.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobes, 4.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacterial vaginosis and vaginitis, 3.2.1.193.2.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biopsy specimens and tissue sections, 3.2.1.83.2.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body fluids, bronchoalveolar lavage fluid, and CSF, 3.2.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth cultures, 3.2.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cerebrospinal fluid (CSF) cultures, 3.5.1, 3.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colonies from solid media, 3.2.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>counterstain, 3.2.1.1, 3.2.1.173.2.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decolorizers, 3.2.1.1, 3.2.1.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>direct smears, 3.2.1.103.2.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ear cultures, 3.10.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Grams iodine, 3.2.1.163.2.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>history, 3.2.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.2.1.1, 3.2.1.143.2.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.2.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.2.1.53.2.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Gram stain (Brown-Brenn), 8.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>morphology, 4.13.64.13.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic cocci, 4.15.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic gram-negative bacilli, 4.13.64.13.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular specimens, 3.9.53.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principles, 3.2.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.2.1.73.2.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.2.1.63.2.1.7, 16.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 3.2.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation, 3.2.1.163.2.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.2.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sputum and endotracheal aspirates, 3.2.1.183.2.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 3.2.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slide preparation, 3.2.1.103.2.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>smear fixation, 3.2.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.2.1.23.2.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen handling (aerobes), 3.3.1.6, 3.3.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens not on swabs, 3.2.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens on swabs, 3.2.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sputum, rejection criteria, 3.2.1.183.2.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>staining characteristics, 3.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>staining procedures, 3.2.1.10, 3.2.1.163.2.1.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urine specimens, 3.2.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>uses, 3.2.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>very small specimen, 3.2.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.13, 3.12.1.14, 3.12.1.15, 3.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram-variable bacilli, 3.2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram-variable cocci, 3.2.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Granulicatella, 7.17.1.14, 7.17.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>satellite test, 3.17.43.1, 3.17.43.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Granulicatella balaenopterae, 3.17.43.1, 3.17.43.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Granulomas, potential etiological agents, 2.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Granulomatous amebic encephalitis, 11.9.1.1, 11.9.1.4, 11.11.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acanthamoeba, 11.4.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Balamuthia mandrillaris, 11.4.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Graphium, phenotypic identification, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Grinding, for fungal cell lysis, 10.11.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Griseofulvin, antifungal susceptibility testing, broth dilution, 10.12.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Group A streptococci (GAS)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.77.1.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>emm typing, 13.2.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, rapid, 3.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), 3.10.8.5313.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract culture and nonculture tests, 3.10.1.2, 3.10.8.13.10.8.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>algorithm for laboratory diagnosis, 3.10.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.10.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>latex agglutination method, 3.10.8.93.10.8.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 3.10.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.10.8.23.10.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification tests (NAATs), 3.10.8.13.10.8.5, 3.10.8.73.10.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.10.8.13.10.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.10.8.33.10.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.10.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid antigen detection tests (RADTs), 3.10.8.13.10.8.3, 3.10.8.5, 3.10.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.10.8.73.10.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.10.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12, 7.23.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serologic diagnosis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>ADB (anti-DNase B) test, 13.2.1.113.2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anti-streptolysin O and anti-DNase B tests, 13.2.1.113.2.1.3, 13.2.2.113.2.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ASO (anti-streptolysin O) test, 13.2.1.113.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.2.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>surveillance, 15.5.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Group B streptococci (GBS)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.77.1.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital cultures, 3.8.2.13.8.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 3.8.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.8.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.8.2.93.8.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.8.2.53.8.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.8.1.1, 3.8.2.13.8.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.8.2.63.8.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.8.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.8.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.8.2.83.8.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.8.2.23.8.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.6, 3.10.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance, 15.5.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Group C/G Streptococcus, respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Group C streptococci (GCS), 3.18.4, 13.2.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.77.1.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pharyngitis, 3.10.8.1, 3.10.8.53.10.8.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Group G streptococci (GGS), 3.18.4, 13.2.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.77.1.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pharyngitis, 3.10.8.1, 3.10.8.53.10.8.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Growth-dependent carbohydrate degradation, N. gonorrhoeae cultures, 3.8.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Growth factor tests, 10.10.2010.10.28, 10.10.5210.10.54</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Growth on MAC without crystal violet, mycobacteria, 9.5.1.1, 9.5.1.3, 9.5.1.4, 9.5.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Growth rate and pigment production, mycobacteria, 9.5.1.19.5.1.4, 9.5.1.79.5.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>GS HIV Combo Ag/Ab EIA, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>GS HIV-1/2 Plus O, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>G-tube, 3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Guanarito virus, 15.8.4.2, 17.5.3.2, 18.14.27, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Guanylate kinase, 15.6.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Guiana extended-spectrum -lactamase (GES), 7.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Guideline preparation, Outbreak Database, 15.5.3.615.5.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gums, specimen collection from, 2.1.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>H</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>H (hemagglutinin), 18.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HACEK group, beta-lactamase test, 7.7.67.7.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Haemophilus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>-aminolevulinic acid (ALA) test, 3.17.3.13.17.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.6, 7.7.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vs. Brucella, 18.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital culture, 3.8.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.3, 3.19.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media for, 3.3.1.23.3.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>minimum bactericidal concentration testing, 7.17.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.1, 3.10.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>satellite test, 3.17.43.13.17.43.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.2, 7.23.5, 7.23.8, 7.23.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serum inhibitory and bactericidal titers, 7.18.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sodium polyethanol sulfonate (SPS) disk test, 3.17.44.13.17.44.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>time-kill assay, 7.17.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Haemophilus aphrophilus, 3.17.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Haemophilus ducreyi</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>-aminolevulinic acid (ALA) test, 3.17.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital cultures, 3.8.4.13.8.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>satellite test, 3.17.43.3, 18.15.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sodium polyethanol sulfonate (SPS) disk test, 3.17.44.13.17.44.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Haemophilus haemolyticus, 3.3.2.8, 3.17.3.3, 3.17.43.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>satellite test, 18.15.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Haemophilus influenzae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>-aminolevulinic acid (ALA) test, 3.17.3.2, 3.17.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation of agar and broth media, 7.24.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.2, 7.23.5, 7.23.6, 7.23.8, 7.23.11, 7.23.12, 7.23.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.17.7.2, 7.7.57.7.8, 7.7.9, 18.15.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 5.6.7, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.1, 7.4.1.4, 7.4.1.12, 7.4.1.14, 7.4.1.15, 7.4.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cefotaxime-resistant, 7.20.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CHOC medium, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>conjunctivitis, 3.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dacryocystitis/dacryoadenitis canaliculitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.4, 7.2.7, 7.2.10, 7.2.12, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.2, 7.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.5, 3.19.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation, 3.3.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.13.5.2, 3.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.1, 3.10.9.33.10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>N. gonorrhoeae cultures, 3.8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>orbital cellulitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>otitis media, 3.10.5.13.10.5.2, 3.10.5.43.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>periorbital (preseptal) cellulitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>primary plating media, 3.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.13.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.3.13.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.1, 3.10.2.53.10.2.7, 3.10.2.10, 3.10.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>satellite test, 3.17.43.13.17.43.2, 18.15.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance, 15.5.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>throat culture, 3.10.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Haemophilus paraaphrophilus, identification, 3.19.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Haemophilus parahaemolyticus, 3.17.3.3, 3.17.43.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>satellite test, 18.15.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Haemophilus parainfluenzae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>-aminolevulinic acid (ALA) test, 3.17.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.1, 7.4.1.4, 7.4.1.12, 7.4.1.14, 7.4.1.15, 7.4.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.7, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Haemophilus paraphrophilus, 3.17.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Haemophilus test medium agar, 7.24.3.4, 7.24.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Haemophilus test medium broth, 7.24.3.57.24.3.6, 7.24.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hafnia, 3.7.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hafnia alvei</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>HAI. See Health care-associated infections</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HAI (Hemagglutination inhibition assay), 12.11.112.11.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HAIC (Healthcare-Associated InfectionsCommunity Interface), 15.5.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hair, 10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal specimens, 10.3.4, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hair perforation test, 10.10.11, 10.10.2310.10.28, 10.10.3010.10.31</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>H. alvei, AmpC beta-lactamase testing, 7.15.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hamigera insecticola, AFST, broth dilution, 10.12.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hamigera insecticola, disk diffusion, 10.12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hand hygiene, 17.2.5.117.2.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>and garbing related practices, of compounding personnel, 15.3.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hanks balanced salt solution (HBSS), 12.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hansenula, 10.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hansenula anomala, acid-fast bacilli, 5.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hantaan virus, 17.6.10, 18.12.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hantaviruses, 17.6.10, 18.12.3, 18.14.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hathewaya</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical characteristics of, 4.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gram stain and colonial morphology of, 4.14.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hathewaya histolytica, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hathewaya histolyticum, 4.14.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hathewaya limosa, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Haverhill fever, 2.1.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hazards, risk assessment, 17.9.117.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HBAT (heptavalent botulinum antitoxin), 18.11.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HBSS (Hanks balanced salt solution), 12.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HBV. See Hepatitis B virus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HC (hemorrhagic colitis), 3.7.1.1, 3.7.1.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HC2 HPV DNA test, 14.3.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HCPCS (Healthcare Common Procedure Coding System), 1.2.3.51.2.3.6, 1.2.3.7, 1.2.4.13, 1.2.4.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HCPCS (Healthcare Common Procedure Coding System) codes, 1.1.3, 1.2.1.11.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HCT/Ps (human cells, tissues, and cellular and tissue-based products), culture of human cadaveric tissues for transplantation, 15.4.6.115.4.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HCV. See Hepatitis C virus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HCV Recombinant Immunoblot Assay, 13.11.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Head and neck infections</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic specimen selection, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.62.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Health careassociated infections (HAI), 15.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial stewardship, 15.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>education, 15.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>infection control committee, 15.2.315.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>outbreak detection and management, 15.2.215.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting, 15.5.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>surveillance, 15.2.115.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Healthcare-Associated InfectionsCommunity Interface (HAIC), 15.5.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Healthcare Common Procedure Coding System (HCPCS), 1.2.3.51.2.3.6, 1.2.3.7, 1.2.4.13, 1.2.4.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Healthcare Effectiveness Data and Information Set (HEDIS), 1.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Health Care Financing Administration (HCFA), 1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Health care personal (HCP), 15.5.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Health care-related pneumonia, 3.10.2.13.10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Health care worker (HCW), nosocomial outbreaks, 15.5.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Health Effectiveness Data and Information Set (HEDIS) parameters, 1.2.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Health Emergency Response Data System (HERDS), 15.5.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Health Information Technology for Economic and Clinical Health Act of 2009 (HITECH), 1.2.4.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Health Information Technology for Economic and Clinical Health (HITECH) Acts, 1.1.11.1.2, 1.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Health Insurance Portability and Accountability Act (HIPAA, 1996), 1.1.11.1.2, 1.1.4, 1.2.4.12, 13.6.1, 15.5.4.3, 15.5.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Heart infusion fermentation base, 16.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Heat-inactivated normal human serum, 7.18.117.18.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HEDIS (Health Effectiveness Data and Information Set) parameters, 1.2.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hektoen enteric agar (HEK), 3.7.1.2, 3.7.1.9, 3.7.1.10, 3.7.1.16, 16.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Helcococcus kunzii, identification, 3.18.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Helicobacter</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 3.17.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.2.8, 3.7.2.9, 3.7.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>indoxyl acetate disk test, 3.17.23.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, 3.7.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Helicobacter bilis, 3.7.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Helicobacter cinaedi, 3.7.2.2, 3.7.2.6, 3.7.2.7, 3.7.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indoxyl acetate disk test, 3.17.23.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Helicobacter fennelliae, 3.7.2.2, 3.7.2.6, 3.7.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indoxyl acetate disk test, 3.17.23.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Helicobacter heilmannii, 3.7.2.2, 3.7.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Helicobacter pullorum, indoxyl acetate disk test, 3.17.23.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Helicobacter pylori, 3.7.3.13.7.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.1, 7.6.1.7, 7.6.1.10, 7.6.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indoxyl acetate disk test, 3.17.23.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, known sources, and disease associations, 3.7.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1, 3.17.46.33.17.46.4, 18.15.6.1, 18.15.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Helicobacter pylori antigens in human stool (HpSA) assay, 3.7.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Helminth eggs, artifacts mimicking, 11.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Helminth larvae, artifacts mimicking, 11.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Helminths, 11.1.2111.1.26</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.2, 11.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood, 11.11.2.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct smears, 11.3.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>eggs in sigmoidoscopy specimen (permanent stained smear), 11.6.3.1, 11.6.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formalin-ethyl acetate sedimentation, 11.3.3.1, 11.3.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.111.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>collection and submission, 11.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 11.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 11.10.1, 11.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 11.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 11.10.211.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 11.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 11.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results and identification, 11.10.311.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 11.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>iron hematoxylin stain (modified Spencer-Monroe method), 11.3.6.3, 11.3.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.1611.11.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>macroscopic examination, 11.3.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained smear (trichrome), 11.3.5.411.3.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recovery of scolices and proglottids of cestodes, 11.5.6.111.5.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zinc sulfate flotation, 11.3.4.111.3.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hemagen Chagas kit (ELISA), 13.15.213.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hemagglutination inhibition (HAI) assay</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 12.11.1012.11.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 12.11.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 12.11.212.11.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 12.11.112.11.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 12.11.612.11.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 12.11.1112.11.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 12.11.412.11.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 12.11.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 12.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hemagglutinin (H), 18.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hematomas, specimen collection, 2.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hematopoietic stem cell (HSC) product culture, blood products, 15.4.5.115.4.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hematopoietic stem cell transplant (HSCT), infection surveillance, 15.7.7.115.7.7.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hematoxylin and eosin (H&amp;E) stain, 12.9.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic actinomycetes, 8.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hemin stock solution, 7.4.2.9, 7.6.2.87.6.2.9, 11.9.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hemocytometer, 12.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hemodialysis fluids, heterotrophic plate count and endotoxin assay, 15.4.2.115.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>frequency and timing, 15.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 15.4.2.715.4.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 15.4.2.415.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 15.4.2.115.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 15.4.2.615.4.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 15.4.2.515.4.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 15.4.2.815.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 15.4.2.215.4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hemolysin, 13.14.3.513.14.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hemolysis, 3.3.2.2, 3.3.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hemolytic streptococci, breast milk, 2.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hemolytic-uremic syndrome (HUS), 3.7.1.1, 3.7.1.12, 3.7.1.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hemorrhagic colitis (HC), 3.7.1.1, 3.7.1.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hemorrhagic fever (HF) viruses, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hemorrhagic fever with renal syndrome (HFRS), 18.12.3, 18.12.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hendra henipavirus, 18.12.4, 18.12.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hendra virus (HeV), 17.5.3.2, 18.12.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Henipaviruses, 18.12.418.12.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Heparin, 15.5.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hepatitis A virus (HAV)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnosis, 13.11.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor screening, 15.7.7.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>symptoms, 13.11.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>transmission, 13.11.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hepatitis A virus (HAV) serology, 13.11.1.113.11.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>choosing correct test, 13.11.1.113.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evolution of markers over time, 13.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>expected results from testing, 13.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>FDA-approved assays, 13.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.11.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.11.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedure, 13.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.11.1.413.11.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.11.1.2, 13.11.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>suggested reporting comments, 13.11.1.513.11.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test ordering strategies, 13.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hepatitis B virus (HBV), 12.9.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnosis, 13.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor screening, 15.7.7.315.7.7.5, 15.7.7.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>exposure, 17.7.517.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immune tolerance phase, 13.11.2.1, 13.11.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation, 17.1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory safety, 18.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2, 15.5.3.5, 15.5.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>occupational blood-borne exposure, 15.8.2.115.8.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>prevalence, 13.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serology, 13.11.2.113.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>choosing correct test, 13.11.2.113.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnostic markers, significance of, 13.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>FDA-approved assays, 13.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.11.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>introduction, 13.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.11.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedures, 13.11.2.513.11.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.11.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting comments, 13.11.2.713.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serologic profiles, 13.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 13.11.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test ordering strategies, 13.11.2.3, 13.11.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>shipping, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stages of chronic infection, 13.11.2.1, 13.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vaccine for laboratory personnel, 15.8.1.1, 15.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>viral load testing, 14.2.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hepatitis C virus (HCV)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnostic testing algorithm, 13.11.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor screening, 15.7.7.315.7.7.5, 15.7.7.1215.7.7.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>exposure, 17.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inoculation, 17.1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation of test results, 13.11.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>occupational blood-borne exposure, 15.8.2.115.8.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>prevalence, 13.11.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>symptoms, 13.11.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>WHO International Standard, 14.2.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hepatitis C virus (HCV) serology, 13.11.3.113.11.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>choosing correct test, 13.11.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evolution of response over time, 13.11.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>FDA-approved assays, 13.11.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.11.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>introduction, 13.11.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.11.3.513.11.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.11.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedure, 13.11.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.11.3.413.11.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting comments, 13.11.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.11.3.313.11.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test ordering strategies, 13.11.3.213.11.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hepatitis D virus (HDV)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hepatitis E virus (HEV)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hepatitis viruses</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.1215.7.7.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hepatocellular carcinoma (HCC), 13.11.2.1, 13.11.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Heptavalent botulinum antitoxin (HBAT), 18.11.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Herbaspirillum, respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Herpes B virus, 17.5.3.2, 17.6.10, 18.12.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Herpes simplex virus (HSV), 12.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital tract, 3.8.1.1, 3.8.1.2, 3.8.1.3, 3.8.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>keratitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.33</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Herpes simplex virus (HSV) type 2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular detection, 14.3.4.114.3.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>commercially available assays, 14.3.4.2, 14.3.4.314.3.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 14.3.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.3.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 14.3.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.3.4.1, 14.3.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.3.4.614.3.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.3.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 14.3.4.714.3.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.3.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Herpes simplex virus type 1 (HSV 1), clinical manifestations, 12.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Herpes simplex virus type 2 (HSV 2), clinical manifestations, 12.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Herpes simplex virus (HSV) type 1, molecular detection, 14.3.4.114.3.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>commercially available assays, 14.3.4.2, 14.3.4.314.3.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 14.3.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.3.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 14.3.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.3.4.1, 14.3.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.3.4.614.3.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.3.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 14.3.4.714.3.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.3.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Herpesviridae, 13.8.1.1, 13.9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Herpesviruses, 18.12.518.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.512.1.6, 12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.1015.7.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zoonotic, 12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Herpes zoster virus, keratitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Herpotrichiellaceae, temperature tests, 10.10.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Heterophile antibodies, Epstein-Barr virus (EBV), 13.8.1.113.8.1.2, 13.8.2.113.8.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Heterophyes heterophyes, 11.11.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Heteroploid monolayer cell cultures, 12.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Heterothallism, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Heterotrophic plate count, hemodialysis fluids, 15.4.2.115.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>frequency and timing, 15.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 15.4.2.715.4.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 15.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 15.4.2.415.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedure, 15.4.2.615.4.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 15.4.2.515.4.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 15.4.2.815.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 15.4.2.215.4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>HF (hemorrhagic fever) viruses, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>H. histolytica, 4.14.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>H. histolyticum, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HHV. See Human herpesvirus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>High-consequence viral pathogens, 18.12.118.12.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood specimens, 18.12.918.12.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>filoviruses, 18.12.218.12.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>flaviviruses, 18.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>henipaviruses, 18.12.418.12.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>herpesviruses, 18.12.518.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.12.1018.12.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation and reporting, 18.12.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mammarenaviruses, 18.12.618.12.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 18.12.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification tests (NAATs), 18.12.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>orthohantaviruses, 18.12.318.12.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>orthonairoviruses, 18.12.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packaging and shipping specimens, 18.12.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>peripheral blood smear examination, 18.12.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.12.118.12.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.12.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.12.718.12.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serology, 18.12.1018.12.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection and transport, 18.12.818.12.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.12.918.12.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen types, 18.12.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>High-level aminoglycoside resistance (HLAR), 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>in enterococci, 7.12.17.12.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>in Enterococcus, 7.12.17.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>High-level mupirocin resistant (HLMR) Staphylococcus aureus, 7.10.17.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Highly pathogenic bacteria, 6.3.16.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>additional safety considerations, 6.3.66.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biological risk assessment, 6.3.16.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bruker Biotyper, 6.3.36.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calibration and quality control, 6.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 6.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 6.3.16.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 6.3.36.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents and equipment, 6.3.26.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 6.3.56.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 6.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, 6.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VITEK MS, 6.3.36.3.4, 6.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Highly pathogenic coronaviruses</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>coronaviruses, 18.9.218.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture, 18.9.818.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cytopathic effect, 18.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescent antibody staining of antigens, 18.9.718.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.9.718.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation and reporting of results, 18.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MERS-CoV, 18.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methods, 18.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification, 18.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 18.9.118.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid antigen tests, 18.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.9.418.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SARS-CoV, 18.9.318.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SARS-CoV-2, 18.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serology, 18.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 18.9.518.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.9.618.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>H. influenzae, respiratory tract cultures, cystic fibrosis, 3.10.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HIPAA (Health Insurance Portability and Accountability Act, 1996), 1.2.4.12, 15.5.4.3, 15.5.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hippurate broth, 16.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hippurate hydrolysis rapid test, 3.17.20.13.17.20.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Histology, virus identification, 12.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Histopathologic stains, aerobic actinomycetes, 8.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Histoplasma, 10.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood films, 11.8.1.1, 11.8.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>buffy coat concentration, 11.8.9.1, 11.8.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Coccidioides cross-reactive antigens, 13.14.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>conversion, 10.10.10, 10.10.1510.10.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>exoantigen testing, 10.10.1710.10.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>filamentous fungi, 6.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inhalation, 17.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.13, 10.4.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mold phase characteristics, 10.10.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.4, 10.10.5, 10.10.6, 10.10.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.610.5.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slide cultures, 10.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Histoplasma capsulatum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial resistance, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conversion, 10.10.51</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnosis, 13.13.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious, 5.11.3.15.11.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 10.4.1.410.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory safety, 18.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media, 10.10.51</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>particulate phase, 10.10.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>complement fixation, 13.13.1.1, 13.13.2.113.13.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunodiffusion, 13.13.1.1, 13.13.3.113.13.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.13.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Histoplasma capsulatum (histoplasmosis), laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Histoplasma dermatitidis, particulate phase, 10.10.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Histoplasma duboisii, particulate phase, 10.10.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Histoplasmosis, 13.13.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bone marrow, 2.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.815.7.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection and culture medium, 2.1.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Historical overview, 1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Historical quality review, 16.5.3, 16.5.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HITECH (Health Information Technology for Economic and Clinical Health Act of 2009), 1.2.4.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HIV. See Human immunodeficiency virus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HIV-1 Microelisa system, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HK-U1, 12.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HKU1, specimen collection, 2.1.31</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HLAR (high-level aminoglycoside resistance), 7.22.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>H. limosa, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HLMR (high-level mupirocin resistant) Staphylococcus aureus, 7.10.17.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>Hockey sticks, 7.17.1.147.17.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Holdemania filiformis, 4.14.5, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hologic Panther/Tigris, 14.3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Homothallism, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hookworm, 11.1.21, 11.11.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar plate culture, 11.5.4.111.5.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autofluorescence of eggs, 11.4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.1, 11.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>macroscopic examination, 11.3.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hornsby-Alt-Nally (HAN) medium, 3.13.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Horse blood, lysed, 7.24.3.6, 7.24.3.8, 7.24.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hortaea, microscopic examination, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hortaea werneckii, 10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hospital-Acquired Infection (HAI), 1.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hospital-acquired pneumonia (HAP), 3.10.1.3, 3.10.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hospital water culture for Legionellaceae, 15.4.1.115.4.1.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 15.4.1.1115.4.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 15.4.1.415.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 15.4.1.115.4.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 15.4.1.715.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 15.4.1.615.4.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 15.4.1.1515.4.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 15.4.1.215.4.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>HPA (Hybridization Protection Assay), 14.3.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HpSA (Helicobacter pylori antigens in human stool) assay, 3.7.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HPV. See Human papillomavirus(es)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HSC (hematopoietic stem cell) product culture, 15.4.5.115.4.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>H2S (hydrogen sulfide) production, 3.17.21.13.17.21.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HSV. See Herpes simplex virus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HSV (Herpes simplex virus), 12.9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HTLV 1, specimen collection, 2.1.31</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HTLV 2, specimen collection, 2.1.31</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hugh-Leifson medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hlle cells, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human bites, 3.12.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human cells, tissues, and cellular and tissuebased products (HCT/Ps), culture of human cadaveric tissues for transplantation, 15.4.6.115.4.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human coronaviruses</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HCoV-229E, 18.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HCoV-HKU1, 18.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HCoV-NL63, 18.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HCoV-OC43, 18.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human cytomegalovirus, specimen collection, 2.1.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human granulocytic anaplasmosis, donor screening, 15.7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human granulocytic ehrlichiosis, 2.1.28</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human herpesvirus 5 (HHV 5). See Cytomegalovirus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human herpesvirus 6, 15.7.7.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human herpesvirus 7, 15.7.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.33</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Human herpesvirus 8 (HHV-8), 15.7.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Human herpesvirus 6A, specimen collection, 2.1.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human herpesvirus 6B, specimen collection, 2.1.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human herpes virus 7 (HHV-7), clinical manifestations, 12.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human immunodeficiency virus (HIV)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>circulating recombinant forms (CRFs), 13.10.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>classification, 13.10.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnostic testing algorithm, 13.10.1.213.10.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor screening, 15.7.7.315.7.7.5, 15.7.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>exposure, 17.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital tract, 3.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>genome, 13.10.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>genotypic resistance testing, 14.3.2.114.3.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>genotypic assay, 14.3.2.114.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic assay, 14.3.2.414.3.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inoculation, 17.1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory safety, 18.2.2, 18.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>national coverage determination (NCD), 1.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nucleic acid amplification tests (NAATs), 13.10.1.2, 13.10.1.4, 13.10.2.1, 13.10.2.3, 13.10.3.1, 13.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>occupational blood-borne exposure, 15.8.2.115.8.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>public health reporting, 15.5.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>relevant proteins in diagnostic platforms, 13.10.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sequence of appearance of laboratory markers, 13.10.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serology, 13.10.1.113.10.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Alere Determine HIV-1/2 Ag/Ab Combo rapid test, 13.10.1.213.10.1.3, 13.10.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BioRad Geenius supplemental assay, 13.10.3.113.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnostic testing algorithm, 13.10.1.213.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enzyme immunoassays (EIAs), 13.10.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>evolution of assay design, 13.10.1.113.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fifth-generation assays, 13.10.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>first-generation assays, 13.10.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>fourth-generation assays, 13.10.1.113.10.1.4, 13.10.2.1, 13.10.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.10.1.113.10.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>relevant protein in diagnostic platforms, 13.10.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reported results and interpretation, 13.10.2.213.10.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>screening immunoassays, 13.10.1.313.10.1.4, 13.10.2.113.10.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>screening immunoassays for HIV-1/2, 13.10.1.3, 13.10.1.4, 13.10.2.113.10.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>second-generation assays, 13.10.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>supplemental assays, 13.10.1.313.10.1.4, 13.10.3.113.10.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>supplemental HIV-1/2 assays, 13.10.1.313.10.1.4, 13.10.3.113.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>third-generation assays, 13.10.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>timeline for antigen and antibody detection, 13.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>shipping, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>structure, 13.10.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>viral load testing, 14.2.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Human immunodeficiency virus (HIV 1/2), specimen collection, 2.1.31</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human immunodeficiency virus type 1 (HIV-1)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>classification, 13.10.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular diagnostics, 14.3.1.114.3.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 14.3.1.614.3.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.3.1.714.3.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and required equipment, 14.3.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.3.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.3.1.514.3.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.3.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 14.3.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.3.1.314.3.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification test (NAAT), 13.10.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.10.1.113.10.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>screening immunoassays, 13.10.1.313.10.1.4, 13.10.2.113.10.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>screening immunoassays for HIV-1/2, 13.10.1.3, 13.10.1.4, 13.10.2.113.10.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>supplemental assays, 13.10.1.313.10.1.4, 13.10.3.113.10.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>supplemental HIV-1/2 immunoassays, 13.10.1.313.10.1.4, 13.10.3.113.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Human immunodeficiency virus type 2 (HIV-2)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>classification, 13.10.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification test (NAAT), 13.10.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.10.1.113.10.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>screening immunoassays, 13.10.1.313.10.1.4, 13.10.2.113.10.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>screening immunoassays for HIV-1/2, 13.10.1.3, 13.10.1.4, 13.10.2.113.10.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>supplemental HIV-1/2 immunoassays, 13.10.1.313.10.1.4, 13.10.3.113.10.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>supplemental immunoassays, 13.10.1.313.10.1.4, 13.10.3.113.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Human metapneumonia virus, specimen collection, 2.1.31</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human metapneumovirus, clinical manifestations, 12.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human monocytic ehrlichiosis, 2.1.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Human papillomavirus(es) (HPV), 12.9.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital tract, 3.8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular diagnostics for identification of high-risk, 14.3.3.114.3.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cross-reactivity, 14.3.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indications and guidelines, 14.3.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>intended use, 14.3.3.214.3.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interfering substances, 14.3.3.1014.3.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.3.3.914.3.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 14.3.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methods and procedures, 14.3.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.3.3.114.3.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedural principles and workflow, 14.3.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>public health reporting, 14.3.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.3.3.714.3.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>result interpretation, 14.3.3.814.3.3.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection and preparation, 14.3.3.314.3.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection criteria, 14.3.3.414.3.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport and storage stability, 14.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test characteristics, 14.3.3.1, 14.3.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Human parvoviruses, specimen collection, 2.1.34</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human polyomaviruses, specimen collection, 2.1.34</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human retroviruses, donor screening, 15.7.7.1115.7.7.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human specimens, exempt, 17.6.11, 17.6.12, 17.6.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Human T-cell leukemia virus 1 (HTLV-1), 11.5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Strongyloides stercoralis hyperinfection syndrome and, 11.5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Human T-lymphotropic virus types 1 and 2 (HTLV-1/2)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.315.7.7.4, 15.7.7.1115.7.7.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hungatella hathewayi, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HUS (hemolytic-uremic syndrome), 3.7.1.1, 3.7.1.12, 3.7.1.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hutsoniella, identification, 3.18.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hVISA. See Vancomycin-heteroresistant Staphylococcus aureus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hyaline molds, nasal and facial sinus scrapings, 10.10.38</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hyalohyphomycetes, 10.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.3510.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hyalohyphomycosis, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hybridization Protection Assay (HPA), 14.3.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hydatid disease, 11.11.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hydrogen peroxide, neutralizers of, 15.4.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hydrogen peroxide reagent, 3.17.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hydrogen sulfide (H2S) production, 3.17.21.13.17.21.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.13.17.24.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.13.17.24.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hymenolepis diminuta, gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hymenolepis nana</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autofluorescence, 11.4.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autofluorescence of eggs, 11.4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>eggs, 11.5.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gross examination, 11.10.1, 11.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recovery of scolices and proglottids, 11.5.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen handling, 11.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hymenolepsis nana, key characteristics, 11.11.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hyphae, 10.10.2, 10.10.48</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Hypomycetes, 10.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>I</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IATA (International Air Transport Association), 10.3.7, 17.6.16, 17.6.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Iatrogenic Creutzfeldt-Jakob disease (iCJD), 17.5.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IB. See Immunoblotting</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IBB (inositolbrilliant greenbile salt agar), 3.7.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ICAO (International Civil Aviation Organization), 10.3.7, 17.6.19, 17.6.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ICD-CM (International Classification of Diseases, Clinical Modification) code, 1.2.4.101.2.4.14, 1.2.4.171.2.4.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ICD-9-CM, ICD-10-CM (International Classification of Diseases, Clinical Modification code), 1.2.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ICD-10 designations, 1.2.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ICR. See Inducible clindamycin resistance</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ICU (intensive care unit), nosocomial outbreaks, 15.5.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IDSA (Infectious Diseases Society of America), 15.5.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IF. See Immunofluorescence</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IFA (immunofluorescence assay), 13.1.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IFN-. See Interferon gamma</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IgG avidity assay</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cytomegalovirus (CMV), 13.9.1.113.9.1.2, 13.9.3.113.9.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epstein-Barr virus (EBV), 13.8.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>IgG avidity testing, cytomegalovirus (CMV), 13.9.3.113.9.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IgM detection, for Leptospira, 3.13.1, 3.13.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IgM immunosorbent agglutination assay (ISAGA), 13.16.3.113.16.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.16.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.16.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.16.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.3.113.16.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>results and interpretation, 13.16.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection considerations, 13.16.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Ignavigranum, identification, 3.18.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ileal conduit, 3.11.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Illumina MiSeq, 15.6.6.1, 15.6.6.2, 15.6.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Illumina NextSeq, 15.6.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IM (infectious mononucleosis), 14.3.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Imipenem (Primaxin)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.3, 7.20.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.6, 7.23.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>M. peregrinum, 9.9.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapidly growing mycobacteria, 9.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Imipenem-hydrolyzing -lactamase (IMI)/not metalloenzyme carbapenemase (NMC), 7.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Immunization(s)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microbiology laboratory personnel, 15.8.1.115.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recommended, 15.8.1.115.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>required, 15.8.1.1, 15.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Immunoassay(s). See also Enzyme-linked immunoassays (EIAs)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common for antibody and antigen detection from infectious pathogens, 13.1.2.113.1.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>competitive EIAs/CIAs, 13.1.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>complement fixation, 13.1.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>IFA (immunofluorescence assay), 13.1.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>immunoblotting, 13.1.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>immunodiffusion, 13.1.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>latex agglutination, 13.1.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LFA (lateral-flow assay), 13.1.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>noncompetitive EIAs/CIAs, 13.1.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enzyme-linked (See Enzyme-linked immunoassays)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal flowchart, 11.11.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>human immunodeficiency virus (HIV), 13.10.1.113.10.1.4, 13.10.2.113.10.2.4, 13.10.3.113.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.10.1.113.10.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>screening immunoassays, 13.10.1.113.10.1.5, 13.10.2.3, 13.10.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>supplemental HIV-1/2 immunoassays, 13.10.1.313.10.1.4, 13.10.3.113.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microbead, syphilis, 13.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.1.1.113.1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reflex and composite testing scenarios, 1.2.4.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>syphilis, 13.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>chemiluminescence immunoassays (CIAs), 13.5.7.113.5.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>INNO-LIA Syphilis Score, 13.5.8.113.5.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microbead immunoassay (MBIA), 13.5.7.113.5.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trep-Sure enzyme immunoassay, 13.5.6.113.5.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>virus identification, 12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Immunoblot</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>detection of Borrelia burgdorferi antibodies, 13.6.2, 13.6.413.6.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trypanosoma cruzi, 13.15.313.15.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Immunoblotting, 13.1.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Immunocompromised hosts, surveillance cultures, 15.7.6.115.7.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Immunocompromised patient, respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Immunodiffusion</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Coccidioides, 13.14.2.113.14.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Histoplasma capsulatum, 13.13.1.1, 13.13.3.113.13.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Immunodiffusion test, 13.1.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Immunofluorescence (IF) staining, 12.9.1.112.9.1.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Immunofluorescence, virus identification, 12.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Immunofluorescent-antibody assay (IFA), detection of Borrelia burgdorferi antibodies, 13.6.2, 13.6.5, 13.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Immunofluorescent assay, Pneumocystis jirovecii, 10.4.2.1, 10.4.2.410.4.2.5, 10.4.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Immunohistochemical staining, syphilis, 13.5.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Immunohistochemistry, for Leptospira, 3.13.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Immunological tests, virus identification, 12.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Immunology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cytomegalovirus (CMV), 13.9.113.9.2, 13.9.2.113.9.2.4, 13.9.3.113.9.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epstein-Barr virus (EBV), 13.8.1.113.8.1.3, 13.8.2.113.8.2.2, 13.8.3.113.8.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>group A streptococcal infections, 13.2.1.113.2.1.3, 13.2.2.113.2.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>human immunodeficiency virus (HIV), 13.10.1.113.10.1.4, 13.10.1.113.10.1.5, 13.10.2.113.10.2.4, 13.10.3.113.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>syphilis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>automated nontreponemal rapid plasma reagin (RPR) tests, 13.5.4.113.5.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>automated treponemal tests, 13.5.7.113.5.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dark-field microscopy for T. pallidum, 3.8.1.2, 13.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>INNO-LIA Syphilis Score, 13.5.1.3, 13.5.8.113.5.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.5.1.113.5.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid plasma reagin (RPR) test, 13.5.3.113.5.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Treponema pallidum particle agglutination test (TP-PA), 13.5.5.113.5.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trep-Sure enzyme immunoassay, 13.5.6.113.5.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Venereal Disease Research Laboratory (VDRL) tests, 13.5.2.113.5.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Impetigo, 13.2.1.113.2.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Impingers, 15.4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Impression smears</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.7.3.111.7.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitology, 11.7.3.111.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Inactivation, prions, 17.5.5.317.5.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>In and out catheter urine collection, 3.11.1.2, 3.11.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>In Bios Chagas Detect Plus, 13.15.213.15.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Incident reports, 16.6.5, 17.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Incubation</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic culture, 3.3.1.33.3.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 16.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen processing for anaerobic culture, 4.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>techniques for anaerobes, 4.6.14.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>India ink, 10.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>India ink injection technique, 11.10.2, 11.10.411.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>India ink method, 10.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Indifference, synergism testing, 7.19.15, 7.19.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Indirect immunofluorescence assays (IFA)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epstein-Barr virus (EBV), 13.8.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trypanosoma cruzi, 13.15.313.15.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Individualized quality control plan (IQCP), 16.2.23, 16.5.116.5.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>background and history, 16.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for commercial antimicrobial susceptibility testing system, 16.5.316.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>for commercially prepared CLSI-exempt media, 16.5.1116.5.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examples, 16.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>final, 16.5.7, 16.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>historical quality review, 16.5.3, 16.5.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for multiplex respiratory panel, 16.5.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ongoing monitoring for effectiveness, 16.5.18, 16.5.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>process, 16.5.116.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality assessment, 16.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quality control plan, 16.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>risk acceptability, 16.5.5, 16.5.14, 16.5.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>risk assessment, 16.5.1616.5.18, 16.5.2216.5.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>and determination of risk level, 16.5.516.5.11, 16.5.14, 16.5.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>information used to conduct, 16.5.3, 16.5.1216.5.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>possible sources of error, 16.5.15, 16.5.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test system information, 16.5.4, 16.5.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>voluntary nature, 16.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Indole test, 3.17.22.13.17.22.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobes, 4.9.2.14.9.2.3, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Indoxyl acetate disk test, 3.17.23.13.17.23.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inducement, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inducible clindamycin resistance (ICR), 7.11.17.11.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of antimicrobial susceptibility test systems, 7.22.11, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Indwelling catheter, urine collection, 3.11.1.2, 3.11.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inermicapsifer, gross examination, 11.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Infected animals, shipping, 17.6.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Infection control</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>environmental sampling and cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>air cultures for fungi, 15.4.3.115.4.3.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture of blood and cellular therapy products in blood banking, 15.4.5.115.4.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture of hospital water for Legionellaceae, 15.4.1.115.4.1.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture of human cadaveric tissues for transplantation, 15.4.6.115.4.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pre-and postimplant testing of medical devices, 3.6.13.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>in laboratory</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hand hygiene, 17.2.5.117.2.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunization, 15.8.1.115.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>investigation of laboratory exposures, 15.8.3.115.8.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory isolation codes and notification fan-out for suspected biosafety risk Group 3 and 4 microorganisms, 15.8.4.115.8.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory support of blood-borne pathogen exposures, 15.8.2.115.8.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory support, 15.2.315.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.415.5.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>outbreak investigations</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>collection and storage of isolates, 15.5.2.115.5.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>collection and tracking of surveillance and clinical specimens, 15.5.1.115.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>public health reporting, 15.5.4.115.5.4.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>systematic analysis of nosocomial outbreaks, 15.5.3.115.5.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 3.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality assurance, 16.1.116.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>surveillance cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunocompromised hosts, 15.7.6.115.7.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methicillin-resistant S. aureus, 15.7.2.115.7.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multidrug-resistant Acinetobacter baumannii, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multidrug-resistant Enterobacterales, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multidrug-resistant Pseudomonas aeruginosa, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vancomycin-resistant enterococci, 15.7.3.115.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Infection control committee, 15.2.315.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Infection prevention (IP). See Infection control</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Infection prevention programs (IPPs), 15.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Infection, routes of, 17.1.1.117.1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Infection surveillance prior to transplantation, 15.7.7.115.7.7.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.315.7.7.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>general approach, 15.7.7.115.7.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 15.7.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.1415.7.7.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Infectious Disease and Medical Microbiology Case Review, 16.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Infectious Disease Society of America/American Thoracic Society (IDSA/ATS), 3.10.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Infectious Diseases Society of America (IDSA), 15.5.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Infectious mononucleosis (IM), 13.8.1.1, 13.8.2.2, 13.8.3.3, 13.9.1.1, 14.3.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Infectious substance, 17.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Infectious waste, 17.8.117.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autoclave, 17.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>availability of equipment and services, 17.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>benefits, 17.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>contingency planning, 17.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>defined, 17.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disposal, 17.8.217.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disposal of untreated, 17.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>emergency response, 17.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>handling and collection, 17.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 17.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>implementation, 17.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incident and accident analysis, 17.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>management plan, 17.8.217.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>minimization, 17.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>off-site treatment, 17.8.1, 17.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>on-site treatment, 17.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>and other wastes, 17.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>plan development, 17.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality assurance and quality control, 17.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>record keeping, 17.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>regulatory requirements, 17.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>review, 17.8.517.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>storage, 17.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>training, 17.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>treatment, 17.8.317.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Influenza vaccination, 15.5.3.615.5.3.7, 15.5.4.5, 15.8.1.3, 18.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Influenza virus(es), 12.9.2.112.9.2.16, 12.11.112.11.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>avian, 12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.615.5.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>novel, 18.9.118.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 18.9.818.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescent antibody staining of antigens, 18.9.718.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.9.718.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation and reporting of results, 18.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methods, 18.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification, 18.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 18.9.118.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid antigen tests, 18.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.9.418.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serology, 18.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 18.9.518.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.9.618.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.31</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance, 15.5.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>swine, 12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zoonotic, 12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Influenza virus type A</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>novel subtypes, 18.9.118.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Influenza virus type A H1N1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>epidemiology, 18.9.1, 18.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.9.718.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation and reporting of results, 18.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 18.9.118.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.9.418.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 18.9.518.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.9.618.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Influenza virus type A H2N2, 18.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Influenza virus type A H3N2, 18.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Influenza virus type A H5N1, 18.9.1, 18.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Influenza virus type A H3N2v, 18.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Influenza virus type B, clinical manifestations, 12.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Influenza virus type H7N7, 18.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Influenza virus type H7N9, 18.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Influenza virus type H9N2, 18.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Information checklist, suspected bioterrorism, 18.14.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Infralaryngeal aspirate, 2.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Infrequently encountered organisms, 5.11.3.15.11.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ingestion, biohazards, 17.1.1.1, 17.1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inguinal lymphadenopathy, 3.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inhalation, biohazards, 17.1.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inhibitory mold agar, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inhibitory titers, 7.18.17.18.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>INNO-LIA Syphilis Score, 13.5.1.3, 13.5.8.113.5.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>INNO-LiPA MYCOBACTERIA v 2 line probe assay, 9.5.3.19.5.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inoculation</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biohazards, 17.1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular diagnostics, 14.2.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Inoculation of media, specimen processing for anaerobic culture, 4.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inoculation technique</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>automated inoculation, 3.3.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>manual inoculation, 3.3.1.8, 3.3.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Inoculum, quality control, 16.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inositol, 16.2.6, 16.2.10, 16.2.12, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inositol assimilation, by yeast, 10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inositolbrilliant greenbile salt agar (IBB), 3.7.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>In-process control cultures, human cadaveric tissues for transplantation, 15.4.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>In-process cultures, human cadaveric tissues for transplantation, 15.4.6.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inquilinusi, respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inquilinus, respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>In situ hybridization (ISH), Epstein-Barr virus, 14.3.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>INSTI HIV-1/HIV-2 antibody test, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Instrument performance, 16.2.26</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Intensive care unit (ICU), nosocomial outbreaks, 15.5.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Interferon gamma release assay (IGRA), donor/recipient screening, 15.7.7.4, 15.7.7.715.7.7.8, 15.7.7.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Interferon gamma (IFN-k) release assay (IGRA), laboratory exposure, 15.8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Interferon gamma release assays, LTBI, 13.17.113.17.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>assays for detection, 13.17.113.17.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>IGRAs, 13.17.3, 13.17.613.17.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.17.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.17.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quantiFERON-TB, 13.17.213.17.3, 13.17.513.17.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood tube incubation and processing, 13.17.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunomodulation, 13.17.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phlebotomy, 13.17.313.17.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>step or assay method</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>IFN- ELISA or CIA, 13.17.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IFN- ELISpot, 13.17.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>plasma harvest, 13.17.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>T-SPOT TB, 13.17.3, 13.17.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Interinstitutional comparisons, 16.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>International Air Transport Association (IATA), 10.3.7, 17.6.1, 17.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>International Air Transport Association (IATA) Dangerous Goods Regulations, 2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>International Civil Aviation Organization (ICAO), 10.3.7, 17.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>International Classification of Diseases (ICD), 1.1.31.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>International Classification of Diseases, Clinical Modification (ICD-CM) code, 1.2.4.101.2.4.14, 1.2.4.171.2.4.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>International Classification of Diseases, Clinical Modification code (ICD-9-CM, ICD-10-CM), 1.2.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>International Code of Nomenclature of Bacteria (ICNB), 4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>International Committee on Systematics of Prokaryotes (ICSP), 4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>International Committee on Taxonomy of Viruses (ICTV), 18.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>International Organization for Standardization (ISO) accreditation standard, 16.4.116.4.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>International Standard for ribotyping, 15.6.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Interpretive drug resistance categories, 7.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Interventional radiology (IR)-guided biopsies/aspirates, anaeroic specimen selection, collection, and transport for, 4.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Intestinal biopsy, parasites, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Intestinal parasites. See also specific organisms</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cellulose tape preparation (pinworm), 11.6.1.111.6.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>duodenal contents (duodenal aspirate), 11.6.4.111.6.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays, 11.11.2.2311.11.2.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>fecal specimens (See Parasite(s), fecal specimens; Parasitology, fecal specimens)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy (direct smear), 11.6.2.111.6.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sigmoidoscopy (permanent stained smear), 11.6.3.111.6.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Intestinal tract</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.611.11.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, parasites, 2.1.36, 11.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Intestinal tract infections</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.92.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.222.1.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Intestinal tularemia, 18.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Intra-abdominal infections, potential etiological agents, 2.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Intra-amniotic infection syndrome, 3.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Intraocular fluid, 10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal specimen collection, 10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Intrauterine device (IUD), 2.1.21, 4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Intravenous transmission, biohazards, 17.1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Intrinsic resistance, 7.20.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Inulin, 16.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Invader chemistry, high-risk human papillomaviruses, 14.3.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Invanz. See Ertapenem (Invanz)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Investigational Use Only (IUO), 1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Investigational Use Only (IUO) tests, 1.2.4.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>in vitro mutations, 15.6.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Iodamoeba betschlii</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>identification versus Endolimax nana trophozoites, 11.11.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>trophozoites, 11.11.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Iodamoeba btschlii</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Iodine, 3.2.1.163.2.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DAntonis, 11.3.2.311.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lugols, 11.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>neutralizers of, 15.4.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitology direct smears, 11.3.2.111.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tincture of, 11.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Iodine solution, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Iodometric method, 7.7.5, 7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ion Torrent PGM, 15.6.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ion Torrent S5, 15.6.6.1, 15.6.6.2, 15.6.6.515.6.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ion Torrent S5 Gene Studio, 15.6.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IP (infection prevention). See Infection control</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IPPs (infection prevention programs), 15.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IQCP. See Individualized quality control plan</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Iron-depleted Mueller-Hinton broth, 7.24.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Iron hematoxylin stain</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified incorporating carbol fuchsin step, 11.3.6.611.3.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipe, 11.3.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Iron hematoxylin stain (modified Spencer-Monroe method), 11.3.6.111.3.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbol fuchsin step incorporation, 11.3.6.611.3.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 11.3.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 11.3.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 11.3.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 11.3.6.211.3.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 11.3.6.411.3.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 11.3.6.111.3.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 11.3.6.511.3.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 11.3.6.311.3.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results, 11.3.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 11.3.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Iron uptake medium, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Iron uptake, mycobacteria, 9.5.1.1, 9.5.1.3, 9.5.1.4, 9.5.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Isavuconazole, antifungal susceptibility testing, 10.13.8, 10.13.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.2, 10.12.1.4, 10.12.1.610.12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>ISH (in situ hybridization), Epstein-Barr virus, 14.3.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ISO 15189 Accreditation, 16.4.916.4.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Isolator system, 5.4.15.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 5.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 5.4.15.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.4.25.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>ISOLATOR system, Bartonella, 3.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Isoniazid (INH), 9.9.3.2, 9.9.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar proportion method, 9.8.19.8.3, 9.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT SIRE kit, 9.7.1.1, 9.7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK automated microbial detection system, 9.7.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Isoniazid (INH) resistance</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/XDR test, 9.6.3.1, 9.6.3.39.6.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Isospora, specimen rejection, 2.1.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Itraconazole</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.8, 10.13.9, 10.13.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing, broth dilution, 10.12.1.2, 10.12.1.4, 10.12.1.610.12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>IUO (investigational use only) tests, 1.2.4.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ixodes, 13.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>Ixodes ricinus, 13.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ixodes scapularis, 13.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>J</title>
            <indexentry>
               <primaryie>J</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Jackson-Pratt device, 3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Jar gassing systems, 4.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>JC virus (JCV), 12.9.3.2, 14.3.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quantification of, 14.2.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>J</title>
            <indexentry>
               <primaryie>Joint Commission (JCAHO), 15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Joint Commission, requirements for quality control of antimicrobial susceptibility tests, 7.20.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Joint fluid, 3.4.1, 3.4.2, 10.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>J</title>
            <indexentry>
               <primaryie>Joint infections, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>J</title>
            <indexentry>
               <primaryie>Jonquetella anthropi, 4.13.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>J</title>
            <indexentry>
               <primaryie>Junin virus, 15.8.4.2, 17.5.3.2, 18.14.27, 18.14.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>K</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kala-azar, 11.9.3.1, 11.11.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kanamycin, 9.9.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar proportion method, 9.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-level aminoglycoside resistance (HLAR) in Enterococcus, 7.12.17.12.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>high-level resistance in Enterococcus, 7.12.17.12.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special-potency disks, 4.9.5.14.9.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kanamycin (Kantrex, Klebcil), 7.23.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kanamycin (KAN) resistance</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/XDR test, 9.6.3.59.6.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kanamycin special-potency disks, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kanamycin-vancomycin-laked blood agar (KVLB or LKV), 4.4.1.1, 4.4.1.3, 4.4.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kantrex (kanamycin), 7.23.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kazachstania telluris, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Keflex (cephalexin), 7.23.6, 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kefurox. See Cefuroxime</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kefzol (cephalexin), 7.23.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Keratitis, 2.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acanthamoeba, 11.4.8.1, 11.9.1.1, 11.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacterial, 3.9.2, 3.9.4, 3.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Ketolides, 7.20.4, 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>KG (methyl green) agar, 3.17.16.13.17.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>KIA (Kliglers iron agar), 3.17.9.1, 3.17.24.13.17.24.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kickback, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kidney biopsy, parasites, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kingella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>N. gonorrhoeae cultures, 3.8.3.7, 3.8.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kingella denitrificans, identification, 3.19.10, 3.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kingella kingae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.8, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.6, 3.19.10, 3.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>King medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kinyoun carbol fuchsin stain, 9.2.3.29.2.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kinyouns acid-fast stain (cold), modified, 11.4.1.111.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kinyoun stain, modified, 8.2.28.2.4, 8.2.78.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kirby-Bauer diffusion testing. See Disk diffusion test</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kirchner medium, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Klebcil (kanamycin), 7.23.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Klebsiella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), testing and reporting considerations, 7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood products, 15.4.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>malonate test, 3.17.28.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting antimicrobial agents for testing and reporting, 7.23.4, 7.23.5, 7.23.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1, 18.15.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urine culture, 3.11.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Klebsiella aerogenes</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), testing and reporting considerations, 7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Klebsiella oxytoca</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), testing and reporting considerations, 7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.1, 7.14.5, 7.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Klebsiella ozaenae, malonate test, 3.17.28.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Klebsiella pneumoniae, 7.3.1, 7.3.5, 7.3.6, 7.21.3, 7.25.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1, 7.15.2, 7.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Andrades fermentation medium, 16.2.21, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), testing and reporting considerations, 7.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.6, 7.22.12, 7.22.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.6, 7.20.9, 7.20.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase (Moeller) broth, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.4, 7.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.17.14.2, 7.14.47.14.5, 7.14.77.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>esculin agar, 16.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>flagellum stain, 16.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>heart infusion fermentation base, 16.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>malonate broth, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>malonate test, 3.17.28.13.17.28.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>4</title>
            <indexentry>
               <primaryie>4-methylumbelliferone derivative substrates test, 4.9.18.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>motility-indole-lysine medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility-indole-ornithine medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.2, 16.2.11, 18.15.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MUG (4-methylumbelliferyl- -D-glucuronide) test, 3.17.33.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxidative-fermentative medium, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenol red agar, 16.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>positive blood culture broth, 5.13.11, 5.13.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>purple broth, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Simmons citrate agar, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance cultures, 15.7.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tryptone medium, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Klebsiella pneumoniae carbapenemase (KPC), 7.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Klebsiella pneumoniae chromosomal DNA, 15.6.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Klebsiella rhinoscleromatis, 3.19.7, 3.19.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Klebsiella variicola, positive blood culture broth, 5.13.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA) test, 3.17.9.1, 3.17.24.13.17.24.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kloeckera, 10.6.4, 10.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kluyvera, 7.14.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kluyveromyces delphensis, presumptive identfication, 10.7.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kluyveromyces marxianus, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Knott concentration, 11.8.11.111.8.11.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kodamaea ohmeri, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>KOH (potassium hydroxide)-calcofluor mount, 10.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>KOH-DMSO (potassium hydroxidedimethyl sulfoxide) mount, 10.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>KOH (potassium hydroxide) mount, 10.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kovcs indole reagent, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kovacs reagent, 3.17.22.13.17.22.4, 3.17.38.13.17.38.2, 4.9.2.14.9.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kroppenstedtia eburnean, Gram stain, 8.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kurung-Yegian medium, 10.10.51</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kyasanur Forest disease virus (KFDV), 18.12.2, 18.14.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Labeling for shipping, 17.6.5, 17.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Labia, 2.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laboratory accidents, 17.7.117.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biohazardous spills, 17.1.4.117.1.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biological hazard results, 17.7.317.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood-borne exposures, 17.7.4, 17.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>employee accident and exposure report, 17.7.4, 17.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hepatitis B virus, 17.7.517.7.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hepatitis C virus, 17.7.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HIV exposure, 17.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incident reports, 17.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>physical hazard results, 17.7.117.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>postexposure prophylaxis, 17.7.517.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Laboratory-acquired infections (LAIs), 17.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.117.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>epidemiology, 18.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>investigation, 15.8.3.115.8.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>accidents involving potential exposure to M. tuberculosis, 15.8.3.715.8.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>establishment of Laboratory and Occupational Health Response Team (LOHRT), 15.8.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>exposures involving all other BSL3 high-risk pathogens, 15.8.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>exposure to blood or body fluids, 15.8.3.315.8.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-risk pathogenic agent considerations, 15.8.3.815.8.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>illness response protocols by type of symptoms and level of exposure risk, 15.8.3.515.8.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>managing symptomatic employees, 15.8.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postexposure assessment, 15.8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>preexposure establishment of protocols, 15.8.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 15.8.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>questions for assessment of employee exposure risk, 15.8.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>response to potential exposures to biological agents or toxins by risk level, 15.8.3.415.8.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>response to workplace exposure or potential exposure, 15.8.3.215.8.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>symptom monitoring log, 15.8.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>use of medical alert cards, 15.8.3.115.8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory biosafety, 18.2.118.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laboratory and Occupational Health Response Team (LOHRT), 15.8.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laboratory biosafety, laboratory-acquired infections, 18.2.118.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laboratory developed tests (LDTs), 1.1.2, 14.2.5.4, 14.2.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trypanosoma cruzi, 13.15.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>verification and validation, 14.2.4.114.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Laboratory infection control</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hand hygiene, 17.2.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunization, 15.8.1.115.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>investigation of laboratory exposures, 15.8.3.115.8.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory isolation codes and notification fan-out for suspected biosafety risk group 3 and 4 microorganisms, 15.8.4.115.8.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laboratory information system (LIS)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>electronic specimen worksheet, 16.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Laboratory isolation code(s), 15.8.4.215.8.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laboratory notification fan-out, 15.8.4.315.8.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laboratory personnel</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hand hygiene, 17.2.5.117.2.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunization, 15.8.1.115.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Laboratory policies, 17.5.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laboratory records, 16.6.116.6.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>accession list, 16.6.2, 16.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>essential, 16.6.216.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examples, 16.6.4, 16.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>format, 16.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incident (problem) reports, 16.6.1, 16.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>personnel, 16.6.2, 16.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control and quality assurance, 16.2.1, 16.2.2, 16.2.3, 16.6.3, 16.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reportable-disease, 16.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>requirements, 16.6.716.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>requisition, 16.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>retention, 1.2.4.7, 16.6.2, 16.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety, 16.6.2, 16.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test reports, 16.6.2, 16.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>work card or LIS electronic specimen worksheet, 16.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Laboratory Response Network (LRN), 18.1.118.1.5, 18.14.218.14.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laboratory responsibility, 1.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laboratory services, coverage of, 1.2.3.71.2.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laboratory support</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood-borne pathogen exposures, 15.8.2.115.8.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>infection prevention, 15.2.315.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Laboratory training documentation, bioterrorism, 18.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laboratory water, 16.3.116.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbon adsorption, 16.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>deionization, 16.3.1, 16.3.316.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>distillation, 16.3.116.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>filtration, 16.3.1, 16.3.316.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>particulate matter, 16.3.116.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>preparation methods, 16.3.216.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 16.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 16.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>resistivity, 16.3.1, 16.3.2, 16.3.4, 16.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reverse osmosis, 16.3.1, 16.3.316.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specifications, 16.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens, 16.3.116.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>storage and distribution, 16.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing frequency, 16.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>tests, 16.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>total bacterial counts, determination of, 16.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>total organic content (TOC), 16.3.116.3.2, 16.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>types of water, 16.3.216.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>ultrafiltration, 16.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>UV oxidation, 16.3.316.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Laboratory workers, vaccines for, 17.7.317.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lacazia, 10.4.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lachnoanaerobaculum saburreum, 4.2.3, 4.14.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lacrimal duct system</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>canaliculitis, 3.9.23.9.3, 3.9.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dacryocystitis, 3.9.23.9.3, 3.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>dacryodenitis, 3.9.23.9.3, 3.9.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.9.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lacrimispora aerotolerans, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lacrimispora algidixylanolytica, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lacrimispora amygdalina, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lacrimispora celerecrescens, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lacrimispora indolis, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lacrimispora saccharolytica, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lacrimispora sphenoides, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lacticaseibacillus casei, 4.14.4, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lacticaseibacillus rhamnosus, 4.14.4, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lactobacillus, 4.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar screen test for vancomycin-resistant enterococci, 7.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autopsy blood cultures, 5.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical correlations, 4.14.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital tract, 3.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.10, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MRS broth, 3.17.31.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.3, 3.11.1.10, 3.11.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lactobacillus acidophilus, culture media, 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lactobacillus confusus, 3.17.31.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lactobacillus MRS agar (LMRS), 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lactococcus, 3.17.5.3, 3.17.25.1, 3.17.25.2, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lactococcus garvieae, 3.18.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lactoferrin, 3.2.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lactophenol, for gross examination of helminths, 11.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lactose</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Andrades fermentation control, 16.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cysteine proteose peptone agar, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>heart infusion fermentation base, 16.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>King medium, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenol red agar, 16.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>purple broth, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeast carbohydrate assimilation medium, 16.2.1816.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>yeast carbohydrate fermentation broth, 16.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lactose assimilation, by yeast, 10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lagochilascaris, body sites, 11.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LAI(s). See Laboratory-acquired infections</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laked blood agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LAL. See Limulus amebocyte lysate</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laminar-airflow workbenches (LAFWs), 15.3.1.1, 15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laminar-flow hoods (LFHs), 15.3.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lancefieldella parvula, 4.2.2, 4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lancefieldella rimae, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LAP (leucine aminopeptidase) test, 3.17.25.13.17.25.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Larval stage culture of nematodes, 11.5.4.111.5.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Laryngitis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.62.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lassa fever virus, 17.5.3.2, 17.6.35, 18.14.27, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lassa virus (Lassa fever), 15.8.4.2, 18.12.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Latent TB infection (LTB1), 15.7.7.715.7.7.8, 15.7.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interferon gamma release assays, 13.17.113.17.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>assays for detection, 13.17.113.17.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>IGRAs, 13.17.3, 13.17.613.17.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.17.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.17.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quantiFERON-TB, 13.17.213.17.3, 13.17.513.17.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood tube incubation and processing, 13.17.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunomodulation, 13.17.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phlebotomy, 13.17.313.17.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>step or assay method</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>IFN- ELISA or CIA, 13.17.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IFN- ELISpot, 13.17.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>plasma harvest, 13.17.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>T-SPOT TB, 13.17.3, 13.17.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lateral flow assay (LFA), 10.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Coccidioides, 13.14.1.113.14.1.2, 13.14.5.113.14.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hepatitis C virus (HCV), 13.11.3.2, 13.11.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trypanosoma cruzi, 13.15.213.15.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trypanosoma cruzi, serologic diagnosis, 13.15.613.15.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Latex agglutination method</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-hemolytic streptococcal, 3.10.8.93.10.8.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Histoplasma capsulatum, 13.13.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Latex agglutination test, 3.7.1.203.7.1.22, 13.1.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lawsonella, 8.1.1, 8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lawsonella clevelandensis, 4.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lawsonibacter asaccharolyticus, 4.14.5, 4.14.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LB (Lyme borreliosis). See Lyme disease</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LBC (liquid-based cytology), cervical samples for NAAT testing, 14.3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LCDs (local coverage determinations), 1.2.3.71.2.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LD (Legionnaires disease), 3.10.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LDTs (laboratory-developed tests), 1.2.4.13, 13.9.3.113.9.3.2, 14.2.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lead acetate strips, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lecithinase and lipase detection, 3.17.26.13.17.26.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lecithinase test</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 3.17.26.13.17.26.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobes, 4.9.10.14.9.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lefamulin, broth microdilution MIC test, 7.4.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Legionella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antibody testing, 3.10.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body fluids, 3.4.5, 3.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bordetella cultures, 3.10.6.6, 3.10.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>and C. burnetii, 18.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious, 5.11.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.1, 3.2.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hospital water culture, 15.4.1.115.4.1.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 15.4.1.1115.4.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 15.4.1.415.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 15.4.1.115.4.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 15.4.1.715.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 15.4.1.615.4.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 15.4.1.1515.4.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 15.4.1.215.4.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media for, 3.3.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>molecular detection, 3.10.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.1, 3.17.30.33.17.30.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2, 3.10.4.13.10.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acceptance/rejection criteria, 3.10.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 3.10.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture examination, 3.10.4.53.10.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture inoculation, 3.10.4.43.10.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>definitive identification of isolates, 3.10.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.10.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lower, 3.10.2.13.10.2.2, 3.10.2.5, 3.10.2.10, 3.10.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.10.4.33.10.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preliminary identification of isolates, 3.10.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 3.10.4.13.10.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedures, 3.10.4.43.10.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.10.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 3.10.4.73.10.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.10.4.23.10.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urinary antigen testing, 3.10.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.11, 7.23.12, 7.23.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Legionella agars, 16.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Legionella bozemanii, 16.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Legionella gormanii, 15.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Legionella jordanis, 15.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Legionella longbeachae, 3.10.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Legionella micdadei, 3.10.4.3, 15.4.1.6, 15.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Legionella oakridgensis, 15.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Legionella pneumophila, 3.14.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Legionella agars, 16.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>motility tests, 3.17.30.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acceptance/rejection criteria, 3.10.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 3.10.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture examination, 3.10.4.53.10.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture inoculation, 3.10.4.43.10.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>definitive identification of isolates, 3.10.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.10.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.10.4.33.10.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preliminary identification of isolates, 3.10.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 3.10.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedures, 3.10.4.43.10.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.10.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 3.10.4.73.10.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.10.4.23.10.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urinary antigen testing, 3.10.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Legionella spiritensis, 15.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Legionella wadsworthii, 15.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Legionellosis, 3.10.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Legionnaires disease (LD), 3.10.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Leifsonia aquatica, 3.18.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Leishmania</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.1, 11.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.211.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood films, 11.8.1.1, 11.8.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>buffy coat concentration, 11.8.9.1, 11.8.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cross-reactivity of anti-Leishmania antibodies and Trypanosoma cruzi, 13.15.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture, 11.7.3.211.7.3.4, 11.9.3.111.9.3.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 11.8.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sputum expectorated, 11.7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Leishmania braziliensis, 11.11.2.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Leishmania donovani</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>STAT testing, 11.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Leishmaniasis, 11.9.3.1, 11.9.3.511.9.3.9, 11.11.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Leishmania subgenus Leishmania, 11.9.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Leishmania subgenus Viannia, 11.9.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lemierres disease, respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lemierres syndrome, 4.13.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Leonians agar, 10.10.7, 10.10.10, 10.10.49</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Leptospira</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 3.13.13.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious, 5.11.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serovars, 3.13.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.29</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wet mount, 3.13.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Leptospira culture, 3.13.13.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnostic tests for leptospirosis, 3.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.13.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.13.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.13.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.13.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.13.33.13.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 3.13.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.13.13.13.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Leptospira interrogans serovar Canicola, 3, 3.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Leptospira kirschneri serovar Grippotyphosa, 3.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Leptospirosis, 3.13.13.13.2, 3.13.5, 3.13.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Leptotrichia, 4.13.1, 4.13.2, 4.13.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology, 4.13.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy update, 4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lesion swab culture, viral, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lesion swabs or scrapings</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct detection, 12.9.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Leucine aminopeptidase (LAP) test, 3.17.25.13.17.25.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Leuconostoc, 3.3.2.9, 3.17.25.1, 3.17.25.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar screen test for vancomycin-resistant enterococci, 7.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial disk tests, 3.17.4.2, 3.17.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.2, 3.17.9.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MRS broth, 3.17.31.1, 3.17.31.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Leuconostoc mesenteroides, 3.17.31.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Leukocyte(s), wet mount, 3.2.3.1, 3.2.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Levels of service, M. tuberculosis, 9.2.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Levofloxacin (Tequin), 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Levofloxacin, agar proportion method, 9.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LFA (lateral-flow assay), 10.3.8, 13.1.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liaison Treponema screen, 13.5.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liason Anti-HAV, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liason HAV-IgM, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LIASON Treponema Screen, 13.5.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liason XL Murex Anti-HBc Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liason XL Murex Anti-HBc IgM Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liason XL Murex Anti-HBe Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liason XL Murex Anti-HBs Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liason XL Murex HBeAg Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liason XL Murex HBsAg Qual Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liason XL Murex HCV, 13.11.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lice, gross examination, 11.10.1, 11.10.4, 11.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lichtheimia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing by broth dilution, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cycloheximide susceptibility, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sporangiophores and sporangia, 10.10.46</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Light microscope, parasitology, 11.1.111.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Limit of detection (LOD), 14.2.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Limulus amebocyte lysate (LAL) assay, hemodialysis fluids</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>frequency and timing, 15.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 15.4.2.715.4.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 15.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 15.4.2.415.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 15.4.2.115.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 15.4.2.615.4.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 15.4.2.515.4.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 15.4.2.815.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 15.4.2.215.4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lincosamides, 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Linearity, 16.2.26</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Linezolid</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.8, 7.4.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slowly growing nontuberculous mycobacteria, 9.9.2.1, 9.9.2.3, 9.9.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Linezolid (Zyvox)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.11, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control of, 7.20.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria, 9.9.1.2, 9.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Linezolid-resistant Staphylococcus aureus, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lipase test</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 3.17.26.13.17.26.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobes, 4.9.9.14.9.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lipoglycopeptides, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lipopeptide, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lipophilism test, 3.17.27.13.17.27.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liquid-based cytology (LBC), cervical samples for NAAT testing, 14.3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liquid media, anaerobes, 4.4.1.2, 4.4.1.5, 4.4.1.94.4.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liquid media for isolation of mycobacteria</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT automated mycobacterial culture system, 9.4.1.19.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BACTEC MGIT automated system, 9.4.1.19.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK Myco Culture system, 9.4.2.19.4.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Liquid nitrogen storage, 17.4.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LIS (laboratory information system) electronic specimen worksheet, 16.6.3, 16.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Listeria</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile-esculin and esculin tests, 3.17.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, laboratory process, 5.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CAMP factor tests and reverse CAMP test, 3.17.8.1, 3.17.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.33.17.32.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.1, 3.17.30.33.17.30.4, 18.15.5.1, 18.15.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting antimicrobial agents for testing and reporting, 7.23.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance, 15.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Listeria monocytogenes</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile-esculin and esculin tests, 3.17.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CAMP factor tests and reverse CAMP test, 3.17.8.1, 3.17.8.4, 3.17.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.8, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.3, 14.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>genital infections, 3.8.1.3, 3.8.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>group B streptococcus cultures, 3.8.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hippurate hydrolysis rapid test, 3.17.20.1, 3.17.20.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.2, 3.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>List of Dangerous Goods, 17.6.13, 17.6.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liver</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, parasites, 2.1.37, 11.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Liver biopsy, parasites, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liver granulomata, 2.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Liver infection, 2.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LKV (kanamycin-vancomycin-laked blood agar), 4.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Llaked sheep blood, 7.6.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Loa loa, 11.1.21, 11.6.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine concentration: membrane filter (Nuclepore), 11.6.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Local coverage determinations (LCDs), 1.1.11.1.2, 1.2.3.71.2.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lochia, 2.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Loculoascomycetes, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LOD (limit of detection), 14.2.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Loeffler medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Logical Observation Identifiers, Names, and Codes (LOINC), 1.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LOHRT (Laboratory and Occupational Health Response Team), 15.8.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lombard-Dowell agar, 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lomefloxacin (Maxaquin), 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lomentospora, processing specimens for culture, 10.5.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lomentospora prolificans</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing by broth dilution, 10.12.1.8, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cycloheximide susceptibility, 10.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ear canals, 10.10.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Long-term storage</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>of anaerobes, 4.11.1, 4.11.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>of stock cultures, 16.2.2316.2.25</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lophophyton gallinae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.23, 10.10.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Loracarbef, broth microdilution MIC test, 7.4.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lowenstein-Jensen media, 9.5.1.19.5.1.2, 9.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for isolation of mycobacteria, 9.3.29.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lowenstein-Jensen medium, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lower respiratory tract cultures, 3.10.2.13.10.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture methods, colony equivalents, and thresholds for significant growth, 3.10.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification of primary pathogens, 3.10.2.93.10.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 3.10.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.10.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.10.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.10.2.13.10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.10.2.73.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.10.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quantitative culture of protected specimen brush and bronchoalveolar lavage fluid specimens, 3.10.2.133.10.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.10.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.10.2.6, 3.10.2.113.10.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.10.2.13.10.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lower respiratory tract infections (LRTI), 14.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LPCB solution, 10.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>LRN (Laboratory Response Network), 18.1.118.1.5, 18.14.218.14.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lugols iodine, 11.3.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lugols iodine solution, 3.2.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lujo virus (South Africa), 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lumbar puncture, 3.5.13.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Luminex, syndromic panels, 14.4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lumpy skin disease virus, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lung abscess, respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lung aspirates, 3.10.2.43.10.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lung biopsy, parasites, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lung biopsy (LB) specimens, 3.10.2.43.10.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lung flukes, 11.11.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lungs</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, anaerobic, 4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, parasites, 2.1.37, 11.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen selection, anaerobic, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lyme borreliosis (LB). See Lyme disease</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lyme disease (Lyme borreliosis), 11.11.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnosis, 13.6.113.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indications for antibody testing, 13.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.28</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stages of, 13.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lymph nodes, 3.12.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.21, 2.1.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lymphocytic choriomeningitis virus (LCMV)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lymphoid interstitial pneumonitis, 13.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lymphoma</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diffuse large B-cell, 14.3.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epstein-Barr virus (EBV) and, 13.8.1.113.8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lyophilization, 4.11.1, 16.2.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lyra Direct HSV1+2 or VZV assay, 14.3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lysed horse blood (50%), 7.4.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lysine, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lysine iron agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Lysis centrifugation, 5.4.15.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 5.4.15.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.4.25.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lysozyme test, 8.3.108.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>M</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MAAA (multianalyte assays with algorithmic analyses), 1.1.3, 1.2.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Macacine alphaherpesvirus, 18.12.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mac Conkey agar (MAC), 3.3.2.2, 3.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic culture, 3.3.1.2, 3.3.1.63.3.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>performance standards</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacteria, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Salmonella and Shigella, 3.7.1.2, 3.7.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sorbitol with cefixime and tellurite (CT-SMAC), 3.7.1.7, 3.7.1.8, 3.7.1.9, 3.7.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mac Conkey broth, 3.7.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mac Conkey-sorbitol agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Machupo virus, 15.8.4.2, 17.5.3.2, 18.14.27, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Macracanthorhynchus, 11.1.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.1, 11.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Macro(aleurio)conidia, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Macroconidium, 10.10.46, 10.10.48</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Macrodantin (nitrofurantoin), 7.20.9, 7.23.3, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Macrodilution, antifungal susceptibility testing by broth dilution, 10.12.1.2, 10.12.1.510.12.1.6, 10.12.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Macrodilution method, 7.17.1.17.17.1.6, 7.18.67.18.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Macrolides</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.9, 7.4.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Macrophage, identification of Entamoeba histolytica trophozoite versus, 11.11.3.411.11.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Madurella, microscopic examination, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Magnusiomyces capitatus, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Maine Molecular Quality Controls, Inc., 14.4.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Malaria. See also Plasmodium; Plasmodium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.2, 11.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>buffy coat concentration, 11.8.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>capillary blood tube centrifugation for parasite detection, 11.8.9.311.8.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>characteristics of parasites, 11.11.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>determination of parasitemia, 11.8.7.111.8.7.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor screening, 15.7.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identifying test, 11.8.12.211.8.12.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid detection, 11.8.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitemia, 11.8.7.111.8.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid antigen testing, 11.8.12.111.8.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>resistance, 11.8.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Malassezia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics to differentiate species, 10.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lysis centrifugation, 5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>molecular methods for identification, 10.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identification, 10.7.2, 10.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.310.5.4, 10.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.110.3.12, 10.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Malassezia dermatis, characteristics, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Malassezia furfur, 10.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catheter-related bloodstream infection, 5.12.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>characteristics, 10.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious, 5.11.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Malassezia globosa, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Malassezia japonica, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Malassezia nana, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Malassezia obtusa, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Malassezia pachydermatis, 10.6.7, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Malassezia restricta, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Malassezia slooffiae, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Malassezia sympodialis, 10.6.7, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Malassezia yamatoensis, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Malbranchea, phenotypic identification, 10.10.4, 10.10.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MALDI. See Matrix-assisted laser desorption ionization</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MALDI Biotyper (MBT)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 6.4.26.4.5, 6.4.76.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CA system, filamentous fungi, 6.5.26.5.5, 6.5.76.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Maledivibacter halophilus, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Male genital tract</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cultures (See Genital cultures)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>infections, 3.8.1.1, 3.8.1.43.8.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.8.1.63.8.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Malonate broth, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Malonate test, 3.17.28.13.17.28.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Malta fever, 18.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Maltose</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Andrades fermentation control, 16.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cysteine proteose peptone agar, 16.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>heart infusion fermentation base, 16.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>King medium, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>purple broth, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeast carbohydrate assimilation medium, 16.2.1816.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>yeast carbohydrate fermentation broth, 16.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Maltose fermentation, by yeast, 10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mammarenaviruses, 18.12.618.12.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mandol (cefamandole), 7.19.12, 7.23.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mannheimia haemolytica, 3.19.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mannitol, 16.2.9, 16.2.10, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mannitol salt agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mansonella, 11.6.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine concentration: membrane filter (Nuclepore), 11.6.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mansonella ozzardi, 11.8.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mansonella perstans, 11.8.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mansonella streptocerca</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.3, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mapped, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Marburg virus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory safety, 18.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>select agent, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>shipping, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.14.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Marketing, 1.2.4.7, 1.2.4.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Marking for shipping, 17.6.14, 17.6.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Martin-Lewis agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Marvinbryantia, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Marvinbryantia formatexigens, 4.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mass spectrometry (MS). See Matrix-assisted laser desorption ionizationtime of flight mass spectrometry</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Matrix-assisted laser desorption ionization (MALDI) Biotyper CA system, 6.2.2, 6.2.96.2.11, 6.6.26.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mold identification on primary culture, 10.8.1, 10.8.6, 10.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeasts, 10.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), 3.3.2.1, 3.3.2.6, 4.1.2, 4.8.2, 4.10.1, 4.13.2, 8.1.1, 14.5.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.4, 6.4.16.4.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aerobes, 3.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aerobic actinomycetes, 6.4.16.4.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobes, 4.12.14.12.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical specimens, 4.12.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>database and differentiation, 4.12.24.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>failure factors, 4.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory culture, 4.12.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 4.12.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 4.12.14.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sequencing, 4.12.34.12.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, 4.12.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>typing and subtyping, 4.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic cocci, 4.15.1, 4.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calibration and quality control, 6.2.56.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Clostridium difficile, 4.16.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>defined, 6.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ear cultures, 3.10.5.33.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>filamentous fungi, 6.5.16.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram-positive bacteria, 3.18.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>group A streptococci, 3.10.8.53.10.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>highly pathogenic bacteria, 6.3.16.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 6.2.116.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>misidentifications of, 6.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>N. gonorrhoeae cultures, 3.8.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular cultures, 3.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>positive blood culture broth, 6.6.16.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 6.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 6.2.66.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents and equipment, 6.2.16.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 6.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 6.2.46.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Maxaquin (lomefloxacin), 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Maxipime. See Cefepime</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MBC testing. See Minimum bactericidal concentration testing</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MBIA. See Microbead immunoassay (MBIA)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mc Clung-Toabe agar base with egg yolk, 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mc Farland requirements, 4.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mc Farland standards, 7.4.2.2, 7.4.2.5, 7.24.1.17.24.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.24.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.24.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation, 7.24.1.2, 7.24.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 7.24.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.24.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.24.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>use of, 7.24.1.27.24.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mc Farland turbidity standard, 7.2.3, 7.2.57.2.6, 7.14.57.14.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MDROs (multidrug-resistant organisms), 15.5.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Measles/mumps/rubella (MMR) vaccine, laboratory personnel, 15.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Measles virus, 12.9.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mecillinam (Co Actin), 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MEDCAC (Medicare Evidence Development and Coverge Advisory Committee), 1.2.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Media. See Culture media</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for aerobic cultures, 3.3.1.23.3.1.3, 3.3.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>order of inoculation, 2.1.382.1.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection and labeling, 2.1.38</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>streaking plates for primary isolation, 2.1.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Media-fill challenge testing, 15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Media fill test procedure, 15.3.4.115.3.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for high-risk compounds, 15.3.4.515.3.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>for low-risk sterile compounding, 15.3.4.215.3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>for medium-risk sterile compounding, 15.3.4.315.3.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Medicaid, 1.2.4.91.2.4.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Medical alert cards, 15.8.3.115.8.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Medical devices, pre-and postimplant testing, 3.6.13.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Medical instruments, environmental surface testing of, 15.4.4.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Medically unlikely edits (MUEs), 1.1.4, 1.2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Medical necessity, 1.1.6, 1.2.4.21.2.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Medical-necessity items, 1.2.4.101.2.4.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Medical waste, shipping, 17.6.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Medicare</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>compliance programs and, 1.2.4.91.2.4.13, 1.2.4.151.2.4.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>coverage of laboratory services, 1.2.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedure billing, 1.2.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Medicare administrative contractors (MACs), 1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Medicare Carrier Advisory Committee (MCAC), 1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Medicare Claims Processing Manual, 1.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Medicare Evidence Development and Coverge Advisory Committee (MEDCAC), 1.2.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Medicare Learning Network, 1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fact sheet series, 1.1.91.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mediterraneibacter glycyrrhizinilyticus, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mediterraniebacter gnavus, 4.15.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mediterrieania, 4.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Medium. See Culture media</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mefoxin. See Cefoxitin</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Megasphaera, 4.15.2, 4.15.3, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Melanized molds, 10.4.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Melibiose, 16.2.6, 16.2.10, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Melibiose assimilation, by yeast, 10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Melioidosis, 18.7.118.7.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility, 18.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.1.2, 18.7.118.7.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical summary, 18.14.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture identification, 18.7.618.7.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>destruction, 18.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.7.218.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of cultures, 18.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>geographic distribution, 18.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation period, 18.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 18.7.1618.7.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 17.6.1, 17.6.4, 18.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>referral to LRN reference laboratory, 18.7.1518.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting, notification, and transfer, 18.7.1318.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.7.318.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance, 18.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.7.1518.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.7.5, 18.14.2318.14.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.7.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 18.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>therapy, 18.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MEM (Minimal essential medium), 12.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Membrane filter, parasite urine concentration, 11.6.8.111.6.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Membrane filter (Nuclepore) urine concentration, 11.6.8.111.6.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Membrane filtration concentration, 11.8.10.111.8.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Membrane filtration technique, 15.3.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Meningitis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acute community-acquired, 3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacterial, 3.5.13.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cerebrospinal fluid (CSF) cultures, 3.5.13.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>encephalitis molecular panels, 14.4.3.114.4.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>additional reporting comments, 14.4.3.614.4.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory result interpretation and reporting, 14.4.3.514.4.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 14.4.3.714.4.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.4.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.4.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>proficiency testing, 14.4.3.314.4.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>provider result interpretation, 14.4.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>resolution of discrepant results, 14.4.3.414.4.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 14.4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection and handling, 14.4.3.114.4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen storage, 14.4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>verification panels, 14.4.3.214.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.152.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Meningococcal polysaccharide vaccine, 15.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Meningoencephalitis, chronic, 11.11.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mercuric chloride, parasites, 11.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Merdimonas, 4.14.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Merdimonas faecis, 4.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Meropenem, broth microdilution MIC test, 7.4.1.16, 7.4.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Meropenem (Merrem), selection of agents for testing and reporting, 7.23.3, 7.23.6, 7.23.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Merosporangia, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Merthiolate (thimerosal)-iodine-formalin (MIF), 11.2.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Metagenomic next generation sequencing (mNGS)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for DNA</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 14.5.4.714.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and equipment, 14.5.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.5.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.5.4.514.5.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.5.4.414.5.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 14.5.4.614.5.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RNA, 14.5.4.814.5.4.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.5.4.214.5.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for RNA</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 14.5.4.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.5.4.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and equipment, 14.5.4.914.5.4.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.5.4.814.5.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.5.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.5.4.1014.5.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 14.5.4.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.5.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Metagenomic next-generation sequencing (mNGS), 5.14.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Metagonimus yokogawai, 11.11.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Metallo--lactamases (MBLs), 7.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Methanol, as perservative, 11.2.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Methenamine-silver nitrate stain, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Methenamine silver stain, for Pneumocystis jirovecii, 10.4.2.410.4.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Methicillin, 7.6.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Methicillin-resistant staphylococci, broth microdilution MIC test, 7.4.1.97.4.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Methicillin-resistant Staphylococcus aureus (MRSA)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>chromogenic media, 5.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.1415.7.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Methicillin-susceptible S. aureus (MSSA), multiplex molecular panels, 5.13.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Methyl glucopyranoside (MGP) test, 3.17.29.13.17.29.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Methyl green (MG) agar, 3.17.16.13.17.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Methylobacterium, 3.17.43.3, 18.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>motility tests, 3.17.30.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>satellite test, 18.15.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Methylorubrum, 3.19.5, 3.19.6, 3.19.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Methyl red (MR) reagent, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Methyl red (MR) test, 3.17.32.13.17.32.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Methyl redVogesProskauer (MR-VP) medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Methyl redVogesProskauer (MR-VP) tests, 3.17.32.13.17.32.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>4</title>
            <indexentry>
               <primaryie>4-Methylumbelliferone derivative substrates test, 4.9.18.14.9.18.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>4-Methylumbelliferyl--D-glucuronide (MUG), 3.17.33.13.17.33.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>4-Methylumbelliferyl butyrate (MUB), 3.17.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Metorchis, gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Metronidazole (Flagyl), 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Metronidazole, agar dilution MIC test, 7.6.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Metschnikowia pulcherrima, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Meyerozyma guilliermondii, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MGB Alert BK Virus Primers, 14.3.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MGB Alert BK Virus Probe, 14.3.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MGIT (Mycobacteria Growth Indicator Tube), 9.4.1.19.4.1.5, 9.7.1.19.7.1.5, 9.7.2.19.7.2.4, 9.8.49.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MGP (methyl glucopyranoside) test, 3.17.29.13.17.29.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MIC(s). See Minimum inhibitory concentration(s)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Micafungin</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.2, 10.13.3, 10.13.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.2, 10.12.1.4, 10.12.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.2, 10.12.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Microagglutination test (MAT), Brucella, 13.3.413.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microarray analysis, 3.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microascus cinereus, toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microbact 12A (12E), 12B, and 24E, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microbacterium, 3.18.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microbact Listeria 12L, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microbact Staph 12S, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microbead immunoassays (MBIAs), syphilis, 13.5.1.4, 13.5.7.113.5.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microbial Pharmacy Surveillance Program, 15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microbiological loops</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calibration, 16.8.1.116.8.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 16.8.1.116.8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 16.8.1.216.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>types, 16.8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>use and performance verification, 16.8.1.116.8.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Microbiological sampling, for pharmacies, 15.3.115.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microbiologics Inc., 14.4.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microbiology laboratory personnel, immunization, 15.8.1.115.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Micrococcineae, 8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Micrococcus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial disk tests, 3.17.4.1, 3.17.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autopsy blood cultures, 5.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hematopoietic stem cell products, 15.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.3, 3.18.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxidase test, 3.17.38.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Micro(aleurio)conidia, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microconidium, 10.10.46</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microdase disks, 3.17.38.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microdilution method</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CLSI, 10.12.1.110.12.1.3, 10.12.1.510.12.1.7, 10.12.1.9, 10.12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>EUCAST, 10.12.1.110.12.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MIC for anaerobic bacteria, 7.4.2.17.4.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MIC in ESBL testing, 7.14.67.14.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>minimum bactericidal concentration testing, 7.17.1.67.17.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serum inhibitory and bactericidal titers, 7.18.27.18.6, 7.18.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Microfilariae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood films, 11.8.1.1, 11.8.1.2, 11.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>buffy coat concentration, 11.8.9.111.8.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>centrifugation, 11.6.7.111.6.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>characteristics, 11.11.2.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Delafields hematoxylin stain, 11.8.8.111.8.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Knott concentration, 11.8.11.111.8.11.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>membrane filter, parasite urine concentration, 11.6.8.111.6.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>membrane filtration concentration, 11.8.10.111.8.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine concentration: membrane filter (Nuclepore), 11.6.8.111.6.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Micro-ID, 3.16.2, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Micromonospora</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Microorganism retention, 17.4.6.117.4.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microorganism storage, 17.4.6.117.4.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Micro Scan NEG ID Type 2, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Micro Scan POS ID 3, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Micro Scan Rapid NEG ID Type 4, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Micro Scan Rapid POS ID 2, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microscope</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calibration with ocular micrometer, 11.1.111.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitology, 11.1.111.1.2, 11.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Microscopic agglutination test (MAT), for Leptospira, 3.13.1, 3.13.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microscopic morphology, molds on primary culture, 10.8.210.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microscopy, dark-field, 3.8.1.2, 13.5.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microsporidia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast modified trichrome stain, 11.4.5.111.4.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.211.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.2, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calcofluor white for detection of microsporidial spores, 11.4.8.111.4.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formalin-ethyl acetate sedimentation, 11.3.3.1, 11.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>iron hematoxylin stain (modified Spencer-Monroe method), 11.3.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified trichrome-Ryan blue stain, 11.4.4.111.4.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified trichrome stain for microsporodia (Kokoskin hot method), 11.4.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified trichrome-Weber green stain, 11.4.3.111.4.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained smear (trichrome), 11.3.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy specimen permanent stained smear, 11.6.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spores in sigmoidoscopy specimen (permanent stained smear), 11.6.3.111.6.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.611.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine concentration, 11.6.7.111.6.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zinc sulfate flotation, 11.3.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Microsporidiosis, 2.1.35, 11.11.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microsporidium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Microsporum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, broth dilution, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BCP milk glucose test, 10.10.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>macroconidium and microconidia, 10.10.46</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.12, 10.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>polished-rice test for, 10.10.11, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Microsporum audouinii, 10.4.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair perforation test, 10.10.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hyphae, 10.10.48</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.3210.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>polished-rice medium, 10.10.11, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Microsporum canis, 10.4.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BCP milk glucose test, 10.10.29</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair perforation test, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.3210.10.33</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>polished-rice medium, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Microsporum cookei</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>macroconidium, 10.10.48</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.2310.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Microsporum ferrugineum, phenotypic identification characteristics, 10.10.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microsporum gallinae, phenotypic identification characteristics, 10.10.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microsporum gypseum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair perforation test, 10.10.3010.10.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>polished-rice medium, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Microsporum nanum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Microsporum praecox</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair perforation test, 10.10.3010.10.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Microsporum racemosum, micromorphological structures, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Microsporum vanbreuseghemii</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Middlebrook media, 9.3.29.3.3, 9.5.1.19.5.1.2, 9.5.1.5, 9.7.1.1, 9.7.2.1, 9.8.19.8.4, 9.9.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Middlebrook medium, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Middle East respiratory syndrome (MERS), 18.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Middle East respiratory syndrome coronavirus (MERS-CoV), 18.9.218.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 18.9.818.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescent antibody staining of antigens, 18.9.718.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.9.718.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation and reporting of results, 18.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methods, 18.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification, 18.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 18.9.118.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid antigen tests, 18.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.9.418.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serology, 18.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 18.9.518.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.9.618.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Midstream urine collection, 3.11.1.23.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MIF (merthiolate (thimerosal)-iodine-formalin), 11.2.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Millipore Sigma Sigma-Aldrich, 12.7.1312.7.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Minimal essential medium (MEM), 12.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Minimum&amp; bactericidal concentration (MBC) testing, 7.17.1.17.17.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bent glass rod hockey sticks for colony counts, 7.17.1.147.17.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.17.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>macrodilution method, 7.17.1.17.17.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 7.17.1.17.17.1.2, 7.17.1.6, 7.17.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microdilution method, 7.17.1.67.17.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.17.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.17.1.37.17.1.10, 7.17.1.107.17.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.17.1.2, 7.17.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection value and calculated sensitivity and specificity, 7.17.1.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 7.17.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.17.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>worksheet, 7.17.1.16, 7.17.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Minimum effective concentration (MEC), antifungal susceptibility testing, broth dilution, 10.12.1.7, 10.12.1.1010.12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Minimum inhibitory concentration(s) (MICs)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution, aerobic bacteria, 7.6.1.17.6.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar dilution MIC test, anaerobic bacteria, 7.6.2.17.6.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.2.1, 10.12.2.410.12.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing, broth dilution, 10.12.1.1, 10.12.1.610.12.1.7, 10.12.1.910.12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic bacteria, 7.4.1.17.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic bacteria, 7.4.2.17.4.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.67.14.7, 7.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>evaluation and verification of antimicrobial susceptibility test systems, 7.22.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MIC test strips (MTS), ESBL testing, 7.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>minimum bactericidal concentration testing, 7.17.1.47.17.1.5, 7.17.1.9, 7.17.1.127.17.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycoplasma and Ureaplasma, 3.14.2.2, 3.14.2.5, 3.14.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting and applying clinical breakpoints, 7.1.2.17.1.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sensititre SLOWMYCO2 broth microdilution plate, 9.9.2.19.9.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Minocycline (Minocin, Vectrin), 7.23.13, 9.9.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.18, 7.4.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slowly growing nontuberculous mycobacteria, 9.9.2.1, 9.9.2.3, 9.9.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mitsuokella, taxonomy update, 4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mixed acid fermentation, 3.17.32.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mlluscum contagiosum virus (MCV), 18.8.1, 18.8.418.8.5, 18.8.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MMR (measles/mumps/rubella) vaccine, laboratory personnel, 15.8.1.1, 15.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mobiluncus, 3.2.1.20, 3.8.1.3, 4.14.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mobiluncus curtisii, 4.14.4, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Modified acid-fast staining, biopsy specimens for parasitology, 11.7.3.111.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Modified Gram stain (Brown-Brenn), aerobic actinomycetes, 8.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Modified Kinyouns acid-fast stain (cold), 11.4.1.111.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Modified Martin-Lewis agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Modified Nelsons medium for Naegleria, 11.9.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Modified Nelsons medium for N. fowleri, 11.9.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Modified safranin technique with microwave heating, 11.4.6.111.4.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Modified Thayer-Martin (MTM) agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Modified Thayer-Martin media, 3.3.1.3, 3.3.1.7, 3.3.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Modified trichrome-Ryan blue stain, 11.4.4.111.4.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Modified trichrome stain for microsporodia (Kokoskin hot method), 11.4.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Modified trichrome-Weber green, 11.4.3.111.4.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 11.4.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 11.4.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 11.4.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 11.4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 11.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 11.4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 11.4.3.411.4.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 11.4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results, 11.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 11.4.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Modified Ziehl-Neelsen acid-fast stain (hot), 11.4.2.111.4.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Modifiers, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Moeller broth, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mogibacterium, 4.14.5, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mogibacterium timidum, 4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mold cultures, examination and evaluation of primary, 10.6.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mold-form cultures, laboratory safety, 18.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mold identification, 10.10.110.10.55</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical and physiological techniques, 10.10.1110.10.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cycloheximide responses, 10.10.10, 10.10.12, 10.10.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>exoantigen testing, 10.10.7, 10.10.1510.10.18, 10.10.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.10.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>species confirmation of dimorphic molds, 10.10.1210.10.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tolerance tests, 10.10.810.10.9, 10.10.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conidia, 10.10.110.10.2, 10.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dermatophytes, 10.10.1910.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BCP milk glucose test, 10.10.11, 10.10.2210.10.29, 10.10.3210.10.34, 10.10.53</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Christensens urea agar, 10.10.11, 10.10.53</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cornmeal glucose agar, 10.10.11, 10.10.2910.10.30, 10.10.54</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cyclohexide responses, 10.10.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decontamination of cultures contaminated with antimicrobial agentpolyresistant bacteria, 10.10.1910.10.20, 10.10.31, 10.10.54</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>growth factor tests, 10.10.2010.10.28, 10.10.5210.10.54</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair perforation test, 10.10.11, 10.10.2310.10.28, 10.10.3010.10.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media, 10.10.7, 10.10.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>micromorphology, 10.10.20, 10.10.21, 10.10.2310.10.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>physiological and other special medium tests, 10.10.2010.10.31</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>polished-rice test for Microsporum, 10.10.11, 10.10.30, 10.10.54</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>practical scheme, 10.10.3110.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.10.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sabouraud dermatophyte decontamination broth, 10.10.7, 10.10.54</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton agars, 10.10.7, 10.10.20, 10.10.2210.10.23, 10.10.25, 10.10.2710.10.28, 10.10.32, 10.10.5210.10.53</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 10.10.2210.10.28, 10.10.3310.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dimorphic, 10.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conversion to particulate phases, 10.10.12, 10.10.1510.10.17, 10.10.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media, 10.10.5010.10.51</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.10.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting and interpretation, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>species conformation, 10.10.1210.10.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>macromorphology, 10.10.2310.10.28</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 10.10.710.10.9, 10.10.4910.10.55</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>micromorphology, 10.10.210.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Ascomycota, 10.10.2, 10.10.410.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Basidiomycota, 10.10.510.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>definition of terms, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>dermatophytes, 10.10.20, 10.10.21, 10.10.2310.10.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>general characteristics, 10.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular, 10.11.110.11.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DNA extraction, 10.11.210.11.3, 10.11.510.11.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNA sequencing, 10.11.910.11.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lysis of fungal cells, 10.11.3, 10.11.510.11.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 10.11.110.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>polymerase chain reaction (PCR), 10.11.210.11.4, 10.11.610.11.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>preparation of materials, 10.11.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 10.11.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control and best practices, 10.11.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimens, 10.11.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preliminary and subsequent confirmatory tests, 10.10.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>on primary culture, 10.8.110.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cellophane tape mount, 10.8.310.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony characteristics, 10.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture examination, 10.8.110.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cycloheximide resistance, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>detatological specimens, 10.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation temperatures, 10.8.2, 10.8.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation and reporting, 10.8.710.8.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 10.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>medium selection, 10.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microscopic morphology, 10.8.210.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>molecular methodologies, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>primary, 10.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedures, 10.8.310.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory and sterile-body-site specimens, 10.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slide cultures, 10.8.410.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sterile molds, 10.8.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>subcultures, 10.8.510.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tease mount, 10.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 10.10.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.10.910.10.11, 10.10.4910.10.55</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting and interpretation, 10.10.3510.10.44</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>corneal scrapings or ocular aspirates, 10.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dimorphic fungi, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ear canals, 10.10.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>general considerations, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.3810.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.3710.10.38</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>opportunistic and subcutaneous fungi from normally sterile sites, 10.10.3510.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>skin scrapings yielding nondermatophytes, 10.10.3910.10.40</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>syringe-aspirated pus, 10.10.4310.10.44</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>toenails and fingernails yielding nondermatophytes, 10.10.4010.10.43</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wounds and ulcers sampled by swabs, 10.10.4310.10.44</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Molds</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing by broth dilution, 10.12.1.1, 10.12.1.5, 10.12.1.710.12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.1, 3.10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Molecular amplification, virus identification, 12.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Molecular assays fungal, 10.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Molecular diagnostics</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>assay harmonization, 14.2.5.414.2.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bartonella, 3.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BK virus infections, 14.3.8.114.3.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calibration curves, 14.2.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>contamination, 14.2.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>controls and calibrators, 14.2.5.114.2.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. trachomatis and N. gonorrhoeae, 14.3.9.114.3.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cytomegalovirus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>drug resistance testing, 14.3.6.114.3.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and required equipment, 14.3.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quantitative detection by real-time PCR, 14.3.5.114.3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>data analysis, 14.2.4.614.2.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>engineering and design controls, 14.2.2.114.2.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Epstein-Barr virus infections, 14.3.7.114.3.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>herpes simplex viruses 1 and 2 and varicella zoster virus, 14.3.4.114.3.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>high-risk human papillomaviruses, 14.3.3.114.3.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>human immunodeficiency virus (HIV) genotypic resistance testing, 14.3.2.114.3.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>monitoring, 14.2.2.514.2.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>performance specifications, 14.2.4.3, 14.2.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive identification of yeasts, 10.7.210.7.4, 10.7.1010.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sequencing-based identification of microorganisms, 14.5.1.114.5.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>verification and validation, 14.2.4.114.2.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>viral load testing, 14.2.5.414.2.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>workflow and procedural controls, 14.2.2.314.2.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Molecular methodologies</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.114.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification of yeasts and molds, 10.11.110.11.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold identification on primary culture, 10.8.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Molecular methods, yeast identification, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Molecular microbiology laboratory biosafety</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>employee health and/or emergency medical services, 14.2.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>extraction protocols, 14.2.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>handling of specimens following biohazardous agent identification, 14.2.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>high-risk organisms within the laboratory, 14.2.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 14.2.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>molecular methods, 14.2.3.614.2.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid sequencing, 14.2.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nucleic acid target amplification, 14.2.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pathogen heat inactivation, 14.2.3.514.2.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 14.2.3.114.2.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.2.3.214.2.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Molecular panels, reflex and composite testing scenarios, 1.2.4.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Molecular strain typing, 15.6.3.115.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Molecular testing</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical considerations</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calibration and AMR, 14.2.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>monitoring positivity and validation for genetic drift, 14.2.6.514.2.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.2.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control and molecular interpretations, 14.2.6.114.2.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting and monitoring errors, 14.2.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preanalytical considerations, 14.2.1.114.2.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinician/customer education, 14.2.1.1114.2.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disease natural history, 14.2.1.214.2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease prevalence, 14.2.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification and mitigation, 14.2.1.714.2.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.2.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapidly expanding/diversifying testing capacity, 14.2.1.1014.2.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 14.2.1.614.2.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen handling and storage, 14.2.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 14.2.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>supply shortfalls, 14.2.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test comprehensiveness, 14.2.1.114.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>test ordering, 14.2.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>test performance characteristics, 14.2.1.314.2.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Molecular typing tests, 15.6.3.2, 15.6.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Molecular workflow</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>contamination, engineering and design controls to minimize, 14.2.2.114.2.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular diagnostics, 14.2.2.114.2.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Molluscum contagiosum, clinical manifestations, 12.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Molluscum contagiosum virus, 12.9.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Moniliformis, 11.1.21, 11.10.1, 11.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Monitoring, 1.2.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>contamination in molecular diagnostics, 14.2.2.514.2.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>individualized quality control plan, 16.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tests and use of test results, 16.1.3, 16.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Monitoring compliance, 1.2.4.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Monkeypox (MPXV) virus, 17.5.3.2, 17.6.10, 18.8.1, 18.8.3, 18.8.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Monobactam, 7.23.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Monocid. See Cefuroxime</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Monoclonal antiT. pallidum antibody, 13.5.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Monolayer viral cell cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cell count, 12.7.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>continuous or heteroploid, 12.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diploid, 12.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>primary, 12.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serial propagation and maintenance, 12.7.112.7.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cell types, 12.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>contaminants, 12.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cryopreservation of cell lines, 12.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 12.7.312.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>obtaining cells, 12.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation, 12.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 12.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 12.7.812.7.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 12.7.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 12.7.512.7.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recovery of cryopreserved cells, 12.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>subpassage of stock cell cultures, 12.7.912.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Monolisa Anti-HAV EIA, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Monolisa Anti-HAV IgM EIA, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Monolisa Anti-HBc EIA, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Monolisa Anti-HBc IgM EIA, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Monolisa Anti-HBs EIA, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mononucleosis, infectious, 13.8.1.1, 13.8.2.2, 13.8.3.3, 13.9.1.1, 14.3.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Monurol (fosfomycin), 7.23.3, 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Moraxella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>butyrate esterase test, 3.17.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conjunctivitis, 3.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hematopoietic stem cell products, 15.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>indoxyl acetate disk test, 3.17.23.13.17.23.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>keratitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxidase test, 3.17.38.2, 3.17.38.3, 18.15.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Moraxella bovis, 3.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Moraxella catarrhalis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.67.7.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>butyrate esterase test, 3.17.7.13.17.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cysteine proteose peptone agar, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.8, 7.2.12, 7.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.13.17.16.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.3, 3.19.4, 3.19.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indoxyl acetate disk test, 3.17.23.13.17.23.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.1, 3.10.9.33.10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>N. gonorrhoeae cultures, 3.8.3.6, 3.8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nitrate/nitrite reduction test, 3.17.34.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>otitis media, 3.10.5.13.10.5.2, 3.10.5.43.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.13.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.6, 7.23.8, 7.23.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Moraxella osloensis, 16.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Morganella, 3.7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenylalanine deaminase (PDA) test, 3.17.39.1, 3.17.39.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stone cultures, 3.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Morganellaceae, stone cultures, 3.11.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Morganella morganii, 3.7.1.2, 16.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1, 7.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Morphology agar, 10.9.3, 10.9.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mortar-and-pestle method, 3.12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mortierella polycephala, temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mortierella, temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mortierella wolfii, temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mother-to-child transmission (MTCT) of syphilis, 13.5.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Motility-indole-lysine medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Motility-indole-ornithine medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Motility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes (s), 3.17.30.13.17.30.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic Gram-negative bacilli, 4.13.134.13.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.15.5.118.15.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>B. pseudomallei and B. mallei, 18.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>performance standards, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Moulds, respiratory tract cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.6, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Moxifloxacin, 9.9.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar proportion method, 9.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slowly growing nontuberculous mycobacteria, 9.9.2.1, 9.9.2.3, 9.9.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Moxifloxacin (Avelox), 7.23.11, 9.9.1.2, 9.9.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MR (methyl red) reagent, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MRSA. See Methicillin-resistant Staphylococcus aureus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MRS broth, 3.17.31.13.17.31.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MR (methyl red) test, 3.17.32.13.17.32.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MR-VP (methyl redVogesProskauer) medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MR-VP (methyl red-Voges Proskauer) tests, 3.17.32.13.17.32.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MS (mass spectrometry)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic actinomycetes, 6.4.16.4.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>matrix-assisted laser desorption ionization time of flight (MALDI-TOF) (See Matrix-assisted laser desorption ionization-time of flight mass spectrometry)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MTB. See Mycobacterium tuberculosis</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MTBC. See Mycobacterium tuberculosis complex</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MTB/RIF test, 9.6.2.19.6.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MTCT (mother-to-child transmission) of syphilis, 13.5.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MTD Test. See Mycobacterium tuberculosis Direct Test</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MTM (modified Thayer-Martin) agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MUB (4-methylumbelliferyl butyrate), 3.17.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mucocutaneous leishmaniasis, 11.11.2.9, 11.11.2.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mucocutaneous tissue, fungal specimens, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mucor</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing by broth dilution, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cycloheximide susceptibility, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation temperature, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mucoraceous molds, 10.4.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mucorales</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing by broth dilution, 10.12.1.8, 10.12.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>asexual reproduction, 10.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cycloheximide susceptibility, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification on primary media, 10.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation temperature, 10.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold identification on primary culture, 10.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.1, 10.10.3, 10.10.7, 10.10.13, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mucorales, orbital cellulitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mucor circinelloides, temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mucor indicus, incubation temperature, 10.8.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mucor janssenii, temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mucormycotina, microscopic examination, 10.4.1.11, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mucoromycota, 10.10.1, 10.10.8, 10.10.13, 10.10.35, 10.10.38</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mucor ramosissimus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mucor velutinosus, temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mucosal swab culture, viral, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mucous membranes, biohazards, 17.1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mueller-Hinton agar (MHA), 7.2.17.2.2, 7.6.1.11, 7.14.47.14.5, 7.24.3.3, 7.24.3.67.24.3.7, 7.24.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inducible clindamycin resistance, 7.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sheep-blood (5%)-supplemented, 7.24.3.37.24.3.4, 7.24.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mueller-Hinton broth, 7.24.3.7, 7.24.3.8, 7.24.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MUEs (medically unlikely edits), 1.1.4, 1.2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MUG (4-methylumbelliferyl--D-glucuronide) test, 3.17.33.13.17.33.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Multi Code BK Virus Primers, 14.3.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Multicode-RTx Herpes Simplex Viruses 1&amp;2 assay, 14.3.4.2, 14.3.4.5, 14.3.4.6, 14.3.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Multidrug-resistant Acinetobacter baumannii, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Multidrug-resistant Candida auris, 10.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Multidrug-resistant Enterobacterales, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Multidrug-resistant Enterobacteriaceae, 15.7.6.115.7.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Multidrug-resistant Gram-negative rods (MDR-GNR), 15.7.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Multidrug-resistant microorganisms, 15.5.3.2, 15.5.3.5, 15.5.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Multidrug-resistant organisms (MDROs), 15.5.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Multidrug-resistant Pseudomonas aeruginosa, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Multidrug-resistant Streptococcus pneumoniae, AST and serotyping of, 15.7.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Multilocus sequence typing (MLST), 15.6.1.1, 15.6.5.115.6.5.3, 15.6.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gene sequences, 15.6.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 15.6.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations of testing, 15.6.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 15.6.5.115.6.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedure, 15.6.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 15.6.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 15.6.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Multiplex bead flow cytometric assays, Epstein-Barr virus (EBV), 13.8.3.113.8.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Multiplex molecular panels, 5.13.15.13.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretations, 5.13.105.13.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations of testing, 5.13.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 5.13.35.13.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.13.15.13.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.13.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 5.13.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 5.13.105.13.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, 5.13.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Multiplex molecular tests, verification of, 14.2.4.3, 14.2.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Multitest kits, 3.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mumps virus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mupirocin, 7.10.17.10.3, 7.20.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Murdochiella, 4.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Murdochiella asaccharolytica, 4.15.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>spot indole, 4.15.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Muscle biopsy, parasites, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Muscles</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, parasites, 2.1.37, 11.11.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Musculoskeletal tissues, culture of human cadaveric tissues for transplantation, 15.4.6.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycelia sterilia, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycelium, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycetoma, 2.1.35, 10.4.1.13, 10.10.35, 10.10.43</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycifradin (neomycin), 7.23.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacteria</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Accu Probe tests for identification, 9.1.1, 9.5.2.19.5.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar proportion method, 9.8.19.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT PZA kit, 9.7.2.19.7.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BACTEC MGIT SIRE kit, 9.7.1.19.7.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sensititre SLOWMYCO2 broth microdilution plate, 9.9.2.19.9.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>chronic otitis, 3.10.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>conventional biochemical, 9.5.1.19.5.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>arylsulfatase tests, 9.5.1.19.5.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase tests, 9.5.1.1, 9.5.1.2, 9.5.1.4, 9.5.1.69.5.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>growth on MAC without crystal violet, 9.5.1.1, 9.5.1.3, 9.5.1.4, 9.5.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>growth rate and pigment production, 9.5.1.19.5.1.4, 9.5.1.79.5.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>iron uptake, 9.5.1.1, 9.5.1.3, 9.5.1.4, 9.5.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 9.5.1.29.5.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>niacin accumulation, 9.5.1.1, 9.5.1.3, 9.5.1.4, 9.5.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nitrate reduction, 9.5.1.1, 9.5.1.3, 9.5.1.4, 9.5.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 9.5.1.19.5.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedures, results, and quality control, 9.5.1.39.5.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pyrazinamidase, 9.5.1.19.5.1.4, 9.5.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 9.5.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sodium chloride (NaCl) tolerance, 9.5.1.29.5.1.4, 9.5.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen, 9.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tellurite reduction, 9.5.1.29.5.1.4, 9.5.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>thiophene-2-carboxylic acid hydrazide (TCH) inhibition, 9.5.1.29.5.1.4, 9.5.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tween 80 hydrolysis, 9.5.1.29.5.1.4, 9.5.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease, 9.5.1.29.5.1.4, 9.5.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>liquid media for isolation</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT automated system, 9.4.1.19.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK Myco Culture system, 9.4.2.19.4.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification tests (NAATs), 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/RIF assays, 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium tuberculosis direct test (MTD), 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular cultures, 3.9.83.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>overview, 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.3.1, 3.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>solid media used for isolation, 9.3.19.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacteria, fastidious, 5.11.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacteria Growth Indicator Tube (MGIT), 9.4.1.19.4.1.5, 9.7.1.19.7.1.5, 9.7.2.19.7.2.4, 9.8.49.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterial infections</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor-derived, 15.7.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor screening, 15.7.7.715.7.7.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterial media and tests, quality control, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacteriology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/RIF test, 9.6.1.19.6.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/XDR test, 9.6.3.19.6.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>digestion and decontamination, 9.2.2.19.2.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>liquid media used for isolation, BACTEC MGIT automated mycobacterial culture system, 9.4.1.19.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification procedures, Cepheid Xpert MTB/RIF test, 9.6.2.19.6.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pyrosequencing prediction of drug resistance in Mycobacterium tuberculosis complex, 9.10.1.19.10.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reflex and composite testing scenarios, 1.2.4.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rejection of specimens, 2.1.26</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting, 9.2.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety and levels of service, 9.2.1.19.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, by TREK sensitivity microdilution plates, 9.9.1.19.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 6.4.1, 6.4.4, 6.4.8, 6.4.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>liquid media for isolation, VersaTREK Myco Culture system, 9.4.2.19.4.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lysis centrifugation, 5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pyrosequencing, 14.5.1.1, 14.5.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pyrosequencing (PSQ), 9.10.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sequencing-based identification, 14.5.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1, 8.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium abscessus, 9.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 9.9.1.19.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium africanum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/XDR test, 9.6.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium asiaticum, distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium avium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Accu Probe tests for identification, 9.5.2.19.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 9.9.2.19.9.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>continuous monitoring blood culture systems, 5.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tellurite reduction, 9.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium avium complex (MAC)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Accu Probe tests for identification, 9.1.1, 9.5.2.19.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 9.9.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium bolletii, 9.9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium bovis, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 9.5.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/XDR test, 9.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>niacin accumulation, 9.5.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>thiophene (TCH), 9.5.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>thiophene-2 carboxylic acid hydrazide (TCH) inhibition, 9.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium bovis BCG, 15.7.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium canettii, Cepheid Xpert MTB/XDR test, 9.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium caprae, Cepheid Xpert MTB/XDR test, 9.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium celatum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Accu Probe tests for identification, 9.5.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tellurite reduction, 9.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium chelonae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 9.9.1.19.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>growth on MAC without crystal violet, 9.5.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>iron uptake, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>niacin accumulation, 9.5.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sodium chloride (NaCl) tolerance, 9.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium chelonae complex, distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium flavescens, distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium fortuitum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 9.9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>arylsulfatase, 9.5.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>arylsulfatase agar, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT automated system for isolation, 9.4.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 9.5.1.6, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>growth on MAC without crystal violet, 9.5.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>growth rate, 9.5.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>iron uptake, 9.5.1.1, 9.5.1.8, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>liquid media for isolation, 9.4.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK Myco Culture system, 9.4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lowenstein-Jensen medium, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MAC medium, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Middlebrook medium, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>salt tolerance, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sodium chloride (NaCl) tolerance, 9.5.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>solid media used for isolation, 9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium fortuitum group, distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium gastri</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium genavense, distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium goodii, 9.9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium gordonae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Accu Probe tests for identification, 9.1.1, 9.5.2.19.5.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 9.5.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>growth rate, 9.5.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pigment production, 9.5.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>salt tolerance, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium haemophilum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>continuous monitoring blood culture systems, 5.5.7, 5.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>liquid media for isolation, VersaTREK Myco Culture system, 9.4.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>solid media used for isolation, 9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium intracellulare</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Accu Probe tests for identification, 9.5.2.19.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>arylsulfatase agar, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>continuous monitoring blood culture systems, 5.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Dubos broth, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kirchner medium, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lowenstein-Jensen medium, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Middlebrook medium, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>niacin medium, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nitrate reduction, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pigment production, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pyrazinamidase, 9.5.1.9, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>solid media used for isolation, 9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tellurite reduction, 9.5.1.10, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tween hydrolysis, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tween 80 hydrolysis, 9.5.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease broth, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium kansasii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Accu Probe tests for identification, 9.1.1, 9.5.2.19.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 9.9.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT automated system for isolation, 9.4.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>growth rate, 9.5.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>liquid media for isolation, 9.4.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK Myco Culture system, 9.4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lowenstein-Jensen medium, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Middlebrook medium, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>niacin medium, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nitrate reduction, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pigment production, 9.5.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pyrazinamidase, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>solid media used for isolation, 9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Tween hydrolysis, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease, 9.5.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urease broth, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium leprae, 8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium malmoense</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 9.9.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>continuous monitoring blood culture systems, 5.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium marinum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 9.9.2.19.9.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/XDR test, 9.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>continuous monitoring blood culture systems, 5.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>liquid media for isolation, VersaTREK Myco Culture system, 9.4.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>solid media used for isolation, 9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium microti, Cepheid Xpert MTB/XDR test, 9.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium mucogenicum, 9.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sodium chloride (NaCl) tolerance, 9.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium mungi, Cepheid Xpert MTB/XDR test, 9.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium orygis, Cepheid Xpert MTB/XDR test, 9.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium peregrinum, 9.9.1.2, 9.9.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium phlei, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium pinnipedii, Cepheid Xpert MTB/XDR test, 9.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium scrofulaceum, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Accu Probe tests for identification, 9.5.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>solid media used for isolation, 9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium shimoidei, distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium simiae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 9.9.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>niacin accumulation, 9.5.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium smegmatis, 9.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 6.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium szulgai</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium terrae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>growth rate, 9.5.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium terrae complex</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 9.9.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium triviale</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>arylsulfatase, 9.5.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sodium chloride (NaCl) tolerance, 9.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium tuberculosis (MTB), 8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Accu Probe tests for identification, 9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1, 6.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acid-fast stain, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar proportion method, 9.8.19.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT PZA kit, 9.7.2.19.7.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BACTEC MGIT SIRE kit, 9.7.1.19.7.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biosafety levels, 17.3.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 9.5.1.1, 9.5.1.6, 9.5.1.7, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>continuous monitoring blood culture systems, 5.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>drug resistance, 14.5.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Dubos broth, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital tract, 3.8.1.4, 3.8.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inhalation, 17.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kirchner medium, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.1, 15.8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory safety, 18.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>liquid media for isolation</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT automated system, 9.4.1.19.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK Myco Culture system, 9.4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>liquid media used for isolation</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT automated mycobacterial culture system, 9.4.1.19.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Lowenstein-Jensen medium, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Middlebrook medium, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>niacin accumulation, 9.5.1.1, 9.5.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>niacin medium, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nitrate reduction, 9.5.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nucleic acid amplification procedures, Cepheid Xpert MTB/RIF test, 9.6.2.19.6.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nucleic acid amplification tests (NAATs), 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/RIF assays, 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium tuberculosis direct test (MTD), 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>X</title>
            <indexentry>
               <primaryie>Xpert MTB/RIF Ultra assay, 9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Xpert MTB/XDR assay, 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PZA resistance, 9.5.1.19.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety and levels of service, 9.2.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>shipping, 17.6.10, 17.6.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>solid media used for isolation, 9.3.19.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tellurite reduction, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>thiophene-2 carboxylic acid hydrazide (TCH) inhibition, 9.5.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>thiophene-2-carboxylic acid hydrazide susceptibility, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK automated microbial detection system, 9.7.3.19.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium tuberculosis complex (MTBC)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Accu Probe tests for identification, 9.1.1, 9.5.2.19.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 9.9.3.19.9.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar proportion method, 9.8.19.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT SIRE kit, 9.7.1.19.7.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/RIF test, 9.6.1.19.6.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/XDR test, 9.6.3.19.6.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification procedures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/RIF test, 9.6.2.19.6.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>X</title>
            <indexentry>
               <primaryie>Xpert MTB/RIF test, 9.6.2.19.6.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification tests (NAATs), 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/RIF assays, 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium tuberculosis direct test (MTD), 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>X</title>
            <indexentry>
               <primaryie>Xpert MTB/RIF Ultra assay, 9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Xpert MTB/XDR assay, 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pyrosequencing prediction of drug resistance, 9.10.1.19.10.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting, 9.2.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium tuberculosis direct test (MTD), 9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium tuberculosis (tuberculosis), laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium ulcerans</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>continuous monitoring blood culture systems, 5.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>liquid media for isolation, VersaTREK Myco Culture system, 9.4.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>solid media used for isolation, 9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium vaccae, distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium wolinskyi, 9.9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium xenopi</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 9.9.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>arylsulfatase, 9.5.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colonial morphology, 9.5.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>continuous monitoring blood culture systems, 5.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>distinctive properties in clinical specimens, 9.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>solid media used for isolation, 9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycolic acid-containing genera, 8.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycologic media, 16.2.1716.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), broth dilution, 10.12.1.110.12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>classification, 10.1.1, 10.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 2.1.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>epidemiologic cutoff values (ECV/ECOFF), 10.13.110.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination and evaluation of primary, 10.6.110.6.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 10.6.410.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 10.6.610.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 10.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microscopic examination, 10.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation of culture materials, 10.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 10.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting, 10.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>subsequent testing, 10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>useful tests, 10.6.310.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>learning more, 10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic clinical specimen examination, 10.4.1.110.4.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood, 10.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bone and bone marrow, 10.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>brain, 10.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bronchial lavage, wash, 10.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>corneal scrapings, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CSF, 10.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>external auditory canal, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 10.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>India ink method, 10.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>KOH and KOH-DMSO mount, 10.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>KOH-calcofluor mount, 10.4.1.310.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 10.4.1.110.4.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>morphologies seen, 10.4.1.510.4.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mucocutaneous tissue, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nail, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nasal tissue, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>paranasal sinus, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>peritoneal fluid, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 10.4.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedures, 10.4.1.310.4.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>prostatic fluid/tissue, 10.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.4.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 10.4.1.1410.4.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>skin, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 10.4.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sputum, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stratum corneum, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>subcutaneous granules, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>subcutaneous tissue, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synovial fluid, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vaginal specimens, 10.4.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>vitreous, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold identification on primary culture, 10.8.110.8.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>molecular identification of yeasts and molds, 10.11.110.11.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 10.1.110.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identification tests for yeast, 10.7.110.7.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.110.5.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reflex and composite testing scenarios, 1.2.4.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rejection of specimens, 2.1.26</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety, 10.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.3, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 2.1.26</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.110.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>staining for direct microscopic detection of Pneumocystis jirovecii in respiratory samples, 10.4.2.110.4.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.110.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph versus teleomorph, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>classification, 10.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cryptic species and species complexes, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incorporation of taxonomic changes, 10.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>name changes, 10.2.110.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>significance of species identification, 10.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycology cultures, maintenance of stock, 16.2.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycology worksheet, 16.6.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycoplasma, 12.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acridine orange stain, 3.2.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 3.14.2.13.14.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital culture, 3.8.1.1, 3.8.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection and transport, 2.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycoplasma and Ureaplasma. See Mycoplasma; Ureaplasma</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycoplasma fermentans, 3.14.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycoplasma genitalium, 3.8.1.2, 3.8.1.5, 3.14.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>by nucleic acid amplification tests, 3.14.4.13.14.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycoplasma hominis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 3.14.2.13.14.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 3.14.1.13.14.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of culture media, 3.14.1.73.14.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation, 3.14.1.63.14.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation, 3.14.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 3.14.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.14.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.14.1.4, 3.14.1.113.14.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.14.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.14.1.63.14.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.14.1.53.14.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.14.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.14.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.14.1.23.14.1.4, 3.14.1.113.14.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious, 5.11.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>by nucleic acid amplification tests, 3.14.4.13.14.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycoplasma pneumoniae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 3.14.2.13.14.2.3, 7.23.11, 7.23.12, 7.23.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 3.14.1.13.14.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of culture media, 3.14.1.73.14.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation, 3.14.1.63.14.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation, 3.14.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 3.14.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.14.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.14.1.4, 3.14.1.113.14.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.14.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.14.1.63.14.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.14.1.53.14.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.14.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.14.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.14.1.23.14.1.4, 3.14.1.113.14.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sterile body fluids, 3.14.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious, 5.11.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification tests, 3.14.3.13.14.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycoplasmas, fastidious, 5.11.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycoses, specimen collection and culture medium, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Myocarditis, potential etiological agents, 2.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Myositis, 2.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Myroides odoratus/odoratimimus, 3.19.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>N</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>N (neuraminidase), 18.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NAATs. See Nucleic acid amplification tests</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NaCl. See Sodium chloride</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NaCl (0.85%), 11.3.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NaClO (sodium hypochlorite) solution, prion decontamination, 17.5.5.317.5.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Naegleria</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.211.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calcofluor white stain, 11.4.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture, 11.7.3.211.7.3.4, 11.9.1.111.9.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 11.9.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 11.9.1.2, 11.9.1.611.9.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 11.9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 11.9.1.311.9.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 11.9.1.511.9.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 11.9.1.211.9.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 11.9.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results, 11.9.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 11.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enflagellation experiment, 11.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.5, 11.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Naegleria fowleri</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>amebic meningoencephalitis, 11.9.1.1, 11.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture, 11.9.1.111.9.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enflagellation experiment, 11.9.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Nelsons medium for, 11.9.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>STAT testing, 11.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Naegleria gruberi, 11.9.1.2, 18.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nafcillin, 7.6.1.6, 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nafcillin (Staphcillin, Nafcil, Nallpen, Unipen), 7.6.1.6, 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Naglers test, 16.2.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nails, fungal specimens, 10.3.4, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nalidixic acid (Neg Gram), 7.23.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nalidixic acid, broth microdilution MIC test, 7.4.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nalidixic acid + Tween agar (NAT), 4.4.1.2, 4.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nallpen (nafcillin), 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nannizzia gypsea</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair perforation test, 10.10.3010.10.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>polished-rice test, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nannizzia nana</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nannizzia persicolor</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.33</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nannizzia, phenotypic identification, 10.10.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nannizzia praecox</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair perforation test, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nasal and facial sinus scrapings, mold identification, 10.10.3810.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nasal aspirate, Bordetella, 3.10.6.33.10.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nasal sinuses</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cultures, 3.10.9.13.10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.10.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.10.9.23.10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 3.10.9.33.10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.10.9.13.10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 3.10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nasal/sinus tissue, 10.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nasal swab culture, viral, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nasal tissue, fungal specimens, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nasal wash, Bordetella, 3.10.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nasopharyngeal (NP) aspirate, Bordetella, 3.10.6.33.10.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nasopharyngeal aspirate culture, viral, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nasopharyngeal carcinoma, 13.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nasopharyngeal (NP) specimen, Bordetella, 3.10.6.23.10.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nasopharyngeal (NP) swab</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bordetella, 3.10.6.23.10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, viral, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nasopharynx</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, specimens and recommended stains, 11.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>National Correct Coding Initiative (NCCI), 1.1.4, 1.2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>National coverage determinations (NCDs), 1.1.11.1.3, 1.2.3.71.2.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>National Electronic Disease Surveillance System (NEDSS), 15.5.4.215.5.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>National Healthcare Safety Network (NHSN), 1.1.1, 15.5.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>National Healthcare Safety Network Hemovigilance Module, 20102016, 5.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>National Laboratories, bioterrorism, 18.14.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>National Limitation Amounts (NLA), 1.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>National Marrow Donor Program questionnaire, 15.7.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>National Notifiable Diseases Surveillance System (NNDSS), 15.5.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Native-joint infections, 3.4.23.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nattrassia mangiferae, 10.10.3910.10.40</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NCDs (national coverage determinations), 1.2.3.71.2.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nebcin. See Tobramycin</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Necator americanus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar plate culture, 11.5.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Neck infections, anaerobic specimen selection, 4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Necrobacillosis, 4.13.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NEDSS (National Electronic Disease Surveillance System), 15.5.4.215.5.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Needle(s), safety, 17.1.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Negative controls, molecular diagnostics, 14.2.2.6, 14.2.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Negative predictive value (NPV), 14.2.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Negativicoccus, 4.15.3, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Negativococcus, 4.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neg Gram (nalidixic acid), 7.23.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Negotiated Rulemaking Committee, 1.1.21.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>Neg Reg, 1.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Neisseria</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>butyrate esterase test, 3.17.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.23.17.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>continuous-monitoring blood culture systems, 5.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.2, 3.19.3, 3.19.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF, 6.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>media for, 3.3.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate/nitrite reduction test, 3.17.34.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ONPG (o-nitrophenyl--D-galactopyranoside) test, 3.17.36.13.17.36.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oxidase test, 3.17.38.1, 3.17.38.3, 18.15.1.2, 18.15.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Neisseria animaloris, 3.19.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neisseriaceae, 3.17.19.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neisseria cinerea, 3.8.3.7, 3.8.3.10, 3.19.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neisseria elongata, 3.8.3.7, 3.19.10, 3.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neisseria flavescens, 3.8.3.7, 3.19.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neisseria gonorrhoeae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.1, 7.6.1.97.6.1.10, 7.6.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>amniotic fluid, 2.1.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), preparation of agar and broth media, 7.24.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.20.6, 7.20.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood cultures, 3.8.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body fluids, 3.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>butyrate esterase test, 3.17.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 3.17.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cervix, 2.1.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CHOC medium, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>conjunctival specimens, 3.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>conjunctivitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cysteine proteose peptone agar, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.4, 7.2.8, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital cultures, 3.8.3.13.8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 3.8.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical syndromes, 3.8.1.2, 3.8.1.3, 3.8.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture confirmation, 3.8.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture examination, 3.8.1.9, 3.8.3.83.8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture methods, 3.8.3.63.8.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct test, 3.8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.8.1.11, 3.8.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.8.3.123.8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.8.1.83.8.1.9, 3.8.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification test, 3.8.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.8.1.1, 3.8.3.13.8.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedures, 3.8.3.63.8.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.8.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.8.1.11, 3.8.3.113.8.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.8.1.4, 3.8.1.5, 3.8.1.6, 3.8.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen sources, 3.8.3.23.8.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 3.8.1.8, 3.8.3.23.8.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.2, 7.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.4, 3.19.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation, 3.3.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media for, 3.3.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>New York city agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nucleic acid amplification tests, 14.3.9.114.3.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 14.3.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>epidemiology, 14.3.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.3.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 14.3.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>other considerations, 14.3.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.3.9.114.3.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure and methodology, 14.3.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.3.9.714.3.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>result reporting and interpretation, 14.3.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>screening, 14.3.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.3.9.414.3.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>strain typing and genotypic resistance testing, 14.3.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>suspected child abuse, 14.3.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>workflow, 14.3.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ONPG (o-nitrophenyl--D-galactopyranoside) test, 3.17.36.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pharyngitis, 3.10.8.1, 3.10.8.33.10.8.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>primary plating media, 3.3.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>public health reporting, 15.5.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rectum, 3.8.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.6, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.8.1.4, 3.8.1.5, 3.8.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection and transport, 2.1.2, 2.1.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 2.1.26</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 3.8.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>systemic infection, 3.8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test utilization monitoring, 1.2.4.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>transport media, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urethra, 3.8.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urine culture, 3.11.1.3, 3.11.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Neisseria lactamica, 3.3.2.4, 3.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>butyrate esterase test, 3.17.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cysteine proteose peptone agar, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.4, 3.19.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>N. gonorrhoeae cultures, 3.8.3.5, 3.8.3.6, 3.8.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ONPG (o-nitrophenyl--D-galactopyranoside) test, 3.17.36.23.17.36.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Neisseria meningitidis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.1, 7.6.1.8, 7.6.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.20.13, 7.23.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood cultures, 5.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.1, 7.4.1.4, 7.4.1.12, 7.4.1.14, 7.4.1.187.4.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cysteine proteose peptone agar, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.8, 7.2.13, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.217.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital culture, 3.8.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>highly pathogenic bacteria, 6.3.3, 6.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.4, 3.19.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunization of laboratory personnel, 15.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation, 17.1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory-acquired, 15.8.3.1, 15.8.3.3, 18.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>multiplex molecular panels, 5.13.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>New York City agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>N. gonorrhoeae cultures, 3.8.3.5, 3.8.3.6, 3.8.3.7, 3.8.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>primary plating media, 3.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>surveillance, 15.5.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Neisseria meningitidis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.13.5.2, 3.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.6, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>throat culture, 3.10.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Neisseria mucosa, nitrate/nitrite reduction test, 3.17.34.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neisseria polysaccharea, 3.19.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neisseria sicca, 16.2.8, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neisseria subflava, 3.8.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neisseria weaveri, 3.19.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neisseria zoodegmatis, identification, 3.19.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nematodes</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.111.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>larval stage culture, 11.5.4.111.5.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Neomycin (Mycifradin, Neobiotic), 7.23.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neonatal surface swabs culture, viral, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neoscytalidium, 10.3.4, 10.10.3910.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cycloheximide susceptibility, 10.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.12, 10.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Neoscytalidium dimidiatum, 10.10.3910.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification on primary media, 10.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Neoscytalidium hyalinum, 10.10.3910.10.40</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nephrostomy, 3.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nerves, infections of, 2.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nervous system infections, potential etiological agents, 2.1.152.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Netilmicin</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-level aminoglycoside resistance (HLAR) in Enterococcus, 7.12.17.12.3, 7.12.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>high-level resistance in Enterococcus, 7.12.17.12.3, 7.12.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Neuraminidase (N), 18.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neurosyphilis, 13.5.1.1, 13.5.1.2, 13.5.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neurotoxin-producing Clostridium botulinum, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Neutralizers of common disinfectant chemicals, 15.4.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Newcastle disease virus, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>New Delhi metallo--lactamase (NDM), 7.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>New England Compounding Center (NECC), 15.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>New technology add-on payments (NTAP), 1.2.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>New York City agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>New York State Department of Health (NYSDOH), 15.5.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Next-generation sequencing (NGS), 14.1.1, 15.6.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>deep amplicon sequencing, 14.5.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>drug resistance-associated mutations (DRMs), HIV, 14.3.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>HIV genotypic resistance testing, 14.3.2.114.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>strain typing, 15.6.6.115.6.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>verification and validation, 14.2.4.514.2.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>virus identification, 12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>whole-genome sequences, 15.6.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>NHS (normal human serum), heat-inactivated, 7.18.117.18.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NHSN Coronavirus Infectious Disease 2019 Module, 15.5.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Niacin accumulation, mycobacteria, 9.5.1.1, 9.5.1.3, 9.5.1.4, 9.5.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Niacin medium, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nickerson-bismuth sulfite-glucose-glycine-yeast agar, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Niclosamide, 11.5.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Niger agar, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ninhydrin, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nipah henipavirus, 18.12.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nipah virus, 15.8.4.2, 17.5.3.2, 18.12.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nitrate, anaerobic Gram-negative bacilli, 4.13.154.13.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nitrate assimilation test for yeast identification, 10.9.3, 10.9.610.9.7, 10.9.8, 10.9.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nitrate disk reduction test, 4.9.3.14.9.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nitrate/nitrite reduction test, aerobic actinomycetes, 8.3.118.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nitrate reagents, performance standards</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobes, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nitrate reduction</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria, 9.5.1.1, 9.5.1.3, 9.5.1.4, 9.5.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identification of yeasts, 10.7.110.7.3, 10.7.710.7.8, 10.7.1110.7.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nitrate reduction agar, performance standards</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacteria, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria, 16.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nitrate reduction broth, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nitrate reduction test, aerobes, 3.17.34.13.17.34.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nitrate test, anaerobic gram-negative bacilli, 4.13.154.13.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nitrite reduction test, 3.17.34.13.17.34.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nitrofuran, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nitrofurantoin (Furadantin, Macrodantin), 7.20.9, 7.23.3, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nitroimidazole, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nitrophenol test, combination enzymatic tablets for nitrophenol, aminopeptidase, and glucosidases, 4.9.19.14.9.19.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NL63, 12.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NL63229E, specimen collection, 2.1.31</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NNDSS (National Notifiable Diseases Surveillance System), 15.5.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NNN medium, 11.9.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Offutt modification, 11.9.3.611.9.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>NO. See Nosocomial outbreaks</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia, 8.1.1, 8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 6.4.1, 6.4.4, 6.4.5, 6.4.8, 6.4.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>chronic otitis, 3.10.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation of growth, 8.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>keratitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lysozyme test, 8.3.10, 8.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF, 6.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.3, 8.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate/nitrite reduction test, 8.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sequencing-based identification, 14.5.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1, 8.2.4, 8.2.68.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 8.3.13, 8.5.18.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urea test, 8.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3, 3.12.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardia abscessus, 8.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>susceptibility profile indexes, 8.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardia acid-fast stain, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia africana, 8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia anaemiae, 8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia aobensis, 8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia araoensis, 8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia arthritidis, 8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia asiatica, 8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia asteroides</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast stain, 16.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>casein agar, 16.2.17, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Czapek-Dox agar, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.6, 8.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characterization, 8.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tyrosine agar, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>X</title>
            <indexentry>
               <primaryie>xanthine agar, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardia beijingensis, 8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia blacklockiae, 8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia brasiliensis, 8.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>casein agar, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>susceptibility profile indexes, 8.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 8.3.12, 8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tyrosine agar, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardia brevicatena, 8.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lysozyme test, 8.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>susceptibility testing, 8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardia carnea, 8.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characterization, 8.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardia concava, 8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia cyriacigeorgica, 8.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>susceptibility profile indexes, 8.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 8.3.12, 8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardia elegans, 8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia exalbida, 8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia farcinica, 8.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acetamide utilization test, 8.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lysozyme test, 8.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characterization, 8.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>susceptibility profile indexes, 8.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 8.3.12, 8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardia grenadensis, 8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia higoensis, 8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia inohanensis, 8.3.3, 8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia kruczakiae, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia mexicana, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia niigatensis, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia ninae, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia nova, 8.3.3, 8.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>susceptibility profile indexes, 8.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 8.3.12, 8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardia otitidiscaviarum, 8.3.8, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>susceptibility profile indexes, 8.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardia paucivorans, 8.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>susceptibility testing, 8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardia pneumoniae, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia pseudobrasiliensis, 8.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>susceptibility profile indexes, 8.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardia puris, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia rhamnosiphila, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia sienata, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia testacea, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia thailandica, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia transvalensis, 8.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>susceptibility profile indexes, 8.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 8.3.12, 8.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardia vermiculata, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia veterana, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia vinacea, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia wallacei, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardia yamanashiensis, 8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardiopsis, 8.1.1, 8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>citrate utilization test, 8.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.5, 8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2, 8.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardiopsis alba, 8.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 8.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nocardiopsis dassonvillei, 8.3.5, 8.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardiopsis farcinica, decomposition of substrates, 8.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardiopsis halophila, 8.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardiopsis listeri, 8.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardiopsis lucentensis, 8.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardiopsis prasina, 8.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardiopsis pseudobrasiliensis, 8.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nocardiopsis synnemataformans, 8.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nodular bodies, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nodules, 2.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nomenclature</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal, 10.2.110.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>of fungi, 10.2.110.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph versus teleomorph, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>classification, 10.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cryptic species and species complexes, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incorporation of taxonomic changes, 10.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>name changes, 10.2.110.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>significance of species identification, 10.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Non-animal specimens and substances, 17.5.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Non-Cryptococcus neoformans, supplement tests, 10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nondermatophytic onychomycosis, 2.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Non-human specimens and substances, 17.5.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Noninducible chromosomal resistance, AmpC beta-lactamases, 7.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nonsterile respiratory sites, mold identification, 10.10.3710.10.38</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nontreponemal tests, 13.5.1.113.5.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nontuberculous mycobacterium (NTM)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 9.9.1.19.9.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing for slowly growing, 9.9.2.19.9.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT automated system for isolation, 9.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/XDR test, 9.6.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nonviable surrogate samplers, air cultures for fungi, 15.4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Norfloxacin (Noroxin), 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Normal human serum (NHS), heat-inactivated, 7.18.117.18.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>Normal values, 2.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Noroviruses</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5, 14.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Noroxin (norfloxacin), 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nosema</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nose, specimen collection, 2.1.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nosocomial outbreaks (NO)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>defined, 15.5.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>ICU, 15.5.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>outbreak reports and intervention studies, 15.5.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reemergence, 15.5.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>statistical epidemic modeling, 15.5.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>systematic analysis, 15.5.3.115.5.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>affected medical departments, 15.5.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>database, 15.5.3.415.5.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>distribution of pathogens, 15.5.3.215.5.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>infection control measures, 15.5.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 15.5.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>types of infection, 15.5.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Notifiable disease, 15.5.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Not medically necessary, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Novel influenza viruses, Sentinel Level Clinical Microbiology Laboratory Guidelines, 18.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Novobiocin disk, 3.17.4.1, 3.17.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NP. See Nasopharyngeal</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NPV (negative predictive value), 14.2.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NTAP (new technology add-on payments), 1.2.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NTM. See Nontuberculous mycobacteria</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>NTM Elite Agar, 9.3.19.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nucleic acid amplification tests (NAATs), 3.14.3.13.14.3.3, 18.12.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brucella, 13.3.1, 13.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>C. difficile, 4.16.3, 4.16.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/RIF test, 9.6.1.19.6.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/XDR test, 9.6.3.19.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chlamydia trachomatis and Neisseria gonorrhoeae, 14.3.9.114.3.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.3.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 14.3.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>other considerations, 14.3.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.3.9.114.3.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure and methodology, 14.3.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.3.9.714.3.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>result reporting and interpretation, 14.3.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.3.9.414.3.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>strain typing and genotypic resistance testing, 14.3.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>suspected child abuse, 14.3.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>workflow, 14.3.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>eastern equine encephalitis virus, 18.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>group A streptococci (GAS), 3.10.8.13.10.8.5, 3.10.8.73.10.8.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>group B streptococci, 3.8.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>human immunodeficiency virus (HIV), 13.10.1.2, 13.10.1.4, 13.10.2.1, 13.10.2.3, 13.10.3.1, 13.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>influenza, 18.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria, Cepheid Xpert MTB/RIF test, 9.6.2.19.6.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mycobacterium, 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/RIF assays, 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>Mycobacterium tuberculosis direct test (MTD), 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>X</title>
            <indexentry>
               <primaryie>Xpert MTB/RIF Ultra assay, 9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Xpert MTB/XDR assay, 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>N. gonorrhoeae, 3.8.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular specimens, 3.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pretransplant workup, 15.7.7.215.7.7.6, 15.7.7.1115.7.7.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection of specimens, 2.1.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichomonas vaginalis, 11.6.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nucleic acid extraction, 15.6.6.315.6.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>Nucleic acid hybridization, high-risk human papillomaviruses, 14.3.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nucleic acid sequencing systems, verification, 14.2.4.514.2.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nucleopore, 11.6.8.111.6.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nucleotide BLAST (nBLAST), 10.11.1010.11.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nucleotide sequence analysis, 15.6.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nuclepore, 11.6.8.111.6.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nucli Sens HIV-1 QT test, 14.3.1.2, 14.3.1.3, 14.3.1.5, 14.3.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nutritionally variant streptococci (NVS), 3.17.43.1, 3.17.43.3, 7.18.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nutrition base agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Nutrition base broth, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>O</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>O antigens, 3.7.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>OC43, 12.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Occupational exposure, 15.8.3.3, 15.8.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>accidents involving all other BSL3 high-risk pathogens, 15.8.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood or body fluids, 15.8.3.315.8.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>illness response protocols by type of symptoms and level of exposure risk, 15.8.3.5, 15.8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Laboratory and Occupational Health Response Team (LOHRT), 15.8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>managing symptomatic employees, 15.8.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>M. tuberculosis, 15.8.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postexposure assessment, 15.8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>preexposure establishment of protocols, 15.8.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 15.8.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>questions for assessment of employee exposure risk, 15.8.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>response to biological agents or toxins by risk level, 15.8.3.415.8.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>response to exposure or potential exposure, 15.8.3.2, 15.8.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>symptom monitoring log, 15.8.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>use of medical alert cards, 15.8.3.115.8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Occupational exposure, laboratory support for blood-borne exposures, 15.8.2.115.8.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Occupational Safety and Health Administration (OSHA), 1.1.1, 17.3.4.1, 17.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formaldehyde use, 11.11.6.111.11.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>formaldehyde use regulations, 11.11.6.111.11.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Ochroconis, normally sterile sites, 10.10.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>OC34, specimen collection, 2.1.31</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ocular aspirates, mold identification, 10.10.36</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ocular cultures, 3.9.13.9.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inner-eye infections, 3.9.2, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacterial endophthalmitis, 3.9.2, 3.9.4, 3.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bacterial keratitis, 3.9.2, 3.9.4, 3.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>orbital cellulitis, 3.9.2, 3.9.4, 3.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials s, 3.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.9.73.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 3.9.93.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.9.13.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>general considerations, 3.9.13.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inner-eye specimens, 3.9.2, 3.9.4, 3.9.63.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>superficial eye specimens, 3.9.2, 3.9.33.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>superficial eye infections, 3.9.23.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blepharitis, 3.9.23.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>canaliculitis, 3.9.23.9.3, 3.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>conjunctivitis (pink eye), 3.9.23.9.5, 3.9.93.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dacryocystitis, 3.9.23.9.3, 3.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>dacryodenitis, 3.9.23.9.3, 3.9.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>periorbital (preseptal) cellulitis, 3.9.23.9.3, 3.9.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Ocular micrometer, 11.1.111.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ocular specimens, NAAT testing, 14.3.9.614.3.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oculoglandular tularemia, 18.6.2, 18.14.2018.14.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>O129 disk susceptibility testing, 3.17.35.13.17.35.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Odoribacter splanchnicus, 4.2.3, 4.13.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Oerskovia, identification, 3.18.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Office of the Inspector General (OIG), 1.2.4.9, 1.2.4.151.2.4.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ofloxacin, 9.9.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar proportion method, 9.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Ofloxacin (Floxin), 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>OF (oxidative-fermentative) medium, 3.17.9.1, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>OIG (Office of the Inspector General), 1.2.4.9, 1.2.4.151.2.4.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>OIG Compliance Program Guidance for Clinical Laboratories, 1.1.1, 1.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oligella, phenylalanine deaminase (PDA) test, 3.17.39.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oligella ureolytica, 18.4.8, 18.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.13, 3.19.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stone cultures, 3.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.3, 18.15.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Oligella urethralis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stone cultures, 3.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Olsenella, 4.14.4, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ommaya reservior, 3.5.23.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Omsk hemorrhagic fever, 18.14.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Omsk hemorrhagic fever virus (OHFV), 18.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Onchocerca volvulus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.3, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Onchocerciasis, 11.11.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>o-nitrophenyl--D-galactopyranoside (ONPG), 3.17.36.13.17.36.3, 16.2.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ONPG (o-nitrophenyl--D-galactopyranoside) test, 3.17.36.13.17.36.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Onychocola canadensis, toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Onychomycosis, 2.1.13, 2.1.35, 10.10.4010.10.43</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Onygenales, temperature tests, 10.10.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>O&amp;P examination. See Ova and parasite examination</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Opisthorchis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Opportunistic fungi from normally sterile sites, 10.10.3510.10.36</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Optochin disk, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Optochin susceptibility test, 3.17.37.13.17.37.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oral cavity, specimen collection, 2.1.232.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oral hairy leukoplakia, 13.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oral hydrogen sulfide (H2S) organisms agar with lead acetate (OHO-C), 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ora Quick Advance rapid HIV-1/HIV-2 antibody test, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ora Quick HCV Rapid Antibody Test, 13.11.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Orbactiv (oritavancin), 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Orbital cellulitis, 3.9.2, 3.9.4, 3.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Orchitis, 3.8.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Order sets, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Orf virus (ORFV), 18.8.1, 18.8.4, 18.8.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Organ procurement organizations (OPOs), 15.7.7.415.7.7.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oribacterium, 4.14.4, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oriental sore, 11.9.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ORION (outbreak reports and intervention studies of nosocomial infection), 15.5.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oritavancin (Orbactiv), 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ornithine, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oropharyngeal specimens, 10.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oropharyngeal swabs, NAAT testing, 14.3.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oropharyngeal tularemia, 18.6.2, 18.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oroya fever, 2.1.28, 3.15.2, 3.15.3, 3.15.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Orthohantaviruses, 18.12.318.12.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Orthomyxoviruses, clinical manifestations, 12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Orthonairoviruses, 18.12.5, 18.12.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Orthopoxviruses, 18.8.1, 18.8.318.8.4, 18.8.818.8.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Ortho T. cruzi ELISA system, 13.15.213.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>OSHA (Occupational Safety and Health Administration). See Occupational Safety and Health Administration (OSHA)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Osteomyelitis, potential etiological agents, 2.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Otitis externa</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture examination, 3.10.5.33.10.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations of, 3.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.10.5.23.10.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 3.10.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.10.5.33.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.10.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 3.10.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.10.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal, 2.1.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen transport, 3.10.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Otitis media</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture examination, 3.10.5.43.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations of, 3.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.10.5.23.10.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.6, 2.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 3.10.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.10.5.33.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.10.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 3.10.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 3.10.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 3.10.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Outbreak Database, 15.5.3.415.5.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Outbreak detection and management, 15.2.215.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Outbreak investigations</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>collection and storage of isolates, 15.5.2.115.5.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>collection and tracking of surveillance and clinical specimens, 15.5.1.115.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Outbreak Database, 15.5.3.415.5.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>public health reporting, 15.5.4.115.5.4.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>systematic analysis of nosocomial outbreaks, 15.5.3.115.5.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>affected medical departments, 15.5.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>database, 15.5.3.415.5.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>distribution of pathogens, 15.5.3.215.5.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>infection control measures, 15.5.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 15.5.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>types of infection, 15.5.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Outbreak reports and intervention studies of nosocomial infection (ORION), 15.5.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Outer package for shipping, 17.6.14, 17.6.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ova and parasite (O&amp;P) examination</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.6, 14.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.211.11.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sample rejection criteria, 2.1.262.1.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 11.11.5.111.11.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 11.11.5.111.11.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Ovaries, 2.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Overpack, 17.6.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oxacillin (Prostaphlin)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.22.8, 7.22.11, 7.22.12, 7.23.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Oxacillinase, 7.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oxacillin, broth microdilution MIC test, 7.4.1.97.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oxacillin (cefoxitin), broth microdilution MIC test, 7.4.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oxacillin-resistant Staphylococcus aureus. See Methicillin-resistant Staphylococcus aureus; Methicillin-resistant Staphylococcus aureus (MRSA)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oxacillin salt-agar test, 7.8.17.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.8.17.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.8.37.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.8.1, 7.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 7.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Oxalic acid method, for digestion and decontamination, 9.2.2.1, 9.2.2.39.2.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oxazolidinones, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oxford Nanopore Minion, 15.6.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oxford Nanopore Technology (ONT), 14.5.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oxidase reagent, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oxidase test, 3.17.38.13.17.38.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.15.1.118.15.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>B. pseudomallei and B. mallei, 18.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>Oxidative-fermentative (OF) medium, 3.17.9.1, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Oxidizers, 3.17.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>P</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pacific Biosciences Sequel, 15.6.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Package, 17.6.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Package orientation, 17.6.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Packing instructions (PI), 17.6.13, 17.6.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Packing of infectious substances, 17.6.117.6.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biological products, 17.6.8, 17.6.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biological substance, 17.6.13, 17.6.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cargo only, 17.6.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>carrier, 17.6.26</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Category A substance, 17.6.17, 17.6.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Category B substance, 17.6.10, 17.6.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>classification of substances, 17.6.10, 17.6.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>documentation, 17.6.3, 17.6.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>exempt human or animal specimens, 17.6.11, 17.6.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>exempt substances, 17.6.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genetically modified organisms, 17.6.12, 17.6.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>governing authorities and regulations, 17.6.117.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>infected animals, 17.6.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>marking and labeling outer packages, 17.6.17, 17.6.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>medical waste, 17.6.29</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>naming Category A and Category B substances, 17.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>outer package, 17.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>overpack, 17.6.21, 17.6.33</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing instructions, 17.6.6, 17.6.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>patient specimens, 17.6.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>refrigerants, 17.6.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>select agents, 17.6.34, 17.6.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special provisions, 17.6.14, 17.6.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>terminology, 17.6.19, 17.6.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>training and certification, 17.6.4, 17.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Paecilomyces, 10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>by broth dilution, 10.12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Paecilomyces lilacinus, 10.10.36</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paecilomyces variotii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.38</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Paeniclostridium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical characteristics of, 4.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gram stain and colonial morphology of, 4.14.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Paeniclostridium ghonii, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paeniclostridium sordellii, 4.2.2, 4.14.10, 4.14.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-proline aminopeptidase, 4.9.17.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 4.9.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>P agar, 3.17.17.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pages ameba saline, 11.4.8.5, 11.9.1.611.9.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pandoraea</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.18, 3.19.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Panel, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pantoe, 3.19.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pantoea agglomerans, 3.7.1.6, 3.19.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PAP-AUC. See Population analysis profile area under the curve ratio</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Papilla, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Papules, 2.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Parabacteroides, 4.9.7.1, 4.13.1, 4.13.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile test, 4.13.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution (MIC) test, 7.4.2.1, 7.4.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical considerations, 4.13.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special-potency antimicrobial agent disks, 4.13.144.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole test, 4.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Parabacteroides distasonis, 4.2.3, 4.13.1, 4.13.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>glutamic acid decarboxylase (GDC), 4.9.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Parabacteroides goldsteinii, 4.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Parabacteroides johnsonii, 4.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Parabacteroides merdae, 4.2.3, 4.13.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paraclostridium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical characteristics of, 4.14.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gram stain and colonial morphology of, 4.14.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Paraclostridium bifermentans, 4.2.2, 4.14.9, 4.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paracoccidioides</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conversion, 10.10.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.12, 10.4.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mold phase characteristics, 10.10.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slide cultures, 10.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Paracoccidioides brasiliensis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial resistance, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>particulate phase, 10.10.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paracoccidioidomycosis, 2.1.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Paracoccus yeei, 3.19.9, 3.19.12, 3.19.13, 3.19.19, 18.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paradoxical effect, 7.17.1.10, 7.17.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paraeggerthella hongkongensis, 4.14.4, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paragonimiasis, 11.11.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paragonimus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>expectorated sputum, 11.7.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sputum expectorated, 11.7.1.1, 11.7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Paragonimus kellicotti, 11.11.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paragonimus mexicanus, 11.11.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paragonimus westermani, key characteristics, 11.11.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Parainfluenza virus (PIV), 12.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Paramyxoviruses, clinical manifestations, 12.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paranasal sinuses. See Nasal sinus(es)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Para-Pak-EcoFix, 11.2.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Para-Pak-SVT, 11.2.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paraphyton cookei</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>macroconidium, 10.10.48</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.2310.10.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paraphyton, phenotypic identification, 10.10.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Paraphyton racemosum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Parapoxviruses, 18.8.1, 18.8.4, 18.8.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Parascardovia denticolens, 4.14.5, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Parasite(s)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 11.8.5.111.8.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>staining, 11.8.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>thick blood films, 11.8.1.111.8.1.5, 11.8.3.111.8.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>thin blood films, 11.8.1.111.8.1.5, 11.8.2.111.8.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, Trichomonas vaginalis, 11.9.2.111.9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>equipment, 11.1.111.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal specimens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>age and physical description, 11.3.1.111.3.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calibration of microscope with ocular micrometer, 11.1.111.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>collection of fresh, 11.2.1.111.2.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ova and parasite (O&amp;P) examination, 11.11.5.111.11.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 11.1.711.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen disposal, 11.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen handling, 11.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 11.1.611.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>flowcharts for diagnostic procedures, 11.11.5.111.11.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>malaria diagnosis, 11.8.12.111.8.12.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>O&amp;P examination, specimen processing, 11.11.5.111.11.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>other specimens from intestinal tract and urogenital system</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cellulose tape preparation (pinworm), 11.6.1.111.6.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>duodenal contents (duodenal aspirate), 11.6.4.111.6.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy (direct smear), 11.6.2.111.6.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine concentration (centrifugation), 11.6.7.111.6.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urogenital specimens (permanent stained smear, Giemsa), 11.6.6.111.6.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality assurance, 11.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quality control, 11.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reducing substances (AimTab), 11.5.8.111.5.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reference materials, 11.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Parasitemia, 11.8.7.111.8.7.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Parasitic infections</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor-derived, 15.7.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor screening, 15.7.7.915.7.7.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.1615.7.7.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Parasitology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts, 11.11.1.111.11.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.111.7.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autofluorescence, for Cyclospora, Cystoisospora, and Sarcocystis, 11.4.7.111.4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.111.7.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 11.7.3.111.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>impression smears, 11.7.3.111.7.3.3, 11.7.3.111.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 11.7.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations of procedure, 11.7.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 11.7.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 11.7.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 11.7.3.311.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 11.7.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 11.7.3.211.7.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 11.7.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 11.7.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results, 11.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>skin scrapings, 11.7.3.111.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens, 11.7.3.111.7.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>squash preparations, 11.7.3.111.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>teased preparations, 11.7.3.111.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts, 11.11.1.2, 11.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>buffy coat concentration, 11.8.9.111.8.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>capillary blood tube centrifugation for parasite detection, 11.8.9.311.8.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>characteristics, 11.11.2.1911.11.2.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>combination thick and thin films, 11.8.4.111.8.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Delafields hematoxylin stain, 11.8.8.111.8.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>determination of parasitemia, 11.8.7.111.8.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Knott concentration, 11.8.11.111.8.11.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>membrane filtration concentration, 11.8.10.111.8.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitemia, determination of, 11.8.7.111.8.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>shipment of smears, 11.2.3.111.2.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.36, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test report comments, 11.11.7.411.11.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.111.8.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body fluids, artifacts, 11.11.1.2, 11.11.1.311.11.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites recovered, 11.11.2.211.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.111.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.511.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bone marrow, 2.1.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>central nervous system, 2.1.36</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acanthamoeba and Naegleria, 11.9.1.111.9.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Acanthamoeba or Naegleria, 11.9.1.211.9.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Leishmania spp. and Trypanosoma cruzi, 11.9.3.111.9.3.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cutaneous ulcers, 2.1.36</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissues and body fluids, 11.11.2.911.11.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>expectorated sputum specimen for direct-mount and stained preparations, 11.7.1.111.7.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>eyes, 2.1.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal specimens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast modified trichrome stain for coccidia and microsporidia, 11.4.5.111.4.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>artifacts, 11.11.1.111.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autofluorescence for Cyclospora, Cystoisospora, and Sarcocystis, 11.4.7.111.4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calcofluor white for detection of microsporidial spores, Acanthamoeba, and Balamuthia mandrillaris cysts, 11.4.8.111.4.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>concentration by formalin-ethyl acetate sedimentation, 11.3.3.111.3.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>concentration by zinc sulfate flotation, 11.3.4.111.3.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct smears, 11.3.2.111.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fixation and preservation, 11.2.2.111.2.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>iron hematoxylin stain (modified Spencer-Monroe method), 11.3.6.111.3.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>larval stage culture of nematodes, 11.5.4.111.5.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>larval stage culture of nematodes (agar plate culture for S. stercoralis), 11.5.4.111.5.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyouns acid-fast stain (cold), 11.4.1.111.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified safranin technique with microwave heating, 11.4.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified trichrome-Ryan blue stain, 11.4.4.111.4.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified trichrome-Weber green stain, 11.4.3.111.4.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Ziehl-Neelsen acid-fast stain (hot), 11.4.2.111.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained smear (trichrome), 11.3.5.111.3.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>qualitative fecal fat, 11.5.7.111.5.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recovery of scolices and proglottids of cestodes, 11.5.6.111.5.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>shipment, 11.2.3.111.2.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>submission of, 11.11.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test report comments, 11.11.7.111.11.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fixation and preservation of specimens, 11.2.2.111.2.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 11.2.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 11.2.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 11.2.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 11.2.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 11.2.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 11.2.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 11.2.2.311.2.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 11.2.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formaldehyde use, OSHA regulations on, 11.11.6.111.11.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.114.4.1.7, 14.4.1.914.4.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gross examination of helminths, 11.10.111.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>information tables, 11.11.2.111.11.2.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites and common parasites recovered, 11.11.2.211.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body site, specimen, and recommended stains, 11.11.2.511.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics of parasites found in blood, 11.11.2.1911.11.2.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>characteristics of tissue protozoa, 11.11.2.1411.11.2.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical findings in health and compromised hosts, 11.11.2.2111.11.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissues and body fluids, 11.11.2.911.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays for intestinal parasites, 11.11.2.2311.11.2.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics of helminths, 11.11.2.1611.11.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>key characteristics of protozoa of intestinal tract and urogenital system, 11.11.2.1111.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 2.1.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.611.11.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract specimens, sigmoidoscopy (permanent stained smear), 11.6.3.111.6.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>liver/spleen, 2.1.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lungs, 2.1.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>muscles, 2.1.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasopharynx, sinus cavities, specimens and recommended stains, 11.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>organism identification</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common problems, 11.11.3.111.11.3.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Endolimax nana versus Dientamoeba fragilis trophozoites, 11.11.3.911.11.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Endolimax nana versus Iodamoeba betschlii trophozoites, 11.11.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entamoeba coli versus Entamoeba histolytica/E. dispar precysts and cysts, 11.11.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entamoeba cyst morphology, 11.11.3.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entamoeba histolytica/E. dispar cyst versus PMN, 11.11.3.611.11.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entamoeba histolytica/E. dispar precyst versus PMN, 11.11.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entamoeba histolytica/E. dispar versus Entamoeba coli trophozoites, 11.11.3.111.11.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entamoeba histolytica trophozoite versus human macrophage, 11.11.3.411.11.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Plasmodium versus Babesia ring forms, 11.11.3.1511.11.3.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>RBCs versus yeast cells, 11.11.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Strongyloides stercoralis rhabditiform larva versus plant root hair, 11.11.3.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Taenia egg versus pollen grain, 11.11.3.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichuris trichiura egg versus pollen grain, 11.11.3.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ova-and-parasite (O&amp;P) examination, report comments, 11.11.7.211.11.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control (QC), 11.11.4.111.11.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reflex and composite testing scenarios, 1.2.4.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rejection of specimens, 2.1.262.1.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>shipment of specimens, 11.2.3.111.2.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sigmoidoscopy specimen, permanent stained smear, 11.6.3.111.6.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>skin, 2.1.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.3, 2.1.362.1.37, 11.11.2.111.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sputum expectorated specimen, 11.7.1.111.7.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stains</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast modified trichrome stain for coccidia and microsporidia, 11.4.5.111.4.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyouns acid-fast stain (cold), 11.4.1.111.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified safranin technique with microwave heating, 11.4.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Ziehl-Neelsen acid-fast stain (hot), 11.4.2.111.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test report comments, 11.11.7.111.11.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine concentration (membrane filter, Nucleopore), 11.6.8.111.6.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urogenital specimens, direct saline mount, 11.6.5.111.6.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urogenital system, 2.1.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Parasutterella, 4.13.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Parechoviruses</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Parengyodontium album, nonsterile respiratory sites, 10.10.38</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pareto chart, 16.1.4, 16.1.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pareto diagram, 16.1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Parolsenella catena, 4.14.5, 4.14.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PARR, 14.2.4.214.2.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PARR-AS-AS, 14.2.4.314.2.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Partial synergism, 7.19.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Participant structure for CDC AR Lab Network, Candida auris, 15.7.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Particle counters, 15.4.3.3, 15.4.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Particulate matter, laboratory water, 16.3.116.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Parvimonas, 4.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Parvimonas micra, 4.2.3, 4.15.3, 4.15.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>glutamic acid decarboxylase (GDC), 4.9.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sodium polyanethol sulfonate disk, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Parvoviruses, clinical manifestations, 12.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pasteurella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.67.7.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 3.17.22.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxidase test, 3.17.38.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.8, 3.10.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole test, 18.15.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1, 18.15.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pasteurella bettyae, 3.8.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.11, 3.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>indole test, 3.17.22.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>spot indole test, 18.15.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pasteurella canis, 3.19.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pasteurella dagmatis, 3.19.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pasteurella haemolytica, 3.19.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pasteurella multocida</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.8, 7.2.12, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pasteurella pestis, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pasteurella spp., disk diffusion testing, 7.2.2, 7.2.8, 7.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pasteurella tularensis, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pasturella, 3.19.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pasturella bettyae, 3.19.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pathocil (dicloxacillin), 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pathogen, defined, 17.6.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Patient Protection and Affordable Care Act (PPACA), 1.1.4, 1.2.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Patient reports, quality control, 16.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Patient specimens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>defined, 17.6.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>shipping, 17.6.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pauljensenia, 4.14.2, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pauljensenia hongkongensis, 4.2.2, 4.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Payment. See Billing</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PBS (phosphate-buffered saline), 12.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PCC (Probe Check Control), 9.6.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PCR. See Polymerase chain reaction</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PDA (phenylalanine deaminase) test, 3.17.39.13.17.39.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PDCA (plan-do-check-act) cycle, 16.1.1.3, 16.1.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PEA. See Phenylethyl alcohol agar</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pectinate branching, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pedicels, 10.10.21, 10.10.48</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pediculus humanus, 11.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pediculus humanus subsp. capitis, 11.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pediculus humanus subsp. humanus, 11.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pediococcus, 3.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar screen test for vancomycin-resistant enterococci, 7.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial disk test, 3.17.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial disk tests, 3.17.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>leucine aminopeptidase test, 3.17.25.1, 3.17.25.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MRS broth, 3.17.31.1, 3.17.31.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Peliosis, bacillary, 3.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pelvic cavity, specimen collection, 3.8.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pelvic inflammatory disease (PID), 2.1.11, 3.8.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pelvic thrombophlebitis, septic, 3.8.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Penicillin, 18.15.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.3, 7.20.6, 7.20.14, 7.20.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.5, 7.23.9, 7.23.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Penicillinases, 7.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Penicillin-binding protein 2a (PBP2a), 7.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Penicillin disk, 3.17.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Penicillin disk diffusion zone edge method for Staphylococcus aureus, 7.7.27.7.3, 7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Penicillin G, 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Penicillin-nonsusceptible -hemolytic streptococci, 7.20.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Penicillins, broth microdilution MIC test, 7.4.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Penicillin V, 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Penicillium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>air sampling, 15.4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Penicillium chrysogenum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.38</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Penicillium citrinum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.38</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Penicillium decumbens, temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Penicillium marneffei</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sabouraud agar, 10.10.51</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>slide cultures, 10.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Penicillium purpureogenus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conversion, 10.10.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Penicillium purpurescens, acid-fast bacilli, 5.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Penicillium spinulosum, nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Penicillium subgenus Biverticillium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conversion, 10.10.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold phase characteristics, 10.10.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Penile lesion, 2.1.22, 3.8.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Penile vesicle, 3.8.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Penrose drain, 3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pentatrichomonas hominis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained smear (Giemsa), 11.6.6.211.6.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stool artifacts, 11.11.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine concentration, 11.6.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urogenital specimens, direct saline mount, 11.6.5.311.6.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PEP (postexposure prophylaxis), 18.14.31</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peptide nucleic acid fluorescence in situ hybridization (PNA FISH), 5.13.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peptococcus, 4.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peptone-yeast extract medium, 11.9.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peptoniphilus, 4.15.2, 4.15.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Peptoniphilus asaccharolyticus, 4.2.3, 4.9.6.1, 4.15.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alkaline phosphatase (ALP), 4.9.14.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 3.17.22.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Peptoniphilus gorbachii, 4.15.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peptoniphilus harei, 4.2.3, 4.15.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peptoniphilus indolicus, 4.2.3, 4.15.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid nitrate and urease tests, 4.15.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>spot indole, 4.15.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Peptoniphilus ivorii, 4.2.3, 4.15.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sodium polyanethol sulfonate disk, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Peptoniphilus lacrimalis, 4.2.3, 4.15.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peptoniphilus olsenii, 4.15.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peptostreptococcus, 4.15.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>continuous-monitoring blood culture systems, 5.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy update, 4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Peptostreptococcus anaerobius, 4.11.2, 4.15.3, 4.15.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brucella agar, 16.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.15.5, 4.15.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.3, 4.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sodium polyanethol sulfonate disk, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SPS (sodium polyanethol sulfonate) disk, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SPS disk testing, 4.15.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tryptic soy blood agar, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wilkins-Chalgren anaerobic medium, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Peptostreptococcus asaccharolytica, MALDI-TOF MS, 4.12.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peptostreptococcus hydrogenalis, spot indole, 4.15.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peptostreptococcus ivorii, SPS (sodium polyanethol sulfonate) disk, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peptostreptococcus micros</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>SPS disk, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SPS disk testing, 4.15.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Peptostreptococcus niger, colony morphology, 4.15.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peptostreptococcus stomatis, 4.15.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sodium polyanethol sulfonate disk, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SPS (sodium polyanethol sulfonate) disk, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Peptostreptococcus uenonis, MALDI-TOF MS, 4.12.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peptrostreptococcus, 4.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Percent agreement, 14.2.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Percent sensitivity, 14.2.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Percent specificity, 14.2.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Perforating organ, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Performance specifications, establishing for molecular tests, 14.2.4.3, 14.2.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Performance standards, 16.2.5, 16.2.6, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pericardial fluid</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 3.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, fungal, 10.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pericardial fluid culture, viral, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pericarditis, potential etiological agents, 2.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Perinatal infection with group B streptococci, 3.8.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Perineal ulcers, 3.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Periodic acid-Schiff stain, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Periodontitis, potential etiological agents, 2.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Periorbital (preseptal) cellulitis, 3.9.23.9.3, 3.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peripheral blood specimens, 2.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Perithecium, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peritoneal fluid</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 3.4.2, 3.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal specimens, 10.3.6, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 10.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Peritoneal fluid, specimen collection, 2.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Peritonsilar abscess, potential etiological agents, 2.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Permanent stained smear</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy specimen, 11.6.3.111.6.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 11.6.3.311.6.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 11.6.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 11.6.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 11.6.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 11.6.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 11.6.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 11.6.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results, 11.6.3.211.6.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 11.6.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>trichrome, 11.3.5.111.3.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 11.3.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 11.3.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mounting fluid-sparing procedure, 11.3.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 11.3.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 11.3.5.211.3.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 11.3.5.411.3.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 11.3.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 11.3.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 11.3.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results, 11.3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 11.3.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Permanent stained smear, parasites, 11.6.6.111.6.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy specimens, 11.6.3.111.6.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Permease, 3.17.36.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Persisters, 7.17.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Personal protective equipment (PPE), 17.9.317.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biosafety level 3 and 4 agents, 15.8.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>and engineering controls, 17.3.4.117.3.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>prions, 17.5.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Personnel</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>competency, quality assurance, 16.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 16.2.1, 16.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>records, 16.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pertussis, 3.10.6.13.10.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Petriella setifera, 10.10.37</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Petrifilms, for environmental surface testing, 15.4.4.3, 15.4.4.6, 15.4.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PFGE. See Pulsed-field gel electrophoresis</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PGD system, 15.4.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phaeoannellomyces elegans, 10.6.7, 10.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phaeoannellomyces werneckii, 10.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phaeococcomyces exophialae, 10.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phaeohyphomycetes, 10.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.3510.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Phaeohyphomycosis, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pharmacies, microbiological sampling for, 15.3.115.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pharyngeal culture, N. gonorrhoeae, 3.8.3.1, 3.8.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pharyngeal (throat) swab culture, viral, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pharyngitis, 13.2.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>streptococcal, 13.2.1.113.2.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>throat culture and nonculture tests, 3.10.1.2, 3.10.8.13.10.8.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>algorithm for laboratory diagnosis, 3.10.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.10.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>latex agglutination method, 3.10.8.93.10.8.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 3.10.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.10.8.23.10.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification tests (NAATs), 3.10.8.13.10.8.5, 3.10.8.73.10.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.10.8.13.10.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.10.8.33.10.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.10.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid antigen detection tests (RADTs), 3.10.8.13.10.8.3, 3.10.8.5, 3.10.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.10.8.73.10.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.10.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pharynx, specimen collection, 2.1.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phenicol, 7.23.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phenolics, neutralizers of, 15.4.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phenol red agar, 16.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phenol red broth, 16.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phenotypic assay, human immunodeficiency virus (HIV), 14.3.2.414.3.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phenotypic carbapenemase detection methods, 7.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phenotypic tests, bioterrorism, 18.15.7.118.15.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phenylalanine agar, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phenylalanine deaminase (PDA) test, 3.17.39.13.17.39.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phenylethyl alcohol agar (PEA), 4.4.1.1, 4.4.1.3, 4.4.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic culture, 3.3.1.3, 3.3.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobes, 4.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>performance standards, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phialide, 10.10.5, 10.10.47</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phialophora</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.13, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phialide, 10.10.47</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phocaeicola copracola, 4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phocaeicola, culture media, 4.4.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phocaeicola dorei, 4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phocaeicola massiliensis, 4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phocaeicola vulgatus, 4.2.3, 4.4.1.3, 4.9.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phoenix NID, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phoenix PID, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phoicaecola dorei, MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phoicaecola vulgatus, MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phoma, pycnidia, 10.10.47</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phosphate acetyltransferase, 15.6.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phosphate-buffered saline (PBS), 12.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Photometric method, control standard endotoxin, 15.3.6.3, 15.3.6.515.3.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Photometric methods, 15.3.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Phragmoconidia, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Physical hazards, 17.7.117.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PI (packing instructions), 17.6.23, 17.6.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pichia anomala</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pichia kudriavzevii, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pichia norvegensis, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pichia ohmeri, anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pichia, supplement tests, 10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PID (pelvic inflammatory disease), 3.8.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Piedra, 2.1.13, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Piedraia hortae, 10.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Piedraia, microscopic examination, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pigmentation</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic gram-negative bacilli, 4.13.1, 4.13.104.13.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pigment production agar, performance standards</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacteria, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pigment production, anaerobes, 4.9.11.14.9.11.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pink eye. See Conjunctivitis</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pinworm, 11.6.1.111.6.1.5, 11.11.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Piperacillin (Pipracil)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.2, 7.19.3, 7.19.5, 7.19.6, 7.19.7, 7.19.8, 7.19.10, 7.19.12, 7.19.15, 7.19.16, 7.19.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Piperacillin-tazobactam (Zosyn)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.8, 7.22.12, 7.22.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.3, 7.23.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pipette inoculation methods, 3.11.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pipettors</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>environmental concerns, 16.8.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>frequency of verification, 16.8.2.4, 16.8.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gravimetric method, 16.8.2.516.8.2.7, 16.8.2.1016.8.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>precautions, 16.8.2.316.8.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 16.8.2.116.8.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>spectrophotometric method, 16.8.2.716.8.2.8, 16.8.2.1216.8.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tolerance, 16.8.2.816.8.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>use and performance verification, 16.8.2.116.8.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pipracil. See Piperacillin</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pithomyces chartarum, 10.10.43</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pityriasis versicolor, 2.1.3, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PIV (Parainfluenza virus), 12.9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Placenta, 2.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PLA (proprietary laboratory analysis) codes, 1.1.3, 1.2.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Plague, 18.5.118.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility, 18.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.1.2, 18.5.118.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bubonic, 18.5.1, 18.14.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CDC case classification, 18.5.118.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical summary, 18.14.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture identification, 18.5.418.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>destruction, 18.5.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of cultures, 18.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>geographic distribution, 18.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation period, 18.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory criteria, 18.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 18.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>meningitis, 18.14.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 17.6.1, 17.6.4, 18.5.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pneumonic, 18.5.1, 18.14.19, 18.14.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.5.118.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting, notification, and transfer, 18.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance in U. S., 18.5.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sentinel Level Clinical Microbiology Laboratory Guidelines, 18.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>septicemic, 18.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.5.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.5.3, 18.14.1818.14.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 18.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Plan-do-check-act (PDCA) cycle, 16.1.1.3, 16.1.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Plant root hair, 11.11.3.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Plaque reduction neutralization assay (PRNT), 18.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Plasmodium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.1, 11.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood films, 11.8.1.1, 11.8.1.2, 11.8.1.3, 11.8.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.2, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>capillary blood tube centrifugation for parasite detection, 11.8.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>combination thick and thin films, 11.8.4.311.8.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 11.8.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-consequence viral pathogens, 18.12.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitemia, 11.8.7.111.8.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitemia, determination of, 11.8.7.111.8.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.511.11.7.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ring forms, 11.11.3.1511.11.3.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>STAT testing, 11.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.311.8.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Plasmodium falciparum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 11.8.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitemia, 11.8.7.111.8.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitemia, determination of, 11.8.7.111.8.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.511.11.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Plasmodium knowlesi</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitemia, 11.8.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Plasmodium malariae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Plasmodium ovale</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood films, 11.8.1.2, 11.8.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>combination thick and thin films, 11.8.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 11.8.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitemia, 11.8.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitemia, determination of, 11.8.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Plasmodium vivax</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood films, 11.8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>combination thick and thin films, 11.8.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 11.8.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inoculation, 17.1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitemia, 11.8.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitemia, determination of, 11.8.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.511.11.7.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Plasmodium vivox, 11.8.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Plate count endotoxin assay, hemodialysis fluids, 15.4.2.115.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>frequency and timing, 15.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 15.4.2.715.4.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 15.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 15.4.2.415.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 15.4.2.115.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 15.4.2.615.4.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 15.4.2.515.4.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 15.4.2.815.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 15.4.2.215.4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Platelet unit culture, 15.4.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pleistophora</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Plesiomonas</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.3, 3.7.1.12, 3.7.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.3, 3.19.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>O129 disk susceptibility testing, 3.17.35.1, 3.17.35.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>spot indole test, 18.15.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Plesiomonas shigelloides</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.23.17.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.1, 3.17.16.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.3, 3.7.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.314.4.1.4, 14.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>O129 disk susceptibility testing, 3.17.35.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oxidase test, 3.17.38.3, 18.15.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.1, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pleural fluid</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 3.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture, viral, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.19, 10.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pleuropulmonary infections, potential etiological agents, 2.1.72.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PNA-FISH, presumptive identification tests of yeasts, 10.7.210.7.4, 10.7.1010.7.11, 10.7.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pneumatic tube system, 17.4.5.117.4.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pneumococci, Quellung reaction, 3.17.41.13.17.41.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pneumocystis, 10.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pneumocystis carinii. See Pneumocystis jirovecii</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pneumocystis jirovecii, 10.3.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methenamine-silver nitrate stain, 16.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>staining procedure for direct microscopic detection in respiratory samples, 10.4.2.110.4.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 10.4.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 10.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 10.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 10.4.2.310.4.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 10.4.2.610.4.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 10.4.2.810.4.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 10.4.2.510.4.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results, 10.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 10.4.2.110.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pneumocystis jirovecii (PJP), respiratory tract cultures, 3.10.1.23.10.1.3, 3.10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pneumocystis pneumonia, 10.4.2.110.4.2.2, 10.4.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pneumonia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspiration, 2.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>community-acquired, 2.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>in immunocpmpromised host, 2.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pneumonic plague, 18.5.1, 18.14.19, 18.14.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pneumonic tularemia, 18.6.2, 18.6.3, 18.14.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Point mutations, 15.6.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Policy review documentation, bioterrorism, 18.14.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Polioviruses, 17.6.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Polished-rice test for Microsporum, 10.10.11, 10.10.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pollen grains, 11.11.3.1811.11.3.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Polyclonal antiT. pallidum antibody, 13.5.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Polymerase chain reaction (PCR), 15.6.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>air cultures for fungi, 15.4.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>amplification, 15.6.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>amplification and analysis, 15.6.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>assays, for Leptospira, 3.13.1, 3.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body fluid culture, 3.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broad-range, 5.14.15.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/RIF test, 9.6.1.19.6.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/XDR test, 9.6.3.19.6.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>controls and calibrators, 14.2.5.214.2.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cytomegalovirus (CMV), 13.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epstein-Barr virus (EBV), 13.8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for molecular identification of yeasts and molds, 10.11.210.11.4, 10.11.610.11.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PCR-based assays, 15.6.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pneumocystis jirovecii, 10.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>poxviruses, 18.8.918.8.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pyrosequencing prediction of drug resistance in Mycobacterium tuberculosis complex, 9.10.1.19.10.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reverse transcription (See Reverse transcription polymerase chain reaction)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ribotyping, 15.6.2.115.6.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sequencing-based identification and, 14.5.1.114.5.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>systems, 15.6.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>verification and validation, 14.2.4.1, 14.2.4.6, 14.2.4.8, 14.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Polymorphisms, sequence, 14.2.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Polymorphonuclear leukocytes (PMNs)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Entamoeba histolytica/E. dispar cyst identification versus, 11.11.3.611.11.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Entamoeba histolytica/E. dispar precyst identification versus, 11.11.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Polymyxin B, 18.15.7.1, 18.15.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Polymyxin B disk, 3.17.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Polymyxin E, 18.15.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Polyomaviruses</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quantification of, 14.2.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Polyvinyl alcohol (PVA)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fixative for parasitology, 11.2.2.2, 11.2.2.311.2.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified PVA (copper based), 11.2.2.411.2.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified PVA (zinc based), 11.2.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pontiac fever, 3.10.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pooled human serum, as diluent for serum inhibitory and bactericidal titers, 7.18.117.18.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Population analysis profile area under the curve (PAP-AUC) ratio, 7.9.17.9.4, 7.9.6, 7.9.87.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pork tapeworm, 11.11.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Porphyrin synthesis, 3.17.3.13.17.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Porphyrin test, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Porphyromonas</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>API 20A systems, 4.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical considerations, 4.13.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.34.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.1, 4.7.3, 4.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescence, 4.13.12, 4.13.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain morphology, 4.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification by special-potency antimicrobial agent disks, 4.9.5.14.9.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pigmentation, 4.13.104.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pigment production, 4.9.11.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special-potency antimicrobial agent disks, 4.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, 4.13.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Porphyromonas asaccharolytica, 4.13.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescence, 4.9.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 3.17.22.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Porphyromonas bennonis, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Porphyromonas catoniae, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Porphyromonas endodontalis, 4.13.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescence, 4.9.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Porphyromonas gingivalis, 4.13.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture media, 4.4.2.14.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescence, 4.9.8.1, 4.13.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pigment production, 4.9.11.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Porphyromonas gingivalis agar (PGING), 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Porphyromonas intermedia, MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Porphyromonas levii, 16.2.7, 16.2.14, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic incubation system monitoring, 4.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Porphyromonas nigrescens, MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Porphyromonas pogonae, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Porphyromonas somerae, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Porphyromonas uenonis, 4.13.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Posaconazole</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.8, 10.13.9, 10.13.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.2, 10.12.2.3, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal susceptibility testing, broth dilution, 10.12.1.2, 10.12.1.4, 10.12.1.610.12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Positive blood cultures, 5.13.15.13.13. See also Acid-fast bacilli (AFB)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretations, 5.13.105.13.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations of testing, 5.13.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 5.13.35.13.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.13.15.13.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.13.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 5.13.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 5.13.105.13.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, 5.13.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Positive controls, molecular diagnostics, 14.2.5.214.2.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Positive predictive value (PPV), 14.2.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Positive product control (PPC), 15.3.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Positivity rates, molecular diagnostics, 14.2.2.614.2.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Postanalytical blood cultures, 5.9.15.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.9.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 5.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 5.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 5.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>negative cultures, 5.9.25.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>positive cultures, 5.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 5.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.9.25.9.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 5.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting, 5.9.55.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, 5.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Postexposure assessment, 15.8.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Postexposure prophylaxis (PEP), 17.7.517.7.6, 18.14.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>occupational blood-borne exposures, 15.8.2.215.8.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Postimplant testing, 3.6.13.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Postpartum endometritis, 3.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Postpartum endomyometritis, 3.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Postpartum endoparametritis, 3.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Poststreptococcal glomerulonephritis, 13.2.1.113.2.1.3, 13.2.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Posttransplant lymphoproliferative disease (PTLD), 13.8.1.113.8.1.2, 14.3.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Potassium hydroxide (KOH)-calcofluor mount, 10.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Potassium hydroxidedimethyl sulfoxide (KOHDMSO) mount, 10.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Potassium hydroxide (KOH) mount, 10.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic actinomycetes, 8.2.4, 8.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Potassium tellurite cystine agar, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Potato dextrose agar, 10.10.7, 10.10.10, 10.10.49, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Potato flake agar, 10.10.7, 10.10.10, 10.10.4910.10.50</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Poxviruses, 18.8.118.8.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>classification, 18.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.8, 12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.8.1218.8.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 18.8.1318.8.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>electron microscopy, 18.8.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PCR, 18.8.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serology, 18.8.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 18.8.1418.8.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.8.518.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 18.8.118.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>camelpox virus (CMLV), 18.8.318.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cowpox virus (CPXV), 18.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molluscum contagiosum (MCV), 18.8.418.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>monkeypox (MPXV), 18.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>orthopoxviruses, 18.8.318.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Parapoxvirus, 18.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>smallpox (variola virus/VARV), 18.8.218.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vaccinia virus (VACV), 18.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>Yatapoxvirus, 18.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedure, 18.8.918.8.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recommended BSL, 18.14.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 18.8.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.34, 18.8.618.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing and storage, 18.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 18.8.718.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zoonotic, 12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PPE. See Personal protective equipment</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PPV (positive predictive value), 14.2.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Practice guidelines, 16.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PRAS (prereduced, anaerobically sterilized ) media, 4.4.1.14.4.1.2, 4.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Praziquantel, 11.5.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Precision</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interassay, 14.2.4.4, 14.2.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>intra-assy, 14.2.4.4, 14.2.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular tests, 14.2.4.114.2.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 16.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pregnancy</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital cultures, 3.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>group B streptococcus infection, 3.8.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Preimplant testing, 3.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Preliminary report, 16.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Preprocessing cultures, human cadaveric tissues for transplantation, 15.4.6.515.4.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prereduced, anaerobically sterilized (PRAS) media, 4.4.1.14.4.1.2, 4.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Preservatives, parasitology, 11.2.2.111.2.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Presumptive identification tests of yeasts, 10.7.210.7.4, 10.7.1010.7.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pretomanis, agar proportion method, 9.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Preventive services, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>API 20A systems, 4.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile disk test/bile broth test/Bacteroides bile esculin agar, 4.9.7.14.9.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biochemical/rapid enzymatic systems, 4.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth culture, 4.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 4.13.11, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical considerations, 4.13.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.34.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of primary culture plates, 4.7.3, 4.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescence, 4.9.8.1, 4.13.13, 4.13.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain morphology, 4.13.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification by special-potency antimicrobial agent disks, 4.9.5.14.9.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pigmentation, 4.13.10, 4.13.11, 4.13.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pigment production, 4.9.11.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special-potency antimicrobial agent disks, 4.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy, 4.13.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Prevotella amnii, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella aurantiaca, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella baroniae, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella bergensis, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella bivia, 4.13.10, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella buccae, 4.9.7.24.9.7.3, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella buccalis, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella copri, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella corporis, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella dentalis, 4.2.3, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella denticola, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella disiens, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella enoeca, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella heparinolytica, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella histicola, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella intermedia, 4.13.11, 4.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella jejuni, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella loescheii, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella maculosa, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella marshii, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella melaninogenic, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella melaninogenica, 4.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile disk test/bile broth test/Bacteroides bile esculin agar, 4.9.7.14.9.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescence, 4.9.8.14.9.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pigment production, 4.9.11.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella micans, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella multiformis, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella multisaccharivorax, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella nanceiensis, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella nigrescens, 4.13.11, 4.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella oralis, 4.9.7.24.9.7.3, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella oris, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella oulorum, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella pallens, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella pleuritidis, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella saccharolytica, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella salivae, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella shahii, 4.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella stercorea, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella timonensis, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella veroralis, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prevotella vespertina, 4.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prices charged to physicians and other providers, 1.2.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Primary amebic meningoencephalitis, 11.11.2.9, 11.11.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Primary culture examination</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 3.3.2.13.3.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical tests, 3.3.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>contaminants, 3.3.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enumeration of colony type, 3.3.2.2, 3.3.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross colonial morphology, 3.3.2.2, 3.3.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>handling of broth cultures, 3.3.2.103.3.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hemolysis, 3.3.2.2, 3.3.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>initial examination of primary plates, 3.3.2.23.3.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 3.3.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation of colony morphology, 3.3.2.2, 3.3.2.53.3.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.3.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.3.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mixed cultures, 3.3.2.113.3.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>odor, 3.3.2.53.3.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preliminary testing on primary plates, 3.3.2.63.3.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>primary plating media, 3.3.2.2, 3.3.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 3.3.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.3.2.23.3.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.3.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 3.3.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.3.2.113.3.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 3.3.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.7.14.7.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaBAP, 4.7.1, 4.7.24.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth culture, 4.7.44.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CHOC, 4.7.34.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology, 4.7.2, 4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 4.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 4.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 4.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 4.7.24.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 4.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selective media, 4.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>supplemental media, 4.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Primary engineering controls (PEC), 15.3.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Primary monolayer cell cultures, 12.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Primary specimen container, 17.6.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Primary spores, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Primaxin. See Imipenem</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prion(s), 17.5.5.117.5.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prion disease, 17.5.5.117.5.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Probe Check Control (PCC), 9.6.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Problem reports, 16.6.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Procedure billing, 1.2.2.51.2.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Procedure coding. See Coding</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Process improvement, 16.1.1.116.1.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cause-and-effect diagrams, 16.1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>check sheet, 16.1.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>control charts, 16.1.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>data summary and graph, 16.1.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>flowcharts, 16.1.1.4, 16.1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>FOCUS summary, 16.1.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>impact, 16.1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>intervention statement of plan, 16.1.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>metrics, selection and utilization, 16.1.1.216.1.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>observation over time, 16.1.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>outline of typical project, 16.1.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pareto diagram, 16.1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>plan-do-check-act (PDCA) cycle, 16.1.1.3, 16.1.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 16.1.1.116.1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>process improvement cycle, 16.1.1.316.1.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>project title, 16.1.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vs. quality assurance, 16.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>run charts, 16.1.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>summary of actions, 16.1.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>team composition, 16.1.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>tools, 16.1.1.416.1.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>variation, types, 16.1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Processing specimens for fungal culture, quality control, 10.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Proconidia, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Proficiency challenges, molecular diagnostics, 14.2.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Proficiency testing (PT), 16.2.3, 16.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CLIA certificate of compliance and accreditation laboratories, 16.4.1616.4.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality assurance, 16.1.116.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Proglottids, artifacts mimicking, 11.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Proglottids, recovery of, 11.5.6.111.5.6.3, 11.5.6.111.5.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Program integrity, 1.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-proline aminopeptidase, 4.9.17.14.9.17.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Proloprim. See Trimethoprim</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Proper shipping name, 17.6.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Propionibacterium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy update, 4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Propionibacterium acnes, 3.12.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Propionibacterium avidum, 3.17.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Propionibacterium granulosum, 3.17.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Propioniferax, 4.14.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Propionimicrobium, 4.14.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Propionimicrobium lymphophilum, 4.2.3, 4.14.3, 4.14.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prospective payment, 1.1.6, 1.2.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prostaphlin. See Oxacillin</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prostate fluid, 10.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prostatic abscess, 3.8.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prostatic fluid, 2.1.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal specimens, 10.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine collection with expressed, 3.11.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Prostatitis, 2.1.11, 3.8.1.4, 3.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prosthetic joint infections, 3.4.1, 3.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Protease mirabilis, urease test, 10.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Protecting Access to Medicare Act (PAMA), 1.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Protective clothing, 17.3.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Protein A/clumping factor agglutination method, 3.17.13.13.17.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Proteobacteria, 3.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Proteomics-based identification, 3.18.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Proteus, 3.3.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gelatin liquefaction, 3.17.18.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media for, 3.3.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenylalanine deaminase (PDA) test, 3.17.39.13.17.39.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>primary plating media, 3.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>small bowel, 3.7.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stone cultures, 3.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1, 18.15.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urine culture, 3.11.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Proteus hauseri</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stone cultures, 3.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Proteus mirabilis, 7.21.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1, 7.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Andrades fermentation medium, 16.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.6, 7.22.12, 7.22.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.5, 7.23.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood products, 15.4.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella agar, 16.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter agars, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CHOC agars, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Columbia agar base, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.1, 7.14.5, 7.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>flagellum stain, 16.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gardnerella agar, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>genital infections, 3.8.1.2, 3.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>group B streptococcus cultures, 3.8.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>heart infusion fermentation base, 16.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lysine iron agar, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MAC medium, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mannitol salt agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>New York City agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nitrate reduction agar or broth, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ONPG (o-nitrophenyl--D-galactopyranoside) test, 3.17.36.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenol red medium, 16.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenylalanine deaminase (PDA) test, 3.17.39.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenylethyl alcohol agar, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>purple broth, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stone cultures, 3.11.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus selective sheep blood medium, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urea broth or agar, 16.2.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urease test, 3.17.46.3, 18.15.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>Yersinia selective agar, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Proteus penneri, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stone cultures, 3.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Proteus vulgaris</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystine lactose electrolyte-deficient agar, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>motility tests, 3.17.30.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stone cultures, 3.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Proto-fix, 11.2.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prototheca, 10.6.4, 10.6.7, 10.10.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prototheca wickerhamii, culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Protozoa</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.111.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.311.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics of tissue, 11.11.2.1411.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct smears, 11.3.2.111.3.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.911.11.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>expectorated sputum, 11.7.1.1, 11.7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal immunoassays, 11.11.2.2311.11.2.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>formalin-ethyl acetate sedimentation, 11.3.3.111.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.1, 14.4.1.514.4.1.6, 14.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>iron hematoxylin stain (modified Spencer-Monroe method), 11.3.6.111.3.6.4, 11.3.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics of protozoa of intestinal tract and urogenital system, 11.11.2.1111.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained smear (trichrome), 11.3.5.111.3.5.2, 11.3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy specimen permanent stained smear, 11.6.3.111.6.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>trophozoites, 11.2.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urogenital specimens, direct saline mount, 11.6.5.111.6.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zinc sulfate flotation, 11.3.4.111.3.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Providencia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenylalanine deaminase (PDA) test, 3.17.39.1, 3.17.39.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stone cultures, 3.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Providencia rettgeri, 3.7.1.2, 15.4.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Provider-performed microscopy (PPM) procedures, 16.4.316.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Prozone reaction, 13.5.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudallescheria, 10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudallescheria boydii, nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudocowpox virus (PCPV), 18.8.1, 18.8.4, 18.8.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudoflavonifractor capillosus, 4.2.3, 4.13.9, 4.14.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudoleptotrichia goodfellowii, 4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudomonas</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood products, 15.4.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter fecal culture, 3.7.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>and C. burnetii, 18.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>chromogenic media, 5.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.23.17.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>digestion and decontamination, 9.2.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.8, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>fluorescent-pigment agars, 3.17.17.13.17.17.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gelatin liquefaction, 3.17.18.1, 3.17.18.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>genital infections, 3.8.1.4, 3.8.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.3, 3.19.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic tests, 18.15.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.2, 7.23.3, 7.23.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vs. Y. pestis, 18.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pseudomonas acidovorans, 3.17.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudomonas aeruginosa, 3.7.1.14, 7.3.1, 7.3.3, 15.3.5.2, 16.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acetamide hydrolysis medium, 16.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acetamide utilization test, 3.17.1.13.17.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.2, 7.6.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar media, 15.7.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial disk tests, 3.17.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.7, 7.22.8, 7.22.12, 7.22.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation of agar and broth media, 7.24.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.3, 7.20.4, 7.20.6, 7.20.8, 7.20.9, 7.20.12, 7.20.13, 7.20.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.2, 7.23.3, 7.23.5, 7.23.6, 7.23.7, 7.23.97.23.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autopsy blood cultures, 5.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>B. cepacia agar, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 5.6.7, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.2, 7.4.1.11, 7.4.1.13, 7.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter agars, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>carbapenemase, 7.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catheter-related bloodstream infection, 5.12.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cetrimide test, 3.17.11.13.17.11.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>conjunctivitis, 3.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dacryocystitis/dacryoadenitis canaliculitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.4, 7.2.8, 7.2.13, 7.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.3, 3.7.1.8, 3.7.1.12, 3.7.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>fluorescent-pigment agars, 3.17.17.13.17.17.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gelatin liquefaction, 3.17.18.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.2, 7.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hematopoietic stem cell products, 15.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.3, 3.19.8, 3.19.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 3.17.22.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>keratitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.23.17.26.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MUG (4-methylumbelliferyl--D-glucuronide) test, 3.17.33.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multidrug-resistant, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.1, 3.10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nitrate/nitrite reduction test, 3.17.34.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nitrate reduction agar or broth, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2, 15.5.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular cultures, 3.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>odor, 3.3.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>orbital cellulitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>otitis externa, 3.10.5.13.10.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oxidase test, 3.17.38.2, 18.15.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oxidative-fermentative media, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>peritoneal fluid, 3.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypic tests, 18.15.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pigment production agar, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>positive blood culture broth, 5.13.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>primary plating media, 3.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.23.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.1.2, 3.10.3.1, 3.10.3.33.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Legionella, 3.10.4.5, 3.10.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lower, 3.10.2.1, 3.10.2.6, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>spot indole test, 18.15.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.2, 7.19.6, 7.19.12, 7.19.15, 7.19.16, 7.19.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>time-kill assay of, 7.17.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.2, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess and soft tissue cultures, 3.12.1.1, 3.12.1.2, 3.12.1.6, 3.12.1.7, 3.12.1.8, 3.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>Yersinia selective agar, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pseudomonas alcaligenes, identification, 3.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudomonas fluorescens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acetamide utilization test, 3.17.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bloodstream infections, 15.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cetrimide test, 3.17.11.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>duodenoscope surveillance, 15.4.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescent-pigment agars, 3.17.17.1, 3.17.17.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gelatin liquefaction, 3.17.18.1, 3.17.18.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.1, 3.17.26.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF, 6.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pigment production agar, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>transfusion reactions, 5.11.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pseudomonas luteola, 3.19.8, 3.19.15, 3.19.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudomonas mallei, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudomonas mendocina, 3.19.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudomonas monteilii, 3.19.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudomonas oleovorans, 3.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudomonas oryzihabitans, 3.19.8, 3.19.15, 3.19.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudomonas pseudomallei, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudomonas putida</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cetrimide test, 3.17.11.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescent-pigment agars, 3.17.17.1, 3.17.17.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gelatin liquefaction, 3.17.18.1, 3.17.18.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.1, 3.17.26.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pseudomonas stutzeri, 3.19.8, 3.19.9, 3.19.15, 3.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudonocardia, 8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudonocardineae, 8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudo-outbreaks, 15.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudopithomyces chartarum, 10.10.43</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudoramibacter alactolyticus, 4.14.4, 4.14.5, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pseudoterranova, 11.1.21, 11.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Psychrobacter, identification, 3.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Psychrobacter immobilis, 3.19.13, 18.4.8, 18.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Psychrobacter phenylpyruvicus, 18.4.8, 18.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenylalanine deaminase (PDA) test, 3.17.39.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pthirus pubis, 11.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PTLD (posttransplant lymphoproliferative disease), 14.3.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Public health departments, Candida auris, 15.7.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Public health reporting, 15.5.4.115.5.4.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial resistance surveillance, 15.5.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>COVID-19 and urgency, 15.5.4.815.5.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. trachomatis and N. gonorrhoeae, 14.3.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>definitions, 15.5.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>electronic, 15.5.4.215.5.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>health careassociated infections as unique example of reportable diseases, 15.5.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>high-risk human papillomaviruses, 14.3.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HIPAA and, 15.5.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>historical perspective, 15.5.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>HIV-1 RNA test, 14.3.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 15.5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>role of clinician, 15.5.4.315.5.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>role of laboratory, 15.5.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplementary surveillance systems, 15.5.4.615.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Puerperal sepsis, 3.8.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pulsed-field gel electrophoresis (PFGE), 15.6.1.1, 15.6.3.115.6.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>foodborne illness surveillance, 15.5.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PulseNet, 15.5.4.715.5.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Purple broth, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Purpureocillium lilacinum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing by broth dilution, 10.12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>corneal scrapings or ocular aspirates, 10.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pus, 3.12.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic culture, 2.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>male genital tract, 2.1.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>syringe-aspirated, mold identification, 10.10.4310.10.44</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Puumala virus, 18.12.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pycnidia, 10.10.47</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pycnidium, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PYG medium for Acanthamoeba, 11.9.1.711.9.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pyocyanin, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.13.17.40.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pyrazinamidase</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>medium, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mycobacteria, 9.5.1.19.5.1.4, 9.5.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pyrazinamide (PZA)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT PZA kit, 9.7.2.19.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK automated microbial detection system, 9.7.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pyridoxal, broth microdilution MIC test, 7.4.1.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pyrogenic reactions, endotoxin-mediated, 15.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pyro Mark Q96 ID platform, 9.10.1.19.10.1.2, 9.10.1.6, 9.10.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pyrosequencing, 9.10.1.1, 14.5.1.1, 14.5.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pyrosequencing prediction of drug resistance in Mycobacterium tuberculosis complex, 9.10.1.19.10.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dispensation order for PSQ subassays, 9.10.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 9.10.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>library for PSQ subassays, 9.10.1.129.10.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 9.10.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 9.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>positive controls for PSQ subassays, 9.10.1.169.10.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>primers required, 9.10.1.109.10.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 9.10.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 9.10.1.29.10.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 9.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 9.10.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 9.10.1.19.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>thermocycling conditions, 9.10.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>L-Pyrrolidonyl--naphthylamide (PYR), 3.17.40.13.17.40.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>Pyruvate broth, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pythium, normally sterile sites, 10.10.36</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Pyuria, 3.11.1.2, 3.11.1.9, 3.11.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>Q</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>QA. See Quality assurance</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>QBC capillary blood tube, 11.8.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>QC. See Quality control</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>QCPs. See Quality control plans</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Q fever, 2.1.29, 18.10.118.10.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acute vs. chronic, 18.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial therapy, 18.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.1.2, 18.10.118.10.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical presentation, 18.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical summary, 18.14.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of cultures, 18.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>geographic distribution, 18.10.1, 18.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.10.418.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 18.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>notifications, 18.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 18.10.118.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.2.5, 18.10.218.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serologic results, 18.10.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.10.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.10.318.10.4, 18.14.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 18.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 17.6.11, 17.6.12, 18.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>qPCR (quantitative real-time PCR), Epstein-Barr virus), 14.3.7.114.3.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Q-Probes, 16.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Qualitative fecal fat, 11.5.7.111.5.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Quality assessment, 16.1.116.1.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Quality assurance (QA), 16.1.116.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 7.20.17.20.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>attributes of, 16.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.6.85.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 5.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 5.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.6.15.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.6.25.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 5.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 5.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, 5.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>data analysis, 16.1.7, 16.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>definitions, 16.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>documentation, 16.1.4, 16.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>error tracking, 16.1.15, 16.1.16, 16.1.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examples, 16.1.2, 16.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>external programs, 16.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>infection control, 16.1.3, 16.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>information, 16.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>internal assessments, 16.1.216.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and resources, 16.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>molecular diagnostics, 14.2.2.614.2.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>monitoring and evaluating tests and use of test results, 16.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonconforming events, 16.1.4, 16.1.1516.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>objectives, 16.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>outline of procedure, 16.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>personnel, 16.1.8, 16.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principles, 16.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>problem-solving skills, 16.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure development, 16.1.3, 16.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>process improvement (continuous) vs., 16.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality indicators, 16.1.4, 16.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>result reporting, 16.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection and transportation, 16.1.2, 16.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sputum collection, 16.1.11, 16.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>strategies for improvement, 16.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>turnaround time, 16.1.2, 16.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine specimen examinations, 16.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>Quality control (QC), 16.2.116.2.29</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acanthamoeba or Naegleria culture, 11.9.1.211.9.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.2.27.6.2.3, 7.6.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar plate culture for Strongyloides stercoralis larvae, 11.5.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aminoglycoside resistance in Enterococcus spp., 7.12.2, 7.12.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.2.210.12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial stock solutions, 7.24.2.2, 7.24.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.24.3.27.24.3.3, 7.24.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>assay verification and validation, 12.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>assessment, 16.2.26</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>assessments, 12.3.1112.3.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacteriological media, 16.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>beta-lactamase tests, 7.7.17.7.2, 7.7.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biopsy specimens for parasites, 11.7.3.211.7.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biopsy specimens for parasitology, 11.7.3.211.7.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BioRad Geenius supplemental assay, 13.10.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.6.85.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 5.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 5.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.6.15.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.6.25.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 5.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 5.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, 5.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution (MIC) test for anaerobic bacteria, 7.4.2.27.4.2.4, 7.4.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella microagglutination test (MAT), 13.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Brucella tube agglutination test (TAT), 13.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/RIF test, 9.6.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/XDR test, 9.6.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cerebrospinal fluid (CSF) cultures, 3.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chagas disease serologic diagnosis, 13.15.413.15.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coccidioides complement fixation (CF), 13.14.3.913.14.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>commercial kits, 16.2.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>commercially prepared media exempt from, 16.2.5, 16.2.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>continuous quality improvement, 12.3.1212.3.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>controls and calibrators in molecular diagnostics, 14.2.5.214.2.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cystic fibrosis respiratory tract cultures, 3.10.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cytomegalovirus serology, 13.9.2.3, 13.9.3.213.9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>digestion and decontamination, 9.2.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.37.2.4, 7.2.157.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>documentation, 12.3.612.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>documents and records management, 12.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ear cultures, 3.10.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Epstein-Barr virus serology, 13.8.2.2, 13.8.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>equivalent, 16.2.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ESBL testing, 7.14.4, 7.14.97.14.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>expiration date, 16.2.20, 16.2.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>external, 16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formalin-ethyl acetate sedimentation, 11.3.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.814.4.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>general parameters, 16.2.24, 16.2.26</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hepatitis A virus (HAV) serology, 13.11.1.413.11.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hepatitis B virus (HBV) serology, 13.11.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Histoplasma capsulatum antibody detection by complement fixation, 13.13.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>human immunodeficiency virus (HIV) serology, 13.10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inducible clindamycin resistance, 7.11.17.11.2, 7.11.77.11.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>information management, 12.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculum, 16.2.17, 16.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>instrument and equipment performance, 16.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>internal, 16.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>iron hematoxylin stain (modified Spencer-Monroe method), 11.3.6.111.3.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory water, 16.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Leptospira culture, 3.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lower respiratory tract cultures, 3.10.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>maintenance of stock cultures, 16.2.2316.2.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Mc Farland standards, 7.24.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>medium preparation, 16.2.5, 16.2.6, 16.2.7, 16.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>method selection, 12.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microbiological loops, 16.8.1.216.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified trichrome-Ryan blue stain, 11.4.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified trichrome-Weber green stain, 11.4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mold identification, 10.10.910.10.11, 10.10.4910.10.55</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mold identification on primary culture, 10.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>molecular identification of yeasts and molds, 10.11.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mycobacterial media and tests, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mycologic media, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonconforming event management, 12.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular cultures, 3.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>organisms or strains, antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antibiograms, 7.20.107.20.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>confirmation of results, 7.20.97.20.10, 7.20.157.20.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>control and limitations, 7.20.8, 7.20.147.20.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>maintenance, 7.20.57.20.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>on-scale endpoints, 7.20.4, 7.20.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.20.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>requirements of accrediting agencies, 7.20.17.20.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sources, 7.20.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>suggested microorganisms, 7.20.37.20.5, 7.20.127.20.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxacillin salt-agar test, 7.8.1, 7.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitemia, determination of, 11.8.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitology, 11.11.4.111.11.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>patient reports, 16.2.4, 16.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>performance standards, 16.2.5, 16.2.616.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>permanent stained smear (trichrome), 11.3.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>postanalytical, 12.3.1012.3.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>poxviruses, 18.8.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>preanalytical, 12.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive identification tests of yeasts, 10.7.210.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>primary culture examination, 3.3.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure manual, 16.2.216.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>proficiency testing, 16.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pyrosequencing prediction of drug resistance in Mycobacterium tuberculosis complex, 9.10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>QC records, 16.2.316.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>of qualitative and quantitative serology, 16.2.2516.2.26</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>referral specimens, 16.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sample forms, 16.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SARS-CoV-2 serologic testing, 13.7.313.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sequencing-based identification of microorganisms, 14.5.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sigmoidoscopy specimen permanent stained smear, 11.6.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sources for guidelines, 16.2.1, 16.2.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specific parameters, 16.2.1916.2.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection and transport, 16.2.1, 16.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing for aerobic bacteriology, 3.3.1.33.3.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>staining procedure for direct microscopic detection of Pneumocystis jirovecii, 10.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stains, reagents, and antisera, 16.2.2, 16.2.2016.2.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stock cultures, maintenance, 16.2.2316.2.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>systematic errors, 16.2.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test performance, 12.3.812.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>throat specimens, 3.10.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>user-prepared or commercially prepared media requiring testing, 16.2.5, 16.2.2716.2.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>validation of test method, 16.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Venereal Disease Research Laboratory (VDRL) tests, 13.5.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>working control strains, 16.2.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>worksheet, 16.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeast full identification, 10.9.510.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zinc sulfate flotation, 11.3.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>Quality control plan (QCP), 16.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>individualized (See Individualized quality control plan)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>Quality improvement, 16.1.116.1.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Quality indicators, 16.1.3, 16.1.13, 16.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quality assurance, 16.1.316.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Quality management, 16.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Quality management system (QMS)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>customer focus, 12.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>deputy director, 12.3.212.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>division/section director (technical supervisor), 12.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>equipment, 12.3.512.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>facility design and maintenance, 12.3.312.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification and remediation of individual sample errors, 14.2.1.714.2.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>intervention, 14.2.1.914.2.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory leadership and hierarchy, 12.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory managers, 12.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory supervisors, 12.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>medical director, 12.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>personnel management, 12.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>purchasing and inventory, 12.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>technical staff, 12.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>tracking errors and error sources, 14.2.1.814.2.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>Quantitative culture</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar spread plate method, 15.4.4.5, 15.4.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>to detect low numbers of selected groups of microorganisms in heterogeneous microbial populations, 15.4.4.715.4.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>membrane filter method, 15.4.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pour plate method, 15.4.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound tissues, 3.12.2.13.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>Quantitative real-time PCR (qPCR)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>controls and calibrators, 14.2.5.2, 14.2.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epstein-Barr virus, 14.3.7.114.3.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>Quaternary ammonium compounds, neutralizers of, 15.4.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Quellung reaction, 3.17.41.13.17.41.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Quinolones</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 7.20.14, 7.23.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>time-kill assay, 7.17.2.1, 7.17.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>Quinupristin-dalfopristin (Synercid), 7.23.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>R</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rabbit blood agar (RBA), 4.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rabbit plasma method, 3.17.14.13.17.14.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rabies vaccination, laboratory personnel, 15.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rabies virus, 12.9.3.2, 15.8.3.1, 15.8.3.10, 17.6.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Racemose, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rachis, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Raffinose, 16.2.6, 16.2.9, 16.2.12, 16.2.13, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Raillietina, gross examination, 11.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ralstonia, 18.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ralstonia mannitolilytica, identification, 3.19.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ralstonia pickettii, identification, 3.19.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Random Review for Errors Worksheet, 16.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Raoultella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), testing and reporting considerations, 7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.1, 7.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rapid antigen detection tests (RADTs), group A streptococci (GAS), 3.10.8.13.10.8.3, 3.10.8.5, 3.10.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rapid antigen tests (RATs), influenza, 18.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rapid biochemical tests, anaerobes, L-Alanyl-alanylaminopeptidase, 4.9.16.14.9.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rapid cartridge assays, 11.11.2.2311.11.2.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RapID CB PLUS, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rapid disk, spot tests, and other rapid or primary methods for identification of anaerobes, 4.9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rapid growing mycobacteria (RGM), 9.9.1.19.9.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rapid identification systems</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics of, 4.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 4.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedure for, 4.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rapid influenza diagnostics tests (RIDTs), 18.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RapID NF PLUS, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RapID NH PLUS, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RapID ONE, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rapid plasma reagin (RPR) test, 13.5.3.113.5.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rapid presumptive identification tests, anaerobic Gram-negative bacilli, 4.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rapid solid-phase immunoassays, 12.9.2.112.9.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RapID STAPH PLUS, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RapID STR, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rapid thermonuclease test, 3.17.16.13.17.16.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rapid virus isolation, shell vial/multiwell plate culture, 12.6.112.6.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 12.6.912.6.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 12.6.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 12.6.212.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 12.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 12.6.612.6.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 12.6.1212.6.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 12.6.412.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 12.6.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 12.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>RapID Yeast Plus, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rash, 2.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rat bite fever, 2.1.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RAT(s) (rapid antigen tests), influenza, 18.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rat tapeworm, 11.11.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RBA (Rabbit blood agar), 4.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RBC (red blood cell) unit culture, 15.4.5.115.4.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RDT (rapid detection test), for Leptospira, 3.13.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reagents</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct detection, 12.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular diagnostics, 14.2.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.1.711.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 16.2.2, 16.2.2016.2.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quality control sheets, 11.11.4.211.11.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Real Star</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BKV PCR Kit, 14.3.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>EBV PCR Kit, 14.3.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Real-time polymerase chain reaction</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 3.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>controls and calibrators, 14.2.5.2, 14.2.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>verification and validation, 14.2.4.1, 14.2.4.6, 14.2.4.8, 14.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Real Time TaqMan HIV-1 test, 14.3.1.2, 14.3.1.3, 14.3.1.5, 14.3.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reasonable charge methodology, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Recipient screening, 15.7.7.1415.7.7.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacterial infections, 15.7.7.1415.7.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal infections, 15.7.7.1515.7.7.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>general approach, 15.7.7.115.7.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacterial infections, 15.7.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 15.7.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitic infections, 15.7.7.1615.7.7.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>regulatory requirements, 15.7.7.215.7.7.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Records</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory (See Laboratory records)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>retention of, 1.2.4.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rectal culture, N. gonorrhoeae and C. trachomatis culture, 3.8.1.7, 3.8.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rectal swab, 2.1.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, viral, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>NAAT testing, 14.3.9.514.3.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Red blood cells (RBCs), 12.11.1, 5.11.1.15.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification versus yeast cells, 11.11.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.11.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>unit culture, 15.4.5.115.4.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Red Rubber Catheter (RRC), 3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reducing substances, 11.5.8.111.5.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reference-based analysis methods, 15.6.6.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reference laboratories</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.1.5, 18.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 16.2.3, 16.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Reference strains, 7.20.17.20.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>confirmation of results, 7.20.97.20.10, 7.20.157.20.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>control and limitations, 7.20.8, 7.20.147.20.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>maintenance, 7.20.57.20.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>on-scale endpoints, 7.20.4, 7.20.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.20.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>requirements of accrediting agencies, 7.20.17.20.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sources, 7.20.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>suggested microorganisms, 7.20.37.20.5, 7.20.127.20.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Reference value, molecular tests, 14.2.4.214.2.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Referral specimens, 16.2.3, 16.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reflex, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reflexive branching, 10.10.21, 10.10.48</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reflex testing, 1.2.4.6, 1.2.4.101.2.4.11, 1.2.4.14, 1.2.4.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Refrigeration</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteriology culture stock, 16.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasitology, 11.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>shipping, 17.6.33, 17.6.34</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>storage, 17.4.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Regan-Lowe pertussis agar, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Regan-Lowe pertussis transport medium, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Regional laboratory testing, AR Lab Network, 15.7.1.515.7.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reimbursement</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>glossary of terminology and acronyms, 1.1.51.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for laboratory services, 1.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedure billing, 1.2.2.51.2.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rejection criteria</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.5, 3.2.1.183.2.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wet mount, 3.2.3.1, 3.2.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rejection of specimens, 2.1.3, 2.1.4, 2.1.252.1.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Relapsing fever, 2.1.28</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Remington method</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Toxoplasma IgA antibodies by ELISA detection</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.16.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.4.113.16.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.16.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.16.4.313.16.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.4.213.16.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 13.16.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.16.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Toxoplasma IgE antibodies by ELISA detection</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.16.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.16.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.16.5.213.16.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 13.16.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.16.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Toxoplasma IgM antibodies by ELISA</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high background, 13.16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.16.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.16.2.213.16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection considerations, 13.16.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Remittance advice codes, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Renal abscess, potential etiological agents, 2.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Renal transplant patients, BK virus, 14.3.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Renisora flavissima, 10.10.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reo tube, 3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reoviruses, clinical manifestations, 12.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Replicate organism direct agar contact (RODA) method, 15.4.4.3, 15.4.4.6, 15.4.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Report(s), 16.6.2, 16.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reportable disease, 15.5.4.2, 15.5.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reportable disease record, 16.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reportable range, molecular tests, 14.2.4.114.2.4.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reported Error Description Log, 16.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reported error summary, 16.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reporting, mycobacteria, 9.2.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Requisition design, 1.2.4.31.2.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Requisition form, 16.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Research use only (RUO), 1.1.2, 1.2.4.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Resistance, intrinsic, 7.20.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Resistivity, 16.3.116.3.2, 16.3.4, 16.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Respiratory culture, order of inoculation media, 2.1.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Respiratory samples, 10.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>staining for direct microscopic detection of Pneumocystis jirovecii, 10.4.2.110.4.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Respiratory sites, nonsterile, mold identification, 10.10.3710.10.38</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Respiratory specimens, direct detection, 12.9.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Respiratory synctial virus (RSV), 12.9.1.1, 12.9.2.112.9.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Respiratory syndromic panels</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 14.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.4.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 14.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.4.2.114.4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.4.2.6, 14.4.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.4.2.614.4.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 14.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.4.2.414.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Respiratory tract</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic culture, 2.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacteriological analysis, 2.1.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen rejection, 2.1.26</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Respiratory tract cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>appropriate specimens, 3.10.1.13.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Bordetella, 3.10.6.13.10.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>C. diphtheriae, 3.10.7.13.10.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cyctic fibrosis, 3.10.1.2, 3.10.3.13.10.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.3.13.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.10.3.23.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>organisms workup criteria, 3.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.10.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.10.3.33.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, 3.10.3.13.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>group A streptococci (GAS), 3.10.1.2, 3.10.8.13.10.8.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>guidelines, 3.10.1.13.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Legionella, 3.10.4.13.10.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lower respiratory tract, 3.10.2.13.10.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quantitative culture of protected specimen brush and bronchoalveolar lavage fluid specimens, 3.10.2.133.10.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>throat culture for pharyngitis, 3.10.8.13.10.8.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Respiratory tract infections (RTI), specimen collection, 10.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Respiratory viruses, respiratory tract cultures, 3.10.1.23.10.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Restriction digestion, 15.6.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Retention of records, 1.2.4.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Retina infections, 2.1.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Retortamonas intestinalis, report comments, 11.11.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Retrospective payment, 1.1.6, 1.2.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Retroviruses, clinical manifestations, 12.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reverse CAMP test, 3.17.8.13.17.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reverse osmosis, laboratory water, 16.3.1, 16.3.316.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Reverse transcription polymerase chain reaction (RT-PCR), 18.9.5, 18.9.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RGM (rapid growing mycobacteria), 9.9.1.19.9.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhamnose, 16.2.6, 16.2.10, 16.2.12, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhamnose assimilation, by yeast, 10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rheumatic fever, 13.2.1.113.2.1.3, 13.2.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rheumatoid factor, 13.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhinocladiella, microscopic examination, 10.4.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhinosinusitis, 3.10.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhinosporidium, microscopic examination, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhinovirus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rhizoids, 10.10.3, 10.10.46</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhizomucor</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rhizomucor miehei, temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhizomucor pusillus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation temperature, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rhizopus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.1.10, 10.12.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cycloheximide susceptibility, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation temperature, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.3810.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sporangiophores and rhizoids, 10.10.46</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rhizopus arrhizus, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhizopus microsporus, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhizopus microsporus var. microsporus, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhizopus microsporus var. rhizopodiformis, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhizopus oryzae, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhizopus stolonifer, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhodococcus, 8.1.1, 8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.3, 8.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1, 8.2.68.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 8.5.1, 8.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rhodococcusa, phenotypic characteristics, 8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhodococcus coprophilus, 8.2.6, 8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhodococcus equi, 3.17.8.4, 8.3.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 8.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhodococcus erythropolis, 8.2.6, 8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhodococcus fascians, 8.2.6, 8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhodococcus globerulus, 8.2.6, 8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhodococcus marinonascens, 8.2.6, 8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhodococcus rhodnii, 8.2.6, 8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhodococcus rhodochrous, 8.2.6, 8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhodococcus ruber, 8.2.6, 8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rhodotorula, 10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.6, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.7, 10.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identification, 10.7.2, 10.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rhodotorula glutinis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rhodotorula rubra</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Ribosomal RNA (rRNA) genes, 15.6.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ribotyping, 15.6.2.115.6.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 15.6.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations of testing, 15.6.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 15.6.2.115.6.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 15.6.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 15.6.2.215.6.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 15.6.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 15.6.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rice extract agar, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ricin, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ricin toxin, 15.8.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rickettsia, 2.1.29, 18.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rickettsia prowazekii, 15.8.4.2, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rickettsia rickettsii, shipping, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ridom Staph Type, 15.6.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RIDTs (Rapid influenza diagnostics tests), 18.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rifabutin, 9.9.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar proportion method, 9.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slowly growing nontuberculous mycobacteria, 9.9.2.1, 9.9.2.3, 9.9.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rifampin (RIF, Rifadin, Rimactane), 9.9.3.2, 9.9.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar proportion method, 9.8.19.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT SIRE kit, 9.7.1.1, 9.7.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>slowly growing nontuberculous mycobacteria, 9.9.2.1, 9.9.2.3, 9.9.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK automated microbial detection system, 9.7.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>X</title>
            <indexentry>
               <primaryie>Xpert MTB/RIF assay, 9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Xpert MTB/RIF test, 9.6.2.19.6.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Xpert MTB/RIF Ultra assay, 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rifampin (RIF) resistance, Cepheid Xpert MTB/RIF test, 9.6.1.19.6.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rift valley fever virus, 15.8.4.2, 17.5.3.2, 17.6.10, 18.14.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rimactane. See Rifampin</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rinse fluid, for environmental surface testing, 15.4.4.5, 15.4.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rinse sampling method</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>containment, 15.4.4.6, 15.4.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct immersion, 15.4.4.6, 15.4.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Risk acceptability, individualized quality control plan</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>assignment, 16.5.5, 16.5.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>matrix, 16.5.14, 16.5.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Risk assessment, 17.9.117.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>components of, 17.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>consequence characterization, 17.9.317.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation of controls and risk mitigation strategies, 17.9.417.9.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification of hazards and risks in the CML, 17.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>implementation of controls and risk mitigation strategies, 17.9.517.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>individualized quality control plan</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>and determination of risk level, 16.5.14, 16.5.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>information used to conduct, 16.5.3, 16.5.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>possible sources of error, 16.5.15, 16.5.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>likelihood characterization, 17.9.3, 17.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>review of assessment and mitigation strategies, 17.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Risk level determination, individualized quality control plan, 16.5.20, 16.5.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Risk matrix, 17.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RNA, armored RNA (aRNA), 14.2.5.114.2.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RNA tests, HIV-1, 14.3.1.114.3.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 14.3.1.614.3.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.3.1.714.3.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and required equipment, 14.3.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.3.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.3.1.514.3.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.3.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 14.3.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.3.1.314.3.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rocephin. See Ceftriaxone</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Roche COBAS 4800, C. trachomatis and N. gonorrhoeae, 14.3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Roche Diagnostics Elecsys Syphilis, 13.5.7.1, 13.5.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Roche MagNA Pure LC System, herpes simplex viruses 1 and 2 and varicella zoster virus, 14.3.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rock of Gibraltar fever, 18.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rocky Mountain spotted fever, donor screening, 15.7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Romboutsia lituseburensis, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Room temperature storage, 17.4.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Root abscess, 2.1.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Roseburia, 4.14.5, 4.14.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Roseomonas, 3.19.8, 3.19.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rosette, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rotaviruses</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5, 14.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rothia, 3.17.4.1, 3.17.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.4, 3.18.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rothia mucilaginosa</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial disk tests, 3.17.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.4, 3.18.6, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Rotorods, 15.4.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Roundworms, key characteristics, 11.11.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RPMI 1640, 10.12.1.210.12.1.9, 11.9.3.811.9.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RPR test. See Rapid plasma reagin test</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RRC (Red Rubber Catheter), 3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rRNA genes, yeast, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rRT-PCR, Candida auris, 15.7.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RSV. See Respiratory syncytial virus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RTI (Respiratory tract infections), specimen collection, 10.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RT-PCR. See Real-time polymerase chain reaction; Reverse transcription polymerase chain reaction</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Rubella virus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>Ruminocccus, 4.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ruminococcus gauvreauii, 4.15.9, 4.15.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ruminococcus, taxonomy update, 4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Run charts, 16.1.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ruoffia, 3.18.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>RUO (research use only) tests, 1.2.4.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>S</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sabia virus, 15.8.4.2, 17.5.3.2, 18.14.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sabouraud agar, 10.10.51</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sabouraud dermatophyte decontamination broth, 10.10.7, 10.10.54</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sabouraud medium, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sabouraud salt dulcitol broth (SSD broth), Candida auris, 15.7.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Saccharomonospora, 8.1.1, 8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Saccharomyces, 10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identfication, 10.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Saccharomyces cerevisiae, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>ascospore and ascus characteristics, 10.9.3, 10.9.6, 10.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Saccharopolyspora, 8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Saccharopolyspora hordei, Gram stain, 8.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SAF (sodium acetate-acetic acid-formalin), 11.2.2.2, 11.2.2.511.2.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Safe laboratory practices, 18.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Safety</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>checklist, 16.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>chemical, 12.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>commercial products, 17.3.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>containment, 17.3.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biological safety cabinet, 17.3.3.117.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PPE and engineering controls, 17.3.4.117.3.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>containment, 17.3.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biosafety levels, 17.3.2.117.3.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>electrical, 12.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>environmental, 12.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fire, 12.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory-acquired infections, 18.2.118.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory instrumentation and equipment, 17.4.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autoclave, 17.4.2.117.4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>centrifuge, 17.4.3.117.4.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>compressed gas cylinders, 17.4.4.117.4.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>other equipment and devices, 17.4.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pneumatic tube system, 17.4.5.117.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen/microorganism storage and retention, 17.4.6.117.4.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>management of infectious waste, 17.8.117.8.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>M. tuberculosis, 9.2.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mycology, 10.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 17.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 17.6.2, 17.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasites, 11.1.111.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>prevention</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decontamination, 17.1.3.117.1.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>routes of infection and laboratory activities, 17.1.1.117.1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>spills, 17.1.4.117.1.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>work practices, 17.1.2.117.1.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing specimens for fungal culture, 10.5.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>records, 16.6.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>risk assessment, 17.9.117.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special pathogens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.117.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>environmental, nonanimal, and suspicious specimens and substances, 17.5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>prions, 17.5.5.117.5.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>resources for information, 17.5.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>select agents, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Safety considerations, poxviruses, 18.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Safranin, 3.2.1.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Safranin technique with microwave heating, modified, 11.4.6.111.4.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Saksenaea</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification on primary media, 10.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold identification on primary culture, 10.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Salicin, 16.2.6, 16.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Salmonella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Andrades fermentation medium, 16.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.20.9, 7.22.12, 7.23.4, 7.23.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood cultures, laboratory process, 5.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>collection and storage of outbreak isolates, 15.5.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.1, 7.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.1, 3.7.1.3, 3.7.1.5, 3.7.1.6, 3.7.1.63.7.1.7, 3.7.1.8, 3.7.1.93.7.1.12, 3.7.1.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5, 14.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>heart infusion fermentation base, 16.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hydrogen sulfide production, 3.17.21.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ingestion, 17.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory safety, 17.3.2.1, 18.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF, 6.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>malonate test, 3.17.28.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MUG (4-methylumbelliferyl--D-glucuronide) test, 3.17.33.13.17.33.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>public health reporting, 15.5.4.3, 15.5.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>purple broth, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen handling, 11.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance, 15.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.1, 3.17.24.33.17.24.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vs. Y. pestis, 18.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Salmonella enterica</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.8, 3.7.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunization of laboratory personnel, 15.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Salmonella enterica serotype Typhimurium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>deoxycholate agar, 16.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>eosin methylene blue medium, 16.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram-negative broth, 16.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hektoen enteric agar, 16.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lysine iron agar, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MAC medium, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Salmonella-Shigella agar, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triple-sugar iron agar, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>X</title>
            <indexentry>
               <primaryie>xylose lysine deoxycholate agar, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Salmonella enterica serovar Typhimurium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Salmonella-Shigella agar (SS), 3.7.1.2, 3.7.1.9, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Salmonellosis, 18.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Salpingitis, 3.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.13.17.42.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Salt tolerance medium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacteria, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sample preparation, molecular diagnostics, 14.2.2.414.2.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sample processing control (SPC), Xpert MTB/RIF test, 9.6.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>Sample to result instrumentation, molecular workflow, 14.2.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sanger sequencing, 15.6.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>HIV genotypic resistance testing, 14.3.2.114.3.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>verification and validation, 14.2.4.514.2.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>So Paulo metallo--lactamase (SPM), 7.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sapovirus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5, 14.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sappinia, STAT testing, 11.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Saprochaete capitata</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph-teleomorph binomial, 10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate fermentation test, 10.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>SA(s) (state agencies), quality control, 7.20.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sarcina, 4.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calcofluor white stain, 11.4.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sarcocystis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autofluorescence, 11.4.7.111.4.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyouns acid-fast stain (cold), 11.4.1.111.4.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Ziehl-Neelsen acid-fast stain (hot), 11.4.2.111.4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sarcocystis heydorni, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autofluorescence, 11.4.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sarcocystis hominis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autofluorescence, 11.4.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyouns acid-fast stain (cold), 11.4.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified safranin technique with microwave heating, 11.4.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Ziehl-Neelsen acid-fast stain (hot), 11.4.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sarcocystis suihominis, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autofluorescence, 11.4.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyouns acid-fast stain (cold), 11.4.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified safranin technique with microwave heating, 11.4.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Ziehl-Neelsen acid-fast stain (hot), 11.4.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sarcoptes scabiei, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sarocladium strictum, 10.10.40</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SARS-CoV. See Severe acute respiratory syndrome coronavirus (SARS-CoV)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Satellite test, 3.17.43.13.17.43.3, 18.15.8.118.15.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Saxitoxin, 15.8.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SBT. See Serum bactericidal titers</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Scabies, 11.7.3.1, 11.7.3.3, 11.11.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Scalp brushings/scrapings, 10.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Scardovia inopinata, 4.14.5, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Scedosporium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), by broth dilution, 10.12.1.8, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conidia, 10.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>continuous monitoring blood culture systems, 5.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cycloheximide susceptibility, 10.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.12, 10.4.1.13, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.3710.10.38</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.3510.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.4, 10.5.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.3.1, 3.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Scedosporium apiospermum, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ear canals, 10.10.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.3810.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.3710.10.38</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Scedosporium apiospermum sensu stricto, 10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Scedosporium apiospermum species complex</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.38</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Scedosporium aurantiacum, taxonomy and nomenclature, 10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Scedosporium boydii, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nonsterile respiratory sites, 10.10.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Scedosporium prolificans, 10.10.36</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schaalia, 4.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Schaalia canis, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schaalia cardiffensis, 4.2.2, 4.14.2, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schaalia funkei, 4.2.2, 4.14.2, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schaalia georgiae, 4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schaalia meyeri, 4.2.2, 4.14.2, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schaalia odontolytica, 4.2.2, 4.14.2, 4.14.8, 4.14.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schaalia radingae, 4.2.2, 4.14.2, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schaalia turicensis, 4.2.2, 4.14.2, 4.14.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schaedler blood agar, 4.4.1.3, 4.4.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schaudinns fixative, 11.2.2.3, 11.6.3.111.6.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schistosoma, 11.6.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine concentration (membrane filter, Nucleopore), 11.6.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Schistosoma haematobium, 11.6.7.111.6.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine concentration (membrane filter, Nucleopore), 11.6.8.111.6.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Schistosoma japonicum, 11.6.7.3, 11.11.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schistosoma mansoni, 11.6.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Schistosomiasis, 11.11.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schizophyllum, 10.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schizophyllum commune</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphology, 10.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.38</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Schneiders Drosphila medium, 11.9.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Schffners dots, 11.8.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Scientific research, Outbreak Database, 15.5.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sclerotia, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sclerotic fission cells, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Scolices, recovery of, 11.5.6.111.5.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Scopulariopsis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Scopulariopsis brevicaulis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal and facial sinus scrapings, 10.10.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>toenails and fingernails, 10.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Screening</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor (See Donor screening)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methicillin-resistant S. aureus, 15.7.2.115.7.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vancomycin-resistant enterococci, 15.7.3.115.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Scytalidium, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sealpox virus (SPV), 18.8.1, 18.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SEB. See Staphylococcal enterotoxin B</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Secondary microspore, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Secondary specimen container, 17.6.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>secretions, specimen collection, 2.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Segniliparus, 8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 8.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation of growth, 8.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1, 8.2.78.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Select agents, 17.5.3.117.5.3.2, 17.6.3417.6.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Selective commercial chromogenic media, for CRE screening, 15.7.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Selective drug reporting, 7.23.37.23.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Selective media, anaerobes, 4.4.1.14.4.1.2, 4.4.1.74.4.1.9, 4.4.2.2, 4.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Selenite-F, 3.7.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Selenomonas, 4.13.8, 4.13.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sensititre GNID, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sensititre GPID, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sensititre SLOWMYCO2 broth microdilution plate, 9.9.2.19.9.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sensitivity test method, 16.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sentinel level clinical laboratory</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>defined, 18.1.4, 18.14.318.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>guidelines, 18.14.518.14.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>readiness checklist, 18.14.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>recommendations, 18.1.618.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>responsibilities, 18.1.418.1.5, 18.1.6, 18.14.418.14.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sentinel Level Clinical Microbiology Laboratory Guidelines, 17.5.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Seoul virus, 18.12.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sepedonium, 10.10.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sepedonium chrysospermum, 10.10.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sepsis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>transfusion-associated, 2.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Septa, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Septic abortion, 3.8.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Septic arthritis, 2.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Septicemic plague, 18.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Septic pelvic thrombophlebitis, 3.8.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Septic shock, 2.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Septra. See Trimethoprim-sulfamethoxazole</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sequence polymorphisms, 14.2.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sequencing-based identification, 14.5.1.114.5.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 14.5.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations of, 14.5.1.614.5.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and equipment, 14.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.5.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedures, 14.5.1.214.5.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 14.5.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.5.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SERODIA Treponema pallidum particle agglutination test (TP-PA), 13.5.5.113.5.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Serologic diagnosis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>of Arbovirus infections, 13.12.113.12.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnostic approaches, 13.12.113.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.12.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.12.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.12.213.12.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.12.513.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recommended, 13.12.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection considerations, 13.12.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>types of assays, 13.12.313.12.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>of Chagas disease, 13.15.113.15.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acute and chronic phases, 13.15.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CDC reference laboratory testing, 13.15.313.15.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ELISAs, 13.15.513.15.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>epidemiological and clinical indications for, 13.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>FDA-cleared assays for, 13.15.2, 13.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>LFA, 13.15.613.15.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and reagents, 13.15.413.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phase and context diagnosis, 13.15.213.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection and considerations, 13.15.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Serology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brucella, 13.3.113.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Chagas disease diagnosis, 13.15.113.15.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Coccidioides</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>available assays, 13.14.1.113.14.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>complement fixation (CF), 13.14.3.113.14.3.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>EIA, 13.14.4.113.14.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunodiffusion, 13.14.2.113.14.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>introduction, 13.14.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lateral flow assay (LFA), 13.14.5.113.14.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 13.14.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cytomegalovirus (CMV)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>chemiluminescence assay (CIA), 13.9.2.113.9.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enzyme-linked immunosorbent assay and chemiluminescense assay, 13.9.2.113.9.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>enzyme-linked immunosorbent assays (ELISAs), 13.9.2.113.9.2.4, 13.9.3.113.9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>IgG avidity testing, 13.9.1.113.9.1.2, 13.9.3.113.9.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.9.1.113.9.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>detection of Borrelia burgdorferi antibodies, 13.6.113.6.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>eastern equine encephalitis virus, 18.13.218.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Epstein-Barr virus (EBV)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>EBV-specific antibodies, 13.8.1.113.8.1.2, 13.8.3.113.8.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>heterophile antibodies, 13.8.1.113.8.1.2, 13.8.2.113.8.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.8.1.113.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>virus-specific antibodies, 13.8.1.2, 13.8.3.113.8.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>group A streptococci (GAS), 13.2.1.113.2.1.3, 13.2.2.113.2.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hepatitis A virus (HAV), 13.11.1.113.11.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hepatitis B virus (HBV), 13.11.2.113.11.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hepatitis C virus (HCV), 13.11.3.113.11.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>high-consequence viral pathogens, 18.12.1018.12.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Histoplasma capsulatum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>complement fixation, 13.13.1.1, 13.13.2.113.13.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunodiffusion, 13.13.1.1, 13.13.3.113.13.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.13.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>human immunodeficiency virus (HIV)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.10.1.113.10.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>screening immunoassays, 13.10.1.313.10.1.4, 13.10.2.113.10.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>supplemental immunoassays, 13.10.1.313.10.1.4, 13.10.3.113.10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>influenza, 18.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>poxviruses, 18.8.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pretransplant workup, 15.7.7.215.7.7.3, 15.7.7.515.7.7.8, 15.7.7.1015.7.7.11, 15.7.7.1615.7.7.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rheumatic fever and poststreptococcal glomerulonephritis, 13.2.1.113.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>SARS-CoV-2 serologic testing, 13.7.113.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.32.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>virus identification, 12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Serratia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood products, 15.4.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gelatin liquefaction, 3.17.18.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>keratitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>malonate test, 3.17.28.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Serratia fonticola, 3.17.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Serratia liquefaciens, 3.7.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Serratia marcescens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Andrades fermentation medium, 16.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbapenemase, 7.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gelatin, 16.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>heart infusion fermentation base, 16.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenol red agar, 16.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>purple broth, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.10, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Serum agglutination test (SAT), 13.3.213.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Serum bactericidal titers (SBT), 7.18.17.18.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative protocols for variations in sample or diluent, 7.18.117.18.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>determining, 7.18.57.18.6, 7.18.9, 7.18.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.18.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>macrodilution procedure, 7.18.67.18.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 7.18.2, 7.18.6, 7.18.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microdilution procedure, 7.18.27.18.6, 7.18.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>plating, 7.18.5, 7.18.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 7.18.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.18.37.18.6, 7.18.77.18.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.18.97.18.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.18.27.18.3, 7.18.67.18.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection value and calculated sensitivity and specificity, 7.18.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results, 7.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.18.17.18.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>worksheet, 7.18.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Serum inhibitory titers (SIT), 7.18.17.18.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative protocols for variations in sample or diluent, 7.18.117.18.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.18.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>macrodilution procedure, 7.18.67.18.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 7.18.2, 7.18.6, 7.18.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microdilution procedure, 7.18.27.18.6, 7.18.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.18.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.18.37.18.6, 7.18.77.18.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.18.97.18.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.18.27.18.3, 7.18.67.18.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reading and recording, 7.18.47.18.5, 7.18.8, 7.18.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rejection value and calculated sensitivity and specificity, 7.18.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results, 7.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.18.17.18.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>worksheet, 7.18.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Setae, 10.10.5, 10.10.21, 10.10.48</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Settling plates, 15.4.3.3, 15.4.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Severe acute respiratory syndrome (SARS), 2.1.31, 15.5.4.3, 15.5.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Severe acute respiratory syndrome coronavirus (SARS-CoV), 17.5.3.2, 18.9.218.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 18.9.818.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescent antibody staining of antigens, 18.9.718.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.9.718.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation and reporting of results, 18.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methods, 18.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification, 18.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 18.9.118.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid antigen tests, 18.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>recommended BSL, 18.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.9.418.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serology, 18.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 18.9.518.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.9.618.9.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 12.9.2.112.9.2.16, 14.1.1, 14.1.2, 14.2.1.1, 14.2.1.3, 14.2.1.10, 14.2.3.1, 14.4.2.1, 17.5.3.2, 18.9.218.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture, 18.9.818.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.4, 15.7.7.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescent antibody staining of antigens, 18.9.718.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.9.718.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>initial identification and characterization, 12.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation and reporting of results, 18.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.115.8.4.2, 15.8.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methods, 18.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification, 18.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 18.9.118.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid antigen tests, 18.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.9.418.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serologic testing, 13.7.113.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>assay limitations, 13.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>choosing a test, 13.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.7.413.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.7.113.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.7.313.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 13.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>suggested reporting comments, 13.7.513.7.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>summary of assays, 13.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serology, 18.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 18.9.518.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.9.618.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>viral load testing, 14.2.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sexual abuse, N. gonorrhoeae cultures, 3.8.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sexual assault, N. gonorrhoeae cultures, 3.8.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sexually transmitted disease (STD)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cervicitis, 2.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital ulcers with lymphadenopathy, 2.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>neonatal/perinatal complications, 2.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.112.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vaginitis/vulvovaginitis, 2.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>vaginosis, 2.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sexually transmitted infections, 15.5.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shahidi-Ferguson perfringens agar, 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sheep liver fluke, 11.11.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sheeppox virus, 17.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shell vial culture, 12.6.112.6.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shewanella algae, 3.17.21.1, 3.17.21.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shewanella putrefaciens, 3.17.16.13.17.16.2, 3.17.21.1, 3.17.21.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shewanella putrefaciens/algae, 3.19.9, 3.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shiga toxin-producing Escherichia coli (STEC), 3.7.1.1, 3.7.1.223.7.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shigella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acetate utilization test, 3.17.2.13.17.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>AmpC beta-lactamase testing, 7.15.1, 7.15.2, 7.15.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.23.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>collection and storage of outbreak isolates, 15.5.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ESBL testing, 7.14.1, 7.14.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.13.7.1.7, 3.7.1.93.7.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5, 14.4.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>genital tract, 3.8.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.3.2.7, 3.19.7, 3.19.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MUG (4-methylumbelliferyl--D-glucuronide) test, 3.17.33.13.17.33.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>positive blood culture broth, 5.13.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen handling, 11.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance, 15.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vs. Y. pestis, 18.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Shigella boydii, 3.7.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shigella dysenteriae, 3.7.1.10, 17.1.1.1, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shigella flexneri</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acetate agar, 16.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>acetate utilization test, 3.17.2.13.17.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>deoxycholate agar, 16.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.9, 3.7.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hektoen enteric agar, 16.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lysine iron agar, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Salmonella-Shigella agar, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>transport media, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>X</title>
            <indexentry>
               <primaryie>xylose lysine deoxycholate agar, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Shigella sonnei, 3.7.1.2, 3.7.1.10, 16.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shigellosis, laboratory-acquired, 18.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shikimate dehydrogenase, 15.6.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shipment of specimens, 11.2.3.111.2.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shipper, 17.6.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shippers Declaration of Dangerous Goods, 17.6.22, 17.6.26</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shipping of infectious substances, 17.6.117.6.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biological products, 17.6.8, 17.6.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biological substance, 17.6.13, 17.6.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cargo only, 17.6.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>carrier, 17.6.26</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Category A substance, 17.6.17, 17.6.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Category B substance, 17.6.10, 17.6.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>classification of substances, 17.6.617.6.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>couriers, 17.6.2517.6.29</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>documentation, 17.6.3, 17.6.2217.6.25</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>emergency response, 17.6.2917.6.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>exclusive use motor vehicle exception, 17.6.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>exempt human or animal specimens, 17.6.11, 17.6.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>exempt substances, 17.6.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal, 10.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genetically modified organisms, 17.6.12, 17.6.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>governing authorities and regulations, 17.6.117.6.4, 18.14.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incident reporting, 17.6.2917.6.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>infected animals, 17.6.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>marking and labeling outer packages, 17.6.1717.6.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>medical waste, 17.6.29</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>naming Category A and Category B substances, 17.6.3, 17.6.1317.6.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>outer package, 17.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>overpack, 17.6.21, 17.6.33</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing instructions, 17.6.6, 17.6.1417.6.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>patient specimens, 17.6.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>permits, 17.6.3017.6.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>refrigerants, 17.6.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>select agents, 17.6.34, 17.6.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special provisions, 17.6.14, 17.6.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>terminology, 17.6.19, 17.6.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>training and certification, 17.6.417.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Short-read sequencing, 15.6.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Short-term storage of anaerobes, 4.11.1, 4.11.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shotgun metagenomic next generation sequencing (mNGS), 14.5.4.114.5.4.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DNA, 14.5.4.114.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>RNA, 14.5.4.814.5.4.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Shunt infections, 2.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Shuttleworthia satelles, 4.14.4, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Siberian subtype, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Siemens ADVIA Centaur Syphilis, 13.5.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sieve impactors, 15.4.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sigmoidoscopy specimens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.6.2.111.6.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>permanent stained smear, 11.6.3.111.6.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Signal amplification, high-risk human papillomaviruses, 14.3.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Silver stain, for Pneumocystis jirovecii, 10.4.2.410.4.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Simian B virus, 12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Simmons citrate. See Citrate utilization test (Simmons)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Simmons citrate agar, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Simonsiella muelleri, 3.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Simple arthroconidia, 10.10.4, 10.10.46</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Simplexa HSV-1&amp;2 Direct assay, 14.3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Single-nucleotide polymorphism (SNP) analysis, 15.6.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sink testing, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sin Nombre virus (SNV), 18.12.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sinus cultures. See Nasal sinus, cultures</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sinuses</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, specimens and recommended stains, 11.11.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.23, 2.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sinusitis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sinus scrappings, 10.10.3810.10.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sinus tract, specimen collection, 4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SIT. See Serum inhibitory titers</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sivextro (tedizolid), 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Skenes glands, 3.8.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Skenitis, 3.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Skin</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal specimens, 10.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 2.1.37, 11.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Skin biopsy, parasites, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Skin cultures, 3.12.1.13.12.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture workup, 3.12.1.143.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation conditions, 3.12.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>initial evaluation, 3.12.1.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation, 3.12.1.133.12.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 3.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.12.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.12.1.113.12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.12.1.13.12.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.12.1.133.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.12.1.103.12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.12.1.163.12.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety, 3.12.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.12.1.93.12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.13, 3.12.1.14, 3.12.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Skin infections</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biohazards, 17.1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.122.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal, 10.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Skin scrapings, 10.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.7.3.211.7.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitology, 11.7.3.111.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yielding nondermatophytes, 10.10.3910.10.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Slackia exigua, 4.14.5, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Slide agglutination test (Rose Bengal test), Brucella, 13.3.213.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Slide cultures for mold identification, 10.8.410.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Slide preparation, Gram stain, 3.2.1.103.2.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Slit impactor, 15.4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Slowly growing nontuberculous mycobacteria, antimicrobial susceptibility testing for, 9.9.2.19.9.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SLOWMYCO2 broth microdilution plate, 9.9.2.19.9.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Small-bowel contents, quantitative culture, 3.7.4.13.7.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Small intestine biopsy, parasites, 11.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Smallpox, 18.8.118.8.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical forms of, 18.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.217.5.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>global eradication campaign, 18.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.8.1218.8.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.1, 15.8.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 18.8.118.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 18.8.918.8.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recommended BSL, 18.14.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sentinel Level Clinical Microbiology Laboratory Guidelines, 18.14.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 17.6.18, 17.6.19, 18.8.718.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>transmission, 18.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vaccine, 15.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Smear fixation, Gram stain, 3.2.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sneathia, 4.13.1, 4.13.2, 4.13.5, 4.13.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sneathia vaginalis, 4.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SNP-based methods, 14.5.3.34, 14.5.3.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Social Security Act, 1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sodium acetate-acetic acid-formalin (SAF), 11.2.2.2, 11.2.2.511.2.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sodium acetate formalin (SAF) fixative, 11.11.5.311.11.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sodium bicarbonate</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stock solution, 7.6.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sodium chloride (NaCl)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria, 9.5.1.29.5.1.4, 9.5.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sodium hydroxide (NaOH) method</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>digestion and decontamination, 9.2.2.1, 9.2.2.3, 9.2.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>prion decontamination, 17.5.5.317.5.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sodium hypochlorite (NaClO) solution, prion decontamination, 17.5.5.317.5.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sodium polyanethol sulfonate (SPS) disk, 5.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 3.17.44.13.17.44.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic cocci, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for Gram-positive anaerobic cocci, 4.9.6.14.9.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Soft tissue cultures, aerobes, 3.12.1.13.12.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture workup, 3.12.1.143.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation conditions, 3.12.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>initial evaluation, 3.12.1.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation, 3.12.1.133.12.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 3.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.12.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.12.1.113.12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.12.1.13.12.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.12.1.133.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.12.1.103.12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.12.1.163.12.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety, 3.12.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.12.1.93.12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.13, 3.12.1.14, 3.12.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Soft tissue infections</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic specimen selection, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.122.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Solid media, Gram stain of colonies, 3.2.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Solid-organ transplant, 15.7.7.115.7.7.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Solid-phase immunoassays, 12.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Solobacterium moorei, 4.14.4, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SOPs (standard operating procedures), bioterrorism, 18.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sorbitol, 16.2.6, 16.2.9, 16.2.10, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>South American hemorrhagic fever viruses, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spa. See Staphylococcal protein A</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Spa Typer, 15.6.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Spaulding classification, 15.4.4.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SPC (sample processing control), Xpert MTB/RIF test, 9.6.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Special-cause variation, 16.1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Special pathogens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.117.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>environmental, nonanimal, and suspicious specimens and substances, 17.5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>prions, 17.5.5.117.5.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>resources for information, 17.5.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>select agents, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Special-potency antimicrobial agent disks, 4.9.5.14.9.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic Gram-negative bacilli, 4.13.144.13.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Species complexes, 10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Species identification, significance of, 10.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Specificity, test method, 16.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Specimen(s)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory safety, 18.2.218.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection of, 2.1.3, 2.1.4, 2.1.252.1.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Specimen collection</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 2.1.2, 2.1.4, 2.1.18, 4.3.14.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>abdomen, 4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>abscess, 4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bone and joint, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>central nervous system, 4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>collection methods, 4.3.34.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decubiti and other surface ulcers, 4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>female genital tract, 4.3.2, 4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>head and neck, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lung, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 4.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pulmonary specimens, 4.3.2, 4.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sinus tracts and deep-wound drainages, 4.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>soft tissue, 4.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen selection, 4.3.14.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen transport, 4.3.44.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>swabs, 4.3.1, 4.3.2, 4.3.3, 4.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urinary tract, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>by anatomical site, 2.1.1, 2.1.62.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bacteriology, 2.1.3, 2.1.182.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>biosafety level 3 and 4 agents, 15.8.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cerebrospinal fluid (CSF) cultures, 3.5.13.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Chagas disease serologic diagnosis, 13.15.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cystic fibrosis respiratory tract cultures, 3.10.3.13.10.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cytomegalovirus serology, 13.9.2.113.9.2.2, 13.9.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>devices, 2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>digestion and decontamination, 9.2.2.19.2.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ear culture, 3.10.5.13.10.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>expernal ear, 3.10.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tympanocentesis fluid, 3.10.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ear cultures, 3.10.5.13.10.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>environmental surface testing, 15.4.4.515.4.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Epstein-Barr virus serology, 13.8.2.1, 13.8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungi, 2.1.3, 2.1.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.1, 14.4.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hepatitis A virus (HAV) serology, 13.11.1.2, 13.11.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hepatitis B virus (HBV) serology, 13.11.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hepatitis C virus (HCV) serology, 13.11.3.313.11.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Histoplasma capsulatum antibody detection by complement fixation, 13.13.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>infrequently encountered organisms, 2.1.2, 2.1.362.1.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Leptospira culture, 3.13.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lower respiratory tract cultures, 3.10.2.23.10.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.13.10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>outbreak investigation, 15.5.1.115.5.1.2, 15.5.2.115.5.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 2.1.3, 2.1.362.1.37, 11.11.2.111.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitic infections, 11.2.1.111.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>poxviruses, 18.8.618.8.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principles, 2.1.12.1.2, 2.1.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>prions, 17.5.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality assurance, 16.1.116.1.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quality control, 16.2.1, 16.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sequencing-based identification of microorganisms, 14.5.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serology, 2.1.32.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>swabs, 2.1.12.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>throat specimens, 3.10.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>viral culture, 12.2.112.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>viruses, 2.1.3, 2.1.312.1.34, 12.2.112.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Specimen disposal</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Creutzfeldt-Jakob disease, 17.5.5.117.5.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Specimen handling</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>prions, 17.5.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety, 17.1.2.117.1.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Specimen preparation, specimen processing for anaerobic culture, 4.5.14.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Specimen processing</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 3.3.1.13.3.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture media selection, 3.3.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluids, 3.3.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram staining, 3.3.1.6, 3.3.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation, 3.3.1.83.3.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation technique, 3.3.1.83.3.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.3.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>manual incubation, 3.3.1.83.3.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 3.3.1.23.3.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>media commonly used, 3.3.1.23.3.1.3, 3.3.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedure, 3.3.1.43.3.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.3.1.33.3.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting specimen information, 3.3.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>saving specimens, 3.3.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>swabs, 3.3.1.53.3.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>timing, 3.3.1.43.3.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, specimen collection, transport, and handling, 3.3.1.13.3.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>alert request, 2.1.4, 2.1.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for anaerobic culture, 4.5.14.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation, 4.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation of media, 4.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 4.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen preparation, 4.5.14.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>visual examination, 4.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>automated systems, 2.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>critical values in microbiology, 2.1.4, 2.1.40</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for fungal culture, 10.5.110.5.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 2.1.42.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.1.611.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 2.1.4, 2.1.382.1.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection of specimens, 2.1.3, 2.1.4, 2.1.252.1.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety, 17.1.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>streaking plates for primary isolation, 2.1.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>triage, 2.1.4, 2.1.38</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine, 2.1.42.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Specimen retention, 17.4.6.117.4.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Specimen selection, anaerobes, 4.3.14.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Specimen storage, 17.4.6.117.4.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Creutzfeldt-Jakob disease, 17.5.5.117.5.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for digestion and decontamination, 9.2.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.614.4.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>outbreak isolates, 15.5.2.115.5.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>poxviruses, 18.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Specimen transport</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.3.44.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cerebrospinal fluid (CSF) cultures, 3.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cystic fibrosis respiratory tract cultures, 3.10.3.13.10.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>for digestion and decontamination, 9.2.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ear cultures, 3.10.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower respiratory tract cultures, 3.10.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media, 2.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 2.1.22.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>poxviruses, 18.8.718.8.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality assurance, 16.1.2, 16.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quality control, 16.2.1, 16.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety, 17.1.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sequencing-based identification of microorganisms, 14.5.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>shipment of parasitology specimens, 11.2.3.111.2.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>swabs, 2.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature, 2.1.22.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>throat specimens, 3.10.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Spectracef (cefditoren), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Spherule, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sphingobacterium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, cystic fibrosis, 3.10.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sphingobacterium mizutaii, 3.19.11, 3.19.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sphingobacterium multivorum, 3.19.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sphingobacterium spiritivorum, 3.19.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sphingobacterium thalpophilum, 3.19.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sphingomonas paucimobilis, 3.19.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Spills, biohazardous, 17.1.4.117.1.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Spinal cord infections, 2.1.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Spirillum minus, 5.11.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Spleen</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, parasites, 2.1.37, 11.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Splenic abscess, potential etiological agents, 2.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Split decomposition, 15.6.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Split ratio method, 12.7.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>Splitting of stock cell cultures, 12.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sponge-rinse sampling method, 15.4.4.6, 15.4.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sporangia, 10.10.46</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sporangiophores, 10.10.3, 10.10.46</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sporangiospores, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sporangium, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Spore-forming anaerobic Gram-positive bacilli, 4.14.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Spores, definition, 10.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Spore stain, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sporobolomyces, 10.6.4, 10.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sporobolomyces salmonicolor, 10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sporodochium, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sporothrix</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing by broth dilution, 10.12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.13, 10.4.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mold phase characteristics, 10.10.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sporothrix schenckii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial resistance, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blastoconidia, 10.10.46</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sympodial proliferation, 10.10.46</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sporothrix schenckii species complex</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conversion, 10.10.1610.10.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold phase characteristics, 10.10.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>particulate phase, 10.10.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sporothrix stenoceras, 10.10.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sporotrichosis, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sporulation, inducing, 10.8.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sporulation media, 10.10.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Spot indole test, 18.7.9, 18.15.3.118.15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Spotted fevers, 2.1.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>SPS disk. See Sodium polyethanol sulfonate disk</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sputum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>collection, quality assurance, 16.1.11, 16.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture, 3.10.2.13.10.2.2, 3.10.2.5, 3.10.2.73.10.2.9, 3.10.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>expectorated parasites, 11.7.1.111.7.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>expectorated specimen for direct-mount and stained preparations, 11.7.1.111.7.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram smear worksheet, 16.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.10.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.2.1.183.2.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.10.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing and culture examination, 3.10.2.73.10.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality data summary, 16.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.10.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.23, 3.10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sputum specimen</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/RIF test, 9.6.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Cepheid Xpert MTB/XDR test, 9.6.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>digestion and decontamination, 9.2.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing for fungal culture, 10.5.110.5.2, 10.5.4, 10.5.6, 10.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality indicators, 16.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen rejection, 2.1.26</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>staining procedure for direct microscopic detection of Pneumocystis jirovecii, 10.4.2.110.4.2.3, 10.4.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Squash preparations</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.7.3.211.7.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitology, 11.7.3.111.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>1</title>
            <indexentry>
               <primaryie>16S rRNA gene sequencing methods, anaerobic cocci, 4.15.1, 4.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>16S rRNA gene-targeted DNA sequence-based methods, 4.13.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>SS (Salmonella-Shigella agar), 3.7.1.2, 3.7.1.9, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Stain(s) and staining. See also specific stains and organisms</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 16.2.2, 16.2.2016.2.23</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Staining procedures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acridine orange, 3.2.2.13.2.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.13.2.1.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Stains and staining. See also specific organisms; specific stains</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Stains, for parasites, 11.11.2.511.11.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Standard operating procedures (SOPs), bioterrorism, 18.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Standards, enforcing through disciplinary guidelines, 1.2.4.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Standards of conduct, 1.2.4.2, 1.2.4.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Standing orders, 1.1.6, 1.2.4.6, 1.2.4.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphcillin (nafcillin), 7.6.1.6, 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcal enterotoxin B (SEB), 18.11.118.11.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>case definition, 18.11.418.11.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clusters, 18.11.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>destruction, 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.11.318.11.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>geographic distribution, 18.11.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.11.918.11.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation and examination of cultures, 18.11.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.11.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packaging and shipping, 18.11.6, 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive diagnosis, 18.11.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recommended BSL, 18.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rejection criteria, 18.11.618.11.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting and notification, 18.11.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.11.518.11.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance, 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sentinel Level Clinical Microbiology Laboratory Guidelines, 18.14.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.11.1018.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.11.618.11.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.11.818.11.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>treatment, 18.11.4, 18.11.1018.11.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Staphylococcal protein A (spa) typing, 15.6.4.115.6.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococci</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.17.7.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 3.17.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>coagulase-negative (see Coagulase-negative staphylococci (CoNS))</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Staphylococcus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.6, 7.6.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title></title>
            <indexentry>
               <primaryie>-aminolevulinic acid (ALA) test, 3.17.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 3.17.4.13.17.4.5, 7.1.1.47.1.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.2, 7.23.6, 7.23.11, 7.23.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.57.7.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.7, 7.4.1.8, 7.4.1.9, 7.4.1.13, 7.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catheter-related bloodstream infection, 5.12.5, 5.12.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.8, 7.2.9, 7.2.12, 7.2.13, 7.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>enterotoxins, 17.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.2, 3.18.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inducible clindamycin resistance, 7.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media for, 3.3.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>minimum bactericidal concentration testing, 7.17.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>positive blood culture broth, 5.13.11, 5.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid enzymatic biochemical identification, 4.15.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rapid nitrate and urease tests, 4.15.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>satellite test, 18.15.8.1, 18.15.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serum inhibitory and bactericidal titers, 7.18.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>time-kill assay, 7.17.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.6, 3.12.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Staphylococcus(i)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>coagulase-negative (See Coagulase-negative staphylococci)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vancomycin-resistant, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Staphylococcus aureus, 7.21.3, 7.3.1, 7.3.3, 15.3.5.2, 18.11.118.11.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acridine orange stain, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial stewardship program, 15.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.22.6, 7.1.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disks, 3.17.4.13.17.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.6, 7.22.7, 7.22.8, 7.22.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation of agar and broth media, 7.24.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.4, 7.20.9, 7.20.10, 7.20.12, 7.20.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.2, 7.23.6, 7.23.11, 7.23.12, 7.23.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autopsy blood cultures, 5.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-hemolytic Streptococcus agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.17.7.3, 7.7.57.7.8, 18.15.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bioterrorism, 18.11.118.11.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blepharitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood agar base, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 5.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood products, 15.4.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bordetella cultures, 3.10.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Bordet-Gengou agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>breast milk, 2.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.2, 7.4.1.8, 7.4.1.9, 7.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CAMP factor tests and reverse CAMP test, 3.17.8.13.17.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>case definition, 18.11.418.11.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catalase test, 3.17.10.1, 3.17.10.3, 4.9.4.1, 18.15.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catheter-related bloodstream infection, 5.12.1, 5.12.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. diphtheriae cultures, 3.10.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clusters, 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>coagulase test, 3.17.13.13.17.13.3, 3.17.14.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Columbia agar base, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>conjunctivitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture media, 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cystine lactose electrolyte-deficient agar, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dacryocystitis/dacryoadenitis canaliculitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>destruction, 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.11.318.11.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.4, 7.2.9, 7.2.12, 7.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.13.17.16.2, 3.17.16.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.3, 3.7.1.8, 3.7.1.13, 3.7.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>genital tract, 3.8.1.1, 3.8.1.2, 3.8.1.3, 3.8.1.4, 3.8.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>geographic distribution, 18.11.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3, 3.2.1.6, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>group B streptococcus cultures, 3.8.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hematopoietic stem cell products, 15.4.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>high-level mupirocin resistance, 7.10.17.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hospital water, 15.4.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.3, 3.18.4, 3.18.6, 18.11.918.11.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation and examination of cultures, 18.11.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inducible clindamycin resistance, 7.11.17.11.2, 7.11.77.11.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation, 17.1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>isolates, strain typing, 15.6.4.115.6.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>J</title>
            <indexentry>
               <primaryie>joint fluid, 3.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>keratitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laked blood agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Legionella agars, 16.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mannitol salt agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 18.11.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>meningitis, 3.5.2, 3.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methicillin-resistant (see Methicillin-resistant Staphylococcus aureus (MRSA))</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methicillin (oxacillin)-resistant (See Methicillin-resistant Staphylococcus aureus)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multilocus sequence typing of, 15.6.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multiplex molecular panels, 5.13.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.1, 3.10.9.3, 3.10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nutrient base, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular cultures, 3.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>orbital cellulitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>otitis externa, 3.10.5.13.10.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>otitis media, 3.10.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oxacillin salt-agar test for MRSA, 7.8.17.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packaging and shipping, 18.11.6, 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>penicillin disk diffusion zone edge method for, 7.7.27.7.3, 7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>periorbital (preseptal) cellulitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenylethyl alcohol agar, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>positive blood culture broth, 5.13.11, 5.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive diagnosis, 18.11.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control of antimicrobial susceptibility tests, 7.20.12, 7.20.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Regan-Lowe pertussis agar, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rejection criteria, 18.11.618.11.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting and notification, 18.11.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.13.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.1.2, 3.10.3.13.10.3.4, 3.10.3.2, 3.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.1, 3.10.2.6, 3.10.2.10, 3.10.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.11.518.11.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>satellite test, 3.17.43.13.17.43.2, 18.15.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance, 18.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sensititre SLOWMYCO2 broth microdilution plate MIC, 9.9.2.19.9.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.11.1018.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.11.618.11.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.11.818.11.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>strain typing for epidemiology and infection control, 3.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus selective sheep blood agar, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>therapeutic, 18.11.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>thioglycolate broth, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>throat culture, 3.10.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>time-kill assay, 7.17.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>transfusion reactions, 5.11.1.15.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>treatment, 18.11.4, 18.11.1018.11.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>tryptic soy sheep blood agar, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>types, 18.11.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.3, 3.11.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vancomycin-resistant,-intermediate, and-heteroresistant, 7.9.17.9.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar screen test for vancomycin-resistant enterococci, 7.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial disk tests, 3.17.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 7.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.9.47.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.9.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess and soft tissue cultures, 3.12.1.1, 3.12.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.2, 3.12.1.6, 3.12.1.8, 3.12.1.14, 3.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Staphylococcus aureus chromosomal DNA, 15.6.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcus aureus subsp. anaerobius, 3.17.10.3, 4.15.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcus capitis, 3.17.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcus caprae, 3.18.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcus coagulans, 3.18.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcus cohnii, 3.17.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcus delphini, 3.17.14.1, 3.18.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcus epidermidis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial disk tests, 3.17.4.1, 3.17.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.47.1.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood cultures, 5.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Campylobacter agars, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CHOC medium, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>coagulase test, 3.17.13.1, 3.17.13.2, 3.17.14.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hemolysis patterns, 3.3.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mannitol salt agar, 16.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>New York City agar, 16.2.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>N. gonorrhoeae cultures, 3.8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>positive blood culture broth, 5.13.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>potassium tellurite cystine agar, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>satellite test, 3.17.43.1, 18.15.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcus epidermidis, chromogenic media, 5.10.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcus haemolyticus, 3.18.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcus hyicus, 3.17.14.1, 3.17.14.4, 3.18.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcus intermedius, 3.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial disk tests, 3.17.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>coagulase test, 3.17.13.3, 3.17.14.1, 3.17.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.3, 3.18.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Staphylococcus kloosii, 3.17.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcus lugdunensis, 3.3.2.8, 3.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic bacteria, 5.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-lactamase test, 7.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.23.17.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.3.2.8, 3.18.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>ocular cultures, 3.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.23.17.40.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Staphylococcus lutrae, 3.17.14.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcus pseudintermedius</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.47.1.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Staphylococcus saccharolyticus, 4.15.9, 7.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Staphylococcus saprophyticus, 3.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial disk tests, 3.17.4.1, 3.17.4.3, 3.17.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.47.1.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>coagulase test, 3.17.13.13.17.13.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>coagulase test (protein A/clumping factor agglutination method), 3.17.13.13.17.13.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.3, 3.18.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.3, 3.11.1.10, 3.11.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Staphylococcus schleiferi, 3.3.2.8, 3.17.13.1, 3.17.13.3, 3.17.14.1, 3.17.14.2, 3.17.14.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.47.1.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Staphylococcus xylosus, 3.17.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Stapylococci, oxidase test, 3.17.38.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Starch hydrolysis agar or broth, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Starch hydrolysis test, 3.17.45.13.17.45.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Stark Law, 1.1.4, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>State agencies (SAs), quality control, 7.20.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>State and local Healthcare Associated Infection (HAI)/AR programs, Candida auris, 15.7.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>State and local testing, AR Lab Network, 15.7.1.415.7.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Statistical epidemic modeling, 15.5.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>STD. See Sexually transmitted diseases</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>STEC (Shiga toxin-producing Escherichia coli), 3.7.1.223.7.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Stenotrophomonas</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Stenotrophomonas maltophilia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.20.9, 7.22.12, 7.23.2, 7.23.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.6, 7.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cetrimide agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.23.17.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.8, 7.2.9, 7.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.1, 3.17.16.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hematopoietic stem cell products, 15.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.3, 3.19.8, 3.19.9, 3.19.15, 3.19.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxidative-fermentative medium, 16.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.3.1, 3.10.3.33.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Stephanoascus ciferrii, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Stereoscopic microscope, parasitology, 11.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sterile body fluids, 10.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sterile Expert Compounding Committee (SCC), 15.3.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sterile fluids</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal specimen collection, 10.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>N. gonorrhoeae cultures, 3.8.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sterile-scalpel method of tissue homogenizations, 3.12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sterility testing of CSPs, 15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sterilization</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>equipment, 17.1.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>work areas, 17.1.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>St. Louis encephalitis virus, 18.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Stock bacteriology cultures, 16.2.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Stock mycobacteriology cultures, 16.2.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Stock mycology cultures, 16.2.23, 16.2.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Stock virology cultures, 16.2.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Stone cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.11.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.11.2.23.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.11.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 3.11.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.11.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Stool artifacts, parasite, 11.11.1.111.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Stool culture. See Fecal culture</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Stool specimens. See Fecal specimens</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Storage of stock cultures, 16.2.2316.2.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>STR. See Streptomycin</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Straight catheter, 3.11.1.2, 3.11.1.6, 3.11.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Strain relatedness, 15.6.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Strain typing, 15.6.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>of Staphylococcus aureus isolates, 15.6.4.115.6.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>using next-generation sequencing, 15.6.6.115.6.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Stratum corneum, fungal specimens, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streaking plates for primary isolation, 2.1.39</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>StrepB carrot broth, 3.8.2.2, 3.8.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptobacillus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptobacillus moniliformis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>continuous-monitoring blood culture systems, 5.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious, 5.11.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>postanalytical blood cultures, 5.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Streptocerciasis, 11.11.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcal DNases, 13.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcal impetigo, 13.2.1.113.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcal pharyngitis, 13.2.1.113.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococci</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-hemolytic (See Beta-hemolytic streptococci)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catalase test, 3.17.10.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Group A (See Group A streptococci)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Group B (See Group B streptococci)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Group C, 13.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Group G, 13.2.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.2, 3.17.32.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.1, 3.17.42.33.17.42.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>viridans group (See Viridans group streptococci)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Streptococcus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility test, 7.22.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.20.12, 7.20.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile-esculin and esculin tests, 3.17.5.13.17.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood products, 15.4.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.1, 7.4.1.4, 7.4.1.12, 7.4.1.167.4.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate utilization tests, 3.17.9.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.8, 7.2.13, 7.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram reaction enzymatic test, 3.17.19.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.2, 3.18.4, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>leucine aminopeptidase test, 3.17.25.1, 3.17.25.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media for, 3.3.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>minimum bactericidal concentration testing, 7.17.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid enzymatic biochemical identification, 4.15.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.93.10.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting antimicrobial agents for testing and reporting, 7.23.2, 7.23.3, 7.23.8, 7.23.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serum inhibitory and bactericidal titers, 7.18.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>time-kill assay, 7.17.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Streptococcus(i)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alpha-hemolytic, 3.17.6.1, 15.4.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-hemolytic (See Beta-hemolytic streptococci)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Group A (See Group A streptococci)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Group B (See Group B streptococci)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Group C, 3.18.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Group G, 3.18.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nutritionally variant, 3.17.43.1, 3.17.43.3, 7.17.1.14, 7.17.2.7, 7.18.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>viridans group (See Viridans group streptococci)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Streptococcus agalactiae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood cultures, 5.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CAMP factor tests and reverse CAMP test, 3.17.8.13.17.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital cultures, 3.8.2.13.8.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>Hippurate broth, 16.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hippurate hydrolysis rapid test, 3.17.20.13.17.20.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>meningitis, 3.5.2, 3.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.6, 3.10.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>throat culture, 3.10.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.2, 3.12.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Streptococcus alactolyticus, 3.18.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus anginosus, 3.10.8.1, 3.10.8.5, 3.18.7, 7.23.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>group, 3.10.8.1, 3.10.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>4</title>
            <indexentry>
               <primaryie>4-methylumbelliferone derivative substrates test, 4.9.18.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Streptococcus angiosus, wound, abscess, and soft tissue cultures, 3.12.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus australis, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus beta-hemolytic group, inducible clindamycin resistance, 7.11.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus bovis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile-esculin and esculin tests, 3.17.5.1, 3.17.5.2, 3.17.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cysteine proteose peptone agar, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>heart infusion fermentation base, 16.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.4, 3.18.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pyruvate broth, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.2, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>salt tolerance medium, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>starch hydrolysis agar or broth, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>starch hydrolysis test, 3.17.45.13.17.45.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus canis, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus coli, 3.18.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus constellatus, 3.10.8.1, 3.18.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>4</title>
            <indexentry>
               <primaryie>4-methylumbelliferone derivative substrates test, 4.9.18.14.9.18.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Streptococcus criceti, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus cristatus, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus devriesei, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus downei, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus dysgalactiae, pharyngitis, 3.10.8.1, 3.10.8.53.10.8.6, 3.10.8.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus dysgalactiae subsp. equisimilis, 13.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus equi, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus equinus, 3.18.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus gallolyticus, 3.18.4, 3.18.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Streptococcus gordonii, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus group B selective broth, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus hyovaginalis, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus infantarius, 3.18.4, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus infantis, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus iniae, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus intermedius, 3.18.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>4</title>
            <indexentry>
               <primaryie>4-methylumbelliferone derivative substrates test, 4.9.18.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Streptococcus lactarius, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus lutetiensis, 3.18.4, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus macacae, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus macedonicus, 3.18.4, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus massiliensis, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus mitis, 3.18.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF, 6.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Streptococcus mutans, 3.17.45.2, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus oligofermentans, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus oralis, 3.18.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF, 6.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Streptococcus parasanguinis, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus pasteurianus, 3.18.4, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus pneumoniae, 7.21.27.21.3, 7.3.1, 7.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.67.1.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation of agar and broth media, 7.24.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.6, 7.20.9, 7.20.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selection of agents for testing and reporting, 7.23.2, 7.23.3, 7.23.8, 7.23.11, 7.23.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>AST and serotyping of, 15.7.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autopsy blood cultures, 5.11.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-hemolytic Streptococcus agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bile solubility test, 3.17.6.13.17.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood agar base, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood culture broth, 6.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 5.6.7, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.1, 7.4.1.4, 7.4.1.8, 7.4.1.9, 7.4.1.12, 7.4.1.14, 7.4.1.167.4.1.17, 7.4.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Columbia agar base, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>conjunctivitis, 3.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dacryocystitis/dacryoadenitis canaliculitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.4, 7.2.5, 7.2.8, 7.2.12, 7.2.13, 7.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital culture, 3.8.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gradient diffusion tests, 7.5.2, 7.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>heart infusion fermentation base, 16.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hemolysis patterns, 3.3.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation, 3.3.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inducible clindamycin resistance, 7.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>keratitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF, 6.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>meningitis, 3.5.2, 3.5.53.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>minimum bactericidal concentration testing, 7.17.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.1, 3.10.9.33.10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>optochin susceptibility test, 3.17.37.13.17.37.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>orbital cellulitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>otitis media, 3.10.5.13.10.5.2, 3.10.5.43.10.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>periorbital (preseptal) cellulitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenylethyl alcohol agar, 16.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>Quellung reaction, 3.17.41.13.17.41.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.13.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cystic fibrosis, 3.10.1.2, 3.10.3.1, 3.10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.1, 3.10.2.53.10.2.7, 3.10.2.10, 3.10.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serum inhibitory and bactericidal titers, 7.18.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus selective sheep blood agar, 16.2.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance, 15.5.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>throat culture, 3.10.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>time-kill assay, 7.17.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>tryptic soy sheep blood agar, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vaginalis agar, 16.2.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>vs. Y. pestis, 18.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Streptococcus pseudopneumoniae, 3.18.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Streptococcus pyogenes</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial disk tests, 3.17.4.1, 3.17.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>beta-hemolytic Streptococcus agar, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bile-esculin and esculin tests, 3.17.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood agar base, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>blood cultures, 5.6.7, 16.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CAMP factor tests and reverse CAMP test, 3.17.8.3, 3.17.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>catalase test, 4.9.4.1, 18.15.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. diphtheriae cultures, 3.10.7.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Columbia agar base, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>conjunctivitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture of human cadaveric tissues for transplantation, 15.4.6.2, 15.4.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cysteine proteose peptone agar, 16.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>esculin medium, 16.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital infections, 3.8.1.2, 3.8.1.3, 3.8.1.4, 3.8.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hemolysis patterns, 3.3.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hippurate broth, 16.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hippurate hydrolysis rapid test, 3.17.20.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inoculation, 17.1.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.1, 3.10.9.33.10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nosocomial outbreaks, 15.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>orbital cellulitis, 3.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>otitis externa, 3.10.5.13.10.5.2, 3.10.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>otitis media, 3.10.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>periorbital (preseptal) cellulitis, 3.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenylethyl alcohol agar, 16.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>PYR (L-Pyrrolidonyl--naphthylamide), 3.17.40.13.17.40.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.13.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serologic diagnosis, 13.2.1.113.2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus selective sheep blood agar, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>throat culture and nonculture tests for pharyngitis, 3.10.8.1, 3.10.8.43.10.8.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Todd-Hewitt broth, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>transport media, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>tryptic soy sheep blood agar, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.2, 3.12.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Streptococcus ratti, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus salivarius, 3.17.45.2, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus sanguinis, 3.17.15.3, 3.17.44.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus selective medium, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus sinensis, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus sobrinus, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus suis, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus tigurinus, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus vestibularis, 3.17.32.4, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptococcus zooepidemicus, 3.18.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>streptodornase, 13.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptogramins, 7.23.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptolysin O, 13.2.1.113.2.1.3, 13.2.2.113.2.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptomyces, 8.1.1, 8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast stain, 16.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 8.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation of growth, 8.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lysozyme test, 8.3.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characterization, 8.3.1, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1, 8.2.78.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>susceptibility testing, 8.5.1, 8.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptomycin (STR), 9.9.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar proportion method, 9.8.29.8.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.20.14, 7.23.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BACTEC MGIT SIRE kit, 9.7.1.1, 9.7.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-level aminoglycoside resistance (HLAR) in Enterococcus, 7.12.17.12.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>high-level resistance in Enterococcus, 7.12.17.12.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slowly growing nontuberculous mycobacteria, 9.9.2.1, 9.9.2.3, 9.9.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptomycineae, 8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Streptosporangineae, 8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Strongyloides</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hyperinfection syndrome, 3.5.7, 11.5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sputum expectorated, 11.7.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Strongyloides stercoralis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar plate culture for larvae, 11.5.4.111.5.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>agar plates culture for, 11.5.4.111.5.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct smears, 11.3.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>duodenal aspirate, 11.6.4.111.6.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>expectorated sputum, 11.7.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formalin-ethyl acetate sedimentation, 11.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>macroscopic examination, 11.3.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.1615.7.7.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rhabditiform larva identification versus plant root hair, 11.11.3.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen handling, 11.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sputum expectorated, 11.7.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Strongyloidiasis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diagnosis, 11.5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.1615.7.7.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Stuart transport medium, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Subcutaneous fungi from normally sterile sites, 10.10.3510.10.36</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Subcutaneous granules, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Subcutaneous mycoses, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Subcutaneous tissue, fungal specimens, 10.4.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Subcutaneous transmission, biohazards, 17.1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Subpassage, stock cell cultures, 12.7.912.7.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Substrate arthroconidia, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Substrate decomposition, 8.3.58.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sucrose, 16.2.7, 16.2.9, 16.2.10, 16.2.12, 16.2.13, 16.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sulfisoxazole, broth microdilution MIC test, 7.4.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sulfonamides</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.20.4, 7.20.12, 7.20.14, 7.23.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.10, 7.4.1.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sump drain, 3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Superficial mycoses, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Supplemental components, 12.8.112.8.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Supplemental media, anaerobes, 4.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Suprapubic needle aspiration, 3.11.1.2, 3.11.1.5, 3.11.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Suprax (cefixime), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sure Check HIV 1/2 assay, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Surface Air System (SAS), 15.3.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Surface sampling, 15.3.2.115.3.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Surface testing. See Environmental surface testing</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Surgical wounds, 3.12.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Surveillance</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Active Bacterial Core (ABC), 15.5.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>syndromic, 15.5.4.615.5.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Surveillance cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida auris, 15.7.5.115.7.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunocompromised hosts, 15.7.6.115.7.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methicillin-resistant Staphylococcus aureus, 15.7.2.115.7.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multidrug-resistant Acinetobacter baumannii, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multidrug-resistant Enterobacterales, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multidrug-resistant Pseudomonas aeruginosa, 15.7.4.115.7.4.8, 15.7.4.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vancomycin-resistant enterococci, 15.7.3.115.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Surveillance specimens, outbreak investigation, 15.5.1.115.5.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Surveillance systems, 15.2.115.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>National Electronic Disease Surveillance System (NEDSS), 15.5.4.215.5.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>National Notifiable Diseases Surveillance System (NNDSS), 15.5.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>novel, 15.5.4.715.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplementary, 15.5.4.615.5.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Surveillance testing, molecular diagnostics, 14.2.2.514.2.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Susceptibility testing. See Antifungal susceptibility testing; Antimicrobial susceptibility testing; Antimycobacterial susceptibility testing</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Suspicious specimens and substances, 17.5.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sutterella, 4.13.2, 4.13.8, 4.13.9, 4.13.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sutterella wadsworthensis, 4.13.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile test, 4.13.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate and urease tests, 4.13.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Suttonella, 3.19.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Suttonella indologenes, 3.19.11, 3.19.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Swab-rinse sampling method, 15.4.4.6, 15.4.4.815.4.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Swab specimens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.3.1, 4.3.2, 4.3.3, 4.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing, 3.3.1.53.3.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 2.1.252.1.26</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection and transport, 2.1.12.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Swine influenza, 12.1.11, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Swine vesicular disease virus, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Swipe test, 14.2.2.514.2.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sympodial proliferation, 10.10.4, 10.10.46</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Syncephalastrum racemosum, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Syndromic panel</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 14.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.4.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 14.4.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.4.2.114.4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.4.2.6, 14.4.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 14.4.2.614.4.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 14.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.4.2.414.4.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Syndromic surveillance, 15.5.4.615.5.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Synercid (quinupristin-dalfopristin), 7.23.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Synergism</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth macrodilution method, 7.19.17.19.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inoculation and incubation, 7.19.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.19.107.19.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.19.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparing broth macrodilution limited checkerboard, 7.19.67.19.7, 7.19.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>preparing inoculum, 7.19.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 7.19.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.19.67.19.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.19.97.19.10, 7.19.207.19.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.19.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reading MICs, 7.19.8, 7.19.18, 7.19.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 7.19.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.19.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution checkerboard method, 7.19.17.19.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calculations, 7.19.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examples of reported combination interactions, 7.19.1, 7.19.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inoculation and incubation, 7.19.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.19.107.19.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.19.17.19.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparing checkerboard microdilution panels, 7.19.27.19.3, 7.19.13, 7.19.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>preparing inoculum, 7.19.37.19.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 7.19.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.19.27.19.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.19.97.19.10, 7.19.20, 7.19.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.19.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reading MICs, 7.19.4, 7.19.8, 7.19.15, 7.19.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 7.19.57.19.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.19.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk agar diffusion methods, 7.19.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>planning studies, 7.19.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>time-kill assay, 7.17.3.17.17.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Synnema, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Synovial fluid, fungal specimens, 10.4.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Syphilis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>adverse sequelae, 13.5.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>automated nontreponemal rapid plasma reagin (RPR) tests, 13.5.4.113.5.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>automated treponemal tests, 13.5.7.113.5.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>chemiluminescence immunoassays (CIAs), 13.5.7.113.5.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microbead immunoassay (MBIA), 13.5.7.113.5.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical syndromes, 3.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical testing algorithm, 13.5.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>congenital, 13.5.1.1, 13.5.1.713.5.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CSF-VDRL test</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specificity and sensitivity, 13.5.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dark-field microscopy, 3.8.1.2, 13.5.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>darkfield (DF) microscopy for Treponema pallidum, 3.2.5.13.2.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>direct fluorescent antibody staining, 13.5.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor screening, 15.7.7.315.7.7.4, 15.7.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunohistochemical staining, 13.5.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>INNO-LIA Syphilis Score, 13.5.1.3, 13.5.8.113.5.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>latent, 13.5.1.1, 13.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>manufacturers of test kits and reagents, 13.5.1.1, 13.5.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>neuro-, 13.5.1.1, 13.5.1.2, 13.5.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nontreponemal tests, 13.5.1.113.5.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 13.5.1.113.5.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>primary, 13.5.1.1, 13.5.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>public health reporting, 15.5.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid plasma reagin (RPR) test, 13.5.3.113.5.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reverse-sequence testing algorithm, 13.5.1.4, 13.5.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>secondary, 13.5.1.1, 13.5.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serologic testing, 13.5.1.1, 13.5.1.2, 13.5.1.413.5.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stages, 13.5.1.1, 13.5.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tertiary, 13.5.1.1, 13.5.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>treponemal tests, 13.5.1.1, 13.5.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Treponema pallidum particle agglutination test (TP-PA), 13.5.5.113.5.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trep-Sure enzyme immunoassay, 13.5.6.113.5.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Venereal Disease Research Laboratory (VDRL) tests, 13.5.2.113.5.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.5.2.513.5.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.5.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.5.2.113.5.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.5.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.5.2.213.5.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.5.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 13.5.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test procedure for CSF (VDRL-CSF), 13.5.2.413.5.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>test procedure for serum, 13.5.2.213.5.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Syringes, safety, 17.1.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Systematic errors, 16.2.28</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Systemic mycoses, 2.1.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>T</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Taenia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.2, 11.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>egg identification versus pollen grain, 11.11.3.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>eggs, 11.5.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.111.10.2, 11.10.411.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>India ink injection of proglottids, 11.10.2, 11.10.411.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>scolex, 11.5.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Taenia asiatica, gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Taenia saginata, 11.3.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gross examination, 11.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recovery of scolices and proglottids, 11.5.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>scolex, 11.5.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Taenia solium</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>eggs, 11.5.6.211.5.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>gross examination, 11.10.1, 11.10.3, 11.10.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>proglottid, 11.5.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recovery of scolices and proglottids, 11.5.6.211.5.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen handling, 11.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Taenia suihominis, gross examination, 11.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ta Forest virus, 18.12.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Talaromyces</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold phase characteristics, 10.10.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Talaromyces funiculosus, mold phase characteristics, 10.10.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Talaromyces marneffei</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood films, 11.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>buffy coat concentration, 11.8.9.1, 11.8.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conversion, 10.10.10, 10.10.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>filamentous fungi, 6.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mold phase characteristics, 10.10.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>particulate phase, 10.10.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sabouraud agar, 10.10.51</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>slide cultures, 10.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Talaromyces minioluteus, mold phase characteristics, 10.10.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Talaromyces purpureogenus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>conversion, 10.10.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold phase characteristics, 10.10.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tanabox (TPV), 18.8.1, 18.8.4, 18.8.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tannerella forsythensis, 4.13.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tannerella forsythia, 4.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemicals of, 4.13.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Tapeworms. See also Cestodes</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recovery of scolices and proglottids, 11.5.6.111.5.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Tap water agar, 10.10.7, 10.10.50</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Taralomyces marneffei, Giemsa stain, 11.8.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Target amplification, high-risk human papillomaviruses, 14.3.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Target capture, high-risk human papillomaviruses, 14.3.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Targeted metagenomic sequencing. see Deep amplicon sequencing</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Targocid (teicoplanin), 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Taxonomy</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal, 10.2.110.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>of fungi, 10.2.110.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph versus teleomorph, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>classification, 10.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cryptic species and species complexes, 10.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incorporation of taxonomic changes, 10.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>name changes, 10.2.110.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>significance of species identification, 10.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>updates for anaerobes, 4.2.14.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Tazicef. See Ceftazidime</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tazidime. See Ceftazidime</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TB. See Tuberculosis</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TB Kinyoun stain, 10.9.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TBO (toluidine blue O) agar, 3.17.16.13.17.16.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>T. B. Q. (tuberculoidal) disinfectant, 17.1.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TCBS (thiosulfate-citrate-bile salts-sucrose) agar, 3.7.1.6, 3.7.1.8, 3.7.1.13, 3.7.1.15, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tdap (tetanus-diphtheria-acellular pertussis) vaccine, laboratory personnel, 15.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Td (tetanus and diphtheria) vaccine, 15.8.1.1, 15.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Teased preparations</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.7.3.211.7.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitology, 11.7.3.111.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Tease mount, 10.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tech agar, 3.17.17.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Technical Instructions for the Safe Transportation of Dangerous Goods by Air, 17.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tedizolid (Sivextro), 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tedizolid, broth microdilution MIC test, 7.4.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Teeth, specimen collection from, 2.1.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Teflaro (ceftaroline), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Teicoplanin (Targocid), 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Telavancin (Vibativ), 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Teleomorph, 10.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Teleomorphs, 10.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Telephone</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decontamination, 17.1.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report, 16.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Tellurite reduction</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>medium, performance standards, 16.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mycobacteria, 9.5.1.29.5.1.4, 9.5.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Temperature tolerance tests, 10.10.810.10.9, 10.10.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tenckhoff catheter, 3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Terbinafine, 10.12.1.2, 10.12.1.4, 10.12.1.7, 10.12.1.910.12.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Terminal chlamydospores, 10.10.21, 10.10.48</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Terminology, 1.1.51.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Terrisporobacter glycolicus, 4.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Testicular abscess, 3.8.1.63.8.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Test(s), indications for restricting, 16.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Test reports, 11.11.7.111.11.7.5, 16.6.2, 16.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Test system information, 16.5.4, 16.5.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Test utilization monitoring and evaluation, 1.2.4.5, 16.1.13, 16.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tetanus and diphtheria (Td) vaccine, 15.8.1.1, 15.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tetanus-diphtheria-acellular pertussis (Tdap) vaccine, laboratory personnel, 15.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tetracyclines</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.20.14, 7.23.3, 7.23.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.8, 7.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxacillin salt-agar test, 7.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Tetragenococcus, 3.18.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tetramethylrhodamine isothiocyanate (TMRITC), 12.9.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Thallic, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Thayer-Martin (TM) agar, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Thayer-Martin media, 3.3.1.3, 3.3.1.7, 3.3.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Thermoactinomyces</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Thermo Fisher Scientific VersaTREK Myco bottle, 5.5.15.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Thermonuclease test, rapid, 3.17.16.13.17.16.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Thick blood films</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>combination thick and thin films, 11.8.4.111.8.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Delafields hematoxylin stain, 11.8.8.111.8.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>determination of parasitemia, 11.8.7.111.8.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Thick blood films, parasites, 11.8.1.111.8.1.5, 11.8.3.111.8.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Thin blood films</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>combination thick and thin films, 11.8.4.111.8.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Delafields hematoxylin stain, 11.8.8.111.8.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>determination of parasitemia, 11.8.7.111.8.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.8.1.111.8.1.5, 11.8.2.111.8.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Thin-smear preparation, Gram stain, 3.2.1.83.2.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Thioglycolate (THIO)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic culture, 3.3.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth, 4.4.1.14.4.1.2, 4.4.1.5, 4.4.1.9, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobes, 4.11.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enriched, 4.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>without indicator, 4.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>enriched, 7.6.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>media, ocular cultures, 3.9.1, 3.9.33.9.4, 3.9.63.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation, 7.4.2.87.4.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Thiophene-2-carboxylic acid hydrazide (TCH)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria, 9.5.1.29.5.1.4, 9.5.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>susceptibility medium, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Thiosulfate-citrate-bile salts-sucrose (TCBS) agar, 3.7.1.6, 3.7.1.8, 3.7.1.13, 3.7.1.15, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Threshold(s), 16.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Throat culture for pharyngitis, 3.10.8.13.10.8.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Throat, specimen collection, 2.1.23</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Thrombophlebitis, septic pelvic, 3.8.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Thymidine</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.20.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Thyroiditis, potential etiological agents, 2.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ticarcillin-clavulanic acid, 7.20.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tick-borne encephalitis, flaviviruses, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tick-borne encephalitis virus (TBEV), 18.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ticks, gross examination, 11.10.1, 11.10.4, 11.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tigecycline, 9.9.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Time-kill assay, 7.17.2.17.17.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>final concentrations to test, 7.17.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inoculation and incubation, 7.17.2.4, 7.17.2.87.17.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculum preparation, 7.17.2.3, 7.17.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.17.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.17.2.17.17.2.2, 7.17.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation of antimicrobial agent working concentrations, 7.17.2.27.17.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 7.17.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.17.2.27.17.2.4, 7.17.2.87.17.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 7.17.2.57.17.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.17.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reading and recording results, 7.17.2.4, 7.17.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 7.17.2.5, 7.17.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.17.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergy, 7.17.3.17.17.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>worksheet, 7.17.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Tinea nigra, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tissierella praeacuta, 4.13.5, 4.13.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tissue banks, culture of human cadaveric tissues for transplantation, 15.4.6.115.4.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tissue culture, Acanthamoeba or Naegleria culture, 11.9.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tissue, direct detection, 12.9.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tissue handling and processing, Creutzfeldt-Jakob disease, 17.5.5.117.5.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tissue-homogenizing apparatus, 3.12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tissues/biopsies, 10.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tissue sections, Gram stain, 3.2.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tissue specimens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anaerobic culture, 2.1.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>autopsy material, 2.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal, 10.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>skin, 2.1.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>TMA (transcription-mediated amplification), 14.3.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TM (Thayer-Martin) agar, modified, 16.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TME (transmissible spongiform encephalopathy), 17.5.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TMRITC (Tetramethylrhodamine isothiocyanate), 12.9.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tobies medium, Evans modified, 11.9.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tobramycin (Nebcin, Tobrex)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.7, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-level aminoglycoside resistance (HLAR) in Enterococcus, 7.12.17.12.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>high-level resistance in Enterococcus, 7.12.17.12.3, 7.12.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>M. peregrinum, 9.9.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapidly growing mycobacteria, 9.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Todd, E. W., 13.2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Todd-Hewitt broth, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Toenails and fingernails, 10.10.4010.10.43</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Togaviridae, eastern equine encephalitis virus, 18.13.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tolerance, minimum bactericidal concentration testing, 7.17.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Toluidine blue O (TBO) agar, 3.17.16.13.17.16.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Torulopsis, intrauterine devive (IUD), 2.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Total bacterial count of water sample, determination of, 16.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TOTAL-FIX, 11.2.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Total organic content (TOC), laboratory water, 16.3.116.3.2, 16.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Total parenteral nutritions (TPNs), 15.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Touch preparation, 3.2.1.8, 3.2.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Toxic shock syndrome (TSS), 3.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Toxic shock syndrome toxin 1 (TSST-1), 18.11.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Toxin(s), response to potential exposures, 15.8.3.4, 15.8.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Toxocara, 11.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Toxocara canis, 11.11.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Toxocara cati, 11.11.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Toxoplasma, 18.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.315.7.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>IgA antibodies by ELISA detection (Remington method)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 13.16.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.4.113.16.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.16.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.16.4.313.16.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.4.213.16.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 13.16.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.16.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>IgE antibodies by ELISA detection (Remington method)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 13.16.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.16.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.16.5.213.16.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 13.16.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.16.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>IgM antibodies detection ELISA detection (Remington method), 13.16.2.113.16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high background, 13.16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.16.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.16.2.213.16.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection considerations, 13.16.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Toxoplasma gondii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.1, 11.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.411.7.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.2, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical needs for, 13.16.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>IgG and IgM test, 13.16.1.113.16.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>IgG antibodies, dye test</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 13.16.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.16.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.16.1.613.16.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.16.1.813.16.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.1.713.16.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quantitation of stained organisms, 13.16.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagent preparation, 13.16.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 13.16.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection considerations, 13.16.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>NAAT, 3.9.1, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serologic testing performed at local/regional laboratories</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunocompetent patient with clinical signs, 13.16.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>in immunocompromised patients, 13.16.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.16.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>in pregnant women, 13.16.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>procedure, 13.16.1.413.16.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>types of assays, 13.16.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection considerations, 13.16.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>in United States, 13.16.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vidas Toxo IgG avidity assay, 13.16.6.113.16.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Toxoplasma IgM antibodies detection, ISAGA</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.16.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.16.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.16.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.3.113.16.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>results and interpretation, 13.16.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection considerations, 13.16.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Toxoplasmosis, 11.11.2.10. see also Toxoplasma gondii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>TPHA (Treponema pallidum hemagglutination) test, 13.5.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TP-PA (Treponema pallidum particle agglutination test), 13.5.5.113.5.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tracheal aspirate, 2.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trachipleistophora</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical findings in healthy and compromised hosts, 11.11.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Training, compliance, 1.2.4.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Transfusion reaction, blood cultures, 5.11.1.15.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 5.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 5.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 5.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 5.11.1.15.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 5.11.1.25.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 5.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 5.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, 5.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Transfusion-transmitted bacterial infection (TTBI), 5.11.1.15.11.1.4, 15.4.5.115.4.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Transmissible spongiform encephalopathy (TME), 17.5.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Transmittals, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Transplantation</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture of human cadaveric tissues, 15.4.6.115.4.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>infection surveillance prior to, 15.7.7.115.7.7.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.315.7.7.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>general approach, 15.7.7.115.7.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>overview, 15.7.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.1415.7.7.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Transplant recipients, cytomegalovirus (CMV), 13.9.1.113.9.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Transport media, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Transtracheal aspirate, 2.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trauma-associated wounds, 2.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trehalose, 16.2.7, 16.2.10, 16.2.13, 16.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trehalose assimilation test, rapid presumptive identification test of yeasts, 10.7.210.7.4, 10.7.810.7.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TREK Sensititre plate, nontuberculous mycobacteria, rapid growing, 9.9.1.19.9.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trematodes</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.2, 11.10.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trench fever, 2.1.28</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Treponema denticola, 3.2.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Treponemal tests, 13.5.1.1, 13.5.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Treponema pallidum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>automated treponemal tests, 13.5.7.113.5.7.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical syndromes, 3.8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dark field microscopy, 2.1.22, 3.2.5.13.2.5.3, 3.8.1.6, 13.5.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor screening, 15.7.7.4, 15.7.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>FITC-labeled monoclonal antibody, 13.5.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>INNO-LIA syphilis score, 13.5.1.3, 13.5.8.113.5.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.22, 3.8.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Treponema pallidum particle agglutination test (TP-PA), 13.5.5.113.5.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trep-Sure enzyme immunoassay, 13.5.6.113.5.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Treponema pallidum hemagglutination (TPHA) test, 13.5.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Treponema pallidum particle agglutination test (TP-PA), 13.5.5.113.5.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Treponema pallidum subsp. endemicum, 3.2.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Treponema pallidum subsp. pallidum, 3.2.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Treponema pallidum subsp. pertenue, 3.2.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trep-Sure enzyme immunoassay, 13.5.6.113.5.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Triage list, 2.1.4, 2.1.38</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichinella</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.1, 11.7.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>squash preparations for, 11.7.3.1, 11.7.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichinella spiralis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens, 11.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichoderma, normally sterile sites, 10.10.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichomonas, 3.8.1.2, 3.8.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, vagina, 2.1.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichomonascus ciferrii, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichomonas vaginalis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>body sites, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 11.9.2.111.9.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 11.9.2.111.9.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 11.9.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 11.9.2.211.9.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 11.9.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>results, 11.9.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid amplification tests (NAATs), 11.6.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained smear (Giemsa), 11.6.6.111.6.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stool artifacts, 11.11.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urethritis, 3.8.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urine concentration, 11.6.7.111.6.7.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urine culture, 3.11.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urogenital specimens, direct saline mount, 11.6.5.111.6.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wet mount, 3.2.3.13.2.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichomoniasis, 3.8.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichophyton</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>growth factor tests, 10.10.2010.10.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.12, 10.4.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.1910.10.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton agars, 10.10.7, 10.10.20, 10.10.2210.10.23, 10.10.25, 10.10.2710.10.28, 10.10.32, 10.10.5210.10.53, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichophyton ajelloi</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BCP milk glucose test, 10.10.29</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton concentricum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>growth factor tests, 10.10.21, 10.10.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.25</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton equinum, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>growth factor tests, 10.10.21, 10.10.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair perforation test, 10.10.3010.10.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.25</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton equinum var. autotrophicum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair perforation test, 10.10.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.31, 10.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton erinacei</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.25</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton gloriae, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichophyton interdigitale</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological characteristics, 10.10.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.26</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton krajdenii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.26</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton megninii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cornmeal glucose agar, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.25</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton mentagrophytes</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, broth dilution, 10.12.1.7, 10.12.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BCP agar, 10.10.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BHI medium, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Christensens urea agar, 10.10.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dermatophyte test, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungus selection agar, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair perforation test, 10.10.11, 10.10.3010.10.31</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>helical seta (spiral appendage), 10.10.48</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.31, 10.10.3310.10.34</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation temperature, 10.8.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inhibitory mold agar, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological characteristics, 10.10.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.5, 10.10.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.2510.10.26</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>potato dextrose agar, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sabouraud medium, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichophyton agar, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urea dextrose agar, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urease test, 10.10.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton mentagrophytes var. erinacei, 10.10.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichophyton piceus, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichophyton raubitschekii</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.3210.10.33</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.26</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton rubrum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, broth dilution, 10.12.1.2, 10.12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BCP agar, 10.10.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>BCP milk glucose test, 10.10.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Christensens urea agar, 10.10.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cornmeal agar, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cornmeal glucose agar, 10.10.11, 10.10.2910.10.30, 10.10.54</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decontamination, 10.10.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>growth factor tests, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair perforation test, 10.10.11, 10.10.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>hyphae, 10.10.48</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.3110.10.33</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.25, 10.10.26</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>potato flake agar, 10.10.49</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>processing specimens for culture, 10.5.810.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Sabouraud dermatophyte decontamination broth, 10.10.54</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urea dextrose agar, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>urease test, 10.10.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton schoenleinii, 10.4.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>growth factor tests, 10.10.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hyphae, 10.10.48</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.31</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton simii, 10.10.27</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichophyton soudanense, 10.4.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BCP milk glucose test, 10.10.29</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cornmeal glucose agar, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.23, 10.10.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reflexive branching, 10.10.48</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton terrestre</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cornmeal glucose agar, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potato flake agar, 10.10.49</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichophyton tonsurans, 10.3.11, 10.4.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BCP milk glucose test, 10.10.29</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair perforation test, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.31, 10.10.3310.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pedicels, 10.10.48</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>temperature tests, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichophyton agar, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichophyton verrucosum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BCP milk glucose test, 10.10.29</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>growth factor tests, 10.10.2010.10.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hair perforation test, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification on primary media, 10.8.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>identification scheme, 10.10.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation temperature, 10.8.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>mold identification on primary culture, 10.8.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichophyton verruculosus, 10.10.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichophyton violaceum, 10.3.11, 10.4.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>BCP milk glucose test, 10.10.29</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cornmeal glucose agar, 10.10.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification scheme, 10.10.32</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphological structures, 10.10.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>phenotypic identification characteristics, 10.10.28</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichosporon</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics of selected species, 10.9.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.3, 10.6.4, 10.6.6, 10.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>micromorphology, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>microscopic examination, 10.4.1.11, 10.4.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>morphology on cornmeal agar, 10.9.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic identification, 10.10.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive identification, 10.7.2, 10.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>supplement tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichosporon ashahii, 10.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichosporon asteroides, 10.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichosporon capitatum, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichosporon cutaneum, 10.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichosporon inkin, 10.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichosporon loubieri, 10.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichosporon mucoides, 10.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichosporon mycotoxinivorans, 10.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichosporon ovoides, 10.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichosporon pullulans, 10.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trichostrongylus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar plate culture, 11.5.4.1, 11.5.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>Strongyloides differentiated from, 11.5.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichrome stain</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast modified, coccidia and microsporidia, 11.4.5.111.4.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens for parasites, 11.7.2.111.7.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biopsy specimens for parasitology, 11.7.3.211.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified trichrome-Weber green, 11.4.3.111.4.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained fecal smear for parasites, 11.3.5.111.3.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 16.2.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipe, 11.3.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichuris</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formalin-ethyl acetate sedimentation, 11.3.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trichuris trichiura, 11.1.21, 11.4.7.3, 11.11.2.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autofluorescence, 11.4.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>egg identification versus pollen grain, 11.11.3.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formalin-ethyl acetate sedimentation, 11.3.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gross examination, 11.10.1, 11.10.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zinc sulfate flotation, 11.3.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trimethoprim (Proloprim, Trimpex)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.20.4, 7.20.12, 7.20.14, 7.23.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trimethoprim-sulfamethoxazole (Bactrim, Septra)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.4, 7.20.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.4, 7.23.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.6, 7.4.1.7, 7.4.1.9, 7.4.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of antimicrobial susceptibility test systems, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>M. peregrinum, 9.9.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oxacillin salt-agar test, 7.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapidly growing mycobacteria, 9.9.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>slowly growing nontuberculous mycobacteria, 9.9.2.1, 9.9.2.3, 9.9.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trimpex. See Trimethoprim</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Triose phosphate isomerase, 15.6.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Triphenyltetrazolium chloride (TTC), 3.17.30.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Triple sugar iron agar (TSI), 3.17.9.1, 3.17.24.13.17.24.4, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tropheryma whipplei, 2.1.30</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trophozoites, 11.11.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>Acanthamoeba and Naegleria culture, 11.9.1.211.9.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>artifacts mimicking, 11.11.1.111.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct smears, 11.3.2.111.3.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>formalin-ethyl acetate sedimentation, 11.3.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>iron hematoxylin stain (modified Spencer-Monroe method), 11.3.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>permanent stained smear (trichrome), 11.3.5.111.3.5.2, 11.3.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>in sigmoidoscopy specimen (permanent stained smear), 11.6.3.111.6.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy specimen permanent stained smear, 11.6.3.111.6.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urogenital specimens, direct saline mount, 11.6.5.311.6.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zinc sulfate flotation, 11.3.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trueperella bernardiae, 3.18.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trueperella pyogenes</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>hippurate hydrolysis rapid test, 3.17.20.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lecithinase and lipase detection, 3.17.26.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>TRUST kits, 13.5.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trypanosoma</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood films, 11.8.1.1, 11.8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>STAT testing, 11.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trypanosoma brucei gambiense</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 11.8.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trypanosoma brucei rhodesiense</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trypanosoma cruzi</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aspirates and bronchoscopy specimens, 11.7.2.1, 11.7.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood films, 11.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body sites, 11.11.2.2, 11.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>buffy coat concentration, 11.8.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cross-reactivity of anti-Leishmania antibodies, 13.15.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture, 11.9.3.111.9.3.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.5, 15.7.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 11.8.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serologic diagnosis, 13.15.113.15.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acute and chronic phases, 13.15.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CDC reference laboratory testing, 13.15.313.15.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ELISAs, 13.15.513.15.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>epidemiological and clinical indications for, 13.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>FDA-cleared assays for, 13.15.2, 13.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>LFA, 13.15.613.15.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and reagents, 13.15.413.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phase and context diagnosis, 13.15.213.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection and considerations, 13.15.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serologic diagnosis of Chagas disease, 13.15.113.15.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>ELISA, 13.15.213.15.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>epidemiological and clinical indications for testing, 13.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>FDA-cleared assays for anti-T. cruzi antibody detection, 13.15.213.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunoblot, 13.15.313.15.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>indirect immunofluorescence assays (IFA), 13.15.313.15.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lateral flow assay (LFA), 13.15.213.15.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials and reagents, 13.15.413.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.15.113.15.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.15.413.15.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recommended testing by phase and context, 13.15.213.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results reporting and interpretation, 13.15.513.15.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.15.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>types of assays, 13.15.313.15.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>stain recommendation, 11.11.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trypanosomes</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood films, 11.8.1.1, 11.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>buffy coat concentration, 11.8.9.111.8.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>capillary blood tube centrifugation for parasite detection, 11.8.9.311.8.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>characteristics, 11.11.2.1911.11.2.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Trypsin-EDTA (Versene), 12.7.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trypsinization, 12.7.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Trypticase-peptone-glucose-yeast extract broth with trypsin (TPGYT), 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tryptic soy agar (TSA), 4.4.1.3, 4.4.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tryptic soy blood agar, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tryptic soy broth (TSB)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobic culture, 3.3.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobes, 4.11.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Tryptic soy phenylethyl alcohol, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tryptic soy sheep blood agar plate, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tryptone medium, 16.2.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tryptophanase, 3.17.22.1. See Indole test</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tryptose-sulfite-cycloserine agar with polymyxin and kanamycin, 4.4.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TSI (triple sugar iron agar), 3.17.9.1, 3.17.24.13.17.24.4, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TSS (toxic shock syndrome), 3.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TST (tuberculin skin test), laboratory exposure, 15.8.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tsukamurella, 8.1.2, 8.3.9, 8.5.1, 8.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decomposition of substrates, 8.3.5, 8.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 8.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation of growth, 8.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lysozyme test, 8.3.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.3, 8.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1, 8.2.78.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Tsukamurella inchonensis, 8.3.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified Kinyoun stain, 8.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characterization, 8.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Tsukamurella paurometabola, 8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tsukamurella pulmonis, 8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tsukamurella strandjordii, 8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tsukamurella tyrosinosolvens, 8.3.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TTBIs (transfusion-transmitted bacterial infections), 15.4.5.115.4.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>TTC (triphenyltetrazolium chloride), 3.17.30.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>T-tube, 3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tube agglutination test (TAT), 13.3.813.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tuberculin skin test (TST)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor/recipient screening, 15.7.7.4, 15.7.7.715.7.7.8, 15.7.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Tuberculoidal (T. B. Q.) disinfectant, 17.1.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tuberculosis (TB), 9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>autopsy material, 2.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biosafety considerations, 9.6.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bone marrow, 2.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.4, 15.7.7.715.7.7.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>latent TB infection (LTB1), 15.7.7.715.7.7.8, 15.7.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>public health reporting, 15.5.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Tube(s), safety, 17.1.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tularemia, 2.1.29, 18.6.118.6.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility, 18.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.1.2, 18.6.118.6.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>case definition, 18.6.218.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clinical summary, 18.14.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>definition, 13.4.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>destruction, 18.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of cultures, 18.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>geographic distribution, 18.6.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>glandular, 18.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 18.6.618.6.7, 18.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation period, 18.6.2, 18.6.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>intestinal, 18.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 18.6.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.6.318.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>oculoglandular, 18.6.2, 18.14.2018.14.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>oropharyngeal, 18.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 17.6.1, 17.6.3, 18.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pneumonic, 18.6.3, 18.14.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive diagnosis, 18.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.6.118.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting, notification, and transfer, 18.6.718.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.2.5, 18.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance, 18.6.918.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sentinel Level Clinical Microbiology Laboratory Guidelines, 18.14.5, 18.14.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>serologic tests for, 13.4.1.113.4.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.6.918.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.6.418.6.5, 18.14.2018.14.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.6.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 18.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>typhoidal, 18.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>ulceroglandular, 18.6.2, 18.14.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>Turbidimetric technique, 15.3.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Turbidity, Mc Farland standards, 7.24.1.17.24.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Turicella otitidis, 3.17.8.4, 3.18.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Turicibacter sanguinis, 4.14.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Turnaround time, 16.1.4, 16.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tween hydrolysis, 16.2.17</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tween 80 hydrolysis, 9.5.1.29.5.1.4, 9.5.1.10, 10.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tympanocentesis, 3.10.5.13.10.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Typhoidal tularemia, 18.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Typhoid fever vaccine, laboratory personnel, 15.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Typhus, 2.1.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Tyrosine agar, 16.2.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>U</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ulcer(s), 3.12.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>closed, 2.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>corneal, 3.9.33.9.4, 3.9.6, 3.9.93.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cutaneous, 2.1.36</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decubitus, 2.1.24</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastric/duodenal, 2.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>genital, 3.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>genital with lymphadenopathy, 2.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold identification, 10.10.4310.10.44</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>perineal, 3.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vulvovaginal, 3.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>Ulceroglandular tularemia, 18.6.2, 18.14.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ultracef (cefadroxil), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ultrafiltrate, 7.18.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ultrafiltration, laboratory water, 16.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Unasyn. See Ampicillin-sulbactam</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Unbundling, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Uncinocarpus reesei, 10.10.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Undulant fever, 18.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>UNG (uracil DNA glycosylase), 14.2.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Uni-Gold Recombigen HIV-1/2, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Unipen (nafcillin), 7.6.1.6, 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Uniseriate, 10.10.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>United States Pharmacopeia (USP), 15.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>United States Preventive Services Task Force (USPSTF), 1.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>UN numbers, 17.6.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Unvented bottle, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Unweighted pair group method with arithmetic mean (UPGMA), 15.6.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Upcoding, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Upper respiratory tract infections (URTI), 14.4.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Uracil DNA glycosylase (UNG), 14.2.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Urea broth or agar, 16.2.15, 18.4.7, 18.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Urea dextrose agar, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Urea disk, Brucella, 18.4.718.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ureaplasma</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acridine orange stain, 3.2.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 3.14.2.13.14.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture, 3.14.1.13.14.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of culture media, 3.14.1.73.14.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital, 3.8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation, 3.14.1.63.14.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation, 3.14.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 3.14.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.14.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.14.1.4, 3.14.1.113.14.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.14.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.14.1.63.14.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.14.1.53.14.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.14.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.14.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.14.1.23.14.1.4, 3.14.1.113.14.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fastidious, 5.11.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>by nucleic acid amplification tests, 3.14.4.13.14.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection and transport, 2.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stone cultures, 3.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>Ureaplasma parvum, 3.14.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ureaplasma urealyticum</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing, 3.14.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical syndromes, 3.8.1.2, 3.8.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture, 3.14.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.8.1.2, 3.8.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Urease</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth, 16.2.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mycobacteria, 9.5.1.29.5.1.4, 9.5.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>Urease test, 3.17.46.13.17.46.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 3.17.46.13.17.46.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobes, 4.9.12.14.9.12.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic Gram-negative bacilli, 4.13.154.13.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bioterrorism, 18.15.6.118.15.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>dermatophytes, 10.10.2210.10.28, 10.10.3310.10.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identification of yeasts, 10.7.110.7.3, 10.7.610.7.7, 10.7.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>yeast, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>Urea test, aerobic actinomycetes, 8.3.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ureidopenicillin, 7.23.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Urethra, 3.8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>N. gonorrhoeae and C. trachomatis culture, 3.8.1.8, 3.8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>females, 2.1.21</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>males, 2.1.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>Urethral swab, NAAT testing, 14.3.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Urethral syndrome, 3.8.1.3, 3.11.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Urethritis, 2.1.11, 3.8.1.3, 3.8.1.5, 3.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Uricult system, 3.11.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Urinary leukocytes, wet mount, 3.2.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Urinary tract infections (UTI), 3.11.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes (See Urine cultures, aerobes)</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anaerobic specimen selection, 4.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catheter-associated, 15.5.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>complicated, 3.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.14, 15.7.7.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>uncomplicated, 3.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Urine collection</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>catheter, 3.11.1.2, 3.11.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>clean-voided midstream, 3.11.1.23.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cystoscopy, 3.11.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>with expressed prostatic secretions, 3.11.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>ileal conduit, 3.11.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>suprapubic needle aspiration, 3.11.1.5, 3.11.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>timing, 3.11.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>Urine concentration, parasites</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>centrifugation, 11.6.7.111.6.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>membrane filter (Nucleopore), 11.6.8.111.6.8.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>Urine concentration, parasitology, 11.6.8.111.6.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Urine cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 3.11.1.13.11.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony count, 3.11.1.1, 3.11.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>common microbiota, 3.11.1.1, 3.11.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.11.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 3.11.1.113.11.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.11.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.11.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>N. gonorrhoeae, 3.8.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.11.1.13.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.11.1.83.11.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>protocol for workup, 3.11.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.11.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.11.1.63.11.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.11.1.103.11.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.11.1.23.11.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>terminology, 3.11.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>order of inoculation media, 2.1.39</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>viral, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>Urine dipstick, 3.11.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Urine specimen</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal, 10.3.6, 10.4.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>NAAT testing, 14.3.9.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality assurance, 16.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quality indicators, 16.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wet mount, 3.2.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>Urine specimens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>modified trichrome-Ryan blue stain for microsporidia, 11.4.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>processing, 2.1.42.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>Urogenital specimens</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, permanent stained smear (Giemsa), 11.6.6.111.6.6.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>parasitology, direct saline mount, 11.6.5.111.6.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>Urogenital system</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>common parasites recovered, 11.11.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 11.11.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimens and recommended stains, 11.11.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, parasites, 2.1.37, 11.11.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>Uropathogens, 3.11.1.3, 3.11.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Urosepsis, 3.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Urostomy, 3.11.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>U. S. Committee on Antimicrobial Susceptibility Testing (USCAST), 7.1.2.17.1.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>U. S. Department of Transportation (DOT), 17.6.30, 17.6.34, 17.8.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>User-prepared media, requiring quality control testing, 16.2.5, 16.2.2716.2.28</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>U. S. Postal Service (USPS), 17.6.25</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ustilago, 10.6.4, 10.6.7, 10.6.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>UTIs. See Urinary tract infections</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>UV oxidation, laboratory water, 16.3.316.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>V</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vaccines and vaccination</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>health care workers, 15.5.3.515.5.3.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>microbiology laboratory personnel, 15.8.1.115.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recommended, 15.8.1.1, 15.8.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>required, 15.8.1.1, 15.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vaccinia (cowpox) virus, 12.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vaccinia virus (VACV), 18.8.1, 18.8.3, 18.8.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vagina, 3.8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>N. gonorrhoeae cultures, 3.8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.21, 3.8.1.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vaginal cuff, 2.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vaginal fluid, wet mount, 3.2.3.13.2.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vaginalis agar, 16.2.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vaginal smears, Gram stain, 3.2.1.193.2.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vaginal specimens, fungal, 10.4.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vaginal swab culture, viral, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vaginal swabs</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>NAAT testing, 14.3.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.8.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vaginimicrobium propionicum, 4.14.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vaginitis, 2.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vaginitis, Gram stain, 3.2.1.193.2.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vaginosis, 2.1.12, 2.1.21, 3.8.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bacterial, 3.8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vagococcus, 3.17.29.3, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vagococcus fluvialis, 3.18.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Validation of molecular tests, 14.2.4.114.2.4.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Value-based payments, 1.1.6, 1.2.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vancomycin (Vancocin)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>evaluation and verification of systems, 7.22.6, 7.22.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.20.10, 7.20.14, 7.20.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>selecting agents for testing and reporting, 7.23.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.11, 7.4.1.13, 7.4.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>high-level resistance in Enterococcus, 7.12.17.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation of dilutions, 7.9.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special-potency disks, 4.9.5.14.9.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vancomycin disk, 3.17.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>special-potency, 16.2.22</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vancomycin-heteroresistant Staphylococcus aureus (hVISA), 7.9.17.9.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PAP-AUC worksheet, 7.9.107.9.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 7.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.9.47.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 7.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>summary of test methods, 7.9.27.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vancomycin-intermediate Staphylococcus aureus (VISA), 7.9.17.9.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar screen test, 7.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PAP-AUC worksheet, 7.9.107.9.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 7.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.9.47.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quality control of antimicrobial susceptibility tests, 7.9.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 7.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>summary of test methods, 7.9.27.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vancomycin-resistant enterococci (VRE)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar screen test, 7.13.17.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.23.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>chromogenic media, 5.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>collection and storage of outbreak isolates, 15.5.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>immunocompromised hosts, 15.7.6.115.7.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control of antimicrobial susceptibility tests, 7.20.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recipient screening, 15.7.7.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>screening, 15.7.3.115.7.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vancomycin-resistant Enterococcus faecium (VREF), 3.17.29.13.17.29.3, 7.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vancomycin-resistant,-intermediate, and-heteroresistant antimicrobial disk tests, 3.17.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vancomycin-resistant staphylococci, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vancomycin-resistant Staphylococcus aureus (VRSA), 7.9.17.9.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar screen test for vancomycin-resistant enterococci, 7.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial disk tests, 3.17.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 7.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 7.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PAP-AUC worksheet, 7.9.107.9.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 7.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 7.9.47.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 7.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 7.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 7.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>summary of test methods, 7.9.27.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vantin (cefpodoxime), 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Variant form Creutzfeldt-Jakob disease (vCJD), 17.5.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Variation, 16.1.1.2, 16.1.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Varibaculum, 4.14.4, 4.14.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Varicella-zoster virus (VZV), 12.9.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>molecular detection, 14.3.4.114.3.4.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.33</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Variola major (smallpox), 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Variola virus (VARV), 12.1.8, 18.8.218.8.3. See also Smallpox</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vascular cannulae, 2.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vascular graft infection, 2.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vaspar, 11.9.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>vCJD (variant form Creutzfeldt-Jakob disease), 17.5.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>V codes, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>V disks or strips, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VDRL. See Venereal Disease Research Laboratory (VDRL) tests</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vectrin (minocycline), 7.23.13, 9.9.1.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Veillonella, 4.15.2, 4.15.3, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology, 4.15.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluorescence, 4.13.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain morphology, 4.15.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 4.12.24.12.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate and urease tests, 4.13.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nitrate/nitrite reduction test, 3.17.34.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid nitrate and urease tests, 4.15.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 4.9.12.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Veillonella montpellierensis, 4.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Veillonella parvula, 4.9.3.2, 4.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Veillonella spp., 4.9.8.14.9.8.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Velosef (cephradine), 7.23.6, 7.23.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Venereal Disease Research Laboratory (VDRL) tests, 13.5.2.113.5.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biologic false-positives (BFPs), 13.5.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CSF-overview, 13.5.1.2, 13.5.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specificity and sensitivity, 13.5.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.5.2.513.5.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.5.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.5.2.113.5.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.5.2.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.5.2.213.5.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test procedure for CSF (VDRL-CSF), 13.5.2.413.5.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>test procedure for serum, 13.5.2.213.5.2.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.5.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 13.5.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Venezuelan encephalomyelitis virus, 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Venezuelan equine encephalitis virus, 17.1.1.2, 17.5.3.2, 17.6.10, 18.14.28</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Venous access devices, 2.1.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vented bottle, 16.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ventilator associated pneumonia (VAP), 3.10.1.3, 3.10.2.13.10.2.2, 3.10.2.7, 3.10.2.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ventricular shunt, 3.5.23.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Verification of molecular tests, 14.2.4.114.2.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>data analysis, 14.2.4.614.2.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory-developed tests (LDTs), 14.2.4.114.3.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>method verification, 14.2.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>multiplex molecular tests, 14.2.4.3, 14.2.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nucleic acid sequencing systems, 14.2.4.514.2.4.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>performance specifications, establishment of, 14.2.4.3, 14.2.4.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 14.2.4.114.2.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Verona integron-encoded metallo--lactamase (VIM), 7.16.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Veronal Buffer diluent, 13.14.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Verruconis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation temperature, 10.8.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>normally sterile sites, 10.10.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Verruconis gallopava, 10.8.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Verruconis (Ochroconis) gallopava, 10.12.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Verruga peruana, 3.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Versant HIV-1 RNA 3.0 (bDNA) test, 14.3.1.2, 14.3.1.3, 14.3.1.5, 14.3.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VersaTREK bottles, continuous-monitoring blood culture systems, 5.3.4, 5.3.6, 5.3.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VersaTREK-indirect susceptibility test, 9.7.3.19.7.3.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VersaTREK Myco, 5.5.15.5.6, 5.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 5.8.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VersaTREK Myco Culture system, 9.4.2.19.4.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Versene (trypsin-EDTA), 12.7.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vesicle, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vesicle aspirate culture, 12.2.3, 12.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vesicular stomatitis virus, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VHF (viral hemorrhagic fever), 18.14.14, 18.14.27, 18.14.30, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vibativ (telavancin), 7.23.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vibramycin (doxycycline), 7.23.13, 9.9.1.2, 9.9.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vibrio</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>vs. B. pseudomallei and B. mallei, 18.7.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.23.17.15.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.8, 7.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.3, 3.7.1.6, 3.7.1.7, 3.7.1.12, 3.7.1.13, 3.7.1.143.7.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Gram stain, 3.2.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>indole test, 3.17.22.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.2, 3.17.32.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>O129 disk susceptibility testing, 3.17.35.13.17.35.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic tests, 18.15.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.1, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>spot indole test, 18.15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>surveillance, 15.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vibrio alginolyticus, 3.7.1.8, 3.17.35.3, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>otitis externa, 3.10.5.13.10.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vibrio cholerae, 3.7.1.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.3, 3.7.1.6, 3.7.1.13, 3.7.1.15, 3.7.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.314.4.1.5, 14.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>ingestion, 17.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>O129 disk susceptibility testing, 3.17.35.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vibrio damsela, 3.7.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vibrio fluvialis, 3.7.1.13, 3.7.1.14, 3.17.35.2, 3.17.35.3, 3.19.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vibrio furnissii, 3.7.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vibrio hollisae, 3.7.1.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vibrio mimicus, 3.7.1.14, 3.19.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vibrionaceae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DNase test/rapid thermonuclease test, 3.17.16.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vibrio parahaemolyticus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.3, 3.7.1.6, 3.7.1.8, 3.7.1.13, 3.7.1.143.7.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.314.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>O129 disk susceptibility testing, 3.17.35.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>TCBS medium, 16.2.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vibrio vulnificus, 3.7.1.13, 3.17.35.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.314.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vidas Toxo IgG avidity assay</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 13.16.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 13.16.6.213.16.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 13.16.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 13.16.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 13.16.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 13.16.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 13.16.6.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vincents angina, 3.10.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Viral contamination, viral monolayer cell cultures, 12.7.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Viral culture</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal, 3.7.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection and processing, 12.2.112.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>accessioning and evaluation, 12.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ammonium chloride lysis method, 12.2.912.2.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>amniotic fluid, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>anticoagulated blood, 12.2.812.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bone marrow, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bronchoalveolar lavage/bronchial wash, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>buccal swab, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cervical swab, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>conjunctival swab, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>corneal/conjunctival scraping, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CSF, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decontamination, 12.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fluids and aspirates, 12.2.512.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lesion swab, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mucosal swab, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal swab, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nasopharyngeal aspirate, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>nasopharyngeal swab, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>neonatal surface swabs, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>pericardial fluid, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pharyngeal (throat) swab, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pleural fluid, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rectal swab, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>solid specimens, 12.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>stool, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>test ordering and patient information, 12.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>timing of collection, 12.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>tissues, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>transport and storage, 12.2.412.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine, 12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>vaginal swab, 12.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>vesicle aspirate, 12.2.3, 12.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Viral gastroenteritis, potential etiological agents, 2.1.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Viral hemorrhagic fever (VHF), 18.14.14, 18.14.27, 18.14.30, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Viral infections</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical manifestations, 12.1.312.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor-derived, 15.7.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>donor screening, 15.7.7.1015.7.7.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory diagnosis, 12.1.112.1.2, 12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Viral load testing, 14.2.5.414.2.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Viral monolayer cell cultures</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>continuous or heteroploid, 12.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>diploid, 12.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>primary, 12.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>serial propagation and maintenance, 12.7.112.7.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cell types, 12.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>contaminants, 12.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cryopreservation of cell lines, 12.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 12.7.312.7.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>obtaining cells, 12.7.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>preparation, 12.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 12.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 12.7.812.7.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 12.7.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 12.7.512.7.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>recovery of cryopreserved cells, 12.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>subpassage of stock cell cultures, 12.7.912.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Viral serology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cytomegalovirus (CMV), 13.9.1.113.9.1.2, 13.9.2.113.9.2.4, 13.9.3.113.9.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>Epstein-Barr virus (EBV), 13.8.1.113.8.1.3, 13.8.2.113.8.2.2, 13.8.3.113.8.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>human immunodeficiency virus (HIV), 13.10.1.113.10.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>SARS-CoV-2 serologic testing, 13.7.113.7.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Viral transport medium (VTM), 12.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Viridans group streptococci</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>agar dilution MIC test, 7.6.1.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility testing (AST), 7.1.1.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>testing and reporting considerations, 7.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antimicrobial susceptibility tests, 7.22.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>bile-esculin and esculin tests, 3.17.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>broth microdilution MIC test, 7.4.1.167.4.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony morphology on primary media, 3.3.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disk diffusion testing, 7.2.2, 7.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>endophthalmitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.7, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid, 3.3.2.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>keratitis, 3.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.2, 3.17.32.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.1, 3.10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.6, 3.10.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>starch hydrolysis test, 3.17.45.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>synergism testing, 7.19.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.3, 3.11.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.7, 3.12.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Viridans group Streptococcus, 3.10.9.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Viridans, wound, abscess, and soft tissue cultures, 3.12.1.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Virology</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reflex and composite testing scenarios, 1.2.4.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>rejection of specimens, 2.1.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Virus capsid antigens (VCAs), Epstein-Barr virus, 13.8.1.2, 13.8.3.1, 13.8.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Viruses</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>cell cultures, 12.4.612.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>direct detection, 12.9.1.112.9.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 12.9.1.912.9.1.10, 12.9.2.1012.9.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 12.9.1.1012.9.1.11, 12.9.2.1112.9.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 12.9.1.412.9.1.5, 12.9.2.712.9.2.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 12.9.1.2, 12.9.2.112.9.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedural notes, 12.9.1.1112.9.1.12, 12.9.2.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 12.9.1.712.9.1.9, 12.9.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 12.9.1.512.9.1.7, 12.9.2.812.9.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 12.9.1.10, 12.9.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 12.9.1.212.9.1.3, 12.9.2.612.9.2.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.114.4.1.7, 14.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>histologic and cytologic procedures, 12.9.3.112.9.3.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification laboratory methods, 12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory containment, 15.8.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.3, 2.1.312.1.34</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>zoonotic clinical manifestations, 12.1.1012.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VISA. See Vancomycin-intermediate Staphylococcus aureus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Visceral leishmaniasis, 11.11.2.9, 11.11.2.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vitamin K1 solution, 7.4.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vitamin K1 stock solution, 7.6.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vitamin K1 working solution, 7.6.2.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VITEK 2 ANC, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VITEK 2 BCL, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VITEK 2 CBC, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VITEK 2 GN, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VITEK 2 GP, 3.16.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VITEK MS, 6.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acid-fast bacilli, 6.4.16.4.2, 6.4.46.4.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood culture broth, 6.6.26.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>filamentous fungi, 6.5.2, 6.5.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>highly pathogenic bacteria, 6.3.36.3.4, 6.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VITEK MS, 10.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VITEK 2 NH, 3.16.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VITEK yeast biochemical card, 10.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vitreous fluid, 10.4.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vitros Anti-HAV IgM test, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vitros Anti-HAV Total test, 13.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vitros Anti-HBc Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vitros Anti-HBc IgM Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vitros Anti-HBe Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vitros Anti-HCV, 13.11.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vitros ECi/ECiQ anti-HIV 1+2 reagent pack, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vitros HBeAg Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vitros HBs Assay, 13.11.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vitros HIV Combo test, 13.10.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vittaforma, 11.11.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vittaforma corneae</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination of tissue and body fluids, 11.11.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>intestinal tract, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>key characteristics, 11.11.2.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tissue, 11.11.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>V-8 juice agar deeps, 10.9.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Voges-Proskauer (VP) reagent, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Voges Proskauer (VP) test, 3.17.32.13.17.32.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Voided midstream urine collection, 3.11.1.23.11.1.3, 3.11.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Voriconazole</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing, 10.13.2, 10.13.3, 10.13.9, 10.13.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>broth dilution, 10.12.1.2, 10.12.1.4, 10.12.1.610.12.1.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.2, 10.12.2.3, 10.12.2.5, 10.12.2.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>Vortex, decontamination, 17.1.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VP (Voges-Proskauer) reagent, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VP (Voges Proskauer) test, 3.17.32.13.17.32.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VRE. See Vancomycin-resistant enterococci</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VREF (vancomycin-resistant Enterococcus faecium), 3.17.29.13.17.29.3, 7.13.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VRSA. See Vancomycin-resistant Staphylococcus aureus</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VTM (Viral transport medium), 12.2.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vulva, specimen collection, 2.1.21, 3.8.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vulvovaginal ulcers, 3.8.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Vulvovaginitis, 2.1.11, 3.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>VZV. See Varicella-zoster virus</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>W</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Wampole Isostat system, 5.4.25.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Wampole pediatric isolator tubes, 5.4.15.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Wangiella dermatitidis, 10.10.43</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Waste, infectious. See Infectious waste</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Water. See Laboratory water</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>WBCs (white blood cells), wet mount, 3.2.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Weeksella virosa, 3.19.11, 3.19.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Weissella confusa, 3.17.9.2, 3.17.31.1, 3.17.31.2, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decarboxylase-dihydrolase tests, 3.17.15.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>6</title>
            <indexentry>
               <primaryie>6.5% salt and temperature tolerance test, 3.17.42.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Western blot. See also Immunoblot</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>detection of Borrelia burgdorferi antibodies, 13.6.213.6.5, 13.6.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>human immunodeficiency virus (HIV), 13.10.1.3, 13.10.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Western equine encephalitis virus, 15.8.4.2, 17.5.3.2, 18.14.28</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>West Nile virus (WNV), 15.7.7.315.7.7.5, 15.7.7.1315.7.7.14, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Wet mount</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>aerobes, 3.2.3.13.2.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, sigmoidoscopy specimen, 11.6.2.111.6.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Whipworm, 11.11.2.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>White blood cells (WBCs)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>parasites, 11.11.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wet mount, 3.2.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>White piedra, 2.1.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Whole blood, direct detection, 12.9.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Whole genome/core genome MLST strain typing methods, 14.5.3.34, 14.5.3.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Whole-genome sequencing (WGS), 14.5.3.114.5.3.48, 15.6.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antibiotic resistance determinant detection, 14.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>Candida auris, 15.7.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>general aspects of, 14.5.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>inference of subtypes for legacy typing schemes, 14.5.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 14.5.3.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 14.5.3.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 14.5.3.614.5.3.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 14.5.3.214.5.3.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 14.5.3.2714.5.3.35</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>DNA, 14.5.3.11, 14.5.3.12, 14.5.3.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>library preparation, 14.5.3.12, 14.5.3.14, 14.5.3.17, 14.5.3.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>secondary data analysis, 14.5.3.2114.5.3.23, 14.5.3.25</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>tertiary data analysis, 14.5.3.2414.5.3.27</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting results, 14.5.3.37</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>species identification, 14.5.3.114.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 14.5.3.514.5.3.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>strain typing, 14.5.3.214.5.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>technologies and platforms, 14.5.3.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>troubleshooting WGS procedures, 14.5.3.38</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>virulence gene detection, 14.5.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Whooping cough, 3.10.6.13.10.6.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Wickerham card, 7.24.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Wickerhamomyces anomalus, 10.2.2, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Wiener Chagatest v.3 (ELISA), 13.15.213.15.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Wilkins-Chalgren anaerobe agar, 16.2.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Wilkins-Chalgren anaerobe broth, 4.4.2.2, 16.2.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Williamsia, 8.1.1, 8.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic characteristics, 8.3.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen examination and primary isolation, 8.2.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Winkia, 4.14.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 4.14.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Winkia neuii, 4.14.8, 4.14.13, 4.2.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>clinical significance and biochemical characteristics of, 4.14.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.18.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wipe-rinse sampling method, 15.4.4.6, 15.4.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>WNV (West Nile virus), 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Work areas</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>decontamination, 17.1.3.117.1.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety, 17.1.2.217.1.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Work card, 16.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Workflow, molecular diagnostics, 14.2.2.114.2.2.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Working control strains, 16.2.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Work practices, safe, 17.1.2.117.1.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Wound(s)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>acute vs. chronic infections, 3.12.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>aerobic and anaerobic isolates, 3.12.1.1, 3.12.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>deep, 3.12.1.1, 3.12.1.2, 3.12.1.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fungal specimen collection, 10.3.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>mold identification, 10.10.4310.10.44</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>potential etiological agents, 2.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.24</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>superficial, 3.12.1.1, 3.12.1.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>trauma-associated, 2.1.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wound tissue cultures, 3.12.1.13.12.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>culture workup, 3.12.1.143.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Gram stain, 3.12.1.13, 3.12.1.14, 3.12.1.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>incubation conditions, 3.12.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>initial evaluation, 3.12.1.15</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>inoculation, 3.12.1.133.12.1.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>interpretation, 3.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 3.12.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 3.12.1.113.12.1.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 3.12.1.13.12.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 3.12.1.133.12.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 3.12.1.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>quantitative, 3.12.2.13.12.2.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rejection criteria, 3.12.1.103.12.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 3.12.1.163.12.1.17</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, transport, and handling, 3.12.1.93.12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.111.8.6.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Wuchereria bancrofti</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>characteristics, 11.11.2.20</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>Delafields hematoxylin stain, 11.8.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>Giemsa stain, 11.8.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Knott concentration, 11.8.11.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>membrane filtration concentration, 11.8.10.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine concentration</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>centrifugation, 11.6.7.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>membrane filter (Nuclepore), 11.6.8.211.6.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>Wrights stain, 11.8.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>X</title>
            <indexentry>
               <primaryie>X</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Xanthine agar, 16.2.18</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>X disks or strips, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>XLD (xylose, lysine, deoxycholate agar), 3.7.1.2, 3.7.1.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>X-linked lymphoproliferative syndrome, 13.8.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Xpert MTB/RIF assay, 9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Xpert MTB/RIF test, 9.6.2.19.6.2.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Xpert MTB/RIF Ultra assay, 9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Xpert MTB/XDR assay, 9.1.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>XV disks or strips, 16.2.22</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Xylene, 11.1.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Xylose, 3.7.1.2, 3.7.1.9, 16.2.7, 16.2.12, 16.2.15, 16.2.19</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>Y</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yaba-like disease virus (YLDV), 18.8.1, 18.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yaba monkey tumor virus (YYMTV), 18.8.1, 18.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yaegers LIT medium, 11.9.3.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yamadazyma guilliermondii, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yarrowia lipolytica, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yatapoxvirus, 18.8.1, 18.8.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yaws, 3.2.5.1, 3.2.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yeast(s)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>antifungal susceptibility testing (AFST), 10.12.2.310.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>by broth dilution, 10.12.1.1, 10.12.1.610.12.1.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>disk diffusion, 10.12.2.410.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gradient diffusion, 10.12.2.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>colony color, 10.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>examination and evaluation of primary cultures, 10.6.110.6.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>full identification, 10.9.110.9.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>anamorph-teleomorph bionomials, 10.9.1, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ascospore production, 10.9.6, 10.9.7, 10.9.8, 10.9.1110.9.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>carbohydrate fermentation test, 10.9.6, 10.9.710.9.8, 10.9.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>carbon assimilation test, 10.9.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>CGB agar, 10.9.6, 10.9.8, 10.9.1210.9.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>characteristics of Malassezia spp., 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>characteristics of selected Trichosporon spp., 10.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>commercial systems, 10.9.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>cornmeal agar with polysorbate 80, 10.9.6, 10.9.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture and biochemical characteristics, 10.9.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>interpretation, 10.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 10.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 10.9.1, 10.9.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>materials, 10.9.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>medium preparation and sources, 10.9.1110.9.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>molecular methods, 10.9.1, 10.9.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate assimilation test, 10.9.3, 10.9.610.9.7, 10.9.8, 10.9.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 10.9.110.9.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedures, 10.9.610.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.9.510.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reporting, 10.9.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sexual reproductive structures, 10.9.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>supplemental tests, 10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>genital tract, 3.8.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI-TOF MS, 6.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MALDI-TOF MS, 6.6.16.6.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>calibration, 6.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 6.6.66.6.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>MALDI Biotyper CA system, 6.6.26.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>phenotypic correlation, 6.6.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 6.6.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 6.6.46.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 6.6.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents and equipment, 6.6.16.6.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 6.6.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sensitivity, 6.6.66.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specificity, 6.6.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, 6.6.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>V</title>
            <indexentry>
               <primaryie>VITEK MS, 6.6.26.6.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nasal sinus cultures, 3.10.9.1, 3.10.9.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>O</title>
            <indexentry>
               <primaryie>otitis externa, 3.10.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>presumptive identification tests, 10.7.110.7.13</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>caffeic acid disk for C. neoformans screen, 10.7.110.7.3, 10.7.810.7.11, 10.7.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>C. albicans enzyme screen, 10.7.210.7.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture/differential media, 10.7.210.7.3, 10.7.910.7.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>germ tube test, 10.7.110.7.2, 10.7.410.7.6, 10.7.8, 10.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 10.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 10.7.110.7.2, 10.7.1210.7.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>molecular diagnostics, 10.7.210.7.4, 10.7.1010.7.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>N</title>
            <indexentry>
               <primaryie>nitrate reduction, 10.7.110.7.3, 10.7.710.7.8, 10.7.1110.7.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>PNA-FISH, 10.7.210.7.4, 10.7.1010.7.11, 10.7.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 10.7.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedures, 10.7.410.7.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 10.7.210.7.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>rapid trehalose assimilation test, 10.7.210.7.4, 10.7.810.7.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting, 10.7.1110.7.12</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 10.7.110.7.3, 10.7.610.7.7, 10.7.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>report comments, 11.11.7.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, lower, 3.10.2.6, 3.10.2.11</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>sigmoidoscopy specimen (permanent stained smear), 11.6.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection and culture medium, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection, vagina, 2.1.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen selection, collection, and transport, 10.3.4, 10.3.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urine culture, 3.11.1.3, 3.11.1.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wet mount, 3.2.3.23.2.3.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>Yeast budding, 10.10.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yeast carbohydrate assimilation medium, 16.2.1816.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yeast carbohydrate fermentation broth, 16.2.19</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yeast cells, identification versus RBCs, 11.11.3.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yeast identification, molecular, 10.11.110.11.12</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yeast-inhibiting blood agar, 10.10.55</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yellow fever virus, 17.6.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yersinia</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.6, 3.7.1.143.7.1.16, 3.7.1.18</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.314.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.7</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>methyl red-Voges Proskauer (MR-VP) tests, 3.17.32.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>motility tests, 3.17.30.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>MUG (4-methylumbelliferyl--D-glucuronide) test, 3.17.33.1, 3.17.33.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>surveillance, 15.5.4.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1, 18.15.6.1, 18.15.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>Yersinia enterocolitica, 5.11.1.1, 7.1.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>blood products, 15.4.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>citrate utilization test (Simmons), 3.17.12.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>differential diagnosis, 18.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>F</title>
            <indexentry>
               <primaryie>fecal culture, 3.7.1.3, 3.7.1.8, 3.7.1.9, 3.7.1.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.214.4.1.4, 14.4.1.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>K</title>
            <indexentry>
               <primaryie>Kliglers iron agar (KIA), 3.17.24.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>motility tests, 3.17.30.4, 18.15.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>T</title>
            <indexentry>
               <primaryie>transfusion reactions, 5.11.1.1, 5.11.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>transport media, 16.2.14</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>triple sugar iron agar (TSI), 3.17.24.1, 3.17.24.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 3.17.46.1, 18.15.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>X</title>
            <indexentry>
               <primaryie>xylose lysine deoxycholate agar, 16.2.15</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>Yersinia frederiksenii, 18.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yersinia kristensenii, 18.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yersinia pestis, 18.5.118.5.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>A</title>
            <indexentry>
               <primaryie>alternative names, 18.14.32</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>antimicrobial susceptibility, 18.5.8</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>biochemical reactions/tests, 18.5.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bioterrorism, 18.1.2, 18.5.118.5.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>body fluids, 3.4.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>bubonic, 18.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>C</title>
            <indexentry>
               <primaryie>CDC case classification, 18.5.118.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>characteristics, 18.14.29</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>culture identification, 18.5.418.5.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>destruction, 18.5.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>disease and clinical presentation, 18.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>E</title>
            <indexentry>
               <primaryie>early (bench level) recognition, 17.5.2.217.5.2.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>examination of cultures, 18.5.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>geographic distribution, 18.5.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>H</title>
            <indexentry>
               <primaryie>highly pathogenic bacteria, 6.3.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.7, 3.19.16</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>incubation period, 18.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>ingestion, 17.1.1.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>laboratory criteria, 18.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory exposure, 15.8.3.1, 15.8.3.10</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>laboratory safety, 18.2.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>limitations, 18.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 18.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>packing and shipping, 17.6.10, 17.6.35, 18.5.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>pneumonic, 18.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>presumptive identification, 18.5.5, 18.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>principle, 18.5.118.5.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 18.5.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>readiness checklist, 18.14.33</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>recommended BSL, 18.14.13</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting, notification, and transfer, 18.5.7</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>respiratory tract cultures, 3.10.1.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>lower, 3.10.2.6, 3.10.2.10</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>safety considerations, 18.5.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent, 17.5.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>select agent reporting and compliance in U. S., 18.5.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>sentinel level clinical laboratory, 18.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Sentinel Level Clinical Microbiology Laboratory Guidelines, 18.14.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>septicemic, 18.5.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>special considerations, 18.5.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen collection/handling, 18.5.3, 18.14.1818.14.20</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen processing, 18.5.4</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>specimen rejection, 18.5.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>spot indole test, 18.15.3.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>staining, 18.5.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 18.15.6.1, 18.15.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>W</title>
            <indexentry>
               <primaryie>wound, abscess, and soft tissue cultures, 3.12.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>Yersinia pestis (plague), 15.8.4.2</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Yersinia pseudotuberculosis, 3.7.1.14, 18.5.9</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>G</title>
            <indexentry>
               <primaryie>gastroenteritis panels, 14.4.1.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>I</title>
            <indexentry>
               <primaryie>identification, 3.19.16</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>U</title>
            <indexentry>
               <primaryie>urease test, 18.15.6.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Y</title>
            <indexentry>
               <primaryie>Yersinia ruckeri, 18.5.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>YT Micro Plate, 10.9.6</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>Z</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zaire Ebola virus, 18.12.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Z codes, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zefazone. See Cefoxitin</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zeptometrix, 14.4.2.8</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zerbaxa (ceftolozane-tazobactam), 7.23.3, 7.23.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zero-defect process, 16.1.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zero tolerance, 1.1.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ziehl-Neelsen, 9.2.3.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ziehl-Neelsen acid-fast stain (hot), modified, 11.4.2.111.4.2.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Ziehl-Neelsen stain, 16.2.21</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zika virus (ZIKV)</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>D</title>
            <indexentry>
               <primaryie>donor screening, 15.7.7.14</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen collection, 2.1.30</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>Zinacef. See Cefuroxime</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zinc sulfate (33% solution), 11.3.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zinc sulfate flotation, 11.3.4.111.3.4.5</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>limitations, 11.3.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>M</title>
            <indexentry>
               <primaryie>materials, 11.3.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>principle, 11.3.4.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure, 11.3.4.211.3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>procedure notes, 11.3.4.311.3.4.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Q</title>
            <indexentry>
               <primaryie>quality control, 11.3.4.2</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>R</title>
            <indexentry>
               <primaryie>reagents, 11.3.4.411.3.4.5</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>reporting results, 11.3.4.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>results, 11.3.4.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>S</title>
            <indexentry>
               <primaryie>specimen, 11.3.4.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>Zirconia/silica beads, 6.4.8, 6.4.9</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zithromax. See Azithromycin</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zolicef-Keflex (cephalexin), 7.23.6</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zoonosis</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>B</title>
            <indexentry>
               <primaryie>Brucella, 13.3.1</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>L</title>
            <indexentry>
               <primaryie>Leptospira, 3.13.1, 3.13.4</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>P</title>
            <indexentry>
               <primaryie>poxviruses, 18.8.1, 18.8.3</primaryie>
            </indexentry>
         </indexdiv>
         <indexdiv>
            <title>Z</title>
            <indexentry>
               <primaryie>Zoonotic viruses, 12.1.1012.1.11</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zoopagomyceta, 10.10.1</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zosyn. See Piperacillin-tazobactam</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zygomycosis, 2.1.35</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zygospores, 10.10.3</primaryie>
            </indexentry>
            <indexentry>
               <primaryie>Zyvox. See Linezolid</primaryie>
            </indexentry>
         </indexdiv>
      </index>
      <chapter id="ch0480" label="480" role="backmatter">
         <title>
            <emphasis role="strong">WILEY END USER LICENSE AGREEMENT</emphasis>
         </title> &sect1.9781683674832.ch0480s0001;
    </chapter>
   </part>
</book>